"id","prediction","choice","reasoning"
"U9PHZ83RKYV8","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich drug brand name is associated with the treatment of acne?\nA: Salicylic Acid\nB: Minoxidil\nC: Ketoconazole\nD: Fluocinonide\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich drug brand name is associated with the treatment of acne?\nA: Salicylic Acid\nB: Minoxidil\nC: Ketoconazole\nD: Fluocinonide\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich drug brand name is associated with the treatment of acne?\nA: Salicylic Acid\nB: Minoxidil\nC: Ketoconazole\nD: Fluocinonide\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"vIGwm8qguXYi","- Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling of the face or throat, or hives after receiving fosaprepitant for injection.
- It is important to inform healthcare providers about the allergic reaction to fosaprepitant, as they may need to administer emergency treatments such as epinephrine or antihistamines.
- Patients should avoid future doses of fosaprepitant and discuss alternative antiemetic options with their healthcare provider to prevent recurrence of allergic reactions.

MRRV(meta) winner=B; scores={'A': 0.27777777777777773, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should patients do if they experience severe allergic reactions during or after receiving fosaprepitant for injection?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling of the face or throat, or hives after receiving fosaprepitant for injection.\n- It is important to inform healthcare providers about the allergic reaction to fosaprepitant, as they may need to administer emergency treatments such as epinephrine or antihistamines.\n- Patients should avoid future doses of fosaprepitant and discuss alternative antiemetic options with their healthcare provider to prevent recurrence of allergic reactions.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients do if they experience severe allergic reactions during or after receiving fosaprepitant for injection?\nA: Wait for the symptoms to resolve on their own.\nB: Inform their healthcare provider immediately and seek emergency medical care.\nC: Stop chemotherapy treatment permanently.\nD: Take over-the-counter antihistamines.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling of the face or throat, or hives after receiving fosaprepitant for injection.\n- It is important to inform healthcare providers about the allergic reaction to fosaprepitant, as they may need to administer emergency treatments such as epinephrine or antihistamines.\n- Patients should avoid future doses of fosaprepitant and discuss alternative antiemetic options with their healthcare provider to prevent recurrence of allergic reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients do if they experience severe allergic reactions during or after receiving fosaprepitant for injection?\nA: Wait for the symptoms to resolve on their own.\nB: Inform their healthcare provider immediately and seek emergency medical care.\nC: Stop chemotherapy treatment permanently.\nD: Take over-the-counter antihistamines.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling of the face or throat, or hives after receiving fosaprepitant for injection.\n- It is important to inform healthcare providers about the allergic reaction to fosaprepitant, as they may need to administer emergency treatments such as epinephrine or antihistamines.\n- Patients should avoid future doses of fosaprepitant and discuss alternative antiemetic options with their healthcare provider to prevent recurrence of allergic reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients do if they experience severe allergic reactions during or after receiving fosaprepitant for injection?\nA: Wait for the symptoms to resolve on their own.\nB: Inform their healthcare provider immediately and seek emergency medical care.\nC: Stop chemotherapy treatment permanently.\nD: Take over-the-counter antihistamines.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling of the face or throat, or hives after receiving fosaprepitant for injection.\n- It is important to inform healthcare providers about the allergic reaction to fosaprepitant, as they may need to administer emergency treatments such as epinephrine or antihistamines.\n- Patients should avoid future doses of fosaprepitant and discuss alternative antiemetic options with their healthcare provider to prevent recurrence of allergic reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"GlpDnJvMaWbs","- Replace the Stiolto Respimat inhaler with a new one, as the dose indicator reaching 0 indicates that the medication is no longer available for use.
- Ensure to follow the prescribed regimen of Stiolto Respimat, which contains a combination of tiotropium and olodaterol, for the management of chronic obstructive pulmonary disease (COPD).
- Do not attempt to use the inhaler once the dose indicator shows 0, as it will not deliver any active medication.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.3055555555555555}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should you do if the dose indicator on Stiolto Respimat reaches 0?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Replace the Stiolto Respimat inhaler with a new one, as the dose indicator reaching 0 indicates that the medication is no longer available for use.\n- Ensure to follow the prescribed regimen of Stiolto Respimat, which contains a combination of tiotropium and olodaterol, for the management of chronic obstructive pulmonary disease (COPD).\n- Do not attempt to use the inhaler once the dose indicator shows 0, as it will not deliver any active medication.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should you do if the dose indicator on Stiolto Respimat reaches 0?\nA: Continue using the inhaler until the cartridge is empty.\nB: Prepare and use a new Stiolto Respimat inhaler.\nC: Turn the clear base to reset the dose indicator.\nD: Clean the mouthpiece and continue using the inhaler.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Replace the Stiolto Respimat inhaler with a new one, as the dose indicator reaching 0 indicates that the medication is no longer available for use.\n- Ensure to follow the prescribed regimen of Stiolto Respimat, which contains a combination of tiotropium and olodaterol, for the management of chronic obstructive pulmonary disease (COPD).\n- Do not attempt to use the inhaler once the dose indicator shows 0, as it will not deliver any active medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should you do if the dose indicator on Stiolto Respimat reaches 0?\nA: Continue using the inhaler until the cartridge is empty.\nB: Prepare and use a new Stiolto Respimat inhaler.\nC: Turn the clear base to reset the dose indicator.\nD: Clean the mouthpiece and continue using the inhaler.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Replace the Stiolto Respimat inhaler with a new one, as the dose indicator reaching 0 indicates that the medication is no longer available for use.\n- Ensure to follow the prescribed regimen of Stiolto Respimat, which contains a combination of tiotropium and olodaterol, for the management of chronic obstructive pulmonary disease (COPD).\n- Do not attempt to use the inhaler once the dose indicator shows 0, as it will not deliver any active medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should you do if the dose indicator on Stiolto Respimat reaches 0?\nA: Continue using the inhaler until the cartridge is empty.\nB: Prepare and use a new Stiolto Respimat inhaler.\nC: Turn the clear base to reset the dose indicator.\nD: Clean the mouthpiece and continue using the inhaler.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Replace the Stiolto Respimat inhaler with a new one, as the dose indicator reaching 0 indicates that the medication is no longer available for use.\n- Ensure to follow the prescribed regimen of Stiolto Respimat, which contains a combination of tiotropium and olodaterol, for the management of chronic obstructive pulmonary disease (COPD).\n- Do not attempt to use the inhaler once the dose indicator shows 0, as it will not deliver any active medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"WfWiWK0yULaX","- Gadavist is contraindicated in patients with a history of severe allergic reactions to gadolinium-based contrast agents.
- It should not be used in individuals with acute or chronic severe renal impairment, as this increases the risk of nephrogenic systemic fibrosis.
- Patients with known hypersensitivity to Gadavist or any of its components should avoid its use.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following conditions is a contraindication for the use of Gadavist?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Gadavist is contraindicated in patients with a history of severe allergic reactions to gadolinium-based contrast agents.\n- It should not be used in individuals with acute or chronic severe renal impairment, as this increases the risk of nephrogenic systemic fibrosis.\n- Patients with known hypersensitivity to Gadavist or any of its components should avoid its use.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following conditions is a contraindication for the use of Gadavist?\nA: Mild hypersensitivity reactions to Gadavist\nB: History of severe hypersensitivity reactions to Gadavist\nC: Renal impairment\nD: Liver dysfunction\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadavist is contraindicated in patients with a history of severe allergic reactions to gadolinium-based contrast agents.\n- It should not be used in individuals with acute or chronic severe renal impairment, as this increases the risk of nephrogenic systemic fibrosis.\n- Patients with known hypersensitivity to Gadavist or any of its components should avoid its use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following conditions is a contraindication for the use of Gadavist?\nA: Mild hypersensitivity reactions to Gadavist\nB: History of severe hypersensitivity reactions to Gadavist\nC: Renal impairment\nD: Liver dysfunction\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadavist is contraindicated in patients with a history of severe allergic reactions to gadolinium-based contrast agents.\n- It should not be used in individuals with acute or chronic severe renal impairment, as this increases the risk of nephrogenic systemic fibrosis.\n- Patients with known hypersensitivity to Gadavist or any of its components should avoid its use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following conditions is a contraindication for the use of Gadavist?\nA: Mild hypersensitivity reactions to Gadavist\nB: History of severe hypersensitivity reactions to Gadavist\nC: Renal impairment\nD: Liver dysfunction\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadavist is contraindicated in patients with a history of severe allergic reactions to gadolinium-based contrast agents.\n- It should not be used in individuals with acute or chronic severe renal impairment, as this increases the risk of nephrogenic systemic fibrosis.\n- Patients with known hypersensitivity to Gadavist or any of its components should avoid its use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"wzkMQ7uHtlLs","MRRV winner=B; scores={'A': 0.4166666666666667, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'C', 'D'], ['B', 'D', 'C', 'A'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary consideration for lactating mothers using Albuterol Sulfate HFA?\nA: It is contraindicated during lactation.\nB: Plasma levels of albuterol are low, and effects on breastfed children are likely minimal.\nC: It significantly reduces milk production.\nD: It should only be used in emergencies.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary consideration for lactating mothers using Albuterol Sulfate HFA?\nA: It is contraindicated during lactation.\nB: Plasma levels of albuterol are low, and effects on breastfed children are likely minimal.\nC: It significantly reduces milk production.\nD: It should only be used in emergencies.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary consideration for lactating mothers using Albuterol Sulfate HFA?\nA: It is contraindicated during lactation.\nB: Plasma levels of albuterol are low, and effects on breastfed children are likely minimal.\nC: It significantly reduces milk production.\nD: It should only be used in emergencies.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"hcZukKMtrRZ7","MRRV winner=C; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 0.8333333333333334, 'D': 0.6666666666666666}; rankings=[['D', 'C', 'B', 'A'], ['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the minimum SPF value recommended for sunscreens to reduce the risk of skin cancer and early aging, as per the guidelines for the sunscreen branded as '70%'?\nA: 5\nB: 10\nC: 15\nD: 30\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the minimum SPF value recommended for sunscreens to reduce the risk of skin cancer and early aging, as per the guidelines for the sunscreen branded as '70%'?\nA: 5\nB: 10\nC: 15\nD: 30\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the minimum SPF value recommended for sunscreens to reduce the risk of skin cancer and early aging, as per the guidelines for the sunscreen branded as '70%'?\nA: 5\nB: 10\nC: 15\nD: 30\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}]"
"cRbl2ruD1WMZ","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT an indicated use for 'up and up ibuprofen'?\nA: Relief of occasional sleeplessness\nB: Relief of minor aches and pains\nC: Treatment of chronic pain conditions\nD: Helping users stay asleep\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT an indicated use for 'up and up ibuprofen'?\nA: Relief of occasional sleeplessness\nB: Relief of minor aches and pains\nC: Treatment of chronic pain conditions\nD: Helping users stay asleep\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT an indicated use for 'up and up ibuprofen'?\nA: Relief of occasional sleeplessness\nB: Relief of minor aches and pains\nC: Treatment of chronic pain conditions\nD: Helping users stay asleep\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"dlKfnTKdPf9G","- Immediately discontinue the use of PERTZYE and seek emergency medical attention if experiencing symptoms such as difficulty breathing, swelling of the face or throat, or hives.
- Inform the healthcare provider about the allergic reaction to PERTZYE to discuss alternative treatments or medications.
- Consider carrying an epinephrine auto-injector if prescribed, for future severe allergic reactions.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should a patient do if they experience severe allergic reactions while taking PERTZYE?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Immediately discontinue the use of PERTZYE and seek emergency medical attention if experiencing symptoms such as difficulty breathing, swelling of the face or throat, or hives.\n- Inform the healthcare provider about the allergic reaction to PERTZYE to discuss alternative treatments or medications.\n- Consider carrying an epinephrine auto-injector if prescribed, for future severe allergic reactions.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a patient do if they experience severe allergic reactions while taking PERTZYE?\nA: Continue taking the medication and monitor symptoms\nB: Stop taking PERTZYE and seek emergency treatment immediately\nC: Reduce the dose and consult their doctor\nD: Take an over-the-counter antihistamine\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Immediately discontinue the use of PERTZYE and seek emergency medical attention if experiencing symptoms such as difficulty breathing, swelling of the face or throat, or hives.\n- Inform the healthcare provider about the allergic reaction to PERTZYE to discuss alternative treatments or medications.\n- Consider carrying an epinephrine auto-injector if prescribed, for future severe allergic reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a patient do if they experience severe allergic reactions while taking PERTZYE?\nA: Continue taking the medication and monitor symptoms\nB: Stop taking PERTZYE and seek emergency treatment immediately\nC: Reduce the dose and consult their doctor\nD: Take an over-the-counter antihistamine\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Immediately discontinue the use of PERTZYE and seek emergency medical attention if experiencing symptoms such as difficulty breathing, swelling of the face or throat, or hives.\n- Inform the healthcare provider about the allergic reaction to PERTZYE to discuss alternative treatments or medications.\n- Consider carrying an epinephrine auto-injector if prescribed, for future severe allergic reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a patient do if they experience severe allergic reactions while taking PERTZYE?\nA: Continue taking the medication and monitor symptoms\nB: Stop taking PERTZYE and seek emergency treatment immediately\nC: Reduce the dose and consult their doctor\nD: Take an over-the-counter antihistamine\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Immediately discontinue the use of PERTZYE and seek emergency medical attention if experiencing symptoms such as difficulty breathing, swelling of the face or throat, or hives.\n- Inform the healthcare provider about the allergic reaction to PERTZYE to discuss alternative treatments or medications.\n- Consider carrying an epinephrine auto-injector if prescribed, for future severe allergic reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"rYhpGH3kQW8P","- Discontinue Inspra (eplerenone) immediately to prevent further increases in serum potassium levels.
- Monitor the patient's serum potassium levels closely and consider initiating treatment with a potassium-lowering agent if necessary.
- Evaluate the patient's renal function and other medications that may contribute to hyperkalemia.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if a patient\u2019s serum potassium level reaches 6.0 mEq/L while on Inspra therapy?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Discontinue Inspra (eplerenone) immediately to prevent further increases in serum potassium levels.\n- Monitor the patient's serum potassium levels closely and consider initiating treatment with a potassium-lowering agent if necessary.\n- Evaluate the patient's renal function and other medications that may contribute to hyperkalemia.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient\u2019s serum potassium level reaches 6.0 mEq/L while on Inspra therapy?\nA: Reduce the dose to 25 mg every other day\nB: Withhold Inspra therapy\nC: Continue the current dose\nD: Increase the dose to 50 mg once daily\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue Inspra (eplerenone) immediately to prevent further increases in serum potassium levels.\n- Monitor the patient's serum potassium levels closely and consider initiating treatment with a potassium-lowering agent if necessary.\n- Evaluate the patient's renal function and other medications that may contribute to hyperkalemia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient\u2019s serum potassium level reaches 6.0 mEq/L while on Inspra therapy?\nA: Reduce the dose to 25 mg every other day\nB: Withhold Inspra therapy\nC: Continue the current dose\nD: Increase the dose to 50 mg once daily\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue Inspra (eplerenone) immediately to prevent further increases in serum potassium levels.\n- Monitor the patient's serum potassium levels closely and consider initiating treatment with a potassium-lowering agent if necessary.\n- Evaluate the patient's renal function and other medications that may contribute to hyperkalemia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient\u2019s serum potassium level reaches 6.0 mEq/L while on Inspra therapy?\nA: Reduce the dose to 25 mg every other day\nB: Withhold Inspra therapy\nC: Continue the current dose\nD: Increase the dose to 50 mg once daily\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue Inspra (eplerenone) immediately to prevent further increases in serum potassium levels.\n- Monitor the patient's serum potassium levels closely and consider initiating treatment with a potassium-lowering agent if necessary.\n- Evaluate the patient's renal function and other medications that may contribute to hyperkalemia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"ZFU0wbRPwuMG","- Patients with a history of allergic disorders should be closely monitored for hypersensitivity reactions when administering Gadavist, as they may be at increased risk for allergic reactions to gadolinium-based contrast agents.
- Pre-medication with antihistamines or corticosteroids may be considered for patients with a significant history of allergies to contrast agents before the administration of Gadavist.
- It is essential to ensure that emergency medical support is available during the administration of Gadavist for immediate management of any potential allergic reactions.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat precaution should be taken for patients with a history of allergic disorders before administering Gadavist?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients with a history of allergic disorders should be closely monitored for hypersensitivity reactions when administering Gadavist, as they may be at increased risk for allergic reactions to gadolinium-based contrast agents.\n- Pre-medication with antihistamines or corticosteroids may be considered for patients with a significant history of allergies to contrast agents before the administration of Gadavist.\n- It is essential to ensure that emergency medical support is available during the administration of Gadavist for immediate management of any potential allergic reactions.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken for patients with a history of allergic disorders before administering Gadavist?\nA: Administer Gadavist in a diluted form\nB: Avoid Gadavist administration entirely\nC: Assess the patient\u2019s history of reactions to contrast media and ensure trained personnel are available for resuscitation\nD: Perform hemodialysis immediately after administration\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of allergic disorders should be closely monitored for hypersensitivity reactions when administering Gadavist, as they may be at increased risk for allergic reactions to gadolinium-based contrast agents.\n- Pre-medication with antihistamines or corticosteroids may be considered for patients with a significant history of allergies to contrast agents before the administration of Gadavist.\n- It is essential to ensure that emergency medical support is available during the administration of Gadavist for immediate management of any potential allergic reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken for patients with a history of allergic disorders before administering Gadavist?\nA: Administer Gadavist in a diluted form\nB: Avoid Gadavist administration entirely\nC: Assess the patient\u2019s history of reactions to contrast media and ensure trained personnel are available for resuscitation\nD: Perform hemodialysis immediately after administration\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of allergic disorders should be closely monitored for hypersensitivity reactions when administering Gadavist, as they may be at increased risk for allergic reactions to gadolinium-based contrast agents.\n- Pre-medication with antihistamines or corticosteroids may be considered for patients with a significant history of allergies to contrast agents before the administration of Gadavist.\n- It is essential to ensure that emergency medical support is available during the administration of Gadavist for immediate management of any potential allergic reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken for patients with a history of allergic disorders before administering Gadavist?\nA: Administer Gadavist in a diluted form\nB: Avoid Gadavist administration entirely\nC: Assess the patient\u2019s history of reactions to contrast media and ensure trained personnel are available for resuscitation\nD: Perform hemodialysis immediately after administration\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of allergic disorders should be closely monitored for hypersensitivity reactions when administering Gadavist, as they may be at increased risk for allergic reactions to gadolinium-based contrast agents.\n- Pre-medication with antihistamines or corticosteroids may be considered for patients with a significant history of allergies to contrast agents before the administration of Gadavist.\n- It is essential to ensure that emergency medical support is available during the administration of Gadavist for immediate management of any potential allergic reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"1CW71PEfUO3w","- Abrupt discontinuation of fluoxetine can lead to withdrawal symptoms such as dizziness and nausea.
- Patients may experience mood disturbances, including increased anxiety or irritability, after stopping fluoxetine suddenly.
- Fluoxetine discontinuation syndrome may also present with flu-like symptoms, including fatigue and insomnia.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following is a potential adverse reaction upon abrupt discontinuation of fluoxetine?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Abrupt discontinuation of fluoxetine can lead to withdrawal symptoms such as dizziness and nausea.\n- Patients may experience mood disturbances, including increased anxiety or irritability, after stopping fluoxetine suddenly.\n- Fluoxetine discontinuation syndrome may also present with flu-like symptoms, including fatigue and insomnia.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is a potential adverse reaction upon abrupt discontinuation of fluoxetine?\nA: Dysphoric mood and sensory disturbances\nB: Weight gain\nC: Improved glycemic control\nD: Reduced risk of serotonin syndrome\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Abrupt discontinuation of fluoxetine can lead to withdrawal symptoms such as dizziness and nausea.\n- Patients may experience mood disturbances, including increased anxiety or irritability, after stopping fluoxetine suddenly.\n- Fluoxetine discontinuation syndrome may also present with flu-like symptoms, including fatigue and insomnia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is a potential adverse reaction upon abrupt discontinuation of fluoxetine?\nA: Dysphoric mood and sensory disturbances\nB: Weight gain\nC: Improved glycemic control\nD: Reduced risk of serotonin syndrome\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Abrupt discontinuation of fluoxetine can lead to withdrawal symptoms such as dizziness and nausea.\n- Patients may experience mood disturbances, including increased anxiety or irritability, after stopping fluoxetine suddenly.\n- Fluoxetine discontinuation syndrome may also present with flu-like symptoms, including fatigue and insomnia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is a potential adverse reaction upon abrupt discontinuation of fluoxetine?\nA: Dysphoric mood and sensory disturbances\nB: Weight gain\nC: Improved glycemic control\nD: Reduced risk of serotonin syndrome\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Abrupt discontinuation of fluoxetine can lead to withdrawal symptoms such as dizziness and nausea.\n- Patients may experience mood disturbances, including increased anxiety or irritability, after stopping fluoxetine suddenly.\n- Fluoxetine discontinuation syndrome may also present with flu-like symptoms, including fatigue and insomnia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"sMLyoU0d3Mrn","- Evaluate the patient's adherence to the NURTEC ODT regimen, ensuring they are taking the medication as prescribed for migraine management.
- Consider the addition of a blood pressure-lowering medication, such as a calcium channel blocker or ACE inhibitor, if the patient is experiencing persistent hypertension despite NURTEC ODT use.
- Assess for potential drug interactions or side effects from NURTEC ODT that may contribute to elevated blood pressure, and review the patient's overall medication profile.

MRRV(meta) winner=D; scores={'A': 0.25, 'B': 0.5, 'C': 0.3333333333333333, 'D': 1.0}; rankings=[['D', 'B', 'C', 'A'], ['D', 'B', 'C', 'A'], ['D', 'B', 'C', 'A']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should be considered if blood pressure remains inadequately controlled in a patient taking NURTEC ODT?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Evaluate the patient's adherence to the NURTEC ODT regimen, ensuring they are taking the medication as prescribed for migraine management.\n- Consider the addition of a blood pressure-lowering medication, such as a calcium channel blocker or ACE inhibitor, if the patient is experiencing persistent hypertension despite NURTEC ODT use.\n- Assess for potential drug interactions or side effects from NURTEC ODT that may contribute to elevated blood pressure, and review the patient's overall medication profile.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be considered if blood pressure remains inadequately controlled in a patient taking NURTEC ODT?\nA: Increasing the dosage of NURTEC ODT\nB: Discontinuing NURTEC ODT if no alternative etiology is found\nC: Switching to another CGRP antagonist\nD: Prescribing additional antihypertensive medications\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Evaluate the patient's adherence to the NURTEC ODT regimen, ensuring they are taking the medication as prescribed for migraine management.\n- Consider the addition of a blood pressure-lowering medication, such as a calcium channel blocker or ACE inhibitor, if the patient is experiencing persistent hypertension despite NURTEC ODT use.\n- Assess for potential drug interactions or side effects from NURTEC ODT that may contribute to elevated blood pressure, and review the patient's overall medication profile.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > C > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be considered if blood pressure remains inadequately controlled in a patient taking NURTEC ODT?\nA: Increasing the dosage of NURTEC ODT\nB: Discontinuing NURTEC ODT if no alternative etiology is found\nC: Switching to another CGRP antagonist\nD: Prescribing additional antihypertensive medications\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Evaluate the patient's adherence to the NURTEC ODT regimen, ensuring they are taking the medication as prescribed for migraine management.\n- Consider the addition of a blood pressure-lowering medication, such as a calcium channel blocker or ACE inhibitor, if the patient is experiencing persistent hypertension despite NURTEC ODT use.\n- Assess for potential drug interactions or side effects from NURTEC ODT that may contribute to elevated blood pressure, and review the patient's overall medication profile.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > C > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be considered if blood pressure remains inadequately controlled in a patient taking NURTEC ODT?\nA: Increasing the dosage of NURTEC ODT\nB: Discontinuing NURTEC ODT if no alternative etiology is found\nC: Switching to another CGRP antagonist\nD: Prescribing additional antihypertensive medications\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Evaluate the patient's adherence to the NURTEC ODT regimen, ensuring they are taking the medication as prescribed for migraine management.\n- Consider the addition of a blood pressure-lowering medication, such as a calcium channel blocker or ACE inhibitor, if the patient is experiencing persistent hypertension despite NURTEC ODT use.\n- Assess for potential drug interactions or side effects from NURTEC ODT that may contribute to elevated blood pressure, and review the patient's overall medication profile.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > C > A""}]"
"78rb8mSjrZSd","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the appropriate action if a patient experiences a severe infusion reaction during Ogivri administration?\nA: Decrease the rate of infusion\nB: Interrupt the infusion temporarily\nC: Discontinue Ogivri permanently\nD: Administer a higher dose to counteract the reaction\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the appropriate action if a patient experiences a severe infusion reaction during Ogivri administration?\nA: Decrease the rate of infusion\nB: Interrupt the infusion temporarily\nC: Discontinue Ogivri permanently\nD: Administer a higher dose to counteract the reaction\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the appropriate action if a patient experiences a severe infusion reaction during Ogivri administration?\nA: Decrease the rate of infusion\nB: Interrupt the infusion temporarily\nC: Discontinue Ogivri permanently\nD: Administer a higher dose to counteract the reaction\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"4T4a8JGxsPdN","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken when AIRSUPRA is administered within 2 weeks of discontinuing tricyclic antidepressants?\nA: Monitor potassium levels\nB: Use with extreme caution due to potentiation of cardiovascular effects\nC: Evaluate serum digoxin levels\nD: Discontinue AIRSUPRA\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken when AIRSUPRA is administered within 2 weeks of discontinuing tricyclic antidepressants?\nA: Monitor potassium levels\nB: Use with extreme caution due to potentiation of cardiovascular effects\nC: Evaluate serum digoxin levels\nD: Discontinue AIRSUPRA\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken when AIRSUPRA is administered within 2 weeks of discontinuing tricyclic antidepressants?\nA: Monitor potassium levels\nB: Use with extreme caution due to potentiation of cardiovascular effects\nC: Evaluate serum digoxin levels\nD: Discontinue AIRSUPRA\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"8v3EbcdMKqHU","- Monitor patients for potential side effects, particularly hypertension, as venlafaxine can increase blood pressure, especially at higher doses.
- Assess for signs of serotonin syndrome, particularly if venlafaxine is used in combination with other serotonergic medications.
- Evaluate the need for continued treatment and consider tapering the dosage if the patient has been stable on venlafaxine for an extended period to avoid withdrawal symptoms.

MRRV(meta) winner=C; scores={'A': 0.3333333333333333, 'B': 0.25, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should physicians periodically do when prescribing venlafaxine tablets for extended periods?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Monitor patients for potential side effects, particularly hypertension, as venlafaxine can increase blood pressure, especially at higher doses.\n- Assess for signs of serotonin syndrome, particularly if venlafaxine is used in combination with other serotonergic medications.\n- Evaluate the need for continued treatment and consider tapering the dosage if the patient has been stable on venlafaxine for an extended period to avoid withdrawal symptoms.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should physicians periodically do when prescribing venlafaxine tablets for extended periods?\nA: Increase the dosage\nB: Switch to another antidepressant\nC: Re-evaluate the long-term usefulness of the drug\nD: Monitor for psychomotor agitation\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor patients for potential side effects, particularly hypertension, as venlafaxine can increase blood pressure, especially at higher doses.\n- Assess for signs of serotonin syndrome, particularly if venlafaxine is used in combination with other serotonergic medications.\n- Evaluate the need for continued treatment and consider tapering the dosage if the patient has been stable on venlafaxine for an extended period to avoid withdrawal symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should physicians periodically do when prescribing venlafaxine tablets for extended periods?\nA: Increase the dosage\nB: Switch to another antidepressant\nC: Re-evaluate the long-term usefulness of the drug\nD: Monitor for psychomotor agitation\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor patients for potential side effects, particularly hypertension, as venlafaxine can increase blood pressure, especially at higher doses.\n- Assess for signs of serotonin syndrome, particularly if venlafaxine is used in combination with other serotonergic medications.\n- Evaluate the need for continued treatment and consider tapering the dosage if the patient has been stable on venlafaxine for an extended period to avoid withdrawal symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should physicians periodically do when prescribing venlafaxine tablets for extended periods?\nA: Increase the dosage\nB: Switch to another antidepressant\nC: Re-evaluate the long-term usefulness of the drug\nD: Monitor for psychomotor agitation\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor patients for potential side effects, particularly hypertension, as venlafaxine can increase blood pressure, especially at higher doses.\n- Assess for signs of serotonin syndrome, particularly if venlafaxine is used in combination with other serotonergic medications.\n- Evaluate the need for continued treatment and consider tapering the dosage if the patient has been stable on venlafaxine for an extended period to avoid withdrawal symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}]"
"1oUhlFlHKRar","- The combination therapy includes Pemetrexed for Injection and Cisplatin as the initial treatment for malignant pleural mesothelioma.
- Pemetrexed is administered alongside Cisplatin in a regimen that has been shown to improve survival outcomes in patients with this condition.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich combination therapy includes Pemetrexed for Injection for the initial treatment of malignant pleural mesothelioma?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The combination therapy includes Pemetrexed for Injection and Cisplatin as the initial treatment for malignant pleural mesothelioma.\n- Pemetrexed is administered alongside Cisplatin in a regimen that has been shown to improve survival outcomes in patients with this condition.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which combination therapy includes Pemetrexed for Injection for the initial treatment of malignant pleural mesothelioma?\nA: Pemetrexed with pembrolizumab and platinum chemotherapy.\nB: Pemetrexed with cisplatin.\nC: Pemetrexed with EGFR inhibitors.\nD: Pemetrexed with ALK inhibitors.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination therapy includes Pemetrexed for Injection and Cisplatin as the initial treatment for malignant pleural mesothelioma.\n- Pemetrexed is administered alongside Cisplatin in a regimen that has been shown to improve survival outcomes in patients with this condition.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which combination therapy includes Pemetrexed for Injection for the initial treatment of malignant pleural mesothelioma?\nA: Pemetrexed with pembrolizumab and platinum chemotherapy.\nB: Pemetrexed with cisplatin.\nC: Pemetrexed with EGFR inhibitors.\nD: Pemetrexed with ALK inhibitors.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination therapy includes Pemetrexed for Injection and Cisplatin as the initial treatment for malignant pleural mesothelioma.\n- Pemetrexed is administered alongside Cisplatin in a regimen that has been shown to improve survival outcomes in patients with this condition.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which combination therapy includes Pemetrexed for Injection for the initial treatment of malignant pleural mesothelioma?\nA: Pemetrexed with pembrolizumab and platinum chemotherapy.\nB: Pemetrexed with cisplatin.\nC: Pemetrexed with EGFR inhibitors.\nD: Pemetrexed with ALK inhibitors.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination therapy includes Pemetrexed for Injection and Cisplatin as the initial treatment for malignant pleural mesothelioma.\n- Pemetrexed is administered alongside Cisplatin in a regimen that has been shown to improve survival outcomes in patients with this condition.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"BoqCCgWIhC2N","- Patients with a history of substance use disorder, particularly those who have previously abused opioids or other controlled substances, are at higher risk of abusing RoxyBond.
- Individuals with chronic pain conditions who have been prescribed RoxyBond for pain management may develop a psychological dependence on the medication, increasing the risk of abuse.
- Young adults and adolescents, especially those with access to RoxyBond through prescriptions or illicit means, are also at a heightened risk of misuse and abuse.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich patient population is at higher risk of abusing RoxyBond?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients with a history of substance use disorder, particularly those who have previously abused opioids or other controlled substances, are at higher risk of abusing RoxyBond.\n- Individuals with chronic pain conditions who have been prescribed RoxyBond for pain management may develop a psychological dependence on the medication, increasing the risk of abuse.\n- Young adults and adolescents, especially those with access to RoxyBond through prescriptions or illicit means, are also at a heightened risk of misuse and abuse.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient population is at higher risk of abusing RoxyBond?\nA: Patients with a history of prolonged opioid use\nB: Patients with a history of drug or alcohol abuse\nC: Patients combining RoxyBond with other abused drugs\nD: All of the above\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of substance use disorder, particularly those who have previously abused opioids or other controlled substances, are at higher risk of abusing RoxyBond.\n- Individuals with chronic pain conditions who have been prescribed RoxyBond for pain management may develop a psychological dependence on the medication, increasing the risk of abuse.\n- Young adults and adolescents, especially those with access to RoxyBond through prescriptions or illicit means, are also at a heightened risk of misuse and abuse.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient population is at higher risk of abusing RoxyBond?\nA: Patients with a history of prolonged opioid use\nB: Patients with a history of drug or alcohol abuse\nC: Patients combining RoxyBond with other abused drugs\nD: All of the above\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of substance use disorder, particularly those who have previously abused opioids or other controlled substances, are at higher risk of abusing RoxyBond.\n- Individuals with chronic pain conditions who have been prescribed RoxyBond for pain management may develop a psychological dependence on the medication, increasing the risk of abuse.\n- Young adults and adolescents, especially those with access to RoxyBond through prescriptions or illicit means, are also at a heightened risk of misuse and abuse.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient population is at higher risk of abusing RoxyBond?\nA: Patients with a history of prolonged opioid use\nB: Patients with a history of drug or alcohol abuse\nC: Patients combining RoxyBond with other abused drugs\nD: All of the above\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of substance use disorder, particularly those who have previously abused opioids or other controlled substances, are at higher risk of abusing RoxyBond.\n- Individuals with chronic pain conditions who have been prescribed RoxyBond for pain management may develop a psychological dependence on the medication, increasing the risk of abuse.\n- Young adults and adolescents, especially those with access to RoxyBond through prescriptions or illicit means, are also at a heightened risk of misuse and abuse.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"D0Q2hWgZDkHc","- If a patient misses a dose of JAYPIRCA and it has been more than 12 hours since the usual dosing time, they should skip the missed dose and resume their regular dosing schedule.
- Patients should not take two doses of JAYPIRCA at the same time to make up for the missed dose.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if a patient misses a dose of JAYPIRCA and it has been more than 12 hours since the usual dosing time?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- If a patient misses a dose of JAYPIRCA and it has been more than 12 hours since the usual dosing time, they should skip the missed dose and resume their regular dosing schedule.\n- Patients should not take two doses of JAYPIRCA at the same time to make up for the missed dose.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient misses a dose of JAYPIRCA and it has been more than 12 hours since the usual dosing time?\nA: Take the missed dose immediately.\nB: Skip the missed dose and take the next dose at the usual time.\nC: Double the dose the next day.\nD: Stop taking JAYPIRCA entirely.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- If a patient misses a dose of JAYPIRCA and it has been more than 12 hours since the usual dosing time, they should skip the missed dose and resume their regular dosing schedule.\n- Patients should not take two doses of JAYPIRCA at the same time to make up for the missed dose.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient misses a dose of JAYPIRCA and it has been more than 12 hours since the usual dosing time?\nA: Take the missed dose immediately.\nB: Skip the missed dose and take the next dose at the usual time.\nC: Double the dose the next day.\nD: Stop taking JAYPIRCA entirely.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- If a patient misses a dose of JAYPIRCA and it has been more than 12 hours since the usual dosing time, they should skip the missed dose and resume their regular dosing schedule.\n- Patients should not take two doses of JAYPIRCA at the same time to make up for the missed dose.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient misses a dose of JAYPIRCA and it has been more than 12 hours since the usual dosing time?\nA: Take the missed dose immediately.\nB: Skip the missed dose and take the next dose at the usual time.\nC: Double the dose the next day.\nD: Stop taking JAYPIRCA entirely.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- If a patient misses a dose of JAYPIRCA and it has been more than 12 hours since the usual dosing time, they should skip the missed dose and resume their regular dosing schedule.\n- Patients should not take two doses of JAYPIRCA at the same time to make up for the missed dose.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"xFqyj9rw02CP","- Terbinafine should not be prescribed to patients with a history of liver disease, as it can cause hepatotoxicity.
- Patients with a known hypersensitivity to terbinafine or any of its components should avoid this medication to prevent allergic reactions.
- Caution is advised when prescribing terbinafine to individuals with active or chronic renal impairment, as dosage adjustments may be necessary.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nTerbinafine should not be prescribed to patients with which of the following conditions?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Terbinafine should not be prescribed to patients with a history of liver disease, as it can cause hepatotoxicity.\n- Patients with a known hypersensitivity to terbinafine or any of its components should avoid this medication to prevent allergic reactions.\n- Caution is advised when prescribing terbinafine to individuals with active or chronic renal impairment, as dosage adjustments may be necessary.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Terbinafine should not be prescribed to patients with which of the following conditions?\nA: Chronic liver disease\nB: Active liver disease\nC: History of allergic reaction to oral Terbinafine\nD: All of the above\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Terbinafine should not be prescribed to patients with a history of liver disease, as it can cause hepatotoxicity.\n- Patients with a known hypersensitivity to terbinafine or any of its components should avoid this medication to prevent allergic reactions.\n- Caution is advised when prescribing terbinafine to individuals with active or chronic renal impairment, as dosage adjustments may be necessary.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Terbinafine should not be prescribed to patients with which of the following conditions?\nA: Chronic liver disease\nB: Active liver disease\nC: History of allergic reaction to oral Terbinafine\nD: All of the above\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Terbinafine should not be prescribed to patients with a history of liver disease, as it can cause hepatotoxicity.\n- Patients with a known hypersensitivity to terbinafine or any of its components should avoid this medication to prevent allergic reactions.\n- Caution is advised when prescribing terbinafine to individuals with active or chronic renal impairment, as dosage adjustments may be necessary.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Terbinafine should not be prescribed to patients with which of the following conditions?\nA: Chronic liver disease\nB: Active liver disease\nC: History of allergic reaction to oral Terbinafine\nD: All of the above\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Terbinafine should not be prescribed to patients with a history of liver disease, as it can cause hepatotoxicity.\n- Patients with a known hypersensitivity to terbinafine or any of its components should avoid this medication to prevent allergic reactions.\n- Caution is advised when prescribing terbinafine to individuals with active or chronic renal impairment, as dosage adjustments may be necessary.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"EPGUKZNifNtQ","- Women over 35 who smoke should be aware that using Tri Femynor, a combination oral contraceptive, significantly increases the risk of serious cardiovascular events, such as blood clots and stroke.
- It is crucial for these women to discuss alternative contraceptive options with their healthcare provider, as the risks associated with Tri Femynor may outweigh the benefits.
- Smoking cessation is highly recommended before starting Tri Femynor to mitigate these health risks.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the most important precaution for women over 35 who smoke and are considering Tri Femynor?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Women over 35 who smoke should be aware that using Tri Femynor, a combination oral contraceptive, significantly increases the risk of serious cardiovascular events, such as blood clots and stroke.\n- It is crucial for these women to discuss alternative contraceptive options with their healthcare provider, as the risks associated with Tri Femynor may outweigh the benefits.\n- Smoking cessation is highly recommended before starting Tri Femynor to mitigate these health risks.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the most important precaution for women over 35 who smoke and are considering Tri Femynor?\nA: They should reduce their smoking to fewer than 5 cigarettes per day.\nB: They should avoid using Tri Femynor due to increased cardiovascular risks.\nC: They should take Tri Femynor only under close medical supervision.\nD: They should use Tri Femynor only for acne treatment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Women over 35 who smoke should be aware that using Tri Femynor, a combination oral contraceptive, significantly increases the risk of serious cardiovascular events, such as blood clots and stroke.\n- It is crucial for these women to discuss alternative contraceptive options with their healthcare provider, as the risks associated with Tri Femynor may outweigh the benefits.\n- Smoking cessation is highly recommended before starting Tri Femynor to mitigate these health risks.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the most important precaution for women over 35 who smoke and are considering Tri Femynor?\nA: They should reduce their smoking to fewer than 5 cigarettes per day.\nB: They should avoid using Tri Femynor due to increased cardiovascular risks.\nC: They should take Tri Femynor only under close medical supervision.\nD: They should use Tri Femynor only for acne treatment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Women over 35 who smoke should be aware that using Tri Femynor, a combination oral contraceptive, significantly increases the risk of serious cardiovascular events, such as blood clots and stroke.\n- It is crucial for these women to discuss alternative contraceptive options with their healthcare provider, as the risks associated with Tri Femynor may outweigh the benefits.\n- Smoking cessation is highly recommended before starting Tri Femynor to mitigate these health risks.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the most important precaution for women over 35 who smoke and are considering Tri Femynor?\nA: They should reduce their smoking to fewer than 5 cigarettes per day.\nB: They should avoid using Tri Femynor due to increased cardiovascular risks.\nC: They should take Tri Femynor only under close medical supervision.\nD: They should use Tri Femynor only for acne treatment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Women over 35 who smoke should be aware that using Tri Femynor, a combination oral contraceptive, significantly increases the risk of serious cardiovascular events, such as blood clots and stroke.\n- It is crucial for these women to discuss alternative contraceptive options with their healthcare provider, as the risks associated with Tri Femynor may outweigh the benefits.\n- Smoking cessation is highly recommended before starting Tri Femynor to mitigate these health risks.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"bLOmytgqgKvC","MRRV winner=D; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 0.25, 'D': 1.0}; rankings=[['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C']]","D","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following medications should not be taken alongside Fluoxetine capsules due to containing fluoxetine hydrochloride?\nA: Symbyax\nB: Sarafem\nC: Prozac Weekly\nD: All of the above\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following medications should not be taken alongside Fluoxetine capsules due to containing fluoxetine hydrochloride?\nA: Symbyax\nB: Sarafem\nC: Prozac Weekly\nD: All of the above\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following medications should not be taken alongside Fluoxetine capsules due to containing fluoxetine hydrochloride?\nA: Symbyax\nB: Sarafem\nC: Prozac Weekly\nD: All of the above\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}]"
"sukJQfNlj8DK","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be considered before prescribing Pemetrexed to a patient?\nA: History of severe hypersensitivity reaction to Pemetrexed\nB: History of mild hypersensitivity reaction to Pemetrexed\nC: History of cardiovascular disease\nD: History of gastrointestinal issues\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be considered before prescribing Pemetrexed to a patient?\nA: History of severe hypersensitivity reaction to Pemetrexed\nB: History of mild hypersensitivity reaction to Pemetrexed\nC: History of cardiovascular disease\nD: History of gastrointestinal issues\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be considered before prescribing Pemetrexed to a patient?\nA: History of severe hypersensitivity reaction to Pemetrexed\nB: History of mild hypersensitivity reaction to Pemetrexed\nC: History of cardiovascular disease\nD: History of gastrointestinal issues\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"MIpvCrLOnTif","1) Recommendation: Nicotine can help alleviate withdrawal symptoms such as irritability, anxiety, and cravings for tobacco products. However, it is important to consider safer alternatives for managing withdrawal symptoms, such as nicotine replacement therapies or behavioral support.

2) Key rationale:
   - Nicotine acts on the brain's reward pathways, temporarily improving mood and reducing anxiety.
   - Withdrawal symptoms from nicotine can include irritability, restlessness, and intense cravings, which nicotine can help mitigate.
   - Using nicotine replacement therapies can provide a controlled dose of nicotine, reducing withdrawal symptoms while minimizing the risks associated with smoking.

3) Safety/contraindications/interactions:
   - Nicotine replacement therapies should be used cautiously in individuals with cardiovascular conditions, as nicotine can increase heart rate and blood pressure.
   - Pregnant or breastfeeding women should consult a healthcare provider before using nicotine products.
   - Potential interactions with medications that affect the cardiovascular system or mental health should be considered.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhich of the following is a withdrawal symptom that Nicotine helps alleviate?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Nicotine can help alleviate withdrawal symptoms such as irritability, anxiety, and cravings for tobacco products. However, it is important to consider safer alternatives for managing withdrawal symptoms, such as nicotine replacement therapies or behavioral support.\n\n2) Key rationale:\n   - Nicotine acts on the brain's reward pathways, temporarily improving mood and reducing anxiety.\n   - Withdrawal symptoms from nicotine can include irritability, restlessness, and intense cravings, which nicotine can help mitigate.\n   - Using nicotine replacement therapies can provide a controlled dose of nicotine, reducing withdrawal symptoms while minimizing the risks associated with smoking.\n\n3) Safety/contraindications/interactions:\n   - Nicotine replacement therapies should be used cautiously in individuals with cardiovascular conditions, as nicotine can increase heart rate and blood pressure.\n   - Pregnant or breastfeeding women should consult a healthcare provider before using nicotine products.\n   - Potential interactions with medications that affect the cardiovascular system or mental health should be considered.""}]"
"Eic83tab2ldk","- Albuterol sulfate demonstrated no evidence of impaired fertility in rats at an oral dose of 100 mg/kg/day.
- The study indicated that this dose did not adversely affect reproductive parameters in the test subjects.
- Comparatively, lower doses did not show significant effects, reinforcing the safety profile of albuterol sulfate at this level.

MRRV(meta) winner=D; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 0.25, 'D': 1.0}; rankings=[['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nAt what oral dose did albuterol sulfate demonstrate no evidence of impaired fertility in rats?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Albuterol sulfate demonstrated no evidence of impaired fertility in rats at an oral dose of 100 mg/kg/day.\n- The study indicated that this dose did not adversely affect reproductive parameters in the test subjects.\n- Comparatively, lower doses did not show significant effects, reinforcing the safety profile of albuterol sulfate at this level.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: At what oral dose did albuterol sulfate demonstrate no evidence of impaired fertility in rats?\nA: 2 mg/kg\nB: 50 mg/kg\nC: 500 mg/kg\nD: 100 mg/kg\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol sulfate demonstrated no evidence of impaired fertility in rats at an oral dose of 100 mg/kg/day.\n- The study indicated that this dose did not adversely affect reproductive parameters in the test subjects.\n- Comparatively, lower doses did not show significant effects, reinforcing the safety profile of albuterol sulfate at this level.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: At what oral dose did albuterol sulfate demonstrate no evidence of impaired fertility in rats?\nA: 2 mg/kg\nB: 50 mg/kg\nC: 500 mg/kg\nD: 100 mg/kg\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol sulfate demonstrated no evidence of impaired fertility in rats at an oral dose of 100 mg/kg/day.\n- The study indicated that this dose did not adversely affect reproductive parameters in the test subjects.\n- Comparatively, lower doses did not show significant effects, reinforcing the safety profile of albuterol sulfate at this level.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: At what oral dose did albuterol sulfate demonstrate no evidence of impaired fertility in rats?\nA: 2 mg/kg\nB: 50 mg/kg\nC: 500 mg/kg\nD: 100 mg/kg\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol sulfate demonstrated no evidence of impaired fertility in rats at an oral dose of 100 mg/kg/day.\n- The study indicated that this dose did not adversely affect reproductive parameters in the test subjects.\n- Comparatively, lower doses did not show significant effects, reinforcing the safety profile of albuterol sulfate at this level.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}]"
"MyyktgFxM3uA","MRRV winner=B; scores={'A': 0.4444444444444444, 'B': 1.0, 'C': 0.25, 'D': 0.38888888888888884}; rankings=[['B', 'A', 'D', 'C'], ['B', 'D', 'A', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients using Tri Femynor do if they are concurrently taking enzyme-inducing drugs?\nA: Stop taking Tri Femynor immediately.\nB: Use a back-up or alternative method of contraception.\nC: Increase the dose of Tri Femynor.\nD: Take Tri Femynor with food to reduce interactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients using Tri Femynor do if they are concurrently taking enzyme-inducing drugs?\nA: Stop taking Tri Femynor immediately.\nB: Use a back-up or alternative method of contraception.\nC: Increase the dose of Tri Femynor.\nD: Take Tri Femynor with food to reduce interactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients using Tri Femynor do if they are concurrently taking enzyme-inducing drugs?\nA: Stop taking Tri Femynor immediately.\nB: Use a back-up or alternative method of contraception.\nC: Increase the dose of Tri Femynor.\nD: Take Tri Femynor with food to reduce interactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"SeNVyra7uLuW","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was observed regarding the systemic beta-adrenergic adverse effects of 1.25 mg Levalbuterol compared to 2.5 mg racemic albuterol sulfate in clinical studies?\nA: Levalbuterol had a lower rate of systemic beta-adrenergic adverse effects.\nB: Levalbuterol had a slightly higher rate of systemic beta-adrenergic adverse effects.\nC: Both had identical rates of systemic beta-adrenergic adverse effects.\nD: Racemic albuterol sulfate had no systemic beta-adrenergic adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was observed regarding the systemic beta-adrenergic adverse effects of 1.25 mg Levalbuterol compared to 2.5 mg racemic albuterol sulfate in clinical studies?\nA: Levalbuterol had a lower rate of systemic beta-adrenergic adverse effects.\nB: Levalbuterol had a slightly higher rate of systemic beta-adrenergic adverse effects.\nC: Both had identical rates of systemic beta-adrenergic adverse effects.\nD: Racemic albuterol sulfate had no systemic beta-adrenergic adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was observed regarding the systemic beta-adrenergic adverse effects of 1.25 mg Levalbuterol compared to 2.5 mg racemic albuterol sulfate in clinical studies?\nA: Levalbuterol had a lower rate of systemic beta-adrenergic adverse effects.\nB: Levalbuterol had a slightly higher rate of systemic beta-adrenergic adverse effects.\nC: Both had identical rates of systemic beta-adrenergic adverse effects.\nD: Racemic albuterol sulfate had no systemic beta-adrenergic adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"XrpAg6zeqC4x","MRRV winner=B; scores={'A': 0.4444444444444444, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.3333333333333333}; rankings=[['B', 'D', 'A', 'C'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy should Stiolto Respimat be used with extreme caution in patients taking monoamine oxidase inhibitors (MAOIs)?\nA: MAOIs reduce the effectiveness of Stiolto Respimat.\nB: MAOIs may potentiate cardiovascular effects of adrenergic agonists.\nC: MAOIs increase the risk of hypokalemia.\nD: MAOIs cause additive anticholinergic effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy should Stiolto Respimat be used with extreme caution in patients taking monoamine oxidase inhibitors (MAOIs)?\nA: MAOIs reduce the effectiveness of Stiolto Respimat.\nB: MAOIs may potentiate cardiovascular effects of adrenergic agonists.\nC: MAOIs increase the risk of hypokalemia.\nD: MAOIs cause additive anticholinergic effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy should Stiolto Respimat be used with extreme caution in patients taking monoamine oxidase inhibitors (MAOIs)?\nA: MAOIs reduce the effectiveness of Stiolto Respimat.\nB: MAOIs may potentiate cardiovascular effects of adrenergic agonists.\nC: MAOIs increase the risk of hypokalemia.\nD: MAOIs cause additive anticholinergic effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"0xOHfzUCHeUB","- Venlafaxine has a protein binding percentage of approximately 27% in human plasma.
- This low protein binding indicates that a significant portion of venlafaxine remains unbound and active in the bloodstream.
- The pharmacokinetics of venlafaxine can be influenced by its protein binding characteristics, affecting its distribution and efficacy.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the protein binding percentage of venlafaxine in human plasma?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Venlafaxine has a protein binding percentage of approximately 27% in human plasma.\n- This low protein binding indicates that a significant portion of venlafaxine remains unbound and active in the bloodstream.\n- The pharmacokinetics of venlafaxine can be influenced by its protein binding characteristics, affecting its distribution and efficacy.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the protein binding percentage of venlafaxine in human plasma?\nA: 50% \u00b1 5%\nB: 27% \u00b1 2%\nC: 75% \u00b1 10%\nD: 90% \u00b1 5%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine has a protein binding percentage of approximately 27% in human plasma.\n- This low protein binding indicates that a significant portion of venlafaxine remains unbound and active in the bloodstream.\n- The pharmacokinetics of venlafaxine can be influenced by its protein binding characteristics, affecting its distribution and efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the protein binding percentage of venlafaxine in human plasma?\nA: 50% \u00b1 5%\nB: 27% \u00b1 2%\nC: 75% \u00b1 10%\nD: 90% \u00b1 5%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine has a protein binding percentage of approximately 27% in human plasma.\n- This low protein binding indicates that a significant portion of venlafaxine remains unbound and active in the bloodstream.\n- The pharmacokinetics of venlafaxine can be influenced by its protein binding characteristics, affecting its distribution and efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the protein binding percentage of venlafaxine in human plasma?\nA: 50% \u00b1 5%\nB: 27% \u00b1 2%\nC: 75% \u00b1 10%\nD: 90% \u00b1 5%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine has a protein binding percentage of approximately 27% in human plasma.\n- This low protein binding indicates that a significant portion of venlafaxine remains unbound and active in the bloodstream.\n- The pharmacokinetics of venlafaxine can be influenced by its protein binding characteristics, affecting its distribution and efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"AUKWr9SmYhyi","- The drug brand name 'Sterile' is associated with the preparation of injectable medications, ensuring that the solution is free from contaminants.
- It is commonly used in the context of compounding sterile preparations in pharmacies or hospitals, particularly for intravenous (IV) administration.
- The term 'sterile' emphasizes the importance of maintaining aseptic conditions during the preparation and handling of medications to prevent infections.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich step in medical procedures is the drug brand name 'sterile' associated with?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The drug brand name 'Sterile' is associated with the preparation of injectable medications, ensuring that the solution is free from contaminants.\n- It is commonly used in the context of compounding sterile preparations in pharmacies or hospitals, particularly for intravenous (IV) administration.\n- The term 'sterile' emphasizes the importance of maintaining aseptic conditions during the preparation and handling of medications to prevent infections.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which step in medical procedures is the drug brand name 'sterile' associated with?\nA: Post-surgical wound care\nB: Preparation of the skin prior to injection\nC: Treatment of injection site infections\nD: Management of chronic pain\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug brand name 'Sterile' is associated with the preparation of injectable medications, ensuring that the solution is free from contaminants.\n- It is commonly used in the context of compounding sterile preparations in pharmacies or hospitals, particularly for intravenous (IV) administration.\n- The term 'sterile' emphasizes the importance of maintaining aseptic conditions during the preparation and handling of medications to prevent infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which step in medical procedures is the drug brand name 'sterile' associated with?\nA: Post-surgical wound care\nB: Preparation of the skin prior to injection\nC: Treatment of injection site infections\nD: Management of chronic pain\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug brand name 'Sterile' is associated with the preparation of injectable medications, ensuring that the solution is free from contaminants.\n- It is commonly used in the context of compounding sterile preparations in pharmacies or hospitals, particularly for intravenous (IV) administration.\n- The term 'sterile' emphasizes the importance of maintaining aseptic conditions during the preparation and handling of medications to prevent infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which step in medical procedures is the drug brand name 'sterile' associated with?\nA: Post-surgical wound care\nB: Preparation of the skin prior to injection\nC: Treatment of injection site infections\nD: Management of chronic pain\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug brand name 'Sterile' is associated with the preparation of injectable medications, ensuring that the solution is free from contaminants.\n- It is commonly used in the context of compounding sterile preparations in pharmacies or hospitals, particularly for intravenous (IV) administration.\n- The term 'sterile' emphasizes the importance of maintaining aseptic conditions during the preparation and handling of medications to prevent infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"fJCpjsIeX5In","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended intervention for monitoring glycemic control in patients taking SEGLUROMET who have a positive urine glucose test?\nA: Discontinue SEGLUROMET\nB: Use alternative methods to monitor glycemic control\nC: Increase the dose of SEGLUROMET\nD: Monitor serum lithium levels\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended intervention for monitoring glycemic control in patients taking SEGLUROMET who have a positive urine glucose test?\nA: Discontinue SEGLUROMET\nB: Use alternative methods to monitor glycemic control\nC: Increase the dose of SEGLUROMET\nD: Monitor serum lithium levels\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended intervention for monitoring glycemic control in patients taking SEGLUROMET who have a positive urine glucose test?\nA: Discontinue SEGLUROMET\nB: Use alternative methods to monitor glycemic control\nC: Increase the dose of SEGLUROMET\nD: Monitor serum lithium levels\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"myBooDivIEjt","MRRV winner=B; scores={'A': 0.25, 'B': 1.0, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['B', 'C', 'D', 'A'], ['B', 'C', 'D', 'A'], ['B', 'C', 'D', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be done if immediate hypersensitivity reactions occur after administration of Levalbuterol?\nA: Increase the dose\nB: Discontinue Levalbuterol immediately\nC: Administer corticosteroids\nD: Monitor the patient closely without changing treatment\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be done if immediate hypersensitivity reactions occur after administration of Levalbuterol?\nA: Increase the dose\nB: Discontinue Levalbuterol immediately\nC: Administer corticosteroids\nD: Monitor the patient closely without changing treatment\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be done if immediate hypersensitivity reactions occur after administration of Levalbuterol?\nA: Increase the dose\nB: Discontinue Levalbuterol immediately\nC: Administer corticosteroids\nD: Monitor the patient closely without changing treatment\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}]"
"0NpConxVPMFN","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended storage temperature for the drug 'laxative for women'?\nA: 15\u00baC (59\u00baF)\nB: 25\u00baC (77\u00baF)\nC: 30\u00baC (86\u00baF)\nD: 10\u00baC (50\u00baF)\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended storage temperature for the drug 'laxative for women'?\nA: 15\u00baC (59\u00baF)\nB: 25\u00baC (77\u00baF)\nC: 30\u00baC (86\u00baF)\nD: 10\u00baC (50\u00baF)\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended storage temperature for the drug 'laxative for women'?\nA: 15\u00baC (59\u00baF)\nB: 25\u00baC (77\u00baF)\nC: 30\u00baC (86\u00baF)\nD: 10\u00baC (50\u00baF)\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"fvYvt7BhnFrs","- The target basal acid secretion level for patients with Zollinger-Ellison Syndrome without prior gastric surgery was less than 10 mEq/hour during treatment with pantoprazole sodium for injection.
- Pantoprazole sodium for injection was administered to achieve this target level effectively in managing acid secretion.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn patients with Zollinger-Ellison Syndrome, what was the target basal acid secretion level for those without prior gastric surgery during treatment with pantoprazole sodium for injection?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The target basal acid secretion level for patients with Zollinger-Ellison Syndrome without prior gastric surgery was less than 10 mEq/hour during treatment with pantoprazole sodium for injection.\n- Pantoprazole sodium for injection was administered to achieve this target level effectively in managing acid secretion.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In patients with Zollinger-Ellison Syndrome, what was the target basal acid secretion level for those without prior gastric surgery during treatment with pantoprazole sodium for injection?\nA: 5 mEq/h\nB: 10 mEq/h\nC: 15 mEq/h\nD: 20 mEq/h\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The target basal acid secretion level for patients with Zollinger-Ellison Syndrome without prior gastric surgery was less than 10 mEq/hour during treatment with pantoprazole sodium for injection.\n- Pantoprazole sodium for injection was administered to achieve this target level effectively in managing acid secretion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In patients with Zollinger-Ellison Syndrome, what was the target basal acid secretion level for those without prior gastric surgery during treatment with pantoprazole sodium for injection?\nA: 5 mEq/h\nB: 10 mEq/h\nC: 15 mEq/h\nD: 20 mEq/h\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The target basal acid secretion level for patients with Zollinger-Ellison Syndrome without prior gastric surgery was less than 10 mEq/hour during treatment with pantoprazole sodium for injection.\n- Pantoprazole sodium for injection was administered to achieve this target level effectively in managing acid secretion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In patients with Zollinger-Ellison Syndrome, what was the target basal acid secretion level for those without prior gastric surgery during treatment with pantoprazole sodium for injection?\nA: 5 mEq/h\nB: 10 mEq/h\nC: 15 mEq/h\nD: 20 mEq/h\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The target basal acid secretion level for patients with Zollinger-Ellison Syndrome without prior gastric surgery was less than 10 mEq/hour during treatment with pantoprazole sodium for injection.\n- Pantoprazole sodium for injection was administered to achieve this target level effectively in managing acid secretion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"7YXi98NhIrhP","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the administration of Paxlovid in patients with severe hepatic impairment?\nA: Paxlovid is recommended with dose adjustment.\nB: Paxlovid is not recommended for use.\nC: Paxlovid can be used without dose adjustment.\nD: Paxlovid should be administered only under hospital supervision.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the administration of Paxlovid in patients with severe hepatic impairment?\nA: Paxlovid is recommended with dose adjustment.\nB: Paxlovid is not recommended for use.\nC: Paxlovid can be used without dose adjustment.\nD: Paxlovid should be administered only under hospital supervision.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the administration of Paxlovid in patients with severe hepatic impairment?\nA: Paxlovid is recommended with dose adjustment.\nB: Paxlovid is not recommended for use.\nC: Paxlovid can be used without dose adjustment.\nD: Paxlovid should be administered only under hospital supervision.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"WqBaoYjA3L87","- If a CYP3A4 inhibitor is discontinued, it is recommended to monitor the patient closely for increased effects of RoxyBond, as the metabolism of this medication may be altered.
- Consider adjusting the dosage of RoxyBond if the patient experiences increased sedation or respiratory depression after the CYP3A4 inhibitor is stopped.
- Educate the patient about potential changes in the efficacy and side effects of RoxyBond following the discontinuation of the CYP3A4 inhibitor.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.27777777777777773, 'D': 0.3055555555555555}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'C', 'D'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended intervention if a CYP3A4 inhibitor is discontinued in a patient taking RoxyBond?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- If a CYP3A4 inhibitor is discontinued, it is recommended to monitor the patient closely for increased effects of RoxyBond, as the metabolism of this medication may be altered.\n- Consider adjusting the dosage of RoxyBond if the patient experiences increased sedation or respiratory depression after the CYP3A4 inhibitor is stopped.\n- Educate the patient about potential changes in the efficacy and side effects of RoxyBond following the discontinuation of the CYP3A4 inhibitor.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended intervention if a CYP3A4 inhibitor is discontinued in a patient taking RoxyBond?\nA: Decrease the dosage of RoxyBond\nB: Increase the dosage of RoxyBond\nC: Prescribe naloxone\nD: Discontinue RoxyBond\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- If a CYP3A4 inhibitor is discontinued, it is recommended to monitor the patient closely for increased effects of RoxyBond, as the metabolism of this medication may be altered.\n- Consider adjusting the dosage of RoxyBond if the patient experiences increased sedation or respiratory depression after the CYP3A4 inhibitor is stopped.\n- Educate the patient about potential changes in the efficacy and side effects of RoxyBond following the discontinuation of the CYP3A4 inhibitor.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended intervention if a CYP3A4 inhibitor is discontinued in a patient taking RoxyBond?\nA: Decrease the dosage of RoxyBond\nB: Increase the dosage of RoxyBond\nC: Prescribe naloxone\nD: Discontinue RoxyBond\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- If a CYP3A4 inhibitor is discontinued, it is recommended to monitor the patient closely for increased effects of RoxyBond, as the metabolism of this medication may be altered.\n- Consider adjusting the dosage of RoxyBond if the patient experiences increased sedation or respiratory depression after the CYP3A4 inhibitor is stopped.\n- Educate the patient about potential changes in the efficacy and side effects of RoxyBond following the discontinuation of the CYP3A4 inhibitor.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended intervention if a CYP3A4 inhibitor is discontinued in a patient taking RoxyBond?\nA: Decrease the dosage of RoxyBond\nB: Increase the dosage of RoxyBond\nC: Prescribe naloxone\nD: Discontinue RoxyBond\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- If a CYP3A4 inhibitor is discontinued, it is recommended to monitor the patient closely for increased effects of RoxyBond, as the metabolism of this medication may be altered.\n- Consider adjusting the dosage of RoxyBond if the patient experiences increased sedation or respiratory depression after the CYP3A4 inhibitor is stopped.\n- Educate the patient about potential changes in the efficacy and side effects of RoxyBond following the discontinuation of the CYP3A4 inhibitor.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"g6d3RukDWEdj","MRRV winner=A; scores={'A': 1.0, 'B': 0.4166666666666667, 'C': 0.3333333333333333, 'D': 0.3333333333333333}; rankings=[['A', 'D', 'C', 'B'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich brand name drug is specifically indicated for the treatment of head lice?\nA: Sklice\nB: Lotrimin\nC: Nizoral\nD: Rogaine\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich brand name drug is specifically indicated for the treatment of head lice?\nA: Sklice\nB: Lotrimin\nC: Nizoral\nD: Rogaine\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich brand name drug is specifically indicated for the treatment of head lice?\nA: Sklice\nB: Lotrimin\nC: Nizoral\nD: Rogaine\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"96U1YIRLz3S4","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow should patients prime the AIRSUPRA inhaler before use?\nA: Prime the inhaler only once when first using it\nB: Prime the inhaler before first use, if unused for more than 7 days, or after cleaning\nC: Prime the inhaler before every single use\nD: Priming is not required for AIRSUPRA\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow should patients prime the AIRSUPRA inhaler before use?\nA: Prime the inhaler only once when first using it\nB: Prime the inhaler before first use, if unused for more than 7 days, or after cleaning\nC: Prime the inhaler before every single use\nD: Priming is not required for AIRSUPRA\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow should patients prime the AIRSUPRA inhaler before use?\nA: Prime the inhaler only once when first using it\nB: Prime the inhaler before first use, if unused for more than 7 days, or after cleaning\nC: Prime the inhaler before every single use\nD: Priming is not required for AIRSUPRA\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"Gy7o70m8Mhfz","1) Recommendation: The primary indication for the use of esomeprazole magnesium is the treatment of gastroesophageal reflux disease (GERD) and the healing of erosive esophagitis caused by acid reflux. It may also be used in combination with antibiotics to eradicate Helicobacter pylori in patients with peptic ulcer disease.

2) Key rationale:
   - Esomeprazole magnesium is a proton pump inhibitor (PPI) that effectively reduces gastric acid secretion.
   - It provides symptomatic relief from heartburn and acid-related discomfort associated with GERD.
   - The medication promotes healing of the esophagus in patients with erosive esophagitis, improving overall gastrointestinal health.
   - It is beneficial in combination therapy for H. pylori eradication, which is crucial for peptic ulcer management.

3) Safety/contraindications/interactions:
   - Contraindicated in patients with known hypersensitivity to esomeprazole or any component of the formulation.
   - Caution is advised in patients with liver impairment, as dosage adjustments may be necessary.
   - Potential interactions with drugs that require an acidic environment for absorption (e.g., certain antifungals and antiretrovirals).
   - Long-term use may be associated with risks such as Clostridium difficile infection in the colon and potential vitamin B12 deficiency.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the primary indication for the use of esomeprazole magnesium?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: The primary indication for the use of esomeprazole magnesium is the treatment of gastroesophageal reflux disease (GERD) and the healing of erosive esophagitis caused by acid reflux. It may also be used in combination with antibiotics to eradicate Helicobacter pylori in patients with peptic ulcer disease.\n\n2) Key rationale:\n   - Esomeprazole magnesium is a proton pump inhibitor (PPI) that effectively reduces gastric acid secretion.\n   - It provides symptomatic relief from heartburn and acid-related discomfort associated with GERD.\n   - The medication promotes healing of the esophagus in patients with erosive esophagitis, improving overall gastrointestinal health.\n   - It is beneficial in combination therapy for H. pylori eradication, which is crucial for peptic ulcer management.\n\n3) Safety/contraindications/interactions:\n   - Contraindicated in patients with known hypersensitivity to esomeprazole or any component of the formulation.\n   - Caution is advised in patients with liver impairment, as dosage adjustments may be necessary.\n   - Potential interactions with drugs that require an acidic environment for absorption (e.g., certain antifungals and antiretrovirals).\n   - Long-term use may be associated with risks such as Clostridium difficile infection in the colon and potential vitamin B12 deficiency.""}]"
"xcCeWDF4631Z","MRRV winner=C; scores={'A': 0.3333333333333333, 'B': 0.25, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended approach for prescribing Terbinafine tablets to elderly patients?\nA: Start with the maximum dose to ensure efficacy.\nB: Avoid prescribing Terbinafine tablets to elderly patients.\nC: Start at the low end of the dosing range due to potential decreased hepatic, renal, or cardiac function.\nD: Prescribe the same dose as younger patients without adjustments.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended approach for prescribing Terbinafine tablets to elderly patients?\nA: Start with the maximum dose to ensure efficacy.\nB: Avoid prescribing Terbinafine tablets to elderly patients.\nC: Start at the low end of the dosing range due to potential decreased hepatic, renal, or cardiac function.\nD: Prescribe the same dose as younger patients without adjustments.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended approach for prescribing Terbinafine tablets to elderly patients?\nA: Start with the maximum dose to ensure efficacy.\nB: Avoid prescribing Terbinafine tablets to elderly patients.\nC: Start at the low end of the dosing range due to potential decreased hepatic, renal, or cardiac function.\nD: Prescribe the same dose as younger patients without adjustments.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}]"
"NXyjgvs0NhIh","- Use Zithromax (azithromycin) only for confirmed bacterial infections to avoid unnecessary exposure that can lead to resistance.
- Complete the full course of Zithromax as prescribed, even if symptoms improve, to ensure all bacteria are eradicated and reduce the chance of resistance.
- Avoid using Zithromax in combination with other antibiotics unless specifically indicated, as this can contribute to the development of multi-drug resistant strains.

MRRV(meta) winner=B; scores={'A': 0.38888888888888884, 'B': 1.0, 'C': 0.4444444444444444, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended approach to reduce the development of drug-resistant bacteria when using Zithromax?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Use Zithromax (azithromycin) only for confirmed bacterial infections to avoid unnecessary exposure that can lead to resistance.\n- Complete the full course of Zithromax as prescribed, even if symptoms improve, to ensure all bacteria are eradicated and reduce the chance of resistance.\n- Avoid using Zithromax in combination with other antibiotics unless specifically indicated, as this can contribute to the development of multi-drug resistant strains.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach to reduce the development of drug-resistant bacteria when using Zithromax?\nA: Use Zithromax for all bacterial infections.\nB: Use Zithromax only for infections proven or strongly suspected to be caused by susceptible bacteria.\nC: Use Zithromax in combination with other antibiotics.\nD: Use Zithromax for viral infections to prevent bacterial resistance.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Use Zithromax (azithromycin) only for confirmed bacterial infections to avoid unnecessary exposure that can lead to resistance.\n- Complete the full course of Zithromax as prescribed, even if symptoms improve, to ensure all bacteria are eradicated and reduce the chance of resistance.\n- Avoid using Zithromax in combination with other antibiotics unless specifically indicated, as this can contribute to the development of multi-drug resistant strains.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach to reduce the development of drug-resistant bacteria when using Zithromax?\nA: Use Zithromax for all bacterial infections.\nB: Use Zithromax only for infections proven or strongly suspected to be caused by susceptible bacteria.\nC: Use Zithromax in combination with other antibiotics.\nD: Use Zithromax for viral infections to prevent bacterial resistance.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Use Zithromax (azithromycin) only for confirmed bacterial infections to avoid unnecessary exposure that can lead to resistance.\n- Complete the full course of Zithromax as prescribed, even if symptoms improve, to ensure all bacteria are eradicated and reduce the chance of resistance.\n- Avoid using Zithromax in combination with other antibiotics unless specifically indicated, as this can contribute to the development of multi-drug resistant strains.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach to reduce the development of drug-resistant bacteria when using Zithromax?\nA: Use Zithromax for all bacterial infections.\nB: Use Zithromax only for infections proven or strongly suspected to be caused by susceptible bacteria.\nC: Use Zithromax in combination with other antibiotics.\nD: Use Zithromax for viral infections to prevent bacterial resistance.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Use Zithromax (azithromycin) only for confirmed bacterial infections to avoid unnecessary exposure that can lead to resistance.\n- Complete the full course of Zithromax as prescribed, even if symptoms improve, to ensure all bacteria are eradicated and reduce the chance of resistance.\n- Avoid using Zithromax in combination with other antibiotics unless specifically indicated, as this can contribute to the development of multi-drug resistant strains.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"OVBKYqmRT7Cf","MRRV winner=C; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they experience worsening seizure control while taking lamotrigine?\nA: Stop taking lamotrigine immediately\nB: Increase the dosage of lamotrigine\nC: Notify their healthcare providers\nD: Switch to a different antiepileptic drug\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they experience worsening seizure control while taking lamotrigine?\nA: Stop taking lamotrigine immediately\nB: Increase the dosage of lamotrigine\nC: Notify their healthcare providers\nD: Switch to a different antiepileptic drug\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they experience worsening seizure control while taking lamotrigine?\nA: Stop taking lamotrigine immediately\nB: Increase the dosage of lamotrigine\nC: Notify their healthcare providers\nD: Switch to a different antiepileptic drug\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}]"
"ep0KXYKj2lYJ","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich group had the highest percentage of patients reporting headache in the Phase 3 clinical study?\nA: GOPRELTO 4% solution group\nB: Cocaine Hydrochloride 8% solution group\nC: Placebo group\nD: None of the groups\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich group had the highest percentage of patients reporting headache in the Phase 3 clinical study?\nA: GOPRELTO 4% solution group\nB: Cocaine Hydrochloride 8% solution group\nC: Placebo group\nD: None of the groups\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich group had the highest percentage of patients reporting headache in the Phase 3 clinical study?\nA: GOPRELTO 4% solution group\nB: Cocaine Hydrochloride 8% solution group\nC: Placebo group\nD: None of the groups\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"hoDHZ6mKQYsl","1) Recommendation: If a patient experiences paradoxical bronchospasm while using Levalbuterol Inhalation Solution, they should immediately discontinue use of the medication and seek medical attention. It is important to consult a healthcare provider to discuss alternative treatment options and to ensure proper management of their respiratory condition.

2) Key rationale:
- Paradoxical bronchospasm is a rare but serious side effect that can worsen breathing difficulties.
- Discontinuing the medication can prevent further exacerbation of symptoms and potential complications.
- Consulting a healthcare provider allows for a reassessment of the patient's treatment plan and consideration of alternative bronchodilators or therapies.

3) Safety/contraindications/interactions:
- Patients with a known hypersensitivity to Levalbuterol or any of its components should avoid its use.
- Caution is advised in patients with cardiovascular disorders, as beta-agonists can cause increased heart rate and blood pressure.
- Potential interactions with other medications, such as beta-blockers, which may reduce the effectiveness of Levalbuterol.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat should patients do if they experience paradoxical bronchospasm while using Levalbuterol Inhalation Solution?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: If a patient experiences paradoxical bronchospasm while using Levalbuterol Inhalation Solution, they should immediately discontinue use of the medication and seek medical attention. It is important to consult a healthcare provider to discuss alternative treatment options and to ensure proper management of their respiratory condition.\n\n2) Key rationale:\n- Paradoxical bronchospasm is a rare but serious side effect that can worsen breathing difficulties.\n- Discontinuing the medication can prevent further exacerbation of symptoms and potential complications.\n- Consulting a healthcare provider allows for a reassessment of the patient's treatment plan and consideration of alternative bronchodilators or therapies.\n\n3) Safety/contraindications/interactions:\n- Patients with a known hypersensitivity to Levalbuterol or any of its components should avoid its use.\n- Caution is advised in patients with cardiovascular disorders, as beta-agonists can cause increased heart rate and blood pressure.\n- Potential interactions with other medications, such as beta-blockers, which may reduce the effectiveness of Levalbuterol.""}]"
"sN6wz556sK8Y","- NUZYRA (sarecycline) is contraindicated in patients with a known hypersensitivity to any of its excipients, which include lactose monohydrate and sodium lauryl sulfate.
- The presence of excipients in NUZYRA may lead to adverse reactions in individuals with specific allergies, necessitating caution in prescribing to those with such sensitivities.
- Patients with a history of severe allergic reactions to components like magnesium stearate, another excipient, should avoid NUZYRA to prevent potential contraindications.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the relationship between NUZYRA and its excipients in terms of contraindications?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- NUZYRA (sarecycline) is contraindicated in patients with a known hypersensitivity to any of its excipients, which include lactose monohydrate and sodium lauryl sulfate.\n- The presence of excipients in NUZYRA may lead to adverse reactions in individuals with specific allergies, necessitating caution in prescribing to those with such sensitivities.\n- Patients with a history of severe allergic reactions to components like magnesium stearate, another excipient, should avoid NUZYRA to prevent potential contraindications.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the relationship between NUZYRA and its excipients in terms of contraindications?\nA: NUZYRA can be prescribed regardless of excipient hypersensitivity.\nB: NUZYRA is contraindicated in patients with hypersensitivity to its excipients.\nC: NUZYRA is contraindicated only in patients with hypersensitivity to tetracycline class drugs.\nD: NUZYRA is contraindicated in patients with hypersensitivity to fluoroquinolone excipients.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- NUZYRA (sarecycline) is contraindicated in patients with a known hypersensitivity to any of its excipients, which include lactose monohydrate and sodium lauryl sulfate.\n- The presence of excipients in NUZYRA may lead to adverse reactions in individuals with specific allergies, necessitating caution in prescribing to those with such sensitivities.\n- Patients with a history of severe allergic reactions to components like magnesium stearate, another excipient, should avoid NUZYRA to prevent potential contraindications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the relationship between NUZYRA and its excipients in terms of contraindications?\nA: NUZYRA can be prescribed regardless of excipient hypersensitivity.\nB: NUZYRA is contraindicated in patients with hypersensitivity to its excipients.\nC: NUZYRA is contraindicated only in patients with hypersensitivity to tetracycline class drugs.\nD: NUZYRA is contraindicated in patients with hypersensitivity to fluoroquinolone excipients.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- NUZYRA (sarecycline) is contraindicated in patients with a known hypersensitivity to any of its excipients, which include lactose monohydrate and sodium lauryl sulfate.\n- The presence of excipients in NUZYRA may lead to adverse reactions in individuals with specific allergies, necessitating caution in prescribing to those with such sensitivities.\n- Patients with a history of severe allergic reactions to components like magnesium stearate, another excipient, should avoid NUZYRA to prevent potential contraindications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the relationship between NUZYRA and its excipients in terms of contraindications?\nA: NUZYRA can be prescribed regardless of excipient hypersensitivity.\nB: NUZYRA is contraindicated in patients with hypersensitivity to its excipients.\nC: NUZYRA is contraindicated only in patients with hypersensitivity to tetracycline class drugs.\nD: NUZYRA is contraindicated in patients with hypersensitivity to fluoroquinolone excipients.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- NUZYRA (sarecycline) is contraindicated in patients with a known hypersensitivity to any of its excipients, which include lactose monohydrate and sodium lauryl sulfate.\n- The presence of excipients in NUZYRA may lead to adverse reactions in individuals with specific allergies, necessitating caution in prescribing to those with such sensitivities.\n- Patients with a history of severe allergic reactions to components like magnesium stearate, another excipient, should avoid NUZYRA to prevent potential contraindications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"sBOTSLesGAbf","1) Recommendation: The molecular formula of venlafaxine hydrochloride is C17H27NO2HCl. 

2) Key rationale:
   - Venlafaxine is an antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class.
   - The molecular formula indicates the presence of carbon (C), hydrogen (H), nitrogen (N), oxygen (O), and chloride (Cl) in its structure.
   - The hydrochloride (HCl) component is included to indicate the salt form of the drug, which is commonly used for stability and solubility.

3) Safety/contraindications/interactions:
   - Venlafaxine should be used cautiously in patients with a history of hypertension, as it can increase blood pressure.
   - It may interact with other medications, particularly those affecting serotonin levels, leading to an increased risk of serotonin syndrome.
   - Patients with a history of seizures or bipolar disorder should be monitored closely while on this medication.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhich of the following is the molecular formula of venlafaxine hydrochloride?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: The molecular formula of venlafaxine hydrochloride is C17H27NO2\u2022HCl. \n\n2) Key rationale:\n   - Venlafaxine is an antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class.\n   - The molecular formula indicates the presence of carbon (C), hydrogen (H), nitrogen (N), oxygen (O), and chloride (Cl) in its structure.\n   - The hydrochloride (HCl) component is included to indicate the salt form of the drug, which is commonly used for stability and solubility.\n\n3) Safety/contraindications/interactions:\n   - Venlafaxine should be used cautiously in patients with a history of hypertension, as it can increase blood pressure.\n   - It may interact with other medications, particularly those affecting serotonin levels, leading to an increased risk of serotonin syndrome.\n   - Patients with a history of seizures or bipolar disorder should be monitored closely while on this medication.""}]"
"vPiXAVp07Qga","- The suggested water temperature for a sitz bath is typically around 37-40 degrees Celsius (98.6-104 degrees Fahrenheit), which is comfortable and soothing for vaginal use.
- When using vaginal essential oils, ensure that the water is not too hot to avoid irritation or burns, maintaining a safe temperature range.
- Essential oils should be diluted properly in the sitz bath to enhance the therapeutic effects while ensuring safety and comfort.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the suggested water temperature for a sitz bath using vaginal essential oil?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The suggested water temperature for a sitz bath is typically around 37-40 degrees Celsius (98.6-104 degrees Fahrenheit), which is comfortable and soothing for vaginal use.\n- When using vaginal essential oils, ensure that the water is not too hot to avoid irritation or burns, maintaining a safe temperature range.\n- Essential oils should be diluted properly in the sitz bath to enhance the therapeutic effects while ensuring safety and comfort.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the suggested water temperature for a sitz bath using vaginal essential oil?\nA: About 37 degrees Celsius.\nB: About 40 degrees Celsius.\nC: Boiling water without cooling.\nD: Room temperature water.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The suggested water temperature for a sitz bath is typically around 37-40 degrees Celsius (98.6-104 degrees Fahrenheit), which is comfortable and soothing for vaginal use.\n- When using vaginal essential oils, ensure that the water is not too hot to avoid irritation or burns, maintaining a safe temperature range.\n- Essential oils should be diluted properly in the sitz bath to enhance the therapeutic effects while ensuring safety and comfort.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the suggested water temperature for a sitz bath using vaginal essential oil?\nA: About 37 degrees Celsius.\nB: About 40 degrees Celsius.\nC: Boiling water without cooling.\nD: Room temperature water.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The suggested water temperature for a sitz bath is typically around 37-40 degrees Celsius (98.6-104 degrees Fahrenheit), which is comfortable and soothing for vaginal use.\n- When using vaginal essential oils, ensure that the water is not too hot to avoid irritation or burns, maintaining a safe temperature range.\n- Essential oils should be diluted properly in the sitz bath to enhance the therapeutic effects while ensuring safety and comfort.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the suggested water temperature for a sitz bath using vaginal essential oil?\nA: About 37 degrees Celsius.\nB: About 40 degrees Celsius.\nC: Boiling water without cooling.\nD: Room temperature water.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The suggested water temperature for a sitz bath is typically around 37-40 degrees Celsius (98.6-104 degrees Fahrenheit), which is comfortable and soothing for vaginal use.\n- When using vaginal essential oils, ensure that the water is not too hot to avoid irritation or burns, maintaining a safe temperature range.\n- Essential oils should be diluted properly in the sitz bath to enhance the therapeutic effects while ensuring safety and comfort.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"HYmngsJ6SQDQ","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow often should the antifungal brand-name drug be applied to the affected area?\nA: Once daily\nB: Twice daily\nC: Three times daily\nD: Every four hours\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow often should the antifungal brand-name drug be applied to the affected area?\nA: Once daily\nB: Twice daily\nC: Three times daily\nD: Every four hours\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow often should the antifungal brand-name drug be applied to the affected area?\nA: Once daily\nB: Twice daily\nC: Three times daily\nD: Every four hours\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"wQmV7i9BxruD","1) Recommendation: The drug 'sterile' should be stored in a cool, dry place away from direct sunlight and moisture to maintain its efficacy and safety. It is essential to follow the manufacturer's guidelines for storage conditions.

2) Key rationale:
   - Sterile drugs are sensitive to environmental factors such as temperature and humidity, which can compromise their sterility and effectiveness.
   - Proper storage conditions help prevent contamination and degradation of the drug.
   - Following storage recommendations ensures compliance with safety standards and regulations.

3) Safety/contraindications/interactions:
   - Ensure that the storage area is free from contaminants and pests.
   - Avoid storing sterile drugs in areas with fluctuating temperatures, such as near heating vents or in bathrooms.
   - Check for specific storage instructions on the drug's packaging, as some may require refrigeration or protection from light. 

Assumptions: The question refers to a general category of sterile drugs rather than a specific medication. Further details about the specific drug or its formulation may provide more tailored recommendations.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhich of the following statements is true regarding the storage of the drug 'sterile'?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: The drug 'sterile' should be stored in a cool, dry place away from direct sunlight and moisture to maintain its efficacy and safety. It is essential to follow the manufacturer's guidelines for storage conditions.\n\n2) Key rationale:\n   - Sterile drugs are sensitive to environmental factors such as temperature and humidity, which can compromise their sterility and effectiveness.\n   - Proper storage conditions help prevent contamination and degradation of the drug.\n   - Following storage recommendations ensures compliance with safety standards and regulations.\n\n3) Safety/contraindications/interactions:\n   - Ensure that the storage area is free from contaminants and pests.\n   - Avoid storing sterile drugs in areas with fluctuating temperatures, such as near heating vents or in bathrooms.\n   - Check for specific storage instructions on the drug's packaging, as some may require refrigeration or protection from light. \n\nAssumptions: The question refers to a general category of sterile drugs rather than a specific medication. Further details about the specific drug or its formulation may provide more tailored recommendations.""}]"
"2CL48re5Ymei","- Consider confirming the false positive results with a more specific test, such as gas chromatography-mass spectrometry (GC-MS), especially if the patient is on Pantoprazole Sodium.
- Review the patient's medication history and dietary factors, as Pantoprazole Sodium may not directly cause false positives but could interact with other substances leading to such results.
- Educate the patient about potential cross-reactivity in urine tests and the importance of discussing any medication use, including Pantoprazole Sodium, with their healthcare provider.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if false positive urine tests for THC occur in patients receiving Pantoprazole Sodium?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Consider confirming the false positive results with a more specific test, such as gas chromatography-mass spectrometry (GC-MS), especially if the patient is on Pantoprazole Sodium.\n- Review the patient's medication history and dietary factors, as Pantoprazole Sodium may not directly cause false positives but could interact with other substances leading to such results.\n- Educate the patient about potential cross-reactivity in urine tests and the importance of discussing any medication use, including Pantoprazole Sodium, with their healthcare provider.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if false positive urine tests for THC occur in patients receiving Pantoprazole Sodium?\nA: Discontinue Pantoprazole Sodium\nB: Use an alternative confirmatory method\nC: Increase the dose of Pantoprazole Sodium\nD: Monitor INR levels\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider confirming the false positive results with a more specific test, such as gas chromatography-mass spectrometry (GC-MS), especially if the patient is on Pantoprazole Sodium.\n- Review the patient's medication history and dietary factors, as Pantoprazole Sodium may not directly cause false positives but could interact with other substances leading to such results.\n- Educate the patient about potential cross-reactivity in urine tests and the importance of discussing any medication use, including Pantoprazole Sodium, with their healthcare provider.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if false positive urine tests for THC occur in patients receiving Pantoprazole Sodium?\nA: Discontinue Pantoprazole Sodium\nB: Use an alternative confirmatory method\nC: Increase the dose of Pantoprazole Sodium\nD: Monitor INR levels\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider confirming the false positive results with a more specific test, such as gas chromatography-mass spectrometry (GC-MS), especially if the patient is on Pantoprazole Sodium.\n- Review the patient's medication history and dietary factors, as Pantoprazole Sodium may not directly cause false positives but could interact with other substances leading to such results.\n- Educate the patient about potential cross-reactivity in urine tests and the importance of discussing any medication use, including Pantoprazole Sodium, with their healthcare provider.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if false positive urine tests for THC occur in patients receiving Pantoprazole Sodium?\nA: Discontinue Pantoprazole Sodium\nB: Use an alternative confirmatory method\nC: Increase the dose of Pantoprazole Sodium\nD: Monitor INR levels\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider confirming the false positive results with a more specific test, such as gas chromatography-mass spectrometry (GC-MS), especially if the patient is on Pantoprazole Sodium.\n- Review the patient's medication history and dietary factors, as Pantoprazole Sodium may not directly cause false positives but could interact with other substances leading to such results.\n- Educate the patient about potential cross-reactivity in urine tests and the importance of discussing any medication use, including Pantoprazole Sodium, with their healthcare provider.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"qB6uxXE2BBob","- BRILINTA (ticagrelor) demonstrates a greater inhibition of platelet aggregation compared to clopidogrel after 6 weeks of treatment, leading to enhanced antiplatelet effects.
- Clopidogrel, while effective, shows a comparatively lower level of platelet aggregation inhibition than BRILINTA after the same treatment duration.
- The difference in IPA between BRILINTA and clopidogrel may contribute to improved clinical outcomes in patients treated with BRILINTA.

MRRV(meta) winner=C; scores={'A': 0.3333333333333333, 'B': 0.5, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow does the inhibition of platelet aggregation (IPA) compare between BRILINTA and clopidogrel after 6 weeks of treatment?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- BRILINTA (ticagrelor) demonstrates a greater inhibition of platelet aggregation compared to clopidogrel after 6 weeks of treatment, leading to enhanced antiplatelet effects.\n- Clopidogrel, while effective, shows a comparatively lower level of platelet aggregation inhibition than BRILINTA after the same treatment duration.\n- The difference in IPA between BRILINTA and clopidogrel may contribute to improved clinical outcomes in patients treated with BRILINTA.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the inhibition of platelet aggregation (IPA) compare between BRILINTA and clopidogrel after 6 weeks of treatment?\nA: BRILINTA shows lower IPA than clopidogrel.\nB: BRILINTA shows similar IPA to clopidogrel.\nC: BRILINTA shows higher IPA than clopidogrel.\nD: BRILINTA shows no IPA effect.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- BRILINTA (ticagrelor) demonstrates a greater inhibition of platelet aggregation compared to clopidogrel after 6 weeks of treatment, leading to enhanced antiplatelet effects.\n- Clopidogrel, while effective, shows a comparatively lower level of platelet aggregation inhibition than BRILINTA after the same treatment duration.\n- The difference in IPA between BRILINTA and clopidogrel may contribute to improved clinical outcomes in patients treated with BRILINTA.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the inhibition of platelet aggregation (IPA) compare between BRILINTA and clopidogrel after 6 weeks of treatment?\nA: BRILINTA shows lower IPA than clopidogrel.\nB: BRILINTA shows similar IPA to clopidogrel.\nC: BRILINTA shows higher IPA than clopidogrel.\nD: BRILINTA shows no IPA effect.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- BRILINTA (ticagrelor) demonstrates a greater inhibition of platelet aggregation compared to clopidogrel after 6 weeks of treatment, leading to enhanced antiplatelet effects.\n- Clopidogrel, while effective, shows a comparatively lower level of platelet aggregation inhibition than BRILINTA after the same treatment duration.\n- The difference in IPA between BRILINTA and clopidogrel may contribute to improved clinical outcomes in patients treated with BRILINTA.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the inhibition of platelet aggregation (IPA) compare between BRILINTA and clopidogrel after 6 weeks of treatment?\nA: BRILINTA shows lower IPA than clopidogrel.\nB: BRILINTA shows similar IPA to clopidogrel.\nC: BRILINTA shows higher IPA than clopidogrel.\nD: BRILINTA shows no IPA effect.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- BRILINTA (ticagrelor) demonstrates a greater inhibition of platelet aggregation compared to clopidogrel after 6 weeks of treatment, leading to enhanced antiplatelet effects.\n- Clopidogrel, while effective, shows a comparatively lower level of platelet aggregation inhibition than BRILINTA after the same treatment duration.\n- The difference in IPA between BRILINTA and clopidogrel may contribute to improved clinical outcomes in patients treated with BRILINTA.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}]"
"Di1yOrmEewSi","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow does the contraindication profile of XENOVIEW compare to drugs with common contraindications such as pregnancy or renal failure?\nA: XENOVIEW has no contraindications, unlike drugs with common contraindications.\nB: XENOVIEW is contraindicated in pregnancy and renal failure.\nC: XENOVIEW has more contraindications than most drugs.\nD: XENOVIEW's contraindications are limited to hypersensitivity reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow does the contraindication profile of XENOVIEW compare to drugs with common contraindications such as pregnancy or renal failure?\nA: XENOVIEW has no contraindications, unlike drugs with common contraindications.\nB: XENOVIEW is contraindicated in pregnancy and renal failure.\nC: XENOVIEW has more contraindications than most drugs.\nD: XENOVIEW's contraindications are limited to hypersensitivity reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow does the contraindication profile of XENOVIEW compare to drugs with common contraindications such as pregnancy or renal failure?\nA: XENOVIEW has no contraindications, unlike drugs with common contraindications.\nB: XENOVIEW is contraindicated in pregnancy and renal failure.\nC: XENOVIEW has more contraindications than most drugs.\nD: XENOVIEW's contraindications are limited to hypersensitivity reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"ZSuguD8bB8HX","- Studies assessing the mutagenicity of Hydrocort have included in vitro assays using bacterial strains such as the Ames test, which evaluates the potential of the drug to cause mutations.
- In vivo studies have also been conducted, where Hydrocort was administered to animal models to observe any chromosomal aberrations or mutagenic effects.
- Comparative studies with a placebo group have been utilized to establish a baseline for mutagenic effects, ensuring that any observed changes can be attributed to Hydrocort rather than external factors.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich category of studies has been conducted to determine mutagenicity for Hydrocort?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Studies assessing the mutagenicity of Hydrocort have included in vitro assays using bacterial strains such as the Ames test, which evaluates the potential of the drug to cause mutations.\n- In vivo studies have also been conducted, where Hydrocort was administered to animal models to observe any chromosomal aberrations or mutagenic effects.\n- Comparative studies with a placebo group have been utilized to establish a baseline for mutagenic effects, ensuring that any observed changes can be attributed to Hydrocort rather than external factors.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which category of studies has been conducted to determine mutagenicity for Hydrocort?\nA: Studies with prednisolone and hydrocortisone\nB: Studies with dexamethasone and betamethasone\nC: Studies with triamcinolone and fluticasone\nD: Studies with topical corticosteroids in humans\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Studies assessing the mutagenicity of Hydrocort have included in vitro assays using bacterial strains such as the Ames test, which evaluates the potential of the drug to cause mutations.\n- In vivo studies have also been conducted, where Hydrocort was administered to animal models to observe any chromosomal aberrations or mutagenic effects.\n- Comparative studies with a placebo group have been utilized to establish a baseline for mutagenic effects, ensuring that any observed changes can be attributed to Hydrocort rather than external factors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which category of studies has been conducted to determine mutagenicity for Hydrocort?\nA: Studies with prednisolone and hydrocortisone\nB: Studies with dexamethasone and betamethasone\nC: Studies with triamcinolone and fluticasone\nD: Studies with topical corticosteroids in humans\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Studies assessing the mutagenicity of Hydrocort have included in vitro assays using bacterial strains such as the Ames test, which evaluates the potential of the drug to cause mutations.\n- In vivo studies have also been conducted, where Hydrocort was administered to animal models to observe any chromosomal aberrations or mutagenic effects.\n- Comparative studies with a placebo group have been utilized to establish a baseline for mutagenic effects, ensuring that any observed changes can be attributed to Hydrocort rather than external factors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which category of studies has been conducted to determine mutagenicity for Hydrocort?\nA: Studies with prednisolone and hydrocortisone\nB: Studies with dexamethasone and betamethasone\nC: Studies with triamcinolone and fluticasone\nD: Studies with topical corticosteroids in humans\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Studies assessing the mutagenicity of Hydrocort have included in vitro assays using bacterial strains such as the Ames test, which evaluates the potential of the drug to cause mutations.\n- In vivo studies have also been conducted, where Hydrocort was administered to animal models to observe any chromosomal aberrations or mutagenic effects.\n- Comparative studies with a placebo group have been utilized to establish a baseline for mutagenic effects, ensuring that any observed changes can be attributed to Hydrocort rather than external factors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"UYErAdkmaCRq","MRRV winner=C; scores={'A': 0.3333333333333333, 'B': 0.25, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow should Belladona be administered for children aged 2 years and under?\nA: 5 drops mixed with half a cup of water, 3-4 times per day\nB: 10 drops mixed with half a cup of water, 3-4 times per day\nC: Consult your doctor for the dosage\nD: Do not administer Belladona to children under 2 years\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow should Belladona be administered for children aged 2 years and under?\nA: 5 drops mixed with half a cup of water, 3-4 times per day\nB: 10 drops mixed with half a cup of water, 3-4 times per day\nC: Consult your doctor for the dosage\nD: Do not administer Belladona to children under 2 years\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow should Belladona be administered for children aged 2 years and under?\nA: 5 drops mixed with half a cup of water, 3-4 times per day\nB: 10 drops mixed with half a cup of water, 3-4 times per day\nC: Consult your doctor for the dosage\nD: Do not administer Belladona to children under 2 years\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}]"
"1hPNUhXOcSyQ","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true about the storage conditions for 'up and up daytime vapor ice cold and flu nighttime vapor ice cold and flu'?\nA: The drug should be stored below 15 \u00b0C.\nB: The drug should be stored at 20-25 \u00b0C.\nC: The drug should be stored above 30 \u00b0C.\nD: The drug should be stored in a freezer.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true about the storage conditions for 'up and up daytime vapor ice cold and flu nighttime vapor ice cold and flu'?\nA: The drug should be stored below 15 \u00b0C.\nB: The drug should be stored at 20-25 \u00b0C.\nC: The drug should be stored above 30 \u00b0C.\nD: The drug should be stored in a freezer.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true about the storage conditions for 'up and up daytime vapor ice cold and flu nighttime vapor ice cold and flu'?\nA: The drug should be stored below 15 \u00b0C.\nB: The drug should be stored at 20-25 \u00b0C.\nC: The drug should be stored above 30 \u00b0C.\nD: The drug should be stored in a freezer.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"KEFQPh31oTjK","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow many drops of vaginal essential oil are recommended for a sitz bath to address vulvovaginitis itching and odor?\nA: 5-8 drops\nB: 10-20 drops\nC: 15-30 drops\nD: 30-50 drops\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow many drops of vaginal essential oil are recommended for a sitz bath to address vulvovaginitis itching and odor?\nA: 5-8 drops\nB: 10-20 drops\nC: 15-30 drops\nD: 30-50 drops\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow many drops of vaginal essential oil are recommended for a sitz bath to address vulvovaginitis itching and odor?\nA: 5-8 drops\nB: 10-20 drops\nC: 15-30 drops\nD: 30-50 drops\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"L9UyhjxZyK4s","- 'Meijer Stomach Relief Regular Strength' is indicated to treat upset stomach, which can include symptoms such as nausea and indigestion.
- It may also be used to alleviate symptoms associated with heartburn, providing relief from discomfort in the stomach area.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn addition to diarrhea, what other condition is 'meijer stomach relief regular strength' indicated to treat?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- 'Meijer Stomach Relief Regular Strength' is indicated to treat upset stomach, which can include symptoms such as nausea and indigestion.\n- It may also be used to alleviate symptoms associated with heartburn, providing relief from discomfort in the stomach area.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In addition to diarrhea, what other condition is 'meijer stomach relief regular strength' indicated to treat?\nA: Nausea\nB: Vomiting\nC: Constipation\nD: Abdominal pain\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- 'Meijer Stomach Relief Regular Strength' is indicated to treat upset stomach, which can include symptoms such as nausea and indigestion.\n- It may also be used to alleviate symptoms associated with heartburn, providing relief from discomfort in the stomach area.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In addition to diarrhea, what other condition is 'meijer stomach relief regular strength' indicated to treat?\nA: Nausea\nB: Vomiting\nC: Constipation\nD: Abdominal pain\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- 'Meijer Stomach Relief Regular Strength' is indicated to treat upset stomach, which can include symptoms such as nausea and indigestion.\n- It may also be used to alleviate symptoms associated with heartburn, providing relief from discomfort in the stomach area.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In addition to diarrhea, what other condition is 'meijer stomach relief regular strength' indicated to treat?\nA: Nausea\nB: Vomiting\nC: Constipation\nD: Abdominal pain\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- 'Meijer Stomach Relief Regular Strength' is indicated to treat upset stomach, which can include symptoms such as nausea and indigestion.\n- It may also be used to alleviate symptoms associated with heartburn, providing relief from discomfort in the stomach area.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"9QokcypOpnMj","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat type of congestion does 'basic care nighttime cold and flu' help alleviate?\nA: Chest congestion\nB: Nasal and sinus congestion\nC: Ear congestion\nD: Lymphatic congestion\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat type of congestion does 'basic care nighttime cold and flu' help alleviate?\nA: Chest congestion\nB: Nasal and sinus congestion\nC: Ear congestion\nD: Lymphatic congestion\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat type of congestion does 'basic care nighttime cold and flu' help alleviate?\nA: Chest congestion\nB: Nasal and sinus congestion\nC: Ear congestion\nD: Lymphatic congestion\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"c58GDnXAVPVv","- Venlafaxine is known to be approximately 27% bound to plasma proteins, which may lead to increased free concentrations of other highly protein-bound drugs, such as warfarin, potentially enhancing their effects or side effects.
- When venlafaxine is administered alongside drugs like phenytoin, which is highly protein-bound, there may be a displacement effect, resulting in altered pharmacokinetics and increased toxicity of phenytoin.
- The interaction between venlafaxine and other highly protein-bound medications necessitates careful monitoring to avoid adverse effects due to changes in drug levels in the bloodstream.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow does venlafaxine interact with drugs highly bound to plasma proteins?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Venlafaxine is known to be approximately 27% bound to plasma proteins, which may lead to increased free concentrations of other highly protein-bound drugs, such as warfarin, potentially enhancing their effects or side effects.\n- When venlafaxine is administered alongside drugs like phenytoin, which is highly protein-bound, there may be a displacement effect, resulting in altered pharmacokinetics and increased toxicity of phenytoin.\n- The interaction between venlafaxine and other highly protein-bound medications necessitates careful monitoring to avoid adverse effects due to changes in drug levels in the bloodstream.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does venlafaxine interact with drugs highly bound to plasma proteins?\nA: Venlafaxine increases the free concentrations of highly protein-bound drugs.\nB: Venlafaxine decreases the free concentrations of highly protein-bound drugs.\nC: Venlafaxine does not cause increased free concentrations of highly protein-bound drugs.\nD: Venlafaxine enhances the plasma protein binding of other drugs.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine is known to be approximately 27% bound to plasma proteins, which may lead to increased free concentrations of other highly protein-bound drugs, such as warfarin, potentially enhancing their effects or side effects.\n- When venlafaxine is administered alongside drugs like phenytoin, which is highly protein-bound, there may be a displacement effect, resulting in altered pharmacokinetics and increased toxicity of phenytoin.\n- The interaction between venlafaxine and other highly protein-bound medications necessitates careful monitoring to avoid adverse effects due to changes in drug levels in the bloodstream.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does venlafaxine interact with drugs highly bound to plasma proteins?\nA: Venlafaxine increases the free concentrations of highly protein-bound drugs.\nB: Venlafaxine decreases the free concentrations of highly protein-bound drugs.\nC: Venlafaxine does not cause increased free concentrations of highly protein-bound drugs.\nD: Venlafaxine enhances the plasma protein binding of other drugs.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine is known to be approximately 27% bound to plasma proteins, which may lead to increased free concentrations of other highly protein-bound drugs, such as warfarin, potentially enhancing their effects or side effects.\n- When venlafaxine is administered alongside drugs like phenytoin, which is highly protein-bound, there may be a displacement effect, resulting in altered pharmacokinetics and increased toxicity of phenytoin.\n- The interaction between venlafaxine and other highly protein-bound medications necessitates careful monitoring to avoid adverse effects due to changes in drug levels in the bloodstream.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does venlafaxine interact with drugs highly bound to plasma proteins?\nA: Venlafaxine increases the free concentrations of highly protein-bound drugs.\nB: Venlafaxine decreases the free concentrations of highly protein-bound drugs.\nC: Venlafaxine does not cause increased free concentrations of highly protein-bound drugs.\nD: Venlafaxine enhances the plasma protein binding of other drugs.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine is known to be approximately 27% bound to plasma proteins, which may lead to increased free concentrations of other highly protein-bound drugs, such as warfarin, potentially enhancing their effects or side effects.\n- When venlafaxine is administered alongside drugs like phenytoin, which is highly protein-bound, there may be a displacement effect, resulting in altered pharmacokinetics and increased toxicity of phenytoin.\n- The interaction between venlafaxine and other highly protein-bound medications necessitates careful monitoring to avoid adverse effects due to changes in drug levels in the bloodstream.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"POquOjLUeFf5","- Discontinue AIRSUPRA immediately if any hypersensitivity reactions, such as rash or difficulty breathing, occur.
- Consider administering appropriate treatment for hypersensitivity, such as antihistamines or corticosteroids, based on the severity of the reaction.
- Monitor the patient closely for any signs of anaphylaxis or severe allergic reactions following the discontinuation of AIRSUPRA.

MRRV(meta) winner=B; scores={'A': 0.4444444444444444, 'B': 1.0, 'C': 0.38888888888888884, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if hypersensitivity reactions occur with AIRSUPRA use?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Discontinue AIRSUPRA immediately if any hypersensitivity reactions, such as rash or difficulty breathing, occur.\n- Consider administering appropriate treatment for hypersensitivity, such as antihistamines or corticosteroids, based on the severity of the reaction.\n- Monitor the patient closely for any signs of anaphylaxis or severe allergic reactions following the discontinuation of AIRSUPRA.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if hypersensitivity reactions occur with AIRSUPRA use?\nA: Continue using AIRSUPRA and monitor symptoms\nB: Discontinue AIRSUPRA and contact a healthcare provider\nC: Take an antihistamine and continue using AIRSUPRA\nD: Reduce the dosage of AIRSUPRA\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue AIRSUPRA immediately if any hypersensitivity reactions, such as rash or difficulty breathing, occur.\n- Consider administering appropriate treatment for hypersensitivity, such as antihistamines or corticosteroids, based on the severity of the reaction.\n- Monitor the patient closely for any signs of anaphylaxis or severe allergic reactions following the discontinuation of AIRSUPRA.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if hypersensitivity reactions occur with AIRSUPRA use?\nA: Continue using AIRSUPRA and monitor symptoms\nB: Discontinue AIRSUPRA and contact a healthcare provider\nC: Take an antihistamine and continue using AIRSUPRA\nD: Reduce the dosage of AIRSUPRA\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue AIRSUPRA immediately if any hypersensitivity reactions, such as rash or difficulty breathing, occur.\n- Consider administering appropriate treatment for hypersensitivity, such as antihistamines or corticosteroids, based on the severity of the reaction.\n- Monitor the patient closely for any signs of anaphylaxis or severe allergic reactions following the discontinuation of AIRSUPRA.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if hypersensitivity reactions occur with AIRSUPRA use?\nA: Continue using AIRSUPRA and monitor symptoms\nB: Discontinue AIRSUPRA and contact a healthcare provider\nC: Take an antihistamine and continue using AIRSUPRA\nD: Reduce the dosage of AIRSUPRA\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue AIRSUPRA immediately if any hypersensitivity reactions, such as rash or difficulty breathing, occur.\n- Consider administering appropriate treatment for hypersensitivity, such as antihistamines or corticosteroids, based on the severity of the reaction.\n- Monitor the patient closely for any signs of anaphylaxis or severe allergic reactions following the discontinuation of AIRSUPRA.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"37BqRqh855UL","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the result of the non-inferiority analysis in Pediatric Study 2 comparing Palonosetron to Ondansetron for postoperative nausea and vomiting prevention?\nA: Non-inferiority was demonstrated.\nB: Non-inferiority was not demonstrated.\nC: Palonosetron was superior to Ondansetron.\nD: The study was inconclusive.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the result of the non-inferiority analysis in Pediatric Study 2 comparing Palonosetron to Ondansetron for postoperative nausea and vomiting prevention?\nA: Non-inferiority was demonstrated.\nB: Non-inferiority was not demonstrated.\nC: Palonosetron was superior to Ondansetron.\nD: The study was inconclusive.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the result of the non-inferiority analysis in Pediatric Study 2 comparing Palonosetron to Ondansetron for postoperative nausea and vomiting prevention?\nA: Non-inferiority was demonstrated.\nB: Non-inferiority was not demonstrated.\nC: Palonosetron was superior to Ondansetron.\nD: The study was inconclusive.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"RqM53KI1SHyE","- Ondansetron, a 5-HT3 receptor antagonist, has been evaluated for mutagenicity and found to have no significant mutagenic effects in various in vitro and in vivo studies.
- In a study assessing the mutagenic potential of ondansetron, it did not show any positive results in the Ames test, which is commonly used to evaluate the mutagenicity of compounds.
- The overall evidence suggests that ondansetron does not pose a mutagenic risk, making it a safe option for use in patients requiring antiemetic therapy.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following statements is true about ondansetron's mutagenicity?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Ondansetron, a 5-HT3 receptor antagonist, has been evaluated for mutagenicity and found to have no significant mutagenic effects in various in vitro and in vivo studies.\n- In a study assessing the mutagenic potential of ondansetron, it did not show any positive results in the Ames test, which is commonly used to evaluate the mutagenicity of compounds.\n- The overall evidence suggests that ondansetron does not pose a mutagenic risk, making it a safe option for use in patients requiring antiemetic therapy.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true about ondansetron's mutagenicity?\nA: Ondansetron was found to be mutagenic in standard tests.\nB: Ondansetron was not mutagenic in standard tests.\nC: Ondansetron's mutagenicity was not tested.\nD: Ondansetron was mutagenic only in high doses.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Ondansetron, a 5-HT3 receptor antagonist, has been evaluated for mutagenicity and found to have no significant mutagenic effects in various in vitro and in vivo studies.\n- In a study assessing the mutagenic potential of ondansetron, it did not show any positive results in the Ames test, which is commonly used to evaluate the mutagenicity of compounds.\n- The overall evidence suggests that ondansetron does not pose a mutagenic risk, making it a safe option for use in patients requiring antiemetic therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true about ondansetron's mutagenicity?\nA: Ondansetron was found to be mutagenic in standard tests.\nB: Ondansetron was not mutagenic in standard tests.\nC: Ondansetron's mutagenicity was not tested.\nD: Ondansetron was mutagenic only in high doses.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Ondansetron, a 5-HT3 receptor antagonist, has been evaluated for mutagenicity and found to have no significant mutagenic effects in various in vitro and in vivo studies.\n- In a study assessing the mutagenic potential of ondansetron, it did not show any positive results in the Ames test, which is commonly used to evaluate the mutagenicity of compounds.\n- The overall evidence suggests that ondansetron does not pose a mutagenic risk, making it a safe option for use in patients requiring antiemetic therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true about ondansetron's mutagenicity?\nA: Ondansetron was found to be mutagenic in standard tests.\nB: Ondansetron was not mutagenic in standard tests.\nC: Ondansetron's mutagenicity was not tested.\nD: Ondansetron was mutagenic only in high doses.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Ondansetron, a 5-HT3 receptor antagonist, has been evaluated for mutagenicity and found to have no significant mutagenic effects in various in vitro and in vivo studies.\n- In a study assessing the mutagenic potential of ondansetron, it did not show any positive results in the Ames test, which is commonly used to evaluate the mutagenicity of compounds.\n- The overall evidence suggests that ondansetron does not pose a mutagenic risk, making it a safe option for use in patients requiring antiemetic therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"19gpGWDpT2B1","1) Recommendation: Motion sickness medications are primarily used to prevent and treat symptoms associated with motion sickness, such as nausea, vomiting, and dizziness. They are particularly effective for individuals who experience discomfort during travel by car, boat, or airplane.

2) Key rationale:
   - Motion sickness occurs when there is a conflict between the sensory signals received by the brain, particularly between the inner ear and visual inputs.
   - Medications like antihistamines (e.g., dimenhydrinate, meclizine) and anticholinergics (e.g., scopolamine) can help alleviate these symptoms by blocking signals to the brain that trigger nausea.
   - These drugs are often recommended for use before travel to prevent the onset of symptoms.

3) Safety/contraindications/interactions:
   - Antihistamines may cause drowsiness; caution is advised when driving or operating machinery.
   - Scopolamine patches should not be used in individuals with certain medical conditions, such as glaucoma or urinary retention.
   - Potential interactions with other medications, particularly those that also cause sedation or have anticholinergic effects, should be considered.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nFor what purpose is the drug Motion Sickness primarily used?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Motion sickness medications are primarily used to prevent and treat symptoms associated with motion sickness, such as nausea, vomiting, and dizziness. They are particularly effective for individuals who experience discomfort during travel by car, boat, or airplane.\n\n2) Key rationale:\n   - Motion sickness occurs when there is a conflict between the sensory signals received by the brain, particularly between the inner ear and visual inputs.\n   - Medications like antihistamines (e.g., dimenhydrinate, meclizine) and anticholinergics (e.g., scopolamine) can help alleviate these symptoms by blocking signals to the brain that trigger nausea.\n   - These drugs are often recommended for use before travel to prevent the onset of symptoms.\n\n3) Safety/contraindications/interactions:\n   - Antihistamines may cause drowsiness; caution is advised when driving or operating machinery.\n   - Scopolamine patches should not be used in individuals with certain medical conditions, such as glaucoma or urinary retention.\n   - Potential interactions with other medications, particularly those that also cause sedation or have anticholinergic effects, should be considered.""}]"
"ccrJKpnAXqBO","MRRV winner=B; scores={'A': 0.38888888888888884, 'B': 1.0, 'C': 0.25, 'D': 0.4444444444444444}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements about GOPRELTO's effect on QTc interval is correct?\nA: GOPRELTO causes significant QTc prolongation at therapeutic doses.\nB: GOPRELTO has no clinically relevant QTc prolongation at the highest clinically relevant concentrations.\nC: GOPRELTO reduces QTc interval significantly at therapeutic doses.\nD: GOPRELTO increases QTc interval only in patients with hepatic impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements about GOPRELTO's effect on QTc interval is correct?\nA: GOPRELTO causes significant QTc prolongation at therapeutic doses.\nB: GOPRELTO has no clinically relevant QTc prolongation at the highest clinically relevant concentrations.\nC: GOPRELTO reduces QTc interval significantly at therapeutic doses.\nD: GOPRELTO increases QTc interval only in patients with hepatic impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements about GOPRELTO's effect on QTc interval is correct?\nA: GOPRELTO causes significant QTc prolongation at therapeutic doses.\nB: GOPRELTO has no clinically relevant QTc prolongation at the highest clinically relevant concentrations.\nC: GOPRELTO reduces QTc interval significantly at therapeutic doses.\nD: GOPRELTO increases QTc interval only in patients with hepatic impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"CalaKnw3bUkV","- Aprepitant, the active metabolite of FOSAPREPITANT, is primarily eliminated through hepatic metabolism, and there is no specific antidote for overdose.
- In cases of overdose, supportive care is recommended, as aprepitant does not have a known mechanism for rapid removal from the body.
- Hemodialysis is not effective in removing aprepitant due to its high protein binding and extensive metabolism.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following statements is true regarding the removal of aprepitant, the active metabolite of FOSAPREPITANT, in cases of overdose?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Aprepitant, the active metabolite of FOSAPREPITANT, is primarily eliminated through hepatic metabolism, and there is no specific antidote for overdose.\n- In cases of overdose, supportive care is recommended, as aprepitant does not have a known mechanism for rapid removal from the body.\n- Hemodialysis is not effective in removing aprepitant due to its high protein binding and extensive metabolism.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the removal of aprepitant, the active metabolite of FOSAPREPITANT, in cases of overdose?\nA: Aprepitant can be effectively removed by hemodialysis.\nB: Aprepitant is not removed by hemodialysis.\nC: Aprepitant is removed through drug-induced emesis.\nD: Aprepitant is removed by increasing the dosage of FOSAPREPITANT.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Aprepitant, the active metabolite of FOSAPREPITANT, is primarily eliminated through hepatic metabolism, and there is no specific antidote for overdose.\n- In cases of overdose, supportive care is recommended, as aprepitant does not have a known mechanism for rapid removal from the body.\n- Hemodialysis is not effective in removing aprepitant due to its high protein binding and extensive metabolism.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the removal of aprepitant, the active metabolite of FOSAPREPITANT, in cases of overdose?\nA: Aprepitant can be effectively removed by hemodialysis.\nB: Aprepitant is not removed by hemodialysis.\nC: Aprepitant is removed through drug-induced emesis.\nD: Aprepitant is removed by increasing the dosage of FOSAPREPITANT.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Aprepitant, the active metabolite of FOSAPREPITANT, is primarily eliminated through hepatic metabolism, and there is no specific antidote for overdose.\n- In cases of overdose, supportive care is recommended, as aprepitant does not have a known mechanism for rapid removal from the body.\n- Hemodialysis is not effective in removing aprepitant due to its high protein binding and extensive metabolism.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the removal of aprepitant, the active metabolite of FOSAPREPITANT, in cases of overdose?\nA: Aprepitant can be effectively removed by hemodialysis.\nB: Aprepitant is not removed by hemodialysis.\nC: Aprepitant is removed through drug-induced emesis.\nD: Aprepitant is removed by increasing the dosage of FOSAPREPITANT.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Aprepitant, the active metabolite of FOSAPREPITANT, is primarily eliminated through hepatic metabolism, and there is no specific antidote for overdose.\n- In cases of overdose, supportive care is recommended, as aprepitant does not have a known mechanism for rapid removal from the body.\n- Hemodialysis is not effective in removing aprepitant due to its high protein binding and extensive metabolism.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"NFKOQkhba0td","- Tybost (cobicistat) is a booster for antiretroviral medications and may not effectively suppress HIV-1 viral load in breast milk, potentially leading to transmission of the virus to the infant.
- Breastfeeding while on Tybost could expose the infant to the drug, which is not recommended due to unknown long-term effects on the child's health.
- The risk of HIV-1 transmission through breast milk remains a concern, and mothers are advised to use formula feeding as a safer alternative while on Tybost.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy are mothers with HIV-1 infection instructed not to breastfeed while taking Tybost?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Tybost (cobicistat) is a booster for antiretroviral medications and may not effectively suppress HIV-1 viral load in breast milk, potentially leading to transmission of the virus to the infant.\n- Breastfeeding while on Tybost could expose the infant to the drug, which is not recommended due to unknown long-term effects on the child's health.\n- The risk of HIV-1 transmission through breast milk remains a concern, and mothers are advised to use formula feeding as a safer alternative while on Tybost.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why are mothers with HIV-1 infection instructed not to breastfeed while taking Tybost?\nA: Breastfeeding reduces the efficacy of Tybost\nB: HIV-1 can be passed to the baby through breast milk\nC: Tybost causes severe side effects in breastfeeding mothers\nD: Breastfeeding increases the risk of renal impairment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Tybost (cobicistat) is a booster for antiretroviral medications and may not effectively suppress HIV-1 viral load in breast milk, potentially leading to transmission of the virus to the infant.\n- Breastfeeding while on Tybost could expose the infant to the drug, which is not recommended due to unknown long-term effects on the child's health.\n- The risk of HIV-1 transmission through breast milk remains a concern, and mothers are advised to use formula feeding as a safer alternative while on Tybost.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why are mothers with HIV-1 infection instructed not to breastfeed while taking Tybost?\nA: Breastfeeding reduces the efficacy of Tybost\nB: HIV-1 can be passed to the baby through breast milk\nC: Tybost causes severe side effects in breastfeeding mothers\nD: Breastfeeding increases the risk of renal impairment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Tybost (cobicistat) is a booster for antiretroviral medications and may not effectively suppress HIV-1 viral load in breast milk, potentially leading to transmission of the virus to the infant.\n- Breastfeeding while on Tybost could expose the infant to the drug, which is not recommended due to unknown long-term effects on the child's health.\n- The risk of HIV-1 transmission through breast milk remains a concern, and mothers are advised to use formula feeding as a safer alternative while on Tybost.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why are mothers with HIV-1 infection instructed not to breastfeed while taking Tybost?\nA: Breastfeeding reduces the efficacy of Tybost\nB: HIV-1 can be passed to the baby through breast milk\nC: Tybost causes severe side effects in breastfeeding mothers\nD: Breastfeeding increases the risk of renal impairment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Tybost (cobicistat) is a booster for antiretroviral medications and may not effectively suppress HIV-1 viral load in breast milk, potentially leading to transmission of the virus to the infant.\n- Breastfeeding while on Tybost could expose the infant to the drug, which is not recommended due to unknown long-term effects on the child's health.\n- The risk of HIV-1 transmission through breast milk remains a concern, and mothers are advised to use formula feeding as a safer alternative while on Tybost.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"kBq9tA4r2XLf","MRRV winner=B; scores={'A': 0.3055555555555555, 'B': 1.0, 'C': 0.5, 'D': 0.27777777777777773}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'D', 'A'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich statement best describes the onset of action for esomeprazole magnesium?\nA: It works immediately after administration.\nB: It may take 1 to 4 days for full effect.\nC: It provides relief within 12 hours.\nD: It is effective only after 1 week of use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich statement best describes the onset of action for esomeprazole magnesium?\nA: It works immediately after administration.\nB: It may take 1 to 4 days for full effect.\nC: It provides relief within 12 hours.\nD: It is effective only after 1 week of use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich statement best describes the onset of action for esomeprazole magnesium?\nA: It works immediately after administration.\nB: It may take 1 to 4 days for full effect.\nC: It provides relief within 12 hours.\nD: It is effective only after 1 week of use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"08xU4dZzpaHf","MRRV winner=B; scores={'A': 0.3055555555555555, 'B': 1.0, 'C': 0.5, 'D': 0.27777777777777773}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'D', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhen coadministering Guanfacine extended-release tablets with fluconazole, what adjustment should be considered?\nA: Increase the dosage of Guanfacine extended-release tablets.\nB: Reduce the dosage of Guanfacine extended-release tablets by 50%.\nC: Maintain the current dosage of Guanfacine extended-release tablets.\nD: Discontinue Guanfacine extended-release tablets.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhen coadministering Guanfacine extended-release tablets with fluconazole, what adjustment should be considered?\nA: Increase the dosage of Guanfacine extended-release tablets.\nB: Reduce the dosage of Guanfacine extended-release tablets by 50%.\nC: Maintain the current dosage of Guanfacine extended-release tablets.\nD: Discontinue Guanfacine extended-release tablets.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhen coadministering Guanfacine extended-release tablets with fluconazole, what adjustment should be considered?\nA: Increase the dosage of Guanfacine extended-release tablets.\nB: Reduce the dosage of Guanfacine extended-release tablets by 50%.\nC: Maintain the current dosage of Guanfacine extended-release tablets.\nD: Discontinue Guanfacine extended-release tablets.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}]"
"4aqs9mZVpMIe","1) Recommendation: If a patient on Coreg CR (carvedilol extended-release) develops renal function deterioration, it is advisable to assess the severity of the renal impairment and consider discontinuing or adjusting the dosage of Coreg CR. Close monitoring of renal function and blood pressure is essential, and consultation with a nephrologist may be warranted.

2) Key rationale:
- Coreg CR can potentially cause or exacerbate renal impairment, especially in patients with pre-existing kidney issues or those on concomitant medications affecting renal function.
- Deterioration in renal function may indicate reduced renal perfusion, which can be exacerbated by the vasodilatory effects of carvedilol.
- Adjusting the medication can help prevent further renal damage and manage blood pressure effectively without compromising kidney function.
- Monitoring renal function allows for timely intervention and adjustment of treatment as needed.

3) Safety/contraindications/interactions:
- Use with caution in patients with a history of renal impairment or those on diuretics, as these can increase the risk of renal deterioration.
- Monitor for signs of hypotension, as this can further compromise renal perfusion.
- Consider potential interactions with other antihypertensive medications that may also affect renal function.
- Ensure hydration status is adequate before making any changes to medication.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the recommended action if a patient on Coreg CR develops renal function deterioration?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: If a patient on Coreg CR (carvedilol extended-release) develops renal function deterioration, it is advisable to assess the severity of the renal impairment and consider discontinuing or adjusting the dosage of Coreg CR. Close monitoring of renal function and blood pressure is essential, and consultation with a nephrologist may be warranted.\n\n2) Key rationale:\n- Coreg CR can potentially cause or exacerbate renal impairment, especially in patients with pre-existing kidney issues or those on concomitant medications affecting renal function.\n- Deterioration in renal function may indicate reduced renal perfusion, which can be exacerbated by the vasodilatory effects of carvedilol.\n- Adjusting the medication can help prevent further renal damage and manage blood pressure effectively without compromising kidney function.\n- Monitoring renal function allows for timely intervention and adjustment of treatment as needed.\n\n3) Safety/contraindications/interactions:\n- Use with caution in patients with a history of renal impairment or those on diuretics, as these can increase the risk of renal deterioration.\n- Monitor for signs of hypotension, as this can further compromise renal perfusion.\n- Consider potential interactions with other antihypertensive medications that may also affect renal function.\n- Ensure hydration status is adequate before making any changes to medication.""}]"
"KgADkvaEga86","- The bronchodilator response to 1.25 mg Levalbuterol is generally comparable to that of 2.5 mg racemic albuterol sulfate, indicating similar efficacy in improving airflow.
- Both medications are evaluated over a 6-hour period, with Levalbuterol potentially offering a more targeted effect due to its R-enantiomer formulation, while racemic albuterol contains both R- and S-enantiomers.
- Adverse effects may differ, with Levalbuterol often associated with fewer side effects compared to racemic albuterol, which can influence patient preference and adherence.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn clinical studies, how does the bronchodilator response of 1.25 mg Levalbuterol compare to 2.5 mg racemic albuterol sulfate over a 6-hour evaluation period?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The bronchodilator response to 1.25 mg Levalbuterol is generally comparable to that of 2.5 mg racemic albuterol sulfate, indicating similar efficacy in improving airflow.\n- Both medications are evaluated over a 6-hour period, with Levalbuterol potentially offering a more targeted effect due to its R-enantiomer formulation, while racemic albuterol contains both R- and S-enantiomers.\n- Adverse effects may differ, with Levalbuterol often associated with fewer side effects compared to racemic albuterol, which can influence patient preference and adherence.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In clinical studies, how does the bronchodilator response of 1.25 mg Levalbuterol compare to 2.5 mg racemic albuterol sulfate over a 6-hour evaluation period?\nA: Levalbuterol has a significantly shorter duration of action.\nB: Levalbuterol and racemic albuterol sulfate have clinically comparable responses.\nC: Racemic albuterol sulfate has a significantly higher bronchodilator response.\nD: Levalbuterol shows no bronchodilator response.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The bronchodilator response to 1.25 mg Levalbuterol is generally comparable to that of 2.5 mg racemic albuterol sulfate, indicating similar efficacy in improving airflow.\n- Both medications are evaluated over a 6-hour period, with Levalbuterol potentially offering a more targeted effect due to its R-enantiomer formulation, while racemic albuterol contains both R- and S-enantiomers.\n- Adverse effects may differ, with Levalbuterol often associated with fewer side effects compared to racemic albuterol, which can influence patient preference and adherence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In clinical studies, how does the bronchodilator response of 1.25 mg Levalbuterol compare to 2.5 mg racemic albuterol sulfate over a 6-hour evaluation period?\nA: Levalbuterol has a significantly shorter duration of action.\nB: Levalbuterol and racemic albuterol sulfate have clinically comparable responses.\nC: Racemic albuterol sulfate has a significantly higher bronchodilator response.\nD: Levalbuterol shows no bronchodilator response.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The bronchodilator response to 1.25 mg Levalbuterol is generally comparable to that of 2.5 mg racemic albuterol sulfate, indicating similar efficacy in improving airflow.\n- Both medications are evaluated over a 6-hour period, with Levalbuterol potentially offering a more targeted effect due to its R-enantiomer formulation, while racemic albuterol contains both R- and S-enantiomers.\n- Adverse effects may differ, with Levalbuterol often associated with fewer side effects compared to racemic albuterol, which can influence patient preference and adherence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In clinical studies, how does the bronchodilator response of 1.25 mg Levalbuterol compare to 2.5 mg racemic albuterol sulfate over a 6-hour evaluation period?\nA: Levalbuterol has a significantly shorter duration of action.\nB: Levalbuterol and racemic albuterol sulfate have clinically comparable responses.\nC: Racemic albuterol sulfate has a significantly higher bronchodilator response.\nD: Levalbuterol shows no bronchodilator response.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The bronchodilator response to 1.25 mg Levalbuterol is generally comparable to that of 2.5 mg racemic albuterol sulfate, indicating similar efficacy in improving airflow.\n- Both medications are evaluated over a 6-hour period, with Levalbuterol potentially offering a more targeted effect due to its R-enantiomer formulation, while racemic albuterol contains both R- and S-enantiomers.\n- Adverse effects may differ, with Levalbuterol often associated with fewer side effects compared to racemic albuterol, which can influence patient preference and adherence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"S8vLsWVS2kC7","- Users of WL-AAB-Z-W-1350 should avoid wearing contact lenses while using the medication, as it may cause dryness or irritation in the eyes.
- It is recommended to switch to glasses during the treatment period with WL-AAB-Z-W-1350 to prevent discomfort and potential complications.
- If contact lens use is necessary, consult with an eye care professional for appropriate recommendations and possible alternatives.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat precaution should be taken when using WL-AAB-Z-W-1350 with contact lenses?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Users of WL-AAB-Z-W-1350 should avoid wearing contact lenses while using the medication, as it may cause dryness or irritation in the eyes.\n- It is recommended to switch to glasses during the treatment period with WL-AAB-Z-W-1350 to prevent discomfort and potential complications.\n- If contact lens use is necessary, consult with an eye care professional for appropriate recommendations and possible alternatives.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken when using WL-AAB-Z-W-1350 with contact lenses?\nA: Contact lenses should be removed prior to instillation and reinserted immediately after administration.\nB: Contact lenses should be removed prior to instillation and reinserted 15 minutes after administration.\nC: Contact lenses should not be used during treatment with WL-AAB-Z-W-1350.\nD: Contact lenses should be sterilized before using WL-AAB-Z-W-1350.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Users of WL-AAB-Z-W-1350 should avoid wearing contact lenses while using the medication, as it may cause dryness or irritation in the eyes.\n- It is recommended to switch to glasses during the treatment period with WL-AAB-Z-W-1350 to prevent discomfort and potential complications.\n- If contact lens use is necessary, consult with an eye care professional for appropriate recommendations and possible alternatives.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken when using WL-AAB-Z-W-1350 with contact lenses?\nA: Contact lenses should be removed prior to instillation and reinserted immediately after administration.\nB: Contact lenses should be removed prior to instillation and reinserted 15 minutes after administration.\nC: Contact lenses should not be used during treatment with WL-AAB-Z-W-1350.\nD: Contact lenses should be sterilized before using WL-AAB-Z-W-1350.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Users of WL-AAB-Z-W-1350 should avoid wearing contact lenses while using the medication, as it may cause dryness or irritation in the eyes.\n- It is recommended to switch to glasses during the treatment period with WL-AAB-Z-W-1350 to prevent discomfort and potential complications.\n- If contact lens use is necessary, consult with an eye care professional for appropriate recommendations and possible alternatives.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken when using WL-AAB-Z-W-1350 with contact lenses?\nA: Contact lenses should be removed prior to instillation and reinserted immediately after administration.\nB: Contact lenses should be removed prior to instillation and reinserted 15 minutes after administration.\nC: Contact lenses should not be used during treatment with WL-AAB-Z-W-1350.\nD: Contact lenses should be sterilized before using WL-AAB-Z-W-1350.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Users of WL-AAB-Z-W-1350 should avoid wearing contact lenses while using the medication, as it may cause dryness or irritation in the eyes.\n- It is recommended to switch to glasses during the treatment period with WL-AAB-Z-W-1350 to prevent discomfort and potential complications.\n- If contact lens use is necessary, consult with an eye care professional for appropriate recommendations and possible alternatives.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"x5hW0ejtnZTb","- Clinical experience with NURTEC ODT (rimegepant) indicates that doses exceeding the recommended 75 mg in a 24-hour period may lead to increased adverse effects, although specific overdose data is limited.
- In studies, patients taking NURTEC ODT reported side effects such as nausea and somnolence, which may be exacerbated in cases of overdosage.
- There is no specific antidote for NURTEC ODT overdosage, and management typically involves supportive care and monitoring for symptoms.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich statement accurately describes the clinical experience with NURTEC ODT overdosage?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Clinical experience with NURTEC ODT (rimegepant) indicates that doses exceeding the recommended 75 mg in a 24-hour period may lead to increased adverse effects, although specific overdose data is limited.\n- In studies, patients taking NURTEC ODT reported side effects such as nausea and somnolence, which may be exacerbated in cases of overdosage.\n- There is no specific antidote for NURTEC ODT overdosage, and management typically involves supportive care and monitoring for symptoms.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which statement accurately describes the clinical experience with NURTEC ODT overdosage?\nA: There is extensive clinical experience with NURTEC ODT overdosage.\nB: There is limited clinical experience with NURTEC ODT overdosage.\nC: Overdosage of NURTEC ODT is well-documented in clinical trials.\nD: Overdosage of NURTEC ODT requires immediate dialysis.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Clinical experience with NURTEC ODT (rimegepant) indicates that doses exceeding the recommended 75 mg in a 24-hour period may lead to increased adverse effects, although specific overdose data is limited.\n- In studies, patients taking NURTEC ODT reported side effects such as nausea and somnolence, which may be exacerbated in cases of overdosage.\n- There is no specific antidote for NURTEC ODT overdosage, and management typically involves supportive care and monitoring for symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which statement accurately describes the clinical experience with NURTEC ODT overdosage?\nA: There is extensive clinical experience with NURTEC ODT overdosage.\nB: There is limited clinical experience with NURTEC ODT overdosage.\nC: Overdosage of NURTEC ODT is well-documented in clinical trials.\nD: Overdosage of NURTEC ODT requires immediate dialysis.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Clinical experience with NURTEC ODT (rimegepant) indicates that doses exceeding the recommended 75 mg in a 24-hour period may lead to increased adverse effects, although specific overdose data is limited.\n- In studies, patients taking NURTEC ODT reported side effects such as nausea and somnolence, which may be exacerbated in cases of overdosage.\n- There is no specific antidote for NURTEC ODT overdosage, and management typically involves supportive care and monitoring for symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which statement accurately describes the clinical experience with NURTEC ODT overdosage?\nA: There is extensive clinical experience with NURTEC ODT overdosage.\nB: There is limited clinical experience with NURTEC ODT overdosage.\nC: Overdosage of NURTEC ODT is well-documented in clinical trials.\nD: Overdosage of NURTEC ODT requires immediate dialysis.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Clinical experience with NURTEC ODT (rimegepant) indicates that doses exceeding the recommended 75 mg in a 24-hour period may lead to increased adverse effects, although specific overdose data is limited.\n- In studies, patients taking NURTEC ODT reported side effects such as nausea and somnolence, which may be exacerbated in cases of overdosage.\n- There is no specific antidote for NURTEC ODT overdosage, and management typically involves supportive care and monitoring for symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"bdNZvGKaYiCG","- Overdosage of TAKHZYRO (lanadelumab) may lead to increased risk of adverse effects, particularly injection site reactions and hypersensitivity.
- In clinical studies, no specific antidote for TAKHZYRO has been established, and management of overdose primarily involves supportive care.
- The maximum tolerated dose of TAKHZYRO has not been defined, but doses significantly higher than the recommended regimen of 300 mg every two weeks could exacerbate side effects.

MRRV(meta) winner=D; scores={'A': 0.25, 'B': 0.5555555555555555, 'C': 0.5, 'D': 0.7777777777777777}; rankings=[['D', 'C', 'B', 'A'], ['B', 'C', 'D', 'A'], ['D', 'C', 'B', 'A']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following statements is true regarding the overdosage of TAKHZYRO?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Overdosage of TAKHZYRO (lanadelumab) may lead to increased risk of adverse effects, particularly injection site reactions and hypersensitivity.\n- In clinical studies, no specific antidote for TAKHZYRO has been established, and management of overdose primarily involves supportive care.\n- The maximum tolerated dose of TAKHZYRO has not been defined, but doses significantly higher than the recommended regimen of 300 mg every two weeks could exacerbate side effects.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the overdosage of TAKHZYRO?\nA: Overdosage of TAKHZYRO has been extensively studied in clinical settings.\nB: There is no available clinical data on overdosage of TAKHZYRO.\nC: Overdosage of TAKHZYRO is associated with severe adverse effects.\nD: Overdosage of TAKHZYRO has been reported in post-marketing surveillance.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Overdosage of TAKHZYRO (lanadelumab) may lead to increased risk of adverse effects, particularly injection site reactions and hypersensitivity.\n- In clinical studies, no specific antidote for TAKHZYRO has been established, and management of overdose primarily involves supportive care.\n- The maximum tolerated dose of TAKHZYRO has not been defined, but doses significantly higher than the recommended regimen of 300 mg every two weeks could exacerbate side effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the overdosage of TAKHZYRO?\nA: Overdosage of TAKHZYRO has been extensively studied in clinical settings.\nB: There is no available clinical data on overdosage of TAKHZYRO.\nC: Overdosage of TAKHZYRO is associated with severe adverse effects.\nD: Overdosage of TAKHZYRO has been reported in post-marketing surveillance.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Overdosage of TAKHZYRO (lanadelumab) may lead to increased risk of adverse effects, particularly injection site reactions and hypersensitivity.\n- In clinical studies, no specific antidote for TAKHZYRO has been established, and management of overdose primarily involves supportive care.\n- The maximum tolerated dose of TAKHZYRO has not been defined, but doses significantly higher than the recommended regimen of 300 mg every two weeks could exacerbate side effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the overdosage of TAKHZYRO?\nA: Overdosage of TAKHZYRO has been extensively studied in clinical settings.\nB: There is no available clinical data on overdosage of TAKHZYRO.\nC: Overdosage of TAKHZYRO is associated with severe adverse effects.\nD: Overdosage of TAKHZYRO has been reported in post-marketing surveillance.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Overdosage of TAKHZYRO (lanadelumab) may lead to increased risk of adverse effects, particularly injection site reactions and hypersensitivity.\n- In clinical studies, no specific antidote for TAKHZYRO has been established, and management of overdose primarily involves supportive care.\n- The maximum tolerated dose of TAKHZYRO has not been defined, but doses significantly higher than the recommended regimen of 300 mg every two weeks could exacerbate side effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}]"
"eRORKd8kTZwY","- Monitor INR levels closely when Pantoprazole Sodium is co-administered with Warfarin, as Pantoprazole may affect Warfarin metabolism.
- Consider adjusting the Warfarin dosage based on INR results to maintain therapeutic anticoagulation levels.
- Be aware of potential increased bleeding risk due to the interaction between Pantoprazole and Warfarin.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended intervention when Pantoprazole Sodium is co-administered with Warfarin?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Monitor INR levels closely when Pantoprazole Sodium is co-administered with Warfarin, as Pantoprazole may affect Warfarin metabolism.\n- Consider adjusting the Warfarin dosage based on INR results to maintain therapeutic anticoagulation levels.\n- Be aware of potential increased bleeding risk due to the interaction between Pantoprazole and Warfarin.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended intervention when Pantoprazole Sodium is co-administered with Warfarin?\nA: Avoid concomitant use\nB: Monitor INR and prothrombin time\nC: No dose adjustment required\nD: Temporarily withdraw Pantoprazole Sodium\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor INR levels closely when Pantoprazole Sodium is co-administered with Warfarin, as Pantoprazole may affect Warfarin metabolism.\n- Consider adjusting the Warfarin dosage based on INR results to maintain therapeutic anticoagulation levels.\n- Be aware of potential increased bleeding risk due to the interaction between Pantoprazole and Warfarin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended intervention when Pantoprazole Sodium is co-administered with Warfarin?\nA: Avoid concomitant use\nB: Monitor INR and prothrombin time\nC: No dose adjustment required\nD: Temporarily withdraw Pantoprazole Sodium\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor INR levels closely when Pantoprazole Sodium is co-administered with Warfarin, as Pantoprazole may affect Warfarin metabolism.\n- Consider adjusting the Warfarin dosage based on INR results to maintain therapeutic anticoagulation levels.\n- Be aware of potential increased bleeding risk due to the interaction between Pantoprazole and Warfarin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended intervention when Pantoprazole Sodium is co-administered with Warfarin?\nA: Avoid concomitant use\nB: Monitor INR and prothrombin time\nC: No dose adjustment required\nD: Temporarily withdraw Pantoprazole Sodium\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor INR levels closely when Pantoprazole Sodium is co-administered with Warfarin, as Pantoprazole may affect Warfarin metabolism.\n- Consider adjusting the Warfarin dosage based on INR results to maintain therapeutic anticoagulation levels.\n- Be aware of potential increased bleeding risk due to the interaction between Pantoprazole and Warfarin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"meSDxVMG9fwe","MRRV winner=D; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 0.25, 'D': 1.0}; rankings=[['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C']]","D","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended storage temperature range for dg health nasal?\nA: Between 0\u00b0C and 20\u00b0C\nB: Between 4\u00b0C and 30\u00b0C\nC: Between 10\u00b0C and 40\u00b0C\nD: Between 5\u00b0C and 25\u00b0C\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended storage temperature range for dg health nasal?\nA: Between 0\u00b0C and 20\u00b0C\nB: Between 4\u00b0C and 30\u00b0C\nC: Between 10\u00b0C and 40\u00b0C\nD: Between 5\u00b0C and 25\u00b0C\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended storage temperature range for dg health nasal?\nA: Between 0\u00b0C and 20\u00b0C\nB: Between 4\u00b0C and 30\u00b0C\nC: Between 10\u00b0C and 40\u00b0C\nD: Between 5\u00b0C and 25\u00b0C\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}]"
"BFuvT8DFarY8","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary use of the drug brand name 'sterile'?\nA: To treat bacterial infections\nB: For preparation of the skin prior to injection\nC: To reduce inflammation\nD: For pain relief\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary use of the drug brand name 'sterile'?\nA: To treat bacterial infections\nB: For preparation of the skin prior to injection\nC: To reduce inflammation\nD: For pain relief\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary use of the drug brand name 'sterile'?\nA: To treat bacterial infections\nB: For preparation of the skin prior to injection\nC: To reduce inflammation\nD: For pain relief\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"zYx2p6AcHlUy","- Vaginal essential oil may help to enhance the absorption of the subsequent gel application, potentially improving the efficacy of active ingredients in treating chronic inflammation.
- The use of vaginal essential oil can provide a soothing effect, which may alleviate discomfort associated with chronic inflammation before applying the gel.
- Essential oils may possess anti-inflammatory properties that could complement the therapeutic effects of the gel, leading to improved overall outcomes in managing chronic inflammation.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the purpose of using vaginal essential oil before the application of gel during chronic inflammation?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Vaginal essential oil may help to enhance the absorption of the subsequent gel application, potentially improving the efficacy of active ingredients in treating chronic inflammation.\n- The use of vaginal essential oil can provide a soothing effect, which may alleviate discomfort associated with chronic inflammation before applying the gel.\n- Essential oils may possess anti-inflammatory properties that could complement the therapeutic effects of the gel, leading to improved overall outcomes in managing chronic inflammation.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the purpose of using vaginal essential oil before the application of gel during chronic inflammation?\nA: To prevent repeated cross-infection of external bacteria.\nB: To promote the absorption of the gel.\nC: To relieve vulvovaginitis itching and odor.\nD: To remove odors from the environment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Vaginal essential oil may help to enhance the absorption of the subsequent gel application, potentially improving the efficacy of active ingredients in treating chronic inflammation.\n- The use of vaginal essential oil can provide a soothing effect, which may alleviate discomfort associated with chronic inflammation before applying the gel.\n- Essential oils may possess anti-inflammatory properties that could complement the therapeutic effects of the gel, leading to improved overall outcomes in managing chronic inflammation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the purpose of using vaginal essential oil before the application of gel during chronic inflammation?\nA: To prevent repeated cross-infection of external bacteria.\nB: To promote the absorption of the gel.\nC: To relieve vulvovaginitis itching and odor.\nD: To remove odors from the environment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Vaginal essential oil may help to enhance the absorption of the subsequent gel application, potentially improving the efficacy of active ingredients in treating chronic inflammation.\n- The use of vaginal essential oil can provide a soothing effect, which may alleviate discomfort associated with chronic inflammation before applying the gel.\n- Essential oils may possess anti-inflammatory properties that could complement the therapeutic effects of the gel, leading to improved overall outcomes in managing chronic inflammation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the purpose of using vaginal essential oil before the application of gel during chronic inflammation?\nA: To prevent repeated cross-infection of external bacteria.\nB: To promote the absorption of the gel.\nC: To relieve vulvovaginitis itching and odor.\nD: To remove odors from the environment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Vaginal essential oil may help to enhance the absorption of the subsequent gel application, potentially improving the efficacy of active ingredients in treating chronic inflammation.\n- The use of vaginal essential oil can provide a soothing effect, which may alleviate discomfort associated with chronic inflammation before applying the gel.\n- Essential oils may possess anti-inflammatory properties that could complement the therapeutic effects of the gel, leading to improved overall outcomes in managing chronic inflammation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"sxROelTQ13BT","- Zynteglo is contraindicated in patients with active or uncontrolled infections, which is a specific concern not typically highlighted for many conventional therapies.
- Unlike some gene therapies, Zynteglo requires pre-treatment with chemotherapy (such as busulfan) to create space for the new gene-modified cells, which adds a layer of contraindications related to the pre-treatment regimen.
- Zynteglo's contraindications also include hypersensitivity to any of its components, which is a common concern but may differ in severity compared to other drugs that have broader contraindications related to organ function or specific disease states.

MRRV(meta) winner=C; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow does the contraindication profile of Zynteglo differ from drugs with specific contraindications?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Zynteglo is contraindicated in patients with active or uncontrolled infections, which is a specific concern not typically highlighted for many conventional therapies.\n- Unlike some gene therapies, Zynteglo requires pre-treatment with chemotherapy (such as busulfan) to create space for the new gene-modified cells, which adds a layer of contraindications related to the pre-treatment regimen.\n- Zynteglo's contraindications also include hypersensitivity to any of its components, which is a common concern but may differ in severity compared to other drugs that have broader contraindications related to organ function or specific disease states.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the contraindication profile of Zynteglo differ from drugs with specific contraindications?\nA: Zynteglo has no contraindications, making it universally safe for all patients.\nB: Zynteglo has no contraindications, but safety should still be assessed individually.\nC: Zynteglo has contraindications for patients with pre-existing conditions.\nD: Zynteglo has contraindications for patients taking other medications.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Zynteglo is contraindicated in patients with active or uncontrolled infections, which is a specific concern not typically highlighted for many conventional therapies.\n- Unlike some gene therapies, Zynteglo requires pre-treatment with chemotherapy (such as busulfan) to create space for the new gene-modified cells, which adds a layer of contraindications related to the pre-treatment regimen.\n- Zynteglo's contraindications also include hypersensitivity to any of its components, which is a common concern but may differ in severity compared to other drugs that have broader contraindications related to organ function or specific disease states.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the contraindication profile of Zynteglo differ from drugs with specific contraindications?\nA: Zynteglo has no contraindications, making it universally safe for all patients.\nB: Zynteglo has no contraindications, but safety should still be assessed individually.\nC: Zynteglo has contraindications for patients with pre-existing conditions.\nD: Zynteglo has contraindications for patients taking other medications.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Zynteglo is contraindicated in patients with active or uncontrolled infections, which is a specific concern not typically highlighted for many conventional therapies.\n- Unlike some gene therapies, Zynteglo requires pre-treatment with chemotherapy (such as busulfan) to create space for the new gene-modified cells, which adds a layer of contraindications related to the pre-treatment regimen.\n- Zynteglo's contraindications also include hypersensitivity to any of its components, which is a common concern but may differ in severity compared to other drugs that have broader contraindications related to organ function or specific disease states.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the contraindication profile of Zynteglo differ from drugs with specific contraindications?\nA: Zynteglo has no contraindications, making it universally safe for all patients.\nB: Zynteglo has no contraindications, but safety should still be assessed individually.\nC: Zynteglo has contraindications for patients with pre-existing conditions.\nD: Zynteglo has contraindications for patients taking other medications.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Zynteglo is contraindicated in patients with active or uncontrolled infections, which is a specific concern not typically highlighted for many conventional therapies.\n- Unlike some gene therapies, Zynteglo requires pre-treatment with chemotherapy (such as busulfan) to create space for the new gene-modified cells, which adds a layer of contraindications related to the pre-treatment regimen.\n- Zynteglo's contraindications also include hypersensitivity to any of its components, which is a common concern but may differ in severity compared to other drugs that have broader contraindications related to organ function or specific disease states.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}]"
"6PFfh7ypr86Q","- Pemetrexed for injection has a narrow therapeutic index, making it challenging to manage overdose due to the risk of severe toxicity, particularly myelosuppression and mucositis.
- There is no specific antidote for Pemetrexed overdose, complicating treatment options and necessitating supportive care measures.
- The potential for prolonged elimination half-life in cases of overdose can lead to delayed onset of toxicity, making timely intervention difficult.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.38888888888888884, 'C': 0.4444444444444444, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'B', 'C', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the primary limitation in managing Pemetrexed for injection overdose?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Pemetrexed for injection has a narrow therapeutic index, making it challenging to manage overdose due to the risk of severe toxicity, particularly myelosuppression and mucositis.\n- There is no specific antidote for Pemetrexed overdose, complicating treatment options and necessitating supportive care measures.\n- The potential for prolonged elimination half-life in cases of overdose can lead to delayed onset of toxicity, making timely intervention difficult.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary limitation in managing Pemetrexed for injection overdose?\nA: Lack of approved drugs for treatment\nB: Inability to administer leucovorin\nC: High dialyzability of Pemetrexed\nD: Excessive cost of treatment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Pemetrexed for injection has a narrow therapeutic index, making it challenging to manage overdose due to the risk of severe toxicity, particularly myelosuppression and mucositis.\n- There is no specific antidote for Pemetrexed overdose, complicating treatment options and necessitating supportive care measures.\n- The potential for prolonged elimination half-life in cases of overdose can lead to delayed onset of toxicity, making timely intervention difficult.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary limitation in managing Pemetrexed for injection overdose?\nA: Lack of approved drugs for treatment\nB: Inability to administer leucovorin\nC: High dialyzability of Pemetrexed\nD: Excessive cost of treatment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Pemetrexed for injection has a narrow therapeutic index, making it challenging to manage overdose due to the risk of severe toxicity, particularly myelosuppression and mucositis.\n- There is no specific antidote for Pemetrexed overdose, complicating treatment options and necessitating supportive care measures.\n- The potential for prolonged elimination half-life in cases of overdose can lead to delayed onset of toxicity, making timely intervention difficult.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary limitation in managing Pemetrexed for injection overdose?\nA: Lack of approved drugs for treatment\nB: Inability to administer leucovorin\nC: High dialyzability of Pemetrexed\nD: Excessive cost of treatment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Pemetrexed for injection has a narrow therapeutic index, making it challenging to manage overdose due to the risk of severe toxicity, particularly myelosuppression and mucositis.\n- There is no specific antidote for Pemetrexed overdose, complicating treatment options and necessitating supportive care measures.\n- The potential for prolonged elimination half-life in cases of overdose can lead to delayed onset of toxicity, making timely intervention difficult.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"9mRexbkM9AXM","- Consider using G-62 in combination with a broad-spectrum antibiotic such as piperacillin-tazobactam to enhance efficacy against resistant Gram-negative bacteria.
- Monitor for potential interactions if G-62 is administered alongside aminoglycosides like gentamicin, as this may increase the risk of nephrotoxicity.
- Evaluate the patient's renal function before initiating G-62 therapy, especially if using it with other nephrotoxic agents, to adjust dosages accordingly.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended approach for selecting antibacterial therapy when using G-62?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Consider using G-62 in combination with a broad-spectrum antibiotic such as piperacillin-tazobactam to enhance efficacy against resistant Gram-negative bacteria.\n- Monitor for potential interactions if G-62 is administered alongside aminoglycosides like gentamicin, as this may increase the risk of nephrotoxicity.\n- Evaluate the patient's renal function before initiating G-62 therapy, especially if using it with other nephrotoxic agents, to adjust dosages accordingly.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for selecting antibacterial therapy when using G-62?\nA: Consider culture and susceptibility information when available.\nB: Always use G-62 regardless of bacterial susceptibility.\nC: Select therapy based solely on patient age.\nD: Avoid using bacteriological studies for therapy selection.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider using G-62 in combination with a broad-spectrum antibiotic such as piperacillin-tazobactam to enhance efficacy against resistant Gram-negative bacteria.\n- Monitor for potential interactions if G-62 is administered alongside aminoglycosides like gentamicin, as this may increase the risk of nephrotoxicity.\n- Evaluate the patient's renal function before initiating G-62 therapy, especially if using it with other nephrotoxic agents, to adjust dosages accordingly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for selecting antibacterial therapy when using G-62?\nA: Consider culture and susceptibility information when available.\nB: Always use G-62 regardless of bacterial susceptibility.\nC: Select therapy based solely on patient age.\nD: Avoid using bacteriological studies for therapy selection.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider using G-62 in combination with a broad-spectrum antibiotic such as piperacillin-tazobactam to enhance efficacy against resistant Gram-negative bacteria.\n- Monitor for potential interactions if G-62 is administered alongside aminoglycosides like gentamicin, as this may increase the risk of nephrotoxicity.\n- Evaluate the patient's renal function before initiating G-62 therapy, especially if using it with other nephrotoxic agents, to adjust dosages accordingly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for selecting antibacterial therapy when using G-62?\nA: Consider culture and susceptibility information when available.\nB: Always use G-62 regardless of bacterial susceptibility.\nC: Select therapy based solely on patient age.\nD: Avoid using bacteriological studies for therapy selection.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider using G-62 in combination with a broad-spectrum antibiotic such as piperacillin-tazobactam to enhance efficacy against resistant Gram-negative bacteria.\n- Monitor for potential interactions if G-62 is administered alongside aminoglycosides like gentamicin, as this may increase the risk of nephrotoxicity.\n- Evaluate the patient's renal function before initiating G-62 therapy, especially if using it with other nephrotoxic agents, to adjust dosages accordingly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"2GVcXij7hZ8B","- The lack of response to Sumatriptan Injection, a triptan medication, may indicate that the patient's migraine is not of the typical type that responds to this class of drugs, suggesting a need for reevaluation of the diagnosis.
- If the patient does not experience relief from their migraine after using Sumatriptan, it may be necessary to consider alternative diagnoses such as cluster headaches or other primary headache disorders that may require different treatment approaches.
- The failure to respond to an acute treatment like Sumatriptan could also imply the presence of medication overuse headache, necessitating a reassessment of the patient's headache history and treatment regimen.

MRRV(meta) winner=B; scores={'A': 0.4444444444444444, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy should the diagnosis be reconsidered if a patient does not respond to the first migraine attack treated with Sumatriptan Injection?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The lack of response to Sumatriptan Injection, a triptan medication, may indicate that the patient's migraine is not of the typical type that responds to this class of drugs, suggesting a need for reevaluation of the diagnosis.\n- If the patient does not experience relief from their migraine after using Sumatriptan, it may be necessary to consider alternative diagnoses such as cluster headaches or other primary headache disorders that may require different treatment approaches.\n- The failure to respond to an acute treatment like Sumatriptan could also imply the presence of medication overuse headache, necessitating a reassessment of the patient's headache history and treatment regimen.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should the diagnosis be reconsidered if a patient does not respond to the first migraine attack treated with Sumatriptan Injection?\nA: Sumatriptan Injection is only effective for chronic migraines.\nB: The patient may have a different type of headache that is not responsive to Sumatriptan Injection.\nC: Sumatriptan Injection is only effective for cluster headaches.\nD: The dosage of Sumatriptan Injection may need to be increased.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The lack of response to Sumatriptan Injection, a triptan medication, may indicate that the patient's migraine is not of the typical type that responds to this class of drugs, suggesting a need for reevaluation of the diagnosis.\n- If the patient does not experience relief from their migraine after using Sumatriptan, it may be necessary to consider alternative diagnoses such as cluster headaches or other primary headache disorders that may require different treatment approaches.\n- The failure to respond to an acute treatment like Sumatriptan could also imply the presence of medication overuse headache, necessitating a reassessment of the patient's headache history and treatment regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should the diagnosis be reconsidered if a patient does not respond to the first migraine attack treated with Sumatriptan Injection?\nA: Sumatriptan Injection is only effective for chronic migraines.\nB: The patient may have a different type of headache that is not responsive to Sumatriptan Injection.\nC: Sumatriptan Injection is only effective for cluster headaches.\nD: The dosage of Sumatriptan Injection may need to be increased.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The lack of response to Sumatriptan Injection, a triptan medication, may indicate that the patient's migraine is not of the typical type that responds to this class of drugs, suggesting a need for reevaluation of the diagnosis.\n- If the patient does not experience relief from their migraine after using Sumatriptan, it may be necessary to consider alternative diagnoses such as cluster headaches or other primary headache disorders that may require different treatment approaches.\n- The failure to respond to an acute treatment like Sumatriptan could also imply the presence of medication overuse headache, necessitating a reassessment of the patient's headache history and treatment regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should the diagnosis be reconsidered if a patient does not respond to the first migraine attack treated with Sumatriptan Injection?\nA: Sumatriptan Injection is only effective for chronic migraines.\nB: The patient may have a different type of headache that is not responsive to Sumatriptan Injection.\nC: Sumatriptan Injection is only effective for cluster headaches.\nD: The dosage of Sumatriptan Injection may need to be increased.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The lack of response to Sumatriptan Injection, a triptan medication, may indicate that the patient's migraine is not of the typical type that responds to this class of drugs, suggesting a need for reevaluation of the diagnosis.\n- If the patient does not experience relief from their migraine after using Sumatriptan, it may be necessary to consider alternative diagnoses such as cluster headaches or other primary headache disorders that may require different treatment approaches.\n- The failure to respond to an acute treatment like Sumatriptan could also imply the presence of medication overuse headache, necessitating a reassessment of the patient's headache history and treatment regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"Furch2zZts8W","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.3055555555555555}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient experiences febrile neutropenia in two consecutive cycles while on ONUREG?\nA: Continue the same dose and monitor closely\nB: Interrupt treatment and resume at a reduced dose of 200 mg once neutrophils return to 1 Gi/L or higher\nC: Discontinue ONUREG immediately\nD: Reduce the treatment duration by 14 days\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient experiences febrile neutropenia in two consecutive cycles while on ONUREG?\nA: Continue the same dose and monitor closely\nB: Interrupt treatment and resume at a reduced dose of 200 mg once neutrophils return to 1 Gi/L or higher\nC: Discontinue ONUREG immediately\nD: Reduce the treatment duration by 14 days\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient experiences febrile neutropenia in two consecutive cycles while on ONUREG?\nA: Continue the same dose and monitor closely\nB: Interrupt treatment and resume at a reduced dose of 200 mg once neutrophils return to 1 Gi/L or higher\nC: Discontinue ONUREG immediately\nD: Reduce the treatment duration by 14 days\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"ejCuva9Dbvlj","MRRV winner=A; scores={'A': 1.0, 'B': 0.3055555555555555, 'C': 0.5, 'D': 0.27777777777777773}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements about G-62 is true regarding its solubility and absorption?\nA: G-62 has high solubility and rapid absorption.\nB: G-62 has low solubility and slow absorption.\nC: G-62 has moderate solubility and absorption.\nD: G-62 has unpredictable solubility and absorption.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements about G-62 is true regarding its solubility and absorption?\nA: G-62 has high solubility and rapid absorption.\nB: G-62 has low solubility and slow absorption.\nC: G-62 has moderate solubility and absorption.\nD: G-62 has unpredictable solubility and absorption.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements about G-62 is true regarding its solubility and absorption?\nA: G-62 has high solubility and rapid absorption.\nB: G-62 has low solubility and slow absorption.\nC: G-62 has moderate solubility and absorption.\nD: G-62 has unpredictable solubility and absorption.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"1CUtihjeanmk","- Palonosetron has a long half-life of approximately 40 hours, allowing for once-daily dosing in the prevention of chemotherapy-induced nausea and vomiting.
- The drug is primarily metabolized by the liver through the cytochrome P450 system, specifically CYP2D6, CYP3A4, and CYP1A2.
- Palonosetron is administered as a single intravenous dose of 0.25 mg, which is effective for both acute and delayed nausea and vomiting associated with chemotherapy.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following statements about the pharmacokinetics of Palonosetron is correct?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Palonosetron has a long half-life of approximately 40 hours, allowing for once-daily dosing in the prevention of chemotherapy-induced nausea and vomiting.\n- The drug is primarily metabolized by the liver through the cytochrome P450 system, specifically CYP2D6, CYP3A4, and CYP1A2.\n- Palonosetron is administered as a single intravenous dose of 0.25 mg, which is effective for both acute and delayed nausea and vomiting associated with chemotherapy.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements about the pharmacokinetics of Palonosetron is correct?\nA: Palonosetron is primarily eliminated through feces.\nB: Palonosetron has a mean terminal elimination half-life of approximately 40 hours.\nC: Palonosetron is metabolized exclusively by CYP3A4 enzymes.\nD: Palonosetron has a volume of distribution of approximately 2.5 L/kg.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Palonosetron has a long half-life of approximately 40 hours, allowing for once-daily dosing in the prevention of chemotherapy-induced nausea and vomiting.\n- The drug is primarily metabolized by the liver through the cytochrome P450 system, specifically CYP2D6, CYP3A4, and CYP1A2.\n- Palonosetron is administered as a single intravenous dose of 0.25 mg, which is effective for both acute and delayed nausea and vomiting associated with chemotherapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements about the pharmacokinetics of Palonosetron is correct?\nA: Palonosetron is primarily eliminated through feces.\nB: Palonosetron has a mean terminal elimination half-life of approximately 40 hours.\nC: Palonosetron is metabolized exclusively by CYP3A4 enzymes.\nD: Palonosetron has a volume of distribution of approximately 2.5 L/kg.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Palonosetron has a long half-life of approximately 40 hours, allowing for once-daily dosing in the prevention of chemotherapy-induced nausea and vomiting.\n- The drug is primarily metabolized by the liver through the cytochrome P450 system, specifically CYP2D6, CYP3A4, and CYP1A2.\n- Palonosetron is administered as a single intravenous dose of 0.25 mg, which is effective for both acute and delayed nausea and vomiting associated with chemotherapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements about the pharmacokinetics of Palonosetron is correct?\nA: Palonosetron is primarily eliminated through feces.\nB: Palonosetron has a mean terminal elimination half-life of approximately 40 hours.\nC: Palonosetron is metabolized exclusively by CYP3A4 enzymes.\nD: Palonosetron has a volume of distribution of approximately 2.5 L/kg.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Palonosetron has a long half-life of approximately 40 hours, allowing for once-daily dosing in the prevention of chemotherapy-induced nausea and vomiting.\n- The drug is primarily metabolized by the liver through the cytochrome P450 system, specifically CYP2D6, CYP3A4, and CYP1A2.\n- Palonosetron is administered as a single intravenous dose of 0.25 mg, which is effective for both acute and delayed nausea and vomiting associated with chemotherapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"wqm60dYi1JiI","1) Recommendation: Patients prescribed venlafaxine tablets should read and understand the accompanying patient information leaflet (PIL) or medication guide provided by their pharmacist or healthcare provider. This document contains essential information about the medication, including its uses, potential side effects, and important safety information.

2) Key rationale:
- The patient information leaflet provides detailed instructions on how to take venlafaxine, including dosage and timing.
- It outlines potential side effects and adverse reactions, helping patients recognize and report any concerning symptoms.
- The document includes important information about drug interactions and contraindications, ensuring safe use of the medication.
- Understanding the information can enhance patient adherence to the treatment plan and improve overall outcomes.

3) Safety/contraindications/interactions:
- Venlafaxine should be used cautiously in patients with a history of bipolar disorder, seizures, or hypertension.
- It may interact with other medications, including MAO inhibitors, SSRIs, and certain pain medications, increasing the risk of serotonin syndrome.
- Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhich document should patients read and understand when prescribed venlafaxine tablets?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Patients prescribed venlafaxine tablets should read and understand the accompanying patient information leaflet (PIL) or medication guide provided by their pharmacist or healthcare provider. This document contains essential information about the medication, including its uses, potential side effects, and important safety information.\n\n2) Key rationale:\n- The patient information leaflet provides detailed instructions on how to take venlafaxine, including dosage and timing.\n- It outlines potential side effects and adverse reactions, helping patients recognize and report any concerning symptoms.\n- The document includes important information about drug interactions and contraindications, ensuring safe use of the medication.\n- Understanding the information can enhance patient adherence to the treatment plan and improve overall outcomes.\n\n3) Safety/contraindications/interactions:\n- Venlafaxine should be used cautiously in patients with a history of bipolar disorder, seizures, or hypertension.\n- It may interact with other medications, including MAO inhibitors, SSRIs, and certain pain medications, increasing the risk of serotonin syndrome.\n- Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions.""}]"
"UX4E5AdOdqpz","1) Recommendation: When initiating Coreg CR (carvedilol) therapy in patients with diabetes, it is essential to closely monitor blood glucose levels and adjust diabetes management as needed. Additionally, consider starting at a lower dose to assess tolerance and minimize potential side effects.

2) Key rationale:
- Coreg CR can mask hypoglycemic symptoms, making it harder for patients to recognize low blood sugar episodes.
- Carvedilol may affect glucose metabolism and insulin sensitivity, potentially leading to altered blood glucose control.
- Starting at a lower dose allows for gradual titration, reducing the risk of adverse effects and ensuring better patient adherence.
- Regular monitoring helps in timely adjustments to diabetes medications, ensuring optimal glycemic control.

3) Safety/contraindications/interactions:
- Patients with a history of severe asthma or bronchospastic conditions should use caution, as beta-blockers can exacerbate these conditions.
- Monitor for potential interactions with other antihypertensive medications, as they may enhance the hypotensive effects of carvedilol.
- Be cautious in patients with renal impairment, as dosage adjustments may be necessary.
- Advise patients to report any unusual changes in blood sugar levels or symptoms of hypoglycemia.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat precaution should be taken when initiating Coreg CR therapy in patients with diabetes?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: When initiating Coreg CR (carvedilol) therapy in patients with diabetes, it is essential to closely monitor blood glucose levels and adjust diabetes management as needed. Additionally, consider starting at a lower dose to assess tolerance and minimize potential side effects.\n\n2) Key rationale:\n- Coreg CR can mask hypoglycemic symptoms, making it harder for patients to recognize low blood sugar episodes.\n- Carvedilol may affect glucose metabolism and insulin sensitivity, potentially leading to altered blood glucose control.\n- Starting at a lower dose allows for gradual titration, reducing the risk of adverse effects and ensuring better patient adherence.\n- Regular monitoring helps in timely adjustments to diabetes medications, ensuring optimal glycemic control.\n\n3) Safety/contraindications/interactions:\n- Patients with a history of severe asthma or bronchospastic conditions should use caution, as beta-blockers can exacerbate these conditions.\n- Monitor for potential interactions with other antihypertensive medications, as they may enhance the hypotensive effects of carvedilol.\n- Be cautious in patients with renal impairment, as dosage adjustments may be necessary.\n- Advise patients to report any unusual changes in blood sugar levels or symptoms of hypoglycemia.""}]"
"iijfgglTpw13","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the mutagenicity and carcinogenicity studies of Follistim AQ?\nA: Follistim AQ was mutagenic in the Ames test.\nB: Long-term toxicity studies in animals have been performed to evaluate carcinogenic potential.\nC: Follistim AQ did not produce chromosomal aberrations in human lymphocytes.\nD: Follistim AQ was mutagenic in an in vitro assay using human lymphocytes.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the mutagenicity and carcinogenicity studies of Follistim AQ?\nA: Follistim AQ was mutagenic in the Ames test.\nB: Long-term toxicity studies in animals have been performed to evaluate carcinogenic potential.\nC: Follistim AQ did not produce chromosomal aberrations in human lymphocytes.\nD: Follistim AQ was mutagenic in an in vitro assay using human lymphocytes.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the mutagenicity and carcinogenicity studies of Follistim AQ?\nA: Follistim AQ was mutagenic in the Ames test.\nB: Long-term toxicity studies in animals have been performed to evaluate carcinogenic potential.\nC: Follistim AQ did not produce chromosomal aberrations in human lymphocytes.\nD: Follistim AQ was mutagenic in an in vitro assay using human lymphocytes.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"GUUN6GRE9Yg0","- The recommended dosage adjustment for Paxlovid in patients with moderate renal impairment is to reduce the nirmatrelvir/ritonavir regimen to 300 mg/100 mg taken orally twice daily for 5 days.
- Patients with an eGFR of 30 to <60 mL/min should not take the standard dosage of 300 mg/100 mg of nirmatrelvir/ritonavir without this adjustment.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat adjustment is recommended for Paxlovid dosage in patients with moderate renal impairment (eGFR \u226530 to <60 mL/min)?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The recommended dosage adjustment for Paxlovid in patients with moderate renal impairment is to reduce the nirmatrelvir/ritonavir regimen to 300 mg/100 mg taken orally twice daily for 5 days.\n- Patients with an eGFR of 30 to <60 mL/min should not take the standard dosage of 300 mg/100 mg of nirmatrelvir/ritonavir without this adjustment.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What adjustment is recommended for Paxlovid dosage in patients with moderate renal impairment (eGFR \u226530 to <60 mL/min)?\nA: No dosage adjustment is required.\nB: Reduce the Paxlovid dosage.\nC: Increase the Paxlovid dosage.\nD: Discontinue Paxlovid.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage adjustment for Paxlovid in patients with moderate renal impairment is to reduce the nirmatrelvir/ritonavir regimen to 300 mg/100 mg taken orally twice daily for 5 days.\n- Patients with an eGFR of 30 to <60 mL/min should not take the standard dosage of 300 mg/100 mg of nirmatrelvir/ritonavir without this adjustment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What adjustment is recommended for Paxlovid dosage in patients with moderate renal impairment (eGFR \u226530 to <60 mL/min)?\nA: No dosage adjustment is required.\nB: Reduce the Paxlovid dosage.\nC: Increase the Paxlovid dosage.\nD: Discontinue Paxlovid.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage adjustment for Paxlovid in patients with moderate renal impairment is to reduce the nirmatrelvir/ritonavir regimen to 300 mg/100 mg taken orally twice daily for 5 days.\n- Patients with an eGFR of 30 to <60 mL/min should not take the standard dosage of 300 mg/100 mg of nirmatrelvir/ritonavir without this adjustment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What adjustment is recommended for Paxlovid dosage in patients with moderate renal impairment (eGFR \u226530 to <60 mL/min)?\nA: No dosage adjustment is required.\nB: Reduce the Paxlovid dosage.\nC: Increase the Paxlovid dosage.\nD: Discontinue Paxlovid.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage adjustment for Paxlovid in patients with moderate renal impairment is to reduce the nirmatrelvir/ritonavir regimen to 300 mg/100 mg taken orally twice daily for 5 days.\n- Patients with an eGFR of 30 to <60 mL/min should not take the standard dosage of 300 mg/100 mg of nirmatrelvir/ritonavir without this adjustment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"UfqFoSI83kdm","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn the Ames test, what was observed regarding the genotoxic potential of Dopamine HCl?\nA: Dopamine HCl showed clear evidence of genotoxicity in the Ames test.\nB: Dopamine HCl showed no genotoxic potential in the Ames test.\nC: The results of the Ames test for Dopamine HCl were inconclusive regarding genotoxicity.\nD: Dopamine HCl was not tested for genotoxicity in the Ames test.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn the Ames test, what was observed regarding the genotoxic potential of Dopamine HCl?\nA: Dopamine HCl showed clear evidence of genotoxicity in the Ames test.\nB: Dopamine HCl showed no genotoxic potential in the Ames test.\nC: The results of the Ames test for Dopamine HCl were inconclusive regarding genotoxicity.\nD: Dopamine HCl was not tested for genotoxicity in the Ames test.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn the Ames test, what was observed regarding the genotoxic potential of Dopamine HCl?\nA: Dopamine HCl showed clear evidence of genotoxicity in the Ames test.\nB: Dopamine HCl showed no genotoxic potential in the Ames test.\nC: The results of the Ames test for Dopamine HCl were inconclusive regarding genotoxicity.\nD: Dopamine HCl was not tested for genotoxicity in the Ames test.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"UZ9Cq3pCY3vv","- Guanfacine extended-release tablets are indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years.
- The medication works by selectively stimulating alpha-2 adrenergic receptors, which helps to improve attention and reduce hyperactivity and impulsivity.
- Clinical studies have shown that Guanfacine extended-release is more effective than placebo in reducing ADHD symptoms over a specified treatment period.

MRRV(meta) winner=C; scores={'A': 0.4444444444444444, 'B': 0.3055555555555555, 'C': 1.0, 'D': 0.3333333333333333}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'D', 'A', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following statements is true regarding Guanfacine extended-release tablets?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Guanfacine extended-release tablets are indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years.\n- The medication works by selectively stimulating alpha-2 adrenergic receptors, which helps to improve attention and reduce hyperactivity and impulsivity.\n- Clinical studies have shown that Guanfacine extended-release is more effective than placebo in reducing ADHD symptoms over a specified treatment period.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding Guanfacine extended-release tablets?\nA: Guanfacine extended-release tablets are classified as a controlled substance.\nB: Guanfacine extended-release tablets have a high potential for abuse.\nC: Guanfacine extended-release tablets are not a controlled substance and have no known potential for abuse or dependence.\nD: Guanfacine extended-release tablets are known to cause dependence in long-term use.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Guanfacine extended-release tablets are indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years.\n- The medication works by selectively stimulating alpha-2 adrenergic receptors, which helps to improve attention and reduce hyperactivity and impulsivity.\n- Clinical studies have shown that Guanfacine extended-release is more effective than placebo in reducing ADHD symptoms over a specified treatment period.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding Guanfacine extended-release tablets?\nA: Guanfacine extended-release tablets are classified as a controlled substance.\nB: Guanfacine extended-release tablets have a high potential for abuse.\nC: Guanfacine extended-release tablets are not a controlled substance and have no known potential for abuse or dependence.\nD: Guanfacine extended-release tablets are known to cause dependence in long-term use.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Guanfacine extended-release tablets are indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years.\n- The medication works by selectively stimulating alpha-2 adrenergic receptors, which helps to improve attention and reduce hyperactivity and impulsivity.\n- Clinical studies have shown that Guanfacine extended-release is more effective than placebo in reducing ADHD symptoms over a specified treatment period.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding Guanfacine extended-release tablets?\nA: Guanfacine extended-release tablets are classified as a controlled substance.\nB: Guanfacine extended-release tablets have a high potential for abuse.\nC: Guanfacine extended-release tablets are not a controlled substance and have no known potential for abuse or dependence.\nD: Guanfacine extended-release tablets are known to cause dependence in long-term use.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Guanfacine extended-release tablets are indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years.\n- The medication works by selectively stimulating alpha-2 adrenergic receptors, which helps to improve attention and reduce hyperactivity and impulsivity.\n- Clinical studies have shown that Guanfacine extended-release is more effective than placebo in reducing ADHD symptoms over a specified treatment period.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}]"
"HfL6fYIWOQBN","MRRV winner=C; scores={'A': 0.5, 'B': 0.25, 'C': 1.0, 'D': 0.3333333333333333}; rankings=[['C', 'A', 'D', 'B'], ['C', 'A', 'D', 'B'], ['C', 'A', 'D', 'B']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow does coadministration of Palonosetron and dexamethasone affect their pharmacokinetics?\nA: It significantly increases the plasma concentration of Palonosetron.\nB: It significantly decreases the plasma concentration of dexamethasone.\nC: It results in no pharmacokinetic interactions.\nD: It prolongs the elimination half-life of both drugs.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow does coadministration of Palonosetron and dexamethasone affect their pharmacokinetics?\nA: It significantly increases the plasma concentration of Palonosetron.\nB: It significantly decreases the plasma concentration of dexamethasone.\nC: It results in no pharmacokinetic interactions.\nD: It prolongs the elimination half-life of both drugs.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow does coadministration of Palonosetron and dexamethasone affect their pharmacokinetics?\nA: It significantly increases the plasma concentration of Palonosetron.\nB: It significantly decreases the plasma concentration of dexamethasone.\nC: It results in no pharmacokinetic interactions.\nD: It prolongs the elimination half-life of both drugs.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}]"
"54KUBEH7RSZI","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow long might esomeprazole magnesium take to achieve its full effect?\nA: Within a few hours.\nB: 1 to 4 days.\nC: 1 week.\nD: Immediately after administration.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow long might esomeprazole magnesium take to achieve its full effect?\nA: Within a few hours.\nB: 1 to 4 days.\nC: 1 week.\nD: Immediately after administration.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow long might esomeprazole magnesium take to achieve its full effect?\nA: Within a few hours.\nB: 1 to 4 days.\nC: 1 week.\nD: Immediately after administration.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"8FCe7t88KYAS","MRRV winner=D; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 0.5, 'D': 1.0}; rankings=[['D', 'C', 'B', 'A'], ['D', 'C', 'B', 'A'], ['D', 'C', 'B', 'A']]","D","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat percentage of plasma concentrations of albuterol sulfate was found in the brain of rats during intravenous studies?\nA: 5%\nB: 10%\nC: 15%\nD: 20%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat percentage of plasma concentrations of albuterol sulfate was found in the brain of rats during intravenous studies?\nA: 5%\nB: 10%\nC: 15%\nD: 20%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat percentage of plasma concentrations of albuterol sulfate was found in the brain of rats during intravenous studies?\nA: 5%\nB: 10%\nC: 15%\nD: 20%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}]"
"ASklnvPeKO7W","- Carbamazepine significantly reduces the concentration of Lamotrigine, leading to decreased efficacy of Lamotrigine in patients taking both medications.
- Carbamazepine increases its own metabolite, carbamazepine epoxide, due to its induction of hepatic enzymes, which can enhance the metabolism of other drugs.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the effect of Carbamazepine on the concentration of Lamotrigine and its own metabolite, carbamazepine epoxide?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Carbamazepine significantly reduces the concentration of Lamotrigine, leading to decreased efficacy of Lamotrigine in patients taking both medications.\n- Carbamazepine increases its own metabolite, carbamazepine epoxide, due to its induction of hepatic enzymes, which can enhance the metabolism of other drugs.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of Carbamazepine on the concentration of Lamotrigine and its own metabolite, carbamazepine epoxide?\nA: Decreases Lamotrigine concentration by 40% and increases carbamazepine epoxide levels.\nB: Increases Lamotrigine concentration by 40% and decreases carbamazepine epoxide levels.\nC: No effect on Lamotrigine concentration but increases carbamazepine epoxide levels.\nD: Decreases both Lamotrigine and carbamazepine epoxide concentrations.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Carbamazepine significantly reduces the concentration of Lamotrigine, leading to decreased efficacy of Lamotrigine in patients taking both medications.\n- Carbamazepine increases its own metabolite, carbamazepine epoxide, due to its induction of hepatic enzymes, which can enhance the metabolism of other drugs.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of Carbamazepine on the concentration of Lamotrigine and its own metabolite, carbamazepine epoxide?\nA: Decreases Lamotrigine concentration by 40% and increases carbamazepine epoxide levels.\nB: Increases Lamotrigine concentration by 40% and decreases carbamazepine epoxide levels.\nC: No effect on Lamotrigine concentration but increases carbamazepine epoxide levels.\nD: Decreases both Lamotrigine and carbamazepine epoxide concentrations.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Carbamazepine significantly reduces the concentration of Lamotrigine, leading to decreased efficacy of Lamotrigine in patients taking both medications.\n- Carbamazepine increases its own metabolite, carbamazepine epoxide, due to its induction of hepatic enzymes, which can enhance the metabolism of other drugs.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of Carbamazepine on the concentration of Lamotrigine and its own metabolite, carbamazepine epoxide?\nA: Decreases Lamotrigine concentration by 40% and increases carbamazepine epoxide levels.\nB: Increases Lamotrigine concentration by 40% and decreases carbamazepine epoxide levels.\nC: No effect on Lamotrigine concentration but increases carbamazepine epoxide levels.\nD: Decreases both Lamotrigine and carbamazepine epoxide concentrations.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Carbamazepine significantly reduces the concentration of Lamotrigine, leading to decreased efficacy of Lamotrigine in patients taking both medications.\n- Carbamazepine increases its own metabolite, carbamazepine epoxide, due to its induction of hepatic enzymes, which can enhance the metabolism of other drugs.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"M0rQ3mFvSzf2","- Common side effects of fosaprepitant for injection include fatigue, which may occur in patients receiving the drug as part of a regimen for preventing nausea and vomiting associated with chemotherapy.
- Patients may also experience dizziness, particularly when fosaprepitant is administered in conjunction with other antiemetic agents.
- Injection site reactions, such as pain or redness, are frequently reported among adults receiving fosaprepitant for injection.

MRRV(meta) winner=B; scores={'A': 0.3055555555555555, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'C', 'A']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat are the most common side effects of fosaprepitant for injection in adults?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Common side effects of fosaprepitant for injection include fatigue, which may occur in patients receiving the drug as part of a regimen for preventing nausea and vomiting associated with chemotherapy.\n- Patients may also experience dizziness, particularly when fosaprepitant is administered in conjunction with other antiemetic agents.\n- Injection site reactions, such as pain or redness, are frequently reported among adults receiving fosaprepitant for injection.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What are the most common side effects of fosaprepitant for injection in adults?\nA: Low red blood cell count, low white blood cell count, and low platelet count.\nB: Tiredness, diarrhea, and dyspepsia.\nC: Skin rash, itching, and flushing.\nD: Severe allergic reactions and necrosis at the infusion site.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Common side effects of fosaprepitant for injection include fatigue, which may occur in patients receiving the drug as part of a regimen for preventing nausea and vomiting associated with chemotherapy.\n- Patients may also experience dizziness, particularly when fosaprepitant is administered in conjunction with other antiemetic agents.\n- Injection site reactions, such as pain or redness, are frequently reported among adults receiving fosaprepitant for injection.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What are the most common side effects of fosaprepitant for injection in adults?\nA: Low red blood cell count, low white blood cell count, and low platelet count.\nB: Tiredness, diarrhea, and dyspepsia.\nC: Skin rash, itching, and flushing.\nD: Severe allergic reactions and necrosis at the infusion site.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Common side effects of fosaprepitant for injection include fatigue, which may occur in patients receiving the drug as part of a regimen for preventing nausea and vomiting associated with chemotherapy.\n- Patients may also experience dizziness, particularly when fosaprepitant is administered in conjunction with other antiemetic agents.\n- Injection site reactions, such as pain or redness, are frequently reported among adults receiving fosaprepitant for injection.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What are the most common side effects of fosaprepitant for injection in adults?\nA: Low red blood cell count, low white blood cell count, and low platelet count.\nB: Tiredness, diarrhea, and dyspepsia.\nC: Skin rash, itching, and flushing.\nD: Severe allergic reactions and necrosis at the infusion site.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Common side effects of fosaprepitant for injection include fatigue, which may occur in patients receiving the drug as part of a regimen for preventing nausea and vomiting associated with chemotherapy.\n- Patients may also experience dizziness, particularly when fosaprepitant is administered in conjunction with other antiemetic agents.\n- Injection site reactions, such as pain or redness, are frequently reported among adults receiving fosaprepitant for injection.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"PUIIWiIpiUur","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is a benefit of using NICOTINE during smoking cessation?\nA: Reduction in nicotine craving\nB: Improved digestion\nC: Enhanced immune response\nD: Pain relief\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is a benefit of using NICOTINE during smoking cessation?\nA: Reduction in nicotine craving\nB: Improved digestion\nC: Enhanced immune response\nD: Pain relief\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is a benefit of using NICOTINE during smoking cessation?\nA: Reduction in nicotine craving\nB: Improved digestion\nC: Enhanced immune response\nD: Pain relief\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"9bGxOQSans4Z","MRRV winner=C; scores={'A': 0.3333333333333333, 'B': 0.5, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following best describes the application process for hydrocort shampoo on the scalp?\nA: Apply to dry scalp and rinse immediately\nB: Massage into wet scalp and leave for 2 to 3 minutes\nC: Apply to wet scalp and leave for 5 minutes\nD: Use only on the body, not the scalp\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following best describes the application process for hydrocort shampoo on the scalp?\nA: Apply to dry scalp and rinse immediately\nB: Massage into wet scalp and leave for 2 to 3 minutes\nC: Apply to wet scalp and leave for 5 minutes\nD: Use only on the body, not the scalp\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following best describes the application process for hydrocort shampoo on the scalp?\nA: Apply to dry scalp and rinse immediately\nB: Massage into wet scalp and leave for 2 to 3 minutes\nC: Apply to wet scalp and leave for 5 minutes\nD: Use only on the body, not the scalp\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}]"
"0DKmE5ASAkk3","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the structural formula of dopamine hydrochloride (brand name: Dopamine)?\nA: C8H11NO2\u2219HCl\nB: C6H12O6\u2219H2O\nC: H2O\nD: C8H10N2O2\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the structural formula of dopamine hydrochloride (brand name: Dopamine)?\nA: C8H11NO2\u2219HCl\nB: C6H12O6\u2219H2O\nC: H2O\nD: C8H10N2O2\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the structural formula of dopamine hydrochloride (brand name: Dopamine)?\nA: C8H11NO2\u2219HCl\nB: C6H12O6\u2219H2O\nC: H2O\nD: C8H10N2O2\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"fnpuEEQBO8pd","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow should ONUREG dosage be managed in patients with severe renal impairment (CLcr 15 to 29 mL/min)?\nA: No dose adjustment is needed, but patients should be monitored more frequently for adverse reactions.\nB: The dosage should be doubled to compensate for renal impairment.\nC: ONUREG should not be used in patients with severe renal impairment.\nD: The dosage should be reduced by half for all patients with renal impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow should ONUREG dosage be managed in patients with severe renal impairment (CLcr 15 to 29 mL/min)?\nA: No dose adjustment is needed, but patients should be monitored more frequently for adverse reactions.\nB: The dosage should be doubled to compensate for renal impairment.\nC: ONUREG should not be used in patients with severe renal impairment.\nD: The dosage should be reduced by half for all patients with renal impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow should ONUREG dosage be managed in patients with severe renal impairment (CLcr 15 to 29 mL/min)?\nA: No dose adjustment is needed, but patients should be monitored more frequently for adverse reactions.\nB: The dosage should be doubled to compensate for renal impairment.\nC: ONUREG should not be used in patients with severe renal impairment.\nD: The dosage should be reduced by half for all patients with renal impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"eXkGeLQMTcpK","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be avoided when prescribing NUZYRA to a patient with known hypersensitivity to its excipients?\nA: Prescribing NUZYRA\nB: Prescribing a tetracycline class drug\nC: Prescribing a macrolide class drug\nD: Prescribing a fluoroquinolone class drug\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be avoided when prescribing NUZYRA to a patient with known hypersensitivity to its excipients?\nA: Prescribing NUZYRA\nB: Prescribing a tetracycline class drug\nC: Prescribing a macrolide class drug\nD: Prescribing a fluoroquinolone class drug\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be avoided when prescribing NUZYRA to a patient with known hypersensitivity to its excipients?\nA: Prescribing NUZYRA\nB: Prescribing a tetracycline class drug\nC: Prescribing a macrolide class drug\nD: Prescribing a fluoroquinolone class drug\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"cxPX2d4GIWJp","MRRV winner=B; scores={'A': 0.6666666666666666, 'B': 0.8333333333333334, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['A', 'B', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow did Cleocin perform in the Ames Salmonella reversion test?\nA: It showed a positive result, indicating mutagenicity.\nB: It showed a negative result, indicating no mutagenicity.\nC: The test was inconclusive.\nD: The test was not performed for Cleocin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow did Cleocin perform in the Ames Salmonella reversion test?\nA: It showed a positive result, indicating mutagenicity.\nB: It showed a negative result, indicating no mutagenicity.\nC: The test was inconclusive.\nD: The test was not performed for Cleocin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow did Cleocin perform in the Ames Salmonella reversion test?\nA: It showed a positive result, indicating mutagenicity.\nB: It showed a negative result, indicating no mutagenicity.\nC: The test was inconclusive.\nD: The test was not performed for Cleocin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"DJYnbCxWbeU8","MRRV winner=D; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 0.25, 'D': 1.0}; rankings=[['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C']]","D","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action when switching a patient from Fluoxetine to a Tricyclic Antidepressant (TCA)?\nA: Discontinue Fluoxetine and immediately start the TCA at a standard dose\nB: Reduce the TCA dose and monitor plasma TCA concentrations\nC: Increase the TCA dose to compensate for Fluoxetine discontinuation\nD: Switch to another SSRI before starting the TCA\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action when switching a patient from Fluoxetine to a Tricyclic Antidepressant (TCA)?\nA: Discontinue Fluoxetine and immediately start the TCA at a standard dose\nB: Reduce the TCA dose and monitor plasma TCA concentrations\nC: Increase the TCA dose to compensate for Fluoxetine discontinuation\nD: Switch to another SSRI before starting the TCA\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action when switching a patient from Fluoxetine to a Tricyclic Antidepressant (TCA)?\nA: Discontinue Fluoxetine and immediately start the TCA at a standard dose\nB: Reduce the TCA dose and monitor plasma TCA concentrations\nC: Increase the TCA dose to compensate for Fluoxetine discontinuation\nD: Switch to another SSRI before starting the TCA\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}]"
"q8rmHvOAanln","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken regarding fertility before Zynteglo treatment?\nA: No precautions are necessary as Zynteglo does not affect fertility.\nB: Patients should be advised of the option to cryopreserve semen or ova before treatment.\nC: Fertility preservation is only recommended for male patients.\nD: Fertility preservation is only recommended for female patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken regarding fertility before Zynteglo treatment?\nA: No precautions are necessary as Zynteglo does not affect fertility.\nB: Patients should be advised of the option to cryopreserve semen or ova before treatment.\nC: Fertility preservation is only recommended for male patients.\nD: Fertility preservation is only recommended for female patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken regarding fertility before Zynteglo treatment?\nA: No precautions are necessary as Zynteglo does not affect fertility.\nB: Patients should be advised of the option to cryopreserve semen or ova before treatment.\nC: Fertility preservation is only recommended for male patients.\nD: Fertility preservation is only recommended for female patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"6YE3xIPkCm8g","1) Recommendation: It is advisable for pregnant individuals to avoid lamotrigine unless the benefits outweigh the risks, and they should consult their healthcare provider for alternative treatments or close monitoring during pregnancy.

2) Key rationale:
   - Animal studies have shown that exposure to lamotrigine during pregnancy can lead to developmental toxicity, including increased risk of fetal malformations.
   - Specific findings in rats include skeletal abnormalities and potential impacts on neurodevelopment.
   - The timing of exposure during critical periods of fetal development may influence the severity and type of observed effects.

3) Safety/contraindications/interactions:
   - Lamotrigine is classified as a Category C medication, indicating that risk cannot be ruled out in human pregnancies.
   - Potential interactions with other medications that may be used during pregnancy should be carefully considered.
   - Close monitoring of both maternal and fetal health is recommended if lamotrigine is deemed necessary during pregnancy.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nIn animal studies, what developmental toxicity was observed in rats exposed to lamotrigine during pregnancy?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: It is advisable for pregnant individuals to avoid lamotrigine unless the benefits outweigh the risks, and they should consult their healthcare provider for alternative treatments or close monitoring during pregnancy.\n\n2) Key rationale:\n   - Animal studies have shown that exposure to lamotrigine during pregnancy can lead to developmental toxicity, including increased risk of fetal malformations.\n   - Specific findings in rats include skeletal abnormalities and potential impacts on neurodevelopment.\n   - The timing of exposure during critical periods of fetal development may influence the severity and type of observed effects.\n\n3) Safety/contraindications/interactions:\n   - Lamotrigine is classified as a Category C medication, indicating that risk cannot be ruled out in human pregnancies.\n   - Potential interactions with other medications that may be used during pregnancy should be carefully considered.\n   - Close monitoring of both maternal and fetal health is recommended if lamotrigine is deemed necessary during pregnancy.""}]"
"7Kb9pH1BuKVq","- Patients prescribed venlafaxine tablets should be informed about the potential benefits, such as improved mood and anxiety relief, as well as risks like increased blood pressure and withdrawal symptoms.
- Healthcare providers, including doctors and pharmacists, should be involved in discussing the appropriate dosage regimen and monitoring for side effects associated with venlafaxine.
- Family members or caregivers may also play a role in understanding the treatment plan and supporting the patient in managing any adverse effects or adherence to the medication.

MRRV(meta) winner=C; scores={'A': 0.25, 'B': 0.5, 'C': 1.0, 'D': 0.3333333333333333}; rankings=[['C', 'B', 'D', 'A'], ['C', 'B', 'D', 'A'], ['C', 'B', 'D', 'A']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWho should be involved in understanding the benefits and risks of venlafaxine tablets according to the provided information?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients prescribed venlafaxine tablets should be informed about the potential benefits, such as improved mood and anxiety relief, as well as risks like increased blood pressure and withdrawal symptoms.\n- Healthcare providers, including doctors and pharmacists, should be involved in discussing the appropriate dosage regimen and monitoring for side effects associated with venlafaxine.\n- Family members or caregivers may also play a role in understanding the treatment plan and supporting the patient in managing any adverse effects or adherence to the medication.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Who should be involved in understanding the benefits and risks of venlafaxine tablets according to the provided information?\nA: Only the patients themselves.\nB: Patients and their families.\nC: Patients, their families, and caregivers.\nD: Only the prescriber.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients prescribed venlafaxine tablets should be informed about the potential benefits, such as improved mood and anxiety relief, as well as risks like increased blood pressure and withdrawal symptoms.\n- Healthcare providers, including doctors and pharmacists, should be involved in discussing the appropriate dosage regimen and monitoring for side effects associated with venlafaxine.\n- Family members or caregivers may also play a role in understanding the treatment plan and supporting the patient in managing any adverse effects or adherence to the medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > D > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Who should be involved in understanding the benefits and risks of venlafaxine tablets according to the provided information?\nA: Only the patients themselves.\nB: Patients and their families.\nC: Patients, their families, and caregivers.\nD: Only the prescriber.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients prescribed venlafaxine tablets should be informed about the potential benefits, such as improved mood and anxiety relief, as well as risks like increased blood pressure and withdrawal symptoms.\n- Healthcare providers, including doctors and pharmacists, should be involved in discussing the appropriate dosage regimen and monitoring for side effects associated with venlafaxine.\n- Family members or caregivers may also play a role in understanding the treatment plan and supporting the patient in managing any adverse effects or adherence to the medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > D > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Who should be involved in understanding the benefits and risks of venlafaxine tablets according to the provided information?\nA: Only the patients themselves.\nB: Patients and their families.\nC: Patients, their families, and caregivers.\nD: Only the prescriber.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients prescribed venlafaxine tablets should be informed about the potential benefits, such as improved mood and anxiety relief, as well as risks like increased blood pressure and withdrawal symptoms.\n- Healthcare providers, including doctors and pharmacists, should be involved in discussing the appropriate dosage regimen and monitoring for side effects associated with venlafaxine.\n- Family members or caregivers may also play a role in understanding the treatment plan and supporting the patient in managing any adverse effects or adherence to the medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > D > A""}]"
"d4kUpe6ooPwR","1) Recommendation: It is not advisable for individuals under 18 years of age to use nicotine lozenges without the guidance of a healthcare professional. If you are considering using them to quit smoking or for any other reason, consult with a doctor or a qualified healthcare provider for appropriate alternatives and support.

2) Key rationale:
- Nicotine lozenges are intended for adult smokers seeking to quit, and their use in minors is not well-studied.
- Adolescents may be more susceptible to the addictive properties of nicotine, potentially leading to increased dependence.
- There are safer and more effective cessation methods tailored for younger individuals, such as counseling and behavioral therapies.
- The long-term effects of nicotine use in adolescents are not fully understood, raising concerns about brain development and health.

3) Safety/contraindications/interactions:
- Nicotine lozenges are not approved for use in individuals under 18 years of age.
- Potential for increased heart rate and blood pressure, which may be more pronounced in younger users.
- Risk of nicotine poisoning, especially if misused or used in conjunction with other nicotine products.
- Consult a healthcare provider if there are any pre-existing health conditions or if other medications are being taken.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat should a user do if they are under 18 years of age and want to use nicotine lozenges?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: It is not advisable for individuals under 18 years of age to use nicotine lozenges without the guidance of a healthcare professional. If you are considering using them to quit smoking or for any other reason, consult with a doctor or a qualified healthcare provider for appropriate alternatives and support.\n\n2) Key rationale:\n- Nicotine lozenges are intended for adult smokers seeking to quit, and their use in minors is not well-studied.\n- Adolescents may be more susceptible to the addictive properties of nicotine, potentially leading to increased dependence.\n- There are safer and more effective cessation methods tailored for younger individuals, such as counseling and behavioral therapies.\n- The long-term effects of nicotine use in adolescents are not fully understood, raising concerns about brain development and health.\n\n3) Safety/contraindications/interactions:\n- Nicotine lozenges are not approved for use in individuals under 18 years of age.\n- Potential for increased heart rate and blood pressure, which may be more pronounced in younger users.\n- Risk of nicotine poisoning, especially if misused or used in conjunction with other nicotine products.\n- Consult a healthcare provider if there are any pre-existing health conditions or if other medications are being taken.""}]"
"kMXCmthQWKhr","- Ensure that the patient is not allergic to any components of the Albuterol formulation, including inactive ingredients in the inhaler or nebulizer solution.
- Consider prescribing a lower dose or an alternative bronchodilator if the patient has a history of severe allergic reactions to similar medications, such as other beta-agonists.
- Monitor the patient closely for any signs of an allergic reaction after the initial dose of Albuterol, especially if they have a history of multiple drug allergies.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3611111111111111, 'C': 0.3055555555555555, 'D': 0.4166666666666667}; rankings=[['A', 'D', 'C', 'B'], ['A', 'B', 'C', 'D'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat precaution should be taken when prescribing Albuterol to a patient with a known allergy?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Ensure that the patient is not allergic to any components of the Albuterol formulation, including inactive ingredients in the inhaler or nebulizer solution.\n- Consider prescribing a lower dose or an alternative bronchodilator if the patient has a history of severe allergic reactions to similar medications, such as other beta-agonists.\n- Monitor the patient closely for any signs of an allergic reaction after the initial dose of Albuterol, especially if they have a history of multiple drug allergies.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken when prescribing Albuterol to a patient with a known allergy?\nA: Ensure the patient has no hypersensitivity to any of the ingredients\nB: Prescribe a higher dose to counteract the allergy\nC: Combine Albuterol with an antihistamine\nD: No precautions are necessary for allergies\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Ensure that the patient is not allergic to any components of the Albuterol formulation, including inactive ingredients in the inhaler or nebulizer solution.\n- Consider prescribing a lower dose or an alternative bronchodilator if the patient has a history of severe allergic reactions to similar medications, such as other beta-agonists.\n- Monitor the patient closely for any signs of an allergic reaction after the initial dose of Albuterol, especially if they have a history of multiple drug allergies.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken when prescribing Albuterol to a patient with a known allergy?\nA: Ensure the patient has no hypersensitivity to any of the ingredients\nB: Prescribe a higher dose to counteract the allergy\nC: Combine Albuterol with an antihistamine\nD: No precautions are necessary for allergies\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Ensure that the patient is not allergic to any components of the Albuterol formulation, including inactive ingredients in the inhaler or nebulizer solution.\n- Consider prescribing a lower dose or an alternative bronchodilator if the patient has a history of severe allergic reactions to similar medications, such as other beta-agonists.\n- Monitor the patient closely for any signs of an allergic reaction after the initial dose of Albuterol, especially if they have a history of multiple drug allergies.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken when prescribing Albuterol to a patient with a known allergy?\nA: Ensure the patient has no hypersensitivity to any of the ingredients\nB: Prescribe a higher dose to counteract the allergy\nC: Combine Albuterol with an antihistamine\nD: No precautions are necessary for allergies\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Ensure that the patient is not allergic to any components of the Albuterol formulation, including inactive ingredients in the inhaler or nebulizer solution.\n- Consider prescribing a lower dose or an alternative bronchodilator if the patient has a history of severe allergic reactions to similar medications, such as other beta-agonists.\n- Monitor the patient closely for any signs of an allergic reaction after the initial dose of Albuterol, especially if they have a history of multiple drug allergies.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"gsyLl2Ge7zPw","- Gadobutrol is a gadolinium-based contrast agent that has been shown to have a lower retention of gadolinium in the body compared to other agents.
- Compared to other gadolinium agents, gadobutrol's unique structure allows for more efficient clearance from the body, resulting in less accumulation.
- Studies indicate that gadobutrol, when used in imaging procedures, leads to minimal gadolinium deposition in tissues, making it a safer option for patients requiring multiple scans.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.27777777777777773, 'C': 1.0, 'D': 0.3055555555555555}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'D', 'B'], ['C', 'A', 'D', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich gadolinium-based contrast agent retains the least amount of gadolinium in the body?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Gadobutrol is a gadolinium-based contrast agent that has been shown to have a lower retention of gadolinium in the body compared to other agents.\n- Compared to other gadolinium agents, gadobutrol's unique structure allows for more efficient clearance from the body, resulting in less accumulation.\n- Studies indicate that gadobutrol, when used in imaging procedures, leads to minimal gadolinium deposition in tissues, making it a safer option for patients requiring multiple scans.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which gadolinium-based contrast agent retains the least amount of gadolinium in the body?\nA: Omniscan\nB: Optimark\nC: Gadavist\nD: Magnevist\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadobutrol is a gadolinium-based contrast agent that has been shown to have a lower retention of gadolinium in the body compared to other agents.\n- Compared to other gadolinium agents, gadobutrol's unique structure allows for more efficient clearance from the body, resulting in less accumulation.\n- Studies indicate that gadobutrol, when used in imaging procedures, leads to minimal gadolinium deposition in tissues, making it a safer option for patients requiring multiple scans.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which gadolinium-based contrast agent retains the least amount of gadolinium in the body?\nA: Omniscan\nB: Optimark\nC: Gadavist\nD: Magnevist\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadobutrol is a gadolinium-based contrast agent that has been shown to have a lower retention of gadolinium in the body compared to other agents.\n- Compared to other gadolinium agents, gadobutrol's unique structure allows for more efficient clearance from the body, resulting in less accumulation.\n- Studies indicate that gadobutrol, when used in imaging procedures, leads to minimal gadolinium deposition in tissues, making it a safer option for patients requiring multiple scans.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which gadolinium-based contrast agent retains the least amount of gadolinium in the body?\nA: Omniscan\nB: Optimark\nC: Gadavist\nD: Magnevist\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadobutrol is a gadolinium-based contrast agent that has been shown to have a lower retention of gadolinium in the body compared to other agents.\n- Compared to other gadolinium agents, gadobutrol's unique structure allows for more efficient clearance from the body, resulting in less accumulation.\n- Studies indicate that gadobutrol, when used in imaging procedures, leads to minimal gadolinium deposition in tissues, making it a safer option for patients requiring multiple scans.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}]"
"y57Gv9UZlPbn","- Dose increments of venlafaxine should typically be made every 4 to 7 days to monitor for side effects and therapeutic response.
- The maximum recommended dose of venlafaxine is 375 mg per day for the extended-release formulation, and increments should be gradual to avoid adverse effects.
- It is important to adjust the dose based on individual patient response and tolerability, ensuring that increases are not made too rapidly.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow often should dose increments of venlafaxine be made when increasing the dose?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Dose increments of venlafaxine should typically be made every 4 to 7 days to monitor for side effects and therapeutic response.\n- The maximum recommended dose of venlafaxine is 375 mg per day for the extended-release formulation, and increments should be gradual to avoid adverse effects.\n- It is important to adjust the dose based on individual patient response and tolerability, ensuring that increases are not made too rapidly.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How often should dose increments of venlafaxine be made when increasing the dose?\nA: Every 2 days\nB: Every 4 days\nC: Every 7 days\nD: Every 10 days\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Dose increments of venlafaxine should typically be made every 4 to 7 days to monitor for side effects and therapeutic response.\n- The maximum recommended dose of venlafaxine is 375 mg per day for the extended-release formulation, and increments should be gradual to avoid adverse effects.\n- It is important to adjust the dose based on individual patient response and tolerability, ensuring that increases are not made too rapidly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How often should dose increments of venlafaxine be made when increasing the dose?\nA: Every 2 days\nB: Every 4 days\nC: Every 7 days\nD: Every 10 days\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Dose increments of venlafaxine should typically be made every 4 to 7 days to monitor for side effects and therapeutic response.\n- The maximum recommended dose of venlafaxine is 375 mg per day for the extended-release formulation, and increments should be gradual to avoid adverse effects.\n- It is important to adjust the dose based on individual patient response and tolerability, ensuring that increases are not made too rapidly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How often should dose increments of venlafaxine be made when increasing the dose?\nA: Every 2 days\nB: Every 4 days\nC: Every 7 days\nD: Every 10 days\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Dose increments of venlafaxine should typically be made every 4 to 7 days to monitor for side effects and therapeutic response.\n- The maximum recommended dose of venlafaxine is 375 mg per day for the extended-release formulation, and increments should be gradual to avoid adverse effects.\n- It is important to adjust the dose based on individual patient response and tolerability, ensuring that increases are not made too rapidly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"bAglZqMMfand","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn the prevention of nausea and vomiting associated with HEC, how does the incidence of infusion-site reactions compare between FOSAPREPITANT and oral aprepitant?\nA: Higher in FOSAPREPITANT group\nB: Higher in oral aprepitant group\nC: Equal in both groups\nD: Not reported for either group\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn the prevention of nausea and vomiting associated with HEC, how does the incidence of infusion-site reactions compare between FOSAPREPITANT and oral aprepitant?\nA: Higher in FOSAPREPITANT group\nB: Higher in oral aprepitant group\nC: Equal in both groups\nD: Not reported for either group\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn the prevention of nausea and vomiting associated with HEC, how does the incidence of infusion-site reactions compare between FOSAPREPITANT and oral aprepitant?\nA: Higher in FOSAPREPITANT group\nB: Higher in oral aprepitant group\nC: Equal in both groups\nD: Not reported for either group\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"LbhWroiUSSLQ","- The age group of 18 to 24 years showed a reduction in suicidality risk with venlafaxine tablets compared to placebo.
- In clinical studies, venlafaxine was associated with a significant decrease in suicidal thoughts and behaviors in young adults aged 18 to 24.
- The findings indicated that venlafaxine was more effective than placebo in lowering the risk of suicidality in this specific age demographic.

MRRV(meta) winner=B; scores={'A': 0.3055555555555555, 'B': 1.0, 'C': 0.5, 'D': 0.27777777777777773}; rankings=[['B', 'C', 'D', 'A'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich age group showed a reduction in suicidality risk with venlafaxine tablets compared to placebo?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The age group of 18 to 24 years showed a reduction in suicidality risk with venlafaxine tablets compared to placebo.\n- In clinical studies, venlafaxine was associated with a significant decrease in suicidal thoughts and behaviors in young adults aged 18 to 24.\n- The findings indicated that venlafaxine was more effective than placebo in lowering the risk of suicidality in this specific age demographic.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which age group showed a reduction in suicidality risk with venlafaxine tablets compared to placebo?\nA: Children under 12 years\nB: Adolescents aged 13-18 years\nC: Adults aged 24-65 years\nD: Adults aged 65 and older\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The age group of 18 to 24 years showed a reduction in suicidality risk with venlafaxine tablets compared to placebo.\n- In clinical studies, venlafaxine was associated with a significant decrease in suicidal thoughts and behaviors in young adults aged 18 to 24.\n- The findings indicated that venlafaxine was more effective than placebo in lowering the risk of suicidality in this specific age demographic.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which age group showed a reduction in suicidality risk with venlafaxine tablets compared to placebo?\nA: Children under 12 years\nB: Adolescents aged 13-18 years\nC: Adults aged 24-65 years\nD: Adults aged 65 and older\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The age group of 18 to 24 years showed a reduction in suicidality risk with venlafaxine tablets compared to placebo.\n- In clinical studies, venlafaxine was associated with a significant decrease in suicidal thoughts and behaviors in young adults aged 18 to 24.\n- The findings indicated that venlafaxine was more effective than placebo in lowering the risk of suicidality in this specific age demographic.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which age group showed a reduction in suicidality risk with venlafaxine tablets compared to placebo?\nA: Children under 12 years\nB: Adolescents aged 13-18 years\nC: Adults aged 24-65 years\nD: Adults aged 65 and older\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The age group of 18 to 24 years showed a reduction in suicidality risk with venlafaxine tablets compared to placebo.\n- In clinical studies, venlafaxine was associated with a significant decrease in suicidal thoughts and behaviors in young adults aged 18 to 24.\n- The findings indicated that venlafaxine was more effective than placebo in lowering the risk of suicidality in this specific age demographic.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"S8rR9G0u78T2","- Women using hormonal birth control should be aware that fosaprepitant may reduce the effectiveness of their contraceptive methods, potentially leading to unintended pregnancy.
- It is recommended to use an additional non-hormonal contraceptive method, such as condoms, while receiving fosaprepitant and for at least one month after completing the treatment.
- Patients should consult their healthcare provider for alternative contraceptive options during the course of fosaprepitant therapy to ensure continued contraceptive efficacy.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat precaution should women using hormonal birth control take when receiving fosaprepitant for injection?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Women using hormonal birth control should be aware that fosaprepitant may reduce the effectiveness of their contraceptive methods, potentially leading to unintended pregnancy.\n- It is recommended to use an additional non-hormonal contraceptive method, such as condoms, while receiving fosaprepitant and for at least one month after completing the treatment.\n- Patients should consult their healthcare provider for alternative contraceptive options during the course of fosaprepitant therapy to ensure continued contraceptive efficacy.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should women using hormonal birth control take when receiving fosaprepitant for injection?\nA: Stop using hormonal birth control immediately.\nB: Switch to a permanent contraceptive method.\nC: Use a backup non-hormonal method of birth control during treatment and for 1 month after.\nD: No precautions are necessary.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Women using hormonal birth control should be aware that fosaprepitant may reduce the effectiveness of their contraceptive methods, potentially leading to unintended pregnancy.\n- It is recommended to use an additional non-hormonal contraceptive method, such as condoms, while receiving fosaprepitant and for at least one month after completing the treatment.\n- Patients should consult their healthcare provider for alternative contraceptive options during the course of fosaprepitant therapy to ensure continued contraceptive efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should women using hormonal birth control take when receiving fosaprepitant for injection?\nA: Stop using hormonal birth control immediately.\nB: Switch to a permanent contraceptive method.\nC: Use a backup non-hormonal method of birth control during treatment and for 1 month after.\nD: No precautions are necessary.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Women using hormonal birth control should be aware that fosaprepitant may reduce the effectiveness of their contraceptive methods, potentially leading to unintended pregnancy.\n- It is recommended to use an additional non-hormonal contraceptive method, such as condoms, while receiving fosaprepitant and for at least one month after completing the treatment.\n- Patients should consult their healthcare provider for alternative contraceptive options during the course of fosaprepitant therapy to ensure continued contraceptive efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should women using hormonal birth control take when receiving fosaprepitant for injection?\nA: Stop using hormonal birth control immediately.\nB: Switch to a permanent contraceptive method.\nC: Use a backup non-hormonal method of birth control during treatment and for 1 month after.\nD: No precautions are necessary.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Women using hormonal birth control should be aware that fosaprepitant may reduce the effectiveness of their contraceptive methods, potentially leading to unintended pregnancy.\n- It is recommended to use an additional non-hormonal contraceptive method, such as condoms, while receiving fosaprepitant and for at least one month after completing the treatment.\n- Patients should consult their healthcare provider for alternative contraceptive options during the course of fosaprepitant therapy to ensure continued contraceptive efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"S6xqZWAnXkiE","- Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used to treat depression and anxiety, which may not be associated with traditional patterns of misuse seen with controlled substances.
- The long half-life of Fluoxetine and its active metabolite, norfluoxetine, can lead to prolonged effects, making it difficult to gauge immediate misuse potential compared to shorter-acting medications.
- The lack of euphoric effects typically associated with stimulant or opioid drugs may result in underreporting of misuse, complicating the assessment of its abuse potential post-marketing.

MRRV(meta) winner=B; scores={'A': 0.38888888888888884, 'B': 0.8333333333333334, 'C': 0.25, 'D': 0.611111111111111}; rankings=[['B', 'D', 'A', 'C'], ['D', 'B', 'A', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy is it challenging to predict the extent of Fluoxetine misuse or abuse after it is marketed?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used to treat depression and anxiety, which may not be associated with traditional patterns of misuse seen with controlled substances.\n- The long half-life of Fluoxetine and its active metabolite, norfluoxetine, can lead to prolonged effects, making it difficult to gauge immediate misuse potential compared to shorter-acting medications.\n- The lack of euphoric effects typically associated with stimulant or opioid drugs may result in underreporting of misuse, complicating the assessment of its abuse potential post-marketing.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is it challenging to predict the extent of Fluoxetine misuse or abuse after it is marketed?\nA: Because Fluoxetine is not a CNS-active drug.\nB: Because premarketing clinical studies were not systematic in evaluating drug-seeking behavior.\nC: Because Fluoxetine has a high potential for physical dependence.\nD: Because Fluoxetine is not commonly prescribed for conditions associated with drug abuse.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used to treat depression and anxiety, which may not be associated with traditional patterns of misuse seen with controlled substances.\n- The long half-life of Fluoxetine and its active metabolite, norfluoxetine, can lead to prolonged effects, making it difficult to gauge immediate misuse potential compared to shorter-acting medications.\n- The lack of euphoric effects typically associated with stimulant or opioid drugs may result in underreporting of misuse, complicating the assessment of its abuse potential post-marketing.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is it challenging to predict the extent of Fluoxetine misuse or abuse after it is marketed?\nA: Because Fluoxetine is not a CNS-active drug.\nB: Because premarketing clinical studies were not systematic in evaluating drug-seeking behavior.\nC: Because Fluoxetine has a high potential for physical dependence.\nD: Because Fluoxetine is not commonly prescribed for conditions associated with drug abuse.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used to treat depression and anxiety, which may not be associated with traditional patterns of misuse seen with controlled substances.\n- The long half-life of Fluoxetine and its active metabolite, norfluoxetine, can lead to prolonged effects, making it difficult to gauge immediate misuse potential compared to shorter-acting medications.\n- The lack of euphoric effects typically associated with stimulant or opioid drugs may result in underreporting of misuse, complicating the assessment of its abuse potential post-marketing.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is it challenging to predict the extent of Fluoxetine misuse or abuse after it is marketed?\nA: Because Fluoxetine is not a CNS-active drug.\nB: Because premarketing clinical studies were not systematic in evaluating drug-seeking behavior.\nC: Because Fluoxetine has a high potential for physical dependence.\nD: Because Fluoxetine is not commonly prescribed for conditions associated with drug abuse.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used to treat depression and anxiety, which may not be associated with traditional patterns of misuse seen with controlled substances.\n- The long half-life of Fluoxetine and its active metabolite, norfluoxetine, can lead to prolonged effects, making it difficult to gauge immediate misuse potential compared to shorter-acting medications.\n- The lack of euphoric effects typically associated with stimulant or opioid drugs may result in underreporting of misuse, complicating the assessment of its abuse potential post-marketing.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"hisVEgN8wQWx","- The nighttime formulation of 'nighttime severe cold and flu' specifically relieves insomnia associated with cold and flu symptoms due to its sedative ingredients.
- It helps alleviate symptoms such as cough and nasal congestion, allowing for better sleep during the night.
- The formulation typically contains diphenhydramine, which is known for its effectiveness in reducing nighttime cough and promoting restful sleep.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich symptom is specifically relieved by the nighttime formulation of the drug 'nighttime severe cold and flu'?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The nighttime formulation of 'nighttime severe cold and flu' specifically relieves insomnia associated with cold and flu symptoms due to its sedative ingredients.\n- It helps alleviate symptoms such as cough and nasal congestion, allowing for better sleep during the night.\n- The formulation typically contains diphenhydramine, which is known for its effectiveness in reducing nighttime cough and promoting restful sleep.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom is specifically relieved by the nighttime formulation of the drug 'nighttime severe cold and flu'?\nA: Cough\nB: Runny nose\nC: Headache\nD: Nasal congestion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The nighttime formulation of 'nighttime severe cold and flu' specifically relieves insomnia associated with cold and flu symptoms due to its sedative ingredients.\n- It helps alleviate symptoms such as cough and nasal congestion, allowing for better sleep during the night.\n- The formulation typically contains diphenhydramine, which is known for its effectiveness in reducing nighttime cough and promoting restful sleep.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom is specifically relieved by the nighttime formulation of the drug 'nighttime severe cold and flu'?\nA: Cough\nB: Runny nose\nC: Headache\nD: Nasal congestion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The nighttime formulation of 'nighttime severe cold and flu' specifically relieves insomnia associated with cold and flu symptoms due to its sedative ingredients.\n- It helps alleviate symptoms such as cough and nasal congestion, allowing for better sleep during the night.\n- The formulation typically contains diphenhydramine, which is known for its effectiveness in reducing nighttime cough and promoting restful sleep.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom is specifically relieved by the nighttime formulation of the drug 'nighttime severe cold and flu'?\nA: Cough\nB: Runny nose\nC: Headache\nD: Nasal congestion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The nighttime formulation of 'nighttime severe cold and flu' specifically relieves insomnia associated with cold and flu symptoms due to its sedative ingredients.\n- It helps alleviate symptoms such as cough and nasal congestion, allowing for better sleep during the night.\n- The formulation typically contains diphenhydramine, which is known for its effectiveness in reducing nighttime cough and promoting restful sleep.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"mWbD8y8bPqDP","1) Recommendation: The Beloved Coconut & Warm Vanilla Hand Sanitizer is produced by the brand ""Beloved."" It is advisable to check the product label or the brand's official website for the most accurate and up-to-date information.

2) Key rationale:
   - Beloved is known for its personal care products, including hand sanitizers.
   - The brand emphasizes natural ingredients and pleasant scents in its formulations.
   - The specific product name indicates a focus on coconut and vanilla, which aligns with Beloved's product offerings.

3) Safety/contraindications/interactions:
   - Always check for skin sensitivity to ingredients, especially if you have allergies.
   - Ensure the product is used as directed to avoid skin irritation.
   - Keep out of reach of children and avoid ingestion.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhich brand produces the Beloved Coconut & Warm Vanilla Hand Sanitizer?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: The Beloved Coconut & Warm Vanilla Hand Sanitizer is produced by the brand \""Beloved.\"" It is advisable to check the product label or the brand's official website for the most accurate and up-to-date information.\n\n2) Key rationale:\n   - Beloved is known for its personal care products, including hand sanitizers.\n   - The brand emphasizes natural ingredients and pleasant scents in its formulations.\n   - The specific product name indicates a focus on coconut and vanilla, which aligns with Beloved's product offerings.\n\n3) Safety/contraindications/interactions:\n   - Always check for skin sensitivity to ingredients, especially if you have allergies.\n   - Ensure the product is used as directed to avoid skin irritation.\n   - Keep out of reach of children and avoid ingestion.""}]"
"5T5KQwwKLJSh","1) Recommendation: The appropriate dosage of a laxative for children aged 6 to under 12 years should be determined based on the specific laxative being used, as different types have varying dosages. It is crucial to consult a pediatrician for personalized recommendations and to ensure safety.

2) Key rationale:
   - Dosage varies significantly between different laxatives (e.g., osmotic, stimulant, bulk-forming).
   - Children's weight and overall health status can affect the appropriate dosage.
   - Pediatric guidelines often provide specific dosing recommendations based on age and weight.
   - Overuse or incorrect dosing can lead to adverse effects, including dehydration or electrolyte imbalances.

3) Safety/contraindications/interactions:
   - Always consult a healthcare provider before administering laxatives to children.
   - Some laxatives may not be suitable for children with certain medical conditions (e.g., gastrointestinal obstruction).
   - Potential interactions with other medications should be considered.
   - Monitor for side effects such as abdominal pain, diarrhea, or allergic reactions. 

Assumptions: The question assumes that the laxative in question is safe for children and does not specify which type of laxative is being referred to. Additional information about the child's health status and any other medications they may be taking is also necessary for a more tailored recommendation.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nFor children aged 6 to under 12 years, what is the appropriate dosage of the laxative for women?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: The appropriate dosage of a laxative for children aged 6 to under 12 years should be determined based on the specific laxative being used, as different types have varying dosages. It is crucial to consult a pediatrician for personalized recommendations and to ensure safety.\n\n2) Key rationale:\n   - Dosage varies significantly between different laxatives (e.g., osmotic, stimulant, bulk-forming).\n   - Children's weight and overall health status can affect the appropriate dosage.\n   - Pediatric guidelines often provide specific dosing recommendations based on age and weight.\n   - Overuse or incorrect dosing can lead to adverse effects, including dehydration or electrolyte imbalances.\n\n3) Safety/contraindications/interactions:\n   - Always consult a healthcare provider before administering laxatives to children.\n   - Some laxatives may not be suitable for children with certain medical conditions (e.g., gastrointestinal obstruction).\n   - Potential interactions with other medications should be considered.\n   - Monitor for side effects such as abdominal pain, diarrhea, or allergic reactions. \n\nAssumptions: The question assumes that the laxative in question is safe for children and does not specify which type of laxative is being referred to. Additional information about the child's health status and any other medications they may be taking is also necessary for a more tailored recommendation.""}]"
"MC9FHS84zIbx","- The formulation typically includes phenylephrine, which acts as a decongestant to relieve nasal congestion.
- It may contain diphenhydramine, an antihistamine that helps reduce nasal discharge and sneezing.
- The combination of these ingredients can provide symptomatic relief from nasal symptoms associated with cold and flu.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is one of the ways 'basic care nighttime cold and flu' helps with nasal symptoms?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The formulation typically includes phenylephrine, which acts as a decongestant to relieve nasal congestion.\n- It may contain diphenhydramine, an antihistamine that helps reduce nasal discharge and sneezing.\n- The combination of these ingredients can provide symptomatic relief from nasal symptoms associated with cold and flu.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is one of the ways 'basic care nighttime cold and flu' helps with nasal symptoms?\nA: Temporarily restores freer breathing through the nose\nB: Permanently cures nasal congestion\nC: Prevents future nasal congestion\nD: Increases mucus production in the nose\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The formulation typically includes phenylephrine, which acts as a decongestant to relieve nasal congestion.\n- It may contain diphenhydramine, an antihistamine that helps reduce nasal discharge and sneezing.\n- The combination of these ingredients can provide symptomatic relief from nasal symptoms associated with cold and flu.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is one of the ways 'basic care nighttime cold and flu' helps with nasal symptoms?\nA: Temporarily restores freer breathing through the nose\nB: Permanently cures nasal congestion\nC: Prevents future nasal congestion\nD: Increases mucus production in the nose\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The formulation typically includes phenylephrine, which acts as a decongestant to relieve nasal congestion.\n- It may contain diphenhydramine, an antihistamine that helps reduce nasal discharge and sneezing.\n- The combination of these ingredients can provide symptomatic relief from nasal symptoms associated with cold and flu.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is one of the ways 'basic care nighttime cold and flu' helps with nasal symptoms?\nA: Temporarily restores freer breathing through the nose\nB: Permanently cures nasal congestion\nC: Prevents future nasal congestion\nD: Increases mucus production in the nose\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The formulation typically includes phenylephrine, which acts as a decongestant to relieve nasal congestion.\n- It may contain diphenhydramine, an antihistamine that helps reduce nasal discharge and sneezing.\n- The combination of these ingredients can provide symptomatic relief from nasal symptoms associated with cold and flu.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"rkn2WGUj1inH","- The smoker should use the 4 mg Nicotine lozenges, as this dosage is recommended for individuals who smoke their first cigarette within 30 minutes of waking up.
- Using the 4 mg lozenge can help manage withdrawal symptoms and cravings more effectively for those with a higher level of nicotine dependence.

MRRV(meta) winner=C; scores={'A': 0.3333333333333333, 'B': 0.5, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIf a smoker uses Nicotine lozenges and smokes their first cigarette within 30 minutes of waking up, what dosage should they use?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The smoker should use the 4 mg Nicotine lozenges, as this dosage is recommended for individuals who smoke their first cigarette within 30 minutes of waking up.\n- Using the 4 mg lozenge can help manage withdrawal symptoms and cravings more effectively for those with a higher level of nicotine dependence.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: If a smoker uses Nicotine lozenges and smokes their first cigarette within 30 minutes of waking up, what dosage should they use?\nA: 1 mg Nicotine lozenge\nB: 2 mg Nicotine lozenge\nC: 4 mg Nicotine lozenge\nD: 6 mg Nicotine lozenge\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The smoker should use the 4 mg Nicotine lozenges, as this dosage is recommended for individuals who smoke their first cigarette within 30 minutes of waking up.\n- Using the 4 mg lozenge can help manage withdrawal symptoms and cravings more effectively for those with a higher level of nicotine dependence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: If a smoker uses Nicotine lozenges and smokes their first cigarette within 30 minutes of waking up, what dosage should they use?\nA: 1 mg Nicotine lozenge\nB: 2 mg Nicotine lozenge\nC: 4 mg Nicotine lozenge\nD: 6 mg Nicotine lozenge\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The smoker should use the 4 mg Nicotine lozenges, as this dosage is recommended for individuals who smoke their first cigarette within 30 minutes of waking up.\n- Using the 4 mg lozenge can help manage withdrawal symptoms and cravings more effectively for those with a higher level of nicotine dependence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: If a smoker uses Nicotine lozenges and smokes their first cigarette within 30 minutes of waking up, what dosage should they use?\nA: 1 mg Nicotine lozenge\nB: 2 mg Nicotine lozenge\nC: 4 mg Nicotine lozenge\nD: 6 mg Nicotine lozenge\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The smoker should use the 4 mg Nicotine lozenges, as this dosage is recommended for individuals who smoke their first cigarette within 30 minutes of waking up.\n- Using the 4 mg lozenge can help manage withdrawal symptoms and cravings more effectively for those with a higher level of nicotine dependence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}]"
"Y4dnTVj1svSo","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn which scenario should Palonosetron not be prescribed?\nA: A patient with hypersensitivity to palonosetron.\nB: A patient undergoing chemotherapy.\nC: A patient with mild nausea.\nD: A patient with a history of migraines.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn which scenario should Palonosetron not be prescribed?\nA: A patient with hypersensitivity to palonosetron.\nB: A patient undergoing chemotherapy.\nC: A patient with mild nausea.\nD: A patient with a history of migraines.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn which scenario should Palonosetron not be prescribed?\nA: A patient with hypersensitivity to palonosetron.\nB: A patient undergoing chemotherapy.\nC: A patient with mild nausea.\nD: A patient with a history of migraines.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"s2Tb5DRLFTyn","- Albuterol sulfate showed no evidence of tumorigenicity in a rat model at dietary doses up to 500 mg/kg.
- The study involved long-term exposure to albuterol sulfate in the diet without any observed tumor formation in the tested rats.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn which animal model did albuterol sulfate show no evidence of tumorigenicity at dietary doses up to 500 mg/kg?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Albuterol sulfate showed no evidence of tumorigenicity in a rat model at dietary doses up to 500 mg/kg.\n- The study involved long-term exposure to albuterol sulfate in the diet without any observed tumor formation in the tested rats.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In which animal model did albuterol sulfate show no evidence of tumorigenicity at dietary doses up to 500 mg/kg?\nA: CD-1 mice\nB: Sprague-Dawley rats\nC: Golden hamsters\nD: Minipigs\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol sulfate showed no evidence of tumorigenicity in a rat model at dietary doses up to 500 mg/kg.\n- The study involved long-term exposure to albuterol sulfate in the diet without any observed tumor formation in the tested rats.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In which animal model did albuterol sulfate show no evidence of tumorigenicity at dietary doses up to 500 mg/kg?\nA: CD-1 mice\nB: Sprague-Dawley rats\nC: Golden hamsters\nD: Minipigs\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol sulfate showed no evidence of tumorigenicity in a rat model at dietary doses up to 500 mg/kg.\n- The study involved long-term exposure to albuterol sulfate in the diet without any observed tumor formation in the tested rats.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In which animal model did albuterol sulfate show no evidence of tumorigenicity at dietary doses up to 500 mg/kg?\nA: CD-1 mice\nB: Sprague-Dawley rats\nC: Golden hamsters\nD: Minipigs\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol sulfate showed no evidence of tumorigenicity in a rat model at dietary doses up to 500 mg/kg.\n- The study involved long-term exposure to albuterol sulfate in the diet without any observed tumor formation in the tested rats.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"AmYhDx2lQmoY","- Esomeprazole magnesium tablets should be taken once daily for 14 days, ideally before a meal for optimal absorption.
- It is important to swallow the tablets whole and not to crush or chew them to ensure proper release of the medication.
- Patients should complete the full 14-day course, even if symptoms improve before finishing the treatment.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended method of taking esomeprazole magnesium tablets during the 14-day treatment course?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Esomeprazole magnesium tablets should be taken once daily for 14 days, ideally before a meal for optimal absorption.\n- It is important to swallow the tablets whole and not to crush or chew them to ensure proper release of the medication.\n- Patients should complete the full 14-day course, even if symptoms improve before finishing the treatment.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended method of taking esomeprazole magnesium tablets during the 14-day treatment course?\nA: Crush and mix with water\nB: Chew the tablet thoroughly\nC: Swallow whole with a glass of water\nD: Dissolve in a glass of water before drinking\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Esomeprazole magnesium tablets should be taken once daily for 14 days, ideally before a meal for optimal absorption.\n- It is important to swallow the tablets whole and not to crush or chew them to ensure proper release of the medication.\n- Patients should complete the full 14-day course, even if symptoms improve before finishing the treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended method of taking esomeprazole magnesium tablets during the 14-day treatment course?\nA: Crush and mix with water\nB: Chew the tablet thoroughly\nC: Swallow whole with a glass of water\nD: Dissolve in a glass of water before drinking\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Esomeprazole magnesium tablets should be taken once daily for 14 days, ideally before a meal for optimal absorption.\n- It is important to swallow the tablets whole and not to crush or chew them to ensure proper release of the medication.\n- Patients should complete the full 14-day course, even if symptoms improve before finishing the treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended method of taking esomeprazole magnesium tablets during the 14-day treatment course?\nA: Crush and mix with water\nB: Chew the tablet thoroughly\nC: Swallow whole with a glass of water\nD: Dissolve in a glass of water before drinking\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Esomeprazole magnesium tablets should be taken once daily for 14 days, ideally before a meal for optimal absorption.\n- It is important to swallow the tablets whole and not to crush or chew them to ensure proper release of the medication.\n- Patients should complete the full 14-day course, even if symptoms improve before finishing the treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"4fsbbYJzgETq","1) Recommendation: It is advised not to eat or drink 15 minutes before using or while the nicotine lozenge is in the mouth to ensure optimal absorption of nicotine and to enhance the effectiveness of the lozenge.

2) Key rationale:
   - Eating or drinking can alter the pH level in the mouth, which may affect the absorption of nicotine.
   - Food and beverages can create a physical barrier that may prevent the lozenge from dissolving properly.
   - Saliva production can be increased by eating or drinking, which may dilute the nicotine and reduce its effectiveness.
   - To achieve the best therapeutic effect, it is important to allow the lozenge to dissolve slowly without interference.

3) Safety/contraindications/interactions:
   - Avoid acidic beverages (e.g., soda, coffee) as they can further decrease nicotine absorption.
   - Individuals with certain medical conditions (e.g., heart disease) should consult a healthcare provider before using nicotine replacement therapies.
   - Nicotine lozenges should not be used in conjunction with other nicotine products without medical advice.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhy is it recommended not to eat or drink 15 minutes before using or while the NICOTINE lozenge is in the mouth?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: It is advised not to eat or drink 15 minutes before using or while the nicotine lozenge is in the mouth to ensure optimal absorption of nicotine and to enhance the effectiveness of the lozenge.\n\n2) Key rationale:\n   - Eating or drinking can alter the pH level in the mouth, which may affect the absorption of nicotine.\n   - Food and beverages can create a physical barrier that may prevent the lozenge from dissolving properly.\n   - Saliva production can be increased by eating or drinking, which may dilute the nicotine and reduce its effectiveness.\n   - To achieve the best therapeutic effect, it is important to allow the lozenge to dissolve slowly without interference.\n\n3) Safety/contraindications/interactions:\n   - Avoid acidic beverages (e.g., soda, coffee) as they can further decrease nicotine absorption.\n   - Individuals with certain medical conditions (e.g., heart disease) should consult a healthcare provider before using nicotine replacement therapies.\n   - Nicotine lozenges should not be used in conjunction with other nicotine products without medical advice.""}]"
"aUkWUTTiKMPy","MRRV winner=C; scores={'A': 0.3333333333333333, 'B': 0.5, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat type of hypersensitivity reaction is a contraindication for Guanfacine extended-release?\nA: Hypersensitivity to inactive ingredients of Guanfacine extended-release\nB: Hypersensitivity to other products containing guanfacine\nC: Hypersensitivity to both inactive ingredients and other products containing guanfacine\nD: Hypersensitivity to unrelated medications\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat type of hypersensitivity reaction is a contraindication for Guanfacine extended-release?\nA: Hypersensitivity to inactive ingredients of Guanfacine extended-release\nB: Hypersensitivity to other products containing guanfacine\nC: Hypersensitivity to both inactive ingredients and other products containing guanfacine\nD: Hypersensitivity to unrelated medications\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat type of hypersensitivity reaction is a contraindication for Guanfacine extended-release?\nA: Hypersensitivity to inactive ingredients of Guanfacine extended-release\nB: Hypersensitivity to other products containing guanfacine\nC: Hypersensitivity to both inactive ingredients and other products containing guanfacine\nD: Hypersensitivity to unrelated medications\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}]"
"KFO7xIOfSAuj","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich medication should be used for acute asthma symptoms instead of Stiolto Respimat?\nA: Albuterol\nB: Stiolto Respimat\nC: Inhaled corticosteroids\nD: Long-acting beta-2 agonists\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich medication should be used for acute asthma symptoms instead of Stiolto Respimat?\nA: Albuterol\nB: Stiolto Respimat\nC: Inhaled corticosteroids\nD: Long-acting beta-2 agonists\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich medication should be used for acute asthma symptoms instead of Stiolto Respimat?\nA: Albuterol\nB: Stiolto Respimat\nC: Inhaled corticosteroids\nD: Long-acting beta-2 agonists\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"SKQ7tohL65cn","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for patients with a creatinine clearance between 45 mL/min and 79 mL/min who are taking Pemetrexed and require ibuprofen?\nA: Administer ibuprofen at a higher dose for better efficacy.\nB: Avoid ibuprofen for 2 days before, the day of, and 2 days after Pemetrexed administration.\nC: Discontinue Pemetrexed permanently if ibuprofen is required.\nD: Administer ibuprofen without any modifications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for patients with a creatinine clearance between 45 mL/min and 79 mL/min who are taking Pemetrexed and require ibuprofen?\nA: Administer ibuprofen at a higher dose for better efficacy.\nB: Avoid ibuprofen for 2 days before, the day of, and 2 days after Pemetrexed administration.\nC: Discontinue Pemetrexed permanently if ibuprofen is required.\nD: Administer ibuprofen without any modifications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for patients with a creatinine clearance between 45 mL/min and 79 mL/min who are taking Pemetrexed and require ibuprofen?\nA: Administer ibuprofen at a higher dose for better efficacy.\nB: Avoid ibuprofen for 2 days before, the day of, and 2 days after Pemetrexed administration.\nC: Discontinue Pemetrexed permanently if ibuprofen is required.\nD: Administer ibuprofen without any modifications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"UIOPfPRsOFRk","MRRV winner=D; scores={'A': 0.25, 'B': 0.38888888888888884, 'C': 0.4444444444444444, 'D': 1.0}; rankings=[['D', 'C', 'B', 'A'], ['D', 'C', 'B', 'A'], ['D', 'B', 'C', 'A']]","D","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is NOT addressed by the drug 'nasal 12 hour'?\nA: Nasal congestion due to hay fever.\nB: Sinus congestion and pressure.\nC: Nasal congestion due to the common cold.\nD: Chronic sinus infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is NOT addressed by the drug 'nasal 12 hour'?\nA: Nasal congestion due to hay fever.\nB: Sinus congestion and pressure.\nC: Nasal congestion due to the common cold.\nD: Chronic sinus infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is NOT addressed by the drug 'nasal 12 hour'?\nA: Nasal congestion due to hay fever.\nB: Sinus congestion and pressure.\nC: Nasal congestion due to the common cold.\nD: Chronic sinus infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > C > A""}]"
"jWvzRd50HBHy","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended approach for patients undergoing hemodialysis after receiving Gadavist?\nA: Avoid hemodialysis as it has no effect on gadolinium elimination\nB: Initiate hemodialysis promptly to enhance gadolinium elimination\nC: Delay hemodialysis for at least 24 hours\nD: Administer a higher dose of Gadavist before hemodialysis\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended approach for patients undergoing hemodialysis after receiving Gadavist?\nA: Avoid hemodialysis as it has no effect on gadolinium elimination\nB: Initiate hemodialysis promptly to enhance gadolinium elimination\nC: Delay hemodialysis for at least 24 hours\nD: Administer a higher dose of Gadavist before hemodialysis\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended approach for patients undergoing hemodialysis after receiving Gadavist?\nA: Avoid hemodialysis as it has no effect on gadolinium elimination\nB: Initiate hemodialysis promptly to enhance gadolinium elimination\nC: Delay hemodialysis for at least 24 hours\nD: Administer a higher dose of Gadavist before hemodialysis\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"sREowFmeVh0w","- Nivolumab is an appropriate treatment option for recurrent metastatic non-squamous NSCLC after prior chemotherapy, as it is an immune checkpoint inhibitor that has shown efficacy in this setting.
- Atezolizumab can also be considered, as it is another immune checkpoint inhibitor that targets PD-L1 and is indicated for patients with recurrent metastatic non-squamous NSCLC following chemotherapy.
- Docetaxel may be used as a second-line chemotherapy option for patients with recurrent metastatic non-squamous NSCLC after Pemetrexed, providing a different mechanism of action compared to the previous treatment.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich treatment option is appropriate for recurrent metastatic non-squamous NSCLC after prior chemotherapy using Pemetrexed for Injection?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Nivolumab is an appropriate treatment option for recurrent metastatic non-squamous NSCLC after prior chemotherapy, as it is an immune checkpoint inhibitor that has shown efficacy in this setting.\n- Atezolizumab can also be considered, as it is another immune checkpoint inhibitor that targets PD-L1 and is indicated for patients with recurrent metastatic non-squamous NSCLC following chemotherapy.\n- Docetaxel may be used as a second-line chemotherapy option for patients with recurrent metastatic non-squamous NSCLC after Pemetrexed, providing a different mechanism of action compared to the previous treatment.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which treatment option is appropriate for recurrent metastatic non-squamous NSCLC after prior chemotherapy using Pemetrexed for Injection?\nA: Pemetrexed as a single agent.\nB: Pemetrexed in combination with cisplatin.\nC: Pemetrexed in combination with pembrolizumab and platinum chemotherapy.\nD: Pemetrexed in combination with ALK inhibitors.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Nivolumab is an appropriate treatment option for recurrent metastatic non-squamous NSCLC after prior chemotherapy, as it is an immune checkpoint inhibitor that has shown efficacy in this setting.\n- Atezolizumab can also be considered, as it is another immune checkpoint inhibitor that targets PD-L1 and is indicated for patients with recurrent metastatic non-squamous NSCLC following chemotherapy.\n- Docetaxel may be used as a second-line chemotherapy option for patients with recurrent metastatic non-squamous NSCLC after Pemetrexed, providing a different mechanism of action compared to the previous treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which treatment option is appropriate for recurrent metastatic non-squamous NSCLC after prior chemotherapy using Pemetrexed for Injection?\nA: Pemetrexed as a single agent.\nB: Pemetrexed in combination with cisplatin.\nC: Pemetrexed in combination with pembrolizumab and platinum chemotherapy.\nD: Pemetrexed in combination with ALK inhibitors.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Nivolumab is an appropriate treatment option for recurrent metastatic non-squamous NSCLC after prior chemotherapy, as it is an immune checkpoint inhibitor that has shown efficacy in this setting.\n- Atezolizumab can also be considered, as it is another immune checkpoint inhibitor that targets PD-L1 and is indicated for patients with recurrent metastatic non-squamous NSCLC following chemotherapy.\n- Docetaxel may be used as a second-line chemotherapy option for patients with recurrent metastatic non-squamous NSCLC after Pemetrexed, providing a different mechanism of action compared to the previous treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which treatment option is appropriate for recurrent metastatic non-squamous NSCLC after prior chemotherapy using Pemetrexed for Injection?\nA: Pemetrexed as a single agent.\nB: Pemetrexed in combination with cisplatin.\nC: Pemetrexed in combination with pembrolizumab and platinum chemotherapy.\nD: Pemetrexed in combination with ALK inhibitors.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Nivolumab is an appropriate treatment option for recurrent metastatic non-squamous NSCLC after prior chemotherapy, as it is an immune checkpoint inhibitor that has shown efficacy in this setting.\n- Atezolizumab can also be considered, as it is another immune checkpoint inhibitor that targets PD-L1 and is indicated for patients with recurrent metastatic non-squamous NSCLC following chemotherapy.\n- Docetaxel may be used as a second-line chemotherapy option for patients with recurrent metastatic non-squamous NSCLC after Pemetrexed, providing a different mechanism of action compared to the previous treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}]"
"Ndxj5YI9MsBL","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nFor what conditions is hydrocort recommended to be used with occlusive dressings?\nA: Psoriasis and recalcitrant conditions\nB: Acute infections\nC: Minor skin irritations\nD: Allergic reactions\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nFor what conditions is hydrocort recommended to be used with occlusive dressings?\nA: Psoriasis and recalcitrant conditions\nB: Acute infections\nC: Minor skin irritations\nD: Allergic reactions\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nFor what conditions is hydrocort recommended to be used with occlusive dressings?\nA: Psoriasis and recalcitrant conditions\nB: Acute infections\nC: Minor skin irritations\nD: Allergic reactions\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"8fPgRgYwKVAX","1) Recommendation: Albuterol sulfate has shown no evidence of tumorigenicity in animal studies, specifically in the rat model at dietary doses of up to 50 mg/kg. This suggests that albuterol sulfate may be safe for use in therapeutic contexts, but further studies in different models and long-term effects should be considered.

2) Key rationale:
   - The study involved a rat model, which is commonly used for assessing the carcinogenic potential of substances.
   - Doses of up to 50 mg/kg were tested, indicating a thorough evaluation of potential tumorigenic effects.
   - The absence of tumorigenicity suggests that albuterol sulfate does not promote cancer development in this specific model.
   - Findings contribute to the safety profile of albuterol sulfate for clinical use in respiratory conditions.

3) Safety/contraindications/interactions:
   - While no tumorigenicity was observed, albuterol sulfate should still be used according to prescribed guidelines to avoid potential side effects.
   - Patients with certain cardiovascular conditions may need to use caution when taking albuterol.
   - Interactions with other medications, particularly those affecting heart rate or blood pressure, should be monitored.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nIn which animal model did albuterol sulfate show no evidence of tumorigenicity at dietary doses of up to 50 mg/kg?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Albuterol sulfate has shown no evidence of tumorigenicity in animal studies, specifically in the rat model at dietary doses of up to 50 mg/kg. This suggests that albuterol sulfate may be safe for use in therapeutic contexts, but further studies in different models and long-term effects should be considered.\n\n2) Key rationale:\n   - The study involved a rat model, which is commonly used for assessing the carcinogenic potential of substances.\n   - Doses of up to 50 mg/kg were tested, indicating a thorough evaluation of potential tumorigenic effects.\n   - The absence of tumorigenicity suggests that albuterol sulfate does not promote cancer development in this specific model.\n   - Findings contribute to the safety profile of albuterol sulfate for clinical use in respiratory conditions.\n\n3) Safety/contraindications/interactions:\n   - While no tumorigenicity was observed, albuterol sulfate should still be used according to prescribed guidelines to avoid potential side effects.\n   - Patients with certain cardiovascular conditions may need to use caution when taking albuterol.\n   - Interactions with other medications, particularly those affecting heart rate or blood pressure, should be monitored.""}]"
"59HdEoDC6T6a","1) Recommendation: If a patient develops significant ovarian enlargement after ovulation while on Follistim AQ therapy, it is advisable to monitor the patient closely and consider adjusting the dosage or temporarily discontinuing the medication. Referral to a reproductive endocrinologist may also be warranted for further evaluation and management.

2) Key rationale:
- Significant ovarian enlargement can indicate ovarian hyperstimulation syndrome (OHSS), which can lead to serious complications.
- Monitoring allows for timely intervention to prevent progression of symptoms and complications.
- Adjusting the dosage or discontinuing therapy can help mitigate risks associated with excessive ovarian stimulation.
- Referral to a specialist ensures comprehensive management and access to advanced treatment options if necessary.

3) Safety/contraindications/interactions:
- Patients with a history of OHSS should be monitored more closely when using Follistim AQ.
- Caution is advised in patients with polycystic ovary syndrome (PCOS) or those at higher risk for OHSS.
- Potential interactions with other fertility medications should be considered, as they may exacerbate ovarian stimulation.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the recommended action if a patient develops significant ovarian enlargement after ovulation while on Follistim AQ therapy?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: If a patient develops significant ovarian enlargement after ovulation while on Follistim AQ therapy, it is advisable to monitor the patient closely and consider adjusting the dosage or temporarily discontinuing the medication. Referral to a reproductive endocrinologist may also be warranted for further evaluation and management.\n\n2) Key rationale:\n- Significant ovarian enlargement can indicate ovarian hyperstimulation syndrome (OHSS), which can lead to serious complications.\n- Monitoring allows for timely intervention to prevent progression of symptoms and complications.\n- Adjusting the dosage or discontinuing therapy can help mitigate risks associated with excessive ovarian stimulation.\n- Referral to a specialist ensures comprehensive management and access to advanced treatment options if necessary.\n\n3) Safety/contraindications/interactions:\n- Patients with a history of OHSS should be monitored more closely when using Follistim AQ.\n- Caution is advised in patients with polycystic ovary syndrome (PCOS) or those at higher risk for OHSS.\n- Potential interactions with other fertility medications should be considered, as they may exacerbate ovarian stimulation.""}]"
"FXwZ3tkAwUJz","MRRV winner=B; scores={'A': 0.25, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy is coadministration of Tybost with drugs or regimens containing ritonavir not recommended?\nA: It may lead to severe hypoglycemia.\nB: It may result in overlapping effects on CYP3A, leading to adverse drug interactions.\nC: It may cause severe liver toxicity.\nD: It may lead to reduced efficacy of Tybost.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy is coadministration of Tybost with drugs or regimens containing ritonavir not recommended?\nA: It may lead to severe hypoglycemia.\nB: It may result in overlapping effects on CYP3A, leading to adverse drug interactions.\nC: It may cause severe liver toxicity.\nD: It may lead to reduced efficacy of Tybost.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy is coadministration of Tybost with drugs or regimens containing ritonavir not recommended?\nA: It may lead to severe hypoglycemia.\nB: It may result in overlapping effects on CYP3A, leading to adverse drug interactions.\nC: It may cause severe liver toxicity.\nD: It may lead to reduced efficacy of Tybost.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"I4afzU6Ap2Hj","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for pregnant women or females of reproductive potential exposed to OGIVRI during pregnancy?\nA: Continue treatment without consulting a healthcare provider.\nB: Contact their healthcare provider immediately.\nC: Discontinue contraception immediately.\nD: Increase the dosage of OGIVRI.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for pregnant women or females of reproductive potential exposed to OGIVRI during pregnancy?\nA: Continue treatment without consulting a healthcare provider.\nB: Contact their healthcare provider immediately.\nC: Discontinue contraception immediately.\nD: Increase the dosage of OGIVRI.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for pregnant women or females of reproductive potential exposed to OGIVRI during pregnancy?\nA: Continue treatment without consulting a healthcare provider.\nB: Contact their healthcare provider immediately.\nC: Discontinue contraception immediately.\nD: Increase the dosage of OGIVRI.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"GdXT897N4hFB","MRRV winner=C; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the maximum oral dose of ondansetron administered to mice in the carcinogenicity studies, expressed in mg/kg per day?\nA: 10 mg/kg per day\nB: 15 mg/kg per day\nC: 30 mg/kg per day\nD: 24 mg/kg per day\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the maximum oral dose of ondansetron administered to mice in the carcinogenicity studies, expressed in mg/kg per day?\nA: 10 mg/kg per day\nB: 15 mg/kg per day\nC: 30 mg/kg per day\nD: 24 mg/kg per day\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the maximum oral dose of ondansetron administered to mice in the carcinogenicity studies, expressed in mg/kg per day?\nA: 10 mg/kg per day\nB: 15 mg/kg per day\nC: 30 mg/kg per day\nD: 24 mg/kg per day\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}]"
"QQ9RY7AZSLan","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be avoided while taking venlafaxine tablets to prevent impairment in decision-making or reaction time?\nA: Driving or operating heavy machinery\nB: Eating high-fat meals\nC: Taking vitamin supplements\nD: Drinking coffee\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be avoided while taking venlafaxine tablets to prevent impairment in decision-making or reaction time?\nA: Driving or operating heavy machinery\nB: Eating high-fat meals\nC: Taking vitamin supplements\nD: Drinking coffee\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be avoided while taking venlafaxine tablets to prevent impairment in decision-making or reaction time?\nA: Driving or operating heavy machinery\nB: Eating high-fat meals\nC: Taking vitamin supplements\nD: Drinking coffee\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"ptUNZfHPe9iH","1) Recommendation: Caution should be exercised when using Labetalol HCL in combination with tricyclic antidepressants (TCAs), as this combination may lead to increased cardiovascular side effects. Close monitoring of blood pressure and heart rate is advised.

2) Key rationale:
   - Labetalol is an antihypertensive that can cause bradycardia and hypotension, while TCAs can also affect cardiovascular function.
   - The combination may lead to additive effects on heart rate and blood pressure, increasing the risk of adverse cardiovascular events.
   - TCAs can also have anticholinergic effects, which may complicate the cardiovascular response to Labetalol.
   - Patients with pre-existing cardiovascular conditions may be at higher risk when these medications are combined.

3) Safety/contraindications/interactions:
   - Monitor for signs of orthostatic hypotension and bradycardia.
   - Use with caution in patients with a history of heart disease or arrhythmias.
   - Consider potential interactions with other medications that affect cardiovascular function.
   - Ensure that patients are aware of the signs of hypotension and bradycardia.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is a potential risk when Labetalol HCL is used in combination with tricyclic antidepressants?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Caution should be exercised when using Labetalol HCL in combination with tricyclic antidepressants (TCAs), as this combination may lead to increased cardiovascular side effects. Close monitoring of blood pressure and heart rate is advised.\n\n2) Key rationale:\n   - Labetalol is an antihypertensive that can cause bradycardia and hypotension, while TCAs can also affect cardiovascular function.\n   - The combination may lead to additive effects on heart rate and blood pressure, increasing the risk of adverse cardiovascular events.\n   - TCAs can also have anticholinergic effects, which may complicate the cardiovascular response to Labetalol.\n   - Patients with pre-existing cardiovascular conditions may be at higher risk when these medications are combined.\n\n3) Safety/contraindications/interactions:\n   - Monitor for signs of orthostatic hypotension and bradycardia.\n   - Use with caution in patients with a history of heart disease or arrhythmias.\n   - Consider potential interactions with other medications that affect cardiovascular function.\n   - Ensure that patients are aware of the signs of hypotension and bradycardia.""}]"
"JwY4hXr9vZ9f","- Lactating patients should avoid using Agrylin (anagrelide) due to potential risks to the nursing infant, as the drug can be excreted in breast milk.
- If treatment with Agrylin is necessary, it is recommended to discontinue breastfeeding to prevent exposure to the drug.
- Consultation with a healthcare provider is essential to discuss alternative treatments and the implications for both the mother and the infant.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended advice for lactating patients undergoing treatment with Agrylin?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Lactating patients should avoid using Agrylin (anagrelide) due to potential risks to the nursing infant, as the drug can be excreted in breast milk.\n- If treatment with Agrylin is necessary, it is recommended to discontinue breastfeeding to prevent exposure to the drug.\n- Consultation with a healthcare provider is essential to discuss alternative treatments and the implications for both the mother and the infant.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended advice for lactating patients undergoing treatment with Agrylin?\nA: Breastfeeding is safe during treatment with Agrylin.\nB: Breastfeeding is not recommended during treatment with Agrylin and for one week following the last dose.\nC: Breastfeeding is recommended only if the patient has mild thrombocythemia.\nD: Breastfeeding is recommended if the patient has no hepatic impairment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Lactating patients should avoid using Agrylin (anagrelide) due to potential risks to the nursing infant, as the drug can be excreted in breast milk.\n- If treatment with Agrylin is necessary, it is recommended to discontinue breastfeeding to prevent exposure to the drug.\n- Consultation with a healthcare provider is essential to discuss alternative treatments and the implications for both the mother and the infant.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended advice for lactating patients undergoing treatment with Agrylin?\nA: Breastfeeding is safe during treatment with Agrylin.\nB: Breastfeeding is not recommended during treatment with Agrylin and for one week following the last dose.\nC: Breastfeeding is recommended only if the patient has mild thrombocythemia.\nD: Breastfeeding is recommended if the patient has no hepatic impairment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Lactating patients should avoid using Agrylin (anagrelide) due to potential risks to the nursing infant, as the drug can be excreted in breast milk.\n- If treatment with Agrylin is necessary, it is recommended to discontinue breastfeeding to prevent exposure to the drug.\n- Consultation with a healthcare provider is essential to discuss alternative treatments and the implications for both the mother and the infant.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended advice for lactating patients undergoing treatment with Agrylin?\nA: Breastfeeding is safe during treatment with Agrylin.\nB: Breastfeeding is not recommended during treatment with Agrylin and for one week following the last dose.\nC: Breastfeeding is recommended only if the patient has mild thrombocythemia.\nD: Breastfeeding is recommended if the patient has no hepatic impairment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Lactating patients should avoid using Agrylin (anagrelide) due to potential risks to the nursing infant, as the drug can be excreted in breast milk.\n- If treatment with Agrylin is necessary, it is recommended to discontinue breastfeeding to prevent exposure to the drug.\n- Consultation with a healthcare provider is essential to discuss alternative treatments and the implications for both the mother and the infant.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"YtpSBGsbNuZa","- Discontinue the use of hydrocort (hydrocortisone) and remove the occlusive dressings to allow for proper ventilation and healing of the infected area.
- Initiate appropriate antimicrobial therapy based on the type of infection, which may include topical or systemic antibiotics depending on the severity and location of the infection.
- Monitor the infection closely for signs of worsening and consider consulting a healthcare professional for further evaluation and management.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat action should be taken if an infection develops while using hydrocort with occlusive dressings?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Discontinue the use of hydrocort (hydrocortisone) and remove the occlusive dressings to allow for proper ventilation and healing of the infected area.\n- Initiate appropriate antimicrobial therapy based on the type of infection, which may include topical or systemic antibiotics depending on the severity and location of the infection.\n- Monitor the infection closely for signs of worsening and consider consulting a healthcare professional for further evaluation and management.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What action should be taken if an infection develops while using hydrocort with occlusive dressings?\nA: Continue using occlusive dressings\nB: Discontinue occlusive dressings and start antimicrobial therapy\nC: Increase the frequency of hydrocort application\nD: Switch to oral corticosteroids\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue the use of hydrocort (hydrocortisone) and remove the occlusive dressings to allow for proper ventilation and healing of the infected area.\n- Initiate appropriate antimicrobial therapy based on the type of infection, which may include topical or systemic antibiotics depending on the severity and location of the infection.\n- Monitor the infection closely for signs of worsening and consider consulting a healthcare professional for further evaluation and management.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What action should be taken if an infection develops while using hydrocort with occlusive dressings?\nA: Continue using occlusive dressings\nB: Discontinue occlusive dressings and start antimicrobial therapy\nC: Increase the frequency of hydrocort application\nD: Switch to oral corticosteroids\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue the use of hydrocort (hydrocortisone) and remove the occlusive dressings to allow for proper ventilation and healing of the infected area.\n- Initiate appropriate antimicrobial therapy based on the type of infection, which may include topical or systemic antibiotics depending on the severity and location of the infection.\n- Monitor the infection closely for signs of worsening and consider consulting a healthcare professional for further evaluation and management.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What action should be taken if an infection develops while using hydrocort with occlusive dressings?\nA: Continue using occlusive dressings\nB: Discontinue occlusive dressings and start antimicrobial therapy\nC: Increase the frequency of hydrocort application\nD: Switch to oral corticosteroids\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue the use of hydrocort (hydrocortisone) and remove the occlusive dressings to allow for proper ventilation and healing of the infected area.\n- Initiate appropriate antimicrobial therapy based on the type of infection, which may include topical or systemic antibiotics depending on the severity and location of the infection.\n- Monitor the infection closely for signs of worsening and consider consulting a healthcare professional for further evaluation and management.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"vLLqOGKtUreF","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the concentration of hydrocortisone in ALA-SCALP (Hydrocortisone Lotion USP)?\nA: 1%\nB: 2%\nC: 5%\nD: 10%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the concentration of hydrocortisone in ALA-SCALP (Hydrocortisone Lotion USP)?\nA: 1%\nB: 2%\nC: 5%\nD: 10%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the concentration of hydrocortisone in ALA-SCALP (Hydrocortisone Lotion USP)?\nA: 1%\nB: 2%\nC: 5%\nD: 10%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"aZh6K1M3fdr9","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary indication for the use of Nicotine as a drug?\nA: Treatment of nicotine addiction by reducing withdrawal symptoms.\nB: Management of chronic pain.\nC: Treatment of hypertension.\nD: Reduction of anxiety disorders.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary indication for the use of Nicotine as a drug?\nA: Treatment of nicotine addiction by reducing withdrawal symptoms.\nB: Management of chronic pain.\nC: Treatment of hypertension.\nD: Reduction of anxiety disorders.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary indication for the use of Nicotine as a drug?\nA: Treatment of nicotine addiction by reducing withdrawal symptoms.\nB: Management of chronic pain.\nC: Treatment of hypertension.\nD: Reduction of anxiety disorders.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"Cb2arHKByQcE","MRRV winner=B; scores={'A': 0.4166666666666667, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.3333333333333333}; rankings=[['B', 'D', 'C', 'A'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the potential interaction between Labetalol HCL and beta-agonist bronchodilator drugs in patients with bronchospasm?\nA: Labetalol HCL enhances the bronchodilator effect of beta-agonist drugs.\nB: Labetalol HCL blunts the bronchodilator effect, requiring higher doses of beta-agonist drugs.\nC: Labetalol HCL has no interaction with beta-agonist drugs.\nD: Labetalol HCL reduces the risk of bronchospasm when used with beta-agonist drugs.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the potential interaction between Labetalol HCL and beta-agonist bronchodilator drugs in patients with bronchospasm?\nA: Labetalol HCL enhances the bronchodilator effect of beta-agonist drugs.\nB: Labetalol HCL blunts the bronchodilator effect, requiring higher doses of beta-agonist drugs.\nC: Labetalol HCL has no interaction with beta-agonist drugs.\nD: Labetalol HCL reduces the risk of bronchospasm when used with beta-agonist drugs.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the potential interaction between Labetalol HCL and beta-agonist bronchodilator drugs in patients with bronchospasm?\nA: Labetalol HCL enhances the bronchodilator effect of beta-agonist drugs.\nB: Labetalol HCL blunts the bronchodilator effect, requiring higher doses of beta-agonist drugs.\nC: Labetalol HCL has no interaction with beta-agonist drugs.\nD: Labetalol HCL reduces the risk of bronchospasm when used with beta-agonist drugs.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"vWfJIM5uUsDG","- JAIMIESS, which contains the active ingredients of cabotegravir and rilpivirine, should be closely monitored when co-administered with enzyme inducers such as rifampin or carbamazepine, as these can significantly reduce its effectiveness.
- It is recommended to consider alternative antiretroviral therapies that are not affected by enzyme inducers if possible, to maintain therapeutic efficacy.
- If co-administration is necessary, dose adjustments or increased monitoring for viral load may be required to ensure adequate treatment response.

MRRV(meta) winner=B; scores={'A': 0.38888888888888884, 'B': 1.0, 'C': 0.4444444444444444, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended management strategy when JAIMIESS is co-administered with enzyme inducers?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- JAIMIESS, which contains the active ingredients of cabotegravir and rilpivirine, should be closely monitored when co-administered with enzyme inducers such as rifampin or carbamazepine, as these can significantly reduce its effectiveness.\n- It is recommended to consider alternative antiretroviral therapies that are not affected by enzyme inducers if possible, to maintain therapeutic efficacy.\n- If co-administration is necessary, dose adjustments or increased monitoring for viral load may be required to ensure adequate treatment response.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended management strategy when JAIMIESS is co-administered with enzyme inducers?\nA: Increase the dose of JAIMIESS\nB: Use a backup or alternative method of contraception\nC: Administer JAIMIESS 4 hours apart from enzyme inducers\nD: Discontinue JAIMIESS immediately\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- JAIMIESS, which contains the active ingredients of cabotegravir and rilpivirine, should be closely monitored when co-administered with enzyme inducers such as rifampin or carbamazepine, as these can significantly reduce its effectiveness.\n- It is recommended to consider alternative antiretroviral therapies that are not affected by enzyme inducers if possible, to maintain therapeutic efficacy.\n- If co-administration is necessary, dose adjustments or increased monitoring for viral load may be required to ensure adequate treatment response.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended management strategy when JAIMIESS is co-administered with enzyme inducers?\nA: Increase the dose of JAIMIESS\nB: Use a backup or alternative method of contraception\nC: Administer JAIMIESS 4 hours apart from enzyme inducers\nD: Discontinue JAIMIESS immediately\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- JAIMIESS, which contains the active ingredients of cabotegravir and rilpivirine, should be closely monitored when co-administered with enzyme inducers such as rifampin or carbamazepine, as these can significantly reduce its effectiveness.\n- It is recommended to consider alternative antiretroviral therapies that are not affected by enzyme inducers if possible, to maintain therapeutic efficacy.\n- If co-administration is necessary, dose adjustments or increased monitoring for viral load may be required to ensure adequate treatment response.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended management strategy when JAIMIESS is co-administered with enzyme inducers?\nA: Increase the dose of JAIMIESS\nB: Use a backup or alternative method of contraception\nC: Administer JAIMIESS 4 hours apart from enzyme inducers\nD: Discontinue JAIMIESS immediately\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- JAIMIESS, which contains the active ingredients of cabotegravir and rilpivirine, should be closely monitored when co-administered with enzyme inducers such as rifampin or carbamazepine, as these can significantly reduce its effectiveness.\n- It is recommended to consider alternative antiretroviral therapies that are not affected by enzyme inducers if possible, to maintain therapeutic efficacy.\n- If co-administration is necessary, dose adjustments or increased monitoring for viral load may be required to ensure adequate treatment response.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"QbyW3Ja6BOMb","- Monitor patients with severe hepatic impairment closely when using AIRSUPRA, as the drug's metabolism may be significantly affected by liver function.
- Consider dose adjustments or increased monitoring frequency for patients with Child-Pugh Class C hepatic impairment due to potential alterations in drug clearance.
- Evaluate liver function tests regularly to assess any changes in hepatic status that could impact the safety and efficacy of AIRSUPRA therapy.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended approach for monitoring patients with severe hepatic impairment when using AIRSUPRA?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Monitor patients with severe hepatic impairment closely when using AIRSUPRA, as the drug's metabolism may be significantly affected by liver function.\n- Consider dose adjustments or increased monitoring frequency for patients with Child-Pugh Class C hepatic impairment due to potential alterations in drug clearance.\n- Evaluate liver function tests regularly to assess any changes in hepatic status that could impact the safety and efficacy of AIRSUPRA therapy.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for monitoring patients with severe hepatic impairment when using AIRSUPRA?\nA: No monitoring is required.\nB: Monitor patients closely due to increased budesonide systemic exposure.\nC: Reduce the dosage of AIRSUPRA immediately.\nD: Switch to an alternative medication.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor patients with severe hepatic impairment closely when using AIRSUPRA, as the drug's metabolism may be significantly affected by liver function.\n- Consider dose adjustments or increased monitoring frequency for patients with Child-Pugh Class C hepatic impairment due to potential alterations in drug clearance.\n- Evaluate liver function tests regularly to assess any changes in hepatic status that could impact the safety and efficacy of AIRSUPRA therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for monitoring patients with severe hepatic impairment when using AIRSUPRA?\nA: No monitoring is required.\nB: Monitor patients closely due to increased budesonide systemic exposure.\nC: Reduce the dosage of AIRSUPRA immediately.\nD: Switch to an alternative medication.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor patients with severe hepatic impairment closely when using AIRSUPRA, as the drug's metabolism may be significantly affected by liver function.\n- Consider dose adjustments or increased monitoring frequency for patients with Child-Pugh Class C hepatic impairment due to potential alterations in drug clearance.\n- Evaluate liver function tests regularly to assess any changes in hepatic status that could impact the safety and efficacy of AIRSUPRA therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for monitoring patients with severe hepatic impairment when using AIRSUPRA?\nA: No monitoring is required.\nB: Monitor patients closely due to increased budesonide systemic exposure.\nC: Reduce the dosage of AIRSUPRA immediately.\nD: Switch to an alternative medication.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor patients with severe hepatic impairment closely when using AIRSUPRA, as the drug's metabolism may be significantly affected by liver function.\n- Consider dose adjustments or increased monitoring frequency for patients with Child-Pugh Class C hepatic impairment due to potential alterations in drug clearance.\n- Evaluate liver function tests regularly to assess any changes in hepatic status that could impact the safety and efficacy of AIRSUPRA therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"pwRVnkMN1mS2","- In the event of an Iclusig (ponatinib) overdose, it is recommended to provide supportive care and monitor the patient closely for any adverse effects.
- There is no specific antidote for Iclusig overdose; therefore, symptomatic treatment should be initiated as needed.
- Patients should be advised to seek immediate medical attention if they suspect an overdose of Iclusig.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.3055555555555555}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action in the event of an Iclusig overdose?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- In the event of an Iclusig (ponatinib) overdose, it is recommended to provide supportive care and monitor the patient closely for any adverse effects.\n- There is no specific antidote for Iclusig overdose; therefore, symptomatic treatment should be initiated as needed.\n- Patients should be advised to seek immediate medical attention if they suspect an overdose of Iclusig.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action in the event of an Iclusig overdose?\nA: Administer a higher dose to counteract the overdose\nB: Stop Iclusig and provide supportive treatment\nC: Perform immediate cardiac surgery\nD: Increase fluid intake to flush the drug\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In the event of an Iclusig (ponatinib) overdose, it is recommended to provide supportive care and monitor the patient closely for any adverse effects.\n- There is no specific antidote for Iclusig overdose; therefore, symptomatic treatment should be initiated as needed.\n- Patients should be advised to seek immediate medical attention if they suspect an overdose of Iclusig.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action in the event of an Iclusig overdose?\nA: Administer a higher dose to counteract the overdose\nB: Stop Iclusig and provide supportive treatment\nC: Perform immediate cardiac surgery\nD: Increase fluid intake to flush the drug\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In the event of an Iclusig (ponatinib) overdose, it is recommended to provide supportive care and monitor the patient closely for any adverse effects.\n- There is no specific antidote for Iclusig overdose; therefore, symptomatic treatment should be initiated as needed.\n- Patients should be advised to seek immediate medical attention if they suspect an overdose of Iclusig.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action in the event of an Iclusig overdose?\nA: Administer a higher dose to counteract the overdose\nB: Stop Iclusig and provide supportive treatment\nC: Perform immediate cardiac surgery\nD: Increase fluid intake to flush the drug\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In the event of an Iclusig (ponatinib) overdose, it is recommended to provide supportive care and monitor the patient closely for any adverse effects.\n- There is no specific antidote for Iclusig overdose; therefore, symptomatic treatment should be initiated as needed.\n- Patients should be advised to seek immediate medical attention if they suspect an overdose of Iclusig.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"n872XeXhpIce","- Sumatriptan is classified as a Category C medication, indicating that risk cannot be ruled out during pregnancy, and should only be used if the potential benefit justifies the potential risk to the fetus.
- Some studies suggest that the use of Sumatriptan during pregnancy may be associated with a slightly increased risk of certain adverse outcomes, but the overall evidence remains inconclusive.
- Pregnant women experiencing migraines should consult their healthcare provider to weigh the risks and benefits of using Sumatriptan compared to non-pharmacological treatments or other medications.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following statements about the use of Sumatriptan during pregnancy is accurate?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Sumatriptan is classified as a Category C medication, indicating that risk cannot be ruled out during pregnancy, and should only be used if the potential benefit justifies the potential risk to the fetus.\n- Some studies suggest that the use of Sumatriptan during pregnancy may be associated with a slightly increased risk of certain adverse outcomes, but the overall evidence remains inconclusive.\n- Pregnant women experiencing migraines should consult their healthcare provider to weigh the risks and benefits of using Sumatriptan compared to non-pharmacological treatments or other medications.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements about the use of Sumatriptan during pregnancy is accurate?\nA: Sumatriptan has been proven to cause major birth defects in humans.\nB: Animal studies have shown embryolethality and fetal abnormalities with Sumatriptan use.\nC: Sumatriptan is completely safe for use during all trimesters of pregnancy.\nD: Sumatriptan use during pregnancy has been associated with a significant increase in miscarriage rates.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Sumatriptan is classified as a Category C medication, indicating that risk cannot be ruled out during pregnancy, and should only be used if the potential benefit justifies the potential risk to the fetus.\n- Some studies suggest that the use of Sumatriptan during pregnancy may be associated with a slightly increased risk of certain adverse outcomes, but the overall evidence remains inconclusive.\n- Pregnant women experiencing migraines should consult their healthcare provider to weigh the risks and benefits of using Sumatriptan compared to non-pharmacological treatments or other medications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements about the use of Sumatriptan during pregnancy is accurate?\nA: Sumatriptan has been proven to cause major birth defects in humans.\nB: Animal studies have shown embryolethality and fetal abnormalities with Sumatriptan use.\nC: Sumatriptan is completely safe for use during all trimesters of pregnancy.\nD: Sumatriptan use during pregnancy has been associated with a significant increase in miscarriage rates.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Sumatriptan is classified as a Category C medication, indicating that risk cannot be ruled out during pregnancy, and should only be used if the potential benefit justifies the potential risk to the fetus.\n- Some studies suggest that the use of Sumatriptan during pregnancy may be associated with a slightly increased risk of certain adverse outcomes, but the overall evidence remains inconclusive.\n- Pregnant women experiencing migraines should consult their healthcare provider to weigh the risks and benefits of using Sumatriptan compared to non-pharmacological treatments or other medications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements about the use of Sumatriptan during pregnancy is accurate?\nA: Sumatriptan has been proven to cause major birth defects in humans.\nB: Animal studies have shown embryolethality and fetal abnormalities with Sumatriptan use.\nC: Sumatriptan is completely safe for use during all trimesters of pregnancy.\nD: Sumatriptan use during pregnancy has been associated with a significant increase in miscarriage rates.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Sumatriptan is classified as a Category C medication, indicating that risk cannot be ruled out during pregnancy, and should only be used if the potential benefit justifies the potential risk to the fetus.\n- Some studies suggest that the use of Sumatriptan during pregnancy may be associated with a slightly increased risk of certain adverse outcomes, but the overall evidence remains inconclusive.\n- Pregnant women experiencing migraines should consult their healthcare provider to weigh the risks and benefits of using Sumatriptan compared to non-pharmacological treatments or other medications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"9HNAMjqLMyAO","- Reapply the sunscreen branded as '70%' immediately after swimming or sweating heavily, as these activities can reduce its effectiveness.
- If the sunscreen has been on the skin for more than two hours, it should be reapplied to maintain optimal protection.
- Reapply the '70%' sunscreen immediately after towel drying, as this can remove the product from the skin.

MRRV(meta) winner=C; scores={'A': 0.3333333333333333, 'B': 0.5, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nUnder which of the following circumstances should the sunscreen branded as '70%' be reapplied immediately?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Reapply the sunscreen branded as '70%' immediately after swimming or sweating heavily, as these activities can reduce its effectiveness.\n- If the sunscreen has been on the skin for more than two hours, it should be reapplied to maintain optimal protection.\n- Reapply the '70%' sunscreen immediately after towel drying, as this can remove the product from the skin.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Under which of the following circumstances should the sunscreen branded as '70%' be reapplied immediately?\nA: After 80 minutes of swimming or sweating\nB: Immediately after towel drying\nC: Both A and B\nD: None of the above\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Reapply the sunscreen branded as '70%' immediately after swimming or sweating heavily, as these activities can reduce its effectiveness.\n- If the sunscreen has been on the skin for more than two hours, it should be reapplied to maintain optimal protection.\n- Reapply the '70%' sunscreen immediately after towel drying, as this can remove the product from the skin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Under which of the following circumstances should the sunscreen branded as '70%' be reapplied immediately?\nA: After 80 minutes of swimming or sweating\nB: Immediately after towel drying\nC: Both A and B\nD: None of the above\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Reapply the sunscreen branded as '70%' immediately after swimming or sweating heavily, as these activities can reduce its effectiveness.\n- If the sunscreen has been on the skin for more than two hours, it should be reapplied to maintain optimal protection.\n- Reapply the '70%' sunscreen immediately after towel drying, as this can remove the product from the skin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Under which of the following circumstances should the sunscreen branded as '70%' be reapplied immediately?\nA: After 80 minutes of swimming or sweating\nB: Immediately after towel drying\nC: Both A and B\nD: None of the above\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Reapply the sunscreen branded as '70%' immediately after swimming or sweating heavily, as these activities can reduce its effectiveness.\n- If the sunscreen has been on the skin for more than two hours, it should be reapplied to maintain optimal protection.\n- Reapply the '70%' sunscreen immediately after towel drying, as this can remove the product from the skin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}]"
"I7RTo2O85Wzp","- Patients with a history of hypersensitivity to Levalbuterol or any of its components should avoid using this medication.
- Individuals with severe hypersensitivity reactions to other beta-agonists may also be contraindicated for Levalbuterol use.
- Caution is advised in patients with cardiovascular disorders, particularly those with a history of arrhythmias, as Levalbuterol can exacerbate these conditions.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich patient condition is a contraindication for the use of Levalbuterol?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients with a history of hypersensitivity to Levalbuterol or any of its components should avoid using this medication.\n- Individuals with severe hypersensitivity reactions to other beta-agonists may also be contraindicated for Levalbuterol use.\n- Caution is advised in patients with cardiovascular disorders, particularly those with a history of arrhythmias, as Levalbuterol can exacerbate these conditions.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient condition is a contraindication for the use of Levalbuterol?\nA: Hypersensitivity to levalbuterol\nB: Diabetes mellitus\nC: Hypertension\nD: Renal failure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of hypersensitivity to Levalbuterol or any of its components should avoid using this medication.\n- Individuals with severe hypersensitivity reactions to other beta-agonists may also be contraindicated for Levalbuterol use.\n- Caution is advised in patients with cardiovascular disorders, particularly those with a history of arrhythmias, as Levalbuterol can exacerbate these conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient condition is a contraindication for the use of Levalbuterol?\nA: Hypersensitivity to levalbuterol\nB: Diabetes mellitus\nC: Hypertension\nD: Renal failure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of hypersensitivity to Levalbuterol or any of its components should avoid using this medication.\n- Individuals with severe hypersensitivity reactions to other beta-agonists may also be contraindicated for Levalbuterol use.\n- Caution is advised in patients with cardiovascular disorders, particularly those with a history of arrhythmias, as Levalbuterol can exacerbate these conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient condition is a contraindication for the use of Levalbuterol?\nA: Hypersensitivity to levalbuterol\nB: Diabetes mellitus\nC: Hypertension\nD: Renal failure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of hypersensitivity to Levalbuterol or any of its components should avoid using this medication.\n- Individuals with severe hypersensitivity reactions to other beta-agonists may also be contraindicated for Levalbuterol use.\n- Caution is advised in patients with cardiovascular disorders, particularly those with a history of arrhythmias, as Levalbuterol can exacerbate these conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"iCq0NCBVCYkg","MRRV winner=B; scores={'A': 0.25, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf a patient develops Stevens-Johnson syndrome while taking Paxlovid, what is the recommended course of action?\nA: Continue Paxlovid and monitor symptoms closely.\nB: Discontinue Paxlovid and initiate supportive care.\nC: Reduce the dose of Paxlovid and consult a specialist.\nD: Switch to an alternative antiviral medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf a patient develops Stevens-Johnson syndrome while taking Paxlovid, what is the recommended course of action?\nA: Continue Paxlovid and monitor symptoms closely.\nB: Discontinue Paxlovid and initiate supportive care.\nC: Reduce the dose of Paxlovid and consult a specialist.\nD: Switch to an alternative antiviral medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf a patient develops Stevens-Johnson syndrome while taking Paxlovid, what is the recommended course of action?\nA: Continue Paxlovid and monitor symptoms closely.\nB: Discontinue Paxlovid and initiate supportive care.\nC: Reduce the dose of Paxlovid and consult a specialist.\nD: Switch to an alternative antiviral medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"JAjrKcIMqCs9","- GOPRELTO contains the active ingredient remimazolam, which is a sedative that may pass into breast milk and could potentially affect a breastfeeding infant.
- The manufacturer recommends waiting at least 24 hours after GOPRELTO administration before breastfeeding to minimize the risk of sedation in the infant.
- Immediate breastfeeding after administration of GOPRELTO may lead to unintended sedation or respiratory depression in the nursing infant due to the drug's pharmacological effects.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the potential risk of breastfeeding immediately after GOPRELTO administration?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- GOPRELTO contains the active ingredient remimazolam, which is a sedative that may pass into breast milk and could potentially affect a breastfeeding infant.\n- The manufacturer recommends waiting at least 24 hours after GOPRELTO administration before breastfeeding to minimize the risk of sedation in the infant.\n- Immediate breastfeeding after administration of GOPRELTO may lead to unintended sedation or respiratory depression in the nursing infant due to the drug's pharmacological effects.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the potential risk of breastfeeding immediately after GOPRELTO administration?\nA: No risk, as GOPRELTO does not affect breastmilk.\nB: Infant plasma concentrations may reach half the maternal plasma concentrations, leading to adverse reactions.\nC: Breastmilk production may be permanently reduced.\nD: Infants may develop vertebral and rib abnormalities.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- GOPRELTO contains the active ingredient remimazolam, which is a sedative that may pass into breast milk and could potentially affect a breastfeeding infant.\n- The manufacturer recommends waiting at least 24 hours after GOPRELTO administration before breastfeeding to minimize the risk of sedation in the infant.\n- Immediate breastfeeding after administration of GOPRELTO may lead to unintended sedation or respiratory depression in the nursing infant due to the drug's pharmacological effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the potential risk of breastfeeding immediately after GOPRELTO administration?\nA: No risk, as GOPRELTO does not affect breastmilk.\nB: Infant plasma concentrations may reach half the maternal plasma concentrations, leading to adverse reactions.\nC: Breastmilk production may be permanently reduced.\nD: Infants may develop vertebral and rib abnormalities.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- GOPRELTO contains the active ingredient remimazolam, which is a sedative that may pass into breast milk and could potentially affect a breastfeeding infant.\n- The manufacturer recommends waiting at least 24 hours after GOPRELTO administration before breastfeeding to minimize the risk of sedation in the infant.\n- Immediate breastfeeding after administration of GOPRELTO may lead to unintended sedation or respiratory depression in the nursing infant due to the drug's pharmacological effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the potential risk of breastfeeding immediately after GOPRELTO administration?\nA: No risk, as GOPRELTO does not affect breastmilk.\nB: Infant plasma concentrations may reach half the maternal plasma concentrations, leading to adverse reactions.\nC: Breastmilk production may be permanently reduced.\nD: Infants may develop vertebral and rib abnormalities.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- GOPRELTO contains the active ingredient remimazolam, which is a sedative that may pass into breast milk and could potentially affect a breastfeeding infant.\n- The manufacturer recommends waiting at least 24 hours after GOPRELTO administration before breastfeeding to minimize the risk of sedation in the infant.\n- Immediate breastfeeding after administration of GOPRELTO may lead to unintended sedation or respiratory depression in the nursing infant due to the drug's pharmacological effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"PgBb1gLHnIFY","MRRV winner=B; scores={'A': 0.38888888888888884, 'B': 0.7777777777777777, 'C': 0.4166666666666667, 'D': 0.5}; rankings=[['B', 'C', 'A', 'D'], ['D', 'A', 'B', 'C'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following inactive ingredients is NOT found in venlafaxine tablets?\nA: Ferric oxide red\nB: Magnesium stearate\nC: Microcrystalline cellulose\nD: Acetaminophen\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following inactive ingredients is NOT found in venlafaxine tablets?\nA: Ferric oxide red\nB: Magnesium stearate\nC: Microcrystalline cellulose\nD: Acetaminophen\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following inactive ingredients is NOT found in venlafaxine tablets?\nA: Ferric oxide red\nB: Magnesium stearate\nC: Microcrystalline cellulose\nD: Acetaminophen\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"fNENKA00h8jO","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient taking Tri Femynor develops jaundice?\nA: Continue the medication and monitor liver function.\nB: Discontinue Tri Femynor immediately.\nC: Reduce the dosage of Tri Femynor.\nD: Switch to a different contraceptive method only if symptoms worsen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient taking Tri Femynor develops jaundice?\nA: Continue the medication and monitor liver function.\nB: Discontinue Tri Femynor immediately.\nC: Reduce the dosage of Tri Femynor.\nD: Switch to a different contraceptive method only if symptoms worsen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient taking Tri Femynor develops jaundice?\nA: Continue the medication and monitor liver function.\nB: Discontinue Tri Femynor immediately.\nC: Reduce the dosage of Tri Femynor.\nD: Switch to a different contraceptive method only if symptoms worsen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"X8m86YEeVpYu","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action when Cleocin is used with strong CYP3A4 inducers like rifampicin?\nA: Monitor for adverse reactions.\nB: Monitor for loss of effectiveness.\nC: Increase the dosage of Cleocin.\nD: No monitoring is required.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action when Cleocin is used with strong CYP3A4 inducers like rifampicin?\nA: Monitor for adverse reactions.\nB: Monitor for loss of effectiveness.\nC: Increase the dosage of Cleocin.\nD: No monitoring is required.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action when Cleocin is used with strong CYP3A4 inducers like rifampicin?\nA: Monitor for adverse reactions.\nB: Monitor for loss of effectiveness.\nC: Increase the dosage of Cleocin.\nD: No monitoring is required.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"Wt6G8F6Qxyyj","- The combination of venlafaxine tablets, a serotonin-norepinephrine reuptake inhibitor (SNRI), with MAOIs (monoamine oxidase inhibitors) can lead to a dangerous increase in serotonin levels, resulting in serotonin syndrome.
- MAOIs inhibit the breakdown of neurotransmitters, and when taken with venlafaxine, this can cause excessive accumulation of serotonin and norepinephrine, leading to severe side effects.
- The risk of hypertensive crisis is also elevated when venlafaxine is used concurrently with MAOIs due to the potential for increased norepinephrine levels.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy is the concurrent use of venlafaxine tablets and MAOIs contraindicated?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The combination of venlafaxine tablets, a serotonin-norepinephrine reuptake inhibitor (SNRI), with MAOIs (monoamine oxidase inhibitors) can lead to a dangerous increase in serotonin levels, resulting in serotonin syndrome.\n- MAOIs inhibit the breakdown of neurotransmitters, and when taken with venlafaxine, this can cause excessive accumulation of serotonin and norepinephrine, leading to severe side effects.\n- The risk of hypertensive crisis is also elevated when venlafaxine is used concurrently with MAOIs due to the potential for increased norepinephrine levels.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is the concurrent use of venlafaxine tablets and MAOIs contraindicated?\nA: Increased risk of serotonin syndrome\nB: Increased risk of hypertension\nC: Increased risk of liver toxicity\nD: Increased risk of renal failure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination of venlafaxine tablets, a serotonin-norepinephrine reuptake inhibitor (SNRI), with MAOIs (monoamine oxidase inhibitors) can lead to a dangerous increase in serotonin levels, resulting in serotonin syndrome.\n- MAOIs inhibit the breakdown of neurotransmitters, and when taken with venlafaxine, this can cause excessive accumulation of serotonin and norepinephrine, leading to severe side effects.\n- The risk of hypertensive crisis is also elevated when venlafaxine is used concurrently with MAOIs due to the potential for increased norepinephrine levels.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is the concurrent use of venlafaxine tablets and MAOIs contraindicated?\nA: Increased risk of serotonin syndrome\nB: Increased risk of hypertension\nC: Increased risk of liver toxicity\nD: Increased risk of renal failure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination of venlafaxine tablets, a serotonin-norepinephrine reuptake inhibitor (SNRI), with MAOIs (monoamine oxidase inhibitors) can lead to a dangerous increase in serotonin levels, resulting in serotonin syndrome.\n- MAOIs inhibit the breakdown of neurotransmitters, and when taken with venlafaxine, this can cause excessive accumulation of serotonin and norepinephrine, leading to severe side effects.\n- The risk of hypertensive crisis is also elevated when venlafaxine is used concurrently with MAOIs due to the potential for increased norepinephrine levels.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is the concurrent use of venlafaxine tablets and MAOIs contraindicated?\nA: Increased risk of serotonin syndrome\nB: Increased risk of hypertension\nC: Increased risk of liver toxicity\nD: Increased risk of renal failure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination of venlafaxine tablets, a serotonin-norepinephrine reuptake inhibitor (SNRI), with MAOIs (monoamine oxidase inhibitors) can lead to a dangerous increase in serotonin levels, resulting in serotonin syndrome.\n- MAOIs inhibit the breakdown of neurotransmitters, and when taken with venlafaxine, this can cause excessive accumulation of serotonin and norepinephrine, leading to severe side effects.\n- The risk of hypertensive crisis is also elevated when venlafaxine is used concurrently with MAOIs due to the potential for increased norepinephrine levels.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"6f0P2aXi6BuR","- Monitor the patient closely for any signs of cardiovascular complications, as GOPRELTO (a combination of phenylephrine and ketorolac) may pose risks in individuals with a history of myocardial infarction.
- Consider alternative pain management strategies that do not involve NSAIDs or sympathomimetics, especially in patients with a significant cardiac history.
- Consult with a cardiologist to evaluate the appropriateness of using GOPRELTO in this patient, given the potential for increased cardiovascular risk.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if GOPRELTO is administered to a patient with a history of myocardial infarction?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Monitor the patient closely for any signs of cardiovascular complications, as GOPRELTO (a combination of phenylephrine and ketorolac) may pose risks in individuals with a history of myocardial infarction.\n- Consider alternative pain management strategies that do not involve NSAIDs or sympathomimetics, especially in patients with a significant cardiac history.\n- Consult with a cardiologist to evaluate the appropriateness of using GOPRELTO in this patient, given the potential for increased cardiovascular risk.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if GOPRELTO is administered to a patient with a history of myocardial infarction?\nA: Administer a higher dose of GOPRELTO\nB: Monitor vital signs and ECG closely\nC: Discontinue GOPRELTO immediately\nD: No special precautions are needed\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor the patient closely for any signs of cardiovascular complications, as GOPRELTO (a combination of phenylephrine and ketorolac) may pose risks in individuals with a history of myocardial infarction.\n- Consider alternative pain management strategies that do not involve NSAIDs or sympathomimetics, especially in patients with a significant cardiac history.\n- Consult with a cardiologist to evaluate the appropriateness of using GOPRELTO in this patient, given the potential for increased cardiovascular risk.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if GOPRELTO is administered to a patient with a history of myocardial infarction?\nA: Administer a higher dose of GOPRELTO\nB: Monitor vital signs and ECG closely\nC: Discontinue GOPRELTO immediately\nD: No special precautions are needed\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor the patient closely for any signs of cardiovascular complications, as GOPRELTO (a combination of phenylephrine and ketorolac) may pose risks in individuals with a history of myocardial infarction.\n- Consider alternative pain management strategies that do not involve NSAIDs or sympathomimetics, especially in patients with a significant cardiac history.\n- Consult with a cardiologist to evaluate the appropriateness of using GOPRELTO in this patient, given the potential for increased cardiovascular risk.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if GOPRELTO is administered to a patient with a history of myocardial infarction?\nA: Administer a higher dose of GOPRELTO\nB: Monitor vital signs and ECG closely\nC: Discontinue GOPRELTO immediately\nD: No special precautions are needed\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor the patient closely for any signs of cardiovascular complications, as GOPRELTO (a combination of phenylephrine and ketorolac) may pose risks in individuals with a history of myocardial infarction.\n- Consider alternative pain management strategies that do not involve NSAIDs or sympathomimetics, especially in patients with a significant cardiac history.\n- Consult with a cardiologist to evaluate the appropriateness of using GOPRELTO in this patient, given the potential for increased cardiovascular risk.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"wnJ6nx17EB1Z","- Completing the full course of Cleocin Phosphate is crucial to ensure that all bacteria are eradicated, reducing the risk of developing antibiotic resistance.
- Stopping treatment early, even if symptoms improve, can lead to a resurgence of the infection, as residual bacteria may survive and multiply.
- Adhering to the prescribed regimen helps prevent the potential for a more severe or chronic infection that may require more aggressive treatment.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy should patients prescribed Cleocin Phosphate complete the full course of therapy even if they feel better early in the treatment?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Completing the full course of Cleocin Phosphate is crucial to ensure that all bacteria are eradicated, reducing the risk of developing antibiotic resistance.\n- Stopping treatment early, even if symptoms improve, can lead to a resurgence of the infection, as residual bacteria may survive and multiply.\n- Adhering to the prescribed regimen helps prevent the potential for a more severe or chronic infection that may require more aggressive treatment.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should patients prescribed Cleocin Phosphate complete the full course of therapy even if they feel better early in the treatment?\nA: To ensure the medication treats viral infections effectively.\nB: To prevent the development of bacterial resistance to Cleocin Phosphate and other antibacterial drugs.\nC: To avoid common side effects like diarrhea.\nD: To reduce the risk of developing watery and bloody stools.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Completing the full course of Cleocin Phosphate is crucial to ensure that all bacteria are eradicated, reducing the risk of developing antibiotic resistance.\n- Stopping treatment early, even if symptoms improve, can lead to a resurgence of the infection, as residual bacteria may survive and multiply.\n- Adhering to the prescribed regimen helps prevent the potential for a more severe or chronic infection that may require more aggressive treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should patients prescribed Cleocin Phosphate complete the full course of therapy even if they feel better early in the treatment?\nA: To ensure the medication treats viral infections effectively.\nB: To prevent the development of bacterial resistance to Cleocin Phosphate and other antibacterial drugs.\nC: To avoid common side effects like diarrhea.\nD: To reduce the risk of developing watery and bloody stools.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Completing the full course of Cleocin Phosphate is crucial to ensure that all bacteria are eradicated, reducing the risk of developing antibiotic resistance.\n- Stopping treatment early, even if symptoms improve, can lead to a resurgence of the infection, as residual bacteria may survive and multiply.\n- Adhering to the prescribed regimen helps prevent the potential for a more severe or chronic infection that may require more aggressive treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should patients prescribed Cleocin Phosphate complete the full course of therapy even if they feel better early in the treatment?\nA: To ensure the medication treats viral infections effectively.\nB: To prevent the development of bacterial resistance to Cleocin Phosphate and other antibacterial drugs.\nC: To avoid common side effects like diarrhea.\nD: To reduce the risk of developing watery and bloody stools.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Completing the full course of Cleocin Phosphate is crucial to ensure that all bacteria are eradicated, reducing the risk of developing antibiotic resistance.\n- Stopping treatment early, even if symptoms improve, can lead to a resurgence of the infection, as residual bacteria may survive and multiply.\n- Adhering to the prescribed regimen helps prevent the potential for a more severe or chronic infection that may require more aggressive treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"Gdqxh1gO6Xss","- The recommended dosage of Belladonna for children aged 2 to 12 years is typically 0.5 to 1.0 mg per dose, administered every 4 to 6 hours as needed.
- It is important to note that Belladonna should be used with caution and under medical supervision due to potential side effects and toxicity.
- Always consult a healthcare professional before administering Belladonna to ensure appropriate dosing and safety for the child.

MRRV(meta) winner=C; scores={'A': 0.3055555555555555, 'B': 0.27777777777777773, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'B', 'A'], ['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nFor children aged 2 to 12 years, what is the recommended dosage of Belladona?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The recommended dosage of Belladonna for children aged 2 to 12 years is typically 0.5 to 1.0 mg per dose, administered every 4 to 6 hours as needed.\n- It is important to note that Belladonna should be used with caution and under medical supervision due to potential side effects and toxicity.\n- Always consult a healthcare professional before administering Belladonna to ensure appropriate dosing and safety for the child.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: For children aged 2 to 12 years, what is the recommended dosage of Belladona?\nA: 10 drops mixed with half a cup of water, 3-4 times per day\nB: 5 drops mixed with half a cup of water, 3-4 times per day\nC: Consult your doctor for the dosage\nD: Do not administer Belladona to children aged 2 to 12 years\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage of Belladonna for children aged 2 to 12 years is typically 0.5 to 1.0 mg per dose, administered every 4 to 6 hours as needed.\n- It is important to note that Belladonna should be used with caution and under medical supervision due to potential side effects and toxicity.\n- Always consult a healthcare professional before administering Belladonna to ensure appropriate dosing and safety for the child.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: For children aged 2 to 12 years, what is the recommended dosage of Belladona?\nA: 10 drops mixed with half a cup of water, 3-4 times per day\nB: 5 drops mixed with half a cup of water, 3-4 times per day\nC: Consult your doctor for the dosage\nD: Do not administer Belladona to children aged 2 to 12 years\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage of Belladonna for children aged 2 to 12 years is typically 0.5 to 1.0 mg per dose, administered every 4 to 6 hours as needed.\n- It is important to note that Belladonna should be used with caution and under medical supervision due to potential side effects and toxicity.\n- Always consult a healthcare professional before administering Belladonna to ensure appropriate dosing and safety for the child.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: For children aged 2 to 12 years, what is the recommended dosage of Belladona?\nA: 10 drops mixed with half a cup of water, 3-4 times per day\nB: 5 drops mixed with half a cup of water, 3-4 times per day\nC: Consult your doctor for the dosage\nD: Do not administer Belladona to children aged 2 to 12 years\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage of Belladonna for children aged 2 to 12 years is typically 0.5 to 1.0 mg per dose, administered every 4 to 6 hours as needed.\n- It is important to note that Belladonna should be used with caution and under medical supervision due to potential side effects and toxicity.\n- Always consult a healthcare professional before administering Belladonna to ensure appropriate dosing and safety for the child.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}]"
"0jekAqEqsylh","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken when using Verkazia with contact lenses?\nA: Contact lenses can be worn immediately after administering Verkazia\nB: Contact lenses should be removed before using Verkazia and can be put back after 15 minutes\nC: Contact lenses should be removed permanently during Verkazia treatment\nD: Contact lenses should be cleaned with Verkazia before use\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken when using Verkazia with contact lenses?\nA: Contact lenses can be worn immediately after administering Verkazia\nB: Contact lenses should be removed before using Verkazia and can be put back after 15 minutes\nC: Contact lenses should be removed permanently during Verkazia treatment\nD: Contact lenses should be cleaned with Verkazia before use\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken when using Verkazia with contact lenses?\nA: Contact lenses can be worn immediately after administering Verkazia\nB: Contact lenses should be removed before using Verkazia and can be put back after 15 minutes\nC: Contact lenses should be removed permanently during Verkazia treatment\nD: Contact lenses should be cleaned with Verkazia before use\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"8WMX8spTFirm","MRRV winner=B; scores={'A': 0.25, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended administration method for fosaprepitant for injection in children aged 6 months to 17 years?\nA: Oral tablets.\nB: Intravenous infusion into a large vein through a central venous catheter.\nC: Subcutaneous injection.\nD: Intramuscular injection.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended administration method for fosaprepitant for injection in children aged 6 months to 17 years?\nA: Oral tablets.\nB: Intravenous infusion into a large vein through a central venous catheter.\nC: Subcutaneous injection.\nD: Intramuscular injection.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended administration method for fosaprepitant for injection in children aged 6 months to 17 years?\nA: Oral tablets.\nB: Intravenous infusion into a large vein through a central venous catheter.\nC: Subcutaneous injection.\nD: Intramuscular injection.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"8lHsQuZ55RtA","- Discontinue Agrylin (anagrelide) immediately, as it may be contributing to pulmonary complications.
- Consider evaluating the patient for potential drug-induced lung injury or other underlying conditions that could explain the dyspnea and lung infiltrations.
- Initiate supportive care, including oxygen therapy and possibly corticosteroids, depending on the severity of the respiratory symptoms and clinical judgment.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should be done if a patient on Agrylin develops progressive dyspnea and lung infiltrations?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Discontinue Agrylin (anagrelide) immediately, as it may be contributing to pulmonary complications.\n- Consider evaluating the patient for potential drug-induced lung injury or other underlying conditions that could explain the dyspnea and lung infiltrations.\n- Initiate supportive care, including oxygen therapy and possibly corticosteroids, depending on the severity of the respiratory symptoms and clinical judgment.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if a patient on Agrylin develops progressive dyspnea and lung infiltrations?\nA: Increase the dose of Agrylin\nB: Discontinue Agrylin and evaluate the patient\nC: Prescribe a bronchodilator\nD: Continue therapy and monitor symptoms\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue Agrylin (anagrelide) immediately, as it may be contributing to pulmonary complications.\n- Consider evaluating the patient for potential drug-induced lung injury or other underlying conditions that could explain the dyspnea and lung infiltrations.\n- Initiate supportive care, including oxygen therapy and possibly corticosteroids, depending on the severity of the respiratory symptoms and clinical judgment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if a patient on Agrylin develops progressive dyspnea and lung infiltrations?\nA: Increase the dose of Agrylin\nB: Discontinue Agrylin and evaluate the patient\nC: Prescribe a bronchodilator\nD: Continue therapy and monitor symptoms\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue Agrylin (anagrelide) immediately, as it may be contributing to pulmonary complications.\n- Consider evaluating the patient for potential drug-induced lung injury or other underlying conditions that could explain the dyspnea and lung infiltrations.\n- Initiate supportive care, including oxygen therapy and possibly corticosteroids, depending on the severity of the respiratory symptoms and clinical judgment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if a patient on Agrylin develops progressive dyspnea and lung infiltrations?\nA: Increase the dose of Agrylin\nB: Discontinue Agrylin and evaluate the patient\nC: Prescribe a bronchodilator\nD: Continue therapy and monitor symptoms\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue Agrylin (anagrelide) immediately, as it may be contributing to pulmonary complications.\n- Consider evaluating the patient for potential drug-induced lung injury or other underlying conditions that could explain the dyspnea and lung infiltrations.\n- Initiate supportive care, including oxygen therapy and possibly corticosteroids, depending on the severity of the respiratory symptoms and clinical judgment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"VmCeoLbwpomV","- Patients taking PERTZYE should consume a diet that is high in calories and protein to support their nutritional needs.
- It is recommended to take PERTZYE with meals and snacks to ensure proper digestion and absorption of nutrients.
- Patients should avoid high-fat meals, as they may reduce the effectiveness of PERTZYE in aiding digestion.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat dietary instruction is provided for patients taking PERTZYE?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients taking PERTZYE should consume a diet that is high in calories and protein to support their nutritional needs.\n- It is recommended to take PERTZYE with meals and snacks to ensure proper digestion and absorption of nutrients.\n- Patients should avoid high-fat meals, as they may reduce the effectiveness of PERTZYE in aiding digestion.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What dietary instruction is provided for patients taking PERTZYE?\nA: Take PERTZYE on an empty stomach\nB: Take PERTZYE with meals or snacks\nC: Take PERTZYE before bedtime\nD: Take PERTZYE with acidic beverages\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking PERTZYE should consume a diet that is high in calories and protein to support their nutritional needs.\n- It is recommended to take PERTZYE with meals and snacks to ensure proper digestion and absorption of nutrients.\n- Patients should avoid high-fat meals, as they may reduce the effectiveness of PERTZYE in aiding digestion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What dietary instruction is provided for patients taking PERTZYE?\nA: Take PERTZYE on an empty stomach\nB: Take PERTZYE with meals or snacks\nC: Take PERTZYE before bedtime\nD: Take PERTZYE with acidic beverages\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking PERTZYE should consume a diet that is high in calories and protein to support their nutritional needs.\n- It is recommended to take PERTZYE with meals and snacks to ensure proper digestion and absorption of nutrients.\n- Patients should avoid high-fat meals, as they may reduce the effectiveness of PERTZYE in aiding digestion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What dietary instruction is provided for patients taking PERTZYE?\nA: Take PERTZYE on an empty stomach\nB: Take PERTZYE with meals or snacks\nC: Take PERTZYE before bedtime\nD: Take PERTZYE with acidic beverages\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking PERTZYE should consume a diet that is high in calories and protein to support their nutritional needs.\n- It is recommended to take PERTZYE with meals and snacks to ensure proper digestion and absorption of nutrients.\n- Patients should avoid high-fat meals, as they may reduce the effectiveness of PERTZYE in aiding digestion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"9SIC14KQED3R","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn a study comparing pantoprazole sodium delayed-release tablets and pantoprazole sodium for injection in GERD patients with a history of erosive esophagitis (EE), what was the mean basal acid output (BAO) for patients treated with intravenous placebo on Day 7?\nA: 0.53 mEq/h\nB: 0.80 mEq/h\nC: 4.14 mEq/h\nD: 6.49 mEq/h\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn a study comparing pantoprazole sodium delayed-release tablets and pantoprazole sodium for injection in GERD patients with a history of erosive esophagitis (EE), what was the mean basal acid output (BAO) for patients treated with intravenous placebo on Day 7?\nA: 0.53 mEq/h\nB: 0.80 mEq/h\nC: 4.14 mEq/h\nD: 6.49 mEq/h\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn a study comparing pantoprazole sodium delayed-release tablets and pantoprazole sodium for injection in GERD patients with a history of erosive esophagitis (EE), what was the mean basal acid output (BAO) for patients treated with intravenous placebo on Day 7?\nA: 0.53 mEq/h\nB: 0.80 mEq/h\nC: 4.14 mEq/h\nD: 6.49 mEq/h\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"MdtMwUZ5jkN9","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow many drops of vaginal essential oil are recommended for environmental spraying when diluted in 30ml of distilled water?\nA: 5-8 drops\nB: 10-20 drops\nC: 15-30 drops\nD: 20-40 drops\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow many drops of vaginal essential oil are recommended for environmental spraying when diluted in 30ml of distilled water?\nA: 5-8 drops\nB: 10-20 drops\nC: 15-30 drops\nD: 20-40 drops\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow many drops of vaginal essential oil are recommended for environmental spraying when diluted in 30ml of distilled water?\nA: 5-8 drops\nB: 10-20 drops\nC: 15-30 drops\nD: 20-40 drops\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"lrl3KR1jMcJC","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient misses a dose of Fluoxetine?\nA: Take the missed dose as soon as remembered, even if it means doubling the dose.\nB: Skip the missed dose and take the next dose at the regular time.\nC: Stop taking Fluoxetine entirely and consult a healthcare provider.\nD: Take two doses at the same time to make up for the missed dose.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient misses a dose of Fluoxetine?\nA: Take the missed dose as soon as remembered, even if it means doubling the dose.\nB: Skip the missed dose and take the next dose at the regular time.\nC: Stop taking Fluoxetine entirely and consult a healthcare provider.\nD: Take two doses at the same time to make up for the missed dose.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient misses a dose of Fluoxetine?\nA: Take the missed dose as soon as remembered, even if it means doubling the dose.\nB: Skip the missed dose and take the next dose at the regular time.\nC: Stop taking Fluoxetine entirely and consult a healthcare provider.\nD: Take two doses at the same time to make up for the missed dose.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"WOsvuiM4Rfs4","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow does food intake affect the absorption of OCELLA components?\nA: Increases the bioavailability of both DRSP and EE.\nB: Reduces the rate of absorption but not the extent for DRSP.\nC: Reduces the extent of absorption for DRSP by 20%.\nD: Has no effect on the pharmacokinetics of OCELLA.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow does food intake affect the absorption of OCELLA components?\nA: Increases the bioavailability of both DRSP and EE.\nB: Reduces the rate of absorption but not the extent for DRSP.\nC: Reduces the extent of absorption for DRSP by 20%.\nD: Has no effect on the pharmacokinetics of OCELLA.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow does food intake affect the absorption of OCELLA components?\nA: Increases the bioavailability of both DRSP and EE.\nB: Reduces the rate of absorption but not the extent for DRSP.\nC: Reduces the extent of absorption for DRSP by 20%.\nD: Has no effect on the pharmacokinetics of OCELLA.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"L15ChSFpmkxV","- Zithromax (azithromycin) may increase the risk of cardiovascular events, particularly in elderly patients with pre-existing heart conditions.
- Elderly patients may experience a higher incidence of gastrointestinal side effects, such as diarrhea and nausea, when using Zithromax compared to younger populations.
- Renal function should be monitored in elderly patients taking Zithromax, as impaired renal function can lead to increased drug accumulation and potential toxicity.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the safety consideration for elderly patients using Zithromax?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Zithromax (azithromycin) may increase the risk of cardiovascular events, particularly in elderly patients with pre-existing heart conditions.\n- Elderly patients may experience a higher incidence of gastrointestinal side effects, such as diarrhea and nausea, when using Zithromax compared to younger populations.\n- Renal function should be monitored in elderly patients taking Zithromax, as impaired renal function can lead to increased drug accumulation and potential toxicity.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the safety consideration for elderly patients using Zithromax?\nA: Elderly patients are less likely to experience side effects compared to younger patients.\nB: Elderly patients may be more susceptible to torsades de pointes arrhythmias.\nC: Elderly patients should avoid Zithromax due to severe adverse reactions.\nD: Elderly patients require a higher dose of Zithromax for effectiveness.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Zithromax (azithromycin) may increase the risk of cardiovascular events, particularly in elderly patients with pre-existing heart conditions.\n- Elderly patients may experience a higher incidence of gastrointestinal side effects, such as diarrhea and nausea, when using Zithromax compared to younger populations.\n- Renal function should be monitored in elderly patients taking Zithromax, as impaired renal function can lead to increased drug accumulation and potential toxicity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the safety consideration for elderly patients using Zithromax?\nA: Elderly patients are less likely to experience side effects compared to younger patients.\nB: Elderly patients may be more susceptible to torsades de pointes arrhythmias.\nC: Elderly patients should avoid Zithromax due to severe adverse reactions.\nD: Elderly patients require a higher dose of Zithromax for effectiveness.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Zithromax (azithromycin) may increase the risk of cardiovascular events, particularly in elderly patients with pre-existing heart conditions.\n- Elderly patients may experience a higher incidence of gastrointestinal side effects, such as diarrhea and nausea, when using Zithromax compared to younger populations.\n- Renal function should be monitored in elderly patients taking Zithromax, as impaired renal function can lead to increased drug accumulation and potential toxicity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the safety consideration for elderly patients using Zithromax?\nA: Elderly patients are less likely to experience side effects compared to younger patients.\nB: Elderly patients may be more susceptible to torsades de pointes arrhythmias.\nC: Elderly patients should avoid Zithromax due to severe adverse reactions.\nD: Elderly patients require a higher dose of Zithromax for effectiveness.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Zithromax (azithromycin) may increase the risk of cardiovascular events, particularly in elderly patients with pre-existing heart conditions.\n- Elderly patients may experience a higher incidence of gastrointestinal side effects, such as diarrhea and nausea, when using Zithromax compared to younger populations.\n- Renal function should be monitored in elderly patients taking Zithromax, as impaired renal function can lead to increased drug accumulation and potential toxicity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"DRZ29l5E2qKY","MRRV winner=A; scores={'A': 0.7777777777777778, 'B': 0.5, 'C': 0.5555555555555555, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['C', 'B', 'A', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow often should the sunscreen branded as '70%' be reapplied during prolonged sun exposure?\nA: Every 30 minutes\nB: Every hour\nC: At least every 2 hours\nD: Only once a day\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow often should the sunscreen branded as '70%' be reapplied during prolonged sun exposure?\nA: Every 30 minutes\nB: Every hour\nC: At least every 2 hours\nD: Only once a day\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nHow often should the sunscreen branded as '70%' be reapplied during prolonged sun exposure?\nA: Every 30 minutes\nB: Every hour\nC: At least every 2 hours\nD: Only once a day\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}]"
"Z2y7sdRRwgTU","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the storage of G-62?\nA: G-62 should be stored at room temperature.\nB: G-62 must be kept from freezing.\nC: G-62 can be stored in a freezer.\nD: G-62 should be exposed to temperatures above 8\u00b0C.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the storage of G-62?\nA: G-62 should be stored at room temperature.\nB: G-62 must be kept from freezing.\nC: G-62 can be stored in a freezer.\nD: G-62 should be exposed to temperatures above 8\u00b0C.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the storage of G-62?\nA: G-62 should be stored at room temperature.\nB: G-62 must be kept from freezing.\nC: G-62 can be stored in a freezer.\nD: G-62 should be exposed to temperatures above 8\u00b0C.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"ySEHOwBIh13K","- When using Tri Femynor, which contains ethinyl estradiol and norgestimate, with enzyme inducers such as rifampin or certain antiepileptics, it is important to consider using an alternative contraceptive method due to the potential for reduced efficacy of the oral contraceptive.
- Patients should be advised to use a backup contraceptive method, such as condoms, while taking enzyme inducers alongside Tri Femynor to prevent unintended pregnancy.
- Monitoring for breakthrough bleeding or changes in menstrual patterns may be necessary when Tri Femynor is used concurrently with enzyme inducers, as these can indicate decreased contraceptive effectiveness.

MRRV(meta) winner=B; scores={'A': 0.3055555555555555, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'C', 'A']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat additional precaution should be taken when using Tri Femynor with enzyme inducers?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- When using Tri Femynor, which contains ethinyl estradiol and norgestimate, with enzyme inducers such as rifampin or certain antiepileptics, it is important to consider using an alternative contraceptive method due to the potential for reduced efficacy of the oral contraceptive.\n- Patients should be advised to use a backup contraceptive method, such as condoms, while taking enzyme inducers alongside Tri Femynor to prevent unintended pregnancy.\n- Monitoring for breakthrough bleeding or changes in menstrual patterns may be necessary when Tri Femynor is used concurrently with enzyme inducers, as these can indicate decreased contraceptive effectiveness.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What additional precaution should be taken when using Tri Femynor with enzyme inducers?\nA: Increase the dosage of Tri Femynor\nB: Use a backup or alternative method of contraception\nC: Discontinue Tri Femynor immediately\nD: Consult a healthcare provider for a different medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- When using Tri Femynor, which contains ethinyl estradiol and norgestimate, with enzyme inducers such as rifampin or certain antiepileptics, it is important to consider using an alternative contraceptive method due to the potential for reduced efficacy of the oral contraceptive.\n- Patients should be advised to use a backup contraceptive method, such as condoms, while taking enzyme inducers alongside Tri Femynor to prevent unintended pregnancy.\n- Monitoring for breakthrough bleeding or changes in menstrual patterns may be necessary when Tri Femynor is used concurrently with enzyme inducers, as these can indicate decreased contraceptive effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What additional precaution should be taken when using Tri Femynor with enzyme inducers?\nA: Increase the dosage of Tri Femynor\nB: Use a backup or alternative method of contraception\nC: Discontinue Tri Femynor immediately\nD: Consult a healthcare provider for a different medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- When using Tri Femynor, which contains ethinyl estradiol and norgestimate, with enzyme inducers such as rifampin or certain antiepileptics, it is important to consider using an alternative contraceptive method due to the potential for reduced efficacy of the oral contraceptive.\n- Patients should be advised to use a backup contraceptive method, such as condoms, while taking enzyme inducers alongside Tri Femynor to prevent unintended pregnancy.\n- Monitoring for breakthrough bleeding or changes in menstrual patterns may be necessary when Tri Femynor is used concurrently with enzyme inducers, as these can indicate decreased contraceptive effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What additional precaution should be taken when using Tri Femynor with enzyme inducers?\nA: Increase the dosage of Tri Femynor\nB: Use a backup or alternative method of contraception\nC: Discontinue Tri Femynor immediately\nD: Consult a healthcare provider for a different medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- When using Tri Femynor, which contains ethinyl estradiol and norgestimate, with enzyme inducers such as rifampin or certain antiepileptics, it is important to consider using an alternative contraceptive method due to the potential for reduced efficacy of the oral contraceptive.\n- Patients should be advised to use a backup contraceptive method, such as condoms, while taking enzyme inducers alongside Tri Femynor to prevent unintended pregnancy.\n- Monitoring for breakthrough bleeding or changes in menstrual patterns may be necessary when Tri Femynor is used concurrently with enzyme inducers, as these can indicate decreased contraceptive effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"AfbIMw2Vozx5","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn the study comparing pantoprazole sodium for injection and delayed-release tablets, what was the mean basal acid output (BAO) for patients treated with pantoprazole sodium for injection on Day 7?\nA: 0.4 \u00b1 0.5 mEq/h\nB: 0.6 \u00b1 0.8 mEq/h\nC: 2.8 \u00b1 3.0 mEq/h\nD: 8.4 \u00b1 5.9 mEq/h\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn the study comparing pantoprazole sodium for injection and delayed-release tablets, what was the mean basal acid output (BAO) for patients treated with pantoprazole sodium for injection on Day 7?\nA: 0.4 \u00b1 0.5 mEq/h\nB: 0.6 \u00b1 0.8 mEq/h\nC: 2.8 \u00b1 3.0 mEq/h\nD: 8.4 \u00b1 5.9 mEq/h\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn the study comparing pantoprazole sodium for injection and delayed-release tablets, what was the mean basal acid output (BAO) for patients treated with pantoprazole sodium for injection on Day 7?\nA: 0.4 \u00b1 0.5 mEq/h\nB: 0.6 \u00b1 0.8 mEq/h\nC: 2.8 \u00b1 3.0 mEq/h\nD: 8.4 \u00b1 5.9 mEq/h\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"PPKPWRjyGvg5","MRRV winner=B; scores={'A': 0.25, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken when Fluoxetine is coadministered with drugs tightly bound to plasma proteins?\nA: No precaution is necessary\nB: Monitor plasma concentrations of both drugs\nC: Increase the dose of Fluoxetine\nD: Switch to a different SSRI\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken when Fluoxetine is coadministered with drugs tightly bound to plasma proteins?\nA: No precaution is necessary\nB: Monitor plasma concentrations of both drugs\nC: Increase the dose of Fluoxetine\nD: Switch to a different SSRI\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat precaution should be taken when Fluoxetine is coadministered with drugs tightly bound to plasma proteins?\nA: No precaution is necessary\nB: Monitor plasma concentrations of both drugs\nC: Increase the dose of Fluoxetine\nD: Switch to a different SSRI\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"mUAkbujPizzk","MRRV winner=B; scores={'A': 0.611111111111111, 'B': 0.8333333333333334, 'C': 0.38888888888888884, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['A', 'B', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the duration of the acute treatment phase in the trial that demonstrated the efficacy of venlafaxine extended-release capsules in maintaining an antidepressant response?\nA: 4 weeks\nB: 8 weeks\nC: 12 weeks\nD: 26 weeks\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the duration of the acute treatment phase in the trial that demonstrated the efficacy of venlafaxine extended-release capsules in maintaining an antidepressant response?\nA: 4 weeks\nB: 8 weeks\nC: 12 weeks\nD: 26 weeks\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the duration of the acute treatment phase in the trial that demonstrated the efficacy of venlafaxine extended-release capsules in maintaining an antidepressant response?\nA: 4 weeks\nB: 8 weeks\nC: 12 weeks\nD: 26 weeks\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"kyvPgeo7KwHJ","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following products is most likely to be used for skincare purposes?\nA: Complexion Protection Moisturizer SPF\nB: Antibiotic Ointment\nC: Cough Suppressant Syrup\nD: Pain Reliever Tablets\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following products is most likely to be used for skincare purposes?\nA: Complexion Protection Moisturizer SPF\nB: Antibiotic Ointment\nC: Cough Suppressant Syrup\nD: Pain Reliever Tablets\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following products is most likely to be used for skincare purposes?\nA: Complexion Protection Moisturizer SPF\nB: Antibiotic Ointment\nC: Cough Suppressant Syrup\nD: Pain Reliever Tablets\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"byy1gIhaBWyp","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich type of drug interaction should be considered when co-administering AIRSUPRA with strong CYP3A4 inhibitors?\nA: Increased risk of hypokalemia.\nB: Increased systemic exposure to budesonide.\nC: Decreased effectiveness of AIRSUPRA.\nD: Increased risk of paradoxical bronchospasm.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich type of drug interaction should be considered when co-administering AIRSUPRA with strong CYP3A4 inhibitors?\nA: Increased risk of hypokalemia.\nB: Increased systemic exposure to budesonide.\nC: Decreased effectiveness of AIRSUPRA.\nD: Increased risk of paradoxical bronchospasm.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich type of drug interaction should be considered when co-administering AIRSUPRA with strong CYP3A4 inhibitors?\nA: Increased risk of hypokalemia.\nB: Increased systemic exposure to budesonide.\nC: Decreased effectiveness of AIRSUPRA.\nD: Increased risk of paradoxical bronchospasm.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"QW5VLMBYgT5M","- Avoid using clindamycin due to the patient's history of hypersensitivity to this antibiotic.
- Consider avoiding any combination products that contain clindamycin, such as clindamycin phosphate topical solution.
- Monitor for cross-reactivity with other lincosamide antibiotics, as they may also pose a risk for hypersensitivity reactions.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIf a patient has a history of hypersensitivity to clindamycin, which drug should be avoided?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Avoid using clindamycin due to the patient's history of hypersensitivity to this antibiotic.\n- Consider avoiding any combination products that contain clindamycin, such as clindamycin phosphate topical solution.\n- Monitor for cross-reactivity with other lincosamide antibiotics, as they may also pose a risk for hypersensitivity reactions.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: If a patient has a history of hypersensitivity to clindamycin, which drug should be avoided?\nA: Cleocin\nB: Vancomycin\nC: Doxycycline\nD: Azithromycin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Avoid using clindamycin due to the patient's history of hypersensitivity to this antibiotic.\n- Consider avoiding any combination products that contain clindamycin, such as clindamycin phosphate topical solution.\n- Monitor for cross-reactivity with other lincosamide antibiotics, as they may also pose a risk for hypersensitivity reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: If a patient has a history of hypersensitivity to clindamycin, which drug should be avoided?\nA: Cleocin\nB: Vancomycin\nC: Doxycycline\nD: Azithromycin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Avoid using clindamycin due to the patient's history of hypersensitivity to this antibiotic.\n- Consider avoiding any combination products that contain clindamycin, such as clindamycin phosphate topical solution.\n- Monitor for cross-reactivity with other lincosamide antibiotics, as they may also pose a risk for hypersensitivity reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: If a patient has a history of hypersensitivity to clindamycin, which drug should be avoided?\nA: Cleocin\nB: Vancomycin\nC: Doxycycline\nD: Azithromycin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Avoid using clindamycin due to the patient's history of hypersensitivity to this antibiotic.\n- Consider avoiding any combination products that contain clindamycin, such as clindamycin phosphate topical solution.\n- Monitor for cross-reactivity with other lincosamide antibiotics, as they may also pose a risk for hypersensitivity reactions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"0wlqrmdhbcV6","1) Recommendation: It is important to consult a healthcare professional for accurate diagnosis and management if an overdose of lamotrigine is suspected. Monitoring and supportive care may be necessary.

2) Key rationale:
   - Lamotrigine overdose can lead to symptoms such as dizziness, ataxia, nausea, vomiting, and seizures.
   - Symptoms not typically associated with lamotrigine overdose may include severe respiratory depression or profound sedation, which are more common with other classes of medications.
   - Understanding the specific symptoms associated with lamotrigine overdose can help differentiate it from other drug overdoses.

3) Safety/contraindications/interactions:
   - Lamotrigine should be used cautiously in patients with a history of hypersensitivity to the drug.
   - It may interact with other medications that affect liver enzymes, potentially altering its metabolism.
   - Patients with renal or hepatic impairment may require dosage adjustments to avoid toxicity.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhich of the following symptoms is NOT associated with a lamotrigine overdose?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: It is important to consult a healthcare professional for accurate diagnosis and management if an overdose of lamotrigine is suspected. Monitoring and supportive care may be necessary.\n\n2) Key rationale:\n   - Lamotrigine overdose can lead to symptoms such as dizziness, ataxia, nausea, vomiting, and seizures.\n   - Symptoms not typically associated with lamotrigine overdose may include severe respiratory depression or profound sedation, which are more common with other classes of medications.\n   - Understanding the specific symptoms associated with lamotrigine overdose can help differentiate it from other drug overdoses.\n\n3) Safety/contraindications/interactions:\n   - Lamotrigine should be used cautiously in patients with a history of hypersensitivity to the drug.\n   - It may interact with other medications that affect liver enzymes, potentially altering its metabolism.\n   - Patients with renal or hepatic impairment may require dosage adjustments to avoid toxicity.""}]"
"eNk4M0zpsiD7","- Patients taking lamotrigine should immediately contact their healthcare provider if they experience any symptoms of depression or suicidal thoughts, as these can be serious side effects associated with the medication.
- It is important for patients to not abruptly stop taking lamotrigine without medical guidance, as this can lead to withdrawal symptoms or seizure exacerbation.
- Regular monitoring and communication with a healthcare professional are essential for those on lamotrigine, especially if they have a history of mood disorders.

MRRV(meta) winner=B; scores={'A': 0.4166666666666667, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.3611111111111111}; rankings=[['B', 'A', 'D', 'C'], ['B', 'D', 'C', 'A'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should patients taking lamotrigine do if they develop symptoms of depression or suicidal thoughts?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients taking lamotrigine should immediately contact their healthcare provider if they experience any symptoms of depression or suicidal thoughts, as these can be serious side effects associated with the medication.\n- It is important for patients to not abruptly stop taking lamotrigine without medical guidance, as this can lead to withdrawal symptoms or seizure exacerbation.\n- Regular monitoring and communication with a healthcare professional are essential for those on lamotrigine, especially if they have a history of mood disorders.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients taking lamotrigine do if they develop symptoms of depression or suicidal thoughts?\nA: Ignore the symptoms\nB: Notify their healthcare providers immediately\nC: Reduce the dosage of lamotrigine\nD: Switch to a different antiepileptic drug\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking lamotrigine should immediately contact their healthcare provider if they experience any symptoms of depression or suicidal thoughts, as these can be serious side effects associated with the medication.\n- It is important for patients to not abruptly stop taking lamotrigine without medical guidance, as this can lead to withdrawal symptoms or seizure exacerbation.\n- Regular monitoring and communication with a healthcare professional are essential for those on lamotrigine, especially if they have a history of mood disorders.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients taking lamotrigine do if they develop symptoms of depression or suicidal thoughts?\nA: Ignore the symptoms\nB: Notify their healthcare providers immediately\nC: Reduce the dosage of lamotrigine\nD: Switch to a different antiepileptic drug\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking lamotrigine should immediately contact their healthcare provider if they experience any symptoms of depression or suicidal thoughts, as these can be serious side effects associated with the medication.\n- It is important for patients to not abruptly stop taking lamotrigine without medical guidance, as this can lead to withdrawal symptoms or seizure exacerbation.\n- Regular monitoring and communication with a healthcare professional are essential for those on lamotrigine, especially if they have a history of mood disorders.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients taking lamotrigine do if they develop symptoms of depression or suicidal thoughts?\nA: Ignore the symptoms\nB: Notify their healthcare providers immediately\nC: Reduce the dosage of lamotrigine\nD: Switch to a different antiepileptic drug\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking lamotrigine should immediately contact their healthcare provider if they experience any symptoms of depression or suicidal thoughts, as these can be serious side effects associated with the medication.\n- It is important for patients to not abruptly stop taking lamotrigine without medical guidance, as this can lead to withdrawal symptoms or seizure exacerbation.\n- Regular monitoring and communication with a healthcare professional are essential for those on lamotrigine, especially if they have a history of mood disorders.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"ETdY5Tg5Ir46","- Evaluate the patient for potential side effects of Jaimiess, as severe or recurrent headaches may be a known adverse effect of the medication.
- Consider discontinuing Jaimiess and switching to an alternative treatment if headaches persist, ensuring to monitor the patient for any withdrawal symptoms or changes in condition.
- Advise the patient to keep a headache diary to track the frequency, duration, and intensity of headaches, which can help in assessing the impact of Jaimiess on their symptoms.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should be done if a patient taking Jaimiess experiences new, severe, or recurrent headaches?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Evaluate the patient for potential side effects of Jaimiess, as severe or recurrent headaches may be a known adverse effect of the medication.\n- Consider discontinuing Jaimiess and switching to an alternative treatment if headaches persist, ensuring to monitor the patient for any withdrawal symptoms or changes in condition.\n- Advise the patient to keep a headache diary to track the frequency, duration, and intensity of headaches, which can help in assessing the impact of Jaimiess on their symptoms.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if a patient taking Jaimiess experiences new, severe, or recurrent headaches?\nA: Continue the medication and monitor symptoms.\nB: Evaluate the cause and discontinue Jaimiess if indicated.\nC: Switch to a lower dose of Jaimiess.\nD: Prescribe painkillers to manage the headaches.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Evaluate the patient for potential side effects of Jaimiess, as severe or recurrent headaches may be a known adverse effect of the medication.\n- Consider discontinuing Jaimiess and switching to an alternative treatment if headaches persist, ensuring to monitor the patient for any withdrawal symptoms or changes in condition.\n- Advise the patient to keep a headache diary to track the frequency, duration, and intensity of headaches, which can help in assessing the impact of Jaimiess on their symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if a patient taking Jaimiess experiences new, severe, or recurrent headaches?\nA: Continue the medication and monitor symptoms.\nB: Evaluate the cause and discontinue Jaimiess if indicated.\nC: Switch to a lower dose of Jaimiess.\nD: Prescribe painkillers to manage the headaches.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Evaluate the patient for potential side effects of Jaimiess, as severe or recurrent headaches may be a known adverse effect of the medication.\n- Consider discontinuing Jaimiess and switching to an alternative treatment if headaches persist, ensuring to monitor the patient for any withdrawal symptoms or changes in condition.\n- Advise the patient to keep a headache diary to track the frequency, duration, and intensity of headaches, which can help in assessing the impact of Jaimiess on their symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if a patient taking Jaimiess experiences new, severe, or recurrent headaches?\nA: Continue the medication and monitor symptoms.\nB: Evaluate the cause and discontinue Jaimiess if indicated.\nC: Switch to a lower dose of Jaimiess.\nD: Prescribe painkillers to manage the headaches.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Evaluate the patient for potential side effects of Jaimiess, as severe or recurrent headaches may be a known adverse effect of the medication.\n- Consider discontinuing Jaimiess and switching to an alternative treatment if headaches persist, ensuring to monitor the patient for any withdrawal symptoms or changes in condition.\n- Advise the patient to keep a headache diary to track the frequency, duration, and intensity of headaches, which can help in assessing the impact of Jaimiess on their symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"dsx1RWY9m6oS","- Consider dose reduction or interruption of MONJUVI (tafasitamab-cxix) if the platelet count falls to 50,000/mcL or less.
- Monitor the patient's platelet levels closely and evaluate for potential causes of thrombocytopenia while on MONJUVI therapy.
- If the platelet count does not improve or worsens, further management may include consultation with a hematologist for potential interventions.

MRRV(meta) winner=D; scores={'A': 0.27777777777777773, 'B': 0.6666666666666666, 'C': 0.3055555555555555, 'D': 0.8333333333333334}; rankings=[['D', 'B', 'C', 'A'], ['B', 'D', 'A', 'C'], ['D', 'B', 'C', 'A']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should be done if a patient\u2019s platelet count drops to 50,000/mcL or less while receiving MONJUVI?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Consider dose reduction or interruption of MONJUVI (tafasitamab-cxix) if the platelet count falls to 50,000/mcL or less.\n- Monitor the patient's platelet levels closely and evaluate for potential causes of thrombocytopenia while on MONJUVI therapy.\n- If the platelet count does not improve or worsens, further management may include consultation with a hematologist for potential interventions.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if a patient\u2019s platelet count drops to 50,000/mcL or less while receiving MONJUVI?\nA: Continue MONJUVI and lenalidomide at the same dose.\nB: Withhold MONJUVI and lenalidomide and monitor CBC weekly until platelet count is 50,000/mcL or higher.\nC: Permanently discontinue MONJUVI and lenalidomide.\nD: Reduce MONJUVI dosage and continue lenalidomide at the same dose.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider dose reduction or interruption of MONJUVI (tafasitamab-cxix) if the platelet count falls to 50,000/mcL or less.\n- Monitor the patient's platelet levels closely and evaluate for potential causes of thrombocytopenia while on MONJUVI therapy.\n- If the platelet count does not improve or worsens, further management may include consultation with a hematologist for potential interventions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > C > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if a patient\u2019s platelet count drops to 50,000/mcL or less while receiving MONJUVI?\nA: Continue MONJUVI and lenalidomide at the same dose.\nB: Withhold MONJUVI and lenalidomide and monitor CBC weekly until platelet count is 50,000/mcL or higher.\nC: Permanently discontinue MONJUVI and lenalidomide.\nD: Reduce MONJUVI dosage and continue lenalidomide at the same dose.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider dose reduction or interruption of MONJUVI (tafasitamab-cxix) if the platelet count falls to 50,000/mcL or less.\n- Monitor the patient's platelet levels closely and evaluate for potential causes of thrombocytopenia while on MONJUVI therapy.\n- If the platelet count does not improve or worsens, further management may include consultation with a hematologist for potential interventions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if a patient\u2019s platelet count drops to 50,000/mcL or less while receiving MONJUVI?\nA: Continue MONJUVI and lenalidomide at the same dose.\nB: Withhold MONJUVI and lenalidomide and monitor CBC weekly until platelet count is 50,000/mcL or higher.\nC: Permanently discontinue MONJUVI and lenalidomide.\nD: Reduce MONJUVI dosage and continue lenalidomide at the same dose.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider dose reduction or interruption of MONJUVI (tafasitamab-cxix) if the platelet count falls to 50,000/mcL or less.\n- Monitor the patient's platelet levels closely and evaluate for potential causes of thrombocytopenia while on MONJUVI therapy.\n- If the platelet count does not improve or worsens, further management may include consultation with a hematologist for potential interventions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > C > A""}]"
"fwIC84WvxCX3","- The American Academy of Pediatrics provides evidence-based recommendations for the safe and effective use of D-109 in pediatric populations, ensuring that dosing and administration align with current clinical guidelines.
- They may also evaluate the safety profile of D-109 through clinical studies and publish findings to inform healthcare providers about potential risks and benefits associated with its use in children.
- The Academy advocates for ongoing research and monitoring of D-109 to address any emerging concerns regarding its efficacy and safety in pediatric patients.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the role of the American Academy of Pediatrics in the usage guidelines for D-109?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The American Academy of Pediatrics provides evidence-based recommendations for the safe and effective use of D-109 in pediatric populations, ensuring that dosing and administration align with current clinical guidelines.\n- They may also evaluate the safety profile of D-109 through clinical studies and publish findings to inform healthcare providers about potential risks and benefits associated with its use in children.\n- The Academy advocates for ongoing research and monitoring of D-109 to address any emerging concerns regarding its efficacy and safety in pediatric patients.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the role of the American Academy of Pediatrics in the usage guidelines for D-109?\nA: They recommend the drug for adults with vitamin deficiencies.\nB: They provide guidelines for fluoride supplementation in children.\nC: They regulate the manufacturing of D-109.\nD: They recommend the drug for treatment of chronic diseases.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The American Academy of Pediatrics provides evidence-based recommendations for the safe and effective use of D-109 in pediatric populations, ensuring that dosing and administration align with current clinical guidelines.\n- They may also evaluate the safety profile of D-109 through clinical studies and publish findings to inform healthcare providers about potential risks and benefits associated with its use in children.\n- The Academy advocates for ongoing research and monitoring of D-109 to address any emerging concerns regarding its efficacy and safety in pediatric patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the role of the American Academy of Pediatrics in the usage guidelines for D-109?\nA: They recommend the drug for adults with vitamin deficiencies.\nB: They provide guidelines for fluoride supplementation in children.\nC: They regulate the manufacturing of D-109.\nD: They recommend the drug for treatment of chronic diseases.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The American Academy of Pediatrics provides evidence-based recommendations for the safe and effective use of D-109 in pediatric populations, ensuring that dosing and administration align with current clinical guidelines.\n- They may also evaluate the safety profile of D-109 through clinical studies and publish findings to inform healthcare providers about potential risks and benefits associated with its use in children.\n- The Academy advocates for ongoing research and monitoring of D-109 to address any emerging concerns regarding its efficacy and safety in pediatric patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the role of the American Academy of Pediatrics in the usage guidelines for D-109?\nA: They recommend the drug for adults with vitamin deficiencies.\nB: They provide guidelines for fluoride supplementation in children.\nC: They regulate the manufacturing of D-109.\nD: They recommend the drug for treatment of chronic diseases.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The American Academy of Pediatrics provides evidence-based recommendations for the safe and effective use of D-109 in pediatric populations, ensuring that dosing and administration align with current clinical guidelines.\n- They may also evaluate the safety profile of D-109 through clinical studies and publish findings to inform healthcare providers about potential risks and benefits associated with its use in children.\n- The Academy advocates for ongoing research and monitoring of D-109 to address any emerging concerns regarding its efficacy and safety in pediatric patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"oev3SalttfqV","- Patients seropositive for HIV should not receive Zynteglo treatment, as the therapy is contraindicated in individuals with active infections, including HIV.
- Zynteglo is specifically designed for the treatment of beta-thalassemia in patients who do not have active viral infections, ensuring safety and efficacy.
- The presence of HIV in patients may complicate the treatment process and increase the risk of adverse effects, making Zynteglo unsuitable for this population.

MRRV(meta) winner=B; scores={'A': 0.3611111111111111, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.4166666666666667}; rankings=[['B', 'D', 'C', 'A'], ['B', 'D', 'A', 'C'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommendation for patients seropositive for HIV regarding Zynteglo treatment?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients seropositive for HIV should not receive Zynteglo treatment, as the therapy is contraindicated in individuals with active infections, including HIV.\n- Zynteglo is specifically designed for the treatment of beta-thalassemia in patients who do not have active viral infections, ensuring safety and efficacy.\n- The presence of HIV in patients may complicate the treatment process and increase the risk of adverse effects, making Zynteglo unsuitable for this population.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for patients seropositive for HIV regarding Zynteglo treatment?\nA: They can proceed with treatment after additional testing.\nB: They are not eligible for Zynteglo treatment as apheresis material from HIV-positive patients is not accepted.\nC: They can receive Zynteglo if their viral load is undetectable.\nD: They must undergo antiviral therapy before Zynteglo treatment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients seropositive for HIV should not receive Zynteglo treatment, as the therapy is contraindicated in individuals with active infections, including HIV.\n- Zynteglo is specifically designed for the treatment of beta-thalassemia in patients who do not have active viral infections, ensuring safety and efficacy.\n- The presence of HIV in patients may complicate the treatment process and increase the risk of adverse effects, making Zynteglo unsuitable for this population.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for patients seropositive for HIV regarding Zynteglo treatment?\nA: They can proceed with treatment after additional testing.\nB: They are not eligible for Zynteglo treatment as apheresis material from HIV-positive patients is not accepted.\nC: They can receive Zynteglo if their viral load is undetectable.\nD: They must undergo antiviral therapy before Zynteglo treatment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients seropositive for HIV should not receive Zynteglo treatment, as the therapy is contraindicated in individuals with active infections, including HIV.\n- Zynteglo is specifically designed for the treatment of beta-thalassemia in patients who do not have active viral infections, ensuring safety and efficacy.\n- The presence of HIV in patients may complicate the treatment process and increase the risk of adverse effects, making Zynteglo unsuitable for this population.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for patients seropositive for HIV regarding Zynteglo treatment?\nA: They can proceed with treatment after additional testing.\nB: They are not eligible for Zynteglo treatment as apheresis material from HIV-positive patients is not accepted.\nC: They can receive Zynteglo if their viral load is undetectable.\nD: They must undergo antiviral therapy before Zynteglo treatment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients seropositive for HIV should not receive Zynteglo treatment, as the therapy is contraindicated in individuals with active infections, including HIV.\n- Zynteglo is specifically designed for the treatment of beta-thalassemia in patients who do not have active viral infections, ensuring safety and efficacy.\n- The presence of HIV in patients may complicate the treatment process and increase the risk of adverse effects, making Zynteglo unsuitable for this population.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"OfV3rJd9x9sx","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended course of action if a patient undergoing Follistim AQ therapy shows early signs of OHSS before hCG administration?\nA: Administer hCG immediately to complete follicular maturation\nB: Withhold hCG administration to prevent worsening of OHSS\nC: Increase the dose of Follistim AQ to counteract OHSS\nD: Perform a pelvic examination to confirm OHSS\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended course of action if a patient undergoing Follistim AQ therapy shows early signs of OHSS before hCG administration?\nA: Administer hCG immediately to complete follicular maturation\nB: Withhold hCG administration to prevent worsening of OHSS\nC: Increase the dose of Follistim AQ to counteract OHSS\nD: Perform a pelvic examination to confirm OHSS\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended course of action if a patient undergoing Follistim AQ therapy shows early signs of OHSS before hCG administration?\nA: Administer hCG immediately to complete follicular maturation\nB: Withhold hCG administration to prevent worsening of OHSS\nC: Increase the dose of Follistim AQ to counteract OHSS\nD: Perform a pelvic examination to confirm OHSS\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"qSZOrts1KUUM","- The active ingredient in fosaprepitant for injection is fosaprepitant dimeglumine, which is a prodrug of aprepitant.
- Fosaprepitant is used as an antiemetic to prevent nausea and vomiting associated with chemotherapy.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the active ingredient in fosaprepitant for injection?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The active ingredient in fosaprepitant for injection is fosaprepitant dimeglumine, which is a prodrug of aprepitant.\n- Fosaprepitant is used as an antiemetic to prevent nausea and vomiting associated with chemotherapy.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the active ingredient in fosaprepitant for injection?\nA: Aprepitant.\nB: Fosaprepitant.\nC: Polysorbate 80.\nD: Edetate disodium.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The active ingredient in fosaprepitant for injection is fosaprepitant dimeglumine, which is a prodrug of aprepitant.\n- Fosaprepitant is used as an antiemetic to prevent nausea and vomiting associated with chemotherapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the active ingredient in fosaprepitant for injection?\nA: Aprepitant.\nB: Fosaprepitant.\nC: Polysorbate 80.\nD: Edetate disodium.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The active ingredient in fosaprepitant for injection is fosaprepitant dimeglumine, which is a prodrug of aprepitant.\n- Fosaprepitant is used as an antiemetic to prevent nausea and vomiting associated with chemotherapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the active ingredient in fosaprepitant for injection?\nA: Aprepitant.\nB: Fosaprepitant.\nC: Polysorbate 80.\nD: Edetate disodium.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The active ingredient in fosaprepitant for injection is fosaprepitant dimeglumine, which is a prodrug of aprepitant.\n- Fosaprepitant is used as an antiemetic to prevent nausea and vomiting associated with chemotherapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"L7UZwKN5EdxD","- Administer Verkazia (cyclosporine ophthalmic emulsion) first before any other eye drops or ointments to ensure optimal absorption and effectiveness.
- Wait at least 15 minutes after applying Verkazia before using any other eye drops to prevent dilution or washout of the medication.
- If using ointments, apply Verkazia first and then wait at least 30 minutes before applying the ointment to avoid interference with the emulsion's action.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the correct sequence for administering Verkazia when using other eye drops or ointments?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Administer Verkazia (cyclosporine ophthalmic emulsion) first before any other eye drops or ointments to ensure optimal absorption and effectiveness.\n- Wait at least 15 minutes after applying Verkazia before using any other eye drops to prevent dilution or washout of the medication.\n- If using ointments, apply Verkazia first and then wait at least 30 minutes before applying the ointment to avoid interference with the emulsion's action.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the correct sequence for administering Verkazia when using other eye drops or ointments?\nA: Use Verkazia 10 minutes after other eye drops or ointments\nB: Use Verkazia 10 minutes before other eye drops or ointments\nC: Use Verkazia simultaneously with other eye drops or ointments\nD: Do not use Verkazia with other eye drops or ointments\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer Verkazia (cyclosporine ophthalmic emulsion) first before any other eye drops or ointments to ensure optimal absorption and effectiveness.\n- Wait at least 15 minutes after applying Verkazia before using any other eye drops to prevent dilution or washout of the medication.\n- If using ointments, apply Verkazia first and then wait at least 30 minutes before applying the ointment to avoid interference with the emulsion's action.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the correct sequence for administering Verkazia when using other eye drops or ointments?\nA: Use Verkazia 10 minutes after other eye drops or ointments\nB: Use Verkazia 10 minutes before other eye drops or ointments\nC: Use Verkazia simultaneously with other eye drops or ointments\nD: Do not use Verkazia with other eye drops or ointments\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer Verkazia (cyclosporine ophthalmic emulsion) first before any other eye drops or ointments to ensure optimal absorption and effectiveness.\n- Wait at least 15 minutes after applying Verkazia before using any other eye drops to prevent dilution or washout of the medication.\n- If using ointments, apply Verkazia first and then wait at least 30 minutes before applying the ointment to avoid interference with the emulsion's action.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the correct sequence for administering Verkazia when using other eye drops or ointments?\nA: Use Verkazia 10 minutes after other eye drops or ointments\nB: Use Verkazia 10 minutes before other eye drops or ointments\nC: Use Verkazia simultaneously with other eye drops or ointments\nD: Do not use Verkazia with other eye drops or ointments\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer Verkazia (cyclosporine ophthalmic emulsion) first before any other eye drops or ointments to ensure optimal absorption and effectiveness.\n- Wait at least 15 minutes after applying Verkazia before using any other eye drops to prevent dilution or washout of the medication.\n- If using ointments, apply Verkazia first and then wait at least 30 minutes before applying the ointment to avoid interference with the emulsion's action.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"Zom7nc9BaP9N","- The starting regimen for pantoprazole sodium for injection in patients with Zollinger-Ellison Syndrome is typically 80 mg administered intravenously as a bolus.
- Following the initial bolus, a continuous infusion of pantoprazole sodium at a rate of 8 mg per hour is often used to maintain gastric acid control.
- This regimen is aimed at effectively managing excessive gastric acid secretion associated with the syndrome.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat was the starting regimen for pantoprazole sodium for injection in patients with Zollinger-Ellison Syndrome to control gastric acid secretion?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The starting regimen for pantoprazole sodium for injection in patients with Zollinger-Ellison Syndrome is typically 80 mg administered intravenously as a bolus.\n- Following the initial bolus, a continuous infusion of pantoprazole sodium at a rate of 8 mg per hour is often used to maintain gastric acid control.\n- This regimen is aimed at effectively managing excessive gastric acid secretion associated with the syndrome.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the starting regimen for pantoprazole sodium for injection in patients with Zollinger-Ellison Syndrome to control gastric acid secretion?\nA: 40 mg every 12 hours\nB: 80 mg every 12 hours\nC: 160 mg every 24 hours\nD: 240 mg every 24 hours\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The starting regimen for pantoprazole sodium for injection in patients with Zollinger-Ellison Syndrome is typically 80 mg administered intravenously as a bolus.\n- Following the initial bolus, a continuous infusion of pantoprazole sodium at a rate of 8 mg per hour is often used to maintain gastric acid control.\n- This regimen is aimed at effectively managing excessive gastric acid secretion associated with the syndrome.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the starting regimen for pantoprazole sodium for injection in patients with Zollinger-Ellison Syndrome to control gastric acid secretion?\nA: 40 mg every 12 hours\nB: 80 mg every 12 hours\nC: 160 mg every 24 hours\nD: 240 mg every 24 hours\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The starting regimen for pantoprazole sodium for injection in patients with Zollinger-Ellison Syndrome is typically 80 mg administered intravenously as a bolus.\n- Following the initial bolus, a continuous infusion of pantoprazole sodium at a rate of 8 mg per hour is often used to maintain gastric acid control.\n- This regimen is aimed at effectively managing excessive gastric acid secretion associated with the syndrome.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the starting regimen for pantoprazole sodium for injection in patients with Zollinger-Ellison Syndrome to control gastric acid secretion?\nA: 40 mg every 12 hours\nB: 80 mg every 12 hours\nC: 160 mg every 24 hours\nD: 240 mg every 24 hours\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The starting regimen for pantoprazole sodium for injection in patients with Zollinger-Ellison Syndrome is typically 80 mg administered intravenously as a bolus.\n- Following the initial bolus, a continuous infusion of pantoprazole sodium at a rate of 8 mg per hour is often used to maintain gastric acid control.\n- This regimen is aimed at effectively managing excessive gastric acid secretion associated with the syndrome.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"VyLrDy5LffHL","- Using other short-acting sympathomimetic aerosol bronchodilators, such as Levalbuterol, alongside Albuterol can lead to increased risk of cardiovascular side effects due to excessive stimulation of beta-adrenergic receptors.
- Concomitant use of multiple short-acting bronchodilators may not provide additional therapeutic benefit and can complicate the management of asthma or COPD, as both medications work through similar mechanisms.
- The potential for increased side effects, such as tachycardia and tremors, is heightened when combining Albuterol with other short-acting sympathomimetics, which can negatively impact patient safety and adherence to treatment.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy should other short-acting sympathomimetic aerosol bronchodilators not be used concomitantly with Albuterol?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Using other short-acting sympathomimetic aerosol bronchodilators, such as Levalbuterol, alongside Albuterol can lead to increased risk of cardiovascular side effects due to excessive stimulation of beta-adrenergic receptors.\n- Concomitant use of multiple short-acting bronchodilators may not provide additional therapeutic benefit and can complicate the management of asthma or COPD, as both medications work through similar mechanisms.\n- The potential for increased side effects, such as tachycardia and tremors, is heightened when combining Albuterol with other short-acting sympathomimetics, which can negatively impact patient safety and adherence to treatment.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should other short-acting sympathomimetic aerosol bronchodilators not be used concomitantly with Albuterol?\nA: They may cause severe hypokalemia.\nB: They may lead to deleterious cardiovascular effects.\nC: They may block the bronchodilatory effects of Albuterol.\nD: They may increase serum digoxin levels.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Using other short-acting sympathomimetic aerosol bronchodilators, such as Levalbuterol, alongside Albuterol can lead to increased risk of cardiovascular side effects due to excessive stimulation of beta-adrenergic receptors.\n- Concomitant use of multiple short-acting bronchodilators may not provide additional therapeutic benefit and can complicate the management of asthma or COPD, as both medications work through similar mechanisms.\n- The potential for increased side effects, such as tachycardia and tremors, is heightened when combining Albuterol with other short-acting sympathomimetics, which can negatively impact patient safety and adherence to treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should other short-acting sympathomimetic aerosol bronchodilators not be used concomitantly with Albuterol?\nA: They may cause severe hypokalemia.\nB: They may lead to deleterious cardiovascular effects.\nC: They may block the bronchodilatory effects of Albuterol.\nD: They may increase serum digoxin levels.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Using other short-acting sympathomimetic aerosol bronchodilators, such as Levalbuterol, alongside Albuterol can lead to increased risk of cardiovascular side effects due to excessive stimulation of beta-adrenergic receptors.\n- Concomitant use of multiple short-acting bronchodilators may not provide additional therapeutic benefit and can complicate the management of asthma or COPD, as both medications work through similar mechanisms.\n- The potential for increased side effects, such as tachycardia and tremors, is heightened when combining Albuterol with other short-acting sympathomimetics, which can negatively impact patient safety and adherence to treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should other short-acting sympathomimetic aerosol bronchodilators not be used concomitantly with Albuterol?\nA: They may cause severe hypokalemia.\nB: They may lead to deleterious cardiovascular effects.\nC: They may block the bronchodilatory effects of Albuterol.\nD: They may increase serum digoxin levels.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Using other short-acting sympathomimetic aerosol bronchodilators, such as Levalbuterol, alongside Albuterol can lead to increased risk of cardiovascular side effects due to excessive stimulation of beta-adrenergic receptors.\n- Concomitant use of multiple short-acting bronchodilators may not provide additional therapeutic benefit and can complicate the management of asthma or COPD, as both medications work through similar mechanisms.\n- The potential for increased side effects, such as tachycardia and tremors, is heightened when combining Albuterol with other short-acting sympathomimetics, which can negatively impact patient safety and adherence to treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"yVhIKTvGLFwf","1) Recommendation: Before administering Sumatriptan injection to patients with multiple cardiovascular risk factors, it is crucial to conduct a thorough cardiovascular assessment and consider alternative treatments if necessary. Monitoring should be implemented during and after administration to detect any adverse cardiovascular events.

2) Key rationale:
- Sumatriptan can cause vasoconstriction, which may exacerbate existing cardiovascular conditions.
- Patients with risk factors such as hypertension, coronary artery disease, or a history of stroke are at increased risk for serious cardiovascular events.
- A baseline cardiovascular evaluation can help identify patients who may be at higher risk for complications.
- Alternative migraine treatments may be safer for patients with significant cardiovascular risk factors.

3) Safety/contraindications/interactions:
- Contraindicated in patients with a history of ischemic heart disease, uncontrolled hypertension, or cerebrovascular disease.
- Caution is advised when used in conjunction with other vasoconstrictors or medications that affect cardiovascular function.
- Monitor for signs of myocardial ischemia or other cardiovascular complications during and after administration.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat precaution should be taken for patients with multiple cardiovascular risk factors before administering Sumatriptan injection?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Before administering Sumatriptan injection to patients with multiple cardiovascular risk factors, it is crucial to conduct a thorough cardiovascular assessment and consider alternative treatments if necessary. Monitoring should be implemented during and after administration to detect any adverse cardiovascular events.\n\n2) Key rationale:\n- Sumatriptan can cause vasoconstriction, which may exacerbate existing cardiovascular conditions.\n- Patients with risk factors such as hypertension, coronary artery disease, or a history of stroke are at increased risk for serious cardiovascular events.\n- A baseline cardiovascular evaluation can help identify patients who may be at higher risk for complications.\n- Alternative migraine treatments may be safer for patients with significant cardiovascular risk factors.\n\n3) Safety/contraindications/interactions:\n- Contraindicated in patients with a history of ischemic heart disease, uncontrolled hypertension, or cerebrovascular disease.\n- Caution is advised when used in conjunction with other vasoconstrictors or medications that affect cardiovascular function.\n- Monitor for signs of myocardial ischemia or other cardiovascular complications during and after administration.""}]"
"mjGuZZdTzVTw","MRRV winner=B; scores={'A': 0.4166666666666667, 'B': 1.0, 'C': 0.38888888888888884, 'D': 0.27777777777777773}; rankings=[['B', 'A', 'C', 'D'], ['B', 'C', 'D', 'A'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the clinical significance of drug interactions between Zithromax and digoxin, colchicine, or phenytoin?\nA: No interactions have been reported, and no monitoring is required\nB: Interactions have been observed with other macrolides, so careful monitoring is advised\nC: Specific drug interaction studies confirm severe adverse effects\nD: These drugs are contraindicated with Zithromax\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the clinical significance of drug interactions between Zithromax and digoxin, colchicine, or phenytoin?\nA: No interactions have been reported, and no monitoring is required\nB: Interactions have been observed with other macrolides, so careful monitoring is advised\nC: Specific drug interaction studies confirm severe adverse effects\nD: These drugs are contraindicated with Zithromax\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the clinical significance of drug interactions between Zithromax and digoxin, colchicine, or phenytoin?\nA: No interactions have been reported, and no monitoring is required\nB: Interactions have been observed with other macrolides, so careful monitoring is advised\nC: Specific drug interaction studies confirm severe adverse effects\nD: These drugs are contraindicated with Zithromax\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"4R2o2r5F4ecp","1) Recommendation: When prescribing fluoxetine to a patient with diabetes, it is important to monitor blood glucose levels closely and consider potential adjustments to diabetes management plans, as fluoxetine can affect glycemic control.

2) Key rationale:
- Fluoxetine may influence insulin sensitivity and glucose metabolism, potentially leading to fluctuations in blood sugar levels.
- Patients with diabetes may be at increased risk for hypoglycemia or hyperglycemia when starting or adjusting antidepressant therapy.
- Regular monitoring of blood glucose can help identify any adverse effects early and allow for timely adjustments in diabetes medications.

3) Safety/contraindications/interactions:
- Be cautious of potential drug interactions with antidiabetic medications that may exacerbate blood sugar control issues.
- Monitor for signs of serotonin syndrome, especially if fluoxetine is combined with other serotonergic agents.
- Ensure the patient is aware of the importance of reporting any significant changes in mood or energy levels, as these can impact diabetes management.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat precaution should be taken when prescribing fluoxetine to a patient with diabetes?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: When prescribing fluoxetine to a patient with diabetes, it is important to monitor blood glucose levels closely and consider potential adjustments to diabetes management plans, as fluoxetine can affect glycemic control.\n\n2) Key rationale:\n- Fluoxetine may influence insulin sensitivity and glucose metabolism, potentially leading to fluctuations in blood sugar levels.\n- Patients with diabetes may be at increased risk for hypoglycemia or hyperglycemia when starting or adjusting antidepressant therapy.\n- Regular monitoring of blood glucose can help identify any adverse effects early and allow for timely adjustments in diabetes medications.\n\n3) Safety/contraindications/interactions:\n- Be cautious of potential drug interactions with antidiabetic medications that may exacerbate blood sugar control issues.\n- Monitor for signs of serotonin syndrome, especially if fluoxetine is combined with other serotonergic agents.\n- Ensure the patient is aware of the importance of reporting any significant changes in mood or energy levels, as these can impact diabetes management.""}]"
"JkAwz1EI0A0w","- Reduce the JAYPIRCA dosage to 50 mg once daily when co-administered with strong CYP3A inhibitors.
- Monitor for potential increased toxicity due to elevated JAYPIRCA levels when used alongside strong CYP3A inhibitors.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended dosage adjustment for JAYPIRCA when co-administered with strong CYP3A inhibitors?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Reduce the JAYPIRCA dosage to 50 mg once daily when co-administered with strong CYP3A inhibitors.\n- Monitor for potential increased toxicity due to elevated JAYPIRCA levels when used alongside strong CYP3A inhibitors.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended dosage adjustment for JAYPIRCA when co-administered with strong CYP3A inhibitors?\nA: Increase the dose by 50 mg\nB: Reduce the dose by 50 mg\nC: Maintain the current dosage\nD: Discontinue JAYPIRCA permanently\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Reduce the JAYPIRCA dosage to 50 mg once daily when co-administered with strong CYP3A inhibitors.\n- Monitor for potential increased toxicity due to elevated JAYPIRCA levels when used alongside strong CYP3A inhibitors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended dosage adjustment for JAYPIRCA when co-administered with strong CYP3A inhibitors?\nA: Increase the dose by 50 mg\nB: Reduce the dose by 50 mg\nC: Maintain the current dosage\nD: Discontinue JAYPIRCA permanently\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Reduce the JAYPIRCA dosage to 50 mg once daily when co-administered with strong CYP3A inhibitors.\n- Monitor for potential increased toxicity due to elevated JAYPIRCA levels when used alongside strong CYP3A inhibitors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended dosage adjustment for JAYPIRCA when co-administered with strong CYP3A inhibitors?\nA: Increase the dose by 50 mg\nB: Reduce the dose by 50 mg\nC: Maintain the current dosage\nD: Discontinue JAYPIRCA permanently\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Reduce the JAYPIRCA dosage to 50 mg once daily when co-administered with strong CYP3A inhibitors.\n- Monitor for potential increased toxicity due to elevated JAYPIRCA levels when used alongside strong CYP3A inhibitors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"hkiBzNjQVZnX","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nMemantine Hydrochloride is contraindicated in patients with hypersensitivity to which of the following components?\nA: Memantine Hydrochloride and excipients in the formulation\nB: Only excipients in the formulation\nC: Only memantine hydrochloride\nD: Any NMDA receptor antagonist\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nMemantine Hydrochloride is contraindicated in patients with hypersensitivity to which of the following components?\nA: Memantine Hydrochloride and excipients in the formulation\nB: Only excipients in the formulation\nC: Only memantine hydrochloride\nD: Any NMDA receptor antagonist\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nMemantine Hydrochloride is contraindicated in patients with hypersensitivity to which of the following components?\nA: Memantine Hydrochloride and excipients in the formulation\nB: Only excipients in the formulation\nC: Only memantine hydrochloride\nD: Any NMDA receptor antagonist\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"35m9PvWL5yvf","- Paxlovid, which contains nirmatrelvir and ritonavir, may reduce the effectiveness of hormonal contraceptives that contain ethinyl estradiol due to the interaction with ritonavir.
- It is recommended that patients using hormonal contraceptives with ethinyl estradiol consider using additional non-hormonal contraceptive methods during and for at least 28 days after completing Paxlovid treatment.
- Healthcare providers should inform patients about the potential for decreased contraceptive efficacy when taking Paxlovid and discuss alternative contraceptive options.

MRRV(meta) winner=B; scores={'A': 0.3055555555555555, 'B': 1.0, 'C': 0.5, 'D': 0.27777777777777773}; rankings=[['B', 'C', 'D', 'A'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommendation for co-administration of Paxlovid with hormonal contraceptives containing ethinyl estradiol?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Paxlovid, which contains nirmatrelvir and ritonavir, may reduce the effectiveness of hormonal contraceptives that contain ethinyl estradiol due to the interaction with ritonavir.\n- It is recommended that patients using hormonal contraceptives with ethinyl estradiol consider using additional non-hormonal contraceptive methods during and for at least 28 days after completing Paxlovid treatment.\n- Healthcare providers should inform patients about the potential for decreased contraceptive efficacy when taking Paxlovid and discuss alternative contraceptive options.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for co-administration of Paxlovid with hormonal contraceptives containing ethinyl estradiol?\nA: Increase the dose of Paxlovid\nB: Use an additional non-hormonal contraceptive method\nC: No action is required\nD: Discontinue Paxlovid\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Paxlovid, which contains nirmatrelvir and ritonavir, may reduce the effectiveness of hormonal contraceptives that contain ethinyl estradiol due to the interaction with ritonavir.\n- It is recommended that patients using hormonal contraceptives with ethinyl estradiol consider using additional non-hormonal contraceptive methods during and for at least 28 days after completing Paxlovid treatment.\n- Healthcare providers should inform patients about the potential for decreased contraceptive efficacy when taking Paxlovid and discuss alternative contraceptive options.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for co-administration of Paxlovid with hormonal contraceptives containing ethinyl estradiol?\nA: Increase the dose of Paxlovid\nB: Use an additional non-hormonal contraceptive method\nC: No action is required\nD: Discontinue Paxlovid\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Paxlovid, which contains nirmatrelvir and ritonavir, may reduce the effectiveness of hormonal contraceptives that contain ethinyl estradiol due to the interaction with ritonavir.\n- It is recommended that patients using hormonal contraceptives with ethinyl estradiol consider using additional non-hormonal contraceptive methods during and for at least 28 days after completing Paxlovid treatment.\n- Healthcare providers should inform patients about the potential for decreased contraceptive efficacy when taking Paxlovid and discuss alternative contraceptive options.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for co-administration of Paxlovid with hormonal contraceptives containing ethinyl estradiol?\nA: Increase the dose of Paxlovid\nB: Use an additional non-hormonal contraceptive method\nC: No action is required\nD: Discontinue Paxlovid\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Paxlovid, which contains nirmatrelvir and ritonavir, may reduce the effectiveness of hormonal contraceptives that contain ethinyl estradiol due to the interaction with ritonavir.\n- It is recommended that patients using hormonal contraceptives with ethinyl estradiol consider using additional non-hormonal contraceptive methods during and for at least 28 days after completing Paxlovid treatment.\n- Healthcare providers should inform patients about the potential for decreased contraceptive efficacy when taking Paxlovid and discuss alternative contraceptive options.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"dbROsaqBWmgw","- Apply a sufficient amount of hydrocort shampoo to cover the affected area of the scalp thoroughly, typically around 1 to 2 ounces.
- Massage the hydrocort shampoo into the scalp gently and leave it on for 5 to 10 minutes before rinsing.
- Use the hydrocort shampoo as directed, usually 2 to 3 times a week, depending on the severity of the condition being treated.

MRRV(meta) winner=A; scores={'A': 0.8333333333333334, 'B': 0.6666666666666666, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended amount of hydrocort shampoo to use during application?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Apply a sufficient amount of hydrocort shampoo to cover the affected area of the scalp thoroughly, typically around 1 to 2 ounces.\n- Massage the hydrocort shampoo into the scalp gently and leave it on for 5 to 10 minutes before rinsing.\n- Use the hydrocort shampoo as directed, usually 2 to 3 times a week, depending on the severity of the condition being treated.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended amount of hydrocort shampoo to use during application?\nA: A small amount\nB: A moderate amount\nC: A large amount\nD: An unspecified amount\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Apply a sufficient amount of hydrocort shampoo to cover the affected area of the scalp thoroughly, typically around 1 to 2 ounces.\n- Massage the hydrocort shampoo into the scalp gently and leave it on for 5 to 10 minutes before rinsing.\n- Use the hydrocort shampoo as directed, usually 2 to 3 times a week, depending on the severity of the condition being treated.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended amount of hydrocort shampoo to use during application?\nA: A small amount\nB: A moderate amount\nC: A large amount\nD: An unspecified amount\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Apply a sufficient amount of hydrocort shampoo to cover the affected area of the scalp thoroughly, typically around 1 to 2 ounces.\n- Massage the hydrocort shampoo into the scalp gently and leave it on for 5 to 10 minutes before rinsing.\n- Use the hydrocort shampoo as directed, usually 2 to 3 times a week, depending on the severity of the condition being treated.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended amount of hydrocort shampoo to use during application?\nA: A small amount\nB: A moderate amount\nC: A large amount\nD: An unspecified amount\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Apply a sufficient amount of hydrocort shampoo to cover the affected area of the scalp thoroughly, typically around 1 to 2 ounces.\n- Massage the hydrocort shampoo into the scalp gently and leave it on for 5 to 10 minutes before rinsing.\n- Use the hydrocort shampoo as directed, usually 2 to 3 times a week, depending on the severity of the condition being treated.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"zw3qQujW7bK5","MRRV winner=A; scores={'A': 0.611111111111111, 'B': 0.611111111111111, 'C': 0.3611111111111111, 'D': 0.5}; rankings=[['A', 'B', 'C', 'D'], ['B', 'C', 'A', 'D'], ['D', 'A', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich mutagenicity test demonstrated that levalbuterol HCl was not mutagenic?\nA: In vivo micronucleus test in mouse bone marrow\nB: CHO/HPRT Mammalian Forward Gene Mutation Assay\nC: Ames test\nD: All of the above\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich mutagenicity test demonstrated that levalbuterol HCl was not mutagenic?\nA: In vivo micronucleus test in mouse bone marrow\nB: CHO/HPRT Mammalian Forward Gene Mutation Assay\nC: Ames test\nD: All of the above\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich mutagenicity test demonstrated that levalbuterol HCl was not mutagenic?\nA: In vivo micronucleus test in mouse bone marrow\nB: CHO/HPRT Mammalian Forward Gene Mutation Assay\nC: Ames test\nD: All of the above\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}]"
"cAQk37wdlYo1","- The combination of Fluoxetine and Olanzapine has been shown to be effective in reducing depressive symptoms in patients with Bipolar I Disorder, particularly in those experiencing depressive episodes.
- Clinical studies indicate that this combination can lead to a significant improvement in mood stabilization compared to using Fluoxetine alone or a placebo.
- The use of Fluoxetine (an SSRI) alongside Olanzapine (an atypical antipsychotic) may help mitigate the risk of manic episodes that can occur with antidepressant monotherapy in bipolar patients.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following is true regarding the use of Fluoxetine in combination with Olanzapine for treating depressive episodes associated with Bipolar I Disorder?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The combination of Fluoxetine and Olanzapine has been shown to be effective in reducing depressive symptoms in patients with Bipolar I Disorder, particularly in those experiencing depressive episodes.\n- Clinical studies indicate that this combination can lead to a significant improvement in mood stabilization compared to using Fluoxetine alone or a placebo.\n- The use of Fluoxetine (an SSRI) alongside Olanzapine (an atypical antipsychotic) may help mitigate the risk of manic episodes that can occur with antidepressant monotherapy in bipolar patients.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is true regarding the use of Fluoxetine in combination with Olanzapine for treating depressive episodes associated with Bipolar I Disorder?\nA: Fluoxetine monotherapy is sufficient for treatment.\nB: The combination is initiated with 20 mg of Fluoxetine and 5 mg of Olanzapine.\nC: The combination is initiated with 10 mg of Fluoxetine and 2.5 mg of Olanzapine.\nD: Fluoxetine doses above 100 mg/day are recommended.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination of Fluoxetine and Olanzapine has been shown to be effective in reducing depressive symptoms in patients with Bipolar I Disorder, particularly in those experiencing depressive episodes.\n- Clinical studies indicate that this combination can lead to a significant improvement in mood stabilization compared to using Fluoxetine alone or a placebo.\n- The use of Fluoxetine (an SSRI) alongside Olanzapine (an atypical antipsychotic) may help mitigate the risk of manic episodes that can occur with antidepressant monotherapy in bipolar patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is true regarding the use of Fluoxetine in combination with Olanzapine for treating depressive episodes associated with Bipolar I Disorder?\nA: Fluoxetine monotherapy is sufficient for treatment.\nB: The combination is initiated with 20 mg of Fluoxetine and 5 mg of Olanzapine.\nC: The combination is initiated with 10 mg of Fluoxetine and 2.5 mg of Olanzapine.\nD: Fluoxetine doses above 100 mg/day are recommended.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination of Fluoxetine and Olanzapine has been shown to be effective in reducing depressive symptoms in patients with Bipolar I Disorder, particularly in those experiencing depressive episodes.\n- Clinical studies indicate that this combination can lead to a significant improvement in mood stabilization compared to using Fluoxetine alone or a placebo.\n- The use of Fluoxetine (an SSRI) alongside Olanzapine (an atypical antipsychotic) may help mitigate the risk of manic episodes that can occur with antidepressant monotherapy in bipolar patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is true regarding the use of Fluoxetine in combination with Olanzapine for treating depressive episodes associated with Bipolar I Disorder?\nA: Fluoxetine monotherapy is sufficient for treatment.\nB: The combination is initiated with 20 mg of Fluoxetine and 5 mg of Olanzapine.\nC: The combination is initiated with 10 mg of Fluoxetine and 2.5 mg of Olanzapine.\nD: Fluoxetine doses above 100 mg/day are recommended.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination of Fluoxetine and Olanzapine has been shown to be effective in reducing depressive symptoms in patients with Bipolar I Disorder, particularly in those experiencing depressive episodes.\n- Clinical studies indicate that this combination can lead to a significant improvement in mood stabilization compared to using Fluoxetine alone or a placebo.\n- The use of Fluoxetine (an SSRI) alongside Olanzapine (an atypical antipsychotic) may help mitigate the risk of manic episodes that can occur with antidepressant monotherapy in bipolar patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"HVPjw5oroZea","- Diclofenac Sodium extended-release formulation may not be bioequivalent to Diclofenac Potassium tablets, despite having the same milligram strength.
- The different salt forms (sodium vs. potassium) can lead to variations in absorption and onset of action, affecting bioequivalence.
- Diclofenac topical formulations, such as gels or patches, are also not bioequivalent to oral Diclofenac Potassium tablets, even if they contain the same active ingredient.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich formulation of Diclofenac is not necessarily bioequivalent to Diclofenac Potassium tablets even if the milligram strength is the same?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Diclofenac Sodium extended-release formulation may not be bioequivalent to Diclofenac Potassium tablets, despite having the same milligram strength.\n- The different salt forms (sodium vs. potassium) can lead to variations in absorption and onset of action, affecting bioequivalence.\n- Diclofenac topical formulations, such as gels or patches, are also not bioequivalent to oral Diclofenac Potassium tablets, even if they contain the same active ingredient.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which formulation of Diclofenac is not necessarily bioequivalent to Diclofenac Potassium tablets even if the milligram strength is the same?\nA: Voltaren (diclofenac sodium enteric-coated tablets)\nB: Voltaren-XR (diclofenac sodium extended-release tablets)\nC: Diclofenac Potassium tablets\nD: Both A and B\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Diclofenac Sodium extended-release formulation may not be bioequivalent to Diclofenac Potassium tablets, despite having the same milligram strength.\n- The different salt forms (sodium vs. potassium) can lead to variations in absorption and onset of action, affecting bioequivalence.\n- Diclofenac topical formulations, such as gels or patches, are also not bioequivalent to oral Diclofenac Potassium tablets, even if they contain the same active ingredient.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which formulation of Diclofenac is not necessarily bioequivalent to Diclofenac Potassium tablets even if the milligram strength is the same?\nA: Voltaren (diclofenac sodium enteric-coated tablets)\nB: Voltaren-XR (diclofenac sodium extended-release tablets)\nC: Diclofenac Potassium tablets\nD: Both A and B\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Diclofenac Sodium extended-release formulation may not be bioequivalent to Diclofenac Potassium tablets, despite having the same milligram strength.\n- The different salt forms (sodium vs. potassium) can lead to variations in absorption and onset of action, affecting bioequivalence.\n- Diclofenac topical formulations, such as gels or patches, are also not bioequivalent to oral Diclofenac Potassium tablets, even if they contain the same active ingredient.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which formulation of Diclofenac is not necessarily bioequivalent to Diclofenac Potassium tablets even if the milligram strength is the same?\nA: Voltaren (diclofenac sodium enteric-coated tablets)\nB: Voltaren-XR (diclofenac sodium extended-release tablets)\nC: Diclofenac Potassium tablets\nD: Both A and B\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Diclofenac Sodium extended-release formulation may not be bioequivalent to Diclofenac Potassium tablets, despite having the same milligram strength.\n- The different salt forms (sodium vs. potassium) can lead to variations in absorption and onset of action, affecting bioequivalence.\n- Diclofenac topical formulations, such as gels or patches, are also not bioequivalent to oral Diclofenac Potassium tablets, even if they contain the same active ingredient.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"4rJLcaEn5YxD","- After 8 weeks of treatment with pantoprazole sodium delayed-release tablets, 80% of patients achieved endoscopically proven healing of esophageal lesions.
- The study specifically evaluated the efficacy of pantoprazole sodium compared to a placebo in patients with esophageal lesions.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat was the percentage of patients with endoscopically proven healing of esophageal lesions after 8 weeks of treatment with pantoprazole sodium delayed-release tablets?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- After 8 weeks of treatment with pantoprazole sodium delayed-release tablets, 80% of patients achieved endoscopically proven healing of esophageal lesions.\n- The study specifically evaluated the efficacy of pantoprazole sodium compared to a placebo in patients with esophageal lesions.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the percentage of patients with endoscopically proven healing of esophageal lesions after 8 weeks of treatment with pantoprazole sodium delayed-release tablets?\nA: 87%\nB: 86%\nC: 80%\nD: 90%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- After 8 weeks of treatment with pantoprazole sodium delayed-release tablets, 80% of patients achieved endoscopically proven healing of esophageal lesions.\n- The study specifically evaluated the efficacy of pantoprazole sodium compared to a placebo in patients with esophageal lesions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the percentage of patients with endoscopically proven healing of esophageal lesions after 8 weeks of treatment with pantoprazole sodium delayed-release tablets?\nA: 87%\nB: 86%\nC: 80%\nD: 90%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- After 8 weeks of treatment with pantoprazole sodium delayed-release tablets, 80% of patients achieved endoscopically proven healing of esophageal lesions.\n- The study specifically evaluated the efficacy of pantoprazole sodium compared to a placebo in patients with esophageal lesions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the percentage of patients with endoscopically proven healing of esophageal lesions after 8 weeks of treatment with pantoprazole sodium delayed-release tablets?\nA: 87%\nB: 86%\nC: 80%\nD: 90%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- After 8 weeks of treatment with pantoprazole sodium delayed-release tablets, 80% of patients achieved endoscopically proven healing of esophageal lesions.\n- The study specifically evaluated the efficacy of pantoprazole sodium compared to a placebo in patients with esophageal lesions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"e18qOdK7SkUj","- Administer growth factors such as filgrastim or pegfilgrastim to stimulate white blood cell production in patients experiencing neutropenia due to myelosuppression from ONUREG.
- Provide erythropoiesis-stimulating agents like epoetin alfa or darbepoetin alfa to manage anemia associated with myelosuppression in patients receiving ONUREG.
- Ensure adequate hydration and consider prophylactic antibiotics to prevent infections in patients with significant myelosuppression while on ONUREG.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat supportive care is recommended for patients experiencing myelosuppression while on ONUREG?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Administer growth factors such as filgrastim or pegfilgrastim to stimulate white blood cell production in patients experiencing neutropenia due to myelosuppression from ONUREG.\n- Provide erythropoiesis-stimulating agents like epoetin alfa or darbepoetin alfa to manage anemia associated with myelosuppression in patients receiving ONUREG.\n- Ensure adequate hydration and consider prophylactic antibiotics to prevent infections in patients with significant myelosuppression while on ONUREG.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What supportive care is recommended for patients experiencing myelosuppression while on ONUREG?\nA: No supportive care is necessary.\nB: Provide hematopoietic growth factors.\nC: Increase the dosage of ONUREG.\nD: Switch to intravenous azacitidine.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer growth factors such as filgrastim or pegfilgrastim to stimulate white blood cell production in patients experiencing neutropenia due to myelosuppression from ONUREG.\n- Provide erythropoiesis-stimulating agents like epoetin alfa or darbepoetin alfa to manage anemia associated with myelosuppression in patients receiving ONUREG.\n- Ensure adequate hydration and consider prophylactic antibiotics to prevent infections in patients with significant myelosuppression while on ONUREG.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What supportive care is recommended for patients experiencing myelosuppression while on ONUREG?\nA: No supportive care is necessary.\nB: Provide hematopoietic growth factors.\nC: Increase the dosage of ONUREG.\nD: Switch to intravenous azacitidine.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer growth factors such as filgrastim or pegfilgrastim to stimulate white blood cell production in patients experiencing neutropenia due to myelosuppression from ONUREG.\n- Provide erythropoiesis-stimulating agents like epoetin alfa or darbepoetin alfa to manage anemia associated with myelosuppression in patients receiving ONUREG.\n- Ensure adequate hydration and consider prophylactic antibiotics to prevent infections in patients with significant myelosuppression while on ONUREG.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What supportive care is recommended for patients experiencing myelosuppression while on ONUREG?\nA: No supportive care is necessary.\nB: Provide hematopoietic growth factors.\nC: Increase the dosage of ONUREG.\nD: Switch to intravenous azacitidine.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer growth factors such as filgrastim or pegfilgrastim to stimulate white blood cell production in patients experiencing neutropenia due to myelosuppression from ONUREG.\n- Provide erythropoiesis-stimulating agents like epoetin alfa or darbepoetin alfa to manage anemia associated with myelosuppression in patients receiving ONUREG.\n- Ensure adequate hydration and consider prophylactic antibiotics to prevent infections in patients with significant myelosuppression while on ONUREG.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"FSWxaELf91Q6","MRRV winner=C; scores={'A': 0.25, 'B': 0.38888888888888884, 'C': 1.0, 'D': 0.4444444444444444}; rankings=[['C', 'D', 'B', 'A'], ['C', 'B', 'D', 'A'], ['C', 'D', 'B', 'A']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients taking Fluoxetine be advised regarding the use of NSAIDs, aspirin, or warfarin?\nA: These medications can be taken without any precautions.\nB: They should be avoided due to the risk of serotonin syndrome.\nC: They may increase the risk of abnormal bleeding and should be used cautiously.\nD: They are contraindicated and should never be taken with Fluoxetine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients taking Fluoxetine be advised regarding the use of NSAIDs, aspirin, or warfarin?\nA: These medications can be taken without any precautions.\nB: They should be avoided due to the risk of serotonin syndrome.\nC: They may increase the risk of abnormal bleeding and should be used cautiously.\nD: They are contraindicated and should never be taken with Fluoxetine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients taking Fluoxetine be advised regarding the use of NSAIDs, aspirin, or warfarin?\nA: These medications can be taken without any precautions.\nB: They should be avoided due to the risk of serotonin syndrome.\nC: They may increase the risk of abnormal bleeding and should be used cautiously.\nD: They are contraindicated and should never be taken with Fluoxetine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}]"
"UQkPMybvDL2A","MRRV winner=C; scores={'A': 0.3333333333333333, 'B': 0.6666666666666666, 'C': 0.8333333333333334, 'D': 0.25}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D'], ['B', 'C', 'A', 'D']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for breastfeeding females considering OCELLA for contraception?\nA: Breastfeeding females should use OCELLA immediately after childbirth.\nB: Breastfeeding females should avoid OCELLA and use other methods of contraception.\nC: Breastfeeding females should use OCELLA only if milk production is well-established.\nD: Breastfeeding females should use OCELLA to enhance milk production.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for breastfeeding females considering OCELLA for contraception?\nA: Breastfeeding females should use OCELLA immediately after childbirth.\nB: Breastfeeding females should avoid OCELLA and use other methods of contraception.\nC: Breastfeeding females should use OCELLA only if milk production is well-established.\nD: Breastfeeding females should use OCELLA to enhance milk production.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for breastfeeding females considering OCELLA for contraception?\nA: Breastfeeding females should use OCELLA immediately after childbirth.\nB: Breastfeeding females should avoid OCELLA and use other methods of contraception.\nC: Breastfeeding females should use OCELLA only if milk production is well-established.\nD: Breastfeeding females should use OCELLA to enhance milk production.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"qVHiu9Op4pAo","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich rare but severe skin condition has been associated with lamotrigine use in both adult and pediatric patients?\nA: Psoriasis\nB: Toxic epidermal necrolysis\nC: Eczema\nD: Rosacea\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich rare but severe skin condition has been associated with lamotrigine use in both adult and pediatric patients?\nA: Psoriasis\nB: Toxic epidermal necrolysis\nC: Eczema\nD: Rosacea\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich rare but severe skin condition has been associated with lamotrigine use in both adult and pediatric patients?\nA: Psoriasis\nB: Toxic epidermal necrolysis\nC: Eczema\nD: Rosacea\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"VKVpZ2uDEA02","MRRV winner=B; scores={'A': 0.5, 'B': 0.7777777777777777, 'C': 0.25, 'D': 0.5555555555555555}; rankings=[['D', 'A', 'B', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT an inactive ingredient in Terbinafine tablets?\nA: Microcrystalline cellulose\nB: Magnesium stearate\nC: Terbinafine hydrochloride USP\nD: Hypromellose\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT an inactive ingredient in Terbinafine tablets?\nA: Microcrystalline cellulose\nB: Magnesium stearate\nC: Terbinafine hydrochloride USP\nD: Hypromellose\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT an inactive ingredient in Terbinafine tablets?\nA: Microcrystalline cellulose\nB: Magnesium stearate\nC: Terbinafine hydrochloride USP\nD: Hypromellose\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"2xd6ghH1mTAY","- The initial treatment with pantoprazole sodium for injection was administered for a duration of 7 days.
- After the 7-day period, patients were switched to oral pantoprazole sodium delayed-release tablets for continued management of acute reflux esophagitis.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn the study of acute reflux esophagitis, what was the duration of initial treatment with pantoprazole sodium for injection before switching to oral pantoprazole sodium delayed-release tablets?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The initial treatment with pantoprazole sodium for injection was administered for a duration of 7 days.\n- After the 7-day period, patients were switched to oral pantoprazole sodium delayed-release tablets for continued management of acute reflux esophagitis.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In the study of acute reflux esophagitis, what was the duration of initial treatment with pantoprazole sodium for injection before switching to oral pantoprazole sodium delayed-release tablets?\nA: 3 days\nB: 5 days\nC: 7 days\nD: 10 days\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The initial treatment with pantoprazole sodium for injection was administered for a duration of 7 days.\n- After the 7-day period, patients were switched to oral pantoprazole sodium delayed-release tablets for continued management of acute reflux esophagitis.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In the study of acute reflux esophagitis, what was the duration of initial treatment with pantoprazole sodium for injection before switching to oral pantoprazole sodium delayed-release tablets?\nA: 3 days\nB: 5 days\nC: 7 days\nD: 10 days\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The initial treatment with pantoprazole sodium for injection was administered for a duration of 7 days.\n- After the 7-day period, patients were switched to oral pantoprazole sodium delayed-release tablets for continued management of acute reflux esophagitis.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In the study of acute reflux esophagitis, what was the duration of initial treatment with pantoprazole sodium for injection before switching to oral pantoprazole sodium delayed-release tablets?\nA: 3 days\nB: 5 days\nC: 7 days\nD: 10 days\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The initial treatment with pantoprazole sodium for injection was administered for a duration of 7 days.\n- After the 7-day period, patients were switched to oral pantoprazole sodium delayed-release tablets for continued management of acute reflux esophagitis.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"YMuj1nu2uIaL","- Fosaprepitant for injection can cause serious infusion site reactions, including severe pain or swelling at the injection site.
- Patients may experience tissue necrosis or phlebitis as a serious side effect associated with the administration of fosaprepitant.
- Localized allergic reactions, such as rash or urticaria, can also occur at or near the infusion site when receiving fosaprepitant.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat serious side effect can occur at or near the infusion site when receiving fosaprepitant for injection?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Fosaprepitant for injection can cause serious infusion site reactions, including severe pain or swelling at the injection site.\n- Patients may experience tissue necrosis or phlebitis as a serious side effect associated with the administration of fosaprepitant.\n- Localized allergic reactions, such as rash or urticaria, can also occur at or near the infusion site when receiving fosaprepitant.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What serious side effect can occur at or near the infusion site when receiving fosaprepitant for injection?\nA: Severe allergic reactions.\nB: Infusion site reactions, including pain, swelling, and necrosis.\nC: Low platelet count.\nD: Skin rash and peeling.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Fosaprepitant for injection can cause serious infusion site reactions, including severe pain or swelling at the injection site.\n- Patients may experience tissue necrosis or phlebitis as a serious side effect associated with the administration of fosaprepitant.\n- Localized allergic reactions, such as rash or urticaria, can also occur at or near the infusion site when receiving fosaprepitant.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What serious side effect can occur at or near the infusion site when receiving fosaprepitant for injection?\nA: Severe allergic reactions.\nB: Infusion site reactions, including pain, swelling, and necrosis.\nC: Low platelet count.\nD: Skin rash and peeling.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Fosaprepitant for injection can cause serious infusion site reactions, including severe pain or swelling at the injection site.\n- Patients may experience tissue necrosis or phlebitis as a serious side effect associated with the administration of fosaprepitant.\n- Localized allergic reactions, such as rash or urticaria, can also occur at or near the infusion site when receiving fosaprepitant.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What serious side effect can occur at or near the infusion site when receiving fosaprepitant for injection?\nA: Severe allergic reactions.\nB: Infusion site reactions, including pain, swelling, and necrosis.\nC: Low platelet count.\nD: Skin rash and peeling.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Fosaprepitant for injection can cause serious infusion site reactions, including severe pain or swelling at the injection site.\n- Patients may experience tissue necrosis or phlebitis as a serious side effect associated with the administration of fosaprepitant.\n- Localized allergic reactions, such as rash or urticaria, can also occur at or near the infusion site when receiving fosaprepitant.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"1ceD666xombl","MRRV winner=A; scores={'A': 0.611111111111111, 'B': 0.5277777777777778, 'C': 0.5, 'D': 0.4444444444444444}; rankings=[['C', 'A', 'D', 'B'], ['B', 'D', 'A', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the highest dietary dose of albuterol sulfate tested in CD-1 mice that showed no evidence of tumorigenicity?\nA: 50 mg/kg\nB: 500 mg/kg\nC: 2 mg/kg\nD: 100 mg/kg\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the highest dietary dose of albuterol sulfate tested in CD-1 mice that showed no evidence of tumorigenicity?\nA: 50 mg/kg\nB: 500 mg/kg\nC: 2 mg/kg\nD: 100 mg/kg\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the highest dietary dose of albuterol sulfate tested in CD-1 mice that showed no evidence of tumorigenicity?\nA: 50 mg/kg\nB: 500 mg/kg\nC: 2 mg/kg\nD: 100 mg/kg\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"QVqzYhqMqsKc","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is true regarding the contraindications of the drug Agrylin?\nA: Agrylin has specific contraindications listed for certain conditions.\nB: Agrylin has no contraindications mentioned.\nC: Agrylin is contraindicated for use in pediatric patients.\nD: Agrylin is contraindicated for patients with renal impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is true regarding the contraindications of the drug Agrylin?\nA: Agrylin has specific contraindications listed for certain conditions.\nB: Agrylin has no contraindications mentioned.\nC: Agrylin is contraindicated for use in pediatric patients.\nD: Agrylin is contraindicated for patients with renal impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is true regarding the contraindications of the drug Agrylin?\nA: Agrylin has specific contraindications listed for certain conditions.\nB: Agrylin has no contraindications mentioned.\nC: Agrylin is contraindicated for use in pediatric patients.\nD: Agrylin is contraindicated for patients with renal impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"HKBYGpZop2sa","- Assess the patient's cardiovascular status, as Agrylin (anagrelide) can cause dose-dependent cardiotoxicity, particularly in those with pre-existing heart conditions.
- Monitor for signs of pulmonary hypertension, as Agrylin may exacerbate respiratory issues in patients with underlying lung disease.
- Evaluate the patient's overall health and consider alternative treatments if significant cardiopulmonary issues are present, to minimize the risk of adverse effects.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat precaution should be taken before initiating Agrylin therapy in patients with underlying cardiopulmonary disease?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Assess the patient's cardiovascular status, as Agrylin (anagrelide) can cause dose-dependent cardiotoxicity, particularly in those with pre-existing heart conditions.\n- Monitor for signs of pulmonary hypertension, as Agrylin may exacerbate respiratory issues in patients with underlying lung disease.\n- Evaluate the patient's overall health and consider alternative treatments if significant cardiopulmonary issues are present, to minimize the risk of adverse effects.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken before initiating Agrylin therapy in patients with underlying cardiopulmonary disease?\nA: Perform a pulmonary function test\nB: Evaluate for signs and symptoms of pulmonary hypertension\nC: Administer a loading dose of Agrylin\nD: Prescribe a diuretic\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Assess the patient's cardiovascular status, as Agrylin (anagrelide) can cause dose-dependent cardiotoxicity, particularly in those with pre-existing heart conditions.\n- Monitor for signs of pulmonary hypertension, as Agrylin may exacerbate respiratory issues in patients with underlying lung disease.\n- Evaluate the patient's overall health and consider alternative treatments if significant cardiopulmonary issues are present, to minimize the risk of adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken before initiating Agrylin therapy in patients with underlying cardiopulmonary disease?\nA: Perform a pulmonary function test\nB: Evaluate for signs and symptoms of pulmonary hypertension\nC: Administer a loading dose of Agrylin\nD: Prescribe a diuretic\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Assess the patient's cardiovascular status, as Agrylin (anagrelide) can cause dose-dependent cardiotoxicity, particularly in those with pre-existing heart conditions.\n- Monitor for signs of pulmonary hypertension, as Agrylin may exacerbate respiratory issues in patients with underlying lung disease.\n- Evaluate the patient's overall health and consider alternative treatments if significant cardiopulmonary issues are present, to minimize the risk of adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken before initiating Agrylin therapy in patients with underlying cardiopulmonary disease?\nA: Perform a pulmonary function test\nB: Evaluate for signs and symptoms of pulmonary hypertension\nC: Administer a loading dose of Agrylin\nD: Prescribe a diuretic\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Assess the patient's cardiovascular status, as Agrylin (anagrelide) can cause dose-dependent cardiotoxicity, particularly in those with pre-existing heart conditions.\n- Monitor for signs of pulmonary hypertension, as Agrylin may exacerbate respiratory issues in patients with underlying lung disease.\n- Evaluate the patient's overall health and consider alternative treatments if significant cardiopulmonary issues are present, to minimize the risk of adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"FNbYBoljUX01","- BRILINTA (ticagrelor) is not recommended for patients with end-stage renal disease (ESRD) on dialysis due to limited data on its safety and efficacy in this population.
- In patients with ESRD, alternative antiplatelet therapies, such as clopidogrel, may be considered instead of BRILINTA.
- Close monitoring and individualized treatment plans are essential for patients with ESRD who require antiplatelet therapy.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommendation for BRILINTA use in patients with end-stage renal disease (ESRD) on dialysis?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- BRILINTA (ticagrelor) is not recommended for patients with end-stage renal disease (ESRD) on dialysis due to limited data on its safety and efficacy in this population.\n- In patients with ESRD, alternative antiplatelet therapies, such as clopidogrel, may be considered instead of BRILINTA.\n- Close monitoring and individualized treatment plans are essential for patients with ESRD who require antiplatelet therapy.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for BRILINTA use in patients with end-stage renal disease (ESRD) on dialysis?\nA: BRILINTA is contraindicated.\nB: BRILINTA is recommended with dosage adjustment.\nC: BRILINTA can be used, but efficacy and safety are not established.\nD: BRILINTA is safe for use without dosage adjustment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- BRILINTA (ticagrelor) is not recommended for patients with end-stage renal disease (ESRD) on dialysis due to limited data on its safety and efficacy in this population.\n- In patients with ESRD, alternative antiplatelet therapies, such as clopidogrel, may be considered instead of BRILINTA.\n- Close monitoring and individualized treatment plans are essential for patients with ESRD who require antiplatelet therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for BRILINTA use in patients with end-stage renal disease (ESRD) on dialysis?\nA: BRILINTA is contraindicated.\nB: BRILINTA is recommended with dosage adjustment.\nC: BRILINTA can be used, but efficacy and safety are not established.\nD: BRILINTA is safe for use without dosage adjustment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- BRILINTA (ticagrelor) is not recommended for patients with end-stage renal disease (ESRD) on dialysis due to limited data on its safety and efficacy in this population.\n- In patients with ESRD, alternative antiplatelet therapies, such as clopidogrel, may be considered instead of BRILINTA.\n- Close monitoring and individualized treatment plans are essential for patients with ESRD who require antiplatelet therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for BRILINTA use in patients with end-stage renal disease (ESRD) on dialysis?\nA: BRILINTA is contraindicated.\nB: BRILINTA is recommended with dosage adjustment.\nC: BRILINTA can be used, but efficacy and safety are not established.\nD: BRILINTA is safe for use without dosage adjustment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- BRILINTA (ticagrelor) is not recommended for patients with end-stage renal disease (ESRD) on dialysis due to limited data on its safety and efficacy in this population.\n- In patients with ESRD, alternative antiplatelet therapies, such as clopidogrel, may be considered instead of BRILINTA.\n- Close monitoring and individualized treatment plans are essential for patients with ESRD who require antiplatelet therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"SJ9129Y7ivdr","- Antifungal medications like fluconazole and terbinafine are indicated for treating dermatophyte infections such as tinea corporis (ringworm) and tinea pedis (athlete's foot).
- Clotrimazole and miconazole, both antifungal agents, are effective in treating candidiasis, including cutaneous candidiasis and intertrigo.
- Ketoconazole is used for seborrheic dermatitis and tinea versicolor, conditions caused by fungal overgrowth on the skin.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nThe drug 'antifungal' is indicated for which of the following dermatological conditions?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Antifungal medications like fluconazole and terbinafine are indicated for treating dermatophyte infections such as tinea corporis (ringworm) and tinea pedis (athlete's foot).\n- Clotrimazole and miconazole, both antifungal agents, are effective in treating candidiasis, including cutaneous candidiasis and intertrigo.\n- Ketoconazole is used for seborrheic dermatitis and tinea versicolor, conditions caused by fungal overgrowth on the skin.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: The drug 'antifungal' is indicated for which of the following dermatological conditions?\nA: Athlete's foot\nB: Acne\nC: Rosacea\nD: Seborrheic dermatitis\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Antifungal medications like fluconazole and terbinafine are indicated for treating dermatophyte infections such as tinea corporis (ringworm) and tinea pedis (athlete's foot).\n- Clotrimazole and miconazole, both antifungal agents, are effective in treating candidiasis, including cutaneous candidiasis and intertrigo.\n- Ketoconazole is used for seborrheic dermatitis and tinea versicolor, conditions caused by fungal overgrowth on the skin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: The drug 'antifungal' is indicated for which of the following dermatological conditions?\nA: Athlete's foot\nB: Acne\nC: Rosacea\nD: Seborrheic dermatitis\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Antifungal medications like fluconazole and terbinafine are indicated for treating dermatophyte infections such as tinea corporis (ringworm) and tinea pedis (athlete's foot).\n- Clotrimazole and miconazole, both antifungal agents, are effective in treating candidiasis, including cutaneous candidiasis and intertrigo.\n- Ketoconazole is used for seborrheic dermatitis and tinea versicolor, conditions caused by fungal overgrowth on the skin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: The drug 'antifungal' is indicated for which of the following dermatological conditions?\nA: Athlete's foot\nB: Acne\nC: Rosacea\nD: Seborrheic dermatitis\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Antifungal medications like fluconazole and terbinafine are indicated for treating dermatophyte infections such as tinea corporis (ringworm) and tinea pedis (athlete's foot).\n- Clotrimazole and miconazole, both antifungal agents, are effective in treating candidiasis, including cutaneous candidiasis and intertrigo.\n- Ketoconazole is used for seborrheic dermatitis and tinea versicolor, conditions caused by fungal overgrowth on the skin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"yr7PAKbIjJYG","- Patients with a history of hypersensitivity to Levalbuterol should avoid using Levalbuterol itself to prevent potential allergic reactions.
- It is important to consider alternative bronchodilators that do not contain Levalbuterol, such as Albuterol, while monitoring for any signs of hypersensitivity.
- Prior to prescribing any medication, a thorough assessment of the patient's allergy history should be conducted to ensure safety and efficacy.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat precaution should be taken for patients with a history of hypersensitivity to Levalbuterol?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients with a history of hypersensitivity to Levalbuterol should avoid using Levalbuterol itself to prevent potential allergic reactions.\n- It is important to consider alternative bronchodilators that do not contain Levalbuterol, such as Albuterol, while monitoring for any signs of hypersensitivity.\n- Prior to prescribing any medication, a thorough assessment of the patient's allergy history should be conducted to ensure safety and efficacy.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken for patients with a history of hypersensitivity to Levalbuterol?\nA: Avoid prescribing Levalbuterol\nB: Administer a reduced dose of Levalbuterol\nC: Monitor blood pressure during treatment\nD: Combine Levalbuterol with antihistamines\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of hypersensitivity to Levalbuterol should avoid using Levalbuterol itself to prevent potential allergic reactions.\n- It is important to consider alternative bronchodilators that do not contain Levalbuterol, such as Albuterol, while monitoring for any signs of hypersensitivity.\n- Prior to prescribing any medication, a thorough assessment of the patient's allergy history should be conducted to ensure safety and efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken for patients with a history of hypersensitivity to Levalbuterol?\nA: Avoid prescribing Levalbuterol\nB: Administer a reduced dose of Levalbuterol\nC: Monitor blood pressure during treatment\nD: Combine Levalbuterol with antihistamines\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of hypersensitivity to Levalbuterol should avoid using Levalbuterol itself to prevent potential allergic reactions.\n- It is important to consider alternative bronchodilators that do not contain Levalbuterol, such as Albuterol, while monitoring for any signs of hypersensitivity.\n- Prior to prescribing any medication, a thorough assessment of the patient's allergy history should be conducted to ensure safety and efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken for patients with a history of hypersensitivity to Levalbuterol?\nA: Avoid prescribing Levalbuterol\nB: Administer a reduced dose of Levalbuterol\nC: Monitor blood pressure during treatment\nD: Combine Levalbuterol with antihistamines\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with a history of hypersensitivity to Levalbuterol should avoid using Levalbuterol itself to prevent potential allergic reactions.\n- It is important to consider alternative bronchodilators that do not contain Levalbuterol, such as Albuterol, while monitoring for any signs of hypersensitivity.\n- Prior to prescribing any medication, a thorough assessment of the patient's allergy history should be conducted to ensure safety and efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"WeRy9MPlu5Mh","MRRV winner=D; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 0.5, 'D': 1.0}; rankings=[['D', 'C', 'B', 'A'], ['D', 'C', 'B', 'A'], ['D', 'C', 'B', 'A']]","D","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat percentage of lamotrigine in the body was removed during a 4-hour hemodialysis session in renal failure patients?\nA: 10%\nB: 20%\nC: 30%\nD: 40%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat percentage of lamotrigine in the body was removed during a 4-hour hemodialysis session in renal failure patients?\nA: 10%\nB: 20%\nC: 30%\nD: 40%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat percentage of lamotrigine in the body was removed during a 4-hour hemodialysis session in renal failure patients?\nA: 10%\nB: 20%\nC: 30%\nD: 40%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}]"
"Feg0bIyGPpHY","- Fertility studies were not specifically conducted with ARIKAYCE (amikacin liposome inhalation suspension) in humans, as the available data primarily focus on its efficacy and safety in treating pulmonary infections.
- Animal studies indicated that ARIKAYCE did not adversely affect fertility in rats, but these findings may not directly translate to human fertility outcomes.
- The clinical trials for ARIKAYCE did not include specific assessments of fertility as a primary endpoint, focusing instead on its therapeutic effects in patients with cystic fibrosis or other lung conditions.

MRRV(meta) winner=B; scores={'A': 0.4444444444444444, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.3611111111111111}; rankings=[['B', 'A', 'D', 'C'], ['B', 'D', 'A', 'C'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWere fertility studies conducted specifically with ARIKAYCE?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Fertility studies were not specifically conducted with ARIKAYCE (amikacin liposome inhalation suspension) in humans, as the available data primarily focus on its efficacy and safety in treating pulmonary infections.\n- Animal studies indicated that ARIKAYCE did not adversely affect fertility in rats, but these findings may not directly translate to human fertility outcomes.\n- The clinical trials for ARIKAYCE did not include specific assessments of fertility as a primary endpoint, focusing instead on its therapeutic effects in patients with cystic fibrosis or other lung conditions.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Were fertility studies conducted specifically with ARIKAYCE?\nA: Yes, extensive fertility studies were conducted.\nB: No, fertility studies were not conducted with ARIKAYCE.\nC: Yes, but only in humans.\nD: Yes, but only in mice.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Fertility studies were not specifically conducted with ARIKAYCE (amikacin liposome inhalation suspension) in humans, as the available data primarily focus on its efficacy and safety in treating pulmonary infections.\n- Animal studies indicated that ARIKAYCE did not adversely affect fertility in rats, but these findings may not directly translate to human fertility outcomes.\n- The clinical trials for ARIKAYCE did not include specific assessments of fertility as a primary endpoint, focusing instead on its therapeutic effects in patients with cystic fibrosis or other lung conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Were fertility studies conducted specifically with ARIKAYCE?\nA: Yes, extensive fertility studies were conducted.\nB: No, fertility studies were not conducted with ARIKAYCE.\nC: Yes, but only in humans.\nD: Yes, but only in mice.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Fertility studies were not specifically conducted with ARIKAYCE (amikacin liposome inhalation suspension) in humans, as the available data primarily focus on its efficacy and safety in treating pulmonary infections.\n- Animal studies indicated that ARIKAYCE did not adversely affect fertility in rats, but these findings may not directly translate to human fertility outcomes.\n- The clinical trials for ARIKAYCE did not include specific assessments of fertility as a primary endpoint, focusing instead on its therapeutic effects in patients with cystic fibrosis or other lung conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Were fertility studies conducted specifically with ARIKAYCE?\nA: Yes, extensive fertility studies were conducted.\nB: No, fertility studies were not conducted with ARIKAYCE.\nC: Yes, but only in humans.\nD: Yes, but only in mice.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Fertility studies were not specifically conducted with ARIKAYCE (amikacin liposome inhalation suspension) in humans, as the available data primarily focus on its efficacy and safety in treating pulmonary infections.\n- Animal studies indicated that ARIKAYCE did not adversely affect fertility in rats, but these findings may not directly translate to human fertility outcomes.\n- The clinical trials for ARIKAYCE did not include specific assessments of fertility as a primary endpoint, focusing instead on its therapeutic effects in patients with cystic fibrosis or other lung conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"nV3QRM0ZYe8h","- Guanfacine extended-release is contraindicated in patients with a known hypersensitivity to guanfacine or any of its components.
- It should not be prescribed to patients with severe cardiovascular disorders, such as bradycardia or hypotension, due to its potential to lower blood pressure.
- Patients with a history of significant hepatic impairment should avoid guanfacine extended-release, as it may exacerbate liver function issues.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich patient condition is a contraindication for prescribing Guanfacine extended-release?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Guanfacine extended-release is contraindicated in patients with a known hypersensitivity to guanfacine or any of its components.\n- It should not be prescribed to patients with severe cardiovascular disorders, such as bradycardia or hypotension, due to its potential to lower blood pressure.\n- Patients with a history of significant hepatic impairment should avoid guanfacine extended-release, as it may exacerbate liver function issues.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient condition is a contraindication for prescribing Guanfacine extended-release?\nA: History of hypersensitivity to Guanfacine extended-release or its inactive ingredients\nB: History of hypertension\nC: History of diabetes\nD: History of cardiovascular disease\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Guanfacine extended-release is contraindicated in patients with a known hypersensitivity to guanfacine or any of its components.\n- It should not be prescribed to patients with severe cardiovascular disorders, such as bradycardia or hypotension, due to its potential to lower blood pressure.\n- Patients with a history of significant hepatic impairment should avoid guanfacine extended-release, as it may exacerbate liver function issues.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient condition is a contraindication for prescribing Guanfacine extended-release?\nA: History of hypersensitivity to Guanfacine extended-release or its inactive ingredients\nB: History of hypertension\nC: History of diabetes\nD: History of cardiovascular disease\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Guanfacine extended-release is contraindicated in patients with a known hypersensitivity to guanfacine or any of its components.\n- It should not be prescribed to patients with severe cardiovascular disorders, such as bradycardia or hypotension, due to its potential to lower blood pressure.\n- Patients with a history of significant hepatic impairment should avoid guanfacine extended-release, as it may exacerbate liver function issues.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient condition is a contraindication for prescribing Guanfacine extended-release?\nA: History of hypersensitivity to Guanfacine extended-release or its inactive ingredients\nB: History of hypertension\nC: History of diabetes\nD: History of cardiovascular disease\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Guanfacine extended-release is contraindicated in patients with a known hypersensitivity to guanfacine or any of its components.\n- It should not be prescribed to patients with severe cardiovascular disorders, such as bradycardia or hypotension, due to its potential to lower blood pressure.\n- Patients with a history of significant hepatic impairment should avoid guanfacine extended-release, as it may exacerbate liver function issues.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"huVta5thMi4w","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich condition is a contraindication for prescribing venlafaxine?\nA: Hypersensitivity to venlafaxine hydrochloride\nB: Mild depression\nC: Hypertension\nD: Diabetes\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich condition is a contraindication for prescribing venlafaxine?\nA: Hypersensitivity to venlafaxine hydrochloride\nB: Mild depression\nC: Hypertension\nD: Diabetes\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich condition is a contraindication for prescribing venlafaxine?\nA: Hypersensitivity to venlafaxine hydrochloride\nB: Mild depression\nC: Hypertension\nD: Diabetes\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"gnbOJjObrj3g","- Patients with hepatic impairment should be closely monitored when considering Zynteglo treatment, as the drug's metabolism may be affected by liver function.
- It is recommended to assess liver function tests prior to initiating Zynteglo therapy to ensure safety and appropriate dosing.
- Zynteglo may require dose adjustments or additional precautions in patients with moderate to severe hepatic impairment to mitigate potential risks.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommendation for patients with hepatic impairment being considered for Zynteglo treatment?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients with hepatic impairment should be closely monitored when considering Zynteglo treatment, as the drug's metabolism may be affected by liver function.\n- It is recommended to assess liver function tests prior to initiating Zynteglo therapy to ensure safety and appropriate dosing.\n- Zynteglo may require dose adjustments or additional precautions in patients with moderate to severe hepatic impairment to mitigate potential risks.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for patients with hepatic impairment being considered for Zynteglo treatment?\nA: Hepatic function should be assessed to ensure hematopoietic stem cell transplantation is appropriate.\nB: Zynteglo is contraindicated in patients with hepatic impairment.\nC: Zynteglo can be administered without additional assessment.\nD: Patients with hepatic impairment should receive a reduced dose of Zynteglo.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with hepatic impairment should be closely monitored when considering Zynteglo treatment, as the drug's metabolism may be affected by liver function.\n- It is recommended to assess liver function tests prior to initiating Zynteglo therapy to ensure safety and appropriate dosing.\n- Zynteglo may require dose adjustments or additional precautions in patients with moderate to severe hepatic impairment to mitigate potential risks.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for patients with hepatic impairment being considered for Zynteglo treatment?\nA: Hepatic function should be assessed to ensure hematopoietic stem cell transplantation is appropriate.\nB: Zynteglo is contraindicated in patients with hepatic impairment.\nC: Zynteglo can be administered without additional assessment.\nD: Patients with hepatic impairment should receive a reduced dose of Zynteglo.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with hepatic impairment should be closely monitored when considering Zynteglo treatment, as the drug's metabolism may be affected by liver function.\n- It is recommended to assess liver function tests prior to initiating Zynteglo therapy to ensure safety and appropriate dosing.\n- Zynteglo may require dose adjustments or additional precautions in patients with moderate to severe hepatic impairment to mitigate potential risks.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for patients with hepatic impairment being considered for Zynteglo treatment?\nA: Hepatic function should be assessed to ensure hematopoietic stem cell transplantation is appropriate.\nB: Zynteglo is contraindicated in patients with hepatic impairment.\nC: Zynteglo can be administered without additional assessment.\nD: Patients with hepatic impairment should receive a reduced dose of Zynteglo.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with hepatic impairment should be closely monitored when considering Zynteglo treatment, as the drug's metabolism may be affected by liver function.\n- It is recommended to assess liver function tests prior to initiating Zynteglo therapy to ensure safety and appropriate dosing.\n- Zynteglo may require dose adjustments or additional precautions in patients with moderate to severe hepatic impairment to mitigate potential risks.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"JiUdmQEBcGrh","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is commonly associated with major depressive disorder and is treated with venlafaxine?\nA: Increased appetite\nB: Decreased sexual drive\nC: Improved concentration\nD: Euphoria\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is commonly associated with major depressive disorder and is treated with venlafaxine?\nA: Increased appetite\nB: Decreased sexual drive\nC: Improved concentration\nD: Euphoria\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is commonly associated with major depressive disorder and is treated with venlafaxine?\nA: Increased appetite\nB: Decreased sexual drive\nC: Improved concentration\nD: Euphoria\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"lNBiJBnp366x","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they experience symptoms such as nausea, vomiting, and abdominal pain while taking SEGLUROMET?\nA: Continue taking the medication and monitor symptoms\nB: Stop taking SEGLUROMET and call their healthcare provider immediately\nC: Take an over-the-counter pain reliever\nD: Increase fluid intake and rest\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they experience symptoms such as nausea, vomiting, and abdominal pain while taking SEGLUROMET?\nA: Continue taking the medication and monitor symptoms\nB: Stop taking SEGLUROMET and call their healthcare provider immediately\nC: Take an over-the-counter pain reliever\nD: Increase fluid intake and rest\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they experience symptoms such as nausea, vomiting, and abdominal pain while taking SEGLUROMET?\nA: Continue taking the medication and monitor symptoms\nB: Stop taking SEGLUROMET and call their healthcare provider immediately\nC: Take an over-the-counter pain reliever\nD: Increase fluid intake and rest\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"ytkuOzZml5SA","- Motion Sickness is commonly used to treat dizziness associated with motion sickness, particularly in patients experiencing symptoms during travel or other forms of movement.
- The active ingredient in Motion Sickness medications, such as dimenhydrinate or meclizine, helps alleviate nausea and dizziness by blocking signals to the brain that trigger these symptoms.
- These medications are often administered in a regimen prior to travel to prevent the onset of dizziness and nausea associated with motion.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn what context is the drug Motion Sickness used for dizziness?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Motion Sickness is commonly used to treat dizziness associated with motion sickness, particularly in patients experiencing symptoms during travel or other forms of movement.\n- The active ingredient in Motion Sickness medications, such as dimenhydrinate or meclizine, helps alleviate nausea and dizziness by blocking signals to the brain that trigger these symptoms.\n- These medications are often administered in a regimen prior to travel to prevent the onset of dizziness and nausea associated with motion.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In what context is the drug Motion Sickness used for dizziness?\nA: Dizziness caused by motion sickness\nB: Dizziness due to dehydration\nC: Dizziness caused by low blood pressure\nD: Dizziness associated with inner ear infections\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Motion Sickness is commonly used to treat dizziness associated with motion sickness, particularly in patients experiencing symptoms during travel or other forms of movement.\n- The active ingredient in Motion Sickness medications, such as dimenhydrinate or meclizine, helps alleviate nausea and dizziness by blocking signals to the brain that trigger these symptoms.\n- These medications are often administered in a regimen prior to travel to prevent the onset of dizziness and nausea associated with motion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In what context is the drug Motion Sickness used for dizziness?\nA: Dizziness caused by motion sickness\nB: Dizziness due to dehydration\nC: Dizziness caused by low blood pressure\nD: Dizziness associated with inner ear infections\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Motion Sickness is commonly used to treat dizziness associated with motion sickness, particularly in patients experiencing symptoms during travel or other forms of movement.\n- The active ingredient in Motion Sickness medications, such as dimenhydrinate or meclizine, helps alleviate nausea and dizziness by blocking signals to the brain that trigger these symptoms.\n- These medications are often administered in a regimen prior to travel to prevent the onset of dizziness and nausea associated with motion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In what context is the drug Motion Sickness used for dizziness?\nA: Dizziness caused by motion sickness\nB: Dizziness due to dehydration\nC: Dizziness caused by low blood pressure\nD: Dizziness associated with inner ear infections\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Motion Sickness is commonly used to treat dizziness associated with motion sickness, particularly in patients experiencing symptoms during travel or other forms of movement.\n- The active ingredient in Motion Sickness medications, such as dimenhydrinate or meclizine, helps alleviate nausea and dizziness by blocking signals to the brain that trigger these symptoms.\n- These medications are often administered in a regimen prior to travel to prevent the onset of dizziness and nausea associated with motion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"oMZKWCmTG8x4","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.4444444444444444, 'D': 0.38888888888888884}; rankings=[['A', 'C', 'D', 'B'], ['A', 'D', 'C', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the brand name of the product that is associated with Complexion Protection Moisturizer SPF?\nA: Complexion Protection Moisturizer SPF\nB: Generic Moisturizer SPF\nC: Skin Shield SPF\nD: Daily Sun Protection Cream\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the brand name of the product that is associated with Complexion Protection Moisturizer SPF?\nA: Complexion Protection Moisturizer SPF\nB: Generic Moisturizer SPF\nC: Skin Shield SPF\nD: Daily Sun Protection Cream\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the brand name of the product that is associated with Complexion Protection Moisturizer SPF?\nA: Complexion Protection Moisturizer SPF\nB: Generic Moisturizer SPF\nC: Skin Shield SPF\nD: Daily Sun Protection Cream\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"RsT4yEVvPchh","- The drug brand name relevant for the indication is Lipitor, which is used for lowering cholesterol levels.
- Another relevant drug brand name is Lantus, indicated for managing blood sugar levels in diabetes patients.
- For treating hypertension, the brand name relevant is Norvasc, which helps in relaxing blood vessels.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nFor the indication 'INDICATION', which drug brand name is relevant?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The drug brand name relevant for the indication is Lipitor, which is used for lowering cholesterol levels.\n- Another relevant drug brand name is Lantus, indicated for managing blood sugar levels in diabetes patients.\n- For treating hypertension, the brand name relevant is Norvasc, which helps in relaxing blood vessels.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: For the indication 'INDICATION', which drug brand name is relevant?\nA: Arnica gel\nB: Voltaren gel\nC: Neosporin\nD: Benadryl cream\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug brand name relevant for the indication is Lipitor, which is used for lowering cholesterol levels.\n- Another relevant drug brand name is Lantus, indicated for managing blood sugar levels in diabetes patients.\n- For treating hypertension, the brand name relevant is Norvasc, which helps in relaxing blood vessels.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > None > None > None""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: For the indication 'INDICATION', which drug brand name is relevant?\nA: Arnica gel\nB: Voltaren gel\nC: Neosporin\nD: Benadryl cream\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug brand name relevant for the indication is Lipitor, which is used for lowering cholesterol levels.\n- Another relevant drug brand name is Lantus, indicated for managing blood sugar levels in diabetes patients.\n- For treating hypertension, the brand name relevant is Norvasc, which helps in relaxing blood vessels.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > None > None > None""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: For the indication 'INDICATION', which drug brand name is relevant?\nA: Arnica gel\nB: Voltaren gel\nC: Neosporin\nD: Benadryl cream\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug brand name relevant for the indication is Lipitor, which is used for lowering cholesterol levels.\n- Another relevant drug brand name is Lantus, indicated for managing blood sugar levels in diabetes patients.\n- For treating hypertension, the brand name relevant is Norvasc, which helps in relaxing blood vessels.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > None > None > None""}]"
"uIP3X4zoD8Qu","- The maximum number of nicotine lozenges that can be used in a single day is 24 lozenges.
- This dosage is typically recommended for individuals using the nicotine lozenge as part of a smoking cessation program.
- It is important to follow the guidelines provided with the specific nicotine lozenge product to avoid potential side effects.

MRRV(meta) winner=C; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the maximum number of nicotine lozenges that can be used in a single day?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The maximum number of nicotine lozenges that can be used in a single day is 24 lozenges.\n- This dosage is typically recommended for individuals using the nicotine lozenge as part of a smoking cessation program.\n- It is important to follow the guidelines provided with the specific nicotine lozenge product to avoid potential side effects.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the maximum number of nicotine lozenges that can be used in a single day?\nA: 10 lozenges\nB: 15 lozenges\nC: 20 lozenges\nD: 25 lozenges\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum number of nicotine lozenges that can be used in a single day is 24 lozenges.\n- This dosage is typically recommended for individuals using the nicotine lozenge as part of a smoking cessation program.\n- It is important to follow the guidelines provided with the specific nicotine lozenge product to avoid potential side effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the maximum number of nicotine lozenges that can be used in a single day?\nA: 10 lozenges\nB: 15 lozenges\nC: 20 lozenges\nD: 25 lozenges\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum number of nicotine lozenges that can be used in a single day is 24 lozenges.\n- This dosage is typically recommended for individuals using the nicotine lozenge as part of a smoking cessation program.\n- It is important to follow the guidelines provided with the specific nicotine lozenge product to avoid potential side effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the maximum number of nicotine lozenges that can be used in a single day?\nA: 10 lozenges\nB: 15 lozenges\nC: 20 lozenges\nD: 25 lozenges\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum number of nicotine lozenges that can be used in a single day is 24 lozenges.\n- This dosage is typically recommended for individuals using the nicotine lozenge as part of a smoking cessation program.\n- It is important to follow the guidelines provided with the specific nicotine lozenge product to avoid potential side effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}]"
"zUgtVdyrAWqD","1) Recommendation: If a hypersensitivity reaction occurs during TAKHZYRO treatment, the healthcare provider should immediately discontinue the medication and initiate appropriate management, which may include administering antihistamines, corticosteroids, or epinephrine depending on the severity of the reaction.

2) Key rationale:
- Hypersensitivity reactions can range from mild to severe, including anaphylaxis, which poses a significant risk to patient safety.
- Prompt recognition and management of hypersensitivity reactions are crucial to prevent complications and ensure patient well-being.
- Discontinuation of the medication is essential to avoid further exposure to the allergen and worsening of the reaction.

3) Safety/contraindications/interactions:
- Monitor for signs of anaphylaxis, such as difficulty breathing, swelling of the face or throat, and rapid heartbeat.
- Patients with a known history of hypersensitivity to TAKHZYRO or its components should not receive the medication.
- Consider potential interactions with other medications that may exacerbate allergic reactions or affect the immune response.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nIf a hypersensitivity reaction occurs during TAKHZYRO treatment, what is the primary concern for the healthcare provider?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: If a hypersensitivity reaction occurs during TAKHZYRO treatment, the healthcare provider should immediately discontinue the medication and initiate appropriate management, which may include administering antihistamines, corticosteroids, or epinephrine depending on the severity of the reaction.\n\n2) Key rationale:\n- Hypersensitivity reactions can range from mild to severe, including anaphylaxis, which poses a significant risk to patient safety.\n- Prompt recognition and management of hypersensitivity reactions are crucial to prevent complications and ensure patient well-being.\n- Discontinuation of the medication is essential to avoid further exposure to the allergen and worsening of the reaction.\n\n3) Safety/contraindications/interactions:\n- Monitor for signs of anaphylaxis, such as difficulty breathing, swelling of the face or throat, and rapid heartbeat.\n- Patients with a known history of hypersensitivity to TAKHZYRO or its components should not receive the medication.\n- Consider potential interactions with other medications that may exacerbate allergic reactions or affect the immune response.""}]"
"CJpqu7xtgWTW","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the active ingredient in Levalbuterol Inhalation Solution?\nA: Levalbuterol hydrochloride\nB: Racemic albuterol\nC: Edetate disodium\nD: Nitrogen\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the active ingredient in Levalbuterol Inhalation Solution?\nA: Levalbuterol hydrochloride\nB: Racemic albuterol\nC: Edetate disodium\nD: Nitrogen\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the active ingredient in Levalbuterol Inhalation Solution?\nA: Levalbuterol hydrochloride\nB: Racemic albuterol\nC: Edetate disodium\nD: Nitrogen\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"Zrg3qTpO1kyC","- If a patient misses a dose of RoxyBond, they should take the missed dose as soon as they remember, unless it is almost time for the next scheduled dose.
- If it is close to the time for the next dose of RoxyBond, the patient should skip the missed dose and resume their regular dosing schedule.
- Patients should not take two doses of RoxyBond at the same time to make up for a missed dose.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should a patient do if they miss a dose of RoxyBond?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- If a patient misses a dose of RoxyBond, they should take the missed dose as soon as they remember, unless it is almost time for the next scheduled dose.\n- If it is close to the time for the next dose of RoxyBond, the patient should skip the missed dose and resume their regular dosing schedule.\n- Patients should not take two doses of RoxyBond at the same time to make up for a missed dose.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a patient do if they miss a dose of RoxyBond?\nA: Take the missed dose immediately\nB: Double the next dose to compensate\nC: Take the next dose at the usual time\nD: Stop taking RoxyBond and consult a healthcare provider\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- If a patient misses a dose of RoxyBond, they should take the missed dose as soon as they remember, unless it is almost time for the next scheduled dose.\n- If it is close to the time for the next dose of RoxyBond, the patient should skip the missed dose and resume their regular dosing schedule.\n- Patients should not take two doses of RoxyBond at the same time to make up for a missed dose.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a patient do if they miss a dose of RoxyBond?\nA: Take the missed dose immediately\nB: Double the next dose to compensate\nC: Take the next dose at the usual time\nD: Stop taking RoxyBond and consult a healthcare provider\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- If a patient misses a dose of RoxyBond, they should take the missed dose as soon as they remember, unless it is almost time for the next scheduled dose.\n- If it is close to the time for the next dose of RoxyBond, the patient should skip the missed dose and resume their regular dosing schedule.\n- Patients should not take two doses of RoxyBond at the same time to make up for a missed dose.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a patient do if they miss a dose of RoxyBond?\nA: Take the missed dose immediately\nB: Double the next dose to compensate\nC: Take the next dose at the usual time\nD: Stop taking RoxyBond and consult a healthcare provider\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- If a patient misses a dose of RoxyBond, they should take the missed dose as soon as they remember, unless it is almost time for the next scheduled dose.\n- If it is close to the time for the next dose of RoxyBond, the patient should skip the missed dose and resume their regular dosing schedule.\n- Patients should not take two doses of RoxyBond at the same time to make up for a missed dose.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"909wHYQXlUDZ","- Conducting a thorough review of the patient's current medications to identify potential drug interactions, as Paxlovid (nirmatrelvir/ritonavir) can interact with many common drugs.
- Assessing the patient's renal function, since dosage adjustments may be necessary for those with renal impairment before prescribing Paxlovid.
- Evaluating the patient's history for any contraindications to the use of ritonavir, which is a component of Paxlovid, to ensure safe prescribing practices.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following is NOT a recommended action before prescribing Paxlovid?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Conducting a thorough review of the patient's current medications to identify potential drug interactions, as Paxlovid (nirmatrelvir/ritonavir) can interact with many common drugs.\n- Assessing the patient's renal function, since dosage adjustments may be necessary for those with renal impairment before prescribing Paxlovid.\n- Evaluating the patient's history for any contraindications to the use of ritonavir, which is a component of Paxlovid, to ensure safe prescribing practices.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is NOT a recommended action before prescribing Paxlovid?\nA: Reviewing all medications taken by the patient.\nB: Determining if concomitant medications require dose adjustment or interruption.\nC: Ignoring potential drug-drug interactions due to Paxlovid's safety profile.\nD: Considering whether the risk of drug-drug interactions can be managed.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Conducting a thorough review of the patient's current medications to identify potential drug interactions, as Paxlovid (nirmatrelvir/ritonavir) can interact with many common drugs.\n- Assessing the patient's renal function, since dosage adjustments may be necessary for those with renal impairment before prescribing Paxlovid.\n- Evaluating the patient's history for any contraindications to the use of ritonavir, which is a component of Paxlovid, to ensure safe prescribing practices.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is NOT a recommended action before prescribing Paxlovid?\nA: Reviewing all medications taken by the patient.\nB: Determining if concomitant medications require dose adjustment or interruption.\nC: Ignoring potential drug-drug interactions due to Paxlovid's safety profile.\nD: Considering whether the risk of drug-drug interactions can be managed.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Conducting a thorough review of the patient's current medications to identify potential drug interactions, as Paxlovid (nirmatrelvir/ritonavir) can interact with many common drugs.\n- Assessing the patient's renal function, since dosage adjustments may be necessary for those with renal impairment before prescribing Paxlovid.\n- Evaluating the patient's history for any contraindications to the use of ritonavir, which is a component of Paxlovid, to ensure safe prescribing practices.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is NOT a recommended action before prescribing Paxlovid?\nA: Reviewing all medications taken by the patient.\nB: Determining if concomitant medications require dose adjustment or interruption.\nC: Ignoring potential drug-drug interactions due to Paxlovid's safety profile.\nD: Considering whether the risk of drug-drug interactions can be managed.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Conducting a thorough review of the patient's current medications to identify potential drug interactions, as Paxlovid (nirmatrelvir/ritonavir) can interact with many common drugs.\n- Assessing the patient's renal function, since dosage adjustments may be necessary for those with renal impairment before prescribing Paxlovid.\n- Evaluating the patient's history for any contraindications to the use of ritonavir, which is a component of Paxlovid, to ensure safe prescribing practices.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"3Kchwj4Jz7wt","- JAYPIRCA (pazopanib) is known to inhibit CYP3A4, which can lead to increased plasma concentrations of CYP3A substrates when co-administered.
- Patients taking CYP3A substrates, such as midazolam, may require dose adjustments when starting treatment with JAYPIRCA to avoid potential toxicity.
- The use of JAYPIRCA alongside active CYP3A substrates necessitates careful monitoring for adverse effects due to the drug's inhibitory effects on the CYP3A enzyme system.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following statements is true regarding JAYPIRCA's effect on CYP3A substrates?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- JAYPIRCA (pazopanib) is known to inhibit CYP3A4, which can lead to increased plasma concentrations of CYP3A substrates when co-administered.\n- Patients taking CYP3A substrates, such as midazolam, may require dose adjustments when starting treatment with JAYPIRCA to avoid potential toxicity.\n- The use of JAYPIRCA alongside active CYP3A substrates necessitates careful monitoring for adverse effects due to the drug's inhibitory effects on the CYP3A enzyme system.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding JAYPIRCA's effect on CYP3A substrates?\nA: JAYPIRCA strongly inhibits CYP3A substrates.\nB: JAYPIRCA moderately inhibits CYP3A substrates.\nC: JAYPIRCA weakly inhibits CYP3A substrates.\nD: JAYPIRCA has no effect on CYP3A substrates.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- JAYPIRCA (pazopanib) is known to inhibit CYP3A4, which can lead to increased plasma concentrations of CYP3A substrates when co-administered.\n- Patients taking CYP3A substrates, such as midazolam, may require dose adjustments when starting treatment with JAYPIRCA to avoid potential toxicity.\n- The use of JAYPIRCA alongside active CYP3A substrates necessitates careful monitoring for adverse effects due to the drug's inhibitory effects on the CYP3A enzyme system.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding JAYPIRCA's effect on CYP3A substrates?\nA: JAYPIRCA strongly inhibits CYP3A substrates.\nB: JAYPIRCA moderately inhibits CYP3A substrates.\nC: JAYPIRCA weakly inhibits CYP3A substrates.\nD: JAYPIRCA has no effect on CYP3A substrates.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- JAYPIRCA (pazopanib) is known to inhibit CYP3A4, which can lead to increased plasma concentrations of CYP3A substrates when co-administered.\n- Patients taking CYP3A substrates, such as midazolam, may require dose adjustments when starting treatment with JAYPIRCA to avoid potential toxicity.\n- The use of JAYPIRCA alongside active CYP3A substrates necessitates careful monitoring for adverse effects due to the drug's inhibitory effects on the CYP3A enzyme system.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding JAYPIRCA's effect on CYP3A substrates?\nA: JAYPIRCA strongly inhibits CYP3A substrates.\nB: JAYPIRCA moderately inhibits CYP3A substrates.\nC: JAYPIRCA weakly inhibits CYP3A substrates.\nD: JAYPIRCA has no effect on CYP3A substrates.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- JAYPIRCA (pazopanib) is known to inhibit CYP3A4, which can lead to increased plasma concentrations of CYP3A substrates when co-administered.\n- Patients taking CYP3A substrates, such as midazolam, may require dose adjustments when starting treatment with JAYPIRCA to avoid potential toxicity.\n- The use of JAYPIRCA alongside active CYP3A substrates necessitates careful monitoring for adverse effects due to the drug's inhibitory effects on the CYP3A enzyme system.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"cKMIyS0HPRXz","- The dosage of Dopamine should be reduced significantly, as patients who have been treated with MAO inhibitors may have increased sensitivity to catecholamines, leading to a heightened risk of adverse effects.
- Close monitoring of the patient's response to Dopamine is essential, and adjustments should be made based on their blood pressure and heart rate to avoid hypertensive crises.
- It is advisable to start with the lowest effective dose of Dopamine and titrate cautiously, considering the potential for prolonged effects of MAO inhibitors in the system.

MRRV(meta) winner=B; scores={'A': 0.38888888888888884, 'B': 1.0, 'C': 0.4444444444444444, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat adjustment should be made to the dosage of Dopamine when administered to a patient who has been treated with MAO inhibitors within the past two to three weeks?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The dosage of Dopamine should be reduced significantly, as patients who have been treated with MAO inhibitors may have increased sensitivity to catecholamines, leading to a heightened risk of adverse effects.\n- Close monitoring of the patient's response to Dopamine is essential, and adjustments should be made based on their blood pressure and heart rate to avoid hypertensive crises.\n- It is advisable to start with the lowest effective dose of Dopamine and titrate cautiously, considering the potential for prolonged effects of MAO inhibitors in the system.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What adjustment should be made to the dosage of Dopamine when administered to a patient who has been treated with MAO inhibitors within the past two to three weeks?\nA: Increase the dosage to twice the recommended dose.\nB: Reduce the dosage to no greater than one-tenth of the recommended dose.\nC: Administer the standard recommended dose.\nD: Discontinue Dopamine administration entirely.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The dosage of Dopamine should be reduced significantly, as patients who have been treated with MAO inhibitors may have increased sensitivity to catecholamines, leading to a heightened risk of adverse effects.\n- Close monitoring of the patient's response to Dopamine is essential, and adjustments should be made based on their blood pressure and heart rate to avoid hypertensive crises.\n- It is advisable to start with the lowest effective dose of Dopamine and titrate cautiously, considering the potential for prolonged effects of MAO inhibitors in the system.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What adjustment should be made to the dosage of Dopamine when administered to a patient who has been treated with MAO inhibitors within the past two to three weeks?\nA: Increase the dosage to twice the recommended dose.\nB: Reduce the dosage to no greater than one-tenth of the recommended dose.\nC: Administer the standard recommended dose.\nD: Discontinue Dopamine administration entirely.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The dosage of Dopamine should be reduced significantly, as patients who have been treated with MAO inhibitors may have increased sensitivity to catecholamines, leading to a heightened risk of adverse effects.\n- Close monitoring of the patient's response to Dopamine is essential, and adjustments should be made based on their blood pressure and heart rate to avoid hypertensive crises.\n- It is advisable to start with the lowest effective dose of Dopamine and titrate cautiously, considering the potential for prolonged effects of MAO inhibitors in the system.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What adjustment should be made to the dosage of Dopamine when administered to a patient who has been treated with MAO inhibitors within the past two to three weeks?\nA: Increase the dosage to twice the recommended dose.\nB: Reduce the dosage to no greater than one-tenth of the recommended dose.\nC: Administer the standard recommended dose.\nD: Discontinue Dopamine administration entirely.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The dosage of Dopamine should be reduced significantly, as patients who have been treated with MAO inhibitors may have increased sensitivity to catecholamines, leading to a heightened risk of adverse effects.\n- Close monitoring of the patient's response to Dopamine is essential, and adjustments should be made based on their blood pressure and heart rate to avoid hypertensive crises.\n- It is advisable to start with the lowest effective dose of Dopamine and titrate cautiously, considering the potential for prolonged effects of MAO inhibitors in the system.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"wE7D6VSL1llm","1) Recommendation: Venlafaxine hydrochloride typically appears as a white to off-white crystalline powder. It is often formulated into capsules or tablets, which may vary in color depending on the manufacturer and dosage.

2) Key rationale:
   - Venlafaxine hydrochloride is a synthetic antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class.
   - The physical appearance can vary based on the formulation (immediate-release vs. extended-release) and the manufacturer.
   - The powder form is used in the production of various dosage forms, including capsules and tablets, which may have different colors and markings for identification.

3) Safety/contraindications/interactions:
   - Venlafaxine should be used cautiously in patients with a history of hypertension, as it can increase blood pressure.
   - It may interact with other medications, particularly those affecting serotonin levels, leading to an increased risk of serotonin syndrome.
   - Patients with a history of seizures or bipolar disorder should be monitored closely while on this medication.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the physical appearance of venlafaxine hydrochloride?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Venlafaxine hydrochloride typically appears as a white to off-white crystalline powder. It is often formulated into capsules or tablets, which may vary in color depending on the manufacturer and dosage.\n\n2) Key rationale:\n   - Venlafaxine hydrochloride is a synthetic antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class.\n   - The physical appearance can vary based on the formulation (immediate-release vs. extended-release) and the manufacturer.\n   - The powder form is used in the production of various dosage forms, including capsules and tablets, which may have different colors and markings for identification.\n\n3) Safety/contraindications/interactions:\n   - Venlafaxine should be used cautiously in patients with a history of hypertension, as it can increase blood pressure.\n   - It may interact with other medications, particularly those affecting serotonin levels, leading to an increased risk of serotonin syndrome.\n   - Patients with a history of seizures or bipolar disorder should be monitored closely while on this medication.""}]"
"Ug5uEz76FbMg","- G-62 is a cephalosporin antibiotic, which has a similar structure to penicillins; therefore, caution is advised in patients with a history of penicillin allergy.
- It is recommended to avoid prescribing G-62 to this patient due to the potential for cross-reactivity and allergic reactions.
- Consider alternative antibiotics that are not related to penicillins or cephalosporins for this patients treatment.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nA patient reports a previous allergic reaction to penicillins. What is the appropriate action regarding the prescription of G-62?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- G-62 is a cephalosporin antibiotic, which has a similar structure to penicillins; therefore, caution is advised in patients with a history of penicillin allergy.\n- It is recommended to avoid prescribing G-62 to this patient due to the potential for cross-reactivity and allergic reactions.\n- Consider alternative antibiotics that are not related to penicillins or cephalosporins for this patient\u2019s treatment.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: A patient reports a previous allergic reaction to penicillins. What is the appropriate action regarding the prescription of G-62?\nA: Avoid prescribing G-62 due to contraindication.\nB: Prescribe G-62 with a reduced dosage.\nC: Prescribe G-62 with antihistamines to manage potential reactions.\nD: Proceed with prescribing G-62 as the reaction is unrelated.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- G-62 is a cephalosporin antibiotic, which has a similar structure to penicillins; therefore, caution is advised in patients with a history of penicillin allergy.\n- It is recommended to avoid prescribing G-62 to this patient due to the potential for cross-reactivity and allergic reactions.\n- Consider alternative antibiotics that are not related to penicillins or cephalosporins for this patient\u2019s treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: A patient reports a previous allergic reaction to penicillins. What is the appropriate action regarding the prescription of G-62?\nA: Avoid prescribing G-62 due to contraindication.\nB: Prescribe G-62 with a reduced dosage.\nC: Prescribe G-62 with antihistamines to manage potential reactions.\nD: Proceed with prescribing G-62 as the reaction is unrelated.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- G-62 is a cephalosporin antibiotic, which has a similar structure to penicillins; therefore, caution is advised in patients with a history of penicillin allergy.\n- It is recommended to avoid prescribing G-62 to this patient due to the potential for cross-reactivity and allergic reactions.\n- Consider alternative antibiotics that are not related to penicillins or cephalosporins for this patient\u2019s treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: A patient reports a previous allergic reaction to penicillins. What is the appropriate action regarding the prescription of G-62?\nA: Avoid prescribing G-62 due to contraindication.\nB: Prescribe G-62 with a reduced dosage.\nC: Prescribe G-62 with antihistamines to manage potential reactions.\nD: Proceed with prescribing G-62 as the reaction is unrelated.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- G-62 is a cephalosporin antibiotic, which has a similar structure to penicillins; therefore, caution is advised in patients with a history of penicillin allergy.\n- It is recommended to avoid prescribing G-62 to this patient due to the potential for cross-reactivity and allergic reactions.\n- Consider alternative antibiotics that are not related to penicillins or cephalosporins for this patient\u2019s treatment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"GJpVbbwMSuLF","- The primary indication for the use of the drug brand name nicotine is to aid in smoking cessation by reducing withdrawal symptoms and cravings associated with quitting smoking.
- Nicotine is often delivered through various forms such as patches, gum, or lozenges to help individuals transition away from tobacco products.
- It is used as part of a comprehensive smoking cessation program that may include behavioral therapy and support.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the primary indication for the use of the drug brand name nicotine?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The primary indication for the use of the drug brand name nicotine is to aid in smoking cessation by reducing withdrawal symptoms and cravings associated with quitting smoking.\n- Nicotine is often delivered through various forms such as patches, gum, or lozenges to help individuals transition away from tobacco products.\n- It is used as part of a comprehensive smoking cessation program that may include behavioral therapy and support.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary indication for the use of the drug brand name nicotine?\nA: Treatment of chronic pain\nB: Reduction of withdrawal symptoms associated with quitting smoking\nC: Management of hypertension\nD: Treatment of diabetes\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary indication for the use of the drug brand name nicotine is to aid in smoking cessation by reducing withdrawal symptoms and cravings associated with quitting smoking.\n- Nicotine is often delivered through various forms such as patches, gum, or lozenges to help individuals transition away from tobacco products.\n- It is used as part of a comprehensive smoking cessation program that may include behavioral therapy and support.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary indication for the use of the drug brand name nicotine?\nA: Treatment of chronic pain\nB: Reduction of withdrawal symptoms associated with quitting smoking\nC: Management of hypertension\nD: Treatment of diabetes\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary indication for the use of the drug brand name nicotine is to aid in smoking cessation by reducing withdrawal symptoms and cravings associated with quitting smoking.\n- Nicotine is often delivered through various forms such as patches, gum, or lozenges to help individuals transition away from tobacco products.\n- It is used as part of a comprehensive smoking cessation program that may include behavioral therapy and support.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary indication for the use of the drug brand name nicotine?\nA: Treatment of chronic pain\nB: Reduction of withdrawal symptoms associated with quitting smoking\nC: Management of hypertension\nD: Treatment of diabetes\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary indication for the use of the drug brand name nicotine is to aid in smoking cessation by reducing withdrawal symptoms and cravings associated with quitting smoking.\n- Nicotine is often delivered through various forms such as patches, gum, or lozenges to help individuals transition away from tobacco products.\n- It is used as part of a comprehensive smoking cessation program that may include behavioral therapy and support.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"bqqu3LMfWu4h","- The use of 'laxative for women' is expected to provide relief from occasional constipation by promoting bowel movements within 12 to 72 hours after administration.
- Common active ingredients in 'laxative for women' may include polyethylene glycol or bisacodyl, which help soften stool and stimulate intestinal activity.
- Patients may experience improved stool consistency and frequency, leading to a more comfortable and regular bowel routine.

MRRV(meta) winner=B; scores={'A': 0.4444444444444444, 'B': 1.0, 'C': 0.25, 'D': 0.38888888888888884}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the expected outcome after using 'laxative for women' for occasional constipation?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The use of 'laxative for women' is expected to provide relief from occasional constipation by promoting bowel movements within 12 to 72 hours after administration.\n- Common active ingredients in 'laxative for women' may include polyethylene glycol or bisacodyl, which help soften stool and stimulate intestinal activity.\n- Patients may experience improved stool consistency and frequency, leading to a more comfortable and regular bowel routine.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the expected outcome after using 'laxative for women' for occasional constipation?\nA: Immediate relief within minutes\nB: Bowel movement within 6 to 12 hours\nC: No effect on bowel movement\nD: Relief of chronic constipation symptoms\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The use of 'laxative for women' is expected to provide relief from occasional constipation by promoting bowel movements within 12 to 72 hours after administration.\n- Common active ingredients in 'laxative for women' may include polyethylene glycol or bisacodyl, which help soften stool and stimulate intestinal activity.\n- Patients may experience improved stool consistency and frequency, leading to a more comfortable and regular bowel routine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the expected outcome after using 'laxative for women' for occasional constipation?\nA: Immediate relief within minutes\nB: Bowel movement within 6 to 12 hours\nC: No effect on bowel movement\nD: Relief of chronic constipation symptoms\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The use of 'laxative for women' is expected to provide relief from occasional constipation by promoting bowel movements within 12 to 72 hours after administration.\n- Common active ingredients in 'laxative for women' may include polyethylene glycol or bisacodyl, which help soften stool and stimulate intestinal activity.\n- Patients may experience improved stool consistency and frequency, leading to a more comfortable and regular bowel routine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the expected outcome after using 'laxative for women' for occasional constipation?\nA: Immediate relief within minutes\nB: Bowel movement within 6 to 12 hours\nC: No effect on bowel movement\nD: Relief of chronic constipation symptoms\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The use of 'laxative for women' is expected to provide relief from occasional constipation by promoting bowel movements within 12 to 72 hours after administration.\n- Common active ingredients in 'laxative for women' may include polyethylene glycol or bisacodyl, which help soften stool and stimulate intestinal activity.\n- Patients may experience improved stool consistency and frequency, leading to a more comfortable and regular bowel routine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"QBzcFcVzpisx","- At a dosage of less than 5 mcg/kg/minute, Dopamine primarily activates the D1 dopamine receptors, leading to vasodilation and increased renal blood flow.
- This low-dose effect is distinct from higher doses of Dopamine, which can activate beta-adrenergic and alpha-adrenergic receptors.

MRRV(meta) winner=C; scores={'A': 0.3333333333333333, 'B': 0.5, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich receptor does Dopamine primarily activate at a dosage of less than 5 mcg/kg/minute?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- At a dosage of less than 5 mcg/kg/minute, Dopamine primarily activates the D1 dopamine receptors, leading to vasodilation and increased renal blood flow.\n- This low-dose effect is distinct from higher doses of Dopamine, which can activate beta-adrenergic and alpha-adrenergic receptors.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which receptor does Dopamine primarily activate at a dosage of less than 5 mcg/kg/minute?\nA: Alpha-1 receptors\nB: Beta-1 receptors\nC: Dopamine D1 and D2 receptors\nD: Norepinephrine receptors\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- At a dosage of less than 5 mcg/kg/minute, Dopamine primarily activates the D1 dopamine receptors, leading to vasodilation and increased renal blood flow.\n- This low-dose effect is distinct from higher doses of Dopamine, which can activate beta-adrenergic and alpha-adrenergic receptors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which receptor does Dopamine primarily activate at a dosage of less than 5 mcg/kg/minute?\nA: Alpha-1 receptors\nB: Beta-1 receptors\nC: Dopamine D1 and D2 receptors\nD: Norepinephrine receptors\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- At a dosage of less than 5 mcg/kg/minute, Dopamine primarily activates the D1 dopamine receptors, leading to vasodilation and increased renal blood flow.\n- This low-dose effect is distinct from higher doses of Dopamine, which can activate beta-adrenergic and alpha-adrenergic receptors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which receptor does Dopamine primarily activate at a dosage of less than 5 mcg/kg/minute?\nA: Alpha-1 receptors\nB: Beta-1 receptors\nC: Dopamine D1 and D2 receptors\nD: Norepinephrine receptors\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- At a dosage of less than 5 mcg/kg/minute, Dopamine primarily activates the D1 dopamine receptors, leading to vasodilation and increased renal blood flow.\n- This low-dose effect is distinct from higher doses of Dopamine, which can activate beta-adrenergic and alpha-adrenergic receptors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}]"
"lMCGiMsPyJct","- The drug that blocked the tumorigenic effect of albuterol sulfate in Sprague-Dawley rats was propranolol.
- Propranolol was administered in a regimen that effectively countered the tumor-promoting effects observed with albuterol sulfate.
- The study demonstrated a significant reduction in tumor incidence when propranolol was used compared to the control group receiving only albuterol sulfate.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich drug was shown to block the tumorigenic effect of albuterol sulfate in Sprague-Dawley rats?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The drug that blocked the tumorigenic effect of albuterol sulfate in Sprague-Dawley rats was propranolol.\n- Propranolol was administered in a regimen that effectively countered the tumor-promoting effects observed with albuterol sulfate.\n- The study demonstrated a significant reduction in tumor incidence when propranolol was used compared to the control group receiving only albuterol sulfate.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which drug was shown to block the tumorigenic effect of albuterol sulfate in Sprague-Dawley rats?\nA: Propranolol\nB: Metoprolol\nC: Atenolol\nD: Carvedilol\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug that blocked the tumorigenic effect of albuterol sulfate in Sprague-Dawley rats was propranolol.\n- Propranolol was administered in a regimen that effectively countered the tumor-promoting effects observed with albuterol sulfate.\n- The study demonstrated a significant reduction in tumor incidence when propranolol was used compared to the control group receiving only albuterol sulfate.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which drug was shown to block the tumorigenic effect of albuterol sulfate in Sprague-Dawley rats?\nA: Propranolol\nB: Metoprolol\nC: Atenolol\nD: Carvedilol\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug that blocked the tumorigenic effect of albuterol sulfate in Sprague-Dawley rats was propranolol.\n- Propranolol was administered in a regimen that effectively countered the tumor-promoting effects observed with albuterol sulfate.\n- The study demonstrated a significant reduction in tumor incidence when propranolol was used compared to the control group receiving only albuterol sulfate.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which drug was shown to block the tumorigenic effect of albuterol sulfate in Sprague-Dawley rats?\nA: Propranolol\nB: Metoprolol\nC: Atenolol\nD: Carvedilol\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug that blocked the tumorigenic effect of albuterol sulfate in Sprague-Dawley rats was propranolol.\n- Propranolol was administered in a regimen that effectively countered the tumor-promoting effects observed with albuterol sulfate.\n- The study demonstrated a significant reduction in tumor incidence when propranolol was used compared to the control group receiving only albuterol sulfate.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"OhzVvNLVpXly","- Junel 21 Day, a combination oral contraceptive containing ethinyl estradiol and norethindrone, has a typical failure rate of about 7% with typical use.
- In comparison, the typical failure rate for the contraceptive implant (e.g., Nexplanon) is less than 1%, making it significantly more effective than Junel 21 Day.
- Barrier methods, such as male condoms, have a typical failure rate of approximately 18%, which is higher than that of Junel 21 Day.

MRRV(meta) winner=C; scores={'A': 0.4444444444444444, 'B': 0.25, 'C': 1.0, 'D': 0.38888888888888884}; rankings=[['C', 'A', 'D', 'B'], ['C', 'D', 'A', 'B'], ['C', 'A', 'D', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow does Junel 21 Day compare to other contraceptive methods in terms of typical failure rates?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Junel 21 Day, a combination oral contraceptive containing ethinyl estradiol and norethindrone, has a typical failure rate of about 7% with typical use.\n- In comparison, the typical failure rate for the contraceptive implant (e.g., Nexplanon) is less than 1%, making it significantly more effective than Junel 21 Day.\n- Barrier methods, such as male condoms, have a typical failure rate of approximately 18%, which is higher than that of Junel 21 Day.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does Junel 21 Day compare to other contraceptive methods in terms of typical failure rates?\nA: Junel 21 Day has a typical failure rate of 3%, which is higher than IUDs.\nB: Junel 21 Day has a typical failure rate of 3%, which is lower than condoms.\nC: Junel 21 Day has a typical failure rate of 3%, which is higher than periodic abstinence.\nD: Junel 21 Day has a typical failure rate of 3%, which is higher than withdrawal.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Junel 21 Day, a combination oral contraceptive containing ethinyl estradiol and norethindrone, has a typical failure rate of about 7% with typical use.\n- In comparison, the typical failure rate for the contraceptive implant (e.g., Nexplanon) is less than 1%, making it significantly more effective than Junel 21 Day.\n- Barrier methods, such as male condoms, have a typical failure rate of approximately 18%, which is higher than that of Junel 21 Day.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does Junel 21 Day compare to other contraceptive methods in terms of typical failure rates?\nA: Junel 21 Day has a typical failure rate of 3%, which is higher than IUDs.\nB: Junel 21 Day has a typical failure rate of 3%, which is lower than condoms.\nC: Junel 21 Day has a typical failure rate of 3%, which is higher than periodic abstinence.\nD: Junel 21 Day has a typical failure rate of 3%, which is higher than withdrawal.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Junel 21 Day, a combination oral contraceptive containing ethinyl estradiol and norethindrone, has a typical failure rate of about 7% with typical use.\n- In comparison, the typical failure rate for the contraceptive implant (e.g., Nexplanon) is less than 1%, making it significantly more effective than Junel 21 Day.\n- Barrier methods, such as male condoms, have a typical failure rate of approximately 18%, which is higher than that of Junel 21 Day.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does Junel 21 Day compare to other contraceptive methods in terms of typical failure rates?\nA: Junel 21 Day has a typical failure rate of 3%, which is higher than IUDs.\nB: Junel 21 Day has a typical failure rate of 3%, which is lower than condoms.\nC: Junel 21 Day has a typical failure rate of 3%, which is higher than periodic abstinence.\nD: Junel 21 Day has a typical failure rate of 3%, which is higher than withdrawal.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Junel 21 Day, a combination oral contraceptive containing ethinyl estradiol and norethindrone, has a typical failure rate of about 7% with typical use.\n- In comparison, the typical failure rate for the contraceptive implant (e.g., Nexplanon) is less than 1%, making it significantly more effective than Junel 21 Day.\n- Barrier methods, such as male condoms, have a typical failure rate of approximately 18%, which is higher than that of Junel 21 Day.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}]"
"OUTPs0m2REUz","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the chemical designation of sumatriptan succinate, the active ingredient in Sumatriptan injection?\nA: 3-[2-(dimethylamino)ethyl]-N-methyl-indole-5-methanesulfonamide succinate (1:1)\nB: N-methyl-3-indole-5-methanesulfonamide succinate\nC: 2-(dimethylamino)ethyl-indole-5-methanesulfonamide\nD: 3-[2-(dimethylamino)ethyl]-N-methyl-indole-5-methanesulfonamide\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the chemical designation of sumatriptan succinate, the active ingredient in Sumatriptan injection?\nA: 3-[2-(dimethylamino)ethyl]-N-methyl-indole-5-methanesulfonamide succinate (1:1)\nB: N-methyl-3-indole-5-methanesulfonamide succinate\nC: 2-(dimethylamino)ethyl-indole-5-methanesulfonamide\nD: 3-[2-(dimethylamino)ethyl]-N-methyl-indole-5-methanesulfonamide\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the chemical designation of sumatriptan succinate, the active ingredient in Sumatriptan injection?\nA: 3-[2-(dimethylamino)ethyl]-N-methyl-indole-5-methanesulfonamide succinate (1:1)\nB: N-methyl-3-indole-5-methanesulfonamide succinate\nC: 2-(dimethylamino)ethyl-indole-5-methanesulfonamide\nD: 3-[2-(dimethylamino)ethyl]-N-methyl-indole-5-methanesulfonamide\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"wjcRlYtoFsij","1) Recommendation: Ciprofloxacin is generally contraindicated in certain populations, but it is important to assess each patient's individual health status and history before making a definitive conclusion about its use.

2) Key rationale:
   - Ciprofloxacin is contraindicated in patients with a known hypersensitivity to fluoroquinolones.
   - It should be avoided in children and adolescents due to the risk of musculoskeletal disorders.
   - Patients with a history of tendon disorders related to fluoroquinolone use are also advised against using this medication.
   - Certain conditions, such as myasthenia gravis, can be exacerbated by ciprofloxacin.

3) Safety/contraindications/interactions:
   - Contraindicated in patients with a history of tendon rupture or tendonitis related to fluoroquinolone use.
   - Caution in patients with renal impairment, as dosage adjustments may be necessary.
   - Potential interactions with antacids, sucralfate, and certain supplements that can affect absorption.
   - Not recommended for use during pregnancy or breastfeeding without careful consideration of risks versus benefits. 

Assumptions: The question implies a list of contraindications, but specific options are not provided. The answer is based on common contraindications associated with ciprofloxacin.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhich of the following is NOT a contraindication for Ciprofloxacin use?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Ciprofloxacin is generally contraindicated in certain populations, but it is important to assess each patient's individual health status and history before making a definitive conclusion about its use.\n\n2) Key rationale:\n   - Ciprofloxacin is contraindicated in patients with a known hypersensitivity to fluoroquinolones.\n   - It should be avoided in children and adolescents due to the risk of musculoskeletal disorders.\n   - Patients with a history of tendon disorders related to fluoroquinolone use are also advised against using this medication.\n   - Certain conditions, such as myasthenia gravis, can be exacerbated by ciprofloxacin.\n\n3) Safety/contraindications/interactions:\n   - Contraindicated in patients with a history of tendon rupture or tendonitis related to fluoroquinolone use.\n   - Caution in patients with renal impairment, as dosage adjustments may be necessary.\n   - Potential interactions with antacids, sucralfate, and certain supplements that can affect absorption.\n   - Not recommended for use during pregnancy or breastfeeding without careful consideration of risks versus benefits. \n\nAssumptions: The question implies a list of contraindications, but specific options are not provided. The answer is based on common contraindications associated with ciprofloxacin.""}]"
"zb9TBWxgRdKN","- Dialysis may be beneficial in managing AIRSUPRA overdosage due to its ability to remove the active components of the drug from the bloodstream.
- In cases of severe toxicity, hemodialysis can help reduce the plasma concentration of AIRSUPRA, potentially alleviating symptoms and preventing further complications.
- The effectiveness of dialysis in AIRSUPRA overdosage is contingent on the drug's pharmacokinetics, which may warrant consideration of this intervention in clinical settings.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIs dialysis considered beneficial for managing AIRSUPRA overdosage?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Dialysis may be beneficial in managing AIRSUPRA overdosage due to its ability to remove the active components of the drug from the bloodstream.\n- In cases of severe toxicity, hemodialysis can help reduce the plasma concentration of AIRSUPRA, potentially alleviating symptoms and preventing further complications.\n- The effectiveness of dialysis in AIRSUPRA overdosage is contingent on the drug's pharmacokinetics, which may warrant consideration of this intervention in clinical settings.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Is dialysis considered beneficial for managing AIRSUPRA overdosage?\nA: There is insufficient evidence to determine its benefit.\nB: Dialysis is highly effective for AIRSUPRA overdosage.\nC: Dialysis is contraindicated for AIRSUPRA overdosage.\nD: Dialysis is the primary treatment for AIRSUPRA overdosage.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Dialysis may be beneficial in managing AIRSUPRA overdosage due to its ability to remove the active components of the drug from the bloodstream.\n- In cases of severe toxicity, hemodialysis can help reduce the plasma concentration of AIRSUPRA, potentially alleviating symptoms and preventing further complications.\n- The effectiveness of dialysis in AIRSUPRA overdosage is contingent on the drug's pharmacokinetics, which may warrant consideration of this intervention in clinical settings.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Is dialysis considered beneficial for managing AIRSUPRA overdosage?\nA: There is insufficient evidence to determine its benefit.\nB: Dialysis is highly effective for AIRSUPRA overdosage.\nC: Dialysis is contraindicated for AIRSUPRA overdosage.\nD: Dialysis is the primary treatment for AIRSUPRA overdosage.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Dialysis may be beneficial in managing AIRSUPRA overdosage due to its ability to remove the active components of the drug from the bloodstream.\n- In cases of severe toxicity, hemodialysis can help reduce the plasma concentration of AIRSUPRA, potentially alleviating symptoms and preventing further complications.\n- The effectiveness of dialysis in AIRSUPRA overdosage is contingent on the drug's pharmacokinetics, which may warrant consideration of this intervention in clinical settings.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Is dialysis considered beneficial for managing AIRSUPRA overdosage?\nA: There is insufficient evidence to determine its benefit.\nB: Dialysis is highly effective for AIRSUPRA overdosage.\nC: Dialysis is contraindicated for AIRSUPRA overdosage.\nD: Dialysis is the primary treatment for AIRSUPRA overdosage.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Dialysis may be beneficial in managing AIRSUPRA overdosage due to its ability to remove the active components of the drug from the bloodstream.\n- In cases of severe toxicity, hemodialysis can help reduce the plasma concentration of AIRSUPRA, potentially alleviating symptoms and preventing further complications.\n- The effectiveness of dialysis in AIRSUPRA overdosage is contingent on the drug's pharmacokinetics, which may warrant consideration of this intervention in clinical settings.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"xTMxAIMvMomk","- The management of an overdose of Nighttime Sleep Aid, which typically contains diphenhydramine or doxylamine, may involve the administration of activated charcoal if the patient presents within a few hours of ingestion.
- Supportive care is crucial, including monitoring vital signs and providing respiratory support if necessary, as these antihistamines can cause significant sedation and anticholinergic effects.
- In severe cases, the use of physostigmine may be considered to reverse anticholinergic toxicity, although this is not commonly required for typical overdoses of these sleep aids.

MRRV(meta) winner=C; scores={'A': 0.38888888888888884, 'B': 0.25, 'C': 1.0, 'D': 0.4444444444444444}; rankings=[['C', 'A', 'D', 'B'], ['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following statements is true regarding the management of an overdose of Nighttime Sleep Aid?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The management of an overdose of Nighttime Sleep Aid, which typically contains diphenhydramine or doxylamine, may involve the administration of activated charcoal if the patient presents within a few hours of ingestion.\n- Supportive care is crucial, including monitoring vital signs and providing respiratory support if necessary, as these antihistamines can cause significant sedation and anticholinergic effects.\n- In severe cases, the use of physostigmine may be considered to reverse anticholinergic toxicity, although this is not commonly required for typical overdoses of these sleep aids.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the management of an overdose of Nighttime Sleep Aid?\nA: It is safe to wait for symptoms to appear before taking action.\nB: Drinking water can neutralize the effects of the overdose.\nC: Immediate medical help or contacting a Poison Control Center is recommended.\nD: Overdoses of Nighttime Sleep Aid do not require urgent attention.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The management of an overdose of Nighttime Sleep Aid, which typically contains diphenhydramine or doxylamine, may involve the administration of activated charcoal if the patient presents within a few hours of ingestion.\n- Supportive care is crucial, including monitoring vital signs and providing respiratory support if necessary, as these antihistamines can cause significant sedation and anticholinergic effects.\n- In severe cases, the use of physostigmine may be considered to reverse anticholinergic toxicity, although this is not commonly required for typical overdoses of these sleep aids.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the management of an overdose of Nighttime Sleep Aid?\nA: It is safe to wait for symptoms to appear before taking action.\nB: Drinking water can neutralize the effects of the overdose.\nC: Immediate medical help or contacting a Poison Control Center is recommended.\nD: Overdoses of Nighttime Sleep Aid do not require urgent attention.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The management of an overdose of Nighttime Sleep Aid, which typically contains diphenhydramine or doxylamine, may involve the administration of activated charcoal if the patient presents within a few hours of ingestion.\n- Supportive care is crucial, including monitoring vital signs and providing respiratory support if necessary, as these antihistamines can cause significant sedation and anticholinergic effects.\n- In severe cases, the use of physostigmine may be considered to reverse anticholinergic toxicity, although this is not commonly required for typical overdoses of these sleep aids.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the management of an overdose of Nighttime Sleep Aid?\nA: It is safe to wait for symptoms to appear before taking action.\nB: Drinking water can neutralize the effects of the overdose.\nC: Immediate medical help or contacting a Poison Control Center is recommended.\nD: Overdoses of Nighttime Sleep Aid do not require urgent attention.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The management of an overdose of Nighttime Sleep Aid, which typically contains diphenhydramine or doxylamine, may involve the administration of activated charcoal if the patient presents within a few hours of ingestion.\n- Supportive care is crucial, including monitoring vital signs and providing respiratory support if necessary, as these antihistamines can cause significant sedation and anticholinergic effects.\n- In severe cases, the use of physostigmine may be considered to reverse anticholinergic toxicity, although this is not commonly required for typical overdoses of these sleep aids.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}]"
"zr8E4aqPr7wJ","MRRV winner=C; scores={'A': 0.3333333333333333, 'B': 0.5, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients taking Tybost do if they become pregnant?\nA: Continue taking Tybost without consulting a healthcare provider\nB: Stop taking Tybost immediately\nC: Alert their healthcare provider\nD: Switch to a different medication without consulting a healthcare provider\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients taking Tybost do if they become pregnant?\nA: Continue taking Tybost without consulting a healthcare provider\nB: Stop taking Tybost immediately\nC: Alert their healthcare provider\nD: Switch to a different medication without consulting a healthcare provider\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients taking Tybost do if they become pregnant?\nA: Continue taking Tybost without consulting a healthcare provider\nB: Stop taking Tybost immediately\nC: Alert their healthcare provider\nD: Switch to a different medication without consulting a healthcare provider\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}]"
"W9r5mQjuzKvk","- Albuterol sulfate administered at oral doses up to 50 mg/kg did not show any adverse effects on fertility or reproductive performance in rats.
- The study indicated that there were no significant changes in mating performance or reproductive outcomes in the treated groups compared to the control group receiving a placebo.
- Overall, the findings suggest that albuterol sulfate is not detrimental to reproductive health in the tested animal model at the specified dosage.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat was the observed effect of albuterol sulfate on fertility and reproductive performance in rats at oral doses up to 50 mg/kg?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Albuterol sulfate administered at oral doses up to 50 mg/kg did not show any adverse effects on fertility or reproductive performance in rats.\n- The study indicated that there were no significant changes in mating performance or reproductive outcomes in the treated groups compared to the control group receiving a placebo.\n- Overall, the findings suggest that albuterol sulfate is not detrimental to reproductive health in the tested animal model at the specified dosage.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the observed effect of albuterol sulfate on fertility and reproductive performance in rats at oral doses up to 50 mg/kg?\nA: No evidence of impaired fertility\nB: Significant reduction in fertility\nC: Increased reproductive abnormalities\nD: Complete infertility\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol sulfate administered at oral doses up to 50 mg/kg did not show any adverse effects on fertility or reproductive performance in rats.\n- The study indicated that there were no significant changes in mating performance or reproductive outcomes in the treated groups compared to the control group receiving a placebo.\n- Overall, the findings suggest that albuterol sulfate is not detrimental to reproductive health in the tested animal model at the specified dosage.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the observed effect of albuterol sulfate on fertility and reproductive performance in rats at oral doses up to 50 mg/kg?\nA: No evidence of impaired fertility\nB: Significant reduction in fertility\nC: Increased reproductive abnormalities\nD: Complete infertility\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol sulfate administered at oral doses up to 50 mg/kg did not show any adverse effects on fertility or reproductive performance in rats.\n- The study indicated that there were no significant changes in mating performance or reproductive outcomes in the treated groups compared to the control group receiving a placebo.\n- Overall, the findings suggest that albuterol sulfate is not detrimental to reproductive health in the tested animal model at the specified dosage.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the observed effect of albuterol sulfate on fertility and reproductive performance in rats at oral doses up to 50 mg/kg?\nA: No evidence of impaired fertility\nB: Significant reduction in fertility\nC: Increased reproductive abnormalities\nD: Complete infertility\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol sulfate administered at oral doses up to 50 mg/kg did not show any adverse effects on fertility or reproductive performance in rats.\n- The study indicated that there were no significant changes in mating performance or reproductive outcomes in the treated groups compared to the control group receiving a placebo.\n- Overall, the findings suggest that albuterol sulfate is not detrimental to reproductive health in the tested animal model at the specified dosage.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"sLiuYuP68toN","- Consider evaluating for potential infections, as persistent fever may indicate an underlying infection in patients receiving REMICADE (infliximab).
- Monitor the patient's symptoms closely and assess the need for additional diagnostic tests or imaging to rule out serious complications associated with REMICADE therapy.
- If an infection is confirmed, appropriate antimicrobial therapy should be initiated, and the continuation of REMICADE may need to be reassessed based on the clinical situation.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action for patients who develop persistent fever while on REMICADE?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Consider evaluating for potential infections, as persistent fever may indicate an underlying infection in patients receiving REMICADE (infliximab).\n- Monitor the patient's symptoms closely and assess the need for additional diagnostic tests or imaging to rule out serious complications associated with REMICADE therapy.\n- If an infection is confirmed, appropriate antimicrobial therapy should be initiated, and the continuation of REMICADE may need to be reassessed based on the clinical situation.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action for patients who develop persistent fever while on REMICADE?\nA: Take over-the-counter fever reducers.\nB: Seek immediate medical attention.\nC: Continue therapy and monitor symptoms.\nD: Reduce the dosage of REMICADE.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider evaluating for potential infections, as persistent fever may indicate an underlying infection in patients receiving REMICADE (infliximab).\n- Monitor the patient's symptoms closely and assess the need for additional diagnostic tests or imaging to rule out serious complications associated with REMICADE therapy.\n- If an infection is confirmed, appropriate antimicrobial therapy should be initiated, and the continuation of REMICADE may need to be reassessed based on the clinical situation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action for patients who develop persistent fever while on REMICADE?\nA: Take over-the-counter fever reducers.\nB: Seek immediate medical attention.\nC: Continue therapy and monitor symptoms.\nD: Reduce the dosage of REMICADE.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider evaluating for potential infections, as persistent fever may indicate an underlying infection in patients receiving REMICADE (infliximab).\n- Monitor the patient's symptoms closely and assess the need for additional diagnostic tests or imaging to rule out serious complications associated with REMICADE therapy.\n- If an infection is confirmed, appropriate antimicrobial therapy should be initiated, and the continuation of REMICADE may need to be reassessed based on the clinical situation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action for patients who develop persistent fever while on REMICADE?\nA: Take over-the-counter fever reducers.\nB: Seek immediate medical attention.\nC: Continue therapy and monitor symptoms.\nD: Reduce the dosage of REMICADE.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider evaluating for potential infections, as persistent fever may indicate an underlying infection in patients receiving REMICADE (infliximab).\n- Monitor the patient's symptoms closely and assess the need for additional diagnostic tests or imaging to rule out serious complications associated with REMICADE therapy.\n- If an infection is confirmed, appropriate antimicrobial therapy should be initiated, and the continuation of REMICADE may need to be reassessed based on the clinical situation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"lRsX790D2TBk","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they experience symptoms of liver problems while taking Paxlovid?\nA: Continue taking Paxlovid and monitor symptoms\nB: Stop taking Paxlovid immediately and consult a healthcare provider\nC: Reduce the dose of Paxlovid\nD: Take over-the-counter liver supplements\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they experience symptoms of liver problems while taking Paxlovid?\nA: Continue taking Paxlovid and monitor symptoms\nB: Stop taking Paxlovid immediately and consult a healthcare provider\nC: Reduce the dose of Paxlovid\nD: Take over-the-counter liver supplements\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they experience symptoms of liver problems while taking Paxlovid?\nA: Continue taking Paxlovid and monitor symptoms\nB: Stop taking Paxlovid immediately and consult a healthcare provider\nC: Reduce the dose of Paxlovid\nD: Take over-the-counter liver supplements\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"v050tGLBVxvh","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the FDA's stance on the scientific evidence supporting the effectiveness of Drop20?\nA: FDA has approved Drop20 as effective\nB: FDA is aware of scientific evidence supporting Drop20\nC: FDA is not aware of scientific evidence supporting Drop20\nD: FDA has banned Drop20 due to lack of evidence\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the FDA's stance on the scientific evidence supporting the effectiveness of Drop20?\nA: FDA has approved Drop20 as effective\nB: FDA is aware of scientific evidence supporting Drop20\nC: FDA is not aware of scientific evidence supporting Drop20\nD: FDA has banned Drop20 due to lack of evidence\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the FDA's stance on the scientific evidence supporting the effectiveness of Drop20?\nA: FDA has approved Drop20 as effective\nB: FDA is aware of scientific evidence supporting Drop20\nC: FDA is not aware of scientific evidence supporting Drop20\nD: FDA has banned Drop20 due to lack of evidence\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"7Gjqr0zI8xSp","- The treatment arm receiving pembrolizumab in combination with pemetrexed and carboplatin had the highest overall response rate (ORR) as assessed by BICR RECIST v1.1.
- The active treatment group with pembrolizumab showed a significantly improved ORR compared to the placebo plus pemetrexed and carboplatin group.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich treatment arm in the KEYNOTE-189 study had the highest overall response rate (ORR) as assessed by BICR RECIST v1.1?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The treatment arm receiving pembrolizumab in combination with pemetrexed and carboplatin had the highest overall response rate (ORR) as assessed by BICR RECIST v1.1.\n- The active treatment group with pembrolizumab showed a significantly improved ORR compared to the placebo plus pemetrexed and carboplatin group.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which treatment arm in the KEYNOTE-189 study had the highest overall response rate (ORR) as assessed by BICR RECIST v1.1?\nA: Placebo, pemetrexed for Injection, and platinum chemotherapy\nB: Pemetrexed for Injection, pembrolizumab, and platinum chemotherapy\nC: Gemcitabine and cisplatin\nD: Docetaxel and cisplatin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The treatment arm receiving pembrolizumab in combination with pemetrexed and carboplatin had the highest overall response rate (ORR) as assessed by BICR RECIST v1.1.\n- The active treatment group with pembrolizumab showed a significantly improved ORR compared to the placebo plus pemetrexed and carboplatin group.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which treatment arm in the KEYNOTE-189 study had the highest overall response rate (ORR) as assessed by BICR RECIST v1.1?\nA: Placebo, pemetrexed for Injection, and platinum chemotherapy\nB: Pemetrexed for Injection, pembrolizumab, and platinum chemotherapy\nC: Gemcitabine and cisplatin\nD: Docetaxel and cisplatin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The treatment arm receiving pembrolizumab in combination with pemetrexed and carboplatin had the highest overall response rate (ORR) as assessed by BICR RECIST v1.1.\n- The active treatment group with pembrolizumab showed a significantly improved ORR compared to the placebo plus pemetrexed and carboplatin group.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which treatment arm in the KEYNOTE-189 study had the highest overall response rate (ORR) as assessed by BICR RECIST v1.1?\nA: Placebo, pemetrexed for Injection, and platinum chemotherapy\nB: Pemetrexed for Injection, pembrolizumab, and platinum chemotherapy\nC: Gemcitabine and cisplatin\nD: Docetaxel and cisplatin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The treatment arm receiving pembrolizumab in combination with pemetrexed and carboplatin had the highest overall response rate (ORR) as assessed by BICR RECIST v1.1.\n- The active treatment group with pembrolizumab showed a significantly improved ORR compared to the placebo plus pemetrexed and carboplatin group.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"iYIYBHrFYvoO","- Animal studies have shown that pantoprazole sodium, a proton pump inhibitor, can lead to decreased bone mineral density in offspring when administered to pregnant animals.
- The studies indicated that exposure to pantoprazole sodium during gestation resulted in altered bone development and potential long-term skeletal issues in the offspring.
- In comparison to control groups receiving a placebo, the offspring of animals treated with pantoprazole sodium exhibited significant differences in bone growth parameters.

MRRV(meta) winner=A; scores={'A': 0.8333333333333334, 'B': 0.6666666666666666, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['B', 'A', 'C', 'D'], ['A', 'B', 'D', 'C'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow does pantoprazole sodium affect bone development in offspring based on animal studies?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Animal studies have shown that pantoprazole sodium, a proton pump inhibitor, can lead to decreased bone mineral density in offspring when administered to pregnant animals.\n- The studies indicated that exposure to pantoprazole sodium during gestation resulted in altered bone development and potential long-term skeletal issues in the offspring.\n- In comparison to control groups receiving a placebo, the offspring of animals treated with pantoprazole sodium exhibited significant differences in bone growth parameters.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does pantoprazole sodium affect bone development in offspring based on animal studies?\nA: It causes irreversible changes in bone morphology.\nB: It leads to changes in bone parameters that are partially reversible.\nC: It has no impact on bone development.\nD: It increases bone density and mineral content.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Animal studies have shown that pantoprazole sodium, a proton pump inhibitor, can lead to decreased bone mineral density in offspring when administered to pregnant animals.\n- The studies indicated that exposure to pantoprazole sodium during gestation resulted in altered bone development and potential long-term skeletal issues in the offspring.\n- In comparison to control groups receiving a placebo, the offspring of animals treated with pantoprazole sodium exhibited significant differences in bone growth parameters.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does pantoprazole sodium affect bone development in offspring based on animal studies?\nA: It causes irreversible changes in bone morphology.\nB: It leads to changes in bone parameters that are partially reversible.\nC: It has no impact on bone development.\nD: It increases bone density and mineral content.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Animal studies have shown that pantoprazole sodium, a proton pump inhibitor, can lead to decreased bone mineral density in offspring when administered to pregnant animals.\n- The studies indicated that exposure to pantoprazole sodium during gestation resulted in altered bone development and potential long-term skeletal issues in the offspring.\n- In comparison to control groups receiving a placebo, the offspring of animals treated with pantoprazole sodium exhibited significant differences in bone growth parameters.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does pantoprazole sodium affect bone development in offspring based on animal studies?\nA: It causes irreversible changes in bone morphology.\nB: It leads to changes in bone parameters that are partially reversible.\nC: It has no impact on bone development.\nD: It increases bone density and mineral content.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Animal studies have shown that pantoprazole sodium, a proton pump inhibitor, can lead to decreased bone mineral density in offspring when administered to pregnant animals.\n- The studies indicated that exposure to pantoprazole sodium during gestation resulted in altered bone development and potential long-term skeletal issues in the offspring.\n- In comparison to control groups receiving a placebo, the offspring of animals treated with pantoprazole sodium exhibited significant differences in bone growth parameters.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"Fg6rOW2mQerX","- Gadavist is contraindicated in patients with a history of severe allergic reactions to gadolinium-based contrast agents.
- It should not be used in individuals with acute or chronic severe renal impairment, as it increases the risk of nephrogenic systemic fibrosis.
- Patients with known hypersensitivity to Gadavist or any of its components should avoid its use.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following best describes a contraindication for Gadavist?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Gadavist is contraindicated in patients with a history of severe allergic reactions to gadolinium-based contrast agents.\n- It should not be used in individuals with acute or chronic severe renal impairment, as it increases the risk of nephrogenic systemic fibrosis.\n- Patients with known hypersensitivity to Gadavist or any of its components should avoid its use.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following best describes a contraindication for Gadavist?\nA: History of mild allergic reactions to any drug\nB: History of severe hypersensitivity reactions to Gadavist\nC: History of gastrointestinal issues\nD: History of cardiovascular disease\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadavist is contraindicated in patients with a history of severe allergic reactions to gadolinium-based contrast agents.\n- It should not be used in individuals with acute or chronic severe renal impairment, as it increases the risk of nephrogenic systemic fibrosis.\n- Patients with known hypersensitivity to Gadavist or any of its components should avoid its use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following best describes a contraindication for Gadavist?\nA: History of mild allergic reactions to any drug\nB: History of severe hypersensitivity reactions to Gadavist\nC: History of gastrointestinal issues\nD: History of cardiovascular disease\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadavist is contraindicated in patients with a history of severe allergic reactions to gadolinium-based contrast agents.\n- It should not be used in individuals with acute or chronic severe renal impairment, as it increases the risk of nephrogenic systemic fibrosis.\n- Patients with known hypersensitivity to Gadavist or any of its components should avoid its use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following best describes a contraindication for Gadavist?\nA: History of mild allergic reactions to any drug\nB: History of severe hypersensitivity reactions to Gadavist\nC: History of gastrointestinal issues\nD: History of cardiovascular disease\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadavist is contraindicated in patients with a history of severe allergic reactions to gadolinium-based contrast agents.\n- It should not be used in individuals with acute or chronic severe renal impairment, as it increases the risk of nephrogenic systemic fibrosis.\n- Patients with known hypersensitivity to Gadavist or any of its components should avoid its use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"m5wAed5GouIf","MRRV winner=B; scores={'A': 0.25, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the sodium content per 15 mL dose of the drug meijer stomach relief regular strength?\nA: 10 mg\nB: 230 mg\nC: 40 mg\nD: 104 mg\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the sodium content per 15 mL dose of the drug meijer stomach relief regular strength?\nA: 10 mg\nB: 230 mg\nC: 40 mg\nD: 104 mg\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the sodium content per 15 mL dose of the drug meijer stomach relief regular strength?\nA: 10 mg\nB: 230 mg\nC: 40 mg\nD: 104 mg\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"7YmO7oy74913","- The drug branded as 70% is effective in reducing the risk of skin cancer and early skin aging when used as part of a daily regimen that includes broad-spectrum sunscreen application.
- Clinical studies have shown that consistent use of the drug branded as 70% in conjunction with protective measures, such as wearing protective clothing and seeking shade, significantly enhances its protective effects against UV radiation.
- The drug branded as 70% demonstrates a marked decrease in skin cancer risk when applied regularly, particularly in individuals with a history of sunburn or high sun exposure.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nUnder what conditions does the drug branded as 70% decrease the risk of skin cancer and early skin aging?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The drug branded as 70% is effective in reducing the risk of skin cancer and early skin aging when used as part of a daily regimen that includes broad-spectrum sunscreen application.\n- Clinical studies have shown that consistent use of the drug branded as 70% in conjunction with protective measures, such as wearing protective clothing and seeking shade, significantly enhances its protective effects against UV radiation.\n- The drug branded as 70% demonstrates a marked decrease in skin cancer risk when applied regularly, particularly in individuals with a history of sunburn or high sun exposure.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Under what conditions does the drug branded as 70% decrease the risk of skin cancer and early skin aging?\nA: When used alone without any additional measures.\nB: When used as directed with other sun protection measures.\nC: When applied only during nighttime.\nD: When combined with anti-aging creams.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug branded as 70% is effective in reducing the risk of skin cancer and early skin aging when used as part of a daily regimen that includes broad-spectrum sunscreen application.\n- Clinical studies have shown that consistent use of the drug branded as 70% in conjunction with protective measures, such as wearing protective clothing and seeking shade, significantly enhances its protective effects against UV radiation.\n- The drug branded as 70% demonstrates a marked decrease in skin cancer risk when applied regularly, particularly in individuals with a history of sunburn or high sun exposure.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Under what conditions does the drug branded as 70% decrease the risk of skin cancer and early skin aging?\nA: When used alone without any additional measures.\nB: When used as directed with other sun protection measures.\nC: When applied only during nighttime.\nD: When combined with anti-aging creams.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug branded as 70% is effective in reducing the risk of skin cancer and early skin aging when used as part of a daily regimen that includes broad-spectrum sunscreen application.\n- Clinical studies have shown that consistent use of the drug branded as 70% in conjunction with protective measures, such as wearing protective clothing and seeking shade, significantly enhances its protective effects against UV radiation.\n- The drug branded as 70% demonstrates a marked decrease in skin cancer risk when applied regularly, particularly in individuals with a history of sunburn or high sun exposure.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Under what conditions does the drug branded as 70% decrease the risk of skin cancer and early skin aging?\nA: When used alone without any additional measures.\nB: When used as directed with other sun protection measures.\nC: When applied only during nighttime.\nD: When combined with anti-aging creams.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug branded as 70% is effective in reducing the risk of skin cancer and early skin aging when used as part of a daily regimen that includes broad-spectrum sunscreen application.\n- Clinical studies have shown that consistent use of the drug branded as 70% in conjunction with protective measures, such as wearing protective clothing and seeking shade, significantly enhances its protective effects against UV radiation.\n- The drug branded as 70% demonstrates a marked decrease in skin cancer risk when applied regularly, particularly in individuals with a history of sunburn or high sun exposure.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"0B4ZNW5dmHHK","- Juvenile rats treated with fluoxetine exhibited reduced fertility, characterized by decreased sperm count and motility.
- The treatment with fluoxetine led to alterations in reproductive hormone levels, impacting the overall reproductive health of the juvenile rats.
- Observations included delayed onset of puberty and changes in estrous cycle regularity in female rats treated with fluoxetine.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat adverse effects were observed on fertility when juvenile rats were treated with fluoxetine?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Juvenile rats treated with fluoxetine exhibited reduced fertility, characterized by decreased sperm count and motility.\n- The treatment with fluoxetine led to alterations in reproductive hormone levels, impacting the overall reproductive health of the juvenile rats.\n- Observations included delayed onset of puberty and changes in estrous cycle regularity in female rats treated with fluoxetine.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What adverse effects were observed on fertility when juvenile rats were treated with fluoxetine?\nA: No adverse effects on fertility were observed\nB: Adverse effects on fertility were observed\nC: Adverse effects were observed only at doses exceeding 12.5 mg/kg/day\nD: Adverse effects were observed only in combination with other drugs\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Juvenile rats treated with fluoxetine exhibited reduced fertility, characterized by decreased sperm count and motility.\n- The treatment with fluoxetine led to alterations in reproductive hormone levels, impacting the overall reproductive health of the juvenile rats.\n- Observations included delayed onset of puberty and changes in estrous cycle regularity in female rats treated with fluoxetine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What adverse effects were observed on fertility when juvenile rats were treated with fluoxetine?\nA: No adverse effects on fertility were observed\nB: Adverse effects on fertility were observed\nC: Adverse effects were observed only at doses exceeding 12.5 mg/kg/day\nD: Adverse effects were observed only in combination with other drugs\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Juvenile rats treated with fluoxetine exhibited reduced fertility, characterized by decreased sperm count and motility.\n- The treatment with fluoxetine led to alterations in reproductive hormone levels, impacting the overall reproductive health of the juvenile rats.\n- Observations included delayed onset of puberty and changes in estrous cycle regularity in female rats treated with fluoxetine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What adverse effects were observed on fertility when juvenile rats were treated with fluoxetine?\nA: No adverse effects on fertility were observed\nB: Adverse effects on fertility were observed\nC: Adverse effects were observed only at doses exceeding 12.5 mg/kg/day\nD: Adverse effects were observed only in combination with other drugs\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Juvenile rats treated with fluoxetine exhibited reduced fertility, characterized by decreased sperm count and motility.\n- The treatment with fluoxetine led to alterations in reproductive hormone levels, impacting the overall reproductive health of the juvenile rats.\n- Observations included delayed onset of puberty and changes in estrous cycle regularity in female rats treated with fluoxetine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"PKg418YIAWQ0","- The formulation typically includes diphenhydramine, an antihistamine that helps reduce symptoms like runny nose and sneezing, promoting better sleep.
- It may also contain a pain reliever such as acetaminophen, which alleviates discomfort and fever, allowing for a more restful night.
- The combination of these ingredients helps to relieve cold and flu symptoms while also providing a sedative effect, making it easier to fall asleep.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow does 'basic care nighttime cold and flu' assist with sleep during illness?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The formulation typically includes diphenhydramine, an antihistamine that helps reduce symptoms like runny nose and sneezing, promoting better sleep.\n- It may also contain a pain reliever such as acetaminophen, which alleviates discomfort and fever, allowing for a more restful night.\n- The combination of these ingredients helps to relieve cold and flu symptoms while also providing a sedative effect, making it easier to fall asleep.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does 'basic care nighttime cold and flu' assist with sleep during illness?\nA: By reducing fever\nB: By relieving cough to help you sleep\nC: By eliminating nasal congestion\nD: By reducing sinus pressure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The formulation typically includes diphenhydramine, an antihistamine that helps reduce symptoms like runny nose and sneezing, promoting better sleep.\n- It may also contain a pain reliever such as acetaminophen, which alleviates discomfort and fever, allowing for a more restful night.\n- The combination of these ingredients helps to relieve cold and flu symptoms while also providing a sedative effect, making it easier to fall asleep.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does 'basic care nighttime cold and flu' assist with sleep during illness?\nA: By reducing fever\nB: By relieving cough to help you sleep\nC: By eliminating nasal congestion\nD: By reducing sinus pressure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The formulation typically includes diphenhydramine, an antihistamine that helps reduce symptoms like runny nose and sneezing, promoting better sleep.\n- It may also contain a pain reliever such as acetaminophen, which alleviates discomfort and fever, allowing for a more restful night.\n- The combination of these ingredients helps to relieve cold and flu symptoms while also providing a sedative effect, making it easier to fall asleep.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does 'basic care nighttime cold and flu' assist with sleep during illness?\nA: By reducing fever\nB: By relieving cough to help you sleep\nC: By eliminating nasal congestion\nD: By reducing sinus pressure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The formulation typically includes diphenhydramine, an antihistamine that helps reduce symptoms like runny nose and sneezing, promoting better sleep.\n- It may also contain a pain reliever such as acetaminophen, which alleviates discomfort and fever, allowing for a more restful night.\n- The combination of these ingredients helps to relieve cold and flu symptoms while also providing a sedative effect, making it easier to fall asleep.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"HUeKL0sxFUTZ","- In patients with renal impairment, the pharmacokinetics of AIRSUPRA may be altered, leading to increased plasma concentrations of the active components due to reduced clearance.
- Dosage adjustments may be necessary for individuals with moderate to severe renal impairment to avoid potential toxicity or adverse effects.
- Monitoring of renal function is recommended when prescribing AIRSUPRA to ensure safe and effective use in patients with compromised kidney function.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3055555555555555, 'C': 0.27777777777777773, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the effect of renal impairment on the pharmacokinetics of AIRSUPRA?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- In patients with renal impairment, the pharmacokinetics of AIRSUPRA may be altered, leading to increased plasma concentrations of the active components due to reduced clearance.\n- Dosage adjustments may be necessary for individuals with moderate to severe renal impairment to avoid potential toxicity or adverse effects.\n- Monitoring of renal function is recommended when prescribing AIRSUPRA to ensure safe and effective use in patients with compromised kidney function.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of renal impairment on the pharmacokinetics of AIRSUPRA?\nA: No formal pharmacokinetic studies have been conducted.\nB: Renal impairment significantly increases drug clearance.\nC: Renal impairment reduces drug efficacy.\nD: AIRSUPRA is contraindicated in patients with renal impairment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In patients with renal impairment, the pharmacokinetics of AIRSUPRA may be altered, leading to increased plasma concentrations of the active components due to reduced clearance.\n- Dosage adjustments may be necessary for individuals with moderate to severe renal impairment to avoid potential toxicity or adverse effects.\n- Monitoring of renal function is recommended when prescribing AIRSUPRA to ensure safe and effective use in patients with compromised kidney function.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of renal impairment on the pharmacokinetics of AIRSUPRA?\nA: No formal pharmacokinetic studies have been conducted.\nB: Renal impairment significantly increases drug clearance.\nC: Renal impairment reduces drug efficacy.\nD: AIRSUPRA is contraindicated in patients with renal impairment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In patients with renal impairment, the pharmacokinetics of AIRSUPRA may be altered, leading to increased plasma concentrations of the active components due to reduced clearance.\n- Dosage adjustments may be necessary for individuals with moderate to severe renal impairment to avoid potential toxicity or adverse effects.\n- Monitoring of renal function is recommended when prescribing AIRSUPRA to ensure safe and effective use in patients with compromised kidney function.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of renal impairment on the pharmacokinetics of AIRSUPRA?\nA: No formal pharmacokinetic studies have been conducted.\nB: Renal impairment significantly increases drug clearance.\nC: Renal impairment reduces drug efficacy.\nD: AIRSUPRA is contraindicated in patients with renal impairment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In patients with renal impairment, the pharmacokinetics of AIRSUPRA may be altered, leading to increased plasma concentrations of the active components due to reduced clearance.\n- Dosage adjustments may be necessary for individuals with moderate to severe renal impairment to avoid potential toxicity or adverse effects.\n- Monitoring of renal function is recommended when prescribing AIRSUPRA to ensure safe and effective use in patients with compromised kidney function.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"gkhVj6tkeRy9","- The group receiving the placebo showed the smallest mean change in plasma glucose 1 hour after the first dose.
- In contrast, the active treatment group with the drug demonstrated a larger mean change in plasma glucose levels.
- The results indicate that the placebo had a minimal effect on plasma glucose compared to the active drug regimen.

MRRV(meta) winner=D; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 0.25, 'D': 1.0}; rankings=[['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn the clinical trial for adults and adolescents, which group showed the smallest mean change in plasma glucose 1 hour after the first dose?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The group receiving the placebo showed the smallest mean change in plasma glucose 1 hour after the first dose.\n- In contrast, the active treatment group with the drug demonstrated a larger mean change in plasma glucose levels.\n- The results indicate that the placebo had a minimal effect on plasma glucose compared to the active drug regimen.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In the clinical trial for adults and adolescents, which group showed the smallest mean change in plasma glucose 1 hour after the first dose?\nA: Levalbuterol 0.63 mg\nB: Levalbuterol 1.25 mg\nC: Racemic albuterol 2.5 mg\nD: Placebo\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The group receiving the placebo showed the smallest mean change in plasma glucose 1 hour after the first dose.\n- In contrast, the active treatment group with the drug demonstrated a larger mean change in plasma glucose levels.\n- The results indicate that the placebo had a minimal effect on plasma glucose compared to the active drug regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In the clinical trial for adults and adolescents, which group showed the smallest mean change in plasma glucose 1 hour after the first dose?\nA: Levalbuterol 0.63 mg\nB: Levalbuterol 1.25 mg\nC: Racemic albuterol 2.5 mg\nD: Placebo\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The group receiving the placebo showed the smallest mean change in plasma glucose 1 hour after the first dose.\n- In contrast, the active treatment group with the drug demonstrated a larger mean change in plasma glucose levels.\n- The results indicate that the placebo had a minimal effect on plasma glucose compared to the active drug regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In the clinical trial for adults and adolescents, which group showed the smallest mean change in plasma glucose 1 hour after the first dose?\nA: Levalbuterol 0.63 mg\nB: Levalbuterol 1.25 mg\nC: Racemic albuterol 2.5 mg\nD: Placebo\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The group receiving the placebo showed the smallest mean change in plasma glucose 1 hour after the first dose.\n- In contrast, the active treatment group with the drug demonstrated a larger mean change in plasma glucose levels.\n- The results indicate that the placebo had a minimal effect on plasma glucose compared to the active drug regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}]"
"Sgp2AOBeaH9G","1) Recommendation: In geriatric patients, Lantus Solostar (insulin glargine) should be initiated at a lower dose, typically starting at 0.2 to 0.4 units/kg/day, and titrated based on blood glucose monitoring results. Close monitoring is essential to avoid hypoglycemia, especially in those with renal impairment or other comorbidities.

2) Key rationale:
- Geriatric patients often have altered pharmacokinetics and pharmacodynamics, necessitating careful dose adjustments.
- Increased risk of hypoglycemia in older adults due to potential polypharmacy and age-related physiological changes.
- Renal function may decline with age, affecting insulin clearance and requiring further dose adjustments.
- Individualized treatment plans are crucial, considering the patient's overall health status, lifestyle, and preferences.

3) Safety/contraindications/interactions:
- Monitor for signs of hypoglycemia, especially in patients with cognitive impairment or those on medications that can lower blood sugar.
- Caution in patients with renal or hepatic impairment, as these conditions can affect insulin metabolism.
- Review all medications for potential interactions that may affect blood glucose levels, including corticosteroids, diuretics, and beta-blockers.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the recommendation for dosing Lantus Solostar in geriatric patients?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: In geriatric patients, Lantus Solostar (insulin glargine) should be initiated at a lower dose, typically starting at 0.2 to 0.4 units/kg/day, and titrated based on blood glucose monitoring results. Close monitoring is essential to avoid hypoglycemia, especially in those with renal impairment or other comorbidities.\n\n2) Key rationale:\n- Geriatric patients often have altered pharmacokinetics and pharmacodynamics, necessitating careful dose adjustments.\n- Increased risk of hypoglycemia in older adults due to potential polypharmacy and age-related physiological changes.\n- Renal function may decline with age, affecting insulin clearance and requiring further dose adjustments.\n- Individualized treatment plans are crucial, considering the patient's overall health status, lifestyle, and preferences.\n\n3) Safety/contraindications/interactions:\n- Monitor for signs of hypoglycemia, especially in patients with cognitive impairment or those on medications that can lower blood sugar.\n- Caution in patients with renal or hepatic impairment, as these conditions can affect insulin metabolism.\n- Review all medications for potential interactions that may affect blood glucose levels, including corticosteroids, diuretics, and beta-blockers.""}]"
"sw1Azz7b7IuS","- Junel 21 Day contains ethinyl estradiol and norethindrone, which may pass into breast milk and could potentially affect the nursing infant.
- The World Health Organization recommends that breastfeeding mothers wait until at least six weeks postpartum before starting combined oral contraceptives like Junel 21 Day to ensure adequate milk supply.
- Some studies suggest that progestin-only contraceptives may be a safer alternative for breastfeeding mothers, as they have less impact on milk production compared to combined hormonal methods like Junel 21 Day.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should a breastfeeding mother consider before using Junel 21 Day oral contraceptives?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Junel 21 Day contains ethinyl estradiol and norethindrone, which may pass into breast milk and could potentially affect the nursing infant.\n- The World Health Organization recommends that breastfeeding mothers wait until at least six weeks postpartum before starting combined oral contraceptives like Junel 21 Day to ensure adequate milk supply.\n- Some studies suggest that progestin-only contraceptives may be a safer alternative for breastfeeding mothers, as they have less impact on milk production compared to combined hormonal methods like Junel 21 Day.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a breastfeeding mother consider before using Junel 21 Day oral contraceptives?\nA: Breastfeeding provides complete protection against pregnancy.\nB: Junel 21 Day oral contraceptives may decrease milk quantity and quality.\nC: Junel 21 Day oral contraceptives are safe for use during breastfeeding.\nD: Junel 21 Day oral contraceptives increase milk production.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Junel 21 Day contains ethinyl estradiol and norethindrone, which may pass into breast milk and could potentially affect the nursing infant.\n- The World Health Organization recommends that breastfeeding mothers wait until at least six weeks postpartum before starting combined oral contraceptives like Junel 21 Day to ensure adequate milk supply.\n- Some studies suggest that progestin-only contraceptives may be a safer alternative for breastfeeding mothers, as they have less impact on milk production compared to combined hormonal methods like Junel 21 Day.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a breastfeeding mother consider before using Junel 21 Day oral contraceptives?\nA: Breastfeeding provides complete protection against pregnancy.\nB: Junel 21 Day oral contraceptives may decrease milk quantity and quality.\nC: Junel 21 Day oral contraceptives are safe for use during breastfeeding.\nD: Junel 21 Day oral contraceptives increase milk production.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Junel 21 Day contains ethinyl estradiol and norethindrone, which may pass into breast milk and could potentially affect the nursing infant.\n- The World Health Organization recommends that breastfeeding mothers wait until at least six weeks postpartum before starting combined oral contraceptives like Junel 21 Day to ensure adequate milk supply.\n- Some studies suggest that progestin-only contraceptives may be a safer alternative for breastfeeding mothers, as they have less impact on milk production compared to combined hormonal methods like Junel 21 Day.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a breastfeeding mother consider before using Junel 21 Day oral contraceptives?\nA: Breastfeeding provides complete protection against pregnancy.\nB: Junel 21 Day oral contraceptives may decrease milk quantity and quality.\nC: Junel 21 Day oral contraceptives are safe for use during breastfeeding.\nD: Junel 21 Day oral contraceptives increase milk production.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Junel 21 Day contains ethinyl estradiol and norethindrone, which may pass into breast milk and could potentially affect the nursing infant.\n- The World Health Organization recommends that breastfeeding mothers wait until at least six weeks postpartum before starting combined oral contraceptives like Junel 21 Day to ensure adequate milk supply.\n- Some studies suggest that progestin-only contraceptives may be a safer alternative for breastfeeding mothers, as they have less impact on milk production compared to combined hormonal methods like Junel 21 Day.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"dofxOJuv5AyC","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should individuals with difficulty swallowing avoid when using Gentle Lax?\nA: Combining Gentle Lax with starch-based thickeners\nB: Using Gentle Lax with cold beverages\nC: Using Gentle Lax for more than 7 days\nD: Dissolving Gentle Lax in hot beverages\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should individuals with difficulty swallowing avoid when using Gentle Lax?\nA: Combining Gentle Lax with starch-based thickeners\nB: Using Gentle Lax with cold beverages\nC: Using Gentle Lax for more than 7 days\nD: Dissolving Gentle Lax in hot beverages\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should individuals with difficulty swallowing avoid when using Gentle Lax?\nA: Combining Gentle Lax with starch-based thickeners\nB: Using Gentle Lax with cold beverages\nC: Using Gentle Lax for more than 7 days\nD: Dissolving Gentle Lax in hot beverages\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"OgXwAVAh1ayV","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients or caregivers do if they experience symptoms such as hyperpigmentation, extreme fatigue, dizziness, or weight loss while using Skytrofa?\nA: Discontinue the medication immediately\nB: Report these symptoms to their healthcare provider\nC: Increase the dose of Skytrofa\nD: Ignore the symptoms as they are common side effects\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients or caregivers do if they experience symptoms such as hyperpigmentation, extreme fatigue, dizziness, or weight loss while using Skytrofa?\nA: Discontinue the medication immediately\nB: Report these symptoms to their healthcare provider\nC: Increase the dose of Skytrofa\nD: Ignore the symptoms as they are common side effects\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients or caregivers do if they experience symptoms such as hyperpigmentation, extreme fatigue, dizziness, or weight loss while using Skytrofa?\nA: Discontinue the medication immediately\nB: Report these symptoms to their healthcare provider\nC: Increase the dose of Skytrofa\nD: Ignore the symptoms as they are common side effects\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"Cy3rjSsS1u1u","- Consuming food or beverages can interfere with the absorption of nicotine from the lozenge, potentially reducing its effectiveness.
- Drinking acidic beverages, such as coffee or soda, can alter the pH in the mouth, which may affect how well the nicotine is absorbed through the mucous membranes.
- To maximize the therapeutic effect of the nicotine lozenge, it is advised to keep the mouth free of any substances that could hinder nicotine delivery for at least 15 minutes before and during use.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy is it recommended not to eat or drink 15 minutes before using or while the nicotine lozenge is in the mouth?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Consuming food or beverages can interfere with the absorption of nicotine from the lozenge, potentially reducing its effectiveness.\n- Drinking acidic beverages, such as coffee or soda, can alter the pH in the mouth, which may affect how well the nicotine is absorbed through the mucous membranes.\n- To maximize the therapeutic effect of the nicotine lozenge, it is advised to keep the mouth free of any substances that could hinder nicotine delivery for at least 15 minutes before and during use.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is it recommended not to eat or drink 15 minutes before using or while the nicotine lozenge is in the mouth?\nA: To prevent choking\nB: To enhance the effectiveness of the lozenge\nC: To avoid nausea\nD: To reduce the risk of heartburn\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consuming food or beverages can interfere with the absorption of nicotine from the lozenge, potentially reducing its effectiveness.\n- Drinking acidic beverages, such as coffee or soda, can alter the pH in the mouth, which may affect how well the nicotine is absorbed through the mucous membranes.\n- To maximize the therapeutic effect of the nicotine lozenge, it is advised to keep the mouth free of any substances that could hinder nicotine delivery for at least 15 minutes before and during use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is it recommended not to eat or drink 15 minutes before using or while the nicotine lozenge is in the mouth?\nA: To prevent choking\nB: To enhance the effectiveness of the lozenge\nC: To avoid nausea\nD: To reduce the risk of heartburn\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consuming food or beverages can interfere with the absorption of nicotine from the lozenge, potentially reducing its effectiveness.\n- Drinking acidic beverages, such as coffee or soda, can alter the pH in the mouth, which may affect how well the nicotine is absorbed through the mucous membranes.\n- To maximize the therapeutic effect of the nicotine lozenge, it is advised to keep the mouth free of any substances that could hinder nicotine delivery for at least 15 minutes before and during use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is it recommended not to eat or drink 15 minutes before using or while the nicotine lozenge is in the mouth?\nA: To prevent choking\nB: To enhance the effectiveness of the lozenge\nC: To avoid nausea\nD: To reduce the risk of heartburn\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consuming food or beverages can interfere with the absorption of nicotine from the lozenge, potentially reducing its effectiveness.\n- Drinking acidic beverages, such as coffee or soda, can alter the pH in the mouth, which may affect how well the nicotine is absorbed through the mucous membranes.\n- To maximize the therapeutic effect of the nicotine lozenge, it is advised to keep the mouth free of any substances that could hinder nicotine delivery for at least 15 minutes before and during use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"QDa2yAUjFrHJ","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they experience difficulty passing urine or dysuria while using Stiolto Respimat?\nA: Consult a physician immediately\nB: Increase the dosage of Stiolto Respimat\nC: Stop using inhaled corticosteroids\nD: Use additional long-acting beta-2 agonists\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they experience difficulty passing urine or dysuria while using Stiolto Respimat?\nA: Consult a physician immediately\nB: Increase the dosage of Stiolto Respimat\nC: Stop using inhaled corticosteroids\nD: Use additional long-acting beta-2 agonists\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they experience difficulty passing urine or dysuria while using Stiolto Respimat?\nA: Consult a physician immediately\nB: Increase the dosage of Stiolto Respimat\nC: Stop using inhaled corticosteroids\nD: Use additional long-acting beta-2 agonists\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"2UTa21p1FnAF","1) Recommendation: In patients with renal impairment, it is recommended to use Signifor LAR (pasireotide) with caution. Dose adjustments may be necessary based on the severity of renal impairment, and close monitoring for efficacy and adverse effects is advised.

2) Key rationale:
- Pasireotide is primarily metabolized by the liver, but renal impairment can affect its pharmacokinetics and increase the risk of adverse effects.
- Patients with renal impairment may have altered drug clearance, necessitating dose adjustments to avoid toxicity.
- Clinical studies specifically addressing dose adjustments in renal impairment are limited, highlighting the need for individualized treatment plans.

3) Safety/contraindications/interactions:
- Monitor renal function regularly in patients receiving Signifor LAR.
- Use with caution in patients with severe renal impairment (eGFR <30 mL/min).
- Potential interactions with other medications that are renally cleared or that may affect renal function should be considered.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the recommendation for dose adjustment of Signifor LAR in patients with renal impairment?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: In patients with renal impairment, it is recommended to use Signifor LAR (pasireotide) with caution. Dose adjustments may be necessary based on the severity of renal impairment, and close monitoring for efficacy and adverse effects is advised.\n\n2) Key rationale:\n- Pasireotide is primarily metabolized by the liver, but renal impairment can affect its pharmacokinetics and increase the risk of adverse effects.\n- Patients with renal impairment may have altered drug clearance, necessitating dose adjustments to avoid toxicity.\n- Clinical studies specifically addressing dose adjustments in renal impairment are limited, highlighting the need for individualized treatment plans.\n\n3) Safety/contraindications/interactions:\n- Monitor renal function regularly in patients receiving Signifor LAR.\n- Use with caution in patients with severe renal impairment (eGFR <30 mL/min).\n- Potential interactions with other medications that are renally cleared or that may affect renal function should be considered.""}]"
"IBTwA0AnsRhn","- ARIKAYCE is administered via inhalation, which results in localized delivery to the lungs and minimizes systemic absorption, reducing the risk of accumulation in patients with renal impairment.
- The dosing regimen for ARIKAYCE typically involves a lower total daily dose compared to systemic amikacin, further decreasing the likelihood of clinically relevant accumulation.
- In patients with renal impairment, the pharmacokinetics of inhaled amikacin differ significantly from intravenous formulations, leading to reduced systemic exposure and lower risk of toxicity.

MRRV(meta) winner=D; scores={'A': 0.3333333333333333, 'B': 0.5, 'C': 0.25, 'D': 1.0}; rankings=[['D', 'B', 'A', 'C'], ['D', 'B', 'A', 'C'], ['D', 'B', 'A', 'C']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy is clinically relevant accumulation of amikacin unlikely in patients with renal impairment when using ARIKAYCE?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- ARIKAYCE is administered via inhalation, which results in localized delivery to the lungs and minimizes systemic absorption, reducing the risk of accumulation in patients with renal impairment.\n- The dosing regimen for ARIKAYCE typically involves a lower total daily dose compared to systemic amikacin, further decreasing the likelihood of clinically relevant accumulation.\n- In patients with renal impairment, the pharmacokinetics of inhaled amikacin differ significantly from intravenous formulations, leading to reduced systemic exposure and lower risk of toxicity.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is clinically relevant accumulation of amikacin unlikely in patients with renal impairment when using ARIKAYCE?\nA: ARIKAYCE is metabolized by the liver.\nB: ARIKAYCE has low systemic exposure following inhalation.\nC: ARIKAYCE is rapidly excreted in the urine.\nD: ARIKAYCE is not absorbed systemically.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- ARIKAYCE is administered via inhalation, which results in localized delivery to the lungs and minimizes systemic absorption, reducing the risk of accumulation in patients with renal impairment.\n- The dosing regimen for ARIKAYCE typically involves a lower total daily dose compared to systemic amikacin, further decreasing the likelihood of clinically relevant accumulation.\n- In patients with renal impairment, the pharmacokinetics of inhaled amikacin differ significantly from intravenous formulations, leading to reduced systemic exposure and lower risk of toxicity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is clinically relevant accumulation of amikacin unlikely in patients with renal impairment when using ARIKAYCE?\nA: ARIKAYCE is metabolized by the liver.\nB: ARIKAYCE has low systemic exposure following inhalation.\nC: ARIKAYCE is rapidly excreted in the urine.\nD: ARIKAYCE is not absorbed systemically.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- ARIKAYCE is administered via inhalation, which results in localized delivery to the lungs and minimizes systemic absorption, reducing the risk of accumulation in patients with renal impairment.\n- The dosing regimen for ARIKAYCE typically involves a lower total daily dose compared to systemic amikacin, further decreasing the likelihood of clinically relevant accumulation.\n- In patients with renal impairment, the pharmacokinetics of inhaled amikacin differ significantly from intravenous formulations, leading to reduced systemic exposure and lower risk of toxicity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why is clinically relevant accumulation of amikacin unlikely in patients with renal impairment when using ARIKAYCE?\nA: ARIKAYCE is metabolized by the liver.\nB: ARIKAYCE has low systemic exposure following inhalation.\nC: ARIKAYCE is rapidly excreted in the urine.\nD: ARIKAYCE is not absorbed systemically.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- ARIKAYCE is administered via inhalation, which results in localized delivery to the lungs and minimizes systemic absorption, reducing the risk of accumulation in patients with renal impairment.\n- The dosing regimen for ARIKAYCE typically involves a lower total daily dose compared to systemic amikacin, further decreasing the likelihood of clinically relevant accumulation.\n- In patients with renal impairment, the pharmacokinetics of inhaled amikacin differ significantly from intravenous formulations, leading to reduced systemic exposure and lower risk of toxicity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > A > C""}]"
"rhMyn44N2wlJ","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the consequence of administering NURTEC ODT with strong or moderate inducers of CYP3A?\nA: Increased efficacy of NURTEC ODT\nB: Loss of efficacy of NURTEC ODT\nC: No change in efficacy\nD: Increased risk of side effects\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the consequence of administering NURTEC ODT with strong or moderate inducers of CYP3A?\nA: Increased efficacy of NURTEC ODT\nB: Loss of efficacy of NURTEC ODT\nC: No change in efficacy\nD: Increased risk of side effects\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the consequence of administering NURTEC ODT with strong or moderate inducers of CYP3A?\nA: Increased efficacy of NURTEC ODT\nB: Loss of efficacy of NURTEC ODT\nC: No change in efficacy\nD: Increased risk of side effects\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"LA3ZaefDZj8O","- The symptom of ""sore throat"" is not mentioned as being relieved by the 'nighttime severe cold and flu' medication.
- The relief of ""fever"" is specifically noted, while ""sore throat"" is absent from the list of alleviated symptoms.
- The active ingredients in 'nighttime severe cold and flu' do not include any that target sore throat relief.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 0.75, 'C': 0.5277777777777778, 'D': 0.3055555555555555}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D'], ['C', 'A', 'D', 'B']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich symptom is NOT mentioned as being relieved by 'nighttime severe cold and flu'?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The symptom of \""sore throat\"" is not mentioned as being relieved by the 'nighttime severe cold and flu' medication.\n- The relief of \""fever\"" is specifically noted, while \""sore throat\"" is absent from the list of alleviated symptoms.\n- The active ingredients in 'nighttime severe cold and flu' do not include any that target sore throat relief.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom is NOT mentioned as being relieved by 'nighttime severe cold and flu'?\nA: Headache\nB: Fever\nC: Nausea\nD: Sinus congestion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The symptom of \""sore throat\"" is not mentioned as being relieved by the 'nighttime severe cold and flu' medication.\n- The relief of \""fever\"" is specifically noted, while \""sore throat\"" is absent from the list of alleviated symptoms.\n- The active ingredients in 'nighttime severe cold and flu' do not include any that target sore throat relief.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom is NOT mentioned as being relieved by 'nighttime severe cold and flu'?\nA: Headache\nB: Fever\nC: Nausea\nD: Sinus congestion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The symptom of \""sore throat\"" is not mentioned as being relieved by the 'nighttime severe cold and flu' medication.\n- The relief of \""fever\"" is specifically noted, while \""sore throat\"" is absent from the list of alleviated symptoms.\n- The active ingredients in 'nighttime severe cold and flu' do not include any that target sore throat relief.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom is NOT mentioned as being relieved by 'nighttime severe cold and flu'?\nA: Headache\nB: Fever\nC: Nausea\nD: Sinus congestion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The symptom of \""sore throat\"" is not mentioned as being relieved by the 'nighttime severe cold and flu' medication.\n- The relief of \""fever\"" is specifically noted, while \""sore throat\"" is absent from the list of alleviated symptoms.\n- The active ingredients in 'nighttime severe cold and flu' do not include any that target sore throat relief.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}]"
"FupdxwfLFawr","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich test demonstrated that albuterol sulfate is not mutagenic?\nA: Ames test\nB: Mouse micronucleus assay\nC: Human peripheral lymphocyte assay\nD: Chromosome aberration test\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich test demonstrated that albuterol sulfate is not mutagenic?\nA: Ames test\nB: Mouse micronucleus assay\nC: Human peripheral lymphocyte assay\nD: Chromosome aberration test\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich test demonstrated that albuterol sulfate is not mutagenic?\nA: Ames test\nB: Mouse micronucleus assay\nC: Human peripheral lymphocyte assay\nD: Chromosome aberration test\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"1CGGC0QkJrrG","- Dopamine HCl in Dextrose Injection can cause hemolysis when mixed with blood, leading to the destruction of red blood cells.
- The presence of dextrose in the injection may promote bacterial growth if blood products are contaminated, increasing the risk of infection.
- Administering Dopamine HCl with blood can alter the pH and osmolarity of the blood product, potentially compromising its efficacy and safety.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy should Dopamine HCl in Dextrose Injection not be administered with blood?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Dopamine HCl in Dextrose Injection can cause hemolysis when mixed with blood, leading to the destruction of red blood cells.\n- The presence of dextrose in the injection may promote bacterial growth if blood products are contaminated, increasing the risk of infection.\n- Administering Dopamine HCl with blood can alter the pH and osmolarity of the blood product, potentially compromising its efficacy and safety.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should Dopamine HCl in Dextrose Injection not be administered with blood?\nA: It causes hemolysis\nB: It leads to pseudoagglutination of red cells\nC: It reduces the efficacy of dopamine\nD: It increases the risk of infection\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Dopamine HCl in Dextrose Injection can cause hemolysis when mixed with blood, leading to the destruction of red blood cells.\n- The presence of dextrose in the injection may promote bacterial growth if blood products are contaminated, increasing the risk of infection.\n- Administering Dopamine HCl with blood can alter the pH and osmolarity of the blood product, potentially compromising its efficacy and safety.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should Dopamine HCl in Dextrose Injection not be administered with blood?\nA: It causes hemolysis\nB: It leads to pseudoagglutination of red cells\nC: It reduces the efficacy of dopamine\nD: It increases the risk of infection\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Dopamine HCl in Dextrose Injection can cause hemolysis when mixed with blood, leading to the destruction of red blood cells.\n- The presence of dextrose in the injection may promote bacterial growth if blood products are contaminated, increasing the risk of infection.\n- Administering Dopamine HCl with blood can alter the pH and osmolarity of the blood product, potentially compromising its efficacy and safety.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should Dopamine HCl in Dextrose Injection not be administered with blood?\nA: It causes hemolysis\nB: It leads to pseudoagglutination of red cells\nC: It reduces the efficacy of dopamine\nD: It increases the risk of infection\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Dopamine HCl in Dextrose Injection can cause hemolysis when mixed with blood, leading to the destruction of red blood cells.\n- The presence of dextrose in the injection may promote bacterial growth if blood products are contaminated, increasing the risk of infection.\n- Administering Dopamine HCl with blood can alter the pH and osmolarity of the blood product, potentially compromising its efficacy and safety.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"WBClIcXsX4nG","MRRV winner=B; scores={'A': 0.4444444444444444, 'B': 1.0, 'C': 0.25, 'D': 0.38888888888888884}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following best describes the formulation of meijer stomach relief regular strength?\nA: Contains sugar and high sodium\nB: Sugar-free and low sodium\nC: Contains sugar and no salicylate\nD: Sugar-free and high sodium\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following best describes the formulation of meijer stomach relief regular strength?\nA: Contains sugar and high sodium\nB: Sugar-free and low sodium\nC: Contains sugar and no salicylate\nD: Sugar-free and high sodium\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following best describes the formulation of meijer stomach relief regular strength?\nA: Contains sugar and high sodium\nB: Sugar-free and low sodium\nC: Contains sugar and no salicylate\nD: Sugar-free and high sodium\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"xogv0HlPaTbX","MRRV winner=C; scores={'A': 0.6666666666666666, 'B': 0.3333333333333333, 'C': 0.8333333333333334, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for patients using combined hormonal contraceptives while taking Paxlovid?\nA: Continue using combined hormonal contraceptives without any changes.\nB: Switch to a non-hormonal contraceptive method.\nC: Use an effective alternative contraceptive method or an additional barrier method.\nD: Stop using contraceptives entirely while on Paxlovid.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for patients using combined hormonal contraceptives while taking Paxlovid?\nA: Continue using combined hormonal contraceptives without any changes.\nB: Switch to a non-hormonal contraceptive method.\nC: Use an effective alternative contraceptive method or an additional barrier method.\nD: Stop using contraceptives entirely while on Paxlovid.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for patients using combined hormonal contraceptives while taking Paxlovid?\nA: Continue using combined hormonal contraceptives without any changes.\nB: Switch to a non-hormonal contraceptive method.\nC: Use an effective alternative contraceptive method or an additional barrier method.\nD: Stop using contraceptives entirely while on Paxlovid.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"WSTnzbxpi1gq","- Consider discontinuing BRILINTA (ticagrelor) if the dyspnea is severe and persistent, as this side effect is known to occur in some patients.
- Evaluate the patient's overall clinical status and consider alternative antiplatelet therapy, such as clopidogrel, if BRILINTA is not tolerated.
- Monitor the patient closely for any signs of worsening respiratory distress or other complications related to the dyspnea.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if a patient develops intolerable dyspnea while being treated with BRILINTA?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Consider discontinuing BRILINTA (ticagrelor) if the dyspnea is severe and persistent, as this side effect is known to occur in some patients.\n- Evaluate the patient's overall clinical status and consider alternative antiplatelet therapy, such as clopidogrel, if BRILINTA is not tolerated.\n- Monitor the patient closely for any signs of worsening respiratory distress or other complications related to the dyspnea.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops intolerable dyspnea while being treated with BRILINTA?\nA: Discontinue BRILINTA and prescribe another antiplatelet agent.\nB: Continue BRILINTA without interruption regardless of dyspnea severity.\nC: Switch to a thrombolytic agent immediately.\nD: Perform pulmonary function testing and discontinue BRILINTA.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider discontinuing BRILINTA (ticagrelor) if the dyspnea is severe and persistent, as this side effect is known to occur in some patients.\n- Evaluate the patient's overall clinical status and consider alternative antiplatelet therapy, such as clopidogrel, if BRILINTA is not tolerated.\n- Monitor the patient closely for any signs of worsening respiratory distress or other complications related to the dyspnea.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops intolerable dyspnea while being treated with BRILINTA?\nA: Discontinue BRILINTA and prescribe another antiplatelet agent.\nB: Continue BRILINTA without interruption regardless of dyspnea severity.\nC: Switch to a thrombolytic agent immediately.\nD: Perform pulmonary function testing and discontinue BRILINTA.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider discontinuing BRILINTA (ticagrelor) if the dyspnea is severe and persistent, as this side effect is known to occur in some patients.\n- Evaluate the patient's overall clinical status and consider alternative antiplatelet therapy, such as clopidogrel, if BRILINTA is not tolerated.\n- Monitor the patient closely for any signs of worsening respiratory distress or other complications related to the dyspnea.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops intolerable dyspnea while being treated with BRILINTA?\nA: Discontinue BRILINTA and prescribe another antiplatelet agent.\nB: Continue BRILINTA without interruption regardless of dyspnea severity.\nC: Switch to a thrombolytic agent immediately.\nD: Perform pulmonary function testing and discontinue BRILINTA.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider discontinuing BRILINTA (ticagrelor) if the dyspnea is severe and persistent, as this side effect is known to occur in some patients.\n- Evaluate the patient's overall clinical status and consider alternative antiplatelet therapy, such as clopidogrel, if BRILINTA is not tolerated.\n- Monitor the patient closely for any signs of worsening respiratory distress or other complications related to the dyspnea.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"OY7z5v4a1npl","- Physicians should assess the patient's history of hypertension, as venlafaxine can increase blood pressure, particularly at higher doses.
- It is important to evaluate any current medications the patient is taking to avoid potential drug interactions, especially with other serotonergic agents or monoamine oxidase inhibitors (MAOIs).
- Physicians should consider the patient's history of bipolar disorder, as venlafaxine may induce manic episodes in susceptible individuals.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.25, 'C': 1.0, 'D': 0.3333333333333333}; rankings=[['C', 'A', 'D', 'B'], ['C', 'A', 'D', 'B'], ['C', 'A', 'D', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should physicians evaluate before prescribing venlafaxine tablets?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Physicians should assess the patient's history of hypertension, as venlafaxine can increase blood pressure, particularly at higher doses.\n- It is important to evaluate any current medications the patient is taking to avoid potential drug interactions, especially with other serotonergic agents or monoamine oxidase inhibitors (MAOIs).\n- Physicians should consider the patient's history of bipolar disorder, as venlafaxine may induce manic episodes in susceptible individuals.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should physicians evaluate before prescribing venlafaxine tablets?\nA: Patient's history of drug abuse\nB: Patient's history of allergic reactions\nC: Patient's cardiovascular health\nD: Patient's liver function\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Physicians should assess the patient's history of hypertension, as venlafaxine can increase blood pressure, particularly at higher doses.\n- It is important to evaluate any current medications the patient is taking to avoid potential drug interactions, especially with other serotonergic agents or monoamine oxidase inhibitors (MAOIs).\n- Physicians should consider the patient's history of bipolar disorder, as venlafaxine may induce manic episodes in susceptible individuals.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should physicians evaluate before prescribing venlafaxine tablets?\nA: Patient's history of drug abuse\nB: Patient's history of allergic reactions\nC: Patient's cardiovascular health\nD: Patient's liver function\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Physicians should assess the patient's history of hypertension, as venlafaxine can increase blood pressure, particularly at higher doses.\n- It is important to evaluate any current medications the patient is taking to avoid potential drug interactions, especially with other serotonergic agents or monoamine oxidase inhibitors (MAOIs).\n- Physicians should consider the patient's history of bipolar disorder, as venlafaxine may induce manic episodes in susceptible individuals.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should physicians evaluate before prescribing venlafaxine tablets?\nA: Patient's history of drug abuse\nB: Patient's history of allergic reactions\nC: Patient's cardiovascular health\nD: Patient's liver function\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Physicians should assess the patient's history of hypertension, as venlafaxine can increase blood pressure, particularly at higher doses.\n- It is important to evaluate any current medications the patient is taking to avoid potential drug interactions, especially with other serotonergic agents or monoamine oxidase inhibitors (MAOIs).\n- Physicians should consider the patient's history of bipolar disorder, as venlafaxine may induce manic episodes in susceptible individuals.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}]"
"YesvXioTJTL5","- The 'basic care nighttime cold and flu' formulation includes acetaminophen, which is specifically used for pain relief associated with cold and flu symptoms.
- This medication helps alleviate headaches and body aches that often accompany cold and flu illnesses, providing targeted pain management.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.38888888888888884, 'C': 0.4444444444444444, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich symptom relief provided by 'basic care nighttime cold and flu' is specifically related to pain management?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The 'basic care nighttime cold and flu' formulation includes acetaminophen, which is specifically used for pain relief associated with cold and flu symptoms.\n- This medication helps alleviate headaches and body aches that often accompany cold and flu illnesses, providing targeted pain management.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom relief provided by 'basic care nighttime cold and flu' is specifically related to pain management?\nA: Minor aches and pains\nB: Runny nose\nC: Cough due to minor throat irritation\nD: Nasal congestion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The 'basic care nighttime cold and flu' formulation includes acetaminophen, which is specifically used for pain relief associated with cold and flu symptoms.\n- This medication helps alleviate headaches and body aches that often accompany cold and flu illnesses, providing targeted pain management.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom relief provided by 'basic care nighttime cold and flu' is specifically related to pain management?\nA: Minor aches and pains\nB: Runny nose\nC: Cough due to minor throat irritation\nD: Nasal congestion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The 'basic care nighttime cold and flu' formulation includes acetaminophen, which is specifically used for pain relief associated with cold and flu symptoms.\n- This medication helps alleviate headaches and body aches that often accompany cold and flu illnesses, providing targeted pain management.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom relief provided by 'basic care nighttime cold and flu' is specifically related to pain management?\nA: Minor aches and pains\nB: Runny nose\nC: Cough due to minor throat irritation\nD: Nasal congestion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The 'basic care nighttime cold and flu' formulation includes acetaminophen, which is specifically used for pain relief associated with cold and flu symptoms.\n- This medication helps alleviate headaches and body aches that often accompany cold and flu illnesses, providing targeted pain management.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"s0mSOirAUFCM","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich statement is accurate regarding the contraindications of XENOVIEW?\nA: XENOVIEW is contraindicated in patients with severe hepatic impairment.\nB: XENOVIEW has no contraindications listed.\nC: XENOVIEW is contraindicated in pediatric patients.\nD: XENOVIEW is contraindicated in patients with a history of cardiovascular disease.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich statement is accurate regarding the contraindications of XENOVIEW?\nA: XENOVIEW is contraindicated in patients with severe hepatic impairment.\nB: XENOVIEW has no contraindications listed.\nC: XENOVIEW is contraindicated in pediatric patients.\nD: XENOVIEW is contraindicated in patients with a history of cardiovascular disease.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich statement is accurate regarding the contraindications of XENOVIEW?\nA: XENOVIEW is contraindicated in patients with severe hepatic impairment.\nB: XENOVIEW has no contraindications listed.\nC: XENOVIEW is contraindicated in pediatric patients.\nD: XENOVIEW is contraindicated in patients with a history of cardiovascular disease.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"ksohmE8DkBBX","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for SEGLUROMET in patients with volume depletion before initiation?\nA: Start SEGLUROMET immediately without correction.\nB: Correct the volume depletion before initiating SEGLUROMET.\nC: Reduce the dosage of SEGLUROMET.\nD: Switch to a different medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for SEGLUROMET in patients with volume depletion before initiation?\nA: Start SEGLUROMET immediately without correction.\nB: Correct the volume depletion before initiating SEGLUROMET.\nC: Reduce the dosage of SEGLUROMET.\nD: Switch to a different medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for SEGLUROMET in patients with volume depletion before initiation?\nA: Start SEGLUROMET immediately without correction.\nB: Correct the volume depletion before initiating SEGLUROMET.\nC: Reduce the dosage of SEGLUROMET.\nD: Switch to a different medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"EEp7G3X6kxlC","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn which age group is fluoxetine associated with an increased risk of suicidal thoughts and behaviors?\nA: Children, adolescents, and young adults (under 25 years)\nB: Adults aged 25-64 years\nC: Adults aged 65 years and older\nD: All age groups equally\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn which age group is fluoxetine associated with an increased risk of suicidal thoughts and behaviors?\nA: Children, adolescents, and young adults (under 25 years)\nB: Adults aged 25-64 years\nC: Adults aged 65 years and older\nD: All age groups equally\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn which age group is fluoxetine associated with an increased risk of suicidal thoughts and behaviors?\nA: Children, adolescents, and young adults (under 25 years)\nB: Adults aged 25-64 years\nC: Adults aged 65 years and older\nD: All age groups equally\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"UMkpfx07HZ0f","MRRV winner=D; scores={'A': 0.6666666666666666, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.8333333333333334}; rankings=[['D', 'A', 'B', 'C'], ['A', 'D', 'B', 'C'], ['D', 'A', 'B', 'C']]","D","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf an adult's pain or fever does not respond to one sunmark ibuprofen tablet, what is the recommended next step?\nA: Take 2 tablets\nB: Take 3 tablets\nC: Wait 24 hours before taking another tablet\nD: Consult a doctor immediately\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf an adult's pain or fever does not respond to one sunmark ibuprofen tablet, what is the recommended next step?\nA: Take 2 tablets\nB: Take 3 tablets\nC: Wait 24 hours before taking another tablet\nD: Consult a doctor immediately\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf an adult's pain or fever does not respond to one sunmark ibuprofen tablet, what is the recommended next step?\nA: Take 2 tablets\nB: Take 3 tablets\nC: Wait 24 hours before taking another tablet\nD: Consult a doctor immediately\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}]"
"mJIXaEdUE4eg","MRRV winner=A; scores={'A': 0.8333333333333334, 'B': 0.6666666666666666, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['A', 'B', 'C', 'D'], ['B', 'A', 'D', 'C'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the guidance for dosage adjustment of HYDREA in patients with hepatic impairment?\nA: Specific dosage adjustments are provided.\nB: No data supports specific dosage adjustments; close monitoring of hematologic parameters is advised.\nC: Dosage should be increased to compensate for reduced drug metabolism.\nD: HYDREA is contraindicated in patients with hepatic impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the guidance for dosage adjustment of HYDREA in patients with hepatic impairment?\nA: Specific dosage adjustments are provided.\nB: No data supports specific dosage adjustments; close monitoring of hematologic parameters is advised.\nC: Dosage should be increased to compensate for reduced drug metabolism.\nD: HYDREA is contraindicated in patients with hepatic impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the guidance for dosage adjustment of HYDREA in patients with hepatic impairment?\nA: Specific dosage adjustments are provided.\nB: No data supports specific dosage adjustments; close monitoring of hematologic parameters is advised.\nC: Dosage should be increased to compensate for reduced drug metabolism.\nD: HYDREA is contraindicated in patients with hepatic impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"lx92cpo9HfBr","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended amount of hair regrowth treatment to apply per use?\nA: 0.5 mL\nB: 1 mL\nC: 2 mL\nD: 3 mL\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended amount of hair regrowth treatment to apply per use?\nA: 0.5 mL\nB: 1 mL\nC: 2 mL\nD: 3 mL\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended amount of hair regrowth treatment to apply per use?\nA: 0.5 mL\nB: 1 mL\nC: 2 mL\nD: 3 mL\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"MeDSxA6kKDZv","- Discontinue NURTEC ODT, as it may contribute to the exacerbation of Raynauds phenomenon.
- Consider alternative treatments for migraine management that do not have vasoconstrictive properties.
- Monitor the patient for any further symptoms or complications related to Raynauds phenomenon after stopping the medication.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended course of action if a patient develops Raynaud\u2019s phenomenon while taking NURTEC ODT?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Discontinue NURTEC ODT, as it may contribute to the exacerbation of Raynaud\u2019s phenomenon.\n- Consider alternative treatments for migraine management that do not have vasoconstrictive properties.\n- Monitor the patient for any further symptoms or complications related to Raynaud\u2019s phenomenon after stopping the medication.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended course of action if a patient develops Raynaud\u2019s phenomenon while taking NURTEC ODT?\nA: Continue the medication and monitor symptoms.\nB: Discontinue NURTEC ODT and evaluate the patient if symptoms persist.\nC: Increase the dosage of NURTEC ODT to manage symptoms.\nD: Switch to another CGRP antagonist immediately.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue NURTEC ODT, as it may contribute to the exacerbation of Raynaud\u2019s phenomenon.\n- Consider alternative treatments for migraine management that do not have vasoconstrictive properties.\n- Monitor the patient for any further symptoms or complications related to Raynaud\u2019s phenomenon after stopping the medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended course of action if a patient develops Raynaud\u2019s phenomenon while taking NURTEC ODT?\nA: Continue the medication and monitor symptoms.\nB: Discontinue NURTEC ODT and evaluate the patient if symptoms persist.\nC: Increase the dosage of NURTEC ODT to manage symptoms.\nD: Switch to another CGRP antagonist immediately.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue NURTEC ODT, as it may contribute to the exacerbation of Raynaud\u2019s phenomenon.\n- Consider alternative treatments for migraine management that do not have vasoconstrictive properties.\n- Monitor the patient for any further symptoms or complications related to Raynaud\u2019s phenomenon after stopping the medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended course of action if a patient develops Raynaud\u2019s phenomenon while taking NURTEC ODT?\nA: Continue the medication and monitor symptoms.\nB: Discontinue NURTEC ODT and evaluate the patient if symptoms persist.\nC: Increase the dosage of NURTEC ODT to manage symptoms.\nD: Switch to another CGRP antagonist immediately.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue NURTEC ODT, as it may contribute to the exacerbation of Raynaud\u2019s phenomenon.\n- Consider alternative treatments for migraine management that do not have vasoconstrictive properties.\n- Monitor the patient for any further symptoms or complications related to Raynaud\u2019s phenomenon after stopping the medication.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"1qYYsbjR3dU6","- Administer atropine as a first-line treatment to counteract severe bradycardia caused by BREVIBLOC injection.
- Consider discontinuing the BREVIBLOC infusion if bradycardia persists despite atropine administration.
- Monitor the patient's heart rate and rhythm closely after any intervention to ensure stabilization.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.27777777777777773, 'C': 1.0, 'D': 0.3055555555555555}; rankings=[['C', 'A', 'D', 'B'], ['C', 'A', 'B', 'D'], ['C', 'A', 'D', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if a patient develops severe bradycardia while receiving BREVIBLOC injection?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Administer atropine as a first-line treatment to counteract severe bradycardia caused by BREVIBLOC injection.\n- Consider discontinuing the BREVIBLOC infusion if bradycardia persists despite atropine administration.\n- Monitor the patient's heart rate and rhythm closely after any intervention to ensure stabilization.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops severe bradycardia while receiving BREVIBLOC injection?\nA: Increase the dose of BREVIBLOC injection.\nB: Administer an alpha-blocker immediately.\nC: Reduce or stop BREVIBLOC injection.\nD: Switch to a nonselective beta blocker.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer atropine as a first-line treatment to counteract severe bradycardia caused by BREVIBLOC injection.\n- Consider discontinuing the BREVIBLOC infusion if bradycardia persists despite atropine administration.\n- Monitor the patient's heart rate and rhythm closely after any intervention to ensure stabilization.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops severe bradycardia while receiving BREVIBLOC injection?\nA: Increase the dose of BREVIBLOC injection.\nB: Administer an alpha-blocker immediately.\nC: Reduce or stop BREVIBLOC injection.\nD: Switch to a nonselective beta blocker.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer atropine as a first-line treatment to counteract severe bradycardia caused by BREVIBLOC injection.\n- Consider discontinuing the BREVIBLOC infusion if bradycardia persists despite atropine administration.\n- Monitor the patient's heart rate and rhythm closely after any intervention to ensure stabilization.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops severe bradycardia while receiving BREVIBLOC injection?\nA: Increase the dose of BREVIBLOC injection.\nB: Administer an alpha-blocker immediately.\nC: Reduce or stop BREVIBLOC injection.\nD: Switch to a nonselective beta blocker.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer atropine as a first-line treatment to counteract severe bradycardia caused by BREVIBLOC injection.\n- Consider discontinuing the BREVIBLOC infusion if bradycardia persists despite atropine administration.\n- Monitor the patient's heart rate and rhythm closely after any intervention to ensure stabilization.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}]"
"2oQ6XsyENSfg","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nFor patients with mild to moderate renal impairment (creatinine clearance between 45 mL/min and 79 mL/min), what modification is recommended for ibuprofen administration when receiving Pemetrexed for injection?\nA: Avoid ibuprofen administration for 1 day before, the day of, and 1 day after Pemetrexed administration.\nB: Avoid ibuprofen administration for 2 days before, the day of, and 2 days after Pemetrexed administration.\nC: Avoid ibuprofen administration for 3 days before, the day of, and 3 days after Pemetrexed administration.\nD: No modification is required for ibuprofen administration.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nFor patients with mild to moderate renal impairment (creatinine clearance between 45 mL/min and 79 mL/min), what modification is recommended for ibuprofen administration when receiving Pemetrexed for injection?\nA: Avoid ibuprofen administration for 1 day before, the day of, and 1 day after Pemetrexed administration.\nB: Avoid ibuprofen administration for 2 days before, the day of, and 2 days after Pemetrexed administration.\nC: Avoid ibuprofen administration for 3 days before, the day of, and 3 days after Pemetrexed administration.\nD: No modification is required for ibuprofen administration.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nFor patients with mild to moderate renal impairment (creatinine clearance between 45 mL/min and 79 mL/min), what modification is recommended for ibuprofen administration when receiving Pemetrexed for injection?\nA: Avoid ibuprofen administration for 1 day before, the day of, and 1 day after Pemetrexed administration.\nB: Avoid ibuprofen administration for 2 days before, the day of, and 2 days after Pemetrexed administration.\nC: Avoid ibuprofen administration for 3 days before, the day of, and 3 days after Pemetrexed administration.\nD: No modification is required for ibuprofen administration.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"h1xRp2K608us","MRRV winner=B; scores={'A': 0.6666666666666666, 'B': 0.8333333333333334, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['A', 'B', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is a key consideration when converting patients from other opioids to RoxyBond?\nA: Underestimating the total daily dosage of RoxyBond to avoid overdose.\nB: Overestimating the total daily dosage of RoxyBond to ensure pain relief.\nC: Discontinuing all other analgesics immediately.\nD: Using the same dosage as the previous opioid without adjustment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is a key consideration when converting patients from other opioids to RoxyBond?\nA: Underestimating the total daily dosage of RoxyBond to avoid overdose.\nB: Overestimating the total daily dosage of RoxyBond to ensure pain relief.\nC: Discontinuing all other analgesics immediately.\nD: Using the same dosage as the previous opioid without adjustment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is a key consideration when converting patients from other opioids to RoxyBond?\nA: Underestimating the total daily dosage of RoxyBond to avoid overdose.\nB: Overestimating the total daily dosage of RoxyBond to ensure pain relief.\nC: Discontinuing all other analgesics immediately.\nD: Using the same dosage as the previous opioid without adjustment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"9PCE0q2dUlK2","- GOPRELTO contains the active ingredient ketorolac, which can increase the risk of gastrointestinal bleeding, a concern for patients taking disulfiram due to potential interactions.
- Disulfiram can cause adverse reactions when combined with certain medications, and the use of GOPRELTO may exacerbate these effects, leading to increased toxicity or side effects.
- The combination of disulfiram and ketorolac may lead to unpredictable pharmacological responses, making it essential to avoid using GOPRELTO in these patients.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy should GOPRELTO be avoided in patients taking disulfiram?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- GOPRELTO contains the active ingredient ketorolac, which can increase the risk of gastrointestinal bleeding, a concern for patients taking disulfiram due to potential interactions.\n- Disulfiram can cause adverse reactions when combined with certain medications, and the use of GOPRELTO may exacerbate these effects, leading to increased toxicity or side effects.\n- The combination of disulfiram and ketorolac may lead to unpredictable pharmacological responses, making it essential to avoid using GOPRELTO in these patients.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should GOPRELTO be avoided in patients taking disulfiram?\nA: Disulfiram reduces the efficacy of GOPRELTO.\nB: Disulfiram increases plasma cocaine exposure significantly.\nC: Disulfiram causes severe allergic reactions with GOPRELTO.\nD: Disulfiram leads to decreased plasma cholinesterase activity.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- GOPRELTO contains the active ingredient ketorolac, which can increase the risk of gastrointestinal bleeding, a concern for patients taking disulfiram due to potential interactions.\n- Disulfiram can cause adverse reactions when combined with certain medications, and the use of GOPRELTO may exacerbate these effects, leading to increased toxicity or side effects.\n- The combination of disulfiram and ketorolac may lead to unpredictable pharmacological responses, making it essential to avoid using GOPRELTO in these patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should GOPRELTO be avoided in patients taking disulfiram?\nA: Disulfiram reduces the efficacy of GOPRELTO.\nB: Disulfiram increases plasma cocaine exposure significantly.\nC: Disulfiram causes severe allergic reactions with GOPRELTO.\nD: Disulfiram leads to decreased plasma cholinesterase activity.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- GOPRELTO contains the active ingredient ketorolac, which can increase the risk of gastrointestinal bleeding, a concern for patients taking disulfiram due to potential interactions.\n- Disulfiram can cause adverse reactions when combined with certain medications, and the use of GOPRELTO may exacerbate these effects, leading to increased toxicity or side effects.\n- The combination of disulfiram and ketorolac may lead to unpredictable pharmacological responses, making it essential to avoid using GOPRELTO in these patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should GOPRELTO be avoided in patients taking disulfiram?\nA: Disulfiram reduces the efficacy of GOPRELTO.\nB: Disulfiram increases plasma cocaine exposure significantly.\nC: Disulfiram causes severe allergic reactions with GOPRELTO.\nD: Disulfiram leads to decreased plasma cholinesterase activity.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- GOPRELTO contains the active ingredient ketorolac, which can increase the risk of gastrointestinal bleeding, a concern for patients taking disulfiram due to potential interactions.\n- Disulfiram can cause adverse reactions when combined with certain medications, and the use of GOPRELTO may exacerbate these effects, leading to increased toxicity or side effects.\n- The combination of disulfiram and ketorolac may lead to unpredictable pharmacological responses, making it essential to avoid using GOPRELTO in these patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"Xs0qzAqVg2i6","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat serious condition should patients be informed about before starting treatment with lamotrigine that involves excessive immune activation?\nA: Hemophagocytic Lymphohistiocytosis\nB: Aseptic Meningitis\nC: Multiorgan Hypersensitivity Reactions\nD: Cardiac Rhythm Abnormalities\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat serious condition should patients be informed about before starting treatment with lamotrigine that involves excessive immune activation?\nA: Hemophagocytic Lymphohistiocytosis\nB: Aseptic Meningitis\nC: Multiorgan Hypersensitivity Reactions\nD: Cardiac Rhythm Abnormalities\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat serious condition should patients be informed about before starting treatment with lamotrigine that involves excessive immune activation?\nA: Hemophagocytic Lymphohistiocytosis\nB: Aseptic Meningitis\nC: Multiorgan Hypersensitivity Reactions\nD: Cardiac Rhythm Abnormalities\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"OBARnunuMxRf","MRRV winner=B; scores={'A': 0.4444444444444444, 'B': 1.0, 'C': 0.38888888888888884, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they experience vomiting or diarrhea while taking Jaimiess?\nA: Continue taking Jaimiess as usual without any additional precautions\nB: Use a backup contraception method until consulting a healthcare provider\nC: Stop taking Jaimiess immediately\nD: Double the dose of Jaimiess for the next 24 hours\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they experience vomiting or diarrhea while taking Jaimiess?\nA: Continue taking Jaimiess as usual without any additional precautions\nB: Use a backup contraception method until consulting a healthcare provider\nC: Stop taking Jaimiess immediately\nD: Double the dose of Jaimiess for the next 24 hours\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they experience vomiting or diarrhea while taking Jaimiess?\nA: Continue taking Jaimiess as usual without any additional precautions\nB: Use a backup contraception method until consulting a healthcare provider\nC: Stop taking Jaimiess immediately\nD: Double the dose of Jaimiess for the next 24 hours\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"EBeIyLZMbrsE","- Monitor for increased suicidal thoughts or behaviors, particularly during the initial treatment phase or when doses are adjusted, as venlafaxine is an antidepressant that can elevate these risks in younger populations.
- Assess for changes in mood, anxiety levels, and any emergence of agitation or irritability, as these can indicate adverse reactions to venlafaxine therapy.
- Regularly evaluate for signs of serotonin syndrome, especially if venlafaxine is used in conjunction with other serotonergic medications, due to the potential for this serious side effect.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should be monitored in children and adolescents taking venlafaxine tablets?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Monitor for increased suicidal thoughts or behaviors, particularly during the initial treatment phase or when doses are adjusted, as venlafaxine is an antidepressant that can elevate these risks in younger populations.\n- Assess for changes in mood, anxiety levels, and any emergence of agitation or irritability, as these can indicate adverse reactions to venlafaxine therapy.\n- Regularly evaluate for signs of serotonin syndrome, especially if venlafaxine is used in conjunction with other serotonergic medications, due to the potential for this serious side effect.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be monitored in children and adolescents taking venlafaxine tablets?\nA: Blood pressure\nB: Height and weight\nC: Cholesterol levels\nD: Eye pressure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor for increased suicidal thoughts or behaviors, particularly during the initial treatment phase or when doses are adjusted, as venlafaxine is an antidepressant that can elevate these risks in younger populations.\n- Assess for changes in mood, anxiety levels, and any emergence of agitation or irritability, as these can indicate adverse reactions to venlafaxine therapy.\n- Regularly evaluate for signs of serotonin syndrome, especially if venlafaxine is used in conjunction with other serotonergic medications, due to the potential for this serious side effect.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be monitored in children and adolescents taking venlafaxine tablets?\nA: Blood pressure\nB: Height and weight\nC: Cholesterol levels\nD: Eye pressure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor for increased suicidal thoughts or behaviors, particularly during the initial treatment phase or when doses are adjusted, as venlafaxine is an antidepressant that can elevate these risks in younger populations.\n- Assess for changes in mood, anxiety levels, and any emergence of agitation or irritability, as these can indicate adverse reactions to venlafaxine therapy.\n- Regularly evaluate for signs of serotonin syndrome, especially if venlafaxine is used in conjunction with other serotonergic medications, due to the potential for this serious side effect.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be monitored in children and adolescents taking venlafaxine tablets?\nA: Blood pressure\nB: Height and weight\nC: Cholesterol levels\nD: Eye pressure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor for increased suicidal thoughts or behaviors, particularly during the initial treatment phase or when doses are adjusted, as venlafaxine is an antidepressant that can elevate these risks in younger populations.\n- Assess for changes in mood, anxiety levels, and any emergence of agitation or irritability, as these can indicate adverse reactions to venlafaxine therapy.\n- Regularly evaluate for signs of serotonin syndrome, especially if venlafaxine is used in conjunction with other serotonergic medications, due to the potential for this serious side effect.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"hsaKWwtAO0Hc","- OCELLA, which contains the active ingredients ethinyl estradiol and drospirenone, is not recommended for use during pregnancy due to potential risks to the developing fetus.
- Women who become pregnant while taking OCELLA should discontinue the medication immediately and consult their healthcare provider for further guidance.
- The use of OCELLA is contraindicated in pregnant individuals, as hormonal contraceptives are not intended for use during this period.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.3055555555555555}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommendation for OCELLA use during pregnancy?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- OCELLA, which contains the active ingredients ethinyl estradiol and drospirenone, is not recommended for use during pregnancy due to potential risks to the developing fetus.\n- Women who become pregnant while taking OCELLA should discontinue the medication immediately and consult their healthcare provider for further guidance.\n- The use of OCELLA is contraindicated in pregnant individuals, as hormonal contraceptives are not intended for use during this period.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for OCELLA use during pregnancy?\nA: OCELLA should be continued throughout pregnancy.\nB: OCELLA should be discontinued during pregnancy.\nC: OCELLA is recommended for use in the third trimester only.\nD: OCELLA is safe for use during all stages of pregnancy.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- OCELLA, which contains the active ingredients ethinyl estradiol and drospirenone, is not recommended for use during pregnancy due to potential risks to the developing fetus.\n- Women who become pregnant while taking OCELLA should discontinue the medication immediately and consult their healthcare provider for further guidance.\n- The use of OCELLA is contraindicated in pregnant individuals, as hormonal contraceptives are not intended for use during this period.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for OCELLA use during pregnancy?\nA: OCELLA should be continued throughout pregnancy.\nB: OCELLA should be discontinued during pregnancy.\nC: OCELLA is recommended for use in the third trimester only.\nD: OCELLA is safe for use during all stages of pregnancy.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- OCELLA, which contains the active ingredients ethinyl estradiol and drospirenone, is not recommended for use during pregnancy due to potential risks to the developing fetus.\n- Women who become pregnant while taking OCELLA should discontinue the medication immediately and consult their healthcare provider for further guidance.\n- The use of OCELLA is contraindicated in pregnant individuals, as hormonal contraceptives are not intended for use during this period.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation for OCELLA use during pregnancy?\nA: OCELLA should be continued throughout pregnancy.\nB: OCELLA should be discontinued during pregnancy.\nC: OCELLA is recommended for use in the third trimester only.\nD: OCELLA is safe for use during all stages of pregnancy.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- OCELLA, which contains the active ingredients ethinyl estradiol and drospirenone, is not recommended for use during pregnancy due to potential risks to the developing fetus.\n- Women who become pregnant while taking OCELLA should discontinue the medication immediately and consult their healthcare provider for further guidance.\n- The use of OCELLA is contraindicated in pregnant individuals, as hormonal contraceptives are not intended for use during this period.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"4fplb7adlaBG","- The pregnancy registry for Albuterol Sulfate HFA is designed to monitor and collect data on the effects of the drug when used by pregnant women, ensuring safety for both the mother and the fetus.
- It aims to assess any potential risks or adverse outcomes associated with the use of Albuterol Sulfate HFA during pregnancy compared to a control group not using the medication.
- The registry helps in gathering real-world evidence to inform healthcare providers and patients about the implications of using Albuterol Sulfate HFA in pregnant populations.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the purpose of the pregnancy registry associated with Albuterol Sulfate HFA?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The pregnancy registry for Albuterol Sulfate HFA is designed to monitor and collect data on the effects of the drug when used by pregnant women, ensuring safety for both the mother and the fetus.\n- It aims to assess any potential risks or adverse outcomes associated with the use of Albuterol Sulfate HFA during pregnancy compared to a control group not using the medication.\n- The registry helps in gathering real-world evidence to inform healthcare providers and patients about the implications of using Albuterol Sulfate HFA in pregnant populations.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the purpose of the pregnancy registry associated with Albuterol Sulfate HFA?\nA: To collect information about the health of pregnant women and their babies.\nB: To provide free medication to pregnant women.\nC: To monitor the effectiveness of Albuterol Sulfate HFA in children.\nD: To study the long-term effects of Albuterol Sulfate HFA on asthma symptoms.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The pregnancy registry for Albuterol Sulfate HFA is designed to monitor and collect data on the effects of the drug when used by pregnant women, ensuring safety for both the mother and the fetus.\n- It aims to assess any potential risks or adverse outcomes associated with the use of Albuterol Sulfate HFA during pregnancy compared to a control group not using the medication.\n- The registry helps in gathering real-world evidence to inform healthcare providers and patients about the implications of using Albuterol Sulfate HFA in pregnant populations.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the purpose of the pregnancy registry associated with Albuterol Sulfate HFA?\nA: To collect information about the health of pregnant women and their babies.\nB: To provide free medication to pregnant women.\nC: To monitor the effectiveness of Albuterol Sulfate HFA in children.\nD: To study the long-term effects of Albuterol Sulfate HFA on asthma symptoms.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The pregnancy registry for Albuterol Sulfate HFA is designed to monitor and collect data on the effects of the drug when used by pregnant women, ensuring safety for both the mother and the fetus.\n- It aims to assess any potential risks or adverse outcomes associated with the use of Albuterol Sulfate HFA during pregnancy compared to a control group not using the medication.\n- The registry helps in gathering real-world evidence to inform healthcare providers and patients about the implications of using Albuterol Sulfate HFA in pregnant populations.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the purpose of the pregnancy registry associated with Albuterol Sulfate HFA?\nA: To collect information about the health of pregnant women and their babies.\nB: To provide free medication to pregnant women.\nC: To monitor the effectiveness of Albuterol Sulfate HFA in children.\nD: To study the long-term effects of Albuterol Sulfate HFA on asthma symptoms.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The pregnancy registry for Albuterol Sulfate HFA is designed to monitor and collect data on the effects of the drug when used by pregnant women, ensuring safety for both the mother and the fetus.\n- It aims to assess any potential risks or adverse outcomes associated with the use of Albuterol Sulfate HFA during pregnancy compared to a control group not using the medication.\n- The registry helps in gathering real-world evidence to inform healthcare providers and patients about the implications of using Albuterol Sulfate HFA in pregnant populations.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"nz2BZihS2OTS","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the brand name of the drug associated with the MULTI FUNCTION SLEEPING PACK?\nA: MULTI FUNCTION SLEEPING PACK\nB: MULTI FUNCTION SLEEPING PACK\nC: MULTI FUNCTION SLEEPING PACK\nD: MULTI FUNCTION SLEEPING PACK\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the brand name of the drug associated with the MULTI FUNCTION SLEEPING PACK?\nA: MULTI FUNCTION SLEEPING PACK\nB: MULTI FUNCTION SLEEPING PACK\nC: MULTI FUNCTION SLEEPING PACK\nD: MULTI FUNCTION SLEEPING PACK\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the brand name of the drug associated with the MULTI FUNCTION SLEEPING PACK?\nA: MULTI FUNCTION SLEEPING PACK\nB: MULTI FUNCTION SLEEPING PACK\nC: MULTI FUNCTION SLEEPING PACK\nD: MULTI FUNCTION SLEEPING PACK\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"eOekgajwExEk","- Nighttime Severe Cold and Flu contains diphenhydramine, an antihistamine that helps relieve symptoms like nasal congestion, allowing for easier breathing during sleep.
- The formulation includes phenylephrine, which reduces sinus pressure and can alleviate headaches, contributing to improved sleep quality.
- The product also addresses cough symptoms, which can disrupt sleep, helping users to rest more comfortably through the night.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is one of the symptoms that 'nighttime severe cold and flu' helps relieve to improve sleep quality?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Nighttime Severe Cold and Flu contains diphenhydramine, an antihistamine that helps relieve symptoms like nasal congestion, allowing for easier breathing during sleep.\n- The formulation includes phenylephrine, which reduces sinus pressure and can alleviate headaches, contributing to improved sleep quality.\n- The product also addresses cough symptoms, which can disrupt sleep, helping users to rest more comfortably through the night.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is one of the symptoms that 'nighttime severe cold and flu' helps relieve to improve sleep quality?\nA: Sinus congestion\nB: Runny nose\nC: Cough\nD: Headache\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Nighttime Severe Cold and Flu contains diphenhydramine, an antihistamine that helps relieve symptoms like nasal congestion, allowing for easier breathing during sleep.\n- The formulation includes phenylephrine, which reduces sinus pressure and can alleviate headaches, contributing to improved sleep quality.\n- The product also addresses cough symptoms, which can disrupt sleep, helping users to rest more comfortably through the night.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is one of the symptoms that 'nighttime severe cold and flu' helps relieve to improve sleep quality?\nA: Sinus congestion\nB: Runny nose\nC: Cough\nD: Headache\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Nighttime Severe Cold and Flu contains diphenhydramine, an antihistamine that helps relieve symptoms like nasal congestion, allowing for easier breathing during sleep.\n- The formulation includes phenylephrine, which reduces sinus pressure and can alleviate headaches, contributing to improved sleep quality.\n- The product also addresses cough symptoms, which can disrupt sleep, helping users to rest more comfortably through the night.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is one of the symptoms that 'nighttime severe cold and flu' helps relieve to improve sleep quality?\nA: Sinus congestion\nB: Runny nose\nC: Cough\nD: Headache\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Nighttime Severe Cold and Flu contains diphenhydramine, an antihistamine that helps relieve symptoms like nasal congestion, allowing for easier breathing during sleep.\n- The formulation includes phenylephrine, which reduces sinus pressure and can alleviate headaches, contributing to improved sleep quality.\n- The product also addresses cough symptoms, which can disrupt sleep, helping users to rest more comfortably through the night.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"KDk5KEtcd2g7","- The combination of Ondansetron, a 5-HT3 receptor antagonist, with Tramadol, an opioid analgesic, may increase the risk of serotonin syndrome due to Tramadol's serotonergic properties.
- Ondansetron may enhance the analgesic effects of Tramadol, potentially leading to improved pain management in patients experiencing nausea and pain simultaneously.
- Caution should be exercised when using Ondansetron with Tramadol, as both drugs can affect the central nervous system, potentially leading to increased sedation or respiratory depression.

MRRV(meta) winner=C; scores={'A': 0.3333333333333333, 'B': 0.25, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhen Ondansetron is administered with Tramadol, what potential effect might occur?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The combination of Ondansetron, a 5-HT3 receptor antagonist, with Tramadol, an opioid analgesic, may increase the risk of serotonin syndrome due to Tramadol's serotonergic properties.\n- Ondansetron may enhance the analgesic effects of Tramadol, potentially leading to improved pain management in patients experiencing nausea and pain simultaneously.\n- Caution should be exercised when using Ondansetron with Tramadol, as both drugs can affect the central nervous system, potentially leading to increased sedation or respiratory depression.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: When Ondansetron is administered with Tramadol, what potential effect might occur?\nA: Ondansetron reduces the efficacy of Tramadol\nB: Ondansetron increases patient-controlled administration of Tramadol\nC: Ondansetron causes serotonin syndrome with Tramadol\nD: Ondansetron enhances the respiratory depressant effects of Tramadol\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination of Ondansetron, a 5-HT3 receptor antagonist, with Tramadol, an opioid analgesic, may increase the risk of serotonin syndrome due to Tramadol's serotonergic properties.\n- Ondansetron may enhance the analgesic effects of Tramadol, potentially leading to improved pain management in patients experiencing nausea and pain simultaneously.\n- Caution should be exercised when using Ondansetron with Tramadol, as both drugs can affect the central nervous system, potentially leading to increased sedation or respiratory depression.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: When Ondansetron is administered with Tramadol, what potential effect might occur?\nA: Ondansetron reduces the efficacy of Tramadol\nB: Ondansetron increases patient-controlled administration of Tramadol\nC: Ondansetron causes serotonin syndrome with Tramadol\nD: Ondansetron enhances the respiratory depressant effects of Tramadol\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination of Ondansetron, a 5-HT3 receptor antagonist, with Tramadol, an opioid analgesic, may increase the risk of serotonin syndrome due to Tramadol's serotonergic properties.\n- Ondansetron may enhance the analgesic effects of Tramadol, potentially leading to improved pain management in patients experiencing nausea and pain simultaneously.\n- Caution should be exercised when using Ondansetron with Tramadol, as both drugs can affect the central nervous system, potentially leading to increased sedation or respiratory depression.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: When Ondansetron is administered with Tramadol, what potential effect might occur?\nA: Ondansetron reduces the efficacy of Tramadol\nB: Ondansetron increases patient-controlled administration of Tramadol\nC: Ondansetron causes serotonin syndrome with Tramadol\nD: Ondansetron enhances the respiratory depressant effects of Tramadol\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The combination of Ondansetron, a 5-HT3 receptor antagonist, with Tramadol, an opioid analgesic, may increase the risk of serotonin syndrome due to Tramadol's serotonergic properties.\n- Ondansetron may enhance the analgesic effects of Tramadol, potentially leading to improved pain management in patients experiencing nausea and pain simultaneously.\n- Caution should be exercised when using Ondansetron with Tramadol, as both drugs can affect the central nervous system, potentially leading to increased sedation or respiratory depression.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}]"
"ttfRmSgFyt3L","MRRV winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT an intended use of NICOTINE?\nA: Reducing nicotine cravings.\nB: Managing withdrawal symptoms.\nC: Treating chronic respiratory conditions.\nD: Supporting smoking cessation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT an intended use of NICOTINE?\nA: Reducing nicotine cravings.\nB: Managing withdrawal symptoms.\nC: Treating chronic respiratory conditions.\nD: Supporting smoking cessation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT an intended use of NICOTINE?\nA: Reducing nicotine cravings.\nB: Managing withdrawal symptoms.\nC: Treating chronic respiratory conditions.\nD: Supporting smoking cessation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"WLXQgHU9F2BE","- The highest dose of fluoxetine administered to adult rats was 40 mg/kg.
- This dose is approximately 2.5 times the maximum recommended human dose (MRHD) on a mg/m basis.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn fertility studies, what was the highest dose of fluoxetine administered to adult rats, and what was its approximate comparison to the MRHD on a mg/m\u00b2 basis?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The highest dose of fluoxetine administered to adult rats was 40 mg/kg.\n- This dose is approximately 2.5 times the maximum recommended human dose (MRHD) on a mg/m\u00b2 basis.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In fertility studies, what was the highest dose of fluoxetine administered to adult rats, and what was its approximate comparison to the MRHD on a mg/m\u00b2 basis?\nA: 7.5 mg/kg/day, approximately 0.9 times the MRHD\nB: 12.5 mg/kg/day, approximately 1.5 times the MRHD\nC: 10 mg/kg/day, approximately 1.2 times the MRHD\nD: 12 mg/kg/day, approximately 0.7 times the MRHD\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The highest dose of fluoxetine administered to adult rats was 40 mg/kg.\n- This dose is approximately 2.5 times the maximum recommended human dose (MRHD) on a mg/m\u00b2 basis.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In fertility studies, what was the highest dose of fluoxetine administered to adult rats, and what was its approximate comparison to the MRHD on a mg/m\u00b2 basis?\nA: 7.5 mg/kg/day, approximately 0.9 times the MRHD\nB: 12.5 mg/kg/day, approximately 1.5 times the MRHD\nC: 10 mg/kg/day, approximately 1.2 times the MRHD\nD: 12 mg/kg/day, approximately 0.7 times the MRHD\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The highest dose of fluoxetine administered to adult rats was 40 mg/kg.\n- This dose is approximately 2.5 times the maximum recommended human dose (MRHD) on a mg/m\u00b2 basis.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In fertility studies, what was the highest dose of fluoxetine administered to adult rats, and what was its approximate comparison to the MRHD on a mg/m\u00b2 basis?\nA: 7.5 mg/kg/day, approximately 0.9 times the MRHD\nB: 12.5 mg/kg/day, approximately 1.5 times the MRHD\nC: 10 mg/kg/day, approximately 1.2 times the MRHD\nD: 12 mg/kg/day, approximately 0.7 times the MRHD\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The highest dose of fluoxetine administered to adult rats was 40 mg/kg.\n- This dose is approximately 2.5 times the maximum recommended human dose (MRHD) on a mg/m\u00b2 basis.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}]"
"LwvCB0Hz0fYP","- Prioritize assessing the patient's renal function using serum creatinine levels and calculating the estimated glomerular filtration rate (eGFR) before administering Gadavist.
- Consider using alternative imaging modalities that do not require gadolinium-based contrast agents for patients with significantly impaired renal function (eGFR < 30 mL/min).
- Ensure that patients with a history of nephrogenic systemic fibrosis (NSF) are identified and that Gadavist is avoided in these cases.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich diagnostic approach should be prioritized for patients with impaired renal function before considering Gadavist?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Prioritize assessing the patient's renal function using serum creatinine levels and calculating the estimated glomerular filtration rate (eGFR) before administering Gadavist.\n- Consider using alternative imaging modalities that do not require gadolinium-based contrast agents for patients with significantly impaired renal function (eGFR < 30 mL/min).\n- Ensure that patients with a history of nephrogenic systemic fibrosis (NSF) are identified and that Gadavist is avoided in these cases.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which diagnostic approach should be prioritized for patients with impaired renal function before considering Gadavist?\nA: Non-contrasted MRI or other modalities\nB: Intrathecal administration of Gadavist\nC: High-dose Gadavist administration\nD: Immediate re-administration of Gadavist\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Prioritize assessing the patient's renal function using serum creatinine levels and calculating the estimated glomerular filtration rate (eGFR) before administering Gadavist.\n- Consider using alternative imaging modalities that do not require gadolinium-based contrast agents for patients with significantly impaired renal function (eGFR < 30 mL/min).\n- Ensure that patients with a history of nephrogenic systemic fibrosis (NSF) are identified and that Gadavist is avoided in these cases.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which diagnostic approach should be prioritized for patients with impaired renal function before considering Gadavist?\nA: Non-contrasted MRI or other modalities\nB: Intrathecal administration of Gadavist\nC: High-dose Gadavist administration\nD: Immediate re-administration of Gadavist\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Prioritize assessing the patient's renal function using serum creatinine levels and calculating the estimated glomerular filtration rate (eGFR) before administering Gadavist.\n- Consider using alternative imaging modalities that do not require gadolinium-based contrast agents for patients with significantly impaired renal function (eGFR < 30 mL/min).\n- Ensure that patients with a history of nephrogenic systemic fibrosis (NSF) are identified and that Gadavist is avoided in these cases.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which diagnostic approach should be prioritized for patients with impaired renal function before considering Gadavist?\nA: Non-contrasted MRI or other modalities\nB: Intrathecal administration of Gadavist\nC: High-dose Gadavist administration\nD: Immediate re-administration of Gadavist\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Prioritize assessing the patient's renal function using serum creatinine levels and calculating the estimated glomerular filtration rate (eGFR) before administering Gadavist.\n- Consider using alternative imaging modalities that do not require gadolinium-based contrast agents for patients with significantly impaired renal function (eGFR < 30 mL/min).\n- Ensure that patients with a history of nephrogenic systemic fibrosis (NSF) are identified and that Gadavist is avoided in these cases.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"Ae5RpzkwcMKE","- The antifungal brand-name drug Lamisil (terbinafine) should be used daily for 1 week to treat athlete's foot.
- Lotrimin (clotrimazole) is typically applied twice daily for 2 to 4 weeks for effective treatment of athlete's foot.
- Tinactin (tolnaftate) is recommended to be used twice daily for 2 to 4 weeks to ensure complete resolution of athlete's foot symptoms.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.38888888888888884, 'C': 0.4444444444444444, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nFor how long should the antifungal brand-name drug be used daily to treat athlete's foot?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The antifungal brand-name drug Lamisil (terbinafine) should be used daily for 1 week to treat athlete's foot.\n- Lotrimin (clotrimazole) is typically applied twice daily for 2 to 4 weeks for effective treatment of athlete's foot.\n- Tinactin (tolnaftate) is recommended to be used twice daily for 2 to 4 weeks to ensure complete resolution of athlete's foot symptoms.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: For how long should the antifungal brand-name drug be used daily to treat athlete's foot?\nA: 2 weeks\nB: 3 weeks\nC: 4 weeks\nD: 5 weeks\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The antifungal brand-name drug Lamisil (terbinafine) should be used daily for 1 week to treat athlete's foot.\n- Lotrimin (clotrimazole) is typically applied twice daily for 2 to 4 weeks for effective treatment of athlete's foot.\n- Tinactin (tolnaftate) is recommended to be used twice daily for 2 to 4 weeks to ensure complete resolution of athlete's foot symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: For how long should the antifungal brand-name drug be used daily to treat athlete's foot?\nA: 2 weeks\nB: 3 weeks\nC: 4 weeks\nD: 5 weeks\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The antifungal brand-name drug Lamisil (terbinafine) should be used daily for 1 week to treat athlete's foot.\n- Lotrimin (clotrimazole) is typically applied twice daily for 2 to 4 weeks for effective treatment of athlete's foot.\n- Tinactin (tolnaftate) is recommended to be used twice daily for 2 to 4 weeks to ensure complete resolution of athlete's foot symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: For how long should the antifungal brand-name drug be used daily to treat athlete's foot?\nA: 2 weeks\nB: 3 weeks\nC: 4 weeks\nD: 5 weeks\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The antifungal brand-name drug Lamisil (terbinafine) should be used daily for 1 week to treat athlete's foot.\n- Lotrimin (clotrimazole) is typically applied twice daily for 2 to 4 weeks for effective treatment of athlete's foot.\n- Tinactin (tolnaftate) is recommended to be used twice daily for 2 to 4 weeks to ensure complete resolution of athlete's foot symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"MsBTxJCk0VEk","MRRV winner=C; scores={'A': 0.3055555555555555, 'B': 0.5, 'C': 1.0, 'D': 0.27777777777777773}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'D', 'A'], ['C', 'B', 'A', 'D']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for the use of Gadavist in lactating women?\nA: It is contraindicated during lactation.\nB: It should be avoided due to high levels of gadobutrol in breast milk.\nC: The developmental and health benefits of breastfeeding should be weighed against the mother's clinical need for Gadavist.\nD: It is safe to use without any precautions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for the use of Gadavist in lactating women?\nA: It is contraindicated during lactation.\nB: It should be avoided due to high levels of gadobutrol in breast milk.\nC: The developmental and health benefits of breastfeeding should be weighed against the mother's clinical need for Gadavist.\nD: It is safe to use without any precautions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for the use of Gadavist in lactating women?\nA: It is contraindicated during lactation.\nB: It should be avoided due to high levels of gadobutrol in breast milk.\nC: The developmental and health benefits of breastfeeding should be weighed against the mother's clinical need for Gadavist.\nD: It is safe to use without any precautions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}]"
"XfLNyXbbU1TP","- The use of monoamine oxidase inhibitors (MAOIs) such as phenelzine or tranylcypromine within 14 days prior to starting fluoxetine increases the risk of serotonin syndrome.
- Concurrent use of other serotonergic drugs, such as triptans (e.g., sumatriptan) or certain antidepressants (e.g., venlafaxine), can also lead to serotonin syndrome when combined with fluoxetine.
- A history of serotonin syndrome in the patients medical record is a contraindication for prescribing fluoxetine due to the heightened risk of recurrence.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.4444444444444444, 'C': 0.3055555555555555, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'C', 'D'], ['A', 'D', 'B', 'C'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following conditions is a contraindication for the use of fluoxetine due to the risk of serotonin syndrome?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The use of monoamine oxidase inhibitors (MAOIs) such as phenelzine or tranylcypromine within 14 days prior to starting fluoxetine increases the risk of serotonin syndrome.\n- Concurrent use of other serotonergic drugs, such as triptans (e.g., sumatriptan) or certain antidepressants (e.g., venlafaxine), can also lead to serotonin syndrome when combined with fluoxetine.\n- A history of serotonin syndrome in the patient\u2019s medical record is a contraindication for prescribing fluoxetine due to the heightened risk of recurrence.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following conditions is a contraindication for the use of fluoxetine due to the risk of serotonin syndrome?\nA: Concomitant use with MAOIs such as linezolid or intravenous methylene blue\nB: Concomitant use with NSAIDs or aspirin\nC: Concomitant use with diuretics\nD: Concomitant use with beta-blockers\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The use of monoamine oxidase inhibitors (MAOIs) such as phenelzine or tranylcypromine within 14 days prior to starting fluoxetine increases the risk of serotonin syndrome.\n- Concurrent use of other serotonergic drugs, such as triptans (e.g., sumatriptan) or certain antidepressants (e.g., venlafaxine), can also lead to serotonin syndrome when combined with fluoxetine.\n- A history of serotonin syndrome in the patient\u2019s medical record is a contraindication for prescribing fluoxetine due to the heightened risk of recurrence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following conditions is a contraindication for the use of fluoxetine due to the risk of serotonin syndrome?\nA: Concomitant use with MAOIs such as linezolid or intravenous methylene blue\nB: Concomitant use with NSAIDs or aspirin\nC: Concomitant use with diuretics\nD: Concomitant use with beta-blockers\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The use of monoamine oxidase inhibitors (MAOIs) such as phenelzine or tranylcypromine within 14 days prior to starting fluoxetine increases the risk of serotonin syndrome.\n- Concurrent use of other serotonergic drugs, such as triptans (e.g., sumatriptan) or certain antidepressants (e.g., venlafaxine), can also lead to serotonin syndrome when combined with fluoxetine.\n- A history of serotonin syndrome in the patient\u2019s medical record is a contraindication for prescribing fluoxetine due to the heightened risk of recurrence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following conditions is a contraindication for the use of fluoxetine due to the risk of serotonin syndrome?\nA: Concomitant use with MAOIs such as linezolid or intravenous methylene blue\nB: Concomitant use with NSAIDs or aspirin\nC: Concomitant use with diuretics\nD: Concomitant use with beta-blockers\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The use of monoamine oxidase inhibitors (MAOIs) such as phenelzine or tranylcypromine within 14 days prior to starting fluoxetine increases the risk of serotonin syndrome.\n- Concurrent use of other serotonergic drugs, such as triptans (e.g., sumatriptan) or certain antidepressants (e.g., venlafaxine), can also lead to serotonin syndrome when combined with fluoxetine.\n- A history of serotonin syndrome in the patient\u2019s medical record is a contraindication for prescribing fluoxetine due to the heightened risk of recurrence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"QLBjRpllQV7p","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf a biomedical researcher is storing the drug 'sterile' at 10\u00b0C, what issue might arise?\nA: The drug may freeze and lose efficacy.\nB: The drug may degrade due to being stored below the recommended range.\nC: The drug may evaporate due to high temperature.\nD: No issues will arise as 10\u00b0C is within the recommended range.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf a biomedical researcher is storing the drug 'sterile' at 10\u00b0C, what issue might arise?\nA: The drug may freeze and lose efficacy.\nB: The drug may degrade due to being stored below the recommended range.\nC: The drug may evaporate due to high temperature.\nD: No issues will arise as 10\u00b0C is within the recommended range.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf a biomedical researcher is storing the drug 'sterile' at 10\u00b0C, what issue might arise?\nA: The drug may freeze and lose efficacy.\nB: The drug may degrade due to being stored below the recommended range.\nC: The drug may evaporate due to high temperature.\nD: No issues will arise as 10\u00b0C is within the recommended range.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"OB8FmIUYXQmZ","- 'Up and Up Nighttime Cold and Flu' should not be stored at temperatures above 25C (77F), as excessive heat can degrade the active ingredients.
- It is incorrect to store 'Up and Up Nighttime Cold and Flu' in a bathroom, as humidity can affect the stability of the medication.
- The product should not be exposed to direct sunlight, which can also compromise its effectiveness.

MRRV(meta) winner=C; scores={'A': 0.3333333333333333, 'B': 0.25, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following is NOT a correct storage condition for 'up and up nighttime cold and flu'?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- 'Up and Up Nighttime Cold and Flu' should not be stored at temperatures above 25\u00b0C (77\u00b0F), as excessive heat can degrade the active ingredients.\n- It is incorrect to store 'Up and Up Nighttime Cold and Flu' in a bathroom, as humidity can affect the stability of the medication.\n- The product should not be exposed to direct sunlight, which can also compromise its effectiveness.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is NOT a correct storage condition for 'up and up nighttime cold and flu'?\nA: Storing at 20-25 \u00b0C.\nB: Storing at 68-77 \u00b0F.\nC: Storing below 20 \u00b0C.\nD: Storing above 25 \u00b0C.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- 'Up and Up Nighttime Cold and Flu' should not be stored at temperatures above 25\u00b0C (77\u00b0F), as excessive heat can degrade the active ingredients.\n- It is incorrect to store 'Up and Up Nighttime Cold and Flu' in a bathroom, as humidity can affect the stability of the medication.\n- The product should not be exposed to direct sunlight, which can also compromise its effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is NOT a correct storage condition for 'up and up nighttime cold and flu'?\nA: Storing at 20-25 \u00b0C.\nB: Storing at 68-77 \u00b0F.\nC: Storing below 20 \u00b0C.\nD: Storing above 25 \u00b0C.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- 'Up and Up Nighttime Cold and Flu' should not be stored at temperatures above 25\u00b0C (77\u00b0F), as excessive heat can degrade the active ingredients.\n- It is incorrect to store 'Up and Up Nighttime Cold and Flu' in a bathroom, as humidity can affect the stability of the medication.\n- The product should not be exposed to direct sunlight, which can also compromise its effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following is NOT a correct storage condition for 'up and up nighttime cold and flu'?\nA: Storing at 20-25 \u00b0C.\nB: Storing at 68-77 \u00b0F.\nC: Storing below 20 \u00b0C.\nD: Storing above 25 \u00b0C.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- 'Up and Up Nighttime Cold and Flu' should not be stored at temperatures above 25\u00b0C (77\u00b0F), as excessive heat can degrade the active ingredients.\n- It is incorrect to store 'Up and Up Nighttime Cold and Flu' in a bathroom, as humidity can affect the stability of the medication.\n- The product should not be exposed to direct sunlight, which can also compromise its effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}]"
"tuN9GetBGdOd","MRRV winner=B; scores={'A': 0.4444444444444444, 'B': 1.0, 'C': 0.25, 'D': 0.38888888888888884}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy should coadministration of Iclusig with strong CYP3A inhibitors be avoided?\nA: It decreases ponatinib plasma concentrations.\nB: It increases ponatinib plasma concentrations, raising the risk of adverse reactions.\nC: It has no effect on ponatinib plasma concentrations.\nD: It reduces the efficacy of Iclusig.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy should coadministration of Iclusig with strong CYP3A inhibitors be avoided?\nA: It decreases ponatinib plasma concentrations.\nB: It increases ponatinib plasma concentrations, raising the risk of adverse reactions.\nC: It has no effect on ponatinib plasma concentrations.\nD: It reduces the efficacy of Iclusig.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy should coadministration of Iclusig with strong CYP3A inhibitors be avoided?\nA: It decreases ponatinib plasma concentrations.\nB: It increases ponatinib plasma concentrations, raising the risk of adverse reactions.\nC: It has no effect on ponatinib plasma concentrations.\nD: It reduces the efficacy of Iclusig.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"6wFwF1Rn9ib0","MRRV winner=A; scores={'A': 1.0, 'B': 0.3055555555555555, 'C': 0.27777777777777773, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich patient condition is a contraindication for the use of Ondansetron?\nA: Hypersensitivity to Ondansetron or its components\nB: Diabetes mellitus\nC: Hypertension\nD: Renal failure\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich patient condition is a contraindication for the use of Ondansetron?\nA: Hypersensitivity to Ondansetron or its components\nB: Diabetes mellitus\nC: Hypertension\nD: Renal failure\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich patient condition is a contraindication for the use of Ondansetron?\nA: Hypersensitivity to Ondansetron or its components\nB: Diabetes mellitus\nC: Hypertension\nD: Renal failure\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"3uNUJnR0RHi3","1) Recommendation: Lamotrigine should not be prescribed in patients with a known hypersensitivity to the drug or its components, those with a history of severe skin reactions (such as Stevens-Johnson syndrome), or in individuals who are currently taking certain medications that may interact adversely with lamotrigine.

2) Key rationale:
   - Hypersensitivity reactions can lead to serious and potentially life-threatening conditions.
   - A history of severe skin reactions indicates a higher risk for recurrence, which can be fatal.
   - Certain medications, such as valproate, can significantly increase lamotrigine levels, raising the risk of toxicity and adverse effects.
   - Patients with liver impairment may have altered drug metabolism, necessitating caution or avoidance of lamotrigine.

3) Safety/contraindications/interactions:
   - Contraindicated in patients with a known allergy to lamotrigine or its excipients.
   - Avoid in patients with a history of Stevens-Johnson syndrome or toxic epidermal necrolysis.
   - Caution in patients taking valproate, as it can increase lamotrigine levels.
   - Monitor closely in patients with liver disease or those taking other medications that may affect lamotrigine metabolism.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nIn which scenario should Lamotrigine not be prescribed?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Lamotrigine should not be prescribed in patients with a known hypersensitivity to the drug or its components, those with a history of severe skin reactions (such as Stevens-Johnson syndrome), or in individuals who are currently taking certain medications that may interact adversely with lamotrigine.\n\n2) Key rationale:\n   - Hypersensitivity reactions can lead to serious and potentially life-threatening conditions.\n   - A history of severe skin reactions indicates a higher risk for recurrence, which can be fatal.\n   - Certain medications, such as valproate, can significantly increase lamotrigine levels, raising the risk of toxicity and adverse effects.\n   - Patients with liver impairment may have altered drug metabolism, necessitating caution or avoidance of lamotrigine.\n\n3) Safety/contraindications/interactions:\n   - Contraindicated in patients with a known allergy to lamotrigine or its excipients.\n   - Avoid in patients with a history of Stevens-Johnson syndrome or toxic epidermal necrolysis.\n   - Caution in patients taking valproate, as it can increase lamotrigine levels.\n   - Monitor closely in patients with liver disease or those taking other medications that may affect lamotrigine metabolism.""}]"
"2xBlLrIgfF27","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is specifically targeted by NICOTINE to assist individuals in quitting smoking?\nA: Respiratory distress.\nB: Nicotine craving.\nC: Chronic fatigue.\nD: Digestive issues.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is specifically targeted by NICOTINE to assist individuals in quitting smoking?\nA: Respiratory distress.\nB: Nicotine craving.\nC: Chronic fatigue.\nD: Digestive issues.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is specifically targeted by NICOTINE to assist individuals in quitting smoking?\nA: Respiratory distress.\nB: Nicotine craving.\nC: Chronic fatigue.\nD: Digestive issues.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"UxhA39dXgR9u","- The median seizure frequency reduction observed with a 400 mg/day dose of lamotrigine was significantly greater than that of the placebo group.
- Specifically, patients receiving lamotrigine at 400 mg/day experienced a median reduction of approximately 50% in seizure frequency compared to those on placebo.
- This indicates that lamotrigine at this dosage provides a meaningful therapeutic benefit over placebo in managing partial-onset seizures.

MRRV(meta) winner=D; scores={'A': 0.4166666666666667, 'B': 0.3333333333333333, 'C': 0.3333333333333333, 'D': 1.0}; rankings=[['D', 'C', 'B', 'A'], ['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn a trial for adjunctive therapy in adults with partial-onset seizures, what was the median seizure frequency reduction observed with a 400 mg/day dose of lamotrigine compared to placebo?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The median seizure frequency reduction observed with a 400 mg/day dose of lamotrigine was significantly greater than that of the placebo group.\n- Specifically, patients receiving lamotrigine at 400 mg/day experienced a median reduction of approximately 50% in seizure frequency compared to those on placebo.\n- This indicates that lamotrigine at this dosage provides a meaningful therapeutic benefit over placebo in managing partial-onset seizures.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In a trial for adjunctive therapy in adults with partial-onset seizures, what was the median seizure frequency reduction observed with a 400 mg/day dose of lamotrigine compared to placebo?\nA: 15%\nB: 25%\nC: 35%\nD: 50%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The median seizure frequency reduction observed with a 400 mg/day dose of lamotrigine was significantly greater than that of the placebo group.\n- Specifically, patients receiving lamotrigine at 400 mg/day experienced a median reduction of approximately 50% in seizure frequency compared to those on placebo.\n- This indicates that lamotrigine at this dosage provides a meaningful therapeutic benefit over placebo in managing partial-onset seizures.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In a trial for adjunctive therapy in adults with partial-onset seizures, what was the median seizure frequency reduction observed with a 400 mg/day dose of lamotrigine compared to placebo?\nA: 15%\nB: 25%\nC: 35%\nD: 50%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The median seizure frequency reduction observed with a 400 mg/day dose of lamotrigine was significantly greater than that of the placebo group.\n- Specifically, patients receiving lamotrigine at 400 mg/day experienced a median reduction of approximately 50% in seizure frequency compared to those on placebo.\n- This indicates that lamotrigine at this dosage provides a meaningful therapeutic benefit over placebo in managing partial-onset seizures.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In a trial for adjunctive therapy in adults with partial-onset seizures, what was the median seizure frequency reduction observed with a 400 mg/day dose of lamotrigine compared to placebo?\nA: 15%\nB: 25%\nC: 35%\nD: 50%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The median seizure frequency reduction observed with a 400 mg/day dose of lamotrigine was significantly greater than that of the placebo group.\n- Specifically, patients receiving lamotrigine at 400 mg/day experienced a median reduction of approximately 50% in seizure frequency compared to those on placebo.\n- This indicates that lamotrigine at this dosage provides a meaningful therapeutic benefit over placebo in managing partial-onset seizures.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}]"
"a6ZRMYjOIJvy","- Users may experience a tingling or burning sensation in the mouth as the nicotine lozenge dissolves.
- Some individuals report a mild throat irritation or discomfort while using the nicotine lozenge.
- A rush of nicotine may lead to a feeling of increased alertness or a slight buzz shortly after the lozenge begins to dissolve.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat sensation might a user experience while using a nicotine lozenge?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Users may experience a tingling or burning sensation in the mouth as the nicotine lozenge dissolves.\n- Some individuals report a mild throat irritation or discomfort while using the nicotine lozenge.\n- A rush of nicotine may lead to a feeling of increased alertness or a slight buzz shortly after the lozenge begins to dissolve.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What sensation might a user experience while using a nicotine lozenge?\nA: A cold sensation\nB: A warm or tingling sensation\nC: A sharp pain\nD: A numbing sensation\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Users may experience a tingling or burning sensation in the mouth as the nicotine lozenge dissolves.\n- Some individuals report a mild throat irritation or discomfort while using the nicotine lozenge.\n- A rush of nicotine may lead to a feeling of increased alertness or a slight buzz shortly after the lozenge begins to dissolve.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What sensation might a user experience while using a nicotine lozenge?\nA: A cold sensation\nB: A warm or tingling sensation\nC: A sharp pain\nD: A numbing sensation\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Users may experience a tingling or burning sensation in the mouth as the nicotine lozenge dissolves.\n- Some individuals report a mild throat irritation or discomfort while using the nicotine lozenge.\n- A rush of nicotine may lead to a feeling of increased alertness or a slight buzz shortly after the lozenge begins to dissolve.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What sensation might a user experience while using a nicotine lozenge?\nA: A cold sensation\nB: A warm or tingling sensation\nC: A sharp pain\nD: A numbing sensation\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Users may experience a tingling or burning sensation in the mouth as the nicotine lozenge dissolves.\n- Some individuals report a mild throat irritation or discomfort while using the nicotine lozenge.\n- A rush of nicotine may lead to a feeling of increased alertness or a slight buzz shortly after the lozenge begins to dissolve.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"I6CNSylqq7aE","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary route of excretion for venlafaxine and its metabolites?\nA: Fecal excretion\nB: Renal elimination\nC: Pulmonary excretion\nD: Biliary excretion\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary route of excretion for venlafaxine and its metabolites?\nA: Fecal excretion\nB: Renal elimination\nC: Pulmonary excretion\nD: Biliary excretion\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary route of excretion for venlafaxine and its metabolites?\nA: Fecal excretion\nB: Renal elimination\nC: Pulmonary excretion\nD: Biliary excretion\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"VLDnAEemog7l","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the contraindication for using Sumatriptan injection in patients receiving Monoamine Oxidase-A (MAO-A) inhibitors?\nA: Risk of serotonin syndrome\nB: Increased systemic exposure of Sumatriptan\nC: Prolonged vasospastic reactions\nD: Reduced efficacy of Sumatriptan\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the contraindication for using Sumatriptan injection in patients receiving Monoamine Oxidase-A (MAO-A) inhibitors?\nA: Risk of serotonin syndrome\nB: Increased systemic exposure of Sumatriptan\nC: Prolonged vasospastic reactions\nD: Reduced efficacy of Sumatriptan\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the contraindication for using Sumatriptan injection in patients receiving Monoamine Oxidase-A (MAO-A) inhibitors?\nA: Risk of serotonin syndrome\nB: Increased systemic exposure of Sumatriptan\nC: Prolonged vasospastic reactions\nD: Reduced efficacy of Sumatriptan\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"ubrd1XA2Lnj8","- Patients taking OZOBAX DS, which contains the active ingredient buprenorphine, during pregnancy should be monitored for neonatal withdrawal symptoms.
- Infants born to mothers who have been on a regimen of OZOBAX DS may exhibit signs of withdrawal due to the drug's opioid properties.
- Close observation is necessary for newborns if the mother was using OZOBAX DS in the third trimester of pregnancy, as this is when withdrawal symptoms are most likely to manifest.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich patient population should be monitored for neonatal withdrawal symptoms if OZOBAX DS is used during pregnancy?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients taking OZOBAX DS, which contains the active ingredient buprenorphine, during pregnancy should be monitored for neonatal withdrawal symptoms.\n- Infants born to mothers who have been on a regimen of OZOBAX DS may exhibit signs of withdrawal due to the drug's opioid properties.\n- Close observation is necessary for newborns if the mother was using OZOBAX DS in the third trimester of pregnancy, as this is when withdrawal symptoms are most likely to manifest.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient population should be monitored for neonatal withdrawal symptoms if OZOBAX DS is used during pregnancy?\nA: Infants exposed to OZOBAX DS during breastfeeding\nB: Infants exposed to OZOBAX DS throughout pregnancy\nC: Infants exposed to OZOBAX DS during the first trimester only\nD: Infants exposed to OZOBAX DS after birth\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking OZOBAX DS, which contains the active ingredient buprenorphine, during pregnancy should be monitored for neonatal withdrawal symptoms.\n- Infants born to mothers who have been on a regimen of OZOBAX DS may exhibit signs of withdrawal due to the drug's opioid properties.\n- Close observation is necessary for newborns if the mother was using OZOBAX DS in the third trimester of pregnancy, as this is when withdrawal symptoms are most likely to manifest.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient population should be monitored for neonatal withdrawal symptoms if OZOBAX DS is used during pregnancy?\nA: Infants exposed to OZOBAX DS during breastfeeding\nB: Infants exposed to OZOBAX DS throughout pregnancy\nC: Infants exposed to OZOBAX DS during the first trimester only\nD: Infants exposed to OZOBAX DS after birth\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking OZOBAX DS, which contains the active ingredient buprenorphine, during pregnancy should be monitored for neonatal withdrawal symptoms.\n- Infants born to mothers who have been on a regimen of OZOBAX DS may exhibit signs of withdrawal due to the drug's opioid properties.\n- Close observation is necessary for newborns if the mother was using OZOBAX DS in the third trimester of pregnancy, as this is when withdrawal symptoms are most likely to manifest.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient population should be monitored for neonatal withdrawal symptoms if OZOBAX DS is used during pregnancy?\nA: Infants exposed to OZOBAX DS during breastfeeding\nB: Infants exposed to OZOBAX DS throughout pregnancy\nC: Infants exposed to OZOBAX DS during the first trimester only\nD: Infants exposed to OZOBAX DS after birth\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking OZOBAX DS, which contains the active ingredient buprenorphine, during pregnancy should be monitored for neonatal withdrawal symptoms.\n- Infants born to mothers who have been on a regimen of OZOBAX DS may exhibit signs of withdrawal due to the drug's opioid properties.\n- Close observation is necessary for newborns if the mother was using OZOBAX DS in the third trimester of pregnancy, as this is when withdrawal symptoms are most likely to manifest.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"iAeycMX0HKGx","- Breastfeeding is generally considered safe for mothers treated with FOSAPREPITANT, as it is not expected to harm a nursing infant.
- FOSAPREPITANT is a neurokinin-1 receptor antagonist used for the prevention of nausea and vomiting associated with chemotherapy, and its excretion in breast milk is minimal.
- It is advisable for mothers to consult with their healthcare provider for personalized recommendations while on FOSAPREPITANT.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommendation regarding breastfeeding for mothers treated with FOSAPREPITANT?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Breastfeeding is generally considered safe for mothers treated with FOSAPREPITANT, as it is not expected to harm a nursing infant.\n- FOSAPREPITANT is a neurokinin-1 receptor antagonist used for the prevention of nausea and vomiting associated with chemotherapy, and its excretion in breast milk is minimal.\n- It is advisable for mothers to consult with their healthcare provider for personalized recommendations while on FOSAPREPITANT.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation regarding breastfeeding for mothers treated with FOSAPREPITANT?\nA: Breastfeeding should be discontinued during treatment.\nB: Breastfeeding is safe without any precautions.\nC: The developmental and health benefits of breastfeeding should be weighed against the mother's clinical need for FOSAPREPITANT and potential adverse effects on the infant.\nD: Breastfeeding is contraindicated during treatment with FOSAPREPITANT.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Breastfeeding is generally considered safe for mothers treated with FOSAPREPITANT, as it is not expected to harm a nursing infant.\n- FOSAPREPITANT is a neurokinin-1 receptor antagonist used for the prevention of nausea and vomiting associated with chemotherapy, and its excretion in breast milk is minimal.\n- It is advisable for mothers to consult with their healthcare provider for personalized recommendations while on FOSAPREPITANT.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation regarding breastfeeding for mothers treated with FOSAPREPITANT?\nA: Breastfeeding should be discontinued during treatment.\nB: Breastfeeding is safe without any precautions.\nC: The developmental and health benefits of breastfeeding should be weighed against the mother's clinical need for FOSAPREPITANT and potential adverse effects on the infant.\nD: Breastfeeding is contraindicated during treatment with FOSAPREPITANT.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Breastfeeding is generally considered safe for mothers treated with FOSAPREPITANT, as it is not expected to harm a nursing infant.\n- FOSAPREPITANT is a neurokinin-1 receptor antagonist used for the prevention of nausea and vomiting associated with chemotherapy, and its excretion in breast milk is minimal.\n- It is advisable for mothers to consult with their healthcare provider for personalized recommendations while on FOSAPREPITANT.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommendation regarding breastfeeding for mothers treated with FOSAPREPITANT?\nA: Breastfeeding should be discontinued during treatment.\nB: Breastfeeding is safe without any precautions.\nC: The developmental and health benefits of breastfeeding should be weighed against the mother's clinical need for FOSAPREPITANT and potential adverse effects on the infant.\nD: Breastfeeding is contraindicated during treatment with FOSAPREPITANT.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Breastfeeding is generally considered safe for mothers treated with FOSAPREPITANT, as it is not expected to harm a nursing infant.\n- FOSAPREPITANT is a neurokinin-1 receptor antagonist used for the prevention of nausea and vomiting associated with chemotherapy, and its excretion in breast milk is minimal.\n- It is advisable for mothers to consult with their healthcare provider for personalized recommendations while on FOSAPREPITANT.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"0uYBA1VRn6fa","- Liver function tests (LFTs) should be monitored at baseline and then every 4 to 6 weeks during the first 6 months of treatment with Signifor LAR (pasireotide).
- After the initial 6 months, LFTs should be monitored every 3 months for the duration of treatment with Signifor LAR.
- If any significant liver enzyme elevations occur, more frequent monitoring may be necessary, and dose adjustments or discontinuation of Signifor LAR may be required.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.4444444444444444}; rankings=[['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended monitoring protocol for liver function during treatment with Signifor LAR?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Liver function tests (LFTs) should be monitored at baseline and then every 4 to 6 weeks during the first 6 months of treatment with Signifor LAR (pasireotide).\n- After the initial 6 months, LFTs should be monitored every 3 months for the duration of treatment with Signifor LAR.\n- If any significant liver enzyme elevations occur, more frequent monitoring may be necessary, and dose adjustments or discontinuation of Signifor LAR may be required.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended monitoring protocol for liver function during treatment with Signifor LAR?\nA: Liver function should be assessed only at the end of treatment.\nB: Liver function should be assessed prior to treatment and closely monitored for the first three months.\nC: Liver function monitoring is not required for Signifor LAR.\nD: Liver function should be monitored only if symptoms of liver disease appear.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Liver function tests (LFTs) should be monitored at baseline and then every 4 to 6 weeks during the first 6 months of treatment with Signifor LAR (pasireotide).\n- After the initial 6 months, LFTs should be monitored every 3 months for the duration of treatment with Signifor LAR.\n- If any significant liver enzyme elevations occur, more frequent monitoring may be necessary, and dose adjustments or discontinuation of Signifor LAR may be required.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended monitoring protocol for liver function during treatment with Signifor LAR?\nA: Liver function should be assessed only at the end of treatment.\nB: Liver function should be assessed prior to treatment and closely monitored for the first three months.\nC: Liver function monitoring is not required for Signifor LAR.\nD: Liver function should be monitored only if symptoms of liver disease appear.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Liver function tests (LFTs) should be monitored at baseline and then every 4 to 6 weeks during the first 6 months of treatment with Signifor LAR (pasireotide).\n- After the initial 6 months, LFTs should be monitored every 3 months for the duration of treatment with Signifor LAR.\n- If any significant liver enzyme elevations occur, more frequent monitoring may be necessary, and dose adjustments or discontinuation of Signifor LAR may be required.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended monitoring protocol for liver function during treatment with Signifor LAR?\nA: Liver function should be assessed only at the end of treatment.\nB: Liver function should be assessed prior to treatment and closely monitored for the first three months.\nC: Liver function monitoring is not required for Signifor LAR.\nD: Liver function should be monitored only if symptoms of liver disease appear.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Liver function tests (LFTs) should be monitored at baseline and then every 4 to 6 weeks during the first 6 months of treatment with Signifor LAR (pasireotide).\n- After the initial 6 months, LFTs should be monitored every 3 months for the duration of treatment with Signifor LAR.\n- If any significant liver enzyme elevations occur, more frequent monitoring may be necessary, and dose adjustments or discontinuation of Signifor LAR may be required.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"Bg05r9KqcJGd","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the safety status of Terbinafine tablets in pediatric patients with onychomycosis?\nA: The safety and efficacy have been established.\nB: The safety and efficacy have not been established.\nC: Terbinafine tablets are contraindicated for pediatric patients.\nD: Terbinafine tablets are recommended for pediatric patients with onychomycosis.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the safety status of Terbinafine tablets in pediatric patients with onychomycosis?\nA: The safety and efficacy have been established.\nB: The safety and efficacy have not been established.\nC: Terbinafine tablets are contraindicated for pediatric patients.\nD: Terbinafine tablets are recommended for pediatric patients with onychomycosis.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the safety status of Terbinafine tablets in pediatric patients with onychomycosis?\nA: The safety and efficacy have been established.\nB: The safety and efficacy have not been established.\nC: Terbinafine tablets are contraindicated for pediatric patients.\nD: Terbinafine tablets are recommended for pediatric patients with onychomycosis.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"kcGaYmNKayYL","- Physicians should monitor for potential misuse or abuse of Fluoxetine, especially in patients with a history of substance use disorders, as it may lead to increased risk of relapse.
- It is important to assess the patient's overall treatment plan, including any concurrent medications or therapies, to ensure that Fluoxetine does not interact negatively with substances the patient may be using.
- Regular follow-up appointments should be scheduled to evaluate the patient's response to Fluoxetine and to address any emerging issues related to drug abuse or dependence.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is a key consideration for physicians when prescribing Fluoxetine to patients with a history of drug abuse?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Physicians should monitor for potential misuse or abuse of Fluoxetine, especially in patients with a history of substance use disorders, as it may lead to increased risk of relapse.\n- It is important to assess the patient's overall treatment plan, including any concurrent medications or therapies, to ensure that Fluoxetine does not interact negatively with substances the patient may be using.\n- Regular follow-up appointments should be scheduled to evaluate the patient's response to Fluoxetine and to address any emerging issues related to drug abuse or dependence.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is a key consideration for physicians when prescribing Fluoxetine to patients with a history of drug abuse?\nA: Monitoring for signs of liver toxicity.\nB: Observing for signs of misuse or abuse, such as dose incrementation or drug-seeking behavior.\nC: Ensuring the patient does not consume alcohol during treatment.\nD: Checking for allergic reactions to Fluoxetine.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Physicians should monitor for potential misuse or abuse of Fluoxetine, especially in patients with a history of substance use disorders, as it may lead to increased risk of relapse.\n- It is important to assess the patient's overall treatment plan, including any concurrent medications or therapies, to ensure that Fluoxetine does not interact negatively with substances the patient may be using.\n- Regular follow-up appointments should be scheduled to evaluate the patient's response to Fluoxetine and to address any emerging issues related to drug abuse or dependence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is a key consideration for physicians when prescribing Fluoxetine to patients with a history of drug abuse?\nA: Monitoring for signs of liver toxicity.\nB: Observing for signs of misuse or abuse, such as dose incrementation or drug-seeking behavior.\nC: Ensuring the patient does not consume alcohol during treatment.\nD: Checking for allergic reactions to Fluoxetine.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Physicians should monitor for potential misuse or abuse of Fluoxetine, especially in patients with a history of substance use disorders, as it may lead to increased risk of relapse.\n- It is important to assess the patient's overall treatment plan, including any concurrent medications or therapies, to ensure that Fluoxetine does not interact negatively with substances the patient may be using.\n- Regular follow-up appointments should be scheduled to evaluate the patient's response to Fluoxetine and to address any emerging issues related to drug abuse or dependence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is a key consideration for physicians when prescribing Fluoxetine to patients with a history of drug abuse?\nA: Monitoring for signs of liver toxicity.\nB: Observing for signs of misuse or abuse, such as dose incrementation or drug-seeking behavior.\nC: Ensuring the patient does not consume alcohol during treatment.\nD: Checking for allergic reactions to Fluoxetine.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Physicians should monitor for potential misuse or abuse of Fluoxetine, especially in patients with a history of substance use disorders, as it may lead to increased risk of relapse.\n- It is important to assess the patient's overall treatment plan, including any concurrent medications or therapies, to ensure that Fluoxetine does not interact negatively with substances the patient may be using.\n- Regular follow-up appointments should be scheduled to evaluate the patient's response to Fluoxetine and to address any emerging issues related to drug abuse or dependence.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"eeT2Z9SKcyDf","- Monitor lipid levels regularly, as Tri Femynor contains ethinyl estradiol and norgestimate, which may impact lipid metabolism.
- Consider alternative contraceptive options if the patient has a history of thromboembolic events, as Tri Femynor can increase the risk in women with dyslipidemia.
- Educate the patient on lifestyle modifications, including diet and exercise, to help manage dyslipidemia alongside the use of Tri Femynor.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should be considered for women with uncontrolled dyslipidemia who are prescribed Tri Femynor?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Monitor lipid levels regularly, as Tri Femynor contains ethinyl estradiol and norgestimate, which may impact lipid metabolism.\n- Consider alternative contraceptive options if the patient has a history of thromboembolic events, as Tri Femynor can increase the risk in women with dyslipidemia.\n- Educate the patient on lifestyle modifications, including diet and exercise, to help manage dyslipidemia alongside the use of Tri Femynor.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be considered for women with uncontrolled dyslipidemia who are prescribed Tri Femynor?\nA: Continue Tri Femynor with regular lipid monitoring.\nB: Switch to an alternative contraceptive method.\nC: Reduce the dosage of Tri Femynor.\nD: Prescribe lipid-lowering medications alongside Tri Femynor.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor lipid levels regularly, as Tri Femynor contains ethinyl estradiol and norgestimate, which may impact lipid metabolism.\n- Consider alternative contraceptive options if the patient has a history of thromboembolic events, as Tri Femynor can increase the risk in women with dyslipidemia.\n- Educate the patient on lifestyle modifications, including diet and exercise, to help manage dyslipidemia alongside the use of Tri Femynor.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be considered for women with uncontrolled dyslipidemia who are prescribed Tri Femynor?\nA: Continue Tri Femynor with regular lipid monitoring.\nB: Switch to an alternative contraceptive method.\nC: Reduce the dosage of Tri Femynor.\nD: Prescribe lipid-lowering medications alongside Tri Femynor.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor lipid levels regularly, as Tri Femynor contains ethinyl estradiol and norgestimate, which may impact lipid metabolism.\n- Consider alternative contraceptive options if the patient has a history of thromboembolic events, as Tri Femynor can increase the risk in women with dyslipidemia.\n- Educate the patient on lifestyle modifications, including diet and exercise, to help manage dyslipidemia alongside the use of Tri Femynor.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be considered for women with uncontrolled dyslipidemia who are prescribed Tri Femynor?\nA: Continue Tri Femynor with regular lipid monitoring.\nB: Switch to an alternative contraceptive method.\nC: Reduce the dosage of Tri Femynor.\nD: Prescribe lipid-lowering medications alongside Tri Femynor.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor lipid levels regularly, as Tri Femynor contains ethinyl estradiol and norgestimate, which may impact lipid metabolism.\n- Consider alternative contraceptive options if the patient has a history of thromboembolic events, as Tri Femynor can increase the risk in women with dyslipidemia.\n- Educate the patient on lifestyle modifications, including diet and exercise, to help manage dyslipidemia alongside the use of Tri Femynor.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"NHKczcqgQHFH","MRRV winner=C; scores={'A': 0.3333333333333333, 'B': 0.5, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D'], ['C', 'B', 'A', 'D']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the primary finding regarding the efficacy of Albuterol HFA compared to CFC 11/12-propelled Albuterol in the clinical trials for adult and adolescent subjects?\nA: Albuterol HFA was significantly less effective.\nB: Albuterol HFA was significantly more effective.\nC: Albuterol HFA was clinically comparable to CFC 11/12-propelled Albuterol.\nD: Albuterol HFA showed no efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the primary finding regarding the efficacy of Albuterol HFA compared to CFC 11/12-propelled Albuterol in the clinical trials for adult and adolescent subjects?\nA: Albuterol HFA was significantly less effective.\nB: Albuterol HFA was significantly more effective.\nC: Albuterol HFA was clinically comparable to CFC 11/12-propelled Albuterol.\nD: Albuterol HFA showed no efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat was the primary finding regarding the efficacy of Albuterol HFA compared to CFC 11/12-propelled Albuterol in the clinical trials for adult and adolescent subjects?\nA: Albuterol HFA was significantly less effective.\nB: Albuterol HFA was significantly more effective.\nC: Albuterol HFA was clinically comparable to CFC 11/12-propelled Albuterol.\nD: Albuterol HFA showed no efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}]"
"cmpMXD8Z0ned","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended method for using the vaginal essential oil during menstruation to avoid repeated cross-infection of dirt?\nA: Take 5-8 drops of essential oil and put them on sanitary napkins.\nB: Take 10-20 drops of essential oil and dissolve them in warm water for vaginal irrigation.\nC: Take 15-30 drops of essential oil and use it in a sitz bath.\nD: Spray 10-20 drops of essential oil diluted in distilled water around the environment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended method for using the vaginal essential oil during menstruation to avoid repeated cross-infection of dirt?\nA: Take 5-8 drops of essential oil and put them on sanitary napkins.\nB: Take 10-20 drops of essential oil and dissolve them in warm water for vaginal irrigation.\nC: Take 15-30 drops of essential oil and use it in a sitz bath.\nD: Spray 10-20 drops of essential oil diluted in distilled water around the environment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended method for using the vaginal essential oil during menstruation to avoid repeated cross-infection of dirt?\nA: Take 5-8 drops of essential oil and put them on sanitary napkins.\nB: Take 10-20 drops of essential oil and dissolve them in warm water for vaginal irrigation.\nC: Take 15-30 drops of essential oil and use it in a sitz bath.\nD: Spray 10-20 drops of essential oil diluted in distilled water around the environment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"YiXP2nLc1jlb","- Accutane (isotretinoin) is specifically indicated for the treatment of severe acne that has not responded to other therapies.
- Differin (adapalene) is a topical retinoid indicated for the treatment of acne vulgaris.
- Benzaclin (benzoyl peroxide and clindamycin) is a combination topical medication indicated for the treatment of acne.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich brand name drug is specifically indicated for the treatment of acne?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Accutane (isotretinoin) is specifically indicated for the treatment of severe acne that has not responded to other therapies.\n- Differin (adapalene) is a topical retinoid indicated for the treatment of acne vulgaris.\n- Benzaclin (benzoyl peroxide and clindamycin) is a combination topical medication indicated for the treatment of acne.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which brand name drug is specifically indicated for the treatment of acne?\nA: MD-Acne Body Acne Treatment\nB: SkinClear Pro\nC: AcneAway Gel\nD: DermalCare Lotion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Accutane (isotretinoin) is specifically indicated for the treatment of severe acne that has not responded to other therapies.\n- Differin (adapalene) is a topical retinoid indicated for the treatment of acne vulgaris.\n- Benzaclin (benzoyl peroxide and clindamycin) is a combination topical medication indicated for the treatment of acne.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which brand name drug is specifically indicated for the treatment of acne?\nA: MD-Acne Body Acne Treatment\nB: SkinClear Pro\nC: AcneAway Gel\nD: DermalCare Lotion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Accutane (isotretinoin) is specifically indicated for the treatment of severe acne that has not responded to other therapies.\n- Differin (adapalene) is a topical retinoid indicated for the treatment of acne vulgaris.\n- Benzaclin (benzoyl peroxide and clindamycin) is a combination topical medication indicated for the treatment of acne.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which brand name drug is specifically indicated for the treatment of acne?\nA: MD-Acne Body Acne Treatment\nB: SkinClear Pro\nC: AcneAway Gel\nD: DermalCare Lotion\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Accutane (isotretinoin) is specifically indicated for the treatment of severe acne that has not responded to other therapies.\n- Differin (adapalene) is a topical retinoid indicated for the treatment of acne vulgaris.\n- Benzaclin (benzoyl peroxide and clindamycin) is a combination topical medication indicated for the treatment of acne.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"ASoh4BnQ1gV6","- Discontinue the use of Ondansetron immediately to prevent further hypersensitivity reactions.
- Initiate appropriate emergency treatment for anaphylaxis, which may include administering epinephrine and providing supportive care.
- Advise the patient to avoid future use of Ondansetron and consider alternative antiemetic therapies that do not carry the same risk of hypersensitivity.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if a patient develops hypersensitivity reactions, such as anaphylaxis, while taking Ondansetron?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Discontinue the use of Ondansetron immediately to prevent further hypersensitivity reactions.\n- Initiate appropriate emergency treatment for anaphylaxis, which may include administering epinephrine and providing supportive care.\n- Advise the patient to avoid future use of Ondansetron and consider alternative antiemetic therapies that do not carry the same risk of hypersensitivity.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops hypersensitivity reactions, such as anaphylaxis, while taking Ondansetron?\nA: Continue Ondansetron and monitor symptoms\nB: Discontinue Ondansetron and treat promptly per standard of care\nC: Administer Ondansetron intravenously\nD: Increase the dose of Ondansetron\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue the use of Ondansetron immediately to prevent further hypersensitivity reactions.\n- Initiate appropriate emergency treatment for anaphylaxis, which may include administering epinephrine and providing supportive care.\n- Advise the patient to avoid future use of Ondansetron and consider alternative antiemetic therapies that do not carry the same risk of hypersensitivity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops hypersensitivity reactions, such as anaphylaxis, while taking Ondansetron?\nA: Continue Ondansetron and monitor symptoms\nB: Discontinue Ondansetron and treat promptly per standard of care\nC: Administer Ondansetron intravenously\nD: Increase the dose of Ondansetron\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue the use of Ondansetron immediately to prevent further hypersensitivity reactions.\n- Initiate appropriate emergency treatment for anaphylaxis, which may include administering epinephrine and providing supportive care.\n- Advise the patient to avoid future use of Ondansetron and consider alternative antiemetic therapies that do not carry the same risk of hypersensitivity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops hypersensitivity reactions, such as anaphylaxis, while taking Ondansetron?\nA: Continue Ondansetron and monitor symptoms\nB: Discontinue Ondansetron and treat promptly per standard of care\nC: Administer Ondansetron intravenously\nD: Increase the dose of Ondansetron\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue the use of Ondansetron immediately to prevent further hypersensitivity reactions.\n- Initiate appropriate emergency treatment for anaphylaxis, which may include administering epinephrine and providing supportive care.\n- Advise the patient to avoid future use of Ondansetron and consider alternative antiemetic therapies that do not carry the same risk of hypersensitivity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"cLxZbM063q8C","- Patients with mild to moderate renal impairment should avoid using ibuprofen concurrently with Pemetrexed, as ibuprofen can increase the risk of Pemetrexed toxicity due to reduced renal clearance.
- It is recommended that renal function be closely monitored in patients receiving Pemetrexed, especially if they are also taking ibuprofen, to prevent potential adverse effects.
- Patients should ensure adequate hydration and may need dose adjustments of Pemetrexed based on their renal function to minimize the risk of complications.

MRRV(meta) winner=B; scores={'A': 0.6666666666666666, 'B': 0.8333333333333334, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['A', 'B', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat precaution should patients with mild to moderate renal impairment take when using Pemetrexed and ibuprofen?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients with mild to moderate renal impairment should avoid using ibuprofen concurrently with Pemetrexed, as ibuprofen can increase the risk of Pemetrexed toxicity due to reduced renal clearance.\n- It is recommended that renal function be closely monitored in patients receiving Pemetrexed, especially if they are also taking ibuprofen, to prevent potential adverse effects.\n- Patients should ensure adequate hydration and may need dose adjustments of Pemetrexed based on their renal function to minimize the risk of complications.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should patients with mild to moderate renal impairment take when using Pemetrexed and ibuprofen?\nA: Increase ibuprofen dosage\nB: Avoid ibuprofen for 2 days before, the day of, and 2 days after Pemetrexed administration\nC: Take ibuprofen only on the day of Pemetrexed administration\nD: Use ibuprofen without restrictions\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with mild to moderate renal impairment should avoid using ibuprofen concurrently with Pemetrexed, as ibuprofen can increase the risk of Pemetrexed toxicity due to reduced renal clearance.\n- It is recommended that renal function be closely monitored in patients receiving Pemetrexed, especially if they are also taking ibuprofen, to prevent potential adverse effects.\n- Patients should ensure adequate hydration and may need dose adjustments of Pemetrexed based on their renal function to minimize the risk of complications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should patients with mild to moderate renal impairment take when using Pemetrexed and ibuprofen?\nA: Increase ibuprofen dosage\nB: Avoid ibuprofen for 2 days before, the day of, and 2 days after Pemetrexed administration\nC: Take ibuprofen only on the day of Pemetrexed administration\nD: Use ibuprofen without restrictions\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with mild to moderate renal impairment should avoid using ibuprofen concurrently with Pemetrexed, as ibuprofen can increase the risk of Pemetrexed toxicity due to reduced renal clearance.\n- It is recommended that renal function be closely monitored in patients receiving Pemetrexed, especially if they are also taking ibuprofen, to prevent potential adverse effects.\n- Patients should ensure adequate hydration and may need dose adjustments of Pemetrexed based on their renal function to minimize the risk of complications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should patients with mild to moderate renal impairment take when using Pemetrexed and ibuprofen?\nA: Increase ibuprofen dosage\nB: Avoid ibuprofen for 2 days before, the day of, and 2 days after Pemetrexed administration\nC: Take ibuprofen only on the day of Pemetrexed administration\nD: Use ibuprofen without restrictions\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients with mild to moderate renal impairment should avoid using ibuprofen concurrently with Pemetrexed, as ibuprofen can increase the risk of Pemetrexed toxicity due to reduced renal clearance.\n- It is recommended that renal function be closely monitored in patients receiving Pemetrexed, especially if they are also taking ibuprofen, to prevent potential adverse effects.\n- Patients should ensure adequate hydration and may need dose adjustments of Pemetrexed based on their renal function to minimize the risk of complications.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"pqvp7Locno42","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended course of action for managing a guanfacine extended-release overdose?\nA: Administer activated charcoal immediately\nB: Consult a Certified Poison Control Center for guidance\nC: Induce vomiting to remove the drug\nD: Administer high doses of antihypertensive medication\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended course of action for managing a guanfacine extended-release overdose?\nA: Administer activated charcoal immediately\nB: Consult a Certified Poison Control Center for guidance\nC: Induce vomiting to remove the drug\nD: Administer high doses of antihypertensive medication\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended course of action for managing a guanfacine extended-release overdose?\nA: Administer activated charcoal immediately\nB: Consult a Certified Poison Control Center for guidance\nC: Induce vomiting to remove the drug\nD: Administer high doses of antihypertensive medication\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"cFYpWEc3KE0C","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat intervention is recommended when Venlafaxine Hydrochloride Extended-Release Capsules are used with serotonergic drugs?\nA: Discontinue all serotonergic drugs immediately.\nB: Monitor for symptoms of serotonin syndrome.\nC: Increase the dose of Venlafaxine Hydrochloride Extended-Release Capsules.\nD: Administer a monoamine oxidase inhibitor (MAOI) alongside.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat intervention is recommended when Venlafaxine Hydrochloride Extended-Release Capsules are used with serotonergic drugs?\nA: Discontinue all serotonergic drugs immediately.\nB: Monitor for symptoms of serotonin syndrome.\nC: Increase the dose of Venlafaxine Hydrochloride Extended-Release Capsules.\nD: Administer a monoamine oxidase inhibitor (MAOI) alongside.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat intervention is recommended when Venlafaxine Hydrochloride Extended-Release Capsules are used with serotonergic drugs?\nA: Discontinue all serotonergic drugs immediately.\nB: Monitor for symptoms of serotonin syndrome.\nC: Increase the dose of Venlafaxine Hydrochloride Extended-Release Capsules.\nD: Administer a monoamine oxidase inhibitor (MAOI) alongside.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"Q32z2DVuo70T","MRRV winner=B; scores={'A': 0.4444444444444444, 'B': 1.0, 'C': 0.25, 'D': 0.38888888888888884}; rankings=[['B', 'D', 'A', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary purpose of the drug 'nighttime severe cold and flu' in treating nasal congestion?\nA: To reduce fever\nB: To clear nasal passages\nC: To relieve cough\nD: To reduce minor aches and pains\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary purpose of the drug 'nighttime severe cold and flu' in treating nasal congestion?\nA: To reduce fever\nB: To clear nasal passages\nC: To relieve cough\nD: To reduce minor aches and pains\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary purpose of the drug 'nighttime severe cold and flu' in treating nasal congestion?\nA: To reduce fever\nB: To clear nasal passages\nC: To relieve cough\nD: To reduce minor aches and pains\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"NGUr8iAp8e8M","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the percentage of ampicillin and sulbactam excreted unchanged in the urine within the first 8 hours in individuals with normal renal function?\nA: 50-60%\nB: 65-75%\nC: 75-85%\nD: 90-95%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the percentage of ampicillin and sulbactam excreted unchanged in the urine within the first 8 hours in individuals with normal renal function?\nA: 50-60%\nB: 65-75%\nC: 75-85%\nD: 90-95%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the percentage of ampicillin and sulbactam excreted unchanged in the urine within the first 8 hours in individuals with normal renal function?\nA: 50-60%\nB: 65-75%\nC: 75-85%\nD: 90-95%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"ZyEN6RQXfx52","- The primary indication for the use of laxatives for women is to relieve constipation, which can be particularly common during pregnancy or postpartum.
- Laxatives may also be used to prepare for medical procedures, such as colonoscopies, where a clear bowel is necessary.
- Some laxatives, like polyethylene glycol, are specifically formulated to be gentle and effective for women experiencing chronic constipation.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.27777777777777773, 'C': 0.5, 'D': 0.3055555555555555}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the primary indication for the use of the drug 'laxative for women'?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The primary indication for the use of laxatives for women is to relieve constipation, which can be particularly common during pregnancy or postpartum.\n- Laxatives may also be used to prepare for medical procedures, such as colonoscopies, where a clear bowel is necessary.\n- Some laxatives, like polyethylene glycol, are specifically formulated to be gentle and effective for women experiencing chronic constipation.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary indication for the use of the drug 'laxative for women'?\nA: Relief of occasional constipation (irregularity)\nB: Treatment of chronic diarrhea\nC: Management of irritable bowel syndrome\nD: Prevention of dehydration\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary indication for the use of laxatives for women is to relieve constipation, which can be particularly common during pregnancy or postpartum.\n- Laxatives may also be used to prepare for medical procedures, such as colonoscopies, where a clear bowel is necessary.\n- Some laxatives, like polyethylene glycol, are specifically formulated to be gentle and effective for women experiencing chronic constipation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary indication for the use of the drug 'laxative for women'?\nA: Relief of occasional constipation (irregularity)\nB: Treatment of chronic diarrhea\nC: Management of irritable bowel syndrome\nD: Prevention of dehydration\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary indication for the use of laxatives for women is to relieve constipation, which can be particularly common during pregnancy or postpartum.\n- Laxatives may also be used to prepare for medical procedures, such as colonoscopies, where a clear bowel is necessary.\n- Some laxatives, like polyethylene glycol, are specifically formulated to be gentle and effective for women experiencing chronic constipation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary indication for the use of the drug 'laxative for women'?\nA: Relief of occasional constipation (irregularity)\nB: Treatment of chronic diarrhea\nC: Management of irritable bowel syndrome\nD: Prevention of dehydration\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary indication for the use of laxatives for women is to relieve constipation, which can be particularly common during pregnancy or postpartum.\n- Laxatives may also be used to prepare for medical procedures, such as colonoscopies, where a clear bowel is necessary.\n- Some laxatives, like polyethylene glycol, are specifically formulated to be gentle and effective for women experiencing chronic constipation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"XStstm6cvM81","- Consider discontinuing Ogivri if the patient shows a 16% absolute decrease in LVEF from baseline, as this may indicate potential cardiotoxicity.
- Monitor the patient's cardiac function closely, including regular echocardiograms, to assess any further changes in LVEF while on Ogivri.
- Evaluate the need for additional cardiac support or intervention if the decrease in LVEF is significant and persistent, potentially involving cardiology consultation.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if a patient receiving Ogivri experiences a \u226516% absolute decrease in left ventricular ejection fraction (LVEF) from pre-treatment values?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Consider discontinuing Ogivri if the patient shows a \u226516% absolute decrease in LVEF from baseline, as this may indicate potential cardiotoxicity.\n- Monitor the patient's cardiac function closely, including regular echocardiograms, to assess any further changes in LVEF while on Ogivri.\n- Evaluate the need for additional cardiac support or intervention if the decrease in LVEF is significant and persistent, potentially involving cardiology consultation.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient receiving Ogivri experiences a \u226516% absolute decrease in left ventricular ejection fraction (LVEF) from pre-treatment values?\nA: Continue Ogivri treatment with close monitoring.\nB: Withhold Ogivri treatment.\nC: Increase the dosage of Ogivri.\nD: Switch to a different trastuzumab product.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider discontinuing Ogivri if the patient shows a \u226516% absolute decrease in LVEF from baseline, as this may indicate potential cardiotoxicity.\n- Monitor the patient's cardiac function closely, including regular echocardiograms, to assess any further changes in LVEF while on Ogivri.\n- Evaluate the need for additional cardiac support or intervention if the decrease in LVEF is significant and persistent, potentially involving cardiology consultation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient receiving Ogivri experiences a \u226516% absolute decrease in left ventricular ejection fraction (LVEF) from pre-treatment values?\nA: Continue Ogivri treatment with close monitoring.\nB: Withhold Ogivri treatment.\nC: Increase the dosage of Ogivri.\nD: Switch to a different trastuzumab product.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider discontinuing Ogivri if the patient shows a \u226516% absolute decrease in LVEF from baseline, as this may indicate potential cardiotoxicity.\n- Monitor the patient's cardiac function closely, including regular echocardiograms, to assess any further changes in LVEF while on Ogivri.\n- Evaluate the need for additional cardiac support or intervention if the decrease in LVEF is significant and persistent, potentially involving cardiology consultation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient receiving Ogivri experiences a \u226516% absolute decrease in left ventricular ejection fraction (LVEF) from pre-treatment values?\nA: Continue Ogivri treatment with close monitoring.\nB: Withhold Ogivri treatment.\nC: Increase the dosage of Ogivri.\nD: Switch to a different trastuzumab product.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider discontinuing Ogivri if the patient shows a \u226516% absolute decrease in LVEF from baseline, as this may indicate potential cardiotoxicity.\n- Monitor the patient's cardiac function closely, including regular echocardiograms, to assess any further changes in LVEF while on Ogivri.\n- Evaluate the need for additional cardiac support or intervention if the decrease in LVEF is significant and persistent, potentially involving cardiology consultation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"JtkZZ2eDojse","- The recommended storage temperature range for the drug 'sterile' is between 36F to 46F.
- It is important to keep the drug 'sterile' within this temperature range to maintain its efficacy and safety.
- Storing the drug outside of this range may compromise its sterility and effectiveness.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended storage temperature range for the drug 'sterile' in Fahrenheit?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The recommended storage temperature range for the drug 'sterile' is between 36\u00b0F to 46\u00b0F.\n- It is important to keep the drug 'sterile' within this temperature range to maintain its efficacy and safety.\n- Storing the drug outside of this range may compromise its sterility and effectiveness.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended storage temperature range for the drug 'sterile' in Fahrenheit?\nA: 32 - 50\u00b0F\nB: 59 - 86\u00b0F\nC: 86 - 104\u00b0F\nD: 41 - 68\u00b0F\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended storage temperature range for the drug 'sterile' is between 36\u00b0F to 46\u00b0F.\n- It is important to keep the drug 'sterile' within this temperature range to maintain its efficacy and safety.\n- Storing the drug outside of this range may compromise its sterility and effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended storage temperature range for the drug 'sterile' in Fahrenheit?\nA: 32 - 50\u00b0F\nB: 59 - 86\u00b0F\nC: 86 - 104\u00b0F\nD: 41 - 68\u00b0F\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended storage temperature range for the drug 'sterile' is between 36\u00b0F to 46\u00b0F.\n- It is important to keep the drug 'sterile' within this temperature range to maintain its efficacy and safety.\n- Storing the drug outside of this range may compromise its sterility and effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended storage temperature range for the drug 'sterile' in Fahrenheit?\nA: 32 - 50\u00b0F\nB: 59 - 86\u00b0F\nC: 86 - 104\u00b0F\nD: 41 - 68\u00b0F\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended storage temperature range for the drug 'sterile' is between 36\u00b0F to 46\u00b0F.\n- It is important to keep the drug 'sterile' within this temperature range to maintain its efficacy and safety.\n- Storing the drug outside of this range may compromise its sterility and effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"ADHofopHeGcP","- Regular use of dg health nasal may take several days to a few weeks to experience its full effect, as consistent application is necessary for optimal results.
- Users typically report improvements in nasal congestion and overall respiratory comfort after about 1-2 weeks of daily use.
- It is important to follow the recommended dosage and regimen to achieve the best outcomes from dg health nasal.

MRRV(meta) winner=C; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow long might it take to experience the full effect of dg health nasal with regular use?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Regular use of dg health nasal may take several days to a few weeks to experience its full effect, as consistent application is necessary for optimal results.\n- Users typically report improvements in nasal congestion and overall respiratory comfort after about 1-2 weeks of daily use.\n- It is important to follow the recommended dosage and regimen to achieve the best outcomes from dg health nasal.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How long might it take to experience the full effect of dg health nasal with regular use?\nA: Immediately after the first use\nB: Within a few hours\nC: After several days of regular, once-a-day use\nD: After one week of irregular use\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Regular use of dg health nasal may take several days to a few weeks to experience its full effect, as consistent application is necessary for optimal results.\n- Users typically report improvements in nasal congestion and overall respiratory comfort after about 1-2 weeks of daily use.\n- It is important to follow the recommended dosage and regimen to achieve the best outcomes from dg health nasal.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How long might it take to experience the full effect of dg health nasal with regular use?\nA: Immediately after the first use\nB: Within a few hours\nC: After several days of regular, once-a-day use\nD: After one week of irregular use\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Regular use of dg health nasal may take several days to a few weeks to experience its full effect, as consistent application is necessary for optimal results.\n- Users typically report improvements in nasal congestion and overall respiratory comfort after about 1-2 weeks of daily use.\n- It is important to follow the recommended dosage and regimen to achieve the best outcomes from dg health nasal.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How long might it take to experience the full effect of dg health nasal with regular use?\nA: Immediately after the first use\nB: Within a few hours\nC: After several days of regular, once-a-day use\nD: After one week of irregular use\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Regular use of dg health nasal may take several days to a few weeks to experience its full effect, as consistent application is necessary for optimal results.\n- Users typically report improvements in nasal congestion and overall respiratory comfort after about 1-2 weeks of daily use.\n- It is important to follow the recommended dosage and regimen to achieve the best outcomes from dg health nasal.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}]"
"z206feBAIzEX","1) Recommendation: Patients who develop signs of heart failure while on REMICADE (infliximab) should immediately contact their healthcare provider for evaluation and potential discontinuation of the medication. It is crucial to assess the severity of symptoms and consider alternative treatment options.

2) Key rationale:
- REMICADE can exacerbate or induce heart failure, particularly in patients with pre-existing heart conditions.
- Early intervention is essential to prevent worsening of heart failure symptoms and complications.
- Healthcare providers can determine the appropriate course of action, including possible medication adjustments or additional diagnostic tests.

3) Safety/contraindications/interactions:
- Patients with a history of heart failure or significant cardiovascular disease should use REMICADE with caution.
- Monitor for symptoms such as shortness of breath, fatigue, swelling in the legs, or rapid weight gain.
- Potential interactions with other medications that affect heart function should be reviewed with a healthcare provider.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat action should patients take if they develop signs of heart failure while on REMICADE?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Patients who develop signs of heart failure while on REMICADE (infliximab) should immediately contact their healthcare provider for evaluation and potential discontinuation of the medication. It is crucial to assess the severity of symptoms and consider alternative treatment options.\n\n2) Key rationale:\n- REMICADE can exacerbate or induce heart failure, particularly in patients with pre-existing heart conditions.\n- Early intervention is essential to prevent worsening of heart failure symptoms and complications.\n- Healthcare providers can determine the appropriate course of action, including possible medication adjustments or additional diagnostic tests.\n\n3) Safety/contraindications/interactions:\n- Patients with a history of heart failure or significant cardiovascular disease should use REMICADE with caution.\n- Monitor for symptoms such as shortness of breath, fatigue, swelling in the legs, or rapid weight gain.\n- Potential interactions with other medications that affect heart function should be reviewed with a healthcare provider.""}]"
"2wFCIQ5DFRiN","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they require immediate relief of symptoms while using Aspirin 81 mg Low Dose?\nA: Consult their doctor for alternative options\nB: Increase the dosage of Aspirin 81 mg Low Dose\nC: Use Aspirin 81 mg Low Dose more frequently\nD: Wait for the delayed action of the drug\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they require immediate relief of symptoms while using Aspirin 81 mg Low Dose?\nA: Consult their doctor for alternative options\nB: Increase the dosage of Aspirin 81 mg Low Dose\nC: Use Aspirin 81 mg Low Dose more frequently\nD: Wait for the delayed action of the drug\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should a patient do if they require immediate relief of symptoms while using Aspirin 81 mg Low Dose?\nA: Consult their doctor for alternative options\nB: Increase the dosage of Aspirin 81 mg Low Dose\nC: Use Aspirin 81 mg Low Dose more frequently\nD: Wait for the delayed action of the drug\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"A86K9EclfJFn","- Albuterol, a selective beta-2 adrenergic agonist, typically has fewer cardiovascular side effects compared to Isoproterenol, which is a non-selective beta agonist affecting both beta-1 and beta-2 receptors.
- At comparable doses, Isoproterenol is more likely to cause increased heart rate and palpitations due to its action on beta-1 receptors in the heart, while Albuterol primarily targets the lungs with minimal cardiac stimulation.
- In clinical settings, patients using Albuterol may experience less tachycardia compared to those receiving Isoproterenol, making Albuterol a preferred choice for asthma management in patients with cardiovascular concerns.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow does Albuterol compare to Isoproterenol in terms of cardiovascular effects at comparable doses?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Albuterol, a selective beta-2 adrenergic agonist, typically has fewer cardiovascular side effects compared to Isoproterenol, which is a non-selective beta agonist affecting both beta-1 and beta-2 receptors.\n- At comparable doses, Isoproterenol is more likely to cause increased heart rate and palpitations due to its action on beta-1 receptors in the heart, while Albuterol primarily targets the lungs with minimal cardiac stimulation.\n- In clinical settings, patients using Albuterol may experience less tachycardia compared to those receiving Isoproterenol, making Albuterol a preferred choice for asthma management in patients with cardiovascular concerns.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does Albuterol compare to Isoproterenol in terms of cardiovascular effects at comparable doses?\nA: Albuterol produces more cardiovascular effects than Isoproterenol.\nB: Albuterol produces fewer cardiovascular effects than Isoproterenol.\nC: Albuterol and Isoproterenol produce the same cardiovascular effects.\nD: Albuterol does not produce any cardiovascular effects.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol, a selective beta-2 adrenergic agonist, typically has fewer cardiovascular side effects compared to Isoproterenol, which is a non-selective beta agonist affecting both beta-1 and beta-2 receptors.\n- At comparable doses, Isoproterenol is more likely to cause increased heart rate and palpitations due to its action on beta-1 receptors in the heart, while Albuterol primarily targets the lungs with minimal cardiac stimulation.\n- In clinical settings, patients using Albuterol may experience less tachycardia compared to those receiving Isoproterenol, making Albuterol a preferred choice for asthma management in patients with cardiovascular concerns.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does Albuterol compare to Isoproterenol in terms of cardiovascular effects at comparable doses?\nA: Albuterol produces more cardiovascular effects than Isoproterenol.\nB: Albuterol produces fewer cardiovascular effects than Isoproterenol.\nC: Albuterol and Isoproterenol produce the same cardiovascular effects.\nD: Albuterol does not produce any cardiovascular effects.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol, a selective beta-2 adrenergic agonist, typically has fewer cardiovascular side effects compared to Isoproterenol, which is a non-selective beta agonist affecting both beta-1 and beta-2 receptors.\n- At comparable doses, Isoproterenol is more likely to cause increased heart rate and palpitations due to its action on beta-1 receptors in the heart, while Albuterol primarily targets the lungs with minimal cardiac stimulation.\n- In clinical settings, patients using Albuterol may experience less tachycardia compared to those receiving Isoproterenol, making Albuterol a preferred choice for asthma management in patients with cardiovascular concerns.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does Albuterol compare to Isoproterenol in terms of cardiovascular effects at comparable doses?\nA: Albuterol produces more cardiovascular effects than Isoproterenol.\nB: Albuterol produces fewer cardiovascular effects than Isoproterenol.\nC: Albuterol and Isoproterenol produce the same cardiovascular effects.\nD: Albuterol does not produce any cardiovascular effects.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Albuterol, a selective beta-2 adrenergic agonist, typically has fewer cardiovascular side effects compared to Isoproterenol, which is a non-selective beta agonist affecting both beta-1 and beta-2 receptors.\n- At comparable doses, Isoproterenol is more likely to cause increased heart rate and palpitations due to its action on beta-1 receptors in the heart, while Albuterol primarily targets the lungs with minimal cardiac stimulation.\n- In clinical settings, patients using Albuterol may experience less tachycardia compared to those receiving Isoproterenol, making Albuterol a preferred choice for asthma management in patients with cardiovascular concerns.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"cAAH7wJEE024","- The daytime formulation of 'nighttime severe cold and flu' typically contains a non-drowsy antihistamine, allowing users to alleviate cold symptoms without experiencing sedation during the day.
- It often includes a combination of pain relievers and decongestants, providing effective symptom relief while enabling individuals to maintain their daily activities.
- Unlike the nighttime version, which may contain ingredients like diphenhydramine that promote sleep, the daytime formulation is designed to keep users alert and functional.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is one of the benefits of the daytime formulation of 'nighttime severe cold and flu'?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The daytime formulation of 'nighttime severe cold and flu' typically contains a non-drowsy antihistamine, allowing users to alleviate cold symptoms without experiencing sedation during the day.\n- It often includes a combination of pain relievers and decongestants, providing effective symptom relief while enabling individuals to maintain their daily activities.\n- Unlike the nighttime version, which may contain ingredients like diphenhydramine that promote sleep, the daytime formulation is designed to keep users alert and functional.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is one of the benefits of the daytime formulation of 'nighttime severe cold and flu'?\nA: Helps clear nasal passages\nB: Relieves cough to help you sleep\nC: Helps loosen phlegm and thin bronchial secretions\nD: Reduces sinus congestion and pressure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The daytime formulation of 'nighttime severe cold and flu' typically contains a non-drowsy antihistamine, allowing users to alleviate cold symptoms without experiencing sedation during the day.\n- It often includes a combination of pain relievers and decongestants, providing effective symptom relief while enabling individuals to maintain their daily activities.\n- Unlike the nighttime version, which may contain ingredients like diphenhydramine that promote sleep, the daytime formulation is designed to keep users alert and functional.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is one of the benefits of the daytime formulation of 'nighttime severe cold and flu'?\nA: Helps clear nasal passages\nB: Relieves cough to help you sleep\nC: Helps loosen phlegm and thin bronchial secretions\nD: Reduces sinus congestion and pressure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The daytime formulation of 'nighttime severe cold and flu' typically contains a non-drowsy antihistamine, allowing users to alleviate cold symptoms without experiencing sedation during the day.\n- It often includes a combination of pain relievers and decongestants, providing effective symptom relief while enabling individuals to maintain their daily activities.\n- Unlike the nighttime version, which may contain ingredients like diphenhydramine that promote sleep, the daytime formulation is designed to keep users alert and functional.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is one of the benefits of the daytime formulation of 'nighttime severe cold and flu'?\nA: Helps clear nasal passages\nB: Relieves cough to help you sleep\nC: Helps loosen phlegm and thin bronchial secretions\nD: Reduces sinus congestion and pressure\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The daytime formulation of 'nighttime severe cold and flu' typically contains a non-drowsy antihistamine, allowing users to alleviate cold symptoms without experiencing sedation during the day.\n- It often includes a combination of pain relievers and decongestants, providing effective symptom relief while enabling individuals to maintain their daily activities.\n- Unlike the nighttime version, which may contain ingredients like diphenhydramine that promote sleep, the daytime formulation is designed to keep users alert and functional.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"2PMrYbHVdseV","- Nicotine specifically targets cravings for cigarettes, helping to reduce the intense desire to smoke.
- It also addresses withdrawal symptoms such as irritability and anxiety, which can occur when individuals stop smoking.
- By providing a controlled dose of nicotine, it helps to alleviate the physical dependence on nicotine, making the quitting process more manageable.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.38888888888888884, 'C': 0.27777777777777773, 'D': 0.4166666666666667}; rankings=[['A', 'B', 'C', 'D'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich symptom is specifically targeted by Nicotine to assist individuals in quitting smoking?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Nicotine specifically targets cravings for cigarettes, helping to reduce the intense desire to smoke.\n- It also addresses withdrawal symptoms such as irritability and anxiety, which can occur when individuals stop smoking.\n- By providing a controlled dose of nicotine, it helps to alleviate the physical dependence on nicotine, making the quitting process more manageable.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom is specifically targeted by Nicotine to assist individuals in quitting smoking?\nA: Nicotine craving.\nB: Insomnia.\nC: Weight gain.\nD: Depression.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Nicotine specifically targets cravings for cigarettes, helping to reduce the intense desire to smoke.\n- It also addresses withdrawal symptoms such as irritability and anxiety, which can occur when individuals stop smoking.\n- By providing a controlled dose of nicotine, it helps to alleviate the physical dependence on nicotine, making the quitting process more manageable.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom is specifically targeted by Nicotine to assist individuals in quitting smoking?\nA: Nicotine craving.\nB: Insomnia.\nC: Weight gain.\nD: Depression.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Nicotine specifically targets cravings for cigarettes, helping to reduce the intense desire to smoke.\n- It also addresses withdrawal symptoms such as irritability and anxiety, which can occur when individuals stop smoking.\n- By providing a controlled dose of nicotine, it helps to alleviate the physical dependence on nicotine, making the quitting process more manageable.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which symptom is specifically targeted by Nicotine to assist individuals in quitting smoking?\nA: Nicotine craving.\nB: Insomnia.\nC: Weight gain.\nD: Depression.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Nicotine specifically targets cravings for cigarettes, helping to reduce the intense desire to smoke.\n- It also addresses withdrawal symptoms such as irritability and anxiety, which can occur when individuals stop smoking.\n- By providing a controlled dose of nicotine, it helps to alleviate the physical dependence on nicotine, making the quitting process more manageable.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"S4ezK7UqaFcw","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if the patient is unable to sufficiently inhale the contents of the XENOVIEW Dose Delivery Bag?\nA: Repeat the scan with the same dose\nB: Repeat the scan with a new dose of XENOVIEW\nC: Administer supplemental oxygen and retry\nD: Terminate the procedure\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if the patient is unable to sufficiently inhale the contents of the XENOVIEW Dose Delivery Bag?\nA: Repeat the scan with the same dose\nB: Repeat the scan with a new dose of XENOVIEW\nC: Administer supplemental oxygen and retry\nD: Terminate the procedure\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if the patient is unable to sufficiently inhale the contents of the XENOVIEW Dose Delivery Bag?\nA: Repeat the scan with the same dose\nB: Repeat the scan with a new dose of XENOVIEW\nC: Administer supplemental oxygen and retry\nD: Terminate the procedure\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"8fl87Li8o8fV","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is specifically targeted by the brand name drug NICOTINE during smoking cessation?\nA: Nicotine craving\nB: Headache\nC: Muscle pain\nD: Fever\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is specifically targeted by the brand name drug NICOTINE during smoking cessation?\nA: Nicotine craving\nB: Headache\nC: Muscle pain\nD: Fever\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich symptom is specifically targeted by the brand name drug NICOTINE during smoking cessation?\nA: Nicotine craving\nB: Headache\nC: Muscle pain\nD: Fever\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"NgidWPtnq33t","- Caution is advised when administering Albuterol to patients on monoamine oxidase inhibitors, as this combination may increase the risk of hypertensive crises.
- Patients taking tricyclic antidepressants may experience enhanced cardiovascular effects from Albuterol, necessitating careful monitoring of heart rate and blood pressure.
- It is recommended to consider alternative bronchodilators or adjust the Albuterol dosage in patients concurrently using these medications to minimize potential adverse effects.

MRRV(meta) winner=B; scores={'A': 0.25, 'B': 1.0, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['B', 'C', 'D', 'A'], ['B', 'C', 'D', 'A'], ['B', 'C', 'D', 'A']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended approach when administering Albuterol to patients who are currently treated with monoamine oxidase inhibitors or tricyclic antidepressants?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Caution is advised when administering Albuterol to patients on monoamine oxidase inhibitors, as this combination may increase the risk of hypertensive crises.\n- Patients taking tricyclic antidepressants may experience enhanced cardiovascular effects from Albuterol, necessitating careful monitoring of heart rate and blood pressure.\n- It is recommended to consider alternative bronchodilators or adjust the Albuterol dosage in patients concurrently using these medications to minimize potential adverse effects.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach when administering Albuterol to patients who are currently treated with monoamine oxidase inhibitors or tricyclic antidepressants?\nA: Administer Albuterol without any precautions\nB: Administer Albuterol with extreme caution\nC: Avoid administering Albuterol entirely\nD: Administer Albuterol only after discontinuing antidepressants for 4 weeks\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Caution is advised when administering Albuterol to patients on monoamine oxidase inhibitors, as this combination may increase the risk of hypertensive crises.\n- Patients taking tricyclic antidepressants may experience enhanced cardiovascular effects from Albuterol, necessitating careful monitoring of heart rate and blood pressure.\n- It is recommended to consider alternative bronchodilators or adjust the Albuterol dosage in patients concurrently using these medications to minimize potential adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach when administering Albuterol to patients who are currently treated with monoamine oxidase inhibitors or tricyclic antidepressants?\nA: Administer Albuterol without any precautions\nB: Administer Albuterol with extreme caution\nC: Avoid administering Albuterol entirely\nD: Administer Albuterol only after discontinuing antidepressants for 4 weeks\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Caution is advised when administering Albuterol to patients on monoamine oxidase inhibitors, as this combination may increase the risk of hypertensive crises.\n- Patients taking tricyclic antidepressants may experience enhanced cardiovascular effects from Albuterol, necessitating careful monitoring of heart rate and blood pressure.\n- It is recommended to consider alternative bronchodilators or adjust the Albuterol dosage in patients concurrently using these medications to minimize potential adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach when administering Albuterol to patients who are currently treated with monoamine oxidase inhibitors or tricyclic antidepressants?\nA: Administer Albuterol without any precautions\nB: Administer Albuterol with extreme caution\nC: Avoid administering Albuterol entirely\nD: Administer Albuterol only after discontinuing antidepressants for 4 weeks\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Caution is advised when administering Albuterol to patients on monoamine oxidase inhibitors, as this combination may increase the risk of hypertensive crises.\n- Patients taking tricyclic antidepressants may experience enhanced cardiovascular effects from Albuterol, necessitating careful monitoring of heart rate and blood pressure.\n- It is recommended to consider alternative bronchodilators or adjust the Albuterol dosage in patients concurrently using these medications to minimize potential adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}]"
"JEoDA3BpUjj0","- Hepatic impairment can significantly reduce the metabolism of Jaimiess, leading to increased plasma concentrations of the drug.
- Patients with moderate to severe hepatic impairment may require dose adjustments of Jaimiess to avoid potential toxicity.
- The pharmacokinetics of Jaimiess are altered in individuals with liver dysfunction, necessitating careful monitoring and management.

MRRV(meta) winner=C; scores={'A': 0.27777777777777773, 'B': 0.3055555555555555, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A'], ['C', 'D', 'A', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the effect of hepatic impairment on the metabolism of Jaimiess?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Hepatic impairment can significantly reduce the metabolism of Jaimiess, leading to increased plasma concentrations of the drug.\n- Patients with moderate to severe hepatic impairment may require dose adjustments of Jaimiess to avoid potential toxicity.\n- The pharmacokinetics of Jaimiess are altered in individuals with liver dysfunction, necessitating careful monitoring and management.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of hepatic impairment on the metabolism of Jaimiess?\nA: It enhances the metabolism of steroid hormones.\nB: It has no effect on the metabolism of steroid hormones.\nC: It may lead to poor metabolism of steroid hormones.\nD: It improves the efficacy of Jaimiess.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Hepatic impairment can significantly reduce the metabolism of Jaimiess, leading to increased plasma concentrations of the drug.\n- Patients with moderate to severe hepatic impairment may require dose adjustments of Jaimiess to avoid potential toxicity.\n- The pharmacokinetics of Jaimiess are altered in individuals with liver dysfunction, necessitating careful monitoring and management.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of hepatic impairment on the metabolism of Jaimiess?\nA: It enhances the metabolism of steroid hormones.\nB: It has no effect on the metabolism of steroid hormones.\nC: It may lead to poor metabolism of steroid hormones.\nD: It improves the efficacy of Jaimiess.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Hepatic impairment can significantly reduce the metabolism of Jaimiess, leading to increased plasma concentrations of the drug.\n- Patients with moderate to severe hepatic impairment may require dose adjustments of Jaimiess to avoid potential toxicity.\n- The pharmacokinetics of Jaimiess are altered in individuals with liver dysfunction, necessitating careful monitoring and management.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of hepatic impairment on the metabolism of Jaimiess?\nA: It enhances the metabolism of steroid hormones.\nB: It has no effect on the metabolism of steroid hormones.\nC: It may lead to poor metabolism of steroid hormones.\nD: It improves the efficacy of Jaimiess.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Hepatic impairment can significantly reduce the metabolism of Jaimiess, leading to increased plasma concentrations of the drug.\n- Patients with moderate to severe hepatic impairment may require dose adjustments of Jaimiess to avoid potential toxicity.\n- The pharmacokinetics of Jaimiess are altered in individuals with liver dysfunction, necessitating careful monitoring and management.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}]"
"2pIjVD8VXRFI","- The recommended dosage for children aged 6 to under 12 years is 5 to 10 grams of polyethylene glycol 3350, which is commonly used as a laxative.
- It is important to ensure that the polyethylene glycol 3350 is administered with adequate fluids to enhance its effectiveness.
- This dosage is typically part of a regimen that may include dietary adjustments and increased fluid intake to promote bowel regularity.

MRRV(meta) winner=D; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 0.5, 'D': 1.0}; rankings=[['D', 'C', 'B', 'A'], ['D', 'C', 'B', 'A'], ['D', 'C', 'B', 'A']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended dosage for children aged 6 to under 12 years using the laxative for women?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The recommended dosage for children aged 6 to under 12 years is 5 to 10 grams of polyethylene glycol 3350, which is commonly used as a laxative.\n- It is important to ensure that the polyethylene glycol 3350 is administered with adequate fluids to enhance its effectiveness.\n- This dosage is typically part of a regimen that may include dietary adjustments and increased fluid intake to promote bowel regularity.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended dosage for children aged 6 to under 12 years using the laxative for women?\nA: 1 tablet in a single daily dose\nB: 2 tablets in a single daily dose\nC: 1 to 3 tablets in a single daily dose\nD: Consult a doctor\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage for children aged 6 to under 12 years is 5 to 10 grams of polyethylene glycol 3350, which is commonly used as a laxative.\n- It is important to ensure that the polyethylene glycol 3350 is administered with adequate fluids to enhance its effectiveness.\n- This dosage is typically part of a regimen that may include dietary adjustments and increased fluid intake to promote bowel regularity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended dosage for children aged 6 to under 12 years using the laxative for women?\nA: 1 tablet in a single daily dose\nB: 2 tablets in a single daily dose\nC: 1 to 3 tablets in a single daily dose\nD: Consult a doctor\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage for children aged 6 to under 12 years is 5 to 10 grams of polyethylene glycol 3350, which is commonly used as a laxative.\n- It is important to ensure that the polyethylene glycol 3350 is administered with adequate fluids to enhance its effectiveness.\n- This dosage is typically part of a regimen that may include dietary adjustments and increased fluid intake to promote bowel regularity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended dosage for children aged 6 to under 12 years using the laxative for women?\nA: 1 tablet in a single daily dose\nB: 2 tablets in a single daily dose\nC: 1 to 3 tablets in a single daily dose\nD: Consult a doctor\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage for children aged 6 to under 12 years is 5 to 10 grams of polyethylene glycol 3350, which is commonly used as a laxative.\n- It is important to ensure that the polyethylene glycol 3350 is administered with adequate fluids to enhance its effectiveness.\n- This dosage is typically part of a regimen that may include dietary adjustments and increased fluid intake to promote bowel regularity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > C > B > A""}]"
"jK3bUKtr6e91","MRRV winner=B; scores={'A': 0.25, 'B': 1.0, 'C': 0.38888888888888884, 'D': 0.4444444444444444}; rankings=[['B', 'C', 'D', 'A'], ['B', 'D', 'C', 'A'], ['B', 'D', 'C', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is a potential risk for newborns whose mothers take venlafaxine during the third trimester?\nA: Delayed growth\nB: Seizures and feeding problems\nC: Low birth weight\nD: Premature birth\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is a potential risk for newborns whose mothers take venlafaxine during the third trimester?\nA: Delayed growth\nB: Seizures and feeding problems\nC: Low birth weight\nD: Premature birth\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is a potential risk for newborns whose mothers take venlafaxine during the third trimester?\nA: Delayed growth\nB: Seizures and feeding problems\nC: Low birth weight\nD: Premature birth\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"IUDBQ4gmdTcv","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn patients undergoing hemodialysis, how should the venlafaxine dose be adjusted?\nA: No adjustment is needed\nB: Reduce the dose by 25%\nC: Reduce the dose by 50%\nD: Increase the dose by 50%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn patients undergoing hemodialysis, how should the venlafaxine dose be adjusted?\nA: No adjustment is needed\nB: Reduce the dose by 25%\nC: Reduce the dose by 50%\nD: Increase the dose by 50%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn patients undergoing hemodialysis, how should the venlafaxine dose be adjusted?\nA: No adjustment is needed\nB: Reduce the dose by 25%\nC: Reduce the dose by 50%\nD: Increase the dose by 50%\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"T8iPUydIvVGj","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they stop taking lamotrigine for any reason?\nA: Resume taking lamotrigine immediately\nB: Consult their healthcare providers before resuming\nC: Switch to a different antiepileptic drug\nD: Increase the dosage of lamotrigine\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they stop taking lamotrigine for any reason?\nA: Resume taking lamotrigine immediately\nB: Consult their healthcare providers before resuming\nC: Switch to a different antiepileptic drug\nD: Increase the dosage of lamotrigine\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they stop taking lamotrigine for any reason?\nA: Resume taking lamotrigine immediately\nB: Consult their healthcare providers before resuming\nC: Switch to a different antiepileptic drug\nD: Increase the dosage of lamotrigine\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"pwSk8HjDHxpy","- Clindamycin phosphate is present in Clindamycin topical lotion at a concentration of 1% (10 mg/mL).
- The formulation is designed for topical application to treat acne vulgaris.
- Clindamycin phosphate acts as an antibiotic to reduce acne-causing bacteria on the skin.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the concentration of clindamycin phosphate in Clindamycin topical lotion?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Clindamycin phosphate is present in Clindamycin topical lotion at a concentration of 1% (10 mg/mL).\n- The formulation is designed for topical application to treat acne vulgaris.\n- Clindamycin phosphate acts as an antibiotic to reduce acne-causing bacteria on the skin.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the concentration of clindamycin phosphate in Clindamycin topical lotion?\nA: 5 mg per milliliter\nB: 10 mg per milliliter\nC: 15 mg per milliliter\nD: 20 mg per milliliter\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Clindamycin phosphate is present in Clindamycin topical lotion at a concentration of 1% (10 mg/mL).\n- The formulation is designed for topical application to treat acne vulgaris.\n- Clindamycin phosphate acts as an antibiotic to reduce acne-causing bacteria on the skin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the concentration of clindamycin phosphate in Clindamycin topical lotion?\nA: 5 mg per milliliter\nB: 10 mg per milliliter\nC: 15 mg per milliliter\nD: 20 mg per milliliter\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Clindamycin phosphate is present in Clindamycin topical lotion at a concentration of 1% (10 mg/mL).\n- The formulation is designed for topical application to treat acne vulgaris.\n- Clindamycin phosphate acts as an antibiotic to reduce acne-causing bacteria on the skin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the concentration of clindamycin phosphate in Clindamycin topical lotion?\nA: 5 mg per milliliter\nB: 10 mg per milliliter\nC: 15 mg per milliliter\nD: 20 mg per milliliter\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Clindamycin phosphate is present in Clindamycin topical lotion at a concentration of 1% (10 mg/mL).\n- The formulation is designed for topical application to treat acne vulgaris.\n- Clindamycin phosphate acts as an antibiotic to reduce acne-causing bacteria on the skin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"ATtRGbjTSQCv","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following administration instructions is correct for NUZYRA tablets?\nA: Take NUZYRA tablets with dairy products for better absorption.\nB: Fast for at least 4 hours, take NUZYRA tablets with water, and avoid food or drink (except water) for 2 hours after dosing.\nC: Take NUZYRA tablets immediately after a meal.\nD: Take NUZYRA tablets with multivitamins to enhance efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following administration instructions is correct for NUZYRA tablets?\nA: Take NUZYRA tablets with dairy products for better absorption.\nB: Fast for at least 4 hours, take NUZYRA tablets with water, and avoid food or drink (except water) for 2 hours after dosing.\nC: Take NUZYRA tablets immediately after a meal.\nD: Take NUZYRA tablets with multivitamins to enhance efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following administration instructions is correct for NUZYRA tablets?\nA: Take NUZYRA tablets with dairy products for better absorption.\nB: Fast for at least 4 hours, take NUZYRA tablets with water, and avoid food or drink (except water) for 2 hours after dosing.\nC: Take NUZYRA tablets immediately after a meal.\nD: Take NUZYRA tablets with multivitamins to enhance efficacy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"Uc5NEuhLvAQJ","MRRV winner=C; scores={'A': 0.25, 'B': 0.6666666666666666, 'C': 0.8333333333333334, 'D': 0.3333333333333333}; rankings=[['C', 'B', 'D', 'A'], ['B', 'C', 'D', 'A'], ['C', 'B', 'D', 'A']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy might supplemental oxygen degrade the image quality during XENOVIEW imaging?\nA: It increases the imaging time\nB: It causes depolarization of XENOVIEW\nC: It reduces the concentration of XENOVIEW in the lungs\nD: It interferes with the imaging equipment\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy might supplemental oxygen degrade the image quality during XENOVIEW imaging?\nA: It increases the imaging time\nB: It causes depolarization of XENOVIEW\nC: It reduces the concentration of XENOVIEW in the lungs\nD: It interferes with the imaging equipment\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy might supplemental oxygen degrade the image quality during XENOVIEW imaging?\nA: It increases the imaging time\nB: It causes depolarization of XENOVIEW\nC: It reduces the concentration of XENOVIEW in the lungs\nD: It interferes with the imaging equipment\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > D > A""}]"
"tbXhIzSsJKpt","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat serious toxicities should be monitored in children and adolescents after guanfacine extended-release overdose?\nA: Coma, bradycardia, and hypotension\nB: Seizures, tachycardia, and hypertension\nC: Respiratory distress, fever, and hyperactivity\nD: Nausea, vomiting, and diarrhea\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat serious toxicities should be monitored in children and adolescents after guanfacine extended-release overdose?\nA: Coma, bradycardia, and hypotension\nB: Seizures, tachycardia, and hypertension\nC: Respiratory distress, fever, and hyperactivity\nD: Nausea, vomiting, and diarrhea\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat serious toxicities should be monitored in children and adolescents after guanfacine extended-release overdose?\nA: Coma, bradycardia, and hypotension\nB: Seizures, tachycardia, and hypertension\nC: Respiratory distress, fever, and hyperactivity\nD: Nausea, vomiting, and diarrhea\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"Ty4SKTP4J3r7","1) Recommendation: Consider using a broad-spectrum sunscreen with a higher SPF, such as SPF 30 or SPF 50, to provide better protection against UV rays. Additionally, look for water-resistant formulations if engaging in activities that may cause sweating or water exposure.

2) Key rationale:
   - Higher SPF values offer increased protection against UVB rays, which are primarily responsible for sunburn.
   - Broad-spectrum sunscreens protect against both UVA and UVB rays, reducing the risk of skin damage and long-term effects like skin cancer.
   - Water-resistant options ensure that the sunscreen remains effective during physical activities or swimming, which is crucial in sunny environments like Arizona.

3) Safety/contraindications/interactions:
   - Ensure the sunscreen is suitable for your skin type; some formulations may cause irritation for sensitive skin.
   - Check for any known allergies to ingredients in the sunscreen.
   - Be aware that higher SPF does not mean you can stay in the sun longer without reapplication; reapply every two hours or after swimming/sweating.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nIf a user requires higher sunburn protection than Arizona Sun Sunscreen SPF15, what should they consider?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Consider using a broad-spectrum sunscreen with a higher SPF, such as SPF 30 or SPF 50, to provide better protection against UV rays. Additionally, look for water-resistant formulations if engaging in activities that may cause sweating or water exposure.\n\n2) Key rationale:\n   - Higher SPF values offer increased protection against UVB rays, which are primarily responsible for sunburn.\n   - Broad-spectrum sunscreens protect against both UVA and UVB rays, reducing the risk of skin damage and long-term effects like skin cancer.\n   - Water-resistant options ensure that the sunscreen remains effective during physical activities or swimming, which is crucial in sunny environments like Arizona.\n\n3) Safety/contraindications/interactions:\n   - Ensure the sunscreen is suitable for your skin type; some formulations may cause irritation for sensitive skin.\n   - Check for any known allergies to ingredients in the sunscreen.\n   - Be aware that higher SPF does not mean you can stay in the sun longer without reapplication; reapply every two hours or after swimming/sweating.""}]"
"R72aNMGB07QK","- 'Up and Up ibuprofen' should be stored at a maximum temperature of 25C (77F).
- It is important to keep 'up and up ibuprofen' away from excessive heat and moisture to maintain its efficacy.
- The product should not be frozen, as extreme temperatures can affect the stability of the ibuprofen formulation.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the maximum temperature that 'up and up ibuprofen' should be exposed to during storage?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- 'Up and Up ibuprofen' should be stored at a maximum temperature of 25\u00b0C (77\u00b0F).\n- It is important to keep 'up and up ibuprofen' away from excessive heat and moisture to maintain its efficacy.\n- The product should not be frozen, as extreme temperatures can affect the stability of the ibuprofen formulation.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the maximum temperature that 'up and up ibuprofen' should be exposed to during storage?\nA: 25\u00b0C (77\u00b0F)\nB: 30\u00b0C (86\u00b0F)\nC: 40\u00b0C (104\u00b0F)\nD: 50\u00b0C (122\u00b0F)\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- 'Up and Up ibuprofen' should be stored at a maximum temperature of 25\u00b0C (77\u00b0F).\n- It is important to keep 'up and up ibuprofen' away from excessive heat and moisture to maintain its efficacy.\n- The product should not be frozen, as extreme temperatures can affect the stability of the ibuprofen formulation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the maximum temperature that 'up and up ibuprofen' should be exposed to during storage?\nA: 25\u00b0C (77\u00b0F)\nB: 30\u00b0C (86\u00b0F)\nC: 40\u00b0C (104\u00b0F)\nD: 50\u00b0C (122\u00b0F)\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- 'Up and Up ibuprofen' should be stored at a maximum temperature of 25\u00b0C (77\u00b0F).\n- It is important to keep 'up and up ibuprofen' away from excessive heat and moisture to maintain its efficacy.\n- The product should not be frozen, as extreme temperatures can affect the stability of the ibuprofen formulation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the maximum temperature that 'up and up ibuprofen' should be exposed to during storage?\nA: 25\u00b0C (77\u00b0F)\nB: 30\u00b0C (86\u00b0F)\nC: 40\u00b0C (104\u00b0F)\nD: 50\u00b0C (122\u00b0F)\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- 'Up and Up ibuprofen' should be stored at a maximum temperature of 25\u00b0C (77\u00b0F).\n- It is important to keep 'up and up ibuprofen' away from excessive heat and moisture to maintain its efficacy.\n- The product should not be frozen, as extreme temperatures can affect the stability of the ibuprofen formulation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"piaTgmZCJwK2","1) Recommendation: The patient should be advised to discontinue Tri Femynor and consult their healthcare provider immediately for further evaluation and management of their elevated blood pressure. A thorough assessment should be conducted to determine the underlying cause and to consider alternative contraceptive options that may be more suitable.

2) Key rationale:
- Tri Femynor, a combination oral contraceptive, can potentially elevate blood pressure in some individuals due to estrogen content.
- Elevated blood pressure can increase the risk of cardiovascular events, particularly in women with other risk factors.
- Discontinuing the medication allows for the assessment of blood pressure changes and the exploration of safer contraceptive alternatives.

3) Safety/contraindications/interactions:
- Patients with a history of hypertension or cardiovascular disease should be monitored closely when using hormonal contraceptives.
- Other medications that may interact with Tri Femynor and affect blood pressure should be reviewed.
- If the patient is experiencing severe hypertension (e.g., systolic BP  160 mmHg or diastolic BP  100 mmHg), immediate medical attention is warranted.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat should be done if a patient taking Tri Femynor experiences a significant increase in blood pressure?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: The patient should be advised to discontinue Tri Femynor and consult their healthcare provider immediately for further evaluation and management of their elevated blood pressure. A thorough assessment should be conducted to determine the underlying cause and to consider alternative contraceptive options that may be more suitable.\n\n2) Key rationale:\n- Tri Femynor, a combination oral contraceptive, can potentially elevate blood pressure in some individuals due to estrogen content.\n- Elevated blood pressure can increase the risk of cardiovascular events, particularly in women with other risk factors.\n- Discontinuing the medication allows for the assessment of blood pressure changes and the exploration of safer contraceptive alternatives.\n\n3) Safety/contraindications/interactions:\n- Patients with a history of hypertension or cardiovascular disease should be monitored closely when using hormonal contraceptives.\n- Other medications that may interact with Tri Femynor and affect blood pressure should be reviewed.\n- If the patient is experiencing severe hypertension (e.g., systolic BP \u2265 160 mmHg or diastolic BP \u2265 100 mmHg), immediate medical attention is warranted.""}]"
"0GwxPYeoj90n","- RETHYMIC has specific contraindications for patients with active infections, which is a common concern in immunosuppressive therapies like those seen with drugs such as azathioprine.
- Unlike RETHYMIC, which may have contraindications related to hypersensitivity reactions, drugs like methotrexate also have contraindications for patients with liver disease.
- RETHYMIC's contraindications include a history of malignancy, contrasting with other immunosuppressants like mycophenolate mofetil, which may have different risk profiles regarding cancer history.

MRRV(meta) winner=C; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow does the contraindication profile of RETHYMIC compare to drugs with specific contraindications?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- RETHYMIC has specific contraindications for patients with active infections, which is a common concern in immunosuppressive therapies like those seen with drugs such as azathioprine.\n- Unlike RETHYMIC, which may have contraindications related to hypersensitivity reactions, drugs like methotrexate also have contraindications for patients with liver disease.\n- RETHYMIC's contraindications include a history of malignancy, contrasting with other immunosuppressants like mycophenolate mofetil, which may have different risk profiles regarding cancer history.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the contraindication profile of RETHYMIC compare to drugs with specific contraindications?\nA: RETHYMIC has no contraindications, making it unique.\nB: RETHYMIC has fewer contraindications than most drugs.\nC: RETHYMIC has similar contraindications to other drugs.\nD: RETHYMIC has more contraindications than most drugs.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- RETHYMIC has specific contraindications for patients with active infections, which is a common concern in immunosuppressive therapies like those seen with drugs such as azathioprine.\n- Unlike RETHYMIC, which may have contraindications related to hypersensitivity reactions, drugs like methotrexate also have contraindications for patients with liver disease.\n- RETHYMIC's contraindications include a history of malignancy, contrasting with other immunosuppressants like mycophenolate mofetil, which may have different risk profiles regarding cancer history.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the contraindication profile of RETHYMIC compare to drugs with specific contraindications?\nA: RETHYMIC has no contraindications, making it unique.\nB: RETHYMIC has fewer contraindications than most drugs.\nC: RETHYMIC has similar contraindications to other drugs.\nD: RETHYMIC has more contraindications than most drugs.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- RETHYMIC has specific contraindications for patients with active infections, which is a common concern in immunosuppressive therapies like those seen with drugs such as azathioprine.\n- Unlike RETHYMIC, which may have contraindications related to hypersensitivity reactions, drugs like methotrexate also have contraindications for patients with liver disease.\n- RETHYMIC's contraindications include a history of malignancy, contrasting with other immunosuppressants like mycophenolate mofetil, which may have different risk profiles regarding cancer history.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the contraindication profile of RETHYMIC compare to drugs with specific contraindications?\nA: RETHYMIC has no contraindications, making it unique.\nB: RETHYMIC has fewer contraindications than most drugs.\nC: RETHYMIC has similar contraindications to other drugs.\nD: RETHYMIC has more contraindications than most drugs.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- RETHYMIC has specific contraindications for patients with active infections, which is a common concern in immunosuppressive therapies like those seen with drugs such as azathioprine.\n- Unlike RETHYMIC, which may have contraindications related to hypersensitivity reactions, drugs like methotrexate also have contraindications for patients with liver disease.\n- RETHYMIC's contraindications include a history of malignancy, contrasting with other immunosuppressants like mycophenolate mofetil, which may have different risk profiles regarding cancer history.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}]"
"jvPny1zGmoJD","- JAYPIRCA (pirtobrutinib) is contraindicated in patients with a history of hypersensitivity reactions to the drug or any of its components.
- It should not be used in patients who are currently receiving strong CYP3A inhibitors, as this can significantly increase the drug's plasma concentration.
- JAYPIRCA is also contraindicated in patients with active infections that require systemic treatment, as it may exacerbate these conditions.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following statements is true regarding the contraindications of JAYPIRCA?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- JAYPIRCA (pirtobrutinib) is contraindicated in patients with a history of hypersensitivity reactions to the drug or any of its components.\n- It should not be used in patients who are currently receiving strong CYP3A inhibitors, as this can significantly increase the drug's plasma concentration.\n- JAYPIRCA is also contraindicated in patients with active infections that require systemic treatment, as it may exacerbate these conditions.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the contraindications of JAYPIRCA?\nA: JAYPIRCA has contraindications related to cardiovascular diseases.\nB: JAYPIRCA has contraindications related to renal impairment.\nC: JAYPIRCA has no listed contraindications.\nD: JAYPIRCA has contraindications related to pregnancy.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- JAYPIRCA (pirtobrutinib) is contraindicated in patients with a history of hypersensitivity reactions to the drug or any of its components.\n- It should not be used in patients who are currently receiving strong CYP3A inhibitors, as this can significantly increase the drug's plasma concentration.\n- JAYPIRCA is also contraindicated in patients with active infections that require systemic treatment, as it may exacerbate these conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the contraindications of JAYPIRCA?\nA: JAYPIRCA has contraindications related to cardiovascular diseases.\nB: JAYPIRCA has contraindications related to renal impairment.\nC: JAYPIRCA has no listed contraindications.\nD: JAYPIRCA has contraindications related to pregnancy.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- JAYPIRCA (pirtobrutinib) is contraindicated in patients with a history of hypersensitivity reactions to the drug or any of its components.\n- It should not be used in patients who are currently receiving strong CYP3A inhibitors, as this can significantly increase the drug's plasma concentration.\n- JAYPIRCA is also contraindicated in patients with active infections that require systemic treatment, as it may exacerbate these conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements is true regarding the contraindications of JAYPIRCA?\nA: JAYPIRCA has contraindications related to cardiovascular diseases.\nB: JAYPIRCA has contraindications related to renal impairment.\nC: JAYPIRCA has no listed contraindications.\nD: JAYPIRCA has contraindications related to pregnancy.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- JAYPIRCA (pirtobrutinib) is contraindicated in patients with a history of hypersensitivity reactions to the drug or any of its components.\n- It should not be used in patients who are currently receiving strong CYP3A inhibitors, as this can significantly increase the drug's plasma concentration.\n- JAYPIRCA is also contraindicated in patients with active infections that require systemic treatment, as it may exacerbate these conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"ujBPcF5v4RX9","- Patients using AIRSUPRA should rinse their mouth with water after each use to help minimize the risk of developing oropharyngeal candidiasis.
- It is advisable for patients to avoid using AIRSUPRA in conjunction with other inhaled corticosteroids, as this may increase the risk of fungal infections in the mouth and throat.
- Regular dental check-ups and maintaining good oral hygiene can further reduce the likelihood of oropharyngeal candidiasis while on AIRSUPRA therapy.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat precaution should patients take to reduce the risk of oropharyngeal candidiasis while using AIRSUPRA?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients using AIRSUPRA should rinse their mouth with water after each use to help minimize the risk of developing oropharyngeal candidiasis.\n- It is advisable for patients to avoid using AIRSUPRA in conjunction with other inhaled corticosteroids, as this may increase the risk of fungal infections in the mouth and throat.\n- Regular dental check-ups and maintaining good oral hygiene can further reduce the likelihood of oropharyngeal candidiasis while on AIRSUPRA therapy.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should patients take to reduce the risk of oropharyngeal candidiasis while using AIRSUPRA?\nA: Avoid rinsing the mouth after inhalation\nB: Rinse the mouth with water without swallowing after inhalation\nC: Use AIRSUPRA only once a week\nD: Take an antifungal medication before using AIRSUPRA\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients using AIRSUPRA should rinse their mouth with water after each use to help minimize the risk of developing oropharyngeal candidiasis.\n- It is advisable for patients to avoid using AIRSUPRA in conjunction with other inhaled corticosteroids, as this may increase the risk of fungal infections in the mouth and throat.\n- Regular dental check-ups and maintaining good oral hygiene can further reduce the likelihood of oropharyngeal candidiasis while on AIRSUPRA therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should patients take to reduce the risk of oropharyngeal candidiasis while using AIRSUPRA?\nA: Avoid rinsing the mouth after inhalation\nB: Rinse the mouth with water without swallowing after inhalation\nC: Use AIRSUPRA only once a week\nD: Take an antifungal medication before using AIRSUPRA\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients using AIRSUPRA should rinse their mouth with water after each use to help minimize the risk of developing oropharyngeal candidiasis.\n- It is advisable for patients to avoid using AIRSUPRA in conjunction with other inhaled corticosteroids, as this may increase the risk of fungal infections in the mouth and throat.\n- Regular dental check-ups and maintaining good oral hygiene can further reduce the likelihood of oropharyngeal candidiasis while on AIRSUPRA therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should patients take to reduce the risk of oropharyngeal candidiasis while using AIRSUPRA?\nA: Avoid rinsing the mouth after inhalation\nB: Rinse the mouth with water without swallowing after inhalation\nC: Use AIRSUPRA only once a week\nD: Take an antifungal medication before using AIRSUPRA\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients using AIRSUPRA should rinse their mouth with water after each use to help minimize the risk of developing oropharyngeal candidiasis.\n- It is advisable for patients to avoid using AIRSUPRA in conjunction with other inhaled corticosteroids, as this may increase the risk of fungal infections in the mouth and throat.\n- Regular dental check-ups and maintaining good oral hygiene can further reduce the likelihood of oropharyngeal candidiasis while on AIRSUPRA therapy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"FYLl3OYliC4t","- The patient may have a history of significant drug interactions, particularly with medications like certain statins or anticonvulsants, which could lead to adverse effects when combined with Paxlovid (nirmatrelvir/ritonavir).
- The patient may have severe renal impairment, which could necessitate dosage adjustments or contraindicate the use of Paxlovid due to the risk of accumulation and toxicity.
- The patient may present with a mild case of COVID-19 and meet criteria for observation rather than immediate antiviral treatment, especially if they are not at high risk for severe disease.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy might a healthcare provider decide not to prescribe Paxlovid to a patient despite its benefits in reducing hospitalization and death?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The patient may have a history of significant drug interactions, particularly with medications like certain statins or anticonvulsants, which could lead to adverse effects when combined with Paxlovid (nirmatrelvir/ritonavir).\n- The patient may have severe renal impairment, which could necessitate dosage adjustments or contraindicate the use of Paxlovid due to the risk of accumulation and toxicity.\n- The patient may present with a mild case of COVID-19 and meet criteria for observation rather than immediate antiviral treatment, especially if they are not at high risk for severe disease.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why might a healthcare provider decide not to prescribe Paxlovid to a patient despite its benefits in reducing hospitalization and death?\nA: The risk of potential drug-drug interactions cannot be appropriately managed for the patient.\nB: The patient has a mild case of COVID-19 and does not require treatment.\nC: Paxlovid is only effective for bacterial infections.\nD: The patient is allergic to all antiviral medications.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The patient may have a history of significant drug interactions, particularly with medications like certain statins or anticonvulsants, which could lead to adverse effects when combined with Paxlovid (nirmatrelvir/ritonavir).\n- The patient may have severe renal impairment, which could necessitate dosage adjustments or contraindicate the use of Paxlovid due to the risk of accumulation and toxicity.\n- The patient may present with a mild case of COVID-19 and meet criteria for observation rather than immediate antiviral treatment, especially if they are not at high risk for severe disease.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why might a healthcare provider decide not to prescribe Paxlovid to a patient despite its benefits in reducing hospitalization and death?\nA: The risk of potential drug-drug interactions cannot be appropriately managed for the patient.\nB: The patient has a mild case of COVID-19 and does not require treatment.\nC: Paxlovid is only effective for bacterial infections.\nD: The patient is allergic to all antiviral medications.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The patient may have a history of significant drug interactions, particularly with medications like certain statins or anticonvulsants, which could lead to adverse effects when combined with Paxlovid (nirmatrelvir/ritonavir).\n- The patient may have severe renal impairment, which could necessitate dosage adjustments or contraindicate the use of Paxlovid due to the risk of accumulation and toxicity.\n- The patient may present with a mild case of COVID-19 and meet criteria for observation rather than immediate antiviral treatment, especially if they are not at high risk for severe disease.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why might a healthcare provider decide not to prescribe Paxlovid to a patient despite its benefits in reducing hospitalization and death?\nA: The risk of potential drug-drug interactions cannot be appropriately managed for the patient.\nB: The patient has a mild case of COVID-19 and does not require treatment.\nC: Paxlovid is only effective for bacterial infections.\nD: The patient is allergic to all antiviral medications.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The patient may have a history of significant drug interactions, particularly with medications like certain statins or anticonvulsants, which could lead to adverse effects when combined with Paxlovid (nirmatrelvir/ritonavir).\n- The patient may have severe renal impairment, which could necessitate dosage adjustments or contraindicate the use of Paxlovid due to the risk of accumulation and toxicity.\n- The patient may present with a mild case of COVID-19 and meet criteria for observation rather than immediate antiviral treatment, especially if they are not at high risk for severe disease.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"cdthyeg9iByb","- The Ames test demonstrated that Fluoxetine and its metabolite Norfluoxetine do not induce mutations in bacterial strains, indicating no genotoxic effects.
- In vitro assays using human lymphocytes showed that neither Fluoxetine nor Norfluoxetine caused chromosomal damage or increased the frequency of micronuclei.
- The Comet assay results indicated that Fluoxetine and Norfluoxetine did not lead to DNA strand breaks in cultured mammalian cells, further supporting their lack of genotoxicity.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following assays demonstrated that Fluoxetine and its metabolite Norfluoxetine have no genotoxic effects?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The Ames test demonstrated that Fluoxetine and its metabolite Norfluoxetine do not induce mutations in bacterial strains, indicating no genotoxic effects.\n- In vitro assays using human lymphocytes showed that neither Fluoxetine nor Norfluoxetine caused chromosomal damage or increased the frequency of micronuclei.\n- The Comet assay results indicated that Fluoxetine and Norfluoxetine did not lead to DNA strand breaks in cultured mammalian cells, further supporting their lack of genotoxicity.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following assays demonstrated that Fluoxetine and its metabolite Norfluoxetine have no genotoxic effects?\nA: Bacterial mutation assay, DNA repair assay, and mouse lymphoma assay.\nB: In vivo sister chromatid exchange assay and bacterial mutation assay.\nC: All of the above.\nD: None of the above.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The Ames test demonstrated that Fluoxetine and its metabolite Norfluoxetine do not induce mutations in bacterial strains, indicating no genotoxic effects.\n- In vitro assays using human lymphocytes showed that neither Fluoxetine nor Norfluoxetine caused chromosomal damage or increased the frequency of micronuclei.\n- The Comet assay results indicated that Fluoxetine and Norfluoxetine did not lead to DNA strand breaks in cultured mammalian cells, further supporting their lack of genotoxicity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following assays demonstrated that Fluoxetine and its metabolite Norfluoxetine have no genotoxic effects?\nA: Bacterial mutation assay, DNA repair assay, and mouse lymphoma assay.\nB: In vivo sister chromatid exchange assay and bacterial mutation assay.\nC: All of the above.\nD: None of the above.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The Ames test demonstrated that Fluoxetine and its metabolite Norfluoxetine do not induce mutations in bacterial strains, indicating no genotoxic effects.\n- In vitro assays using human lymphocytes showed that neither Fluoxetine nor Norfluoxetine caused chromosomal damage or increased the frequency of micronuclei.\n- The Comet assay results indicated that Fluoxetine and Norfluoxetine did not lead to DNA strand breaks in cultured mammalian cells, further supporting their lack of genotoxicity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following assays demonstrated that Fluoxetine and its metabolite Norfluoxetine have no genotoxic effects?\nA: Bacterial mutation assay, DNA repair assay, and mouse lymphoma assay.\nB: In vivo sister chromatid exchange assay and bacterial mutation assay.\nC: All of the above.\nD: None of the above.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The Ames test demonstrated that Fluoxetine and its metabolite Norfluoxetine do not induce mutations in bacterial strains, indicating no genotoxic effects.\n- In vitro assays using human lymphocytes showed that neither Fluoxetine nor Norfluoxetine caused chromosomal damage or increased the frequency of micronuclei.\n- The Comet assay results indicated that Fluoxetine and Norfluoxetine did not lead to DNA strand breaks in cultured mammalian cells, further supporting their lack of genotoxicity.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"TsGpZkyRAqXD","- In clinical studies, the mortality rate for patients treated with NUZYRA (sarecycline) for Community-Acquired Bacterial Pneumonia (CABP) was observed to be lower than that of patients treated with moxifloxacin.
- Specifically, the mortality rate in the NUZYRA group was reported to be approximately 2.5%, while the moxifloxacin group had a higher mortality rate of around 4.5%.
- These findings suggest that NUZYRA may offer a more favorable outcome in terms of mortality compared to moxifloxacin in the treatment of CABP.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the observed mortality rate in patients treated with NUZYRA for Community-Acquired Bacterial Pneumonia (CABP) compared to those treated with moxifloxacin?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- In clinical studies, the mortality rate for patients treated with NUZYRA (sarecycline) for Community-Acquired Bacterial Pneumonia (CABP) was observed to be lower than that of patients treated with moxifloxacin.\n- Specifically, the mortality rate in the NUZYRA group was reported to be approximately 2.5%, while the moxifloxacin group had a higher mortality rate of around 4.5%.\n- These findings suggest that NUZYRA may offer a more favorable outcome in terms of mortality compared to moxifloxacin in the treatment of CABP.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the observed mortality rate in patients treated with NUZYRA for Community-Acquired Bacterial Pneumonia (CABP) compared to those treated with moxifloxacin?\nA: 1% for NUZYRA and 2% for moxifloxacin\nB: 2% for NUZYRA and 1% for moxifloxacin\nC: 3% for NUZYRA and 1% for moxifloxacin\nD: 2% for both NUZYRA and moxifloxacin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In clinical studies, the mortality rate for patients treated with NUZYRA (sarecycline) for Community-Acquired Bacterial Pneumonia (CABP) was observed to be lower than that of patients treated with moxifloxacin.\n- Specifically, the mortality rate in the NUZYRA group was reported to be approximately 2.5%, while the moxifloxacin group had a higher mortality rate of around 4.5%.\n- These findings suggest that NUZYRA may offer a more favorable outcome in terms of mortality compared to moxifloxacin in the treatment of CABP.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the observed mortality rate in patients treated with NUZYRA for Community-Acquired Bacterial Pneumonia (CABP) compared to those treated with moxifloxacin?\nA: 1% for NUZYRA and 2% for moxifloxacin\nB: 2% for NUZYRA and 1% for moxifloxacin\nC: 3% for NUZYRA and 1% for moxifloxacin\nD: 2% for both NUZYRA and moxifloxacin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In clinical studies, the mortality rate for patients treated with NUZYRA (sarecycline) for Community-Acquired Bacterial Pneumonia (CABP) was observed to be lower than that of patients treated with moxifloxacin.\n- Specifically, the mortality rate in the NUZYRA group was reported to be approximately 2.5%, while the moxifloxacin group had a higher mortality rate of around 4.5%.\n- These findings suggest that NUZYRA may offer a more favorable outcome in terms of mortality compared to moxifloxacin in the treatment of CABP.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the observed mortality rate in patients treated with NUZYRA for Community-Acquired Bacterial Pneumonia (CABP) compared to those treated with moxifloxacin?\nA: 1% for NUZYRA and 2% for moxifloxacin\nB: 2% for NUZYRA and 1% for moxifloxacin\nC: 3% for NUZYRA and 1% for moxifloxacin\nD: 2% for both NUZYRA and moxifloxacin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In clinical studies, the mortality rate for patients treated with NUZYRA (sarecycline) for Community-Acquired Bacterial Pneumonia (CABP) was observed to be lower than that of patients treated with moxifloxacin.\n- Specifically, the mortality rate in the NUZYRA group was reported to be approximately 2.5%, while the moxifloxacin group had a higher mortality rate of around 4.5%.\n- These findings suggest that NUZYRA may offer a more favorable outcome in terms of mortality compared to moxifloxacin in the treatment of CABP.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"vsfDpdLNb0jd","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the storage of Wal-Zyr?\nA: Wal-Zyr should be stored below 10\u2070C (50\u2070F).\nB: Wal-Zyr should be stored at room temperature between 20\u2070 - 25\u2070C (68\u2070 - 77\u2070F).\nC: Wal-Zyr should be refrigerated at 2\u2070 - 8\u2070C (36\u2070 - 46\u2070F).\nD: Wal-Zyr should be stored at temperatures exceeding 30\u2070C (86\u2070F).\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the storage of Wal-Zyr?\nA: Wal-Zyr should be stored below 10\u2070C (50\u2070F).\nB: Wal-Zyr should be stored at room temperature between 20\u2070 - 25\u2070C (68\u2070 - 77\u2070F).\nC: Wal-Zyr should be refrigerated at 2\u2070 - 8\u2070C (36\u2070 - 46\u2070F).\nD: Wal-Zyr should be stored at temperatures exceeding 30\u2070C (86\u2070F).\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following statements is true regarding the storage of Wal-Zyr?\nA: Wal-Zyr should be stored below 10\u2070C (50\u2070F).\nB: Wal-Zyr should be stored at room temperature between 20\u2070 - 25\u2070C (68\u2070 - 77\u2070F).\nC: Wal-Zyr should be refrigerated at 2\u2070 - 8\u2070C (36\u2070 - 46\u2070F).\nD: Wal-Zyr should be stored at temperatures exceeding 30\u2070C (86\u2070F).\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"wVdQN3p4I2gJ","1) Recommendation: The incidence rate of serious rashes, including Stevens-Johnson syndrome (SJS), in pediatric patients taking lamotrigine is estimated to be around 0.1% to 0.4%. It is crucial for healthcare providers to monitor for any signs of rash, especially during the initial titration phase of the medication.

2) Key rationale:
   - Lamotrigine is associated with a risk of serious skin reactions, particularly when the dosage is increased too rapidly.
   - Pediatric patients are at a higher risk for developing SJS compared to adults, especially when co-administered with other medications that may also increase this risk.
   - The risk of rash is significantly higher in patients with a history of previous rashes related to lamotrigine or those with certain genetic predispositions.

3) Safety/contraindications/interactions:
   - Patients should be monitored closely during the first few weeks of treatment for any signs of rash.
   - Rapid dose escalation should be avoided to minimize the risk of serious skin reactions.
   - Co-administration with valproate can increase lamotrigine levels and the risk of rash; dosage adjustments may be necessary.
   - Patients with a history of SJS or toxic epidermal necrolysis (TEN) should not be prescribed lamotrigine. 

Assumptions: The response is based on available literature and clinical guidelines regarding lamotrigine use in pediatric populations. Specific patient history and concurrent medications were not provided, which could influence individual risk assessments.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the approximate incidence rate of serious rashes, including Stevens-Johnson syndrome, in pediatric patients aged 2 to 17 years taking lamotrigine?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: The incidence rate of serious rashes, including Stevens-Johnson syndrome (SJS), in pediatric patients taking lamotrigine is estimated to be around 0.1% to 0.4%. It is crucial for healthcare providers to monitor for any signs of rash, especially during the initial titration phase of the medication.\n\n2) Key rationale:\n   - Lamotrigine is associated with a risk of serious skin reactions, particularly when the dosage is increased too rapidly.\n   - Pediatric patients are at a higher risk for developing SJS compared to adults, especially when co-administered with other medications that may also increase this risk.\n   - The risk of rash is significantly higher in patients with a history of previous rashes related to lamotrigine or those with certain genetic predispositions.\n\n3) Safety/contraindications/interactions:\n   - Patients should be monitored closely during the first few weeks of treatment for any signs of rash.\n   - Rapid dose escalation should be avoided to minimize the risk of serious skin reactions.\n   - Co-administration with valproate can increase lamotrigine levels and the risk of rash; dosage adjustments may be necessary.\n   - Patients with a history of SJS or toxic epidermal necrolysis (TEN) should not be prescribed lamotrigine. \n\nAssumptions: The response is based on available literature and clinical guidelines regarding lamotrigine use in pediatric populations. Specific patient history and concurrent medications were not provided, which could influence individual risk assessments.""}]"
"BoMWNBQPfq3q","- Use CLEOCIN PHOSPHATE (clindamycin phosphate) only for confirmed bacterial infections to minimize unnecessary exposure.
- Complete the full course of treatment with CLEOCIN PHOSPHATE as prescribed, even if symptoms improve, to ensure all bacteria are eradicated.
- Avoid using CLEOCIN PHOSPHATE in combination with other antibiotics unless specifically directed by a healthcare provider, to reduce the risk of resistance development.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended approach to reduce the development of drug-resistant bacteria when using CLEOCIN PHOSPHATE?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Use CLEOCIN PHOSPHATE (clindamycin phosphate) only for confirmed bacterial infections to minimize unnecessary exposure.\n- Complete the full course of treatment with CLEOCIN PHOSPHATE as prescribed, even if symptoms improve, to ensure all bacteria are eradicated.\n- Avoid using CLEOCIN PHOSPHATE in combination with other antibiotics unless specifically directed by a healthcare provider, to reduce the risk of resistance development.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach to reduce the development of drug-resistant bacteria when using CLEOCIN PHOSPHATE?\nA: Use only for infections proven or strongly suspected to be caused by susceptible bacteria.\nB: Prescribe CLEOCIN PHOSPHATE for all bacterial infections.\nC: Use CLEOCIN PHOSPHATE for viral infections.\nD: Avoid bacteriologic studies before prescribing.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Use CLEOCIN PHOSPHATE (clindamycin phosphate) only for confirmed bacterial infections to minimize unnecessary exposure.\n- Complete the full course of treatment with CLEOCIN PHOSPHATE as prescribed, even if symptoms improve, to ensure all bacteria are eradicated.\n- Avoid using CLEOCIN PHOSPHATE in combination with other antibiotics unless specifically directed by a healthcare provider, to reduce the risk of resistance development.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach to reduce the development of drug-resistant bacteria when using CLEOCIN PHOSPHATE?\nA: Use only for infections proven or strongly suspected to be caused by susceptible bacteria.\nB: Prescribe CLEOCIN PHOSPHATE for all bacterial infections.\nC: Use CLEOCIN PHOSPHATE for viral infections.\nD: Avoid bacteriologic studies before prescribing.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Use CLEOCIN PHOSPHATE (clindamycin phosphate) only for confirmed bacterial infections to minimize unnecessary exposure.\n- Complete the full course of treatment with CLEOCIN PHOSPHATE as prescribed, even if symptoms improve, to ensure all bacteria are eradicated.\n- Avoid using CLEOCIN PHOSPHATE in combination with other antibiotics unless specifically directed by a healthcare provider, to reduce the risk of resistance development.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach to reduce the development of drug-resistant bacteria when using CLEOCIN PHOSPHATE?\nA: Use only for infections proven or strongly suspected to be caused by susceptible bacteria.\nB: Prescribe CLEOCIN PHOSPHATE for all bacterial infections.\nC: Use CLEOCIN PHOSPHATE for viral infections.\nD: Avoid bacteriologic studies before prescribing.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Use CLEOCIN PHOSPHATE (clindamycin phosphate) only for confirmed bacterial infections to minimize unnecessary exposure.\n- Complete the full course of treatment with CLEOCIN PHOSPHATE as prescribed, even if symptoms improve, to ensure all bacteria are eradicated.\n- Avoid using CLEOCIN PHOSPHATE in combination with other antibiotics unless specifically directed by a healthcare provider, to reduce the risk of resistance development.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"YjoV6Hje3mRz","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following conditions has been reported during the coadministration of Sumatriptan and SSRIs or SNRIs?\nA: Serotonin syndrome\nB: Prolonged vasospastic reactions\nC: Increased systemic exposure\nD: Reduced efficacy of Sumatriptan\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following conditions has been reported during the coadministration of Sumatriptan and SSRIs or SNRIs?\nA: Serotonin syndrome\nB: Prolonged vasospastic reactions\nC: Increased systemic exposure\nD: Reduced efficacy of Sumatriptan\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following conditions has been reported during the coadministration of Sumatriptan and SSRIs or SNRIs?\nA: Serotonin syndrome\nB: Prolonged vasospastic reactions\nC: Increased systemic exposure\nD: Reduced efficacy of Sumatriptan\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"76QNAyhb624m","- Beard growth oil should be applied twice daily to the beard loss area for optimal results.
- Consistent application is key, so using the oil every morning and evening is recommended.
- Ensure to massage the oil into the facial hair and skin for better absorption and effectiveness.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow often should Beard growth oil be applied to the beard loss area or facial hair?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Beard growth oil should be applied twice daily to the beard loss area for optimal results.\n- Consistent application is key, so using the oil every morning and evening is recommended.\n- Ensure to massage the oil into the facial hair and skin for better absorption and effectiveness.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How often should Beard growth oil be applied to the beard loss area or facial hair?\nA: Once per week\nB: 1-2 times per day\nC: Every hour\nD: Twice per week\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Beard growth oil should be applied twice daily to the beard loss area for optimal results.\n- Consistent application is key, so using the oil every morning and evening is recommended.\n- Ensure to massage the oil into the facial hair and skin for better absorption and effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How often should Beard growth oil be applied to the beard loss area or facial hair?\nA: Once per week\nB: 1-2 times per day\nC: Every hour\nD: Twice per week\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Beard growth oil should be applied twice daily to the beard loss area for optimal results.\n- Consistent application is key, so using the oil every morning and evening is recommended.\n- Ensure to massage the oil into the facial hair and skin for better absorption and effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How often should Beard growth oil be applied to the beard loss area or facial hair?\nA: Once per week\nB: 1-2 times per day\nC: Every hour\nD: Twice per week\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Beard growth oil should be applied twice daily to the beard loss area for optimal results.\n- Consistent application is key, so using the oil every morning and evening is recommended.\n- Ensure to massage the oil into the facial hair and skin for better absorption and effectiveness.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"94cU4dpidmaq","MRRV winner=A; scores={'A': 1.0, 'B': 0.3055555555555555, 'C': 0.27777777777777773, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf a patient has a history of hypersensitivity to Albuterol's ingredients, what action should be taken?\nA: Avoid prescribing Albuterol\nB: Prescribe a reduced dose of Albuterol\nC: Administer Albuterol with close monitoring\nD: Switch to a different brand of Albuterol\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf a patient has a history of hypersensitivity to Albuterol's ingredients, what action should be taken?\nA: Avoid prescribing Albuterol\nB: Prescribe a reduced dose of Albuterol\nC: Administer Albuterol with close monitoring\nD: Switch to a different brand of Albuterol\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIf a patient has a history of hypersensitivity to Albuterol's ingredients, what action should be taken?\nA: Avoid prescribing Albuterol\nB: Prescribe a reduced dose of Albuterol\nC: Administer Albuterol with close monitoring\nD: Switch to a different brand of Albuterol\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"11FOG4hKLE18","1) Recommendation: Patients on chronic warfarin therapy who are administered fosaprepitant should have their INR (International Normalized Ratio) closely monitored, particularly during the initiation of fosaprepitant and for at least two weeks thereafter. Adjustments to the warfarin dose may be necessary based on INR results.

2) Key rationale:
- Fosaprepitant can potentially interact with warfarin, leading to altered anticoagulation effects.
- The interaction may increase the risk of bleeding if INR levels rise due to decreased warfarin metabolism.
- Regular INR monitoring helps ensure that patients remain within the therapeutic range and minimizes the risk of adverse effects.
- Individual patient factors, such as diet, other medications, and overall health, can further influence warfarin metabolism and efficacy.

3) Safety/contraindications/interactions:
- Monitor for signs of bleeding or thrombosis, especially during the first two weeks of co-administration.
- Be aware of other medications that may also affect INR levels, as they can compound the effects of fosaprepitant and warfarin.
- Consider patient-specific factors such as liver function, which may affect drug metabolism.
- Adjust warfarin dosage based on INR results and clinical judgment, as necessary.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat monitoring is recommended for patients on chronic warfarin therapy who are administered FOSAPREPITANT?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Patients on chronic warfarin therapy who are administered fosaprepitant should have their INR (International Normalized Ratio) closely monitored, particularly during the initiation of fosaprepitant and for at least two weeks thereafter. Adjustments to the warfarin dose may be necessary based on INR results.\n\n2) Key rationale:\n- Fosaprepitant can potentially interact with warfarin, leading to altered anticoagulation effects.\n- The interaction may increase the risk of bleeding if INR levels rise due to decreased warfarin metabolism.\n- Regular INR monitoring helps ensure that patients remain within the therapeutic range and minimizes the risk of adverse effects.\n- Individual patient factors, such as diet, other medications, and overall health, can further influence warfarin metabolism and efficacy.\n\n3) Safety/contraindications/interactions:\n- Monitor for signs of bleeding or thrombosis, especially during the first two weeks of co-administration.\n- Be aware of other medications that may also affect INR levels, as they can compound the effects of fosaprepitant and warfarin.\n- Consider patient-specific factors such as liver function, which may affect drug metabolism.\n- Adjust warfarin dosage based on INR results and clinical judgment, as necessary.""}]"
"aSMsEPLeQD23","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy is the antigenicity of Cortrosyn considered important compared to natural ACTH?\nA: Cortrosyn has enhanced antigenicity compared to natural ACTH.\nB: Cortrosyn has reduced antigenicity compared to natural ACTH.\nC: Cortrosyn has no antigenicity compared to natural ACTH.\nD: Cortrosyn has similar antigenicity to natural ACTH.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy is the antigenicity of Cortrosyn considered important compared to natural ACTH?\nA: Cortrosyn has enhanced antigenicity compared to natural ACTH.\nB: Cortrosyn has reduced antigenicity compared to natural ACTH.\nC: Cortrosyn has no antigenicity compared to natural ACTH.\nD: Cortrosyn has similar antigenicity to natural ACTH.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy is the antigenicity of Cortrosyn considered important compared to natural ACTH?\nA: Cortrosyn has enhanced antigenicity compared to natural ACTH.\nB: Cortrosyn has reduced antigenicity compared to natural ACTH.\nC: Cortrosyn has no antigenicity compared to natural ACTH.\nD: Cortrosyn has similar antigenicity to natural ACTH.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"TUkdRsK7My5H","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following actions should be taken if a patient develops interstitial pneumonitis while receiving OGIVRI?\nA: Continue treatment with a reduced dose\nB: Discontinue OGIVRI immediately\nC: Administer additional anthracycline chemotherapy\nD: Monitor the patient without interrupting treatment\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following actions should be taken if a patient develops interstitial pneumonitis while receiving OGIVRI?\nA: Continue treatment with a reduced dose\nB: Discontinue OGIVRI immediately\nC: Administer additional anthracycline chemotherapy\nD: Monitor the patient without interrupting treatment\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following actions should be taken if a patient develops interstitial pneumonitis while receiving OGIVRI?\nA: Continue treatment with a reduced dose\nB: Discontinue OGIVRI immediately\nC: Administer additional anthracycline chemotherapy\nD: Monitor the patient without interrupting treatment\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"D5CAaJoq6i44","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage adjustment for Iclusig in patients with hepatic impairment (Child-Pugh A, B, or C) receiving monotherapy?\nA: Increase the dosage to 45 mg orally once daily\nB: Reduce the starting dose to 30 mg orally once daily\nC: Maintain the dosage at 15 mg orally once daily\nD: Discontinue Iclusig\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage adjustment for Iclusig in patients with hepatic impairment (Child-Pugh A, B, or C) receiving monotherapy?\nA: Increase the dosage to 45 mg orally once daily\nB: Reduce the starting dose to 30 mg orally once daily\nC: Maintain the dosage at 15 mg orally once daily\nD: Discontinue Iclusig\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage adjustment for Iclusig in patients with hepatic impairment (Child-Pugh A, B, or C) receiving monotherapy?\nA: Increase the dosage to 45 mg orally once daily\nB: Reduce the starting dose to 30 mg orally once daily\nC: Maintain the dosage at 15 mg orally once daily\nD: Discontinue Iclusig\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"R3VRfSTWMvBl","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is one of the benefits of 'basic care nighttime cold and flu' for individuals with a cough?\nA: It eliminates the cause of the cough\nB: It relieves cough due to minor throat and bronchial irritation\nC: It prevents future coughs\nD: It increases mucus production to soothe the throat\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is one of the benefits of 'basic care nighttime cold and flu' for individuals with a cough?\nA: It eliminates the cause of the cough\nB: It relieves cough due to minor throat and bronchial irritation\nC: It prevents future coughs\nD: It increases mucus production to soothe the throat\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is one of the benefits of 'basic care nighttime cold and flu' for individuals with a cough?\nA: It eliminates the cause of the cough\nB: It relieves cough due to minor throat and bronchial irritation\nC: It prevents future coughs\nD: It increases mucus production to soothe the throat\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"Rpmxi6RF1uya","- The patient should seek immediate medical attention, as a sudden, severe headache could indicate a serious condition such as a stroke or blood clot, especially while taking Tri Femynor, which contains hormones that may increase the risk of these events.
- It is important to inform the healthcare provider about the use of Tri Femynor, as this medication can affect blood clotting and may require further evaluation or imaging to rule out complications.
- The patient should not ignore the headache or attempt to self-treat, as the nature of the headache is atypical and warrants professional assessment.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should a patient do if they experience a sudden, severe headache unlike their usual headaches while taking Tri Femynor?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The patient should seek immediate medical attention, as a sudden, severe headache could indicate a serious condition such as a stroke or blood clot, especially while taking Tri Femynor, which contains hormones that may increase the risk of these events.\n- It is important to inform the healthcare provider about the use of Tri Femynor, as this medication can affect blood clotting and may require further evaluation or imaging to rule out complications.\n- The patient should not ignore the headache or attempt to self-treat, as the nature of the headache is atypical and warrants professional assessment.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a patient do if they experience a sudden, severe headache unlike their usual headaches while taking Tri Femynor?\nA: Continue taking the medication and monitor symptoms.\nB: Stop taking Tri Femynor and consult their healthcare provider immediately.\nC: Take an over-the-counter pain reliever and rest.\nD: Reduce the dosage of Tri Femynor.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The patient should seek immediate medical attention, as a sudden, severe headache could indicate a serious condition such as a stroke or blood clot, especially while taking Tri Femynor, which contains hormones that may increase the risk of these events.\n- It is important to inform the healthcare provider about the use of Tri Femynor, as this medication can affect blood clotting and may require further evaluation or imaging to rule out complications.\n- The patient should not ignore the headache or attempt to self-treat, as the nature of the headache is atypical and warrants professional assessment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a patient do if they experience a sudden, severe headache unlike their usual headaches while taking Tri Femynor?\nA: Continue taking the medication and monitor symptoms.\nB: Stop taking Tri Femynor and consult their healthcare provider immediately.\nC: Take an over-the-counter pain reliever and rest.\nD: Reduce the dosage of Tri Femynor.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The patient should seek immediate medical attention, as a sudden, severe headache could indicate a serious condition such as a stroke or blood clot, especially while taking Tri Femynor, which contains hormones that may increase the risk of these events.\n- It is important to inform the healthcare provider about the use of Tri Femynor, as this medication can affect blood clotting and may require further evaluation or imaging to rule out complications.\n- The patient should not ignore the headache or attempt to self-treat, as the nature of the headache is atypical and warrants professional assessment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should a patient do if they experience a sudden, severe headache unlike their usual headaches while taking Tri Femynor?\nA: Continue taking the medication and monitor symptoms.\nB: Stop taking Tri Femynor and consult their healthcare provider immediately.\nC: Take an over-the-counter pain reliever and rest.\nD: Reduce the dosage of Tri Femynor.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The patient should seek immediate medical attention, as a sudden, severe headache could indicate a serious condition such as a stroke or blood clot, especially while taking Tri Femynor, which contains hormones that may increase the risk of these events.\n- It is important to inform the healthcare provider about the use of Tri Femynor, as this medication can affect blood clotting and may require further evaluation or imaging to rule out complications.\n- The patient should not ignore the headache or attempt to self-treat, as the nature of the headache is atypical and warrants professional assessment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"Q1RaQhg1Eoy0","- Patients should discontinue the use of NURTEC ODT if they experience signs or symptoms of Raynauds phenomenon, as this condition can be exacerbated by the medication.
- It is important for patients to consult their healthcare provider for further evaluation and management if they notice symptoms such as color changes in fingers or toes, numbness, or pain.
- Patients should not attempt to self-treat or ignore these symptoms while on NURTEC ODT, as timely medical advice is crucial for proper care.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.3055555555555555}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should patients do if they experience signs or symptoms of Raynaud\u2019s phenomenon while taking NURTEC ODT?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients should discontinue the use of NURTEC ODT if they experience signs or symptoms of Raynaud\u2019s phenomenon, as this condition can be exacerbated by the medication.\n- It is important for patients to consult their healthcare provider for further evaluation and management if they notice symptoms such as color changes in fingers or toes, numbness, or pain.\n- Patients should not attempt to self-treat or ignore these symptoms while on NURTEC ODT, as timely medical advice is crucial for proper care.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients do if they experience signs or symptoms of Raynaud\u2019s phenomenon while taking NURTEC ODT?\nA: Continue taking the medication and monitor symptoms.\nB: Discontinue NURTEC ODT and contact their healthcare provider.\nC: Increase the dosage of NURTEC ODT.\nD: Apply topical medication to affected areas.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients should discontinue the use of NURTEC ODT if they experience signs or symptoms of Raynaud\u2019s phenomenon, as this condition can be exacerbated by the medication.\n- It is important for patients to consult their healthcare provider for further evaluation and management if they notice symptoms such as color changes in fingers or toes, numbness, or pain.\n- Patients should not attempt to self-treat or ignore these symptoms while on NURTEC ODT, as timely medical advice is crucial for proper care.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients do if they experience signs or symptoms of Raynaud\u2019s phenomenon while taking NURTEC ODT?\nA: Continue taking the medication and monitor symptoms.\nB: Discontinue NURTEC ODT and contact their healthcare provider.\nC: Increase the dosage of NURTEC ODT.\nD: Apply topical medication to affected areas.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients should discontinue the use of NURTEC ODT if they experience signs or symptoms of Raynaud\u2019s phenomenon, as this condition can be exacerbated by the medication.\n- It is important for patients to consult their healthcare provider for further evaluation and management if they notice symptoms such as color changes in fingers or toes, numbness, or pain.\n- Patients should not attempt to self-treat or ignore these symptoms while on NURTEC ODT, as timely medical advice is crucial for proper care.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients do if they experience signs or symptoms of Raynaud\u2019s phenomenon while taking NURTEC ODT?\nA: Continue taking the medication and monitor symptoms.\nB: Discontinue NURTEC ODT and contact their healthcare provider.\nC: Increase the dosage of NURTEC ODT.\nD: Apply topical medication to affected areas.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients should discontinue the use of NURTEC ODT if they experience signs or symptoms of Raynaud\u2019s phenomenon, as this condition can be exacerbated by the medication.\n- It is important for patients to consult their healthcare provider for further evaluation and management if they notice symptoms such as color changes in fingers or toes, numbness, or pain.\n- Patients should not attempt to self-treat or ignore these symptoms while on NURTEC ODT, as timely medical advice is crucial for proper care.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"O2vig7J3fi3K","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient develops jaundice or marked liver enzyme elevations while being treated with REMICADE?\nA: Continue treatment and monitor liver enzymes closely.\nB: Discontinue REMICADE and investigate the abnormality.\nC: Reduce the dosage of REMICADE.\nD: Switch to another TNF blocker.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient develops jaundice or marked liver enzyme elevations while being treated with REMICADE?\nA: Continue treatment and monitor liver enzymes closely.\nB: Discontinue REMICADE and investigate the abnormality.\nC: Reduce the dosage of REMICADE.\nD: Switch to another TNF blocker.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient develops jaundice or marked liver enzyme elevations while being treated with REMICADE?\nA: Continue treatment and monitor liver enzymes closely.\nB: Discontinue REMICADE and investigate the abnormality.\nC: Reduce the dosage of REMICADE.\nD: Switch to another TNF blocker.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"r7g1hMXiQ0zF","1) Recommendation: If irritation or sensitivity develops while using BP Wash, discontinue use immediately and consult a healthcare professional for further evaluation and guidance. It may be beneficial to switch to a gentler cleanser or a lower concentration of benzoyl peroxide, depending on the severity of the reaction.

2) Key rationale:
- Benzoyl peroxide can cause skin irritation, especially in individuals with sensitive skin or those new to the product.
- Discontinuing use allows the skin to recover and prevents further irritation or potential allergic reactions.
- Consulting a healthcare professional ensures that any underlying issues are addressed and appropriate alternatives are recommended.

3) Safety/contraindications/interactions:
- Avoid using BP Wash on broken or inflamed skin, as this can exacerbate irritation.
- Be cautious when combining with other acne treatments, as this may increase the risk of irritation.
- Always perform a patch test before using new products to assess for sensitivity.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat should a user do if irritation or sensitivity develops while using BP Wash?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: If irritation or sensitivity develops while using BP Wash, discontinue use immediately and consult a healthcare professional for further evaluation and guidance. It may be beneficial to switch to a gentler cleanser or a lower concentration of benzoyl peroxide, depending on the severity of the reaction.\n\n2) Key rationale:\n- Benzoyl peroxide can cause skin irritation, especially in individuals with sensitive skin or those new to the product.\n- Discontinuing use allows the skin to recover and prevents further irritation or potential allergic reactions.\n- Consulting a healthcare professional ensures that any underlying issues are addressed and appropriate alternatives are recommended.\n\n3) Safety/contraindications/interactions:\n- Avoid using BP Wash on broken or inflamed skin, as this can exacerbate irritation.\n- Be cautious when combining with other acne treatments, as this may increase the risk of irritation.\n- Always perform a patch test before using new products to assess for sensitivity.""}]"
"lPVrEQRf666h","MRRV winner=B; scores={'A': 0.6666666666666666, 'B': 0.8333333333333334, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich brand name drug is used for the temporary relief of pain?\nA: LidoPro Patch\nB: PainRelief Gel\nC: NeuroPatch\nD: InflamEase\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich brand name drug is used for the temporary relief of pain?\nA: LidoPro Patch\nB: PainRelief Gel\nC: NeuroPatch\nD: InflamEase\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich brand name drug is used for the temporary relief of pain?\nA: LidoPro Patch\nB: PainRelief Gel\nC: NeuroPatch\nD: InflamEase\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"66k6JlKji7qH","- Monitor patients closely for signs of misuse, abuse, or addiction, especially those with a history of substance use disorders, when prescribing Lyrica CR (pregabalin extended-release).
- Consider alternative treatments for pain or anxiety in patients with a significant history of drug abuse, as Lyrica CR may have potential for dependence.
- Educate patients about the risks associated with Lyrica CR, including the potential for withdrawal symptoms if the medication is discontinued abruptly.

MRRV(meta) winner=B; scores={'A': 0.3055555555555555, 'B': 1.0, 'C': 0.5, 'D': 0.27777777777777773}; rankings=[['B', 'C', 'D', 'A'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat precaution should be taken when prescribing Lyrica CR to patients with a history of drug abuse?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Monitor patients closely for signs of misuse, abuse, or addiction, especially those with a history of substance use disorders, when prescribing Lyrica CR (pregabalin extended-release).\n- Consider alternative treatments for pain or anxiety in patients with a significant history of drug abuse, as Lyrica CR may have potential for dependence.\n- Educate patients about the risks associated with Lyrica CR, including the potential for withdrawal symptoms if the medication is discontinued abruptly.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken when prescribing Lyrica CR to patients with a history of drug abuse?\nA: Prescribe the drug without any restrictions.\nB: Carefully evaluate the patient's history of drug abuse and monitor for signs of misuse or abuse.\nC: Avoid prescribing Lyrica CR under any circumstances.\nD: Prescribe a higher dose to counteract potential tolerance development.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor patients closely for signs of misuse, abuse, or addiction, especially those with a history of substance use disorders, when prescribing Lyrica CR (pregabalin extended-release).\n- Consider alternative treatments for pain or anxiety in patients with a significant history of drug abuse, as Lyrica CR may have potential for dependence.\n- Educate patients about the risks associated with Lyrica CR, including the potential for withdrawal symptoms if the medication is discontinued abruptly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken when prescribing Lyrica CR to patients with a history of drug abuse?\nA: Prescribe the drug without any restrictions.\nB: Carefully evaluate the patient's history of drug abuse and monitor for signs of misuse or abuse.\nC: Avoid prescribing Lyrica CR under any circumstances.\nD: Prescribe a higher dose to counteract potential tolerance development.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor patients closely for signs of misuse, abuse, or addiction, especially those with a history of substance use disorders, when prescribing Lyrica CR (pregabalin extended-release).\n- Consider alternative treatments for pain or anxiety in patients with a significant history of drug abuse, as Lyrica CR may have potential for dependence.\n- Educate patients about the risks associated with Lyrica CR, including the potential for withdrawal symptoms if the medication is discontinued abruptly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What precaution should be taken when prescribing Lyrica CR to patients with a history of drug abuse?\nA: Prescribe the drug without any restrictions.\nB: Carefully evaluate the patient's history of drug abuse and monitor for signs of misuse or abuse.\nC: Avoid prescribing Lyrica CR under any circumstances.\nD: Prescribe a higher dose to counteract potential tolerance development.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor patients closely for signs of misuse, abuse, or addiction, especially those with a history of substance use disorders, when prescribing Lyrica CR (pregabalin extended-release).\n- Consider alternative treatments for pain or anxiety in patients with a significant history of drug abuse, as Lyrica CR may have potential for dependence.\n- Educate patients about the risks associated with Lyrica CR, including the potential for withdrawal symptoms if the medication is discontinued abruptly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"zpjtHEPME7PF","- In severe cases, the use of DEXAMETHASONE is recommended as it has shown efficacy in reducing inflammation and improving outcomes in severe disease.
- Alternatively, the use of REMDESIVIR may be considered for patients with severe viral infections, as it has antiviral properties that can help in managing the disease.
- In some instances, the administration of monoclonal antibodies like BAMLANIVIMAB may be indicated for patients with severe disease to target the virus directly.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn cases of severe forms of disease, what is recommended instead of TOXEX?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- In severe cases, the use of DEXAMETHASONE is recommended as it has shown efficacy in reducing inflammation and improving outcomes in severe disease.\n- Alternatively, the use of REMDESIVIR may be considered for patients with severe viral infections, as it has antiviral properties that can help in managing the disease.\n- In some instances, the administration of monoclonal antibodies like BAMLANIVIMAB may be indicated for patients with severe disease to target the virus directly.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In cases of severe forms of disease, what is recommended instead of TOXEX?\nA: Continued use of TOXEX\nB: A clinically proven therapy\nC: Alternative homeopathic remedies\nD: No treatment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In severe cases, the use of DEXAMETHASONE is recommended as it has shown efficacy in reducing inflammation and improving outcomes in severe disease.\n- Alternatively, the use of REMDESIVIR may be considered for patients with severe viral infections, as it has antiviral properties that can help in managing the disease.\n- In some instances, the administration of monoclonal antibodies like BAMLANIVIMAB may be indicated for patients with severe disease to target the virus directly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In cases of severe forms of disease, what is recommended instead of TOXEX?\nA: Continued use of TOXEX\nB: A clinically proven therapy\nC: Alternative homeopathic remedies\nD: No treatment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In severe cases, the use of DEXAMETHASONE is recommended as it has shown efficacy in reducing inflammation and improving outcomes in severe disease.\n- Alternatively, the use of REMDESIVIR may be considered for patients with severe viral infections, as it has antiviral properties that can help in managing the disease.\n- In some instances, the administration of monoclonal antibodies like BAMLANIVIMAB may be indicated for patients with severe disease to target the virus directly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In cases of severe forms of disease, what is recommended instead of TOXEX?\nA: Continued use of TOXEX\nB: A clinically proven therapy\nC: Alternative homeopathic remedies\nD: No treatment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- In severe cases, the use of DEXAMETHASONE is recommended as it has shown efficacy in reducing inflammation and improving outcomes in severe disease.\n- Alternatively, the use of REMDESIVIR may be considered for patients with severe viral infections, as it has antiviral properties that can help in managing the disease.\n- In some instances, the administration of monoclonal antibodies like BAMLANIVIMAB may be indicated for patients with severe disease to target the virus directly.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"yEUDbvu9TlU3","- Women taking Jaimiess should consider discontinuing the medication at least 4 weeks prior to major surgery to reduce the risk of thromboembolic events.
- It is advisable to consult with a healthcare provider to discuss the timing of stopping Jaimiess and any necessary alternative contraceptive methods during the perioperative period.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action for women taking Jaimiess who are scheduled for major surgery?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Women taking Jaimiess should consider discontinuing the medication at least 4 weeks prior to major surgery to reduce the risk of thromboembolic events.\n- It is advisable to consult with a healthcare provider to discuss the timing of stopping Jaimiess and any necessary alternative contraceptive methods during the perioperative period.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action for women taking Jaimiess who are scheduled for major surgery?\nA: Continue taking Jaimiess as usual\nB: Stop taking Jaimiess at least 4 weeks before surgery\nC: Switch to a different contraceptive method immediately after surgery\nD: Take a double dose of Jaimiess before surgery\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Women taking Jaimiess should consider discontinuing the medication at least 4 weeks prior to major surgery to reduce the risk of thromboembolic events.\n- It is advisable to consult with a healthcare provider to discuss the timing of stopping Jaimiess and any necessary alternative contraceptive methods during the perioperative period.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action for women taking Jaimiess who are scheduled for major surgery?\nA: Continue taking Jaimiess as usual\nB: Stop taking Jaimiess at least 4 weeks before surgery\nC: Switch to a different contraceptive method immediately after surgery\nD: Take a double dose of Jaimiess before surgery\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Women taking Jaimiess should consider discontinuing the medication at least 4 weeks prior to major surgery to reduce the risk of thromboembolic events.\n- It is advisable to consult with a healthcare provider to discuss the timing of stopping Jaimiess and any necessary alternative contraceptive methods during the perioperative period.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action for women taking Jaimiess who are scheduled for major surgery?\nA: Continue taking Jaimiess as usual\nB: Stop taking Jaimiess at least 4 weeks before surgery\nC: Switch to a different contraceptive method immediately after surgery\nD: Take a double dose of Jaimiess before surgery\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Women taking Jaimiess should consider discontinuing the medication at least 4 weeks prior to major surgery to reduce the risk of thromboembolic events.\n- It is advisable to consult with a healthcare provider to discuss the timing of stopping Jaimiess and any necessary alternative contraceptive methods during the perioperative period.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"i6veUyyWMftL","1) Recommendation: Further research is needed to determine the specific incidence of infusion-site erythema in patients receiving fosaprepitant compared to oral aprepitant for highly emetogenic chemotherapy (HEC). Clinicians should monitor patients for any signs of infusion-site reactions and manage them accordingly.

2) Key rationale:
- Fosaprepitant is administered intravenously, which may lead to a different risk profile for infusion-site reactions compared to oral aprepitant.
- The incidence of infusion-site erythema can vary based on the formulation and route of administration.
- Understanding the incidence can help in patient counseling and management of potential side effects.

3) Safety/contraindications/interactions:
- Patients with a history of hypersensitivity to fosaprepitant or any of its components should avoid its use.
- Caution is advised when administering fosaprepitant in patients taking other medications that may interact with its metabolism, such as certain CYP3A4 inhibitors or inducers.
- Monitor for infusion-related reactions, especially in patients with sensitive skin or those receiving concurrent intravenous therapies. 

Assumptions: The question assumes that the reader has a basic understanding of the medications mentioned and their use in chemotherapy. Missing information includes specific studies or data comparing the incidence rates of infusion-site erythema between the two formulations.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the incidence of infusion-site erythema in patients receiving FOSAPREPITANT for HEC compared to oral aprepitant?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Further research is needed to determine the specific incidence of infusion-site erythema in patients receiving fosaprepitant compared to oral aprepitant for highly emetogenic chemotherapy (HEC). Clinicians should monitor patients for any signs of infusion-site reactions and manage them accordingly.\n\n2) Key rationale:\n- Fosaprepitant is administered intravenously, which may lead to a different risk profile for infusion-site reactions compared to oral aprepitant.\n- The incidence of infusion-site erythema can vary based on the formulation and route of administration.\n- Understanding the incidence can help in patient counseling and management of potential side effects.\n\n3) Safety/contraindications/interactions:\n- Patients with a history of hypersensitivity to fosaprepitant or any of its components should avoid its use.\n- Caution is advised when administering fosaprepitant in patients taking other medications that may interact with its metabolism, such as certain CYP3A4 inhibitors or inducers.\n- Monitor for infusion-related reactions, especially in patients with sensitive skin or those receiving concurrent intravenous therapies. \n\nAssumptions: The question assumes that the reader has a basic understanding of the medications mentioned and their use in chemotherapy. Missing information includes specific studies or data comparing the incidence rates of infusion-site erythema between the two formulations.""}]"
"IRaoXZZBD1yr","- Propranolol, a non-selective beta blocker, produced significant bronchospasm in mildly asthmatic patients during clinical studies.
- The adverse effects were particularly noted in patients with a history of asthma when treated with propranolol compared to a placebo.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich beta blocker produced significant bronchospasm in mildly asthmatic patients during clinical studies?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Propranolol, a non-selective beta blocker, produced significant bronchospasm in mildly asthmatic patients during clinical studies.\n- The adverse effects were particularly noted in patients with a history of asthma when treated with propranolol compared to a placebo.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which beta blocker produced significant bronchospasm in mildly asthmatic patients during clinical studies?\nA: BREVIBLOC\nB: Propranolol\nC: Metoprolol\nD: Atenolol\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Propranolol, a non-selective beta blocker, produced significant bronchospasm in mildly asthmatic patients during clinical studies.\n- The adverse effects were particularly noted in patients with a history of asthma when treated with propranolol compared to a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which beta blocker produced significant bronchospasm in mildly asthmatic patients during clinical studies?\nA: BREVIBLOC\nB: Propranolol\nC: Metoprolol\nD: Atenolol\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Propranolol, a non-selective beta blocker, produced significant bronchospasm in mildly asthmatic patients during clinical studies.\n- The adverse effects were particularly noted in patients with a history of asthma when treated with propranolol compared to a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which beta blocker produced significant bronchospasm in mildly asthmatic patients during clinical studies?\nA: BREVIBLOC\nB: Propranolol\nC: Metoprolol\nD: Atenolol\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Propranolol, a non-selective beta blocker, produced significant bronchospasm in mildly asthmatic patients during clinical studies.\n- The adverse effects were particularly noted in patients with a history of asthma when treated with propranolol compared to a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"v31jiwTpNtye","- Co-administration of Lyrica (pregabalin) with ethanol can lead to increased sedation and impairment in cognitive and motor functioning due to the additive central nervous system depressant effects of both substances.
- Patients taking Lyrica may experience heightened dizziness, drowsiness, and difficulty concentrating when consuming ethanol, which can exacerbate the side effects of Lyrica.
- The combination may also increase the risk of falls and accidents, particularly in individuals who are already sensitive to the effects of either Lyrica or alcohol.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the effect of co-administration of Lyrica with ethanol on cognitive and motor functioning?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Co-administration of Lyrica (pregabalin) with ethanol can lead to increased sedation and impairment in cognitive and motor functioning due to the additive central nervous system depressant effects of both substances.\n- Patients taking Lyrica may experience heightened dizziness, drowsiness, and difficulty concentrating when consuming ethanol, which can exacerbate the side effects of Lyrica.\n- The combination may also increase the risk of falls and accidents, particularly in individuals who are already sensitive to the effects of either Lyrica or alcohol.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of co-administration of Lyrica with ethanol on cognitive and motor functioning?\nA: No additive effects are observed.\nB: Additive effects on cognitive and gross motor functioning are observed.\nC: Ethanol reduces the pharmacokinetics of Lyrica.\nD: Ethanol enhances the respiratory effects of Lyrica.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Co-administration of Lyrica (pregabalin) with ethanol can lead to increased sedation and impairment in cognitive and motor functioning due to the additive central nervous system depressant effects of both substances.\n- Patients taking Lyrica may experience heightened dizziness, drowsiness, and difficulty concentrating when consuming ethanol, which can exacerbate the side effects of Lyrica.\n- The combination may also increase the risk of falls and accidents, particularly in individuals who are already sensitive to the effects of either Lyrica or alcohol.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of co-administration of Lyrica with ethanol on cognitive and motor functioning?\nA: No additive effects are observed.\nB: Additive effects on cognitive and gross motor functioning are observed.\nC: Ethanol reduces the pharmacokinetics of Lyrica.\nD: Ethanol enhances the respiratory effects of Lyrica.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Co-administration of Lyrica (pregabalin) with ethanol can lead to increased sedation and impairment in cognitive and motor functioning due to the additive central nervous system depressant effects of both substances.\n- Patients taking Lyrica may experience heightened dizziness, drowsiness, and difficulty concentrating when consuming ethanol, which can exacerbate the side effects of Lyrica.\n- The combination may also increase the risk of falls and accidents, particularly in individuals who are already sensitive to the effects of either Lyrica or alcohol.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of co-administration of Lyrica with ethanol on cognitive and motor functioning?\nA: No additive effects are observed.\nB: Additive effects on cognitive and gross motor functioning are observed.\nC: Ethanol reduces the pharmacokinetics of Lyrica.\nD: Ethanol enhances the respiratory effects of Lyrica.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Co-administration of Lyrica (pregabalin) with ethanol can lead to increased sedation and impairment in cognitive and motor functioning due to the additive central nervous system depressant effects of both substances.\n- Patients taking Lyrica may experience heightened dizziness, drowsiness, and difficulty concentrating when consuming ethanol, which can exacerbate the side effects of Lyrica.\n- The combination may also increase the risk of falls and accidents, particularly in individuals who are already sensitive to the effects of either Lyrica or alcohol.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"6a5Hs6PdNMrU","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.4166666666666667, 'D': 0.3333333333333333}; rankings=[['B', 'C', 'D', 'A'], ['B', 'A', 'D', 'C'], ['B', 'C', 'D', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they experience signs of a hypersensitivity reaction while using ARIKAYCE?\nA: Continue using ARIKAYCE and monitor symptoms\nB: Seek immediate medical attention\nC: Switch to a different medication\nD: Reduce the dosage of ARIKAYCE\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they experience signs of a hypersensitivity reaction while using ARIKAYCE?\nA: Continue using ARIKAYCE and monitor symptoms\nB: Seek immediate medical attention\nC: Switch to a different medication\nD: Reduce the dosage of ARIKAYCE\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients do if they experience signs of a hypersensitivity reaction while using ARIKAYCE?\nA: Continue using ARIKAYCE and monitor symptoms\nB: Seek immediate medical attention\nC: Switch to a different medication\nD: Reduce the dosage of ARIKAYCE\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}]"
"dcvEWEaCZf9G","- Agrylin (anagrelide) is primarily metabolized in the liver, and severe hepatic impairment can lead to increased plasma concentrations of the drug, heightening the risk of toxicity.
- Patients with severe hepatic impairment may experience altered pharmacokinetics, resulting in unpredictable effects and potential exacerbation of side effects associated with Agrylin.
- The prescribing information for Agrylin advises against its use in patients with severe hepatic impairment due to these safety concerns.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy should Agrylin be avoided in patients with severe hepatic impairment?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Agrylin (anagrelide) is primarily metabolized in the liver, and severe hepatic impairment can lead to increased plasma concentrations of the drug, heightening the risk of toxicity.\n- Patients with severe hepatic impairment may experience altered pharmacokinetics, resulting in unpredictable effects and potential exacerbation of side effects associated with Agrylin.\n- The prescribing information for Agrylin advises against its use in patients with severe hepatic impairment due to these safety concerns.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should Agrylin be avoided in patients with severe hepatic impairment?\nA: Agrylin increases the risk of thrombocytopenia in these patients.\nB: Agrylin clearance is significantly reduced due to hepatic metabolism, leading to increased exposure.\nC: Agrylin causes severe adverse effects on fetal development in these patients.\nD: Agrylin is contraindicated due to its effects on lactation.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Agrylin (anagrelide) is primarily metabolized in the liver, and severe hepatic impairment can lead to increased plasma concentrations of the drug, heightening the risk of toxicity.\n- Patients with severe hepatic impairment may experience altered pharmacokinetics, resulting in unpredictable effects and potential exacerbation of side effects associated with Agrylin.\n- The prescribing information for Agrylin advises against its use in patients with severe hepatic impairment due to these safety concerns.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should Agrylin be avoided in patients with severe hepatic impairment?\nA: Agrylin increases the risk of thrombocytopenia in these patients.\nB: Agrylin clearance is significantly reduced due to hepatic metabolism, leading to increased exposure.\nC: Agrylin causes severe adverse effects on fetal development in these patients.\nD: Agrylin is contraindicated due to its effects on lactation.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Agrylin (anagrelide) is primarily metabolized in the liver, and severe hepatic impairment can lead to increased plasma concentrations of the drug, heightening the risk of toxicity.\n- Patients with severe hepatic impairment may experience altered pharmacokinetics, resulting in unpredictable effects and potential exacerbation of side effects associated with Agrylin.\n- The prescribing information for Agrylin advises against its use in patients with severe hepatic impairment due to these safety concerns.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why should Agrylin be avoided in patients with severe hepatic impairment?\nA: Agrylin increases the risk of thrombocytopenia in these patients.\nB: Agrylin clearance is significantly reduced due to hepatic metabolism, leading to increased exposure.\nC: Agrylin causes severe adverse effects on fetal development in these patients.\nD: Agrylin is contraindicated due to its effects on lactation.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Agrylin (anagrelide) is primarily metabolized in the liver, and severe hepatic impairment can lead to increased plasma concentrations of the drug, heightening the risk of toxicity.\n- Patients with severe hepatic impairment may experience altered pharmacokinetics, resulting in unpredictable effects and potential exacerbation of side effects associated with Agrylin.\n- The prescribing information for Agrylin advises against its use in patients with severe hepatic impairment due to these safety concerns.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"9MuafRKNy2LD","1) Recommendation: Based on the trial comparing Ondansetron to metoclopramide for single high-dose fraction radiotherapy, Ondansetron is recommended as it demonstrated superior efficacy in achieving complete control of emesis.

2) Key rationale:
   - Ondansetron is a selective serotonin 5-HT3 receptor antagonist, which is effective in preventing nausea and vomiting associated with chemotherapy and radiotherapy.
   - Clinical trials have shown that Ondansetron provides better control of acute emesis compared to metoclopramide, particularly in patients undergoing radiotherapy.
   - The pharmacological profile of Ondansetron allows for a more targeted approach to managing nausea, leading to improved patient comfort and adherence to treatment.

3) Safety/contraindications/interactions:
   - Ondansetron is generally well-tolerated, but potential side effects include headache, constipation, and dizziness.
   - Caution is advised in patients with a history of cardiac arrhythmias, as Ondansetron can prolong the QT interval.
   - Metoclopramide may cause extrapyramidal symptoms and is contraindicated in patients with a history of tardive dyskinesia or those with gastrointestinal obstruction.
   - Drug interactions may occur with other medications that affect serotonin levels or those that prolong the QT interval. 

Assumptions: The question assumes that the trial data is available and that the comparison is based on a specific patient population undergoing similar treatment regimens. Missing information includes specific trial results, sample sizes, and patient demographics.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nIn the trial comparing Ondansetron to metoclopramide for single high-dose fraction radiotherapy, which drug was more effective in achieving complete control of emesis?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Based on the trial comparing Ondansetron to metoclopramide for single high-dose fraction radiotherapy, Ondansetron is recommended as it demonstrated superior efficacy in achieving complete control of emesis.\n\n2) Key rationale:\n   - Ondansetron is a selective serotonin 5-HT3 receptor antagonist, which is effective in preventing nausea and vomiting associated with chemotherapy and radiotherapy.\n   - Clinical trials have shown that Ondansetron provides better control of acute emesis compared to metoclopramide, particularly in patients undergoing radiotherapy.\n   - The pharmacological profile of Ondansetron allows for a more targeted approach to managing nausea, leading to improved patient comfort and adherence to treatment.\n\n3) Safety/contraindications/interactions:\n   - Ondansetron is generally well-tolerated, but potential side effects include headache, constipation, and dizziness.\n   - Caution is advised in patients with a history of cardiac arrhythmias, as Ondansetron can prolong the QT interval.\n   - Metoclopramide may cause extrapyramidal symptoms and is contraindicated in patients with a history of tardive dyskinesia or those with gastrointestinal obstruction.\n   - Drug interactions may occur with other medications that affect serotonin levels or those that prolong the QT interval. \n\nAssumptions: The question assumes that the trial data is available and that the comparison is based on a specific patient population undergoing similar treatment regimens. Missing information includes specific trial results, sample sizes, and patient demographics.""}]"
"7UHhgzfMTzpg","- Reduce the dose of JAYPIRCA to 50 mg once daily when used with a strong CYP3A inhibitor, such as ketoconazole or itraconazole.
- Monitor for potential increased toxicity or side effects due to the interaction with the strong CYP3A inhibitor.
- Consider alternative treatments that do not involve strong CYP3A inhibitors if possible, to avoid dose adjustments.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should be done if JAYPIRCA must be used concomitantly with a strong CYP3A inhibitor?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Reduce the dose of JAYPIRCA to 50 mg once daily when used with a strong CYP3A inhibitor, such as ketoconazole or itraconazole.\n- Monitor for potential increased toxicity or side effects due to the interaction with the strong CYP3A inhibitor.\n- Consider alternative treatments that do not involve strong CYP3A inhibitors if possible, to avoid dose adjustments.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if JAYPIRCA must be used concomitantly with a strong CYP3A inhibitor?\nA: Increase the JAYPIRCA dosage.\nB: Reduce the JAYPIRCA dosage.\nC: Discontinue JAYPIRCA treatment.\nD: No dosage adjustment is necessary.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Reduce the dose of JAYPIRCA to 50 mg once daily when used with a strong CYP3A inhibitor, such as ketoconazole or itraconazole.\n- Monitor for potential increased toxicity or side effects due to the interaction with the strong CYP3A inhibitor.\n- Consider alternative treatments that do not involve strong CYP3A inhibitors if possible, to avoid dose adjustments.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if JAYPIRCA must be used concomitantly with a strong CYP3A inhibitor?\nA: Increase the JAYPIRCA dosage.\nB: Reduce the JAYPIRCA dosage.\nC: Discontinue JAYPIRCA treatment.\nD: No dosage adjustment is necessary.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Reduce the dose of JAYPIRCA to 50 mg once daily when used with a strong CYP3A inhibitor, such as ketoconazole or itraconazole.\n- Monitor for potential increased toxicity or side effects due to the interaction with the strong CYP3A inhibitor.\n- Consider alternative treatments that do not involve strong CYP3A inhibitors if possible, to avoid dose adjustments.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should be done if JAYPIRCA must be used concomitantly with a strong CYP3A inhibitor?\nA: Increase the JAYPIRCA dosage.\nB: Reduce the JAYPIRCA dosage.\nC: Discontinue JAYPIRCA treatment.\nD: No dosage adjustment is necessary.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Reduce the dose of JAYPIRCA to 50 mg once daily when used with a strong CYP3A inhibitor, such as ketoconazole or itraconazole.\n- Monitor for potential increased toxicity or side effects due to the interaction with the strong CYP3A inhibitor.\n- Consider alternative treatments that do not involve strong CYP3A inhibitors if possible, to avoid dose adjustments.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"LlQ5x39dK65g","- The primary endpoint for evaluating the effectiveness of lamotrigine in the maintenance treatment of bipolar I disorder was the time to intervention for a mood episode, specifically assessing the duration until a manic, hypomanic, or depressive episode occurred.
- Lamotrigine was compared to a placebo in clinical trials to determine its efficacy in prolonging the time to mood episode recurrence in patients with bipolar I disorder.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn the maintenance treatment of bipolar I disorder, what was the primary endpoint used to evaluate the effectiveness of lamotrigine?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The primary endpoint for evaluating the effectiveness of lamotrigine in the maintenance treatment of bipolar I disorder was the time to intervention for a mood episode, specifically assessing the duration until a manic, hypomanic, or depressive episode occurred.\n- Lamotrigine was compared to a placebo in clinical trials to determine its efficacy in prolonging the time to mood episode recurrence in patients with bipolar I disorder.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In the maintenance treatment of bipolar I disorder, what was the primary endpoint used to evaluate the effectiveness of lamotrigine?\nA: Percentage reduction in depressive episodes\nB: Time to intervention for a mood episode\nC: Reduction in manic episodes\nD: Improvement in CGI-severity score\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary endpoint for evaluating the effectiveness of lamotrigine in the maintenance treatment of bipolar I disorder was the time to intervention for a mood episode, specifically assessing the duration until a manic, hypomanic, or depressive episode occurred.\n- Lamotrigine was compared to a placebo in clinical trials to determine its efficacy in prolonging the time to mood episode recurrence in patients with bipolar I disorder.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In the maintenance treatment of bipolar I disorder, what was the primary endpoint used to evaluate the effectiveness of lamotrigine?\nA: Percentage reduction in depressive episodes\nB: Time to intervention for a mood episode\nC: Reduction in manic episodes\nD: Improvement in CGI-severity score\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary endpoint for evaluating the effectiveness of lamotrigine in the maintenance treatment of bipolar I disorder was the time to intervention for a mood episode, specifically assessing the duration until a manic, hypomanic, or depressive episode occurred.\n- Lamotrigine was compared to a placebo in clinical trials to determine its efficacy in prolonging the time to mood episode recurrence in patients with bipolar I disorder.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In the maintenance treatment of bipolar I disorder, what was the primary endpoint used to evaluate the effectiveness of lamotrigine?\nA: Percentage reduction in depressive episodes\nB: Time to intervention for a mood episode\nC: Reduction in manic episodes\nD: Improvement in CGI-severity score\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary endpoint for evaluating the effectiveness of lamotrigine in the maintenance treatment of bipolar I disorder was the time to intervention for a mood episode, specifically assessing the duration until a manic, hypomanic, or depressive episode occurred.\n- Lamotrigine was compared to a placebo in clinical trials to determine its efficacy in prolonging the time to mood episode recurrence in patients with bipolar I disorder.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"Xm3RqXzLTtVx","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the risk associated with using Terbinafine tablets during pregnancy based on animal studies?\nA: Terbinafine caused malformations in animal studies.\nB: Terbinafine caused harm to the fetus in animal studies.\nC: Terbinafine did not cause malformations or harm to the fetus in animal studies.\nD: Terbinafine is contraindicated during pregnancy due to fetal risks.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the risk associated with using Terbinafine tablets during pregnancy based on animal studies?\nA: Terbinafine caused malformations in animal studies.\nB: Terbinafine caused harm to the fetus in animal studies.\nC: Terbinafine did not cause malformations or harm to the fetus in animal studies.\nD: Terbinafine is contraindicated during pregnancy due to fetal risks.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the risk associated with using Terbinafine tablets during pregnancy based on animal studies?\nA: Terbinafine caused malformations in animal studies.\nB: Terbinafine caused harm to the fetus in animal studies.\nC: Terbinafine did not cause malformations or harm to the fetus in animal studies.\nD: Terbinafine is contraindicated during pregnancy due to fetal risks.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"nWYuIaIPaEDC","- The maximum oral dose of ondansetron administered to rats in carcinogenicity studies was 80 mg/kg/day.
- This dose was given for a duration of 2 years to assess the long-term effects of ondansetron.
- The studies aimed to evaluate the potential carcinogenic effects of ondansetron compared to a control group receiving a placebo.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat was the maximum oral dose of ondansetron administered to rats in carcinogenicity studies?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The maximum oral dose of ondansetron administered to rats in carcinogenicity studies was 80 mg/kg/day.\n- This dose was given for a duration of 2 years to assess the long-term effects of ondansetron.\n- The studies aimed to evaluate the potential carcinogenic effects of ondansetron compared to a control group receiving a placebo.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the maximum oral dose of ondansetron administered to rats in carcinogenicity studies?\nA: 10 mg/kg per day\nB: 15 mg/kg per day\nC: 30 mg/kg per day\nD: 24 mg per day\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum oral dose of ondansetron administered to rats in carcinogenicity studies was 80 mg/kg/day.\n- This dose was given for a duration of 2 years to assess the long-term effects of ondansetron.\n- The studies aimed to evaluate the potential carcinogenic effects of ondansetron compared to a control group receiving a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the maximum oral dose of ondansetron administered to rats in carcinogenicity studies?\nA: 10 mg/kg per day\nB: 15 mg/kg per day\nC: 30 mg/kg per day\nD: 24 mg per day\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum oral dose of ondansetron administered to rats in carcinogenicity studies was 80 mg/kg/day.\n- This dose was given for a duration of 2 years to assess the long-term effects of ondansetron.\n- The studies aimed to evaluate the potential carcinogenic effects of ondansetron compared to a control group receiving a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the maximum oral dose of ondansetron administered to rats in carcinogenicity studies?\nA: 10 mg/kg per day\nB: 15 mg/kg per day\nC: 30 mg/kg per day\nD: 24 mg per day\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum oral dose of ondansetron administered to rats in carcinogenicity studies was 80 mg/kg/day.\n- This dose was given for a duration of 2 years to assess the long-term effects of ondansetron.\n- The studies aimed to evaluate the potential carcinogenic effects of ondansetron compared to a control group receiving a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}]"
"kmXWFIvz0GOo","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is a benefit of 'basic care nighttime cold and flu' for individuals experiencing fever?\nA: It reduces fever\nB: It prevents fever from occurring\nC: It eliminates the cause of fever\nD: It increases body temperature to fight infection\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is a benefit of 'basic care nighttime cold and flu' for individuals experiencing fever?\nA: It reduces fever\nB: It prevents fever from occurring\nC: It eliminates the cause of fever\nD: It increases body temperature to fight infection\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is a benefit of 'basic care nighttime cold and flu' for individuals experiencing fever?\nA: It reduces fever\nB: It prevents fever from occurring\nC: It eliminates the cause of fever\nD: It increases body temperature to fight infection\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"ISZ3lrNT7rqP","- Gadavist (gadobutrol) is a gadolinium-based contrast agent, which may pose risks during pregnancy due to potential effects on fetal development and the unknown long-term consequences of fetal exposure to gadolinium.
- Pregnant women may experience altered pharmacokinetics, leading to increased retention of Gadavist in the body, which could heighten the risk of adverse effects for both the mother and the fetus.
- The use of Gadavist is generally contraindicated in pregnancy unless absolutely necessary, as the safety profile in pregnant populations has not been thoroughly established.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhy might pregnant women be at increased risk when using Gadavist?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Gadavist (gadobutrol) is a gadolinium-based contrast agent, which may pose risks during pregnancy due to potential effects on fetal development and the unknown long-term consequences of fetal exposure to gadolinium.\n- Pregnant women may experience altered pharmacokinetics, leading to increased retention of Gadavist in the body, which could heighten the risk of adverse effects for both the mother and the fetus.\n- The use of Gadavist is generally contraindicated in pregnancy unless absolutely necessary, as the safety profile in pregnant populations has not been thoroughly established.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why might pregnant women be at increased risk when using Gadavist?\nA: Gadavist is known to harm unborn babies.\nB: The effects of gadolinium on unborn babies are unknown.\nC: Pregnant women are more likely to experience allergic reactions.\nD: Gadavist is not effective in pregnant women.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadavist (gadobutrol) is a gadolinium-based contrast agent, which may pose risks during pregnancy due to potential effects on fetal development and the unknown long-term consequences of fetal exposure to gadolinium.\n- Pregnant women may experience altered pharmacokinetics, leading to increased retention of Gadavist in the body, which could heighten the risk of adverse effects for both the mother and the fetus.\n- The use of Gadavist is generally contraindicated in pregnancy unless absolutely necessary, as the safety profile in pregnant populations has not been thoroughly established.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why might pregnant women be at increased risk when using Gadavist?\nA: Gadavist is known to harm unborn babies.\nB: The effects of gadolinium on unborn babies are unknown.\nC: Pregnant women are more likely to experience allergic reactions.\nD: Gadavist is not effective in pregnant women.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadavist (gadobutrol) is a gadolinium-based contrast agent, which may pose risks during pregnancy due to potential effects on fetal development and the unknown long-term consequences of fetal exposure to gadolinium.\n- Pregnant women may experience altered pharmacokinetics, leading to increased retention of Gadavist in the body, which could heighten the risk of adverse effects for both the mother and the fetus.\n- The use of Gadavist is generally contraindicated in pregnancy unless absolutely necessary, as the safety profile in pregnant populations has not been thoroughly established.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Why might pregnant women be at increased risk when using Gadavist?\nA: Gadavist is known to harm unborn babies.\nB: The effects of gadolinium on unborn babies are unknown.\nC: Pregnant women are more likely to experience allergic reactions.\nD: Gadavist is not effective in pregnant women.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Gadavist (gadobutrol) is a gadolinium-based contrast agent, which may pose risks during pregnancy due to potential effects on fetal development and the unknown long-term consequences of fetal exposure to gadolinium.\n- Pregnant women may experience altered pharmacokinetics, leading to increased retention of Gadavist in the body, which could heighten the risk of adverse effects for both the mother and the fetus.\n- The use of Gadavist is generally contraindicated in pregnancy unless absolutely necessary, as the safety profile in pregnant populations has not been thoroughly established.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"2ehqCudZk3cr","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.27777777777777773, 'D': 0.3055555555555555}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should healthcare professionals prioritize when prescribing RoxyBond for acute pain conditions?\nA: Use the lowest effective dosage for the shortest duration of time.\nB: Prescribe the highest dose to ensure pain relief.\nC: Avoid prescribing naloxone to minimize costs.\nD: Prescribe RoxyBond only for chronic pain conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should healthcare professionals prioritize when prescribing RoxyBond for acute pain conditions?\nA: Use the lowest effective dosage for the shortest duration of time.\nB: Prescribe the highest dose to ensure pain relief.\nC: Avoid prescribing naloxone to minimize costs.\nD: Prescribe RoxyBond only for chronic pain conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should healthcare professionals prioritize when prescribing RoxyBond for acute pain conditions?\nA: Use the lowest effective dosage for the shortest duration of time.\nB: Prescribe the highest dose to ensure pain relief.\nC: Avoid prescribing naloxone to minimize costs.\nD: Prescribe RoxyBond only for chronic pain conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"NkksqCUrQsZA","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich condition associated with lamotrigine is characterized by systemic inflammation and high mortality rates?\nA: Aseptic meningitis\nB: Hemophagocytic lymphohistiocytosis (HLH)\nC: Multiorgan hypersensitivity reactions\nD: Sudden unexplained death in epilepsy (SUDEP)\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich condition associated with lamotrigine is characterized by systemic inflammation and high mortality rates?\nA: Aseptic meningitis\nB: Hemophagocytic lymphohistiocytosis (HLH)\nC: Multiorgan hypersensitivity reactions\nD: Sudden unexplained death in epilepsy (SUDEP)\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich condition associated with lamotrigine is characterized by systemic inflammation and high mortality rates?\nA: Aseptic meningitis\nB: Hemophagocytic lymphohistiocytosis (HLH)\nC: Multiorgan hypersensitivity reactions\nD: Sudden unexplained death in epilepsy (SUDEP)\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"9UMOZDzi0kSe","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary mechanism of action of pantoprazole sodium?\nA: Inhibition of gastric acid secretion\nB: Activation of gastric acid secretion\nC: Neutralization of gastric acid\nD: Stimulation of gastric mucosa\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary mechanism of action of pantoprazole sodium?\nA: Inhibition of gastric acid secretion\nB: Activation of gastric acid secretion\nC: Neutralization of gastric acid\nD: Stimulation of gastric mucosa\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the primary mechanism of action of pantoprazole sodium?\nA: Inhibition of gastric acid secretion\nB: Activation of gastric acid secretion\nC: Neutralization of gastric acid\nD: Stimulation of gastric mucosa\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"0kF9sHuRtecC","1) Recommendation: In the case of Pemetrexed for injection overdose, leucovorin may be considered as a potential rescue agent to mitigate toxicity, particularly in patients exhibiting signs of severe myelosuppression or mucositis. However, its use should be guided by clinical judgment and the specific circumstances of the overdose.

2) Key rationale:
   - Leucovorin is known to enhance the effectiveness of certain chemotherapeutic agents while potentially reducing their toxicity.
   - Animal studies suggest that leucovorin may help to protect normal cells from the effects of antifolate drugs like Pemetrexed.
   - Leucovorin can aid in the recovery of bone marrow function, which may be compromised in cases of overdose.
   - The timing and dosage of leucovorin administration are critical and should be tailored to the severity of the overdose and the patient's clinical status.

3) Safety/contraindications/interactions:
   - Leucovorin should be used cautiously in patients with hypersensitivity to the drug or its components.
   - There may be interactions with other medications that affect folate metabolism, which could influence the efficacy of leucovorin.
   - Close monitoring is necessary to avoid potential complications from the overdose and to assess the effectiveness of leucovorin treatment. 

Assumptions: The recommendation is based on available animal studies and the known pharmacological properties of leucovorin and Pemetrexed. Further clinical data may be required for definitive guidance.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nBased on animal studies, what is the role of leucovorin in the context of Pemetrexed for injection overdose?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: In the case of Pemetrexed for injection overdose, leucovorin may be considered as a potential rescue agent to mitigate toxicity, particularly in patients exhibiting signs of severe myelosuppression or mucositis. However, its use should be guided by clinical judgment and the specific circumstances of the overdose.\n\n2) Key rationale:\n   - Leucovorin is known to enhance the effectiveness of certain chemotherapeutic agents while potentially reducing their toxicity.\n   - Animal studies suggest that leucovorin may help to protect normal cells from the effects of antifolate drugs like Pemetrexed.\n   - Leucovorin can aid in the recovery of bone marrow function, which may be compromised in cases of overdose.\n   - The timing and dosage of leucovorin administration are critical and should be tailored to the severity of the overdose and the patient's clinical status.\n\n3) Safety/contraindications/interactions:\n   - Leucovorin should be used cautiously in patients with hypersensitivity to the drug or its components.\n   - There may be interactions with other medications that affect folate metabolism, which could influence the efficacy of leucovorin.\n   - Close monitoring is necessary to avoid potential complications from the overdose and to assess the effectiveness of leucovorin treatment. \n\nAssumptions: The recommendation is based on available animal studies and the known pharmacological properties of leucovorin and Pemetrexed. Further clinical data may be required for definitive guidance.""}]"
"ku8SatNgErue","- The study indicates that dg health nasal spray, when administered as an active treatment, may lead to a statistically significant increase in the growth rate of children aged 4 to 11 years compared to a placebo.
- Children receiving the active dg health nasal spray showed improved height velocity measurements over a specified treatment period, suggesting a positive impact on growth.
- In contrast, the placebo group did not exhibit any notable changes in growth rate, highlighting the potential efficacy of the active nasal spray formulation.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3055555555555555, 'C': 0.3333333333333333, 'D': 0.4444444444444444}; rankings=[['A', 'D', 'B', 'C'], ['A', 'C', 'D', 'B'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the potential effect of dg health nasal spray on the growth rate of children aged 4 to 11 years?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The study indicates that dg health nasal spray, when administered as an active treatment, may lead to a statistically significant increase in the growth rate of children aged 4 to 11 years compared to a placebo.\n- Children receiving the active dg health nasal spray showed improved height velocity measurements over a specified treatment period, suggesting a positive impact on growth.\n- In contrast, the placebo group did not exhibit any notable changes in growth rate, highlighting the potential efficacy of the active nasal spray formulation.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the potential effect of dg health nasal spray on the growth rate of children aged 4 to 11 years?\nA: It may accelerate growth rate.\nB: It may slow down growth rate.\nC: It has no effect on growth rate.\nD: It may cause growth rate to fluctuate.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The study indicates that dg health nasal spray, when administered as an active treatment, may lead to a statistically significant increase in the growth rate of children aged 4 to 11 years compared to a placebo.\n- Children receiving the active dg health nasal spray showed improved height velocity measurements over a specified treatment period, suggesting a positive impact on growth.\n- In contrast, the placebo group did not exhibit any notable changes in growth rate, highlighting the potential efficacy of the active nasal spray formulation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the potential effect of dg health nasal spray on the growth rate of children aged 4 to 11 years?\nA: It may accelerate growth rate.\nB: It may slow down growth rate.\nC: It has no effect on growth rate.\nD: It may cause growth rate to fluctuate.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The study indicates that dg health nasal spray, when administered as an active treatment, may lead to a statistically significant increase in the growth rate of children aged 4 to 11 years compared to a placebo.\n- Children receiving the active dg health nasal spray showed improved height velocity measurements over a specified treatment period, suggesting a positive impact on growth.\n- In contrast, the placebo group did not exhibit any notable changes in growth rate, highlighting the potential efficacy of the active nasal spray formulation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the potential effect of dg health nasal spray on the growth rate of children aged 4 to 11 years?\nA: It may accelerate growth rate.\nB: It may slow down growth rate.\nC: It has no effect on growth rate.\nD: It may cause growth rate to fluctuate.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The study indicates that dg health nasal spray, when administered as an active treatment, may lead to a statistically significant increase in the growth rate of children aged 4 to 11 years compared to a placebo.\n- Children receiving the active dg health nasal spray showed improved height velocity measurements over a specified treatment period, suggesting a positive impact on growth.\n- In contrast, the placebo group did not exhibit any notable changes in growth rate, highlighting the potential efficacy of the active nasal spray formulation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"lmDcWcfqSnpF","- Sumatriptan succinate is a salt form of sumatriptan, and it typically contains approximately 85% of the active drug; therefore, 8.4 mg of sumatriptan succinate is equivalent to about 7.14 mg of sumatriptan.
- In the context of the Sumatriptan injection, USP, each 0.5 mL contains 8.4 mg of sumatriptan succinate, which translates to approximately 7.14 mg of the active sumatriptan.

MRRV(meta) winner=A; scores={'A': 0.8333333333333334, 'B': 0.6666666666666666, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['A', 'B', 'C', 'D'], ['B', 'A', 'D', 'C'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow much sumatriptan is equivalent to 8.4 mg of sumatriptan succinate in each 0.5 mL of Sumatriptan injection, USP?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Sumatriptan succinate is a salt form of sumatriptan, and it typically contains approximately 85% of the active drug; therefore, 8.4 mg of sumatriptan succinate is equivalent to about 7.14 mg of sumatriptan.\n- In the context of the Sumatriptan injection, USP, each 0.5 mL contains 8.4 mg of sumatriptan succinate, which translates to approximately 7.14 mg of the active sumatriptan.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How much sumatriptan is equivalent to 8.4 mg of sumatriptan succinate in each 0.5 mL of Sumatriptan injection, USP?\nA: 6 mg\nB: 8 mg\nC: 4 mg\nD: 12 mg\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Sumatriptan succinate is a salt form of sumatriptan, and it typically contains approximately 85% of the active drug; therefore, 8.4 mg of sumatriptan succinate is equivalent to about 7.14 mg of sumatriptan.\n- In the context of the Sumatriptan injection, USP, each 0.5 mL contains 8.4 mg of sumatriptan succinate, which translates to approximately 7.14 mg of the active sumatriptan.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How much sumatriptan is equivalent to 8.4 mg of sumatriptan succinate in each 0.5 mL of Sumatriptan injection, USP?\nA: 6 mg\nB: 8 mg\nC: 4 mg\nD: 12 mg\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Sumatriptan succinate is a salt form of sumatriptan, and it typically contains approximately 85% of the active drug; therefore, 8.4 mg of sumatriptan succinate is equivalent to about 7.14 mg of sumatriptan.\n- In the context of the Sumatriptan injection, USP, each 0.5 mL contains 8.4 mg of sumatriptan succinate, which translates to approximately 7.14 mg of the active sumatriptan.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How much sumatriptan is equivalent to 8.4 mg of sumatriptan succinate in each 0.5 mL of Sumatriptan injection, USP?\nA: 6 mg\nB: 8 mg\nC: 4 mg\nD: 12 mg\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Sumatriptan succinate is a salt form of sumatriptan, and it typically contains approximately 85% of the active drug; therefore, 8.4 mg of sumatriptan succinate is equivalent to about 7.14 mg of sumatriptan.\n- In the context of the Sumatriptan injection, USP, each 0.5 mL contains 8.4 mg of sumatriptan succinate, which translates to approximately 7.14 mg of the active sumatriptan.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"5iXHAVVVk7gs","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat advice should patients follow when taking Cleocin Phosphate to ensure its effectiveness?\nA: Skip doses if they feel better early in the therapy.\nB: Take the medication exactly as directed and complete the full course of therapy.\nC: Double the dose if symptoms persist.\nD: Use Cleocin Phosphate to treat viral infections like the flu.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat advice should patients follow when taking Cleocin Phosphate to ensure its effectiveness?\nA: Skip doses if they feel better early in the therapy.\nB: Take the medication exactly as directed and complete the full course of therapy.\nC: Double the dose if symptoms persist.\nD: Use Cleocin Phosphate to treat viral infections like the flu.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat advice should patients follow when taking Cleocin Phosphate to ensure its effectiveness?\nA: Skip doses if they feel better early in the therapy.\nB: Take the medication exactly as directed and complete the full course of therapy.\nC: Double the dose if symptoms persist.\nD: Use Cleocin Phosphate to treat viral infections like the flu.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"rd8y2NuvFRln","- The recommended dosage of vaginal essential oil for preventing repeated cross-infection during menstruation is typically 2-3 drops of tea tree oil diluted in a carrier oil, applied externally.
- For internal use, a common regimen involves using 1-2 drops of lavender essential oil mixed with a carrier oil, applied to the vaginal area.
- It is important to note that essential oils should not be used undiluted and should be tested for sensitivity prior to use.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended dosage of vaginal essential oil for preventing repeated cross-infection during menstruation?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The recommended dosage of vaginal essential oil for preventing repeated cross-infection during menstruation is typically 2-3 drops of tea tree oil diluted in a carrier oil, applied externally.\n- For internal use, a common regimen involves using 1-2 drops of lavender essential oil mixed with a carrier oil, applied to the vaginal area.\n- It is important to note that essential oils should not be used undiluted and should be tested for sensitivity prior to use.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended dosage of vaginal essential oil for preventing repeated cross-infection during menstruation?\nA: 5-8 drops applied to sanitary napkins\nB: 10-20 drops dissolved in warm water\nC: 15-30 drops used in a sitz bath\nD: 10-20 drops sprayed in the environment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage of vaginal essential oil for preventing repeated cross-infection during menstruation is typically 2-3 drops of tea tree oil diluted in a carrier oil, applied externally.\n- For internal use, a common regimen involves using 1-2 drops of lavender essential oil mixed with a carrier oil, applied to the vaginal area.\n- It is important to note that essential oils should not be used undiluted and should be tested for sensitivity prior to use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended dosage of vaginal essential oil for preventing repeated cross-infection during menstruation?\nA: 5-8 drops applied to sanitary napkins\nB: 10-20 drops dissolved in warm water\nC: 15-30 drops used in a sitz bath\nD: 10-20 drops sprayed in the environment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage of vaginal essential oil for preventing repeated cross-infection during menstruation is typically 2-3 drops of tea tree oil diluted in a carrier oil, applied externally.\n- For internal use, a common regimen involves using 1-2 drops of lavender essential oil mixed with a carrier oil, applied to the vaginal area.\n- It is important to note that essential oils should not be used undiluted and should be tested for sensitivity prior to use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended dosage of vaginal essential oil for preventing repeated cross-infection during menstruation?\nA: 5-8 drops applied to sanitary napkins\nB: 10-20 drops dissolved in warm water\nC: 15-30 drops used in a sitz bath\nD: 10-20 drops sprayed in the environment\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended dosage of vaginal essential oil for preventing repeated cross-infection during menstruation is typically 2-3 drops of tea tree oil diluted in a carrier oil, applied externally.\n- For internal use, a common regimen involves using 1-2 drops of lavender essential oil mixed with a carrier oil, applied to the vaginal area.\n- It is important to note that essential oils should not be used undiluted and should be tested for sensitivity prior to use.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}]"
"5b1YdV02ZSdp","1) Recommendation: The term 'sterile' refers to a state in which a product is free from all living microorganisms. It is crucial to store sterile products in a controlled environment, typically at room temperature or as specified by the manufacturer, to maintain their sterility and efficacy.

2) Key rationale:
   - Sterile products are sensitive to contamination; improper storage can compromise their sterility.
   - Environmental factors such as temperature, humidity, and exposure to light can affect the stability of sterile products.
   - Following manufacturer guidelines for storage conditions ensures the safety and effectiveness of the drug.

3) Safety/contraindications/interactions:
   - Avoid exposing sterile products to extreme temperatures or humidity.
   - Ensure that storage areas are clean and free from potential contaminants.
   - Be cautious of interactions with other substances that may be stored in the same area, which could lead to contamination. 

Assumptions: The question assumes a general understanding of sterile products and their storage requirements. Missing information includes specific types of sterile products being referred to, as storage conditions may vary based on the formulation (e.g., injectables, ophthalmics).","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhich of the following statements is true regarding the storage conditions of the drug 'sterile'?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: The term 'sterile' refers to a state in which a product is free from all living microorganisms. It is crucial to store sterile products in a controlled environment, typically at room temperature or as specified by the manufacturer, to maintain their sterility and efficacy.\n\n2) Key rationale:\n   - Sterile products are sensitive to contamination; improper storage can compromise their sterility.\n   - Environmental factors such as temperature, humidity, and exposure to light can affect the stability of sterile products.\n   - Following manufacturer guidelines for storage conditions ensures the safety and effectiveness of the drug.\n\n3) Safety/contraindications/interactions:\n   - Avoid exposing sterile products to extreme temperatures or humidity.\n   - Ensure that storage areas are clean and free from potential contaminants.\n   - Be cautious of interactions with other substances that may be stored in the same area, which could lead to contamination. \n\nAssumptions: The question assumes a general understanding of sterile products and their storage requirements. Missing information includes specific types of sterile products being referred to, as storage conditions may vary based on the formulation (e.g., injectables, ophthalmics).""}]"
"md2ANeDi62kp","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn what context is 'up and up ibuprofen' recommended for sleeplessness?\nA: Sleeplessness caused by stress\nB: Sleeplessness associated with minor aches and pains\nC: Sleeplessness due to chronic insomnia\nD: Sleeplessness caused by jet lag\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn what context is 'up and up ibuprofen' recommended for sleeplessness?\nA: Sleeplessness caused by stress\nB: Sleeplessness associated with minor aches and pains\nC: Sleeplessness due to chronic insomnia\nD: Sleeplessness caused by jet lag\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nIn what context is 'up and up ibuprofen' recommended for sleeplessness?\nA: Sleeplessness caused by stress\nB: Sleeplessness associated with minor aches and pains\nC: Sleeplessness due to chronic insomnia\nD: Sleeplessness caused by jet lag\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"npL5FtPUKYVK","MRRV winner=C; scores={'A': 0.3333333333333333, 'B': 0.25, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B'], ['C', 'D', 'A', 'B']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT a correct instruction for patients using Hydroxym?\nA: Avoid contact with the eyes.\nB: Use Hydroxym for disorders other than the one prescribed.\nC: Use Hydroxym as directed by the physician.\nD: Do not bandage the treated skin area unless directed by the physician.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT a correct instruction for patients using Hydroxym?\nA: Avoid contact with the eyes.\nB: Use Hydroxym for disorders other than the one prescribed.\nC: Use Hydroxym as directed by the physician.\nD: Do not bandage the treated skin area unless directed by the physician.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT a correct instruction for patients using Hydroxym?\nA: Avoid contact with the eyes.\nB: Use Hydroxym for disorders other than the one prescribed.\nC: Use Hydroxym as directed by the physician.\nD: Do not bandage the treated skin area unless directed by the physician.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > A > B""}]"
"AT9GDszK1hZb","- Use the nicotine lozenge (2 mg or 4 mg) as needed to manage cravings, typically aiming for 1 lozenge every 1-2 hours during Weeks 7 to 9.
- Gradually reduce the number of lozenges used as you approach the end of the 12-week schedule, focusing on tapering down from the initial frequency.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended frequency of nicotine lozenge usage during Weeks 7 to 9 of the 12-week schedule?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Use the nicotine lozenge (2 mg or 4 mg) as needed to manage cravings, typically aiming for 1 lozenge every 1-2 hours during Weeks 7 to 9.\n- Gradually reduce the number of lozenges used as you approach the end of the 12-week schedule, focusing on tapering down from the initial frequency.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended frequency of nicotine lozenge usage during Weeks 7 to 9 of the 12-week schedule?\nA: 1 lozenge every 1 to 2 hours\nB: 1 lozenge every 2 to 4 hours\nC: 1 lozenge every 4 to 8 hours\nD: 1 lozenge every 6 to 10 hours\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Use the nicotine lozenge (2 mg or 4 mg) as needed to manage cravings, typically aiming for 1 lozenge every 1-2 hours during Weeks 7 to 9.\n- Gradually reduce the number of lozenges used as you approach the end of the 12-week schedule, focusing on tapering down from the initial frequency.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended frequency of nicotine lozenge usage during Weeks 7 to 9 of the 12-week schedule?\nA: 1 lozenge every 1 to 2 hours\nB: 1 lozenge every 2 to 4 hours\nC: 1 lozenge every 4 to 8 hours\nD: 1 lozenge every 6 to 10 hours\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Use the nicotine lozenge (2 mg or 4 mg) as needed to manage cravings, typically aiming for 1 lozenge every 1-2 hours during Weeks 7 to 9.\n- Gradually reduce the number of lozenges used as you approach the end of the 12-week schedule, focusing on tapering down from the initial frequency.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended frequency of nicotine lozenge usage during Weeks 7 to 9 of the 12-week schedule?\nA: 1 lozenge every 1 to 2 hours\nB: 1 lozenge every 2 to 4 hours\nC: 1 lozenge every 4 to 8 hours\nD: 1 lozenge every 6 to 10 hours\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Use the nicotine lozenge (2 mg or 4 mg) as needed to manage cravings, typically aiming for 1 lozenge every 1-2 hours during Weeks 7 to 9.\n- Gradually reduce the number of lozenges used as you approach the end of the 12-week schedule, focusing on tapering down from the initial frequency.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"bMCbmuGOb9ga","1) Recommendation: If a patient develops a serious infection while on REMICADE (infliximab) therapy, it is crucial to immediately discontinue the medication and initiate appropriate treatment for the infection. The patient should be closely monitored and may require hospitalization depending on the severity of the infection.

2) Key rationale:
- REMICADE is an immunosuppressive agent that can increase the risk of serious infections, including bacterial, viral, and fungal infections.
- Discontinuing REMICADE allows the immune system to recover and better respond to the infection.
- Prompt treatment of the infection is essential to prevent complications and improve patient outcomes.
- Monitoring is necessary to assess the patient's response to treatment and to determine when it is safe to consider resuming therapy.

3) Safety/contraindications/interactions:
- Patients with active infections should not receive REMICADE until the infection is resolved.
- Caution should be exercised in patients with a history of recurrent infections or those with significant comorbidities that may predispose them to infections.
- Consider potential interactions with other immunosuppressive therapies that the patient may be receiving.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat action should be taken if a patient develops a serious infection while on REMICADE therapy?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: If a patient develops a serious infection while on REMICADE (infliximab) therapy, it is crucial to immediately discontinue the medication and initiate appropriate treatment for the infection. The patient should be closely monitored and may require hospitalization depending on the severity of the infection.\n\n2) Key rationale:\n- REMICADE is an immunosuppressive agent that can increase the risk of serious infections, including bacterial, viral, and fungal infections.\n- Discontinuing REMICADE allows the immune system to recover and better respond to the infection.\n- Prompt treatment of the infection is essential to prevent complications and improve patient outcomes.\n- Monitoring is necessary to assess the patient's response to treatment and to determine when it is safe to consider resuming therapy.\n\n3) Safety/contraindications/interactions:\n- Patients with active infections should not receive REMICADE until the infection is resolved.\n- Caution should be exercised in patients with a history of recurrent infections or those with significant comorbidities that may predispose them to infections.\n- Consider potential interactions with other immunosuppressive therapies that the patient may be receiving.""}]"
"a6QcRXKd3IZW","MRRV winner=B; scores={'A': 0.25, 'B': 1.0, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['B', 'C', 'D', 'A'], ['B', 'C', 'D', 'A'], ['B', 'C', 'D', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich patient population is fosaprepitant for injection approved to prevent nausea and vomiting caused by chemotherapy?\nA: Patients of all ages, including newborns.\nB: Patients 6 months of age and older.\nC: Patients 12 years of age and older.\nD: Only adult patients aged 18 years and older.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich patient population is fosaprepitant for injection approved to prevent nausea and vomiting caused by chemotherapy?\nA: Patients of all ages, including newborns.\nB: Patients 6 months of age and older.\nC: Patients 12 years of age and older.\nD: Only adult patients aged 18 years and older.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich patient population is fosaprepitant for injection approved to prevent nausea and vomiting caused by chemotherapy?\nA: Patients of all ages, including newborns.\nB: Patients 6 months of age and older.\nC: Patients 12 years of age and older.\nD: Only adult patients aged 18 years and older.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}]"
"id1FSDCNhRJi","1) Recommendation: If a patient taking Iclusig (ponatinib) develops hypertension that is not medically controlled, it is essential to evaluate the patient's overall treatment plan. Consider adjusting the antihypertensive regimen, consulting a specialist if necessary, and potentially reassessing the need for Iclusig, as dose reduction or discontinuation may be warranted based on the severity of hypertension and its impact on the patient's health.

2) Key rationale:
- Iclusig can cause hypertension as a side effect, which may require careful management to prevent cardiovascular complications.
- Uncontrolled hypertension can lead to serious health issues, including heart disease and stroke, necessitating prompt intervention.
- Adjusting the treatment plan can help balance the benefits of Iclusig in managing the underlying condition with the risks associated with uncontrolled hypertension.

3) Safety/contraindications/interactions:
- Monitor blood pressure regularly in patients on Iclusig, especially those with a history of hypertension.
- Be cautious when prescribing additional antihypertensive medications, as some may interact with Iclusig or exacerbate side effects.
- Consider the patient's overall health status, including any comorbidities that may influence hypertension management.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the recommended action if a patient taking Iclusig develops hypertension that is not medically controlled?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: If a patient taking Iclusig (ponatinib) develops hypertension that is not medically controlled, it is essential to evaluate the patient's overall treatment plan. Consider adjusting the antihypertensive regimen, consulting a specialist if necessary, and potentially reassessing the need for Iclusig, as dose reduction or discontinuation may be warranted based on the severity of hypertension and its impact on the patient's health.\n\n2) Key rationale:\n- Iclusig can cause hypertension as a side effect, which may require careful management to prevent cardiovascular complications.\n- Uncontrolled hypertension can lead to serious health issues, including heart disease and stroke, necessitating prompt intervention.\n- Adjusting the treatment plan can help balance the benefits of Iclusig in managing the underlying condition with the risks associated with uncontrolled hypertension.\n\n3) Safety/contraindications/interactions:\n- Monitor blood pressure regularly in patients on Iclusig, especially those with a history of hypertension.\n- Be cautious when prescribing additional antihypertensive medications, as some may interact with Iclusig or exacerbate side effects.\n- Consider the patient's overall health status, including any comorbidities that may influence hypertension management.""}]"
"GQJVAHSMIqeF","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for healthcare providers when a pregnant individual is exposed to Tybost?\nA: Discontinue Tybost immediately.\nB: Register the patient in the Antiretroviral Pregnancy Registry (APR).\nC: Switch to a different antiretroviral regimen.\nD: Increase the dosage of Tybost.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for healthcare providers when a pregnant individual is exposed to Tybost?\nA: Discontinue Tybost immediately.\nB: Register the patient in the Antiretroviral Pregnancy Registry (APR).\nC: Switch to a different antiretroviral regimen.\nD: Increase the dosage of Tybost.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for healthcare providers when a pregnant individual is exposed to Tybost?\nA: Discontinue Tybost immediately.\nB: Register the patient in the Antiretroviral Pregnancy Registry (APR).\nC: Switch to a different antiretroviral regimen.\nD: Increase the dosage of Tybost.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"PaxBaeUVWssf","- The drug brand name ""Zyrtec"" is explicitly stated as not being a controlled substance.
- ""Zyrtec"" is an antihistamine used for allergy relief and is available over-the-counter.
- Unlike controlled substances, ""Zyrtec"" does not have restrictions on its prescription or dispensing.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich drug brand name is explicitly stated as not being a controlled substance?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The drug brand name \""Zyrtec\"" is explicitly stated as not being a controlled substance.\n- \""Zyrtec\"" is an antihistamine used for allergy relief and is available over-the-counter.\n- Unlike controlled substances, \""Zyrtec\"" does not have restrictions on its prescription or dispensing.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which drug brand name is explicitly stated as not being a controlled substance?\nA: Bupropion Hydrochloride SR\nB: Diazepam\nC: Morphine\nD: Oxycodone\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug brand name \""Zyrtec\"" is explicitly stated as not being a controlled substance.\n- \""Zyrtec\"" is an antihistamine used for allergy relief and is available over-the-counter.\n- Unlike controlled substances, \""Zyrtec\"" does not have restrictions on its prescription or dispensing.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which drug brand name is explicitly stated as not being a controlled substance?\nA: Bupropion Hydrochloride SR\nB: Diazepam\nC: Morphine\nD: Oxycodone\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug brand name \""Zyrtec\"" is explicitly stated as not being a controlled substance.\n- \""Zyrtec\"" is an antihistamine used for allergy relief and is available over-the-counter.\n- Unlike controlled substances, \""Zyrtec\"" does not have restrictions on its prescription or dispensing.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which drug brand name is explicitly stated as not being a controlled substance?\nA: Bupropion Hydrochloride SR\nB: Diazepam\nC: Morphine\nD: Oxycodone\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug brand name \""Zyrtec\"" is explicitly stated as not being a controlled substance.\n- \""Zyrtec\"" is an antihistamine used for allergy relief and is available over-the-counter.\n- Unlike controlled substances, \""Zyrtec\"" does not have restrictions on its prescription or dispensing.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
"dIQtc2GiPQqZ","MRRV winner=C; scores={'A': 0.25, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.5}; rankings=[['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A'], ['C', 'D', 'B', 'A']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for patients with severe hepatic impairment (Child-Pugh score greater than 9) when administering FOSAPREPITANT?\nA: No dosage adjustment is necessary.\nB: Additional monitoring for adverse reactions may be warranted.\nC: FOSAPREPITANT is contraindicated in these patients.\nD: Patients should receive a reduced dose of FOSAPREPITANT.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for patients with severe hepatic impairment (Child-Pugh score greater than 9) when administering FOSAPREPITANT?\nA: No dosage adjustment is necessary.\nB: Additional monitoring for adverse reactions may be warranted.\nC: FOSAPREPITANT is contraindicated in these patients.\nD: Patients should receive a reduced dose of FOSAPREPITANT.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for patients with severe hepatic impairment (Child-Pugh score greater than 9) when administering FOSAPREPITANT?\nA: No dosage adjustment is necessary.\nB: Additional monitoring for adverse reactions may be warranted.\nC: FOSAPREPITANT is contraindicated in these patients.\nD: Patients should receive a reduced dose of FOSAPREPITANT.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > D > B > A""}]"
"p7YN03M67UUF","- Patients taking lamotrigine in combination with valproate have a higher rate of serious rashes compared to those on lamotrigine alone or with other antiepileptic drugs.
- Pediatric patients, particularly those under 16 years of age, are at an increased risk for serious rashes when treated with lamotrigine.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich patient population has a higher rate of serious rashes caused by lamotrigine?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients taking lamotrigine in combination with valproate have a higher rate of serious rashes compared to those on lamotrigine alone or with other antiepileptic drugs.\n- Pediatric patients, particularly those under 16 years of age, are at an increased risk for serious rashes when treated with lamotrigine.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient population has a higher rate of serious rashes caused by lamotrigine?\nA: Adults\nB: Pediatric patients aged 2 to 17 years\nC: Patients older than 60 years\nD: Pregnant women\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking lamotrigine in combination with valproate have a higher rate of serious rashes compared to those on lamotrigine alone or with other antiepileptic drugs.\n- Pediatric patients, particularly those under 16 years of age, are at an increased risk for serious rashes when treated with lamotrigine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient population has a higher rate of serious rashes caused by lamotrigine?\nA: Adults\nB: Pediatric patients aged 2 to 17 years\nC: Patients older than 60 years\nD: Pregnant women\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking lamotrigine in combination with valproate have a higher rate of serious rashes compared to those on lamotrigine alone or with other antiepileptic drugs.\n- Pediatric patients, particularly those under 16 years of age, are at an increased risk for serious rashes when treated with lamotrigine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which patient population has a higher rate of serious rashes caused by lamotrigine?\nA: Adults\nB: Pediatric patients aged 2 to 17 years\nC: Patients older than 60 years\nD: Pregnant women\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients taking lamotrigine in combination with valproate have a higher rate of serious rashes compared to those on lamotrigine alone or with other antiepileptic drugs.\n- Pediatric patients, particularly those under 16 years of age, are at an increased risk for serious rashes when treated with lamotrigine.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"PejUIYpchlVn","MRRV winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action after 6 months of daily use of dg health nasal spray for adults and children aged 12 years and older?\nA: Continue using the spray without consulting a doctor.\nB: Stop using the spray immediately.\nC: Ask your doctor if you can keep using the spray.\nD: Increase the dosage to 3 sprays in each nostril daily.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action after 6 months of daily use of dg health nasal spray for adults and children aged 12 years and older?\nA: Continue using the spray without consulting a doctor.\nB: Stop using the spray immediately.\nC: Ask your doctor if you can keep using the spray.\nD: Increase the dosage to 3 sprays in each nostril daily.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action after 6 months of daily use of dg health nasal spray for adults and children aged 12 years and older?\nA: Continue using the spray without consulting a doctor.\nB: Stop using the spray immediately.\nC: Ask your doctor if you can keep using the spray.\nD: Increase the dosage to 3 sprays in each nostril daily.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"jfu2YLGGiiLq","- Individuals who become pregnant while on Tybost coadministered with darunavir should continue the therapy, as it is generally considered safe during pregnancy.
- For those on Tybost with atazanavir, it is also recommended to continue the regimen, but close monitoring of the mother and fetus is advised.
- Consultation with a healthcare provider is essential to assess the risks and benefits of continuing therapy during pregnancy.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action for individuals who become pregnant during therapy with Tybost coadministered with darunavir or atazanavir?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Individuals who become pregnant while on Tybost coadministered with darunavir should continue the therapy, as it is generally considered safe during pregnancy.\n- For those on Tybost with atazanavir, it is also recommended to continue the regimen, but close monitoring of the mother and fetus is advised.\n- Consultation with a healthcare provider is essential to assess the risks and benefits of continuing therapy during pregnancy.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action for individuals who become pregnant during therapy with Tybost coadministered with darunavir or atazanavir?\nA: Continue the therapy without changes\nB: Increase the dosage of Tybost\nC: Switch to an alternative regimen\nD: Reduce the dosage of darunavir or atazanavir\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Individuals who become pregnant while on Tybost coadministered with darunavir should continue the therapy, as it is generally considered safe during pregnancy.\n- For those on Tybost with atazanavir, it is also recommended to continue the regimen, but close monitoring of the mother and fetus is advised.\n- Consultation with a healthcare provider is essential to assess the risks and benefits of continuing therapy during pregnancy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action for individuals who become pregnant during therapy with Tybost coadministered with darunavir or atazanavir?\nA: Continue the therapy without changes\nB: Increase the dosage of Tybost\nC: Switch to an alternative regimen\nD: Reduce the dosage of darunavir or atazanavir\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Individuals who become pregnant while on Tybost coadministered with darunavir should continue the therapy, as it is generally considered safe during pregnancy.\n- For those on Tybost with atazanavir, it is also recommended to continue the regimen, but close monitoring of the mother and fetus is advised.\n- Consultation with a healthcare provider is essential to assess the risks and benefits of continuing therapy during pregnancy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action for individuals who become pregnant during therapy with Tybost coadministered with darunavir or atazanavir?\nA: Continue the therapy without changes\nB: Increase the dosage of Tybost\nC: Switch to an alternative regimen\nD: Reduce the dosage of darunavir or atazanavir\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Individuals who become pregnant while on Tybost coadministered with darunavir should continue the therapy, as it is generally considered safe during pregnancy.\n- For those on Tybost with atazanavir, it is also recommended to continue the regimen, but close monitoring of the mother and fetus is advised.\n- Consultation with a healthcare provider is essential to assess the risks and benefits of continuing therapy during pregnancy.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"JbKyZeGI7QXG","- The maximum dose of ondansetron administered to rats in carcinogenicity studies was significantly higher than the maximum recommended human oral dose, which is typically 32 mg per day.
- In these studies, rats received doses of ondansetron up to 100 mg/kg/day, far exceeding the human dosage guidelines.
- This comparison highlights the differences in dosing regimens used in animal studies versus those recommended for human patients.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn carcinogenicity studies, how does the maximum dose of ondansetron administered to rats compare to the maximum recommended human oral dose?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The maximum dose of ondansetron administered to rats in carcinogenicity studies was significantly higher than the maximum recommended human oral dose, which is typically 32 mg per day.\n- In these studies, rats received doses of ondansetron up to 100 mg/kg/day, far exceeding the human dosage guidelines.\n- This comparison highlights the differences in dosing regimens used in animal studies versus those recommended for human patients.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In carcinogenicity studies, how does the maximum dose of ondansetron administered to rats compare to the maximum recommended human oral dose?\nA: Approximately 2 times higher\nB: Approximately 4 times higher\nC: Approximately 6 times higher\nD: Approximately 10 times higher\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum dose of ondansetron administered to rats in carcinogenicity studies was significantly higher than the maximum recommended human oral dose, which is typically 32 mg per day.\n- In these studies, rats received doses of ondansetron up to 100 mg/kg/day, far exceeding the human dosage guidelines.\n- This comparison highlights the differences in dosing regimens used in animal studies versus those recommended for human patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In carcinogenicity studies, how does the maximum dose of ondansetron administered to rats compare to the maximum recommended human oral dose?\nA: Approximately 2 times higher\nB: Approximately 4 times higher\nC: Approximately 6 times higher\nD: Approximately 10 times higher\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum dose of ondansetron administered to rats in carcinogenicity studies was significantly higher than the maximum recommended human oral dose, which is typically 32 mg per day.\n- In these studies, rats received doses of ondansetron up to 100 mg/kg/day, far exceeding the human dosage guidelines.\n- This comparison highlights the differences in dosing regimens used in animal studies versus those recommended for human patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In carcinogenicity studies, how does the maximum dose of ondansetron administered to rats compare to the maximum recommended human oral dose?\nA: Approximately 2 times higher\nB: Approximately 4 times higher\nC: Approximately 6 times higher\nD: Approximately 10 times higher\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum dose of ondansetron administered to rats in carcinogenicity studies was significantly higher than the maximum recommended human oral dose, which is typically 32 mg per day.\n- In these studies, rats received doses of ondansetron up to 100 mg/kg/day, far exceeding the human dosage guidelines.\n- This comparison highlights the differences in dosing regimens used in animal studies versus those recommended for human patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"te8FuqmxwSEe","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be done if withdrawal symptoms arise during the tapering of RoxyBond?\nA: Pause the taper or raise the dose to the previous level.\nB: Discontinue RoxyBond immediately.\nC: Switch to a non-opioid analgesic.\nD: Increase the tapering increment to speed up discontinuation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be done if withdrawal symptoms arise during the tapering of RoxyBond?\nA: Pause the taper or raise the dose to the previous level.\nB: Discontinue RoxyBond immediately.\nC: Switch to a non-opioid analgesic.\nD: Increase the tapering increment to speed up discontinuation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should be done if withdrawal symptoms arise during the tapering of RoxyBond?\nA: Pause the taper or raise the dose to the previous level.\nB: Discontinue RoxyBond immediately.\nC: Switch to a non-opioid analgesic.\nD: Increase the tapering increment to speed up discontinuation.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"BuGbAXZ0F98u","- Ondansetron, a 5-HT3 receptor antagonist, has been evaluated for mutagenicity in various studies and has shown no significant mutagenic effects in standard assays.
- In the context of clinical use, ondansetron has been administered at doses of 8 mg and 16 mg without evidence of mutagenic potential in human studies.
- The drug has been classified as non-mutagenic based on the results from the Ames test and other genotoxicity assessments, indicating it does not pose a risk for genetic mutations.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following statements about ondansetron's mutagenicity is correct?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Ondansetron, a 5-HT3 receptor antagonist, has been evaluated for mutagenicity in various studies and has shown no significant mutagenic effects in standard assays.\n- In the context of clinical use, ondansetron has been administered at doses of 8 mg and 16 mg without evidence of mutagenic potential in human studies.\n- The drug has been classified as non-mutagenic based on the results from the Ames test and other genotoxicity assessments, indicating it does not pose a risk for genetic mutations.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements about ondansetron's mutagenicity is correct?\nA: Ondansetron was found to be mutagenic in standard tests.\nB: Ondansetron was not mutagenic in standard tests.\nC: Mutagenicity of ondansetron was not evaluated.\nD: Ondansetron showed mutagenicity only in high doses.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Ondansetron, a 5-HT3 receptor antagonist, has been evaluated for mutagenicity in various studies and has shown no significant mutagenic effects in standard assays.\n- In the context of clinical use, ondansetron has been administered at doses of 8 mg and 16 mg without evidence of mutagenic potential in human studies.\n- The drug has been classified as non-mutagenic based on the results from the Ames test and other genotoxicity assessments, indicating it does not pose a risk for genetic mutations.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements about ondansetron's mutagenicity is correct?\nA: Ondansetron was found to be mutagenic in standard tests.\nB: Ondansetron was not mutagenic in standard tests.\nC: Mutagenicity of ondansetron was not evaluated.\nD: Ondansetron showed mutagenicity only in high doses.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Ondansetron, a 5-HT3 receptor antagonist, has been evaluated for mutagenicity in various studies and has shown no significant mutagenic effects in standard assays.\n- In the context of clinical use, ondansetron has been administered at doses of 8 mg and 16 mg without evidence of mutagenic potential in human studies.\n- The drug has been classified as non-mutagenic based on the results from the Ames test and other genotoxicity assessments, indicating it does not pose a risk for genetic mutations.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following statements about ondansetron's mutagenicity is correct?\nA: Ondansetron was found to be mutagenic in standard tests.\nB: Ondansetron was not mutagenic in standard tests.\nC: Mutagenicity of ondansetron was not evaluated.\nD: Ondansetron showed mutagenicity only in high doses.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Ondansetron, a 5-HT3 receptor antagonist, has been evaluated for mutagenicity in various studies and has shown no significant mutagenic effects in standard assays.\n- In the context of clinical use, ondansetron has been administered at doses of 8 mg and 16 mg without evidence of mutagenic potential in human studies.\n- The drug has been classified as non-mutagenic based on the results from the Ames test and other genotoxicity assessments, indicating it does not pose a risk for genetic mutations.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"bFEcpa96fGPS","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the empirical formula of sumatriptan succinate in Sumatriptan injection, USP?\nA: C14H21N3O2S\nB: C14H21N3O2S\u2022C4H6O4\nC: C14H21N3O4S\nD: C14H21N3O2\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the empirical formula of sumatriptan succinate in Sumatriptan injection, USP?\nA: C14H21N3O2S\nB: C14H21N3O2S\u2022C4H6O4\nC: C14H21N3O4S\nD: C14H21N3O2\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the empirical formula of sumatriptan succinate in Sumatriptan injection, USP?\nA: C14H21N3O2S\nB: C14H21N3O2S\u2022C4H6O4\nC: C14H21N3O4S\nD: C14H21N3O2\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"t1QtSu8JZj7e","- A minimum of 14 days should elapse after stopping venlafaxine before initiating treatment with an MAOI, such as phenelzine or tranylcypromine, to avoid the risk of serotonin syndrome.
- This washout period is crucial to ensure that venlafaxine is fully cleared from the system, as it has a half-life that can affect the timing of starting an MAOI.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 1.0, 'D': 0.25}; rankings=[['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D'], ['C', 'A', 'B', 'D']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow many days should elapse after stopping venlafaxine tablets before initiating treatment with an MAOI intended to treat psychiatric disorders?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- A minimum of 14 days should elapse after stopping venlafaxine before initiating treatment with an MAOI, such as phenelzine or tranylcypromine, to avoid the risk of serotonin syndrome.\n- This washout period is crucial to ensure that venlafaxine is fully cleared from the system, as it has a half-life that can affect the timing of starting an MAOI.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How many days should elapse after stopping venlafaxine tablets before initiating treatment with an MAOI intended to treat psychiatric disorders?\nA: 3 days\nB: 7 days\nC: 14 days\nD: 21 days\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- A minimum of 14 days should elapse after stopping venlafaxine before initiating treatment with an MAOI, such as phenelzine or tranylcypromine, to avoid the risk of serotonin syndrome.\n- This washout period is crucial to ensure that venlafaxine is fully cleared from the system, as it has a half-life that can affect the timing of starting an MAOI.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How many days should elapse after stopping venlafaxine tablets before initiating treatment with an MAOI intended to treat psychiatric disorders?\nA: 3 days\nB: 7 days\nC: 14 days\nD: 21 days\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- A minimum of 14 days should elapse after stopping venlafaxine before initiating treatment with an MAOI, such as phenelzine or tranylcypromine, to avoid the risk of serotonin syndrome.\n- This washout period is crucial to ensure that venlafaxine is fully cleared from the system, as it has a half-life that can affect the timing of starting an MAOI.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How many days should elapse after stopping venlafaxine tablets before initiating treatment with an MAOI intended to treat psychiatric disorders?\nA: 3 days\nB: 7 days\nC: 14 days\nD: 21 days\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- A minimum of 14 days should elapse after stopping venlafaxine before initiating treatment with an MAOI, such as phenelzine or tranylcypromine, to avoid the risk of serotonin syndrome.\n- This washout period is crucial to ensure that venlafaxine is fully cleared from the system, as it has a half-life that can affect the timing of starting an MAOI.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > B > D""}]"
"FuPqZw2fNqV3","- Venlafaxine did not show a significant increase in the incidence of seizures compared to placebo in clinical trials.
- There was no evidence of a higher rate of psychotic symptoms associated with venlafaxine compared to the active treatment group.
- Clinical trials did not report an increase in the risk of severe allergic reactions with venlafaxine compared to placebo.

MRRV(meta) winner=D; scores={'A': 0.5, 'B': 0.5555555555555555, 'C': 0.27777777777777773, 'D': 0.75}; rankings=[['B', 'A', 'C', 'D'], ['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat behavior was NOT observed in clinical trials of venlafaxine?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Venlafaxine did not show a significant increase in the incidence of seizures compared to placebo in clinical trials.\n- There was no evidence of a higher rate of psychotic symptoms associated with venlafaxine compared to the active treatment group.\n- Clinical trials did not report an increase in the risk of severe allergic reactions with venlafaxine compared to placebo.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What behavior was NOT observed in clinical trials of venlafaxine?\nA: Drug-seeking behavior\nB: Development of tolerance\nC: Incrementation of dose\nD: Significant CNS depressant activity\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine did not show a significant increase in the incidence of seizures compared to placebo in clinical trials.\n- There was no evidence of a higher rate of psychotic symptoms associated with venlafaxine compared to the active treatment group.\n- Clinical trials did not report an increase in the risk of severe allergic reactions with venlafaxine compared to placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What behavior was NOT observed in clinical trials of venlafaxine?\nA: Drug-seeking behavior\nB: Development of tolerance\nC: Incrementation of dose\nD: Significant CNS depressant activity\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine did not show a significant increase in the incidence of seizures compared to placebo in clinical trials.\n- There was no evidence of a higher rate of psychotic symptoms associated with venlafaxine compared to the active treatment group.\n- Clinical trials did not report an increase in the risk of severe allergic reactions with venlafaxine compared to placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What behavior was NOT observed in clinical trials of venlafaxine?\nA: Drug-seeking behavior\nB: Development of tolerance\nC: Incrementation of dose\nD: Significant CNS depressant activity\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine did not show a significant increase in the incidence of seizures compared to placebo in clinical trials.\n- There was no evidence of a higher rate of psychotic symptoms associated with venlafaxine compared to the active treatment group.\n- Clinical trials did not report an increase in the risk of severe allergic reactions with venlafaxine compared to placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}]"
"aXvFbw3EqYUf","1) Recommendation: Sunmark ibuprofen can be used to reduce fever in both adults and children. It is effective in lowering elevated body temperature and providing relief from discomfort associated with fever.

2) Key rationale:
   - Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of prostaglandins, which are responsible for causing fever.
   - It provides both antipyretic (fever-reducing) and analgesic (pain-relieving) effects, making it suitable for managing fever-related discomfort.
   - It is generally well-tolerated and can be used in various age groups, including children, when dosed appropriately.

3) Safety/contraindications/interactions:
   - Contraindicated in individuals with a history of gastrointestinal bleeding, peptic ulcers, or severe kidney disease.
   - Caution is advised in patients with asthma, heart disease, or those who are pregnant or breastfeeding.
   - Potential interactions with other medications, such as anticoagulants, other NSAIDs, and certain antihypertensives, should be considered.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is one of the uses of sunmark ibuprofen related to fever?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Sunmark ibuprofen can be used to reduce fever in both adults and children. It is effective in lowering elevated body temperature and providing relief from discomfort associated with fever.\n\n2) Key rationale:\n   - Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of prostaglandins, which are responsible for causing fever.\n   - It provides both antipyretic (fever-reducing) and analgesic (pain-relieving) effects, making it suitable for managing fever-related discomfort.\n   - It is generally well-tolerated and can be used in various age groups, including children, when dosed appropriately.\n\n3) Safety/contraindications/interactions:\n   - Contraindicated in individuals with a history of gastrointestinal bleeding, peptic ulcers, or severe kidney disease.\n   - Caution is advised in patients with asthma, heart disease, or those who are pregnant or breastfeeding.\n   - Potential interactions with other medications, such as anticoagulants, other NSAIDs, and certain antihypertensives, should be considered.""}]"
"bvwQ4liSv2ti","- WL-AAB-Z-W-982 has a contraindication profile that includes severe hypersensitivity reactions, which is similar to other biologics like omalizumab, known for its risk of anaphylaxis.
- Unlike many traditional medications, WL-AAB-Z-W-982 may have specific contraindications related to concurrent use with immunosuppressants, similar to drugs like rituximab, which also has restrictions when used with other immunosuppressive therapies.
- The contraindications for WL-AAB-Z-W-982 may also include a history of certain autoimmune disorders, paralleling the profile of drugs like adalimumab, which is contraindicated in patients with active infections or certain autoimmune conditions.

MRRV(meta) winner=D; scores={'A': 0.5, 'B': 0.25, 'C': 0.3333333333333333, 'D': 1.0}; rankings=[['D', 'A', 'C', 'B'], ['D', 'A', 'C', 'B'], ['D', 'A', 'C', 'B']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow does the contraindication profile of WL-AAB-Z-W-982 compare to other drugs with known contraindications?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- WL-AAB-Z-W-982 has a contraindication profile that includes severe hypersensitivity reactions, which is similar to other biologics like omalizumab, known for its risk of anaphylaxis.\n- Unlike many traditional medications, WL-AAB-Z-W-982 may have specific contraindications related to concurrent use with immunosuppressants, similar to drugs like rituximab, which also has restrictions when used with other immunosuppressive therapies.\n- The contraindications for WL-AAB-Z-W-982 may also include a history of certain autoimmune disorders, paralleling the profile of drugs like adalimumab, which is contraindicated in patients with active infections or certain autoimmune conditions.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the contraindication profile of WL-AAB-Z-W-982 compare to other drugs with known contraindications?\nA: WL-AAB-Z-W-982 has no contraindications, unlike many other drugs.\nB: WL-AAB-Z-W-982 is contraindicated in all patients.\nC: WL-AAB-Z-W-982 has more contraindications than most drugs.\nD: WL-AAB-Z-W-982 is contraindicated only in specific populations.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- WL-AAB-Z-W-982 has a contraindication profile that includes severe hypersensitivity reactions, which is similar to other biologics like omalizumab, known for its risk of anaphylaxis.\n- Unlike many traditional medications, WL-AAB-Z-W-982 may have specific contraindications related to concurrent use with immunosuppressants, similar to drugs like rituximab, which also has restrictions when used with other immunosuppressive therapies.\n- The contraindications for WL-AAB-Z-W-982 may also include a history of certain autoimmune disorders, paralleling the profile of drugs like adalimumab, which is contraindicated in patients with active infections or certain autoimmune conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the contraindication profile of WL-AAB-Z-W-982 compare to other drugs with known contraindications?\nA: WL-AAB-Z-W-982 has no contraindications, unlike many other drugs.\nB: WL-AAB-Z-W-982 is contraindicated in all patients.\nC: WL-AAB-Z-W-982 has more contraindications than most drugs.\nD: WL-AAB-Z-W-982 is contraindicated only in specific populations.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- WL-AAB-Z-W-982 has a contraindication profile that includes severe hypersensitivity reactions, which is similar to other biologics like omalizumab, known for its risk of anaphylaxis.\n- Unlike many traditional medications, WL-AAB-Z-W-982 may have specific contraindications related to concurrent use with immunosuppressants, similar to drugs like rituximab, which also has restrictions when used with other immunosuppressive therapies.\n- The contraindications for WL-AAB-Z-W-982 may also include a history of certain autoimmune disorders, paralleling the profile of drugs like adalimumab, which is contraindicated in patients with active infections or certain autoimmune conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How does the contraindication profile of WL-AAB-Z-W-982 compare to other drugs with known contraindications?\nA: WL-AAB-Z-W-982 has no contraindications, unlike many other drugs.\nB: WL-AAB-Z-W-982 is contraindicated in all patients.\nC: WL-AAB-Z-W-982 has more contraindications than most drugs.\nD: WL-AAB-Z-W-982 is contraindicated only in specific populations.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- WL-AAB-Z-W-982 has a contraindication profile that includes severe hypersensitivity reactions, which is similar to other biologics like omalizumab, known for its risk of anaphylaxis.\n- Unlike many traditional medications, WL-AAB-Z-W-982 may have specific contraindications related to concurrent use with immunosuppressants, similar to drugs like rituximab, which also has restrictions when used with other immunosuppressive therapies.\n- The contraindications for WL-AAB-Z-W-982 may also include a history of certain autoimmune disorders, paralleling the profile of drugs like adalimumab, which is contraindicated in patients with active infections or certain autoimmune conditions.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > C > B""}]"
"A6GWXshci0Wh","1) Recommendation: Hydrocortisone overdosage can lead to significant adverse effects, including adrenal suppression and Cushing's syndrome. It is crucial to monitor patients closely for signs of overdosage and adjust the dosage accordingly.

2) Key rationale:
   - Hydrocortisone is a corticosteroid that can cause systemic effects when taken in excess, leading to increased cortisol levels.
   - Overdosage may result in symptoms such as weight gain, hypertension, hyperglycemia, and increased susceptibility to infections.
   - Long-term overdosage can lead to adrenal gland suppression, making it difficult for the body to respond to stress.
   - Patients may experience mood changes, insomnia, and other psychological effects due to elevated cortisol levels.

3) Safety/contraindications/interactions:
   - Patients with a history of peptic ulcer disease, diabetes, or hypertension should be monitored closely for exacerbation of these conditions.
   - Caution is advised when hydrocortisone is used in conjunction with other medications that may affect adrenal function or metabolism.
   - Abrupt discontinuation after prolonged use can lead to adrenal crisis; tapering is recommended.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhich statement accurately describes the pharmacological risk of Hydrocort overdosage?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Hydrocortisone overdosage can lead to significant adverse effects, including adrenal suppression and Cushing's syndrome. It is crucial to monitor patients closely for signs of overdosage and adjust the dosage accordingly.\n\n2) Key rationale:\n   - Hydrocortisone is a corticosteroid that can cause systemic effects when taken in excess, leading to increased cortisol levels.\n   - Overdosage may result in symptoms such as weight gain, hypertension, hyperglycemia, and increased susceptibility to infections.\n   - Long-term overdosage can lead to adrenal gland suppression, making it difficult for the body to respond to stress.\n   - Patients may experience mood changes, insomnia, and other psychological effects due to elevated cortisol levels.\n\n3) Safety/contraindications/interactions:\n   - Patients with a history of peptic ulcer disease, diabetes, or hypertension should be monitored closely for exacerbation of these conditions.\n   - Caution is advised when hydrocortisone is used in conjunction with other medications that may affect adrenal function or metabolism.\n   - Abrupt discontinuation after prolonged use can lead to adrenal crisis; tapering is recommended.""}]"
"xYarTTMRvTDn","MRRV winner=C; scores={'A': 0.27777777777777773, 'B': 0.5, 'C': 1.0, 'D': 0.3055555555555555}; rankings=[['C', 'B', 'A', 'D'], ['C', 'B', 'D', 'A'], ['C', 'B', 'D', 'A']]","C","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich property of pantoprazole sodium makes it freely soluble in water?\nA: Its racemic nature\nB: Its weakly basic and acidic properties\nC: Its structural formula\nD: Its empirical formula\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > A > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich property of pantoprazole sodium makes it freely soluble in water?\nA: Its racemic nature\nB: Its weakly basic and acidic properties\nC: Its structural formula\nD: Its empirical formula\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich property of pantoprazole sodium makes it freely soluble in water?\nA: Its racemic nature\nB: Its weakly basic and acidic properties\nC: Its structural formula\nD: Its empirical formula\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > B > D > A""}]"
"lwm2qXkSixus","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient taking Jaimiess is scheduled for major surgery?\nA: Continue taking Jaimiess as prescribed\nB: Stop taking Jaimiess at least 4 weeks before surgery and restart 2 weeks after\nC: Switch to a different hormonal contraceptive\nD: Stop taking Jaimiess 1 week before surgery and restart immediately after\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient taking Jaimiess is scheduled for major surgery?\nA: Continue taking Jaimiess as prescribed\nB: Stop taking Jaimiess at least 4 weeks before surgery and restart 2 weeks after\nC: Switch to a different hormonal contraceptive\nD: Stop taking Jaimiess 1 week before surgery and restart immediately after\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if a patient taking Jaimiess is scheduled for major surgery?\nA: Continue taking Jaimiess as prescribed\nB: Stop taking Jaimiess at least 4 weeks before surgery and restart 2 weeks after\nC: Switch to a different hormonal contraceptive\nD: Stop taking Jaimiess 1 week before surgery and restart immediately after\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"Oh34Ve7SVBuz","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C'], ['A', 'B', 'D', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage adjustment for BREVIBLOC injection in patients with renal impairment?\nA: No dosage adjustment is required for maintenance infusions up to 150 mcg/kg for 4 hours.\nB: Dosage should be reduced by half for all patients with renal impairment.\nC: Dosage should be increased for patients with renal impairment.\nD: BREVIBLOC injection should not be used in patients with renal impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage adjustment for BREVIBLOC injection in patients with renal impairment?\nA: No dosage adjustment is required for maintenance infusions up to 150 mcg/kg for 4 hours.\nB: Dosage should be reduced by half for all patients with renal impairment.\nC: Dosage should be increased for patients with renal impairment.\nD: BREVIBLOC injection should not be used in patients with renal impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage adjustment for BREVIBLOC injection in patients with renal impairment?\nA: No dosage adjustment is required for maintenance infusions up to 150 mcg/kg for 4 hours.\nB: Dosage should be reduced by half for all patients with renal impairment.\nC: Dosage should be increased for patients with renal impairment.\nD: BREVIBLOC injection should not be used in patients with renal impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}]"
"D19iWnmCz6ME","- Co-administration of OCELLA, which contains ethinyl estradiol and drospirenone, with the strong CYP3A4 inhibitor ketoconazole may increase the plasma concentrations of ethinyl estradiol due to reduced metabolism.
- This interaction could potentially enhance the effects and side effects of OCELLA, such as increased risk of thromboembolic events or other estrogen-related adverse effects.
- Monitoring for signs of estrogen excess is recommended when OCELLA is taken alongside ketoconazole or other strong CYP3A4 inhibitors.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the effect of co-administration of OCELLA with a strong CYP3A4 inhibitor like ketoconazole?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Co-administration of OCELLA, which contains ethinyl estradiol and drospirenone, with the strong CYP3A4 inhibitor ketoconazole may increase the plasma concentrations of ethinyl estradiol due to reduced metabolism.\n- This interaction could potentially enhance the effects and side effects of OCELLA, such as increased risk of thromboembolic events or other estrogen-related adverse effects.\n- Monitoring for signs of estrogen excess is recommended when OCELLA is taken alongside ketoconazole or other strong CYP3A4 inhibitors.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of co-administration of OCELLA with a strong CYP3A4 inhibitor like ketoconazole?\nA: Decreases the plasma concentrations of DRSP and EE.\nB: Increases the AUC of DRSP and EE by 2.68-fold and 1.40-fold, respectively.\nC: Has no effect on the pharmacokinetics of DRSP and EE.\nD: Reduces the efficacy of OCELLA.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Co-administration of OCELLA, which contains ethinyl estradiol and drospirenone, with the strong CYP3A4 inhibitor ketoconazole may increase the plasma concentrations of ethinyl estradiol due to reduced metabolism.\n- This interaction could potentially enhance the effects and side effects of OCELLA, such as increased risk of thromboembolic events or other estrogen-related adverse effects.\n- Monitoring for signs of estrogen excess is recommended when OCELLA is taken alongside ketoconazole or other strong CYP3A4 inhibitors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of co-administration of OCELLA with a strong CYP3A4 inhibitor like ketoconazole?\nA: Decreases the plasma concentrations of DRSP and EE.\nB: Increases the AUC of DRSP and EE by 2.68-fold and 1.40-fold, respectively.\nC: Has no effect on the pharmacokinetics of DRSP and EE.\nD: Reduces the efficacy of OCELLA.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Co-administration of OCELLA, which contains ethinyl estradiol and drospirenone, with the strong CYP3A4 inhibitor ketoconazole may increase the plasma concentrations of ethinyl estradiol due to reduced metabolism.\n- This interaction could potentially enhance the effects and side effects of OCELLA, such as increased risk of thromboembolic events or other estrogen-related adverse effects.\n- Monitoring for signs of estrogen excess is recommended when OCELLA is taken alongside ketoconazole or other strong CYP3A4 inhibitors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the effect of co-administration of OCELLA with a strong CYP3A4 inhibitor like ketoconazole?\nA: Decreases the plasma concentrations of DRSP and EE.\nB: Increases the AUC of DRSP and EE by 2.68-fold and 1.40-fold, respectively.\nC: Has no effect on the pharmacokinetics of DRSP and EE.\nD: Reduces the efficacy of OCELLA.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Co-administration of OCELLA, which contains ethinyl estradiol and drospirenone, with the strong CYP3A4 inhibitor ketoconazole may increase the plasma concentrations of ethinyl estradiol due to reduced metabolism.\n- This interaction could potentially enhance the effects and side effects of OCELLA, such as increased risk of thromboembolic events or other estrogen-related adverse effects.\n- Monitoring for signs of estrogen excess is recommended when OCELLA is taken alongside ketoconazole or other strong CYP3A4 inhibitors.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"iKyKI2J6U4id","- Healthcare providers should closely monitor patients with a history of drug abuse when prescribing Venlafaxine Hydrochloride, as it has the potential for misuse and dependence.
- It is advisable to consider alternative treatments or lower doses of Venlafaxine Hydrochloride, especially in patients with a significant history of substance use disorders.
- Providers should engage in thorough discussions with patients about the risks and benefits of using Venlafaxine Hydrochloride, ensuring they understand the importance of adherence to the prescribed regimen.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended approach for healthcare providers when prescribing Venlafaxine Hydrochloride to patients with a history of drug abuse?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Healthcare providers should closely monitor patients with a history of drug abuse when prescribing Venlafaxine Hydrochloride, as it has the potential for misuse and dependence.\n- It is advisable to consider alternative treatments or lower doses of Venlafaxine Hydrochloride, especially in patients with a significant history of substance use disorders.\n- Providers should engage in thorough discussions with patients about the risks and benefits of using Venlafaxine Hydrochloride, ensuring they understand the importance of adherence to the prescribed regimen.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for healthcare providers when prescribing Venlafaxine Hydrochloride to patients with a history of drug abuse?\nA: Prescribe the drug without any additional monitoring\nB: Evaluate the patient's history of drug abuse and monitor for signs of misuse or abuse\nC: Avoid prescribing Venlafaxine Hydrochloride entirely\nD: Increase the dosage to prevent withdrawal symptoms\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Healthcare providers should closely monitor patients with a history of drug abuse when prescribing Venlafaxine Hydrochloride, as it has the potential for misuse and dependence.\n- It is advisable to consider alternative treatments or lower doses of Venlafaxine Hydrochloride, especially in patients with a significant history of substance use disorders.\n- Providers should engage in thorough discussions with patients about the risks and benefits of using Venlafaxine Hydrochloride, ensuring they understand the importance of adherence to the prescribed regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for healthcare providers when prescribing Venlafaxine Hydrochloride to patients with a history of drug abuse?\nA: Prescribe the drug without any additional monitoring\nB: Evaluate the patient's history of drug abuse and monitor for signs of misuse or abuse\nC: Avoid prescribing Venlafaxine Hydrochloride entirely\nD: Increase the dosage to prevent withdrawal symptoms\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Healthcare providers should closely monitor patients with a history of drug abuse when prescribing Venlafaxine Hydrochloride, as it has the potential for misuse and dependence.\n- It is advisable to consider alternative treatments or lower doses of Venlafaxine Hydrochloride, especially in patients with a significant history of substance use disorders.\n- Providers should engage in thorough discussions with patients about the risks and benefits of using Venlafaxine Hydrochloride, ensuring they understand the importance of adherence to the prescribed regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for healthcare providers when prescribing Venlafaxine Hydrochloride to patients with a history of drug abuse?\nA: Prescribe the drug without any additional monitoring\nB: Evaluate the patient's history of drug abuse and monitor for signs of misuse or abuse\nC: Avoid prescribing Venlafaxine Hydrochloride entirely\nD: Increase the dosage to prevent withdrawal symptoms\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Healthcare providers should closely monitor patients with a history of drug abuse when prescribing Venlafaxine Hydrochloride, as it has the potential for misuse and dependence.\n- It is advisable to consider alternative treatments or lower doses of Venlafaxine Hydrochloride, especially in patients with a significant history of substance use disorders.\n- Providers should engage in thorough discussions with patients about the risks and benefits of using Venlafaxine Hydrochloride, ensuring they understand the importance of adherence to the prescribed regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"9M9sDn15vYuW","- Monitor for reduced effectiveness of CLEOCIN PHOSPHATE due to the strong CYP3A4 induction by rifampicin, which may lead to decreased plasma concentrations of the drug.
- Consider adjusting the dosage of CLEOCIN PHOSPHATE or using an alternative antibiotic that is not affected by CYP3A4 inducers when co-administered with rifampicin.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.5, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action when CLEOCIN PHOSPHATE is used with strong CYP3A4 inducers like rifampicin?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Monitor for reduced effectiveness of CLEOCIN PHOSPHATE due to the strong CYP3A4 induction by rifampicin, which may lead to decreased plasma concentrations of the drug.\n- Consider adjusting the dosage of CLEOCIN PHOSPHATE or using an alternative antibiotic that is not affected by CYP3A4 inducers when co-administered with rifampicin.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action when CLEOCIN PHOSPHATE is used with strong CYP3A4 inducers like rifampicin?\nA: Monitor for adverse reactions.\nB: Monitor for loss of effectiveness.\nC: Increase the dose of CLEOCIN PHOSPHATE.\nD: Discontinue CLEOCIN PHOSPHATE.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor for reduced effectiveness of CLEOCIN PHOSPHATE due to the strong CYP3A4 induction by rifampicin, which may lead to decreased plasma concentrations of the drug.\n- Consider adjusting the dosage of CLEOCIN PHOSPHATE or using an alternative antibiotic that is not affected by CYP3A4 inducers when co-administered with rifampicin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action when CLEOCIN PHOSPHATE is used with strong CYP3A4 inducers like rifampicin?\nA: Monitor for adverse reactions.\nB: Monitor for loss of effectiveness.\nC: Increase the dose of CLEOCIN PHOSPHATE.\nD: Discontinue CLEOCIN PHOSPHATE.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor for reduced effectiveness of CLEOCIN PHOSPHATE due to the strong CYP3A4 induction by rifampicin, which may lead to decreased plasma concentrations of the drug.\n- Consider adjusting the dosage of CLEOCIN PHOSPHATE or using an alternative antibiotic that is not affected by CYP3A4 inducers when co-administered with rifampicin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action when CLEOCIN PHOSPHATE is used with strong CYP3A4 inducers like rifampicin?\nA: Monitor for adverse reactions.\nB: Monitor for loss of effectiveness.\nC: Increase the dose of CLEOCIN PHOSPHATE.\nD: Discontinue CLEOCIN PHOSPHATE.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Monitor for reduced effectiveness of CLEOCIN PHOSPHATE due to the strong CYP3A4 induction by rifampicin, which may lead to decreased plasma concentrations of the drug.\n- Consider adjusting the dosage of CLEOCIN PHOSPHATE or using an alternative antibiotic that is not affected by CYP3A4 inducers when co-administered with rifampicin.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}]"
"FJqtQDX1VBgn","- Zynteglo, which contains the active ingredient betibeglogene autotemcel, has undergone clinical trials that assessed its genotoxicity, showing no significant evidence of genotoxic effects in patients treated with the drug.
- In preclinical studies, Zynteglo demonstrated a favorable safety profile, with no observed mutagenic potential in standard genotoxicity assays.
- Long-term follow-up data from patients receiving Zynteglo indicate a low incidence of adverse events related to genotoxicity, supporting its safety in the context of gene therapy for beta-thalassemia.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat evidence is available regarding the genotoxicity of Zynteglo?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Zynteglo, which contains the active ingredient betibeglogene autotemcel, has undergone clinical trials that assessed its genotoxicity, showing no significant evidence of genotoxic effects in patients treated with the drug.\n- In preclinical studies, Zynteglo demonstrated a favorable safety profile, with no observed mutagenic potential in standard genotoxicity assays.\n- Long-term follow-up data from patients receiving Zynteglo indicate a low incidence of adverse events related to genotoxicity, supporting its safety in the context of gene therapy for beta-thalassemia.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What evidence is available regarding the genotoxicity of Zynteglo?\nA: Zynteglo caused genotoxicity in a mouse model of \u03b2-thalassemia.\nB: No evidence of genotoxicity was observed in a mouse model of \u03b2-thalassemia.\nC: Genotoxicity studies were not conducted for Zynteglo.\nD: Zynteglo caused genotoxicity in human clinical trials.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Zynteglo, which contains the active ingredient betibeglogene autotemcel, has undergone clinical trials that assessed its genotoxicity, showing no significant evidence of genotoxic effects in patients treated with the drug.\n- In preclinical studies, Zynteglo demonstrated a favorable safety profile, with no observed mutagenic potential in standard genotoxicity assays.\n- Long-term follow-up data from patients receiving Zynteglo indicate a low incidence of adverse events related to genotoxicity, supporting its safety in the context of gene therapy for beta-thalassemia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What evidence is available regarding the genotoxicity of Zynteglo?\nA: Zynteglo caused genotoxicity in a mouse model of \u03b2-thalassemia.\nB: No evidence of genotoxicity was observed in a mouse model of \u03b2-thalassemia.\nC: Genotoxicity studies were not conducted for Zynteglo.\nD: Zynteglo caused genotoxicity in human clinical trials.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Zynteglo, which contains the active ingredient betibeglogene autotemcel, has undergone clinical trials that assessed its genotoxicity, showing no significant evidence of genotoxic effects in patients treated with the drug.\n- In preclinical studies, Zynteglo demonstrated a favorable safety profile, with no observed mutagenic potential in standard genotoxicity assays.\n- Long-term follow-up data from patients receiving Zynteglo indicate a low incidence of adverse events related to genotoxicity, supporting its safety in the context of gene therapy for beta-thalassemia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What evidence is available regarding the genotoxicity of Zynteglo?\nA: Zynteglo caused genotoxicity in a mouse model of \u03b2-thalassemia.\nB: No evidence of genotoxicity was observed in a mouse model of \u03b2-thalassemia.\nC: Genotoxicity studies were not conducted for Zynteglo.\nD: Zynteglo caused genotoxicity in human clinical trials.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Zynteglo, which contains the active ingredient betibeglogene autotemcel, has undergone clinical trials that assessed its genotoxicity, showing no significant evidence of genotoxic effects in patients treated with the drug.\n- In preclinical studies, Zynteglo demonstrated a favorable safety profile, with no observed mutagenic potential in standard genotoxicity assays.\n- Long-term follow-up data from patients receiving Zynteglo indicate a low incidence of adverse events related to genotoxicity, supporting its safety in the context of gene therapy for beta-thalassemia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"c7nF9hWZevaj","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if jaundice develops in a woman taking OCELLA?\nA: Continue OCELLA and monitor liver function\nB: Discontinue OCELLA immediately\nC: Reduce the dosage of OCELLA\nD: Switch to a different contraceptive method\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if jaundice develops in a woman taking OCELLA?\nA: Continue OCELLA and monitor liver function\nB: Discontinue OCELLA immediately\nC: Reduce the dosage of OCELLA\nD: Switch to a different contraceptive method\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action if jaundice develops in a woman taking OCELLA?\nA: Continue OCELLA and monitor liver function\nB: Discontinue OCELLA immediately\nC: Reduce the dosage of OCELLA\nD: Switch to a different contraceptive method\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"2yMjqMjxvWG7","- The updated label claim for the drug brand name 'sterile' indicates that the product is free from viable microorganisms, ensuring safety for use in medical procedures.
- The label specifies that 'sterile' products must undergo rigorous sterilization processes, such as autoclaving or ethylene oxide treatment, to maintain their sterility.
- The claim emphasizes that the 'sterile' designation is critical for products intended for invasive procedures, where contamination could lead to serious infections.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following best describes the updated label claim for the drug brand name 'sterile'?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The updated label claim for the drug brand name 'sterile' indicates that the product is free from viable microorganisms, ensuring safety for use in medical procedures.\n- The label specifies that 'sterile' products must undergo rigorous sterilization processes, such as autoclaving or ethylene oxide treatment, to maintain their sterility.\n- The claim emphasizes that the 'sterile' designation is critical for products intended for invasive procedures, where contamination could lead to serious infections.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following best describes the updated label claim for the drug brand name 'sterile'?\nA: It is used for treating chronic diseases.\nB: It is used for preparation of the skin prior to injection.\nC: It is used for managing allergic reactions.\nD: It is used for wound healing.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The updated label claim for the drug brand name 'sterile' indicates that the product is free from viable microorganisms, ensuring safety for use in medical procedures.\n- The label specifies that 'sterile' products must undergo rigorous sterilization processes, such as autoclaving or ethylene oxide treatment, to maintain their sterility.\n- The claim emphasizes that the 'sterile' designation is critical for products intended for invasive procedures, where contamination could lead to serious infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following best describes the updated label claim for the drug brand name 'sterile'?\nA: It is used for treating chronic diseases.\nB: It is used for preparation of the skin prior to injection.\nC: It is used for managing allergic reactions.\nD: It is used for wound healing.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The updated label claim for the drug brand name 'sterile' indicates that the product is free from viable microorganisms, ensuring safety for use in medical procedures.\n- The label specifies that 'sterile' products must undergo rigorous sterilization processes, such as autoclaving or ethylene oxide treatment, to maintain their sterility.\n- The claim emphasizes that the 'sterile' designation is critical for products intended for invasive procedures, where contamination could lead to serious infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following best describes the updated label claim for the drug brand name 'sterile'?\nA: It is used for treating chronic diseases.\nB: It is used for preparation of the skin prior to injection.\nC: It is used for managing allergic reactions.\nD: It is used for wound healing.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The updated label claim for the drug brand name 'sterile' indicates that the product is free from viable microorganisms, ensuring safety for use in medical procedures.\n- The label specifies that 'sterile' products must undergo rigorous sterilization processes, such as autoclaving or ethylene oxide treatment, to maintain their sterility.\n- The claim emphasizes that the 'sterile' designation is critical for products intended for invasive procedures, where contamination could lead to serious infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"wo3dFnjLphUs","MRRV winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for ONUREG use in patients with severe hepatic impairment (total bilirubin > 3 \u00d7 ULN)?\nA: ONUREG is safe and effective in patients with severe hepatic impairment.\nB: ONUREG has not been studied in patients with severe hepatic impairment, and no recommended dosage has been established.\nC: ONUREG dosage should be increased for patients with severe hepatic impairment.\nD: ONUREG is contraindicated in all patients with hepatic impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for ONUREG use in patients with severe hepatic impairment (total bilirubin > 3 \u00d7 ULN)?\nA: ONUREG is safe and effective in patients with severe hepatic impairment.\nB: ONUREG has not been studied in patients with severe hepatic impairment, and no recommended dosage has been established.\nC: ONUREG dosage should be increased for patients with severe hepatic impairment.\nD: ONUREG is contraindicated in all patients with hepatic impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for ONUREG use in patients with severe hepatic impairment (total bilirubin > 3 \u00d7 ULN)?\nA: ONUREG is safe and effective in patients with severe hepatic impairment.\nB: ONUREG has not been studied in patients with severe hepatic impairment, and no recommended dosage has been established.\nC: ONUREG dosage should be increased for patients with severe hepatic impairment.\nD: ONUREG is contraindicated in all patients with hepatic impairment.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"KXkWBvqJKGmc","- Venlafaxine, at doses of 10 and 30 mg/kg, produced significant drug-appropriate responding in primates, indicating a potential for abuse.
- The study showed that venlafaxine's effects were comparable to those of the active control, amphetamine, suggesting a moderate level of abuse liability.
- In contrast, the placebo condition resulted in minimal drug-appropriate responding, highlighting the specific effects of venlafaxine compared to non-active substances.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nIn primate drug discrimination studies, what was venlafaxine's abuse liability profile?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Venlafaxine, at doses of 10 and 30 mg/kg, produced significant drug-appropriate responding in primates, indicating a potential for abuse.\n- The study showed that venlafaxine's effects were comparable to those of the active control, amphetamine, suggesting a moderate level of abuse liability.\n- In contrast, the placebo condition resulted in minimal drug-appropriate responding, highlighting the specific effects of venlafaxine compared to non-active substances.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In primate drug discrimination studies, what was venlafaxine's abuse liability profile?\nA: Significant stimulant abuse liability\nB: Significant depressant abuse liability\nC: No significant stimulant or depressant abuse liability\nD: High potential for drug-seeking behavior\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine, at doses of 10 and 30 mg/kg, produced significant drug-appropriate responding in primates, indicating a potential for abuse.\n- The study showed that venlafaxine's effects were comparable to those of the active control, amphetamine, suggesting a moderate level of abuse liability.\n- In contrast, the placebo condition resulted in minimal drug-appropriate responding, highlighting the specific effects of venlafaxine compared to non-active substances.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In primate drug discrimination studies, what was venlafaxine's abuse liability profile?\nA: Significant stimulant abuse liability\nB: Significant depressant abuse liability\nC: No significant stimulant or depressant abuse liability\nD: High potential for drug-seeking behavior\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine, at doses of 10 and 30 mg/kg, produced significant drug-appropriate responding in primates, indicating a potential for abuse.\n- The study showed that venlafaxine's effects were comparable to those of the active control, amphetamine, suggesting a moderate level of abuse liability.\n- In contrast, the placebo condition resulted in minimal drug-appropriate responding, highlighting the specific effects of venlafaxine compared to non-active substances.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: In primate drug discrimination studies, what was venlafaxine's abuse liability profile?\nA: Significant stimulant abuse liability\nB: Significant depressant abuse liability\nC: No significant stimulant or depressant abuse liability\nD: High potential for drug-seeking behavior\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Venlafaxine, at doses of 10 and 30 mg/kg, produced significant drug-appropriate responding in primates, indicating a potential for abuse.\n- The study showed that venlafaxine's effects were comparable to those of the active control, amphetamine, suggesting a moderate level of abuse liability.\n- In contrast, the placebo condition resulted in minimal drug-appropriate responding, highlighting the specific effects of venlafaxine compared to non-active substances.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"zxsyDjctLzg8","- Patients should consult their healthcare provider before taking OZOBAX DS if they are pregnant or planning to become pregnant, as the safety of the drug during pregnancy has not been established.
- It is advised to avoid using OZOBAX DS while breastfeeding, as it may pass into breast milk and affect the nursing infant.
- Patients should discuss alternative treatment options with their healthcare provider to ensure safety for both themselves and their child during pregnancy or breastfeeding.

MRRV(meta) winner=B; scores={'A': 0.3333333333333333, 'B': 1.0, 'C': 0.25, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat should patients do if they are pregnant, plan to become pregnant, or plan to breastfeed while taking OZOBAX DS?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients should consult their healthcare provider before taking OZOBAX DS if they are pregnant or planning to become pregnant, as the safety of the drug during pregnancy has not been established.\n- It is advised to avoid using OZOBAX DS while breastfeeding, as it may pass into breast milk and affect the nursing infant.\n- Patients should discuss alternative treatment options with their healthcare provider to ensure safety for both themselves and their child during pregnancy or breastfeeding.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients do if they are pregnant, plan to become pregnant, or plan to breastfeed while taking OZOBAX DS?\nA: Stop taking the medication immediately\nB: Notify their healthcare provider\nC: Increase their dose of OZOBAX DS\nD: Switch to a different medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients should consult their healthcare provider before taking OZOBAX DS if they are pregnant or planning to become pregnant, as the safety of the drug during pregnancy has not been established.\n- It is advised to avoid using OZOBAX DS while breastfeeding, as it may pass into breast milk and affect the nursing infant.\n- Patients should discuss alternative treatment options with their healthcare provider to ensure safety for both themselves and their child during pregnancy or breastfeeding.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients do if they are pregnant, plan to become pregnant, or plan to breastfeed while taking OZOBAX DS?\nA: Stop taking the medication immediately\nB: Notify their healthcare provider\nC: Increase their dose of OZOBAX DS\nD: Switch to a different medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients should consult their healthcare provider before taking OZOBAX DS if they are pregnant or planning to become pregnant, as the safety of the drug during pregnancy has not been established.\n- It is advised to avoid using OZOBAX DS while breastfeeding, as it may pass into breast milk and affect the nursing infant.\n- Patients should discuss alternative treatment options with their healthcare provider to ensure safety for both themselves and their child during pregnancy or breastfeeding.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What should patients do if they are pregnant, plan to become pregnant, or plan to breastfeed while taking OZOBAX DS?\nA: Stop taking the medication immediately\nB: Notify their healthcare provider\nC: Increase their dose of OZOBAX DS\nD: Switch to a different medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients should consult their healthcare provider before taking OZOBAX DS if they are pregnant or planning to become pregnant, as the safety of the drug during pregnancy has not been established.\n- It is advised to avoid using OZOBAX DS while breastfeeding, as it may pass into breast milk and affect the nursing infant.\n- Patients should discuss alternative treatment options with their healthcare provider to ensure safety for both themselves and their child during pregnancy or breastfeeding.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}]"
"0F3Gg5ESWaJ3","1) Recommendation: When administering Albuterol to patients receiving non-potassium-sparing diuretics, it is important to monitor serum potassium levels closely and consider potassium supplementation if levels drop significantly.

2) Key rationale:
   - Albuterol can cause hypokalemia (low potassium levels) as a side effect, which may be exacerbated by the use of non-potassium-sparing diuretics that also promote potassium loss.
   - Monitoring potassium levels helps prevent complications such as muscle weakness, arrhythmias, or other cardiac issues associated with low potassium.
   - Potassium supplementation may be necessary to maintain normal serum potassium levels and ensure patient safety.

3) Safety/contraindications/interactions:
   - Patients with a history of cardiac arrhythmias or those on other medications that affect potassium levels should be monitored more closely.
   - Be cautious in patients with renal impairment, as they may have altered potassium handling.
   - Educate patients about signs of hypokalemia, such as muscle cramps, weakness, or palpitations, and advise them to report these symptoms promptly.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhich precaution should be taken when administering Albuterol to patients receiving non-potassium-sparing diuretics?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: When administering Albuterol to patients receiving non-potassium-sparing diuretics, it is important to monitor serum potassium levels closely and consider potassium supplementation if levels drop significantly.\n\n2) Key rationale:\n   - Albuterol can cause hypokalemia (low potassium levels) as a side effect, which may be exacerbated by the use of non-potassium-sparing diuretics that also promote potassium loss.\n   - Monitoring potassium levels helps prevent complications such as muscle weakness, arrhythmias, or other cardiac issues associated with low potassium.\n   - Potassium supplementation may be necessary to maintain normal serum potassium levels and ensure patient safety.\n\n3) Safety/contraindications/interactions:\n   - Patients with a history of cardiac arrhythmias or those on other medications that affect potassium levels should be monitored more closely.\n   - Be cautious in patients with renal impairment, as they may have altered potassium handling.\n   - Educate patients about signs of hypokalemia, such as muscle cramps, weakness, or palpitations, and advise them to report these symptoms promptly.""}]"
"gPlSlEHQxSSy","- Remove the spray nozzle from the dg health nasal spray bottle and rinse it under warm running water for about 30 seconds.
- Allow the nozzle to air dry completely before reattaching it to the dg health nasal spray bottle.
- Avoid using any cleaning agents or detergents on the nozzle to prevent contamination of the nasal spray.

MRRV(meta) winner=B; scores={'A': 0.38888888888888884, 'B': 1.0, 'C': 0.4444444444444444, 'D': 0.25}; rankings=[['B', 'C', 'A', 'D'], ['B', 'C', 'A', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the proper procedure for cleaning the spray nozzle of dg health nasal spray?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Remove the spray nozzle from the dg health nasal spray bottle and rinse it under warm running water for about 30 seconds.\n- Allow the nozzle to air dry completely before reattaching it to the dg health nasal spray bottle.\n- Avoid using any cleaning agents or detergents on the nozzle to prevent contamination of the nasal spray.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the proper procedure for cleaning the spray nozzle of dg health nasal spray?\nA: Clean the nozzle once a week.\nB: Clean the nozzle after each use.\nC: Follow the Quick Start Guide for cleaning instructions.\nD: Do not clean the nozzle.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Remove the spray nozzle from the dg health nasal spray bottle and rinse it under warm running water for about 30 seconds.\n- Allow the nozzle to air dry completely before reattaching it to the dg health nasal spray bottle.\n- Avoid using any cleaning agents or detergents on the nozzle to prevent contamination of the nasal spray.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the proper procedure for cleaning the spray nozzle of dg health nasal spray?\nA: Clean the nozzle once a week.\nB: Clean the nozzle after each use.\nC: Follow the Quick Start Guide for cleaning instructions.\nD: Do not clean the nozzle.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Remove the spray nozzle from the dg health nasal spray bottle and rinse it under warm running water for about 30 seconds.\n- Allow the nozzle to air dry completely before reattaching it to the dg health nasal spray bottle.\n- Avoid using any cleaning agents or detergents on the nozzle to prevent contamination of the nasal spray.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > A > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the proper procedure for cleaning the spray nozzle of dg health nasal spray?\nA: Clean the nozzle once a week.\nB: Clean the nozzle after each use.\nC: Follow the Quick Start Guide for cleaning instructions.\nD: Do not clean the nozzle.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Remove the spray nozzle from the dg health nasal spray bottle and rinse it under warm running water for about 30 seconds.\n- Allow the nozzle to air dry completely before reattaching it to the dg health nasal spray bottle.\n- Avoid using any cleaning agents or detergents on the nozzle to prevent contamination of the nasal spray.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"JkAt4pGP73KK","- For patients with moderately impaired hepatic function (Child-Pugh B), the recommended approach is to reduce the dose of Signifor LAR to 60 mg administered every 28 days.
- Close monitoring of clinical response and tolerability is advised when adjusting the dose of Signifor LAR in this patient population.
- It is important to avoid the use of the standard dose of 120 mg in patients with Child-Pugh B hepatic impairment due to increased risk of adverse effects.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.3055555555555555}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended approach for dose adjustment of Signifor LAR in patients with moderately impaired hepatic function (Child-Pugh B)?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- For patients with moderately impaired hepatic function (Child-Pugh B), the recommended approach is to reduce the dose of Signifor LAR to 60 mg administered every 28 days.\n- Close monitoring of clinical response and tolerability is advised when adjusting the dose of Signifor LAR in this patient population.\n- It is important to avoid the use of the standard dose of 120 mg in patients with Child-Pugh B hepatic impairment due to increased risk of adverse effects.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for dose adjustment of Signifor LAR in patients with moderately impaired hepatic function (Child-Pugh B)?\nA: No dose adjustment is required.\nB: Dose adjustment is required.\nC: Signifor LAR is contraindicated.\nD: Clinical studies are insufficient to determine dose adjustment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- For patients with moderately impaired hepatic function (Child-Pugh B), the recommended approach is to reduce the dose of Signifor LAR to 60 mg administered every 28 days.\n- Close monitoring of clinical response and tolerability is advised when adjusting the dose of Signifor LAR in this patient population.\n- It is important to avoid the use of the standard dose of 120 mg in patients with Child-Pugh B hepatic impairment due to increased risk of adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for dose adjustment of Signifor LAR in patients with moderately impaired hepatic function (Child-Pugh B)?\nA: No dose adjustment is required.\nB: Dose adjustment is required.\nC: Signifor LAR is contraindicated.\nD: Clinical studies are insufficient to determine dose adjustment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- For patients with moderately impaired hepatic function (Child-Pugh B), the recommended approach is to reduce the dose of Signifor LAR to 60 mg administered every 28 days.\n- Close monitoring of clinical response and tolerability is advised when adjusting the dose of Signifor LAR in this patient population.\n- It is important to avoid the use of the standard dose of 120 mg in patients with Child-Pugh B hepatic impairment due to increased risk of adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended approach for dose adjustment of Signifor LAR in patients with moderately impaired hepatic function (Child-Pugh B)?\nA: No dose adjustment is required.\nB: Dose adjustment is required.\nC: Signifor LAR is contraindicated.\nD: Clinical studies are insufficient to determine dose adjustment.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- For patients with moderately impaired hepatic function (Child-Pugh B), the recommended approach is to reduce the dose of Signifor LAR to 60 mg administered every 28 days.\n- Close monitoring of clinical response and tolerability is advised when adjusting the dose of Signifor LAR in this patient population.\n- It is important to avoid the use of the standard dose of 120 mg in patients with Child-Pugh B hepatic impairment due to increased risk of adverse effects.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"SkbwBOmwUUBs","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage modification for JAYPIRCA in patients with severe renal impairment (eGFR 15-29 mL/min)?\nA: Reduce the dose to 100 mg once daily if the current dose is 200 mg\nB: Increase the dose to 300 mg once daily\nC: Maintain the current dose of 200 mg once daily\nD: Discontinue JAYPIRCA immediately\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage modification for JAYPIRCA in patients with severe renal impairment (eGFR 15-29 mL/min)?\nA: Reduce the dose to 100 mg once daily if the current dose is 200 mg\nB: Increase the dose to 300 mg once daily\nC: Maintain the current dose of 200 mg once daily\nD: Discontinue JAYPIRCA immediately\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage modification for JAYPIRCA in patients with severe renal impairment (eGFR 15-29 mL/min)?\nA: Reduce the dose to 100 mg once daily if the current dose is 200 mg\nB: Increase the dose to 300 mg once daily\nC: Maintain the current dose of 200 mg once daily\nD: Discontinue JAYPIRCA immediately\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"RdyLGUkqj1un","MRRV winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.25, 'D': 0.5}; rankings=[['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C'], ['A', 'D', 'B', 'C']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage of the laxative for women for adults and children aged 12 years and over?\nA: 1 to 3 tablets in a single daily dose taken with a glass of water\nB: 1 tablet every 6 hours\nC: 2 tablets every 4 hours\nD: 1 to 3 tablets twice daily\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage of the laxative for women for adults and children aged 12 years and over?\nA: 1 to 3 tablets in a single daily dose taken with a glass of water\nB: 1 tablet every 6 hours\nC: 2 tablets every 4 hours\nD: 1 to 3 tablets twice daily\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended dosage of the laxative for women for adults and children aged 12 years and over?\nA: 1 to 3 tablets in a single daily dose taken with a glass of water\nB: 1 tablet every 6 hours\nC: 2 tablets every 4 hours\nD: 1 to 3 tablets twice daily\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > B > C""}]"
"TNwPlk0VqqJt","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended precaution for elderly patients taking SEGLUROMET?\nA: Monitor renal function more frequently\nB: Increase the dose of SEGLUROMET\nC: Administer additional insulin\nD: Avoid iodinated contrast imaging procedures\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended precaution for elderly patients taking SEGLUROMET?\nA: Monitor renal function more frequently\nB: Increase the dose of SEGLUROMET\nC: Administer additional insulin\nD: Avoid iodinated contrast imaging procedures\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended precaution for elderly patients taking SEGLUROMET?\nA: Monitor renal function more frequently\nB: Increase the dose of SEGLUROMET\nC: Administer additional insulin\nD: Avoid iodinated contrast imaging procedures\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"8OCkup9Ka801","- The recommended treatment approach for unresectable malignant pleural mesothelioma includes the use of Pemetrexed for Injection in combination with Cisplatin as a first-line therapy.
- Pemetrexed is administered at a dose of 500 mg/m intravenously on day 1 of each 21-day cycle, alongside Cisplatin at a dose of 75 mg/m.
- Maintenance therapy with Pemetrexed may be considered after the initial treatment, typically following four cycles of the combination regimen.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended treatment approach for unresectable malignant pleural mesothelioma using Pemetrexed for Injection?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The recommended treatment approach for unresectable malignant pleural mesothelioma includes the use of Pemetrexed for Injection in combination with Cisplatin as a first-line therapy.\n- Pemetrexed is administered at a dose of 500 mg/m\u00b2 intravenously on day 1 of each 21-day cycle, alongside Cisplatin at a dose of 75 mg/m\u00b2.\n- Maintenance therapy with Pemetrexed may be considered after the initial treatment, typically following four cycles of the combination regimen.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended treatment approach for unresectable malignant pleural mesothelioma using Pemetrexed for Injection?\nA: Pemetrexed as a single agent.\nB: Pemetrexed in combination with cisplatin.\nC: Pemetrexed in combination with pembrolizumab and platinum chemotherapy.\nD: Pemetrexed in combination with EGFR inhibitors.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended treatment approach for unresectable malignant pleural mesothelioma includes the use of Pemetrexed for Injection in combination with Cisplatin as a first-line therapy.\n- Pemetrexed is administered at a dose of 500 mg/m\u00b2 intravenously on day 1 of each 21-day cycle, alongside Cisplatin at a dose of 75 mg/m\u00b2.\n- Maintenance therapy with Pemetrexed may be considered after the initial treatment, typically following four cycles of the combination regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended treatment approach for unresectable malignant pleural mesothelioma using Pemetrexed for Injection?\nA: Pemetrexed as a single agent.\nB: Pemetrexed in combination with cisplatin.\nC: Pemetrexed in combination with pembrolizumab and platinum chemotherapy.\nD: Pemetrexed in combination with EGFR inhibitors.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended treatment approach for unresectable malignant pleural mesothelioma includes the use of Pemetrexed for Injection in combination with Cisplatin as a first-line therapy.\n- Pemetrexed is administered at a dose of 500 mg/m\u00b2 intravenously on day 1 of each 21-day cycle, alongside Cisplatin at a dose of 75 mg/m\u00b2.\n- Maintenance therapy with Pemetrexed may be considered after the initial treatment, typically following four cycles of the combination regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended treatment approach for unresectable malignant pleural mesothelioma using Pemetrexed for Injection?\nA: Pemetrexed as a single agent.\nB: Pemetrexed in combination with cisplatin.\nC: Pemetrexed in combination with pembrolizumab and platinum chemotherapy.\nD: Pemetrexed in combination with EGFR inhibitors.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The recommended treatment approach for unresectable malignant pleural mesothelioma includes the use of Pemetrexed for Injection in combination with Cisplatin as a first-line therapy.\n- Pemetrexed is administered at a dose of 500 mg/m\u00b2 intravenously on day 1 of each 21-day cycle, alongside Cisplatin at a dose of 75 mg/m\u00b2.\n- Maintenance therapy with Pemetrexed may be considered after the initial treatment, typically following four cycles of the combination regimen.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"mvHWBQqO7ZDK","- Sumatriptan should not be used in patients taking monoamine oxidase-A (MAO-A) inhibitors due to the risk of increased serotonin levels, which can lead to serotonin syndrome.
- The combination of Sumatriptan and MAO-A inhibitors can result in prolonged effects of Sumatriptan, increasing the likelihood of adverse reactions.
- Patients on MAO-A inhibitors should avoid Sumatriptan to prevent potential cardiovascular complications associated with excessive vasoconstriction.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.3333333333333333, 'C': 0.5, 'D': 0.25}; rankings=[['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D'], ['A', 'C', 'B', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the contraindication for Sumatriptan in patients concurrently using monoamine oxidase-A (MAO-A) inhibitors?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Sumatriptan should not be used in patients taking monoamine oxidase-A (MAO-A) inhibitors due to the risk of increased serotonin levels, which can lead to serotonin syndrome.\n- The combination of Sumatriptan and MAO-A inhibitors can result in prolonged effects of Sumatriptan, increasing the likelihood of adverse reactions.\n- Patients on MAO-A inhibitors should avoid Sumatriptan to prevent potential cardiovascular complications associated with excessive vasoconstriction.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the contraindication for Sumatriptan in patients concurrently using monoamine oxidase-A (MAO-A) inhibitors?\nA: Increased risk of serotonin syndrome\nB: Reduced efficacy of Sumatriptan\nC: Increased risk of ischemic heart disease\nD: Development of peripheral vascular disease\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Sumatriptan should not be used in patients taking monoamine oxidase-A (MAO-A) inhibitors due to the risk of increased serotonin levels, which can lead to serotonin syndrome.\n- The combination of Sumatriptan and MAO-A inhibitors can result in prolonged effects of Sumatriptan, increasing the likelihood of adverse reactions.\n- Patients on MAO-A inhibitors should avoid Sumatriptan to prevent potential cardiovascular complications associated with excessive vasoconstriction.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the contraindication for Sumatriptan in patients concurrently using monoamine oxidase-A (MAO-A) inhibitors?\nA: Increased risk of serotonin syndrome\nB: Reduced efficacy of Sumatriptan\nC: Increased risk of ischemic heart disease\nD: Development of peripheral vascular disease\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Sumatriptan should not be used in patients taking monoamine oxidase-A (MAO-A) inhibitors due to the risk of increased serotonin levels, which can lead to serotonin syndrome.\n- The combination of Sumatriptan and MAO-A inhibitors can result in prolonged effects of Sumatriptan, increasing the likelihood of adverse reactions.\n- Patients on MAO-A inhibitors should avoid Sumatriptan to prevent potential cardiovascular complications associated with excessive vasoconstriction.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the contraindication for Sumatriptan in patients concurrently using monoamine oxidase-A (MAO-A) inhibitors?\nA: Increased risk of serotonin syndrome\nB: Reduced efficacy of Sumatriptan\nC: Increased risk of ischemic heart disease\nD: Development of peripheral vascular disease\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Sumatriptan should not be used in patients taking monoamine oxidase-A (MAO-A) inhibitors due to the risk of increased serotonin levels, which can lead to serotonin syndrome.\n- The combination of Sumatriptan and MAO-A inhibitors can result in prolonged effects of Sumatriptan, increasing the likelihood of adverse reactions.\n- Patients on MAO-A inhibitors should avoid Sumatriptan to prevent potential cardiovascular complications associated with excessive vasoconstriction.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > B > D""}]"
"hlJeT6FboayC","- Beard growth oil is specifically intended to be applied to the facial hair area, particularly on the beard and mustache.
- It is designed to nourish and promote the growth of facial hair, enhancing thickness and overall appearance.
- The oil is typically massaged into the skin beneath the beard to support healthy hair follicles.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich area is Beard growth oil specifically intended to be applied to?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Beard growth oil is specifically intended to be applied to the facial hair area, particularly on the beard and mustache.\n- It is designed to nourish and promote the growth of facial hair, enhancing thickness and overall appearance.\n- The oil is typically massaged into the skin beneath the beard to support healthy hair follicles.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which area is Beard growth oil specifically intended to be applied to?\nA: Scalp\nB: Beard loss area or facial hair\nC: Hands\nD: Feet\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Beard growth oil is specifically intended to be applied to the facial hair area, particularly on the beard and mustache.\n- It is designed to nourish and promote the growth of facial hair, enhancing thickness and overall appearance.\n- The oil is typically massaged into the skin beneath the beard to support healthy hair follicles.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which area is Beard growth oil specifically intended to be applied to?\nA: Scalp\nB: Beard loss area or facial hair\nC: Hands\nD: Feet\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Beard growth oil is specifically intended to be applied to the facial hair area, particularly on the beard and mustache.\n- It is designed to nourish and promote the growth of facial hair, enhancing thickness and overall appearance.\n- The oil is typically massaged into the skin beneath the beard to support healthy hair follicles.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which area is Beard growth oil specifically intended to be applied to?\nA: Scalp\nB: Beard loss area or facial hair\nC: Hands\nD: Feet\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Beard growth oil is specifically intended to be applied to the facial hair area, particularly on the beard and mustache.\n- It is designed to nourish and promote the growth of facial hair, enhancing thickness and overall appearance.\n- The oil is typically massaged into the skin beneath the beard to support healthy hair follicles.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"wedPQbaIqDvb","- The drug Metformin is specifically associated with the indication of type 2 diabetes management.
- The medication Lisinopril is specifically indicated for the treatment of hypertension and heart failure.
- The drug Atorvastatin is specifically indicated for lowering cholesterol levels and reducing the risk of cardiovascular disease.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich of the following drugs is specifically associated with the indication 'INDICATION'?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The drug Metformin is specifically associated with the indication of type 2 diabetes management.\n- The medication Lisinopril is specifically indicated for the treatment of hypertension and heart failure.\n- The drug Atorvastatin is specifically indicated for lowering cholesterol levels and reducing the risk of cardiovascular disease.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following drugs is specifically associated with the indication 'INDICATION'?\nA: Arnica gel\nB: Aspirin\nC: Hydrocortisone cream\nD: Lidocaine gel\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug Metformin is specifically associated with the indication of type 2 diabetes management.\n- The medication Lisinopril is specifically indicated for the treatment of hypertension and heart failure.\n- The drug Atorvastatin is specifically indicated for lowering cholesterol levels and reducing the risk of cardiovascular disease.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > None > None > None""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following drugs is specifically associated with the indication 'INDICATION'?\nA: Arnica gel\nB: Aspirin\nC: Hydrocortisone cream\nD: Lidocaine gel\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug Metformin is specifically associated with the indication of type 2 diabetes management.\n- The medication Lisinopril is specifically indicated for the treatment of hypertension and heart failure.\n- The drug Atorvastatin is specifically indicated for lowering cholesterol levels and reducing the risk of cardiovascular disease.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > None > None > None""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which of the following drugs is specifically associated with the indication 'INDICATION'?\nA: Arnica gel\nB: Aspirin\nC: Hydrocortisone cream\nD: Lidocaine gel\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug Metformin is specifically associated with the indication of type 2 diabetes management.\n- The medication Lisinopril is specifically indicated for the treatment of hypertension and heart failure.\n- The drug Atorvastatin is specifically indicated for lowering cholesterol levels and reducing the risk of cardiovascular disease.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > None > None > None""}]"
"Wj4C9lpFvvoj","MRRV winner=B; scores={'A': 0.5, 'B': 0.8333333333333334, 'C': 0.4166666666666667, 'D': 0.3333333333333333}; rankings=[['B', 'C', 'D', 'A'], ['A', 'B', 'D', 'C'], ['B', 'C', 'D', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the relationship between Hydroxym and mutagenicity studies conducted with prednisolone and hydrocortisone?\nA: Hydroxym showed positive mutagenicity results similar to prednisolone and hydrocortisone.\nB: Hydroxym showed negative mutagenicity results similar to prednisolone and hydrocortisone.\nC: Hydroxym has not been tested for mutagenicity, but prednisolone and hydrocortisone showed negative results.\nD: Hydroxym has been tested for mutagenicity, but results are inconclusive.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the relationship between Hydroxym and mutagenicity studies conducted with prednisolone and hydrocortisone?\nA: Hydroxym showed positive mutagenicity results similar to prednisolone and hydrocortisone.\nB: Hydroxym showed negative mutagenicity results similar to prednisolone and hydrocortisone.\nC: Hydroxym has not been tested for mutagenicity, but prednisolone and hydrocortisone showed negative results.\nD: Hydroxym has been tested for mutagenicity, but results are inconclusive.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the relationship between Hydroxym and mutagenicity studies conducted with prednisolone and hydrocortisone?\nA: Hydroxym showed positive mutagenicity results similar to prednisolone and hydrocortisone.\nB: Hydroxym showed negative mutagenicity results similar to prednisolone and hydrocortisone.\nC: Hydroxym has not been tested for mutagenicity, but prednisolone and hydrocortisone showed negative results.\nD: Hydroxym has been tested for mutagenicity, but results are inconclusive.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}]"
"tRGRptFi4PYF","MRRV winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for healthcare providers to mitigate risks associated with RoxyBond use?\nA: Complete a REMS-compliant education program\nB: Prescribe RoxyBond without patient counseling\nC: Avoid prescribing RoxyBond under any circumstances\nD: Discontinue all other medications before prescribing RoxyBond\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for healthcare providers to mitigate risks associated with RoxyBond use?\nA: Complete a REMS-compliant education program\nB: Prescribe RoxyBond without patient counseling\nC: Avoid prescribing RoxyBond under any circumstances\nD: Discontinue all other medications before prescribing RoxyBond\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended action for healthcare providers to mitigate risks associated with RoxyBond use?\nA: Complete a REMS-compliant education program\nB: Prescribe RoxyBond without patient counseling\nC: Avoid prescribing RoxyBond under any circumstances\nD: Discontinue all other medications before prescribing RoxyBond\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"3CIj6jKnojwt","MRRV winner=D; scores={'A': 0.5, 'B': 0.3333333333333333, 'C': 0.25, 'D': 1.0}; rankings=[['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C'], ['D', 'A', 'B', 'C']]","D","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT a contraindication for Lantus Solostar?\nA: Episodes of hypoglycemia\nB: Hypersensitivity to insulin glargine\nC: Hypersensitivity to excipients in Lantus Solostar\nD: Episodes of hyperglycemia\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT a contraindication for Lantus Solostar?\nA: Episodes of hypoglycemia\nB: Hypersensitivity to insulin glargine\nC: Hypersensitivity to excipients in Lantus Solostar\nD: Episodes of hyperglycemia\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhich of the following is NOT a contraindication for Lantus Solostar?\nA: Episodes of hypoglycemia\nB: Hypersensitivity to insulin glargine\nC: Hypersensitivity to excipients in Lantus Solostar\nD: Episodes of hyperglycemia\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > A > B > C""}]"
"qmBdSdTv1DpI","- Patients treated with lamotrigine experienced a median percent reduction in primary generalized tonic-clonic seizures (PGTC) of approximately 50%.
- The clinical trial specifically evaluated the efficacy of lamotrigine compared to a placebo group, highlighting the significant impact of the active treatment.
- The results indicated that lamotrigine was effective in reducing seizure frequency in patients with PGTC, demonstrating its therapeutic benefit.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat was the median percent reduction in primary generalized tonic-clonic seizures (PGTC) observed in patients treated with lamotrigine during a clinical trial?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Patients treated with lamotrigine experienced a median percent reduction in primary generalized tonic-clonic seizures (PGTC) of approximately 50%.\n- The clinical trial specifically evaluated the efficacy of lamotrigine compared to a placebo group, highlighting the significant impact of the active treatment.\n- The results indicated that lamotrigine was effective in reducing seizure frequency in patients with PGTC, demonstrating its therapeutic benefit.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the median percent reduction in primary generalized tonic-clonic seizures (PGTC) observed in patients treated with lamotrigine during a clinical trial?\nA: 34%\nB: 50%\nC: 66%\nD: 75%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients treated with lamotrigine experienced a median percent reduction in primary generalized tonic-clonic seizures (PGTC) of approximately 50%.\n- The clinical trial specifically evaluated the efficacy of lamotrigine compared to a placebo group, highlighting the significant impact of the active treatment.\n- The results indicated that lamotrigine was effective in reducing seizure frequency in patients with PGTC, demonstrating its therapeutic benefit.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the median percent reduction in primary generalized tonic-clonic seizures (PGTC) observed in patients treated with lamotrigine during a clinical trial?\nA: 34%\nB: 50%\nC: 66%\nD: 75%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients treated with lamotrigine experienced a median percent reduction in primary generalized tonic-clonic seizures (PGTC) of approximately 50%.\n- The clinical trial specifically evaluated the efficacy of lamotrigine compared to a placebo group, highlighting the significant impact of the active treatment.\n- The results indicated that lamotrigine was effective in reducing seizure frequency in patients with PGTC, demonstrating its therapeutic benefit.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the median percent reduction in primary generalized tonic-clonic seizures (PGTC) observed in patients treated with lamotrigine during a clinical trial?\nA: 34%\nB: 50%\nC: 66%\nD: 75%\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Patients treated with lamotrigine experienced a median percent reduction in primary generalized tonic-clonic seizures (PGTC) of approximately 50%.\n- The clinical trial specifically evaluated the efficacy of lamotrigine compared to a placebo group, highlighting the significant impact of the active treatment.\n- The results indicated that lamotrigine was effective in reducing seizure frequency in patients with PGTC, demonstrating its therapeutic benefit.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"sVLDWBNddIbK","- The highest dietary dose of albuterol sulfate tested in Golden hamsters that showed no evidence of tumorigenicity was 1,000 mg/kg/day.
- This dose was administered over a period of 2 years in the study.
- No tumors were observed in the hamsters at this dosage compared to the control group receiving a placebo.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat was the highest dietary dose of albuterol sulfate tested in Golden hamsters that showed no evidence of tumorigenicity?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The highest dietary dose of albuterol sulfate tested in Golden hamsters that showed no evidence of tumorigenicity was 1,000 mg/kg/day.\n- This dose was administered over a period of 2 years in the study.\n- No tumors were observed in the hamsters at this dosage compared to the control group receiving a placebo.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the highest dietary dose of albuterol sulfate tested in Golden hamsters that showed no evidence of tumorigenicity?\nA: 50 mg/kg\nB: 500 mg/kg\nC: 2 mg/kg\nD: 100 mg/kg\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The highest dietary dose of albuterol sulfate tested in Golden hamsters that showed no evidence of tumorigenicity was 1,000 mg/kg/day.\n- This dose was administered over a period of 2 years in the study.\n- No tumors were observed in the hamsters at this dosage compared to the control group receiving a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the highest dietary dose of albuterol sulfate tested in Golden hamsters that showed no evidence of tumorigenicity?\nA: 50 mg/kg\nB: 500 mg/kg\nC: 2 mg/kg\nD: 100 mg/kg\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The highest dietary dose of albuterol sulfate tested in Golden hamsters that showed no evidence of tumorigenicity was 1,000 mg/kg/day.\n- This dose was administered over a period of 2 years in the study.\n- No tumors were observed in the hamsters at this dosage compared to the control group receiving a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the highest dietary dose of albuterol sulfate tested in Golden hamsters that showed no evidence of tumorigenicity?\nA: 50 mg/kg\nB: 500 mg/kg\nC: 2 mg/kg\nD: 100 mg/kg\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The highest dietary dose of albuterol sulfate tested in Golden hamsters that showed no evidence of tumorigenicity was 1,000 mg/kg/day.\n- This dose was administered over a period of 2 years in the study.\n- No tumors were observed in the hamsters at this dosage compared to the control group receiving a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}]"
"ZO2WDNaeQKrf","- Minoxidil should be applied twice daily to the scalp in the hair loss area for optimal results.
- Finasteride is taken as a daily oral medication, but it does not involve topical application frequency.
- Placebo treatments do not require any application regimen, as they do not contain active ingredients for hair regrowth.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.3055555555555555}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nHow often should the hair regrowth treatment be applied to the scalp in the hair loss area?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Minoxidil should be applied twice daily to the scalp in the hair loss area for optimal results.\n- Finasteride is taken as a daily oral medication, but it does not involve topical application frequency.\n- Placebo treatments do not require any application regimen, as they do not contain active ingredients for hair regrowth.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How often should the hair regrowth treatment be applied to the scalp in the hair loss area?\nA: Once a day\nB: Twice a day\nC: Three times a day\nD: Every other day\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Minoxidil should be applied twice daily to the scalp in the hair loss area for optimal results.\n- Finasteride is taken as a daily oral medication, but it does not involve topical application frequency.\n- Placebo treatments do not require any application regimen, as they do not contain active ingredients for hair regrowth.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How often should the hair regrowth treatment be applied to the scalp in the hair loss area?\nA: Once a day\nB: Twice a day\nC: Three times a day\nD: Every other day\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Minoxidil should be applied twice daily to the scalp in the hair loss area for optimal results.\n- Finasteride is taken as a daily oral medication, but it does not involve topical application frequency.\n- Placebo treatments do not require any application regimen, as they do not contain active ingredients for hair regrowth.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: How often should the hair regrowth treatment be applied to the scalp in the hair loss area?\nA: Once a day\nB: Twice a day\nC: Three times a day\nD: Every other day\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Minoxidil should be applied twice daily to the scalp in the hair loss area for optimal results.\n- Finasteride is taken as a daily oral medication, but it does not involve topical application frequency.\n- Placebo treatments do not require any application regimen, as they do not contain active ingredients for hair regrowth.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"5WlV4jwibRVk","- Head & Shoulders is a brand name product indicated for preventing the recurrence of flaking and itching associated with dandruff.
- Selsun Blue is another brand that targets dandruff symptoms, specifically formulated to reduce flaking and itching.
- Neutrogena T/Gel is also indicated for dandruff prevention, utilizing coal tar to help alleviate symptoms.

MRRV(meta) winner=B; scores={'A': 0.25, 'B': 1.0, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['B', 'C', 'D', 'A'], ['B', 'C', 'D', 'A'], ['B', 'C', 'D', 'A']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich brand name product is indicated for preventing the recurrence of flaking and itching associated with dandruff?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Head & Shoulders is a brand name product indicated for preventing the recurrence of flaking and itching associated with dandruff.\n- Selsun Blue is another brand that targets dandruff symptoms, specifically formulated to reduce flaking and itching.\n- Neutrogena T/Gel is also indicated for dandruff prevention, utilizing coal tar to help alleviate symptoms.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which brand name product is indicated for preventing the recurrence of flaking and itching associated with dandruff?\nA: EUZ-Clean\nB: Head & Shoulders\nC: Selsun Blue\nD: Neutrogena T/Gel\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Head & Shoulders is a brand name product indicated for preventing the recurrence of flaking and itching associated with dandruff.\n- Selsun Blue is another brand that targets dandruff symptoms, specifically formulated to reduce flaking and itching.\n- Neutrogena T/Gel is also indicated for dandruff prevention, utilizing coal tar to help alleviate symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which brand name product is indicated for preventing the recurrence of flaking and itching associated with dandruff?\nA: EUZ-Clean\nB: Head & Shoulders\nC: Selsun Blue\nD: Neutrogena T/Gel\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Head & Shoulders is a brand name product indicated for preventing the recurrence of flaking and itching associated with dandruff.\n- Selsun Blue is another brand that targets dandruff symptoms, specifically formulated to reduce flaking and itching.\n- Neutrogena T/Gel is also indicated for dandruff prevention, utilizing coal tar to help alleviate symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which brand name product is indicated for preventing the recurrence of flaking and itching associated with dandruff?\nA: EUZ-Clean\nB: Head & Shoulders\nC: Selsun Blue\nD: Neutrogena T/Gel\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Head & Shoulders is a brand name product indicated for preventing the recurrence of flaking and itching associated with dandruff.\n- Selsun Blue is another brand that targets dandruff symptoms, specifically formulated to reduce flaking and itching.\n- Neutrogena T/Gel is also indicated for dandruff prevention, utilizing coal tar to help alleviate symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > C > D > A""}]"
"qR5aqwQ8c3M8","MRRV winner=B; scores={'A': 0.3055555555555555, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.5}; rankings=[['B', 'D', 'A', 'C'], ['B', 'D', 'A', 'C'], ['B', 'D', 'C', 'A']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy should prothrombin times be monitored in patients receiving Zithromax and oral anticoagulants concomitantly?\nA: Because Zithromax decreases the efficacy of anticoagulants\nB: Because Zithromax may potentiate the effects of oral anticoagulants\nC: Because Zithromax increases the risk of bleeding\nD: Because Zithromax causes unpredictable drug interactions\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy should prothrombin times be monitored in patients receiving Zithromax and oral anticoagulants concomitantly?\nA: Because Zithromax decreases the efficacy of anticoagulants\nB: Because Zithromax may potentiate the effects of oral anticoagulants\nC: Because Zithromax increases the risk of bleeding\nD: Because Zithromax causes unpredictable drug interactions\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > A > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy should prothrombin times be monitored in patients receiving Zithromax and oral anticoagulants concomitantly?\nA: Because Zithromax decreases the efficacy of anticoagulants\nB: Because Zithromax may potentiate the effects of oral anticoagulants\nC: Because Zithromax increases the risk of bleeding\nD: Because Zithromax causes unpredictable drug interactions\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"D5Vbn5lS2kRh","- The maximum oral dose of ondansetron administered to rats in the carcinogenicity studies was 80 mg/kg per day.
- This dose was part of a long-term study to evaluate the potential carcinogenic effects of ondansetron.
- The study aimed to assess the safety profile of ondansetron at high doses compared to control groups receiving a placebo.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat was the maximum oral dose of ondansetron administered to rats in the carcinogenicity studies, expressed in mg/kg per day?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The maximum oral dose of ondansetron administered to rats in the carcinogenicity studies was 80 mg/kg per day.\n- This dose was part of a long-term study to evaluate the potential carcinogenic effects of ondansetron.\n- The study aimed to assess the safety profile of ondansetron at high doses compared to control groups receiving a placebo.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the maximum oral dose of ondansetron administered to rats in the carcinogenicity studies, expressed in mg/kg per day?\nA: 10 mg/kg per day\nB: 15 mg/kg per day\nC: 30 mg/kg per day\nD: 24 mg/kg per day\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum oral dose of ondansetron administered to rats in the carcinogenicity studies was 80 mg/kg per day.\n- This dose was part of a long-term study to evaluate the potential carcinogenic effects of ondansetron.\n- The study aimed to assess the safety profile of ondansetron at high doses compared to control groups receiving a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the maximum oral dose of ondansetron administered to rats in the carcinogenicity studies, expressed in mg/kg per day?\nA: 10 mg/kg per day\nB: 15 mg/kg per day\nC: 30 mg/kg per day\nD: 24 mg/kg per day\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum oral dose of ondansetron administered to rats in the carcinogenicity studies was 80 mg/kg per day.\n- This dose was part of a long-term study to evaluate the potential carcinogenic effects of ondansetron.\n- The study aimed to assess the safety profile of ondansetron at high doses compared to control groups receiving a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the maximum oral dose of ondansetron administered to rats in the carcinogenicity studies, expressed in mg/kg per day?\nA: 10 mg/kg per day\nB: 15 mg/kg per day\nC: 30 mg/kg per day\nD: 24 mg/kg per day\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The maximum oral dose of ondansetron administered to rats in the carcinogenicity studies was 80 mg/kg per day.\n- This dose was part of a long-term study to evaluate the potential carcinogenic effects of ondansetron.\n- The study aimed to assess the safety profile of ondansetron at high doses compared to control groups receiving a placebo.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}]"
"pUGlJu7PQGph","1) Recommendation: Venlafaxine tablets are classified as a non-controlled substance in the United States. However, it is important to use this medication under the guidance of a healthcare provider due to its potential side effects and withdrawal symptoms.

2) Key rationale:
   - Venlafaxine is primarily used as an antidepressant and is categorized as a serotonin-norepinephrine reuptake inhibitor (SNRI).
   - It does not have a high potential for abuse or dependence, which is a key factor in the classification of controlled substances.
   - The medication can cause withdrawal symptoms if discontinued abruptly, but this does not equate to a controlled substance classification.

3) Safety/contraindications/interactions:
   - Monitor for increased blood pressure, especially at higher doses.
   - Be cautious in patients with a history of seizures or bipolar disorder.
   - Potential interactions with other medications, particularly those affecting serotonin levels, which can lead to serotonin syndrome.
   - Not recommended for use in patients with severe renal impairment without dose adjustment.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the controlled substance classification of venlafaxine tablets?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Venlafaxine tablets are classified as a non-controlled substance in the United States. However, it is important to use this medication under the guidance of a healthcare provider due to its potential side effects and withdrawal symptoms.\n\n2) Key rationale:\n   - Venlafaxine is primarily used as an antidepressant and is categorized as a serotonin-norepinephrine reuptake inhibitor (SNRI).\n   - It does not have a high potential for abuse or dependence, which is a key factor in the classification of controlled substances.\n   - The medication can cause withdrawal symptoms if discontinued abruptly, but this does not equate to a controlled substance classification.\n\n3) Safety/contraindications/interactions:\n   - Monitor for increased blood pressure, especially at higher doses.\n   - Be cautious in patients with a history of seizures or bipolar disorder.\n   - Potential interactions with other medications, particularly those affecting serotonin levels, which can lead to serotonin syndrome.\n   - Not recommended for use in patients with severe renal impairment without dose adjustment.""}]"
"T2VQsXsNoXFi","- Administer appropriate antiarrhythmic medications to stabilize the patient's heart rhythm following the life-threatening arrhythmias induced by Sumatriptan injection.
- Consider discontinuing the use of Sumatriptan and evaluate alternative treatments for migraine management to prevent recurrence of arrhythmias.
- Monitor the patient closely for any further cardiovascular complications and provide supportive care as needed.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.3333333333333333, 'D': 0.5}; rankings=[['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B'], ['A', 'D', 'C', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if a patient experiences life-threatening arrhythmias after Sumatriptan injection?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Administer appropriate antiarrhythmic medications to stabilize the patient's heart rhythm following the life-threatening arrhythmias induced by Sumatriptan injection.\n- Consider discontinuing the use of Sumatriptan and evaluate alternative treatments for migraine management to prevent recurrence of arrhythmias.\n- Monitor the patient closely for any further cardiovascular complications and provide supportive care as needed.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient experiences life-threatening arrhythmias after Sumatriptan injection?\nA: Discontinue Sumatriptan injection immediately\nB: Administer a lower dose of Sumatriptan\nC: Monitor the patient without discontinuation\nD: Switch to another triptan medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer appropriate antiarrhythmic medications to stabilize the patient's heart rhythm following the life-threatening arrhythmias induced by Sumatriptan injection.\n- Consider discontinuing the use of Sumatriptan and evaluate alternative treatments for migraine management to prevent recurrence of arrhythmias.\n- Monitor the patient closely for any further cardiovascular complications and provide supportive care as needed.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient experiences life-threatening arrhythmias after Sumatriptan injection?\nA: Discontinue Sumatriptan injection immediately\nB: Administer a lower dose of Sumatriptan\nC: Monitor the patient without discontinuation\nD: Switch to another triptan medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer appropriate antiarrhythmic medications to stabilize the patient's heart rhythm following the life-threatening arrhythmias induced by Sumatriptan injection.\n- Consider discontinuing the use of Sumatriptan and evaluate alternative treatments for migraine management to prevent recurrence of arrhythmias.\n- Monitor the patient closely for any further cardiovascular complications and provide supportive care as needed.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient experiences life-threatening arrhythmias after Sumatriptan injection?\nA: Discontinue Sumatriptan injection immediately\nB: Administer a lower dose of Sumatriptan\nC: Monitor the patient without discontinuation\nD: Switch to another triptan medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Administer appropriate antiarrhythmic medications to stabilize the patient's heart rhythm following the life-threatening arrhythmias induced by Sumatriptan injection.\n- Consider discontinuing the use of Sumatriptan and evaluate alternative treatments for migraine management to prevent recurrence of arrhythmias.\n- Monitor the patient closely for any further cardiovascular complications and provide supportive care as needed.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > D > C > B""}]"
"DhvhP8s8ImJs","- Antifungal drugs, such as fluconazole and itraconazole, are primarily used to treat fungal infections like candidiasis and aspergillosis.
- Conditions like bacterial infections or viral infections, such as those treated with antibiotics (e.g., amoxicillin) or antivirals (e.g., acyclovir), are NOT treated by antifungal medications.
- Antifungal treatments do not address conditions like athlete's foot or ringworm, which are specifically fungal infections, but they do not treat non-fungal conditions like bacterial pneumonia.

MRRV(meta) winner=D; scores={'A': 0.25, 'B': 0.5, 'C': 0.3333333333333333, 'D': 1.0}; rankings=[['D', 'B', 'C', 'A'], ['D', 'B', 'C', 'A'], ['D', 'B', 'C', 'A']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich condition is NOT treated by the drug 'antifungal'?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Antifungal drugs, such as fluconazole and itraconazole, are primarily used to treat fungal infections like candidiasis and aspergillosis.\n- Conditions like bacterial infections or viral infections, such as those treated with antibiotics (e.g., amoxicillin) or antivirals (e.g., acyclovir), are NOT treated by antifungal medications.\n- Antifungal treatments do not address conditions like athlete's foot or ringworm, which are specifically fungal infections, but they do not treat non-fungal conditions like bacterial pneumonia.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which condition is NOT treated by the drug 'antifungal'?\nA: Athlete's foot\nB: Eczema\nC: Psoriasis\nD: Bacterial infections\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Antifungal drugs, such as fluconazole and itraconazole, are primarily used to treat fungal infections like candidiasis and aspergillosis.\n- Conditions like bacterial infections or viral infections, such as those treated with antibiotics (e.g., amoxicillin) or antivirals (e.g., acyclovir), are NOT treated by antifungal medications.\n- Antifungal treatments do not address conditions like athlete's foot or ringworm, which are specifically fungal infections, but they do not treat non-fungal conditions like bacterial pneumonia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > C > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which condition is NOT treated by the drug 'antifungal'?\nA: Athlete's foot\nB: Eczema\nC: Psoriasis\nD: Bacterial infections\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Antifungal drugs, such as fluconazole and itraconazole, are primarily used to treat fungal infections like candidiasis and aspergillosis.\n- Conditions like bacterial infections or viral infections, such as those treated with antibiotics (e.g., amoxicillin) or antivirals (e.g., acyclovir), are NOT treated by antifungal medications.\n- Antifungal treatments do not address conditions like athlete's foot or ringworm, which are specifically fungal infections, but they do not treat non-fungal conditions like bacterial pneumonia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > C > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which condition is NOT treated by the drug 'antifungal'?\nA: Athlete's foot\nB: Eczema\nC: Psoriasis\nD: Bacterial infections\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Antifungal drugs, such as fluconazole and itraconazole, are primarily used to treat fungal infections like candidiasis and aspergillosis.\n- Conditions like bacterial infections or viral infections, such as those treated with antibiotics (e.g., amoxicillin) or antivirals (e.g., acyclovir), are NOT treated by antifungal medications.\n- Antifungal treatments do not address conditions like athlete's foot or ringworm, which are specifically fungal infections, but they do not treat non-fungal conditions like bacterial pneumonia.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""D > B > C > A""}]"
"xf6HN4OBnOfO","- The highest dose of fluoxetine administered to rats in the 2-year carcinogenicity study was 60 mg/kg/day.
- When converted to a human equivalent dose based on body surface area, this dose is significantly higher than the maximum recommended human dose (MRHD) of fluoxetine, which is typically around 60 mg/day for adults.
- On a mg/m basis, the rat dose exceeds the MRHD, indicating a potential for increased risk in long-term exposure studies.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat was the highest dose of fluoxetine administered to rats in the 2-year carcinogenicity study, and how does it compare to the maximum recommended human dose (MRHD) on a mg/m\u00b2 basis?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The highest dose of fluoxetine administered to rats in the 2-year carcinogenicity study was 60 mg/kg/day.\n- When converted to a human equivalent dose based on body surface area, this dose is significantly higher than the maximum recommended human dose (MRHD) of fluoxetine, which is typically around 60 mg/day for adults.\n- On a mg/m\u00b2 basis, the rat dose exceeds the MRHD, indicating a potential for increased risk in long-term exposure studies.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the highest dose of fluoxetine administered to rats in the 2-year carcinogenicity study, and how does it compare to the maximum recommended human dose (MRHD) on a mg/m\u00b2 basis?\nA: 10 mg/kg/day, approximately 1.2 times the MRHD\nB: 12 mg/kg/day, approximately 1.5 times the MRHD\nC: 7.5 mg/kg/day, approximately 0.9 times the MRHD\nD: 10 mg/kg/day, approximately 0.7 times the MRHD\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The highest dose of fluoxetine administered to rats in the 2-year carcinogenicity study was 60 mg/kg/day.\n- When converted to a human equivalent dose based on body surface area, this dose is significantly higher than the maximum recommended human dose (MRHD) of fluoxetine, which is typically around 60 mg/day for adults.\n- On a mg/m\u00b2 basis, the rat dose exceeds the MRHD, indicating a potential for increased risk in long-term exposure studies.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the highest dose of fluoxetine administered to rats in the 2-year carcinogenicity study, and how does it compare to the maximum recommended human dose (MRHD) on a mg/m\u00b2 basis?\nA: 10 mg/kg/day, approximately 1.2 times the MRHD\nB: 12 mg/kg/day, approximately 1.5 times the MRHD\nC: 7.5 mg/kg/day, approximately 0.9 times the MRHD\nD: 10 mg/kg/day, approximately 0.7 times the MRHD\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The highest dose of fluoxetine administered to rats in the 2-year carcinogenicity study was 60 mg/kg/day.\n- When converted to a human equivalent dose based on body surface area, this dose is significantly higher than the maximum recommended human dose (MRHD) of fluoxetine, which is typically around 60 mg/day for adults.\n- On a mg/m\u00b2 basis, the rat dose exceeds the MRHD, indicating a potential for increased risk in long-term exposure studies.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What was the highest dose of fluoxetine administered to rats in the 2-year carcinogenicity study, and how does it compare to the maximum recommended human dose (MRHD) on a mg/m\u00b2 basis?\nA: 10 mg/kg/day, approximately 1.2 times the MRHD\nB: 12 mg/kg/day, approximately 1.5 times the MRHD\nC: 7.5 mg/kg/day, approximately 0.9 times the MRHD\nD: 10 mg/kg/day, approximately 0.7 times the MRHD\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The highest dose of fluoxetine administered to rats in the 2-year carcinogenicity study was 60 mg/kg/day.\n- When converted to a human equivalent dose based on body surface area, this dose is significantly higher than the maximum recommended human dose (MRHD) of fluoxetine, which is typically around 60 mg/day for adults.\n- On a mg/m\u00b2 basis, the rat dose exceeds the MRHD, indicating a potential for increased risk in long-term exposure studies.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}]"
"6dYAIxkEOE2L","1) Recommendation: If a patient experiences mild COVID-19 symptoms and is prescribed Paxlovid, they should start the medication as soon as possible, ideally within the first five days of symptom onset. It is important to complete the full course of treatment as directed by their healthcare provider.

2) Key rationale:
- Paxlovid is an antiviral medication that can reduce the risk of severe illness, hospitalization, and death in patients with mild to moderate COVID-19.
- Early initiation of treatment is crucial for maximizing its effectiveness.
- Completing the full course ensures that the virus is adequately suppressed and helps prevent the development of resistance.

3) Safety/contraindications/interactions:
- Paxlovid is contraindicated in patients with a history of severe allergic reactions to any component of the medication.
- It may interact with various medications, including certain anticoagulants, anticonvulsants, and statins, so patients should inform their healthcare provider of all medications they are taking.
- Patients with severe renal impairment may require dosage adjustments or may not be suitable candidates for Paxlovid.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat should a patient do if they experience mild COVID-19 symptoms and are prescribed Paxlovid?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: If a patient experiences mild COVID-19 symptoms and is prescribed Paxlovid, they should start the medication as soon as possible, ideally within the first five days of symptom onset. It is important to complete the full course of treatment as directed by their healthcare provider.\n\n2) Key rationale:\n- Paxlovid is an antiviral medication that can reduce the risk of severe illness, hospitalization, and death in patients with mild to moderate COVID-19.\n- Early initiation of treatment is crucial for maximizing its effectiveness.\n- Completing the full course ensures that the virus is adequately suppressed and helps prevent the development of resistance.\n\n3) Safety/contraindications/interactions:\n- Paxlovid is contraindicated in patients with a history of severe allergic reactions to any component of the medication.\n- It may interact with various medications, including certain anticoagulants, anticonvulsants, and statins, so patients should inform their healthcare provider of all medications they are taking.\n- Patients with severe renal impairment may require dosage adjustments or may not be suitable candidates for Paxlovid.""}]"
"WVif3W39iwVe","1) Recommendation: If a patient on Tybost (cobicistat) experiences a confirmed increase in serum creatinine of greater than 0.4 mg/dL from baseline, it is recommended to evaluate the patient's renal function and consider discontinuing Tybost if the increase is persistent or if the patient shows signs of renal impairment.

2) Key rationale:
- Tybost is a booster for certain antiretroviral medications and can cause elevations in serum creatinine due to its inhibition of renal tubular secretion of creatinine.
- A significant increase in serum creatinine may indicate potential renal impairment, which could lead to further complications if not addressed.
- Monitoring renal function is crucial in patients receiving Tybost, especially in those with pre-existing renal conditions or other risk factors for renal impairment.

3) Safety/contraindications/interactions:
- Patients with severe renal impairment (CrCl < 70 mL/min) should not use Tybost.
- Caution is advised in patients with a history of renal disease or those taking other nephrotoxic medications.
- Regular monitoring of renal function (serum creatinine and estimated glomerular filtration rate) is recommended during treatment.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the recommended action if a patient on Tybost experiences a confirmed increase in serum creatinine of greater than 0.4 mg/dL from baseline?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: If a patient on Tybost (cobicistat) experiences a confirmed increase in serum creatinine of greater than 0.4 mg/dL from baseline, it is recommended to evaluate the patient's renal function and consider discontinuing Tybost if the increase is persistent or if the patient shows signs of renal impairment.\n\n2) Key rationale:\n- Tybost is a booster for certain antiretroviral medications and can cause elevations in serum creatinine due to its inhibition of renal tubular secretion of creatinine.\n- A significant increase in serum creatinine may indicate potential renal impairment, which could lead to further complications if not addressed.\n- Monitoring renal function is crucial in patients receiving Tybost, especially in those with pre-existing renal conditions or other risk factors for renal impairment.\n\n3) Safety/contraindications/interactions:\n- Patients with severe renal impairment (CrCl < 70 mL/min) should not use Tybost.\n- Caution is advised in patients with a history of renal disease or those taking other nephrotoxic medications.\n- Regular monitoring of renal function (serum creatinine and estimated glomerular filtration rate) is recommended during treatment.""}]"
"HztLxQNQqRIv","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.25, 'D': 0.3333333333333333}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy might plasma cortisol levels be considered inaccurate during Cortrosyn testing in patients taking estrogen-containing drugs?\nA: Estrogen decreases cortisol production.\nB: Estrogen elevates cortisol binding globulin levels.\nC: Estrogen interferes with Cortrosyn metabolism.\nD: Estrogen reduces adrenal gland function.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy might plasma cortisol levels be considered inaccurate during Cortrosyn testing in patients taking estrogen-containing drugs?\nA: Estrogen decreases cortisol production.\nB: Estrogen elevates cortisol binding globulin levels.\nC: Estrogen interferes with Cortrosyn metabolism.\nD: Estrogen reduces adrenal gland function.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhy might plasma cortisol levels be considered inaccurate during Cortrosyn testing in patients taking estrogen-containing drugs?\nA: Estrogen decreases cortisol production.\nB: Estrogen elevates cortisol binding globulin levels.\nC: Estrogen interferes with Cortrosyn metabolism.\nD: Estrogen reduces adrenal gland function.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"k48yidJIIw5E","- The primary concern is the increased risk of sedation and respiratory depression when OZOBAX DS, which contains the active ingredient diphenhydramine, is used alongside other CNS depressants such as benzodiazepines or opioids.
- Patients may experience enhanced drowsiness and impaired cognitive function due to the additive effects of OZOBAX DS and other CNS depressants, leading to potential safety issues.
- Monitoring for signs of excessive sedation and respiratory compromise is crucial when OZOBAX DS is administered with other medications that depress the central nervous system.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.27777777777777773, 'D': 0.3055555555555555}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'D', 'C'], ['B', 'A', 'D', 'C']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the primary concern when OZOBAX DS is used concomitantly with other CNS depressants?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The primary concern is the increased risk of sedation and respiratory depression when OZOBAX DS, which contains the active ingredient diphenhydramine, is used alongside other CNS depressants such as benzodiazepines or opioids.\n- Patients may experience enhanced drowsiness and impaired cognitive function due to the additive effects of OZOBAX DS and other CNS depressants, leading to potential safety issues.\n- Monitoring for signs of excessive sedation and respiratory compromise is crucial when OZOBAX DS is administered with other medications that depress the central nervous system.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary concern when OZOBAX DS is used concomitantly with other CNS depressants?\nA: Increased risk of seizures\nB: Additive CNS depression effects\nC: Enhanced metabolism of OZOBAX DS\nD: No significant interaction\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary concern is the increased risk of sedation and respiratory depression when OZOBAX DS, which contains the active ingredient diphenhydramine, is used alongside other CNS depressants such as benzodiazepines or opioids.\n- Patients may experience enhanced drowsiness and impaired cognitive function due to the additive effects of OZOBAX DS and other CNS depressants, leading to potential safety issues.\n- Monitoring for signs of excessive sedation and respiratory compromise is crucial when OZOBAX DS is administered with other medications that depress the central nervous system.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary concern when OZOBAX DS is used concomitantly with other CNS depressants?\nA: Increased risk of seizures\nB: Additive CNS depression effects\nC: Enhanced metabolism of OZOBAX DS\nD: No significant interaction\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary concern is the increased risk of sedation and respiratory depression when OZOBAX DS, which contains the active ingredient diphenhydramine, is used alongside other CNS depressants such as benzodiazepines or opioids.\n- Patients may experience enhanced drowsiness and impaired cognitive function due to the additive effects of OZOBAX DS and other CNS depressants, leading to potential safety issues.\n- Monitoring for signs of excessive sedation and respiratory compromise is crucial when OZOBAX DS is administered with other medications that depress the central nervous system.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary concern when OZOBAX DS is used concomitantly with other CNS depressants?\nA: Increased risk of seizures\nB: Additive CNS depression effects\nC: Enhanced metabolism of OZOBAX DS\nD: No significant interaction\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The primary concern is the increased risk of sedation and respiratory depression when OZOBAX DS, which contains the active ingredient diphenhydramine, is used alongside other CNS depressants such as benzodiazepines or opioids.\n- Patients may experience enhanced drowsiness and impaired cognitive function due to the additive effects of OZOBAX DS and other CNS depressants, leading to potential safety issues.\n- Monitoring for signs of excessive sedation and respiratory compromise is crucial when OZOBAX DS is administered with other medications that depress the central nervous system.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}]"
"NJDRoxbS76eq","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3055555555555555, 'D': 0.27777777777777773}; rankings=[['B', 'A', 'D', 'C'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended approach for patients with severe hypertension when using Inspra?\nA: Use Inspra alone as monotherapy.\nB: Combine Inspra with other antihypertensive agents.\nC: Avoid using Inspra due to its limited efficacy.\nD: Use Inspra only in black patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > D > C""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended approach for patients with severe hypertension when using Inspra?\nA: Use Inspra alone as monotherapy.\nB: Combine Inspra with other antihypertensive agents.\nC: Avoid using Inspra due to its limited efficacy.\nD: Use Inspra only in black patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommended approach for patients with severe hypertension when using Inspra?\nA: Use Inspra alone as monotherapy.\nB: Combine Inspra with other antihypertensive agents.\nC: Avoid using Inspra due to its limited efficacy.\nD: Use Inspra only in black patients.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"bTRBbV6qxZTA","- The brand name of the drug used for general body cleansing processes is GoLYTELY.
- GoLYTELY is commonly used as a bowel preparation solution prior to colonoscopy procedures.
- It contains polyethylene glycol and electrolytes to help cleanse the gastrointestinal tract.

MRRV(meta) winner=D; scores={'A': 0.5, 'B': 0.38888888888888884, 'C': 0.4444444444444444, 'D': 0.75}; rankings=[['D', 'C', 'B', 'A'], ['A', 'B', 'C', 'D'], ['D', 'C', 'B', 'A']]","D","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the brand name of the drug used for general body cleansing processes?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The brand name of the drug used for general body cleansing processes is GoLYTELY.\n- GoLYTELY is commonly used as a bowel preparation solution prior to colonoscopy procedures.\n- It contains polyethylene glycol and electrolytes to help cleanse the gastrointestinal tract.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the brand name of the drug used for general body cleansing processes?\nA: TOXEX\nB: CLEANEX\nC: DETOXIN\nD: PUREBODY\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The brand name of the drug used for general body cleansing processes is GoLYTELY.\n- GoLYTELY is commonly used as a bowel preparation solution prior to colonoscopy procedures.\n- It contains polyethylene glycol and electrolytes to help cleanse the gastrointestinal tract.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > D > C > B > A""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the brand name of the drug used for general body cleansing processes?\nA: TOXEX\nB: CLEANEX\nC: DETOXIN\nD: PUREBODY\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The brand name of the drug used for general body cleansing processes is GoLYTELY.\n- GoLYTELY is commonly used as a bowel preparation solution prior to colonoscopy procedures.\n- It contains polyethylene glycol and electrolytes to help cleanse the gastrointestinal tract.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > A > B > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the brand name of the drug used for general body cleansing processes?\nA: TOXEX\nB: CLEANEX\nC: DETOXIN\nD: PUREBODY\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The brand name of the drug used for general body cleansing processes is GoLYTELY.\n- GoLYTELY is commonly used as a bowel preparation solution prior to colonoscopy procedures.\n- It contains polyethylene glycol and electrolytes to help cleanse the gastrointestinal tract.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""None > D > C > B > A""}]"
"5CcDtCWimuFH","1) Recommendation: The patient should start Tri Femynor at least 7 days after the last injection or removal of the implant to ensure adequate contraceptive coverage. If switching from a progestin-only method, it is advisable to begin Tri Femynor on the same day the progestin-only method is discontinued, using backup contraception for the first 7 days.

2) Key rationale:
- Tri Femynor is a combination oral contraceptive that contains both estrogen and progestin, which may not provide immediate contraceptive protection if started too soon after a progestin-only method.
- Allowing a gap of at least 7 days helps to ensure that the hormonal levels stabilize and that the patient is adequately protected against unintended pregnancy.
- Starting on the same day as the removal of the progestin-only method can help maintain continuous contraceptive coverage, minimizing the risk of ovulation.

3) Safety/contraindications/interactions:
- Patients should be assessed for contraindications to estrogen-containing contraceptives, such as a history of thromboembolic disorders, certain cancers, or uncontrolled hypertension.
- It is important to consider potential interactions with other medications the patient may be taking, as some drugs can affect the efficacy of Tri Femynor.
- Patients should be advised to monitor for any side effects or unusual symptoms after starting the new contraceptive method.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nHow should a patient start Tri Femynor if switching from a progestin-only method such as an implant or injection?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: The patient should start Tri Femynor at least 7 days after the last injection or removal of the implant to ensure adequate contraceptive coverage. If switching from a progestin-only method, it is advisable to begin Tri Femynor on the same day the progestin-only method is discontinued, using backup contraception for the first 7 days.\n\n2) Key rationale:\n- Tri Femynor is a combination oral contraceptive that contains both estrogen and progestin, which may not provide immediate contraceptive protection if started too soon after a progestin-only method.\n- Allowing a gap of at least 7 days helps to ensure that the hormonal levels stabilize and that the patient is adequately protected against unintended pregnancy.\n- Starting on the same day as the removal of the progestin-only method can help maintain continuous contraceptive coverage, minimizing the risk of ovulation.\n\n3) Safety/contraindications/interactions:\n- Patients should be assessed for contraindications to estrogen-containing contraceptives, such as a history of thromboembolic disorders, certain cancers, or uncontrolled hypertension.\n- It is important to consider potential interactions with other medications the patient may be taking, as some drugs can affect the efficacy of Tri Femynor.\n- Patients should be advised to monitor for any side effects or unusual symptoms after starting the new contraceptive method.""}]"
"h21jblZa7lPd","- The drug branded as 70% is primarily used as a topical antiseptic for skin disinfection, particularly in surgical settings.
- It contains 70% isopropyl alcohol, which is effective in killing bacteria and preventing infection.
- This formulation is commonly used in hospitals and clinics for preoperative skin preparation and cleaning of medical instruments.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the primary use of the drug branded as 70%?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- The drug branded as 70% is primarily used as a topical antiseptic for skin disinfection, particularly in surgical settings.\n- It contains 70% isopropyl alcohol, which is effective in killing bacteria and preventing infection.\n- This formulation is commonly used in hospitals and clinics for preoperative skin preparation and cleaning of medical instruments.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary use of the drug branded as 70%?\nA: To treat skin infections\nB: To prevent sunburn\nC: To reduce acne\nD: To moisturize dry skin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug branded as 70% is primarily used as a topical antiseptic for skin disinfection, particularly in surgical settings.\n- It contains 70% isopropyl alcohol, which is effective in killing bacteria and preventing infection.\n- This formulation is commonly used in hospitals and clinics for preoperative skin preparation and cleaning of medical instruments.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary use of the drug branded as 70%?\nA: To treat skin infections\nB: To prevent sunburn\nC: To reduce acne\nD: To moisturize dry skin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug branded as 70% is primarily used as a topical antiseptic for skin disinfection, particularly in surgical settings.\n- It contains 70% isopropyl alcohol, which is effective in killing bacteria and preventing infection.\n- This formulation is commonly used in hospitals and clinics for preoperative skin preparation and cleaning of medical instruments.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary use of the drug branded as 70%?\nA: To treat skin infections\nB: To prevent sunburn\nC: To reduce acne\nD: To moisturize dry skin\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- The drug branded as 70% is primarily used as a topical antiseptic for skin disinfection, particularly in surgical settings.\n- It contains 70% isopropyl alcohol, which is effective in killing bacteria and preventing infection.\n- This formulation is commonly used in hospitals and clinics for preoperative skin preparation and cleaning of medical instruments.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"SClIJ7M452HI","1) Recommendation: Esomeprazole magnesium should be taken in the morning, ideally at least one hour before a meal, to maximize its effectiveness in reducing stomach acid production.

2) Key rationale:
- Esomeprazole is a proton pump inhibitor (PPI) that works best when taken before food, as it inhibits acid secretion more effectively during the active phase of digestion.
- Taking it in the morning aligns with the body's natural circadian rhythm of acid production, which tends to be higher during the day.
- Consistent timing helps maintain stable drug levels in the bloodstream, enhancing therapeutic outcomes.

3) Safety/contraindications/interactions:
- Esomeprazole should be used with caution in patients with liver disease, as dosage adjustments may be necessary.
- It may interact with certain medications, such as clopidogrel, increasing the risk of cardiovascular events.
- Long-term use of PPIs can lead to potential side effects, including vitamin B12 deficiency and increased risk of gastrointestinal infections.","NOTAVALUE","[{""role"": ""user"", ""content"": ""The following is a open_ended question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n1) Recommendation (1\u20133 sentences)\n2) Key rationale (3\u20135 bullet points)\n3) Safety/contraindications/interactions (bullet points, if relevant)\nIf unsure, state assumptions and missing information.\n\nQUESTION:\nWhat is the recommended time of day to take esomeprazole magnesium during the 14-day treatment course?\n\nANSWER:""}, {""role"": ""assistant"", ""content"": ""1) Recommendation: Esomeprazole magnesium should be taken in the morning, ideally at least one hour before a meal, to maximize its effectiveness in reducing stomach acid production.\n\n2) Key rationale:\n- Esomeprazole is a proton pump inhibitor (PPI) that works best when taken before food, as it inhibits acid secretion more effectively during the active phase of digestion.\n- Taking it in the morning aligns with the body's natural circadian rhythm of acid production, which tends to be higher during the day.\n- Consistent timing helps maintain stable drug levels in the bloodstream, enhancing therapeutic outcomes.\n\n3) Safety/contraindications/interactions:\n- Esomeprazole should be used with caution in patients with liver disease, as dosage adjustments may be necessary.\n- It may interact with certain medications, such as clopidogrel, increasing the risk of cardiovascular events.\n- Long-term use of PPIs can lead to potential side effects, including vitamin B12 deficiency and increased risk of gastrointestinal infections.""}]"
"l8daUdwsIZlM","- NUZYRA (sarecycline) may reduce the absorption of iron-containing preparations, leading to decreased effectiveness of the iron supplements.
- Patients should be advised to separate the administration of NUZYRA and iron supplements by at least 2 to 3 hours to minimize interaction.
- Monitoring for signs of iron deficiency or anemia may be necessary for patients on NUZYRA who are also taking iron-containing preparations.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the primary concern for patients taking NUZYRA alongside iron-containing preparations?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- NUZYRA (sarecycline) may reduce the absorption of iron-containing preparations, leading to decreased effectiveness of the iron supplements.\n- Patients should be advised to separate the administration of NUZYRA and iron supplements by at least 2 to 3 hours to minimize interaction.\n- Monitoring for signs of iron deficiency or anemia may be necessary for patients on NUZYRA who are also taking iron-containing preparations.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary concern for patients taking NUZYRA alongside iron-containing preparations?\nA: Iron enhances the drug's effectiveness.\nB: Iron impairs the absorption of NUZYRA.\nC: Iron causes adverse reactions with NUZYRA.\nD: Iron increases plasma prothrombin activity.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- NUZYRA (sarecycline) may reduce the absorption of iron-containing preparations, leading to decreased effectiveness of the iron supplements.\n- Patients should be advised to separate the administration of NUZYRA and iron supplements by at least 2 to 3 hours to minimize interaction.\n- Monitoring for signs of iron deficiency or anemia may be necessary for patients on NUZYRA who are also taking iron-containing preparations.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary concern for patients taking NUZYRA alongside iron-containing preparations?\nA: Iron enhances the drug's effectiveness.\nB: Iron impairs the absorption of NUZYRA.\nC: Iron causes adverse reactions with NUZYRA.\nD: Iron increases plasma prothrombin activity.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- NUZYRA (sarecycline) may reduce the absorption of iron-containing preparations, leading to decreased effectiveness of the iron supplements.\n- Patients should be advised to separate the administration of NUZYRA and iron supplements by at least 2 to 3 hours to minimize interaction.\n- Monitoring for signs of iron deficiency or anemia may be necessary for patients on NUZYRA who are also taking iron-containing preparations.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the primary concern for patients taking NUZYRA alongside iron-containing preparations?\nA: Iron enhances the drug's effectiveness.\nB: Iron impairs the absorption of NUZYRA.\nC: Iron causes adverse reactions with NUZYRA.\nD: Iron increases plasma prothrombin activity.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- NUZYRA (sarecycline) may reduce the absorption of iron-containing preparations, leading to decreased effectiveness of the iron supplements.\n- Patients should be advised to separate the administration of NUZYRA and iron supplements by at least 2 to 3 hours to minimize interaction.\n- Monitoring for signs of iron deficiency or anemia may be necessary for patients on NUZYRA who are also taking iron-containing preparations.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"TWnnFPZnpa81","MRRV winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients be counseled about regarding the use of Cleocin Phosphate for viral infections?\nA: Cleocin Phosphate is effective against viral infections like the common cold.\nB: Cleocin Phosphate should not be used to treat viral infections.\nC: Cleocin Phosphate can be used for both bacterial and viral infections.\nD: Cleocin Phosphate is only effective for fungal infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients be counseled about regarding the use of Cleocin Phosphate for viral infections?\nA: Cleocin Phosphate is effective against viral infections like the common cold.\nB: Cleocin Phosphate should not be used to treat viral infections.\nC: Cleocin Phosphate can be used for both bacterial and viral infections.\nD: Cleocin Phosphate is only effective for fungal infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat should patients be counseled about regarding the use of Cleocin Phosphate for viral infections?\nA: Cleocin Phosphate is effective against viral infections like the common cold.\nB: Cleocin Phosphate should not be used to treat viral infections.\nC: Cleocin Phosphate can be used for both bacterial and viral infections.\nD: Cleocin Phosphate is only effective for fungal infections.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"3Ol2rkb1Io5n","- HIMARK should be stored at room temperature, away from moisture and heat, to maintain its efficacy.
- It is important to keep HIMARK in its original packaging to protect it from light exposure.
- Ensure that HIMARK is kept out of reach of children to prevent accidental ingestion.

MRRV(meta) winner=B; scores={'A': 0.5, 'B': 1.0, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D'], ['B', 'A', 'C', 'D']]","B","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhich statement best describes the storage requirements for HIMARK?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- HIMARK should be stored at room temperature, away from moisture and heat, to maintain its efficacy.\n- It is important to keep HIMARK in its original packaging to protect it from light exposure.\n- Ensure that HIMARK is kept out of reach of children to prevent accidental ingestion.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which statement best describes the storage requirements for HIMARK?\nA: HIMARK must be stored in a freezer to maintain its efficacy.\nB: HIMARK should be stored at room temperature for optimal stability.\nC: HIMARK requires refrigeration to prevent degradation.\nD: HIMARK should be stored in a humid environment to preserve its properties.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- HIMARK should be stored at room temperature, away from moisture and heat, to maintain its efficacy.\n- It is important to keep HIMARK in its original packaging to protect it from light exposure.\n- Ensure that HIMARK is kept out of reach of children to prevent accidental ingestion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which statement best describes the storage requirements for HIMARK?\nA: HIMARK must be stored in a freezer to maintain its efficacy.\nB: HIMARK should be stored at room temperature for optimal stability.\nC: HIMARK requires refrigeration to prevent degradation.\nD: HIMARK should be stored in a humid environment to preserve its properties.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- HIMARK should be stored at room temperature, away from moisture and heat, to maintain its efficacy.\n- It is important to keep HIMARK in its original packaging to protect it from light exposure.\n- Ensure that HIMARK is kept out of reach of children to prevent accidental ingestion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: Which statement best describes the storage requirements for HIMARK?\nA: HIMARK must be stored in a freezer to maintain its efficacy.\nB: HIMARK should be stored at room temperature for optimal stability.\nC: HIMARK requires refrigeration to prevent degradation.\nD: HIMARK should be stored in a humid environment to preserve its properties.\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- HIMARK should be stored at room temperature, away from moisture and heat, to maintain its efficacy.\n- It is important to keep HIMARK in its original packaging to protect it from light exposure.\n- Ensure that HIMARK is kept out of reach of children to prevent accidental ingestion.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > A > C > D""}]"
"CjR6OOOYScyH","- Discontinue the use of Sumatriptan to prevent further medication overuse headaches.
- Implement a preventive treatment regimen, such as a daily oral medication like Topiramate or Propranolol, to manage migraine frequency.
- Consider a gradual tapering of Sumatriptan if the patient has been using it frequently, to minimize withdrawal symptoms.

MRRV(meta) winner=A; scores={'A': 1.0, 'B': 0.25, 'C': 0.5, 'D': 0.3333333333333333}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B']]","A","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat is the recommended action if a patient develops medication overuse headache while using Sumatriptan?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Discontinue the use of Sumatriptan to prevent further medication overuse headaches.\n- Implement a preventive treatment regimen, such as a daily oral medication like Topiramate or Propranolol, to manage migraine frequency.\n- Consider a gradual tapering of Sumatriptan if the patient has been using it frequently, to minimize withdrawal symptoms.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops medication overuse headache while using Sumatriptan?\nA: Discontinue Sumatriptan and detoxify the patient\nB: Increase the dose of Sumatriptan\nC: Switch to another triptan medication\nD: Administer additional pain relief medications\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue the use of Sumatriptan to prevent further medication overuse headaches.\n- Implement a preventive treatment regimen, such as a daily oral medication like Topiramate or Propranolol, to manage migraine frequency.\n- Consider a gradual tapering of Sumatriptan if the patient has been using it frequently, to minimize withdrawal symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops medication overuse headache while using Sumatriptan?\nA: Discontinue Sumatriptan and detoxify the patient\nB: Increase the dose of Sumatriptan\nC: Switch to another triptan medication\nD: Administer additional pain relief medications\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue the use of Sumatriptan to prevent further medication overuse headaches.\n- Implement a preventive treatment regimen, such as a daily oral medication like Topiramate or Propranolol, to manage migraine frequency.\n- Consider a gradual tapering of Sumatriptan if the patient has been using it frequently, to minimize withdrawal symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What is the recommended action if a patient develops medication overuse headache while using Sumatriptan?\nA: Discontinue Sumatriptan and detoxify the patient\nB: Increase the dose of Sumatriptan\nC: Switch to another triptan medication\nD: Administer additional pain relief medications\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Discontinue the use of Sumatriptan to prevent further medication overuse headaches.\n- Implement a preventive treatment regimen, such as a daily oral medication like Topiramate or Propranolol, to manage migraine frequency.\n- Consider a gradual tapering of Sumatriptan if the patient has been using it frequently, to minimize withdrawal symptoms.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}]"
"BBsayWqM2HFH","- Consider reducing the dose of Inspra (eplerenone) for patients on moderate CYP3A inhibitors to mitigate the risk of increased drug exposure.
- Monitor patients closely for signs of hyperkalemia and other potential side effects due to the interaction between Inspra and the CYP3A inhibitors.
- Educate patients about the importance of adhering to the adjusted regimen and reporting any unusual symptoms while on both the moderate CYP3A inhibitor and Inspra.

MRRV(meta) winner=C; scores={'A': 0.5, 'B': 0.25, 'C': 1.0, 'D': 0.3333333333333333}; rankings=[['C', 'A', 'D', 'B'], ['C', 'A', 'D', 'B'], ['C', 'A', 'D', 'B']]","C","[{""role"": ""user"", ""content"": ""The following is a open_ended_multi_choice question.\nYou are a medical expert.\n\nOUTPUT FORMAT:\n- Answer in 1-3 bullet points.\nEach bullet MUST include concrete identifiers from the options (drug names, regimen, placebo vs active).\n- Do NOT mention option letters (A\u2013E) in this step.\n\nQUESTION:\nWhat action should be taken for patients on moderate CYP3A inhibitors who cannot avoid taking them with Inspra?\n\nANSWER (bullets):""}, {""role"": ""assistant"", ""content"": ""- Consider reducing the dose of Inspra (eplerenone) for patients on moderate CYP3A inhibitors to mitigate the risk of increased drug exposure.\n- Monitor patients closely for signs of hyperkalemia and other potential side effects due to the interaction between Inspra and the CYP3A inhibitors.\n- Educate patients about the importance of adhering to the adjusted regimen and reporting any unusual symptoms while on both the moderate CYP3A inhibitor and Inspra.""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What action should be taken for patients on moderate CYP3A inhibitors who cannot avoid taking them with Inspra?\nA: Discontinue Inspra therapy\nB: Increase the dose of Inspra\nC: Reduce the dose of Inspra\nD: Switch to a different medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider reducing the dose of Inspra (eplerenone) for patients on moderate CYP3A inhibitors to mitigate the risk of increased drug exposure.\n- Monitor patients closely for signs of hyperkalemia and other potential side effects due to the interaction between Inspra and the CYP3A inhibitors.\n- Educate patients about the importance of adhering to the adjusted regimen and reporting any unusual symptoms while on both the moderate CYP3A inhibitor and Inspra.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What action should be taken for patients on moderate CYP3A inhibitors who cannot avoid taking them with Inspra?\nA: Discontinue Inspra therapy\nB: Increase the dose of Inspra\nC: Reduce the dose of Inspra\nD: Switch to a different medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider reducing the dose of Inspra (eplerenone) for patients on moderate CYP3A inhibitors to mitigate the risk of increased drug exposure.\n- Monitor patients closely for signs of hyperkalemia and other potential side effects due to the interaction between Inspra and the CYP3A inhibitors.\n- Educate patients about the importance of adhering to the adjusted regimen and reporting any unusual symptoms while on both the moderate CYP3A inhibitor and Inspra.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}, {""role"": ""user"", ""content"": ""The following is a multiple choice question about medicine and the agent's open-ended answer to the question. Convert the agent's answer to the final answer format using the corresponding option label, e.g., 'A', 'B', 'C', 'D', 'E' or 'None'. \n\nQuestion: What action should be taken for patients on moderate CYP3A inhibitors who cannot avoid taking them with Inspra?\nA: Discontinue Inspra therapy\nB: Increase the dose of Inspra\nC: Reduce the dose of Inspra\nD: Switch to a different medication\n\n\nYou are a helpful assistant who reviews an open-end answer.\n\nTask: Rank the options from best match to worst match.\nSTRICT OUTPUT:\nReturn EXACTLY one line.\nThe line must contain ONLY the option letters shown in the meta-question, each EXACTLY ONCE.\nUse EXACTLY this separator: ' > '.\nOutput format MUST be exactly: A > B > C > D\nNo explanation. No other text.\n\nAgent's answer:\n- Consider reducing the dose of Inspra (eplerenone) for patients on moderate CYP3A inhibitors to mitigate the risk of increased drug exposure.\n- Monitor patients closely for signs of hyperkalemia and other potential side effects due to the interaction between Inspra and the CYP3A inhibitors.\n- Educate patients about the importance of adhering to the adjusted regimen and reporting any unusual symptoms while on both the moderate CYP3A inhibitor and Inspra.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""C > A > D > B""}]"
"S3cIBPEoXtAq","MRRV winner=A; scores={'A': 0.75, 'B': 0.5, 'C': 0.4444444444444444, 'D': 0.38888888888888884}; rankings=[['A', 'C', 'D', 'B'], ['A', 'C', 'D', 'B'], ['B', 'D', 'C', 'A']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the potential impact of anti-retroviral medications on Zynteglo treatment?\nA: They enhance the efficacy of Zynteglo\nB: They interfere with the manufacturing of apheresed cells\nC: They reduce the need for myeloablative conditioning\nD: They increase the risk of adverse reactions to live vaccines\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the potential impact of anti-retroviral medications on Zynteglo treatment?\nA: They enhance the efficacy of Zynteglo\nB: They interfere with the manufacturing of apheresed cells\nC: They reduce the need for myeloablative conditioning\nD: They increase the risk of adverse reactions to live vaccines\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > C > D > B""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the potential impact of anti-retroviral medications on Zynteglo treatment?\nA: They enhance the efficacy of Zynteglo\nB: They interfere with the manufacturing of apheresed cells\nC: They reduce the need for myeloablative conditioning\nD: They increase the risk of adverse reactions to live vaccines\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""B > D > C > A""}]"
"HQ8jlMkPtWuT","MRRV winner=A; scores={'A': 1.0, 'B': 0.5, 'C': 0.3333333333333333, 'D': 0.25}; rankings=[['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D'], ['A', 'B', 'C', 'D']]","A","[{""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for administering Memantine Hydrochloride to breastfeeding mothers?\nA: It is contraindicated during breastfeeding.\nB: The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for the drug.\nC: Memantine Hydrochloride should be discontinued immediately.\nD: Breastfeeding mothers should double the dosage.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for administering Memantine Hydrochloride to breastfeeding mothers?\nA: It is contraindicated during breastfeeding.\nB: The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for the drug.\nC: Memantine Hydrochloride should be discontinued immediately.\nD: Breastfeeding mothers should double the dosage.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}, {""role"": ""user"", ""content"": ""TASK: Rank the answer options for the following multiple-choice medical question.\nYou are a medical expert.\n\nOUTPUT RULES (STRICT):\n1) Output EXACTLY one line.\n2) The line must contain ONLY the option letters shown below, each EXACTLY ONCE.\n3) Each letter must appear EXACTLY ONCE (no repeats, no omissions).4) Return the ranking of options by likelihood from best to worst.\n5) Use EXACTLY this separator: ' > ' (space, greater-than, space).\n6) Output format MUST be exactly: A > B > C > D\n7) Valid letters: A, B, C, D\nNo explanation.\n\nQUESTION:\nWhat is the recommendation for administering Memantine Hydrochloride to breastfeeding mothers?\nA: It is contraindicated during breastfeeding.\nB: The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for the drug.\nC: Memantine Hydrochloride should be discontinued immediately.\nD: Breastfeeding mothers should double the dosage.\n\nFINAL RANKING:""}, {""role"": ""assistant"", ""content"": ""A > B > C > D""}]"
